MPEP 1400: Difference between revisions

From wikilawschool.net. Wiki Law School does not provide legal advice. For educational purposes only.
No edit summary
 
m (Text replacement - "__TOC__" to "<div class="noautonum">__TOC__</div>")
 
(6 intermediate revisions by the same user not shown)
Line 1: Line 1:
1400 [No Text]
{{MPEP Chapter|1300|1500}}


1400.01Introduction [R-2]
'''<big>Chapter 1400 Correction of Patents</big>'''
 
<div class="noautonum">__TOC__</div>
 
==1400 [No Text]==
 
===1400.01Introduction===


A patent may be corrected or amended in four  
A patent may be corrected or amended in four  
Line 20: Line 26:
MPEP Chapter 2600 for inter partes reexamination.
MPEP Chapter 2600 for inter partes reexamination.


==1401 Reissue==


 
{{Statute|35 U.S.C. 251. Reissue of defective patents.}}
 
 
1401Reissue [R-3]
 
35 U.S.C. 251. Reissue of defective patents.
 
Whenever any patent is, through error without any deceptive  
Whenever any patent is, through error without any deceptive  
intention, deemed wholly or partly inoperative or invalid, by reason  
intention, deemed wholly or partly inoperative or invalid, by reason  
Line 54: Line 54:
claims of the original patent unless applied for within two years  
claims of the original patent unless applied for within two years  
from the grant of the original patent.
from the grant of the original patent.
|}


The provisions of 35 U.S.C. 251 permit the reissue  
The provisions of 35 U.S.C. 251 permit the reissue  
Line 62: Line 64:
directed to reissue.  
directed to reissue.  


1402Grounds for Filing [R-5]
==1402 Grounds for Filing==


A reissue application is filed to correct an error in  
A reissue application is filed to correct an error in  
Line 96: Line 98:
present).
present).


These corrections may be made via a certificate of  
These corrections may be made via a certificate of  
correction; see MPEP § 1481.
correction; see MPEP § 1481.


Line 102: Line 104:
are:
are:


(A)the claims are too narrow or too broad;  
{{Tab1}}(A)the claims are too narrow or too broad; </p>


(B)the disclosure contains inaccuracies;  
{{Tab1}}(B)the disclosure contains inaccuracies; </p>


(C)applicant failed to or incorrectly claimed foreign  
{{Tab1}}(C)applicant failed to or incorrectly claimed foreign priority; and</p>
priority; and


(D)applicant failed to make reference to or incorrectly  
{{Tab1}}(D)applicant failed to make reference to or incorrectly made reference to prior copending applications.</p>
made reference to prior copending applications.


An attorney’s failure to appreciate the full scope of  
An attorney’s failure to appreciate the full scope of  
the invention was held to be an error correctable  
the invention was held to be an error correctable  
through reissue in the decision of In re Wilder,  
through reissue in the decision of In re Wilder,  
736  
736 F.2d 1516, 222 USPQ 369 (Fed. Cir. 1984). The  
F.2d 1516, 222 USPQ 369 (Fed. Cir. 1984). The  
correction of misjoinder of inventors in divisional  
correction of misjoinder of inventors in divisional  
reissues has been held to be a ground for reissue. See  
reissues has been held to be a ground for reissue. See  
Line 138: Line 137:
by filing a request for a certificate of correction under  
by filing a request for a certificate of correction under  
the provisions of 35 U.S.C. 256 and 37 CFR 1.324.  
the provisions of 35 U.S.C. 256 and 37 CFR 1.324.  
See MPEP §
See MPEP § 1412.04 and § 1481. A Certificate of  
1412.04 and § 1481. A Certificate of  
Correction will be issued if all parties are in agreement  
Correction will be issued if all parties are in agreement  
and the inventorship issue is not contested.
and the inventorship issue is not contested.
Line 146: Line 143:
A reissue was granted in Brenner v. State of Israel,  
A reissue was granted in Brenner v. State of Israel,  
400 F.2d 789, 158 USPQ 584 (D.C. Cir. 1968), where  
400 F.2d 789, 158 USPQ 584 (D.C. Cir. 1968), where  
the only ground urged was failure to file a certified  
the only ground urged was failure to file a certified  
copy of the original foreign application to obtain the  
copy of the original foreign application to obtain the  
Line 197: Line 188:
delayed claim under 35 U.S.C. 119(e) would  
delayed claim under 35 U.S.C. 119(e) would  
not be required in addition to filing a reissue application..
not be required in addition to filing a reissue application..


Section 4503 of the American Inventors Protection  
Section 4503 of the American Inventors Protection  
Line 254: Line 244:
within the time period set forth in 37 CFR 1.78(a)(2),  
within the time period set forth in 37 CFR 1.78(a)(2),  
then a petition for an unintentionally delayed benefit  
then a petition for an unintentionally delayed benefit  
claim under 37 CFR 1.78(a)(3) along with the surcharge  
claim under 37 CFR 1.78(a)(3) along with the surcharge  
set forth in 37 CFR 1.17(t) would be required  
set forth in 37 CFR 1.17(t) would be required  
Line 294: Line 278:
one substantive “error ” under 35 U.S.C. 251.
one substantive “error ” under 35 U.S.C. 251.


1403Diligence in Filing [R-3]
==1403 Diligence in Filing==


When a reissue application is filed within 2 years  
When a reissue application is filed within 2 years  
Line 339: Line 323:
1410.01.
1410.01.


1404Submission of Papers Where Reissue  
==1404 Submission of Papers Where Reissue Patent Is in Litigation==
Patent Is in Litigation [R-2]


Marking of envelope: Applicants and protestors  
Marking of envelope: Applicants and protestors  
Line 360: Line 343:
marked “REISSUE LITIGATION” will be given special  
marked “REISSUE LITIGATION” will be given special  
attention and expedited handling. (For IFW processing,  
attention and expedited handling. (For IFW processing,  
see IFW Manual.) See MPEP §
see IFW Manual.) See MPEP § 1442.01through § 1442.04 for examination of litigation-
1442.01through § 1442.04 for examination of litigation-
related reissue applications. Protestor’s participation,  
related reissue applications. Protestor’s participation,  
including the submission of papers, is limited in  
including the submission of papers, is limited in  
accordance with 37 CFR 1.291(c).
accordance with 37 CFR 1.291(c).


 
==1405 Reissue and Patent Term==
 
 
 
 
 
1405Reissue and Patent Term [R-2]


35 U.S.C. 251 prescribes the effect of reissue on the  
35 U.S.C. 251 prescribes the effect of reissue on the  
Line 452: Line 426:
original patent.”
original patent.”


1406Citation and Consideration of  
==1406 Citation and Consideration of References Cited in Original Patent==
References Cited in Original Patent[R-3]


In a reissue application, the examiner should consider  
In a reissue application, the examiner should consider  
Line 462: Line 435:
patent may no longer be relevant, e.g., in view of a  
patent may no longer be relevant, e.g., in view of a  
narrowing of the claim scope in the reissue application.
narrowing of the claim scope in the reissue application.


Should applicants wish to ensure that all of the references  
Should applicants wish to ensure that all of the references  
Line 475: Line 447:
1.98(a)(2) requires
1.98(a)(2) requires


(A)a legible copy of each foreign patent,
(A) a legible copy of each foreign patent,
 
 
 
 


(B)each publication or that portion which caused  
(B) each publication or that portion which caused  
it to be listed,
it to be listed,


(C)each pending unpublished U.S. application  
(C) each pending unpublished U.S. application  
unless the cited pending U.S. application is stored in  
unless the cited pending U.S. application is stored in  
the Image File Wrapper (IFW) system. The requirement  
the Image File Wrapper (IFW) system. The requirement  
Line 498: Line 465:
(Oct. 19, 2004),
(Oct. 19, 2004),


(D)all other information or that portion which  
(D) all other information or that portion which  
caused it to be listed.
caused it to be listed.


See MPEP § 609.04(a). The Office imposes no  
See MPEP § 609.04(a). The Office imposes no  
responsibility on a reissue applicant to resubmit, in a  
responsibility on a reissue applicant to resubmit, in a  
reissue application, all the “References Cited” in the  
reissue application, all the “References Cited” in the  
Line 518: Line 485:
reference has been considered.
reference has been considered.


1410Content of Reissue Application[R-3]
==1410 Content of Reissue Application==
 
37 CFR 1.171. Application for reissue.


{{Statute|37 CFR 1.171. Application for reissue.}}
An application for reissue must contain the same parts required  
An application for reissue must contain the same parts required  
for an application for an original patent, complying with all the  
for an application for an original patent, complying with all the  
Line 527: Line 493:
must comply with the requirements of the rules relating to  
must comply with the requirements of the rules relating to  
reissue applications.
reissue applications.
|}


37 CFR 1.173. Reissue specification, drawings, and
amendments.


(a)Contents of a reissue application. An application for  
{{Statute|37 CFR 1.173. Reissue specification, drawings, and amendments.}}
(a) Contents of a reissue application. An application for  
reissue must contain the entire specification, including the claims,  
reissue must contain the entire specification, including the claims,  
and the drawings of the patent. No new matter shall be introduced  
and the drawings of the patent. No new matter shall be introduced  
Line 539: Line 505:
35 U.S.C. 251.
35 U.S.C. 251.


(1)Specification, including claims. The entire specification,  
<p style="padding-left: +20px;">(1) Specification, including claims. The entire specification,  
including the claims, of the patent for which reissue is  
including the claims, of the patent for which reissue is  
requested must be furnished in the form of a copy of the printed  
requested must be furnished in the form of a copy of the printed  
Line 550: Line 516:
of correction (§§ 1.322 through 1.324), or reexamination certificate  
of correction (§§ 1.322 through 1.324), or reexamination certificate  
(§ 1.570) issued in the patent must be included. (See also §  
(§ 1.570) issued in the patent must be included. (See also §  
1.178).
1.178).</p>


(2)Drawings. Applicant must submit a clean copy of  
<p style="padding-left: +20px;">(2) Drawings. Applicant must submit a clean copy of  
each drawing sheet of the printed patent at the time the reissue  
each drawing sheet of the printed patent at the time the reissue  
application is filed. If such copy complies with § 1.84, no further  
application is filed. If such copy complies with § 1.84, no further  
Line 559: Line 525:
the changes to the drawing must be made in accordance with  
the changes to the drawing must be made in accordance with  
paragraph (b)(3) of this section. The Office will not transfer the  
paragraph (b)(3) of this section. The Office will not transfer the  
drawings from the patent file to the reissue application.
drawings from the patent file to the reissue application.</p>
 
{{Ellipsis}}
|}




Line 588: Line 555:
made either by:
made either by:


(A)physically incorporating the changes within  
(A) physically incorporating the changes within  
the specification by cutting the column of the printed  
the specification by cutting the column of the printed  
patent and inserting the added material and rejoining  
patent and inserting the added material and rejoining  
Line 595: Line 562:
printed patent. Markings pursuant to 37 CFR 1.173(d)  
printed patent. Markings pursuant to 37 CFR 1.173(d)  
must be used to show the changes. The columnar  
must be used to show the changes. The columnar  
structure of the printed patent must be preserved, and  
structure of the printed patent must be preserved, and  
the physically modified page must comply with  
the physically modified page must comply with  
37  
37 CFR 1.52(a)(1). As to compliance with 37 CFR  
CFR 1.52(a)(1). As to compliance with 37 CFR  
1.52(a)(1)(iv), the “written either by a typewriter or  
1.52(a)(1)(iv), the “written either by a typewriter or  
machine printer in permanent dark ink or its equivalent”  
machine printer in permanent dark ink or its equivalent”  
Line 612: Line 572:
typed legibly in the margin; or
typed legibly in the margin; or


(B)providing a separate amendment paper with  
(B) providing a separate amendment paper with  
the reissue application.
the reissue application.


In either case, the amendment must be made pursuant  
In either case, the amendment must be made pursuant  
to 37 CFR 1.173(b) and must comply with all the  
to 37 CFR 1.173(b) and must comply with all the  
provisions of 37 CFR 1.173(b)– (e) and (g).  
provisions of 37 CFR 1.173(b)– (e) and (g).  
Line 657: Line 617:
The initial contents of a  
The initial contents of a  
reissue application are discussed  
reissue application are discussed  
in detail in MPEP §
in detail in MPEP § 1410.01 through § 1418.
1410.01 through § 1418.


For expedited processing, new and continuing reissue  
For expedited processing, new and continuing reissue  
application filings under 37 CFR 1.53(b) may be  
application filings under 37 CFR 1.53(b) may be  
addressed to: Mail Stop REISSUE, Commissioner for  
addressed to: Mail Stop REISSUE, Commissioner for  
Line 689: Line 647:
MPEP § 1410.01.
MPEP § 1410.01.


Form PTO/SB/50, Reissue Patent Application
===1410.01 Reissue Applicant, Oath or Declaration, and Consent of all Assignees===
Transmittal, may be used for filing reissue applications.


{{Statute|37 CFR 1.172. Applicants, assignees.}}
(a) A reissue oath must be signed and sworn to or declaration
made by the inventor or inventors except as otherwise provided
(see §§ 1.42, 1.43, 1.47), and must be accompanied by the
written consent of all assignees, if any, owning an undivided interest
in the patent, but a reissue oath may be made and sworn to or
declaration made by the assignee of the entire interest if the application
does not seek to enlarge the scope of the claims of the original
patent. All assignees consenting to the reissue must establish
their ownership interest in the patent by filing in the reissue application
a submission in accordance with the provisions of § 3.73(b)
of this chapter.


(b) A reissue will be granted to the original patentee, his
legal representatives or assigns as the interest may appear.
|}




{{Statute|37 CFR 3.73. Establishing right of assignee to take action.}}
{{Ellipsis}}
(b)


<p style="padding-left: +20px;">(1) In order to request or take action in a patent or trademark
matter, the assignee must establish its ownership of the
patent or trademark property of paragraph (a) of this section to the
satisfaction of the Director. The establishment of ownership by
the assignee may be combined with the paper that requests or
takes the action. Ownership is established by submitting to the
Office a signed statement identifying the assignee, accompanied
by either:</p>
 
<p style="padding-left: +40px;">(i) Documentary evidence of a chain of title from the
original owner to the assignee (e.g., copy of an executed assignment).
For trademark matters only, the documents submitted to
establish ownership may be required to be recorded pursuant to §
3.11 in the assignment records of the Office as a condition to permitting
the assignee to take action in a matter pending before the
Office. For patent matters only, the submission of the documentary
evidence must be accompanied by a statement affirming that
the documentary evidence of the chain of title from the original
owner to the assignee was or concurrently is being submitted for
recordation pursuant to § 3.11; or</p>
 
<p style="padding-left: +40px;">(ii) A statement specifying where documentary evidence
of a chain of title from the original owner to the assignee is
recorded in the assignment records of the Office (e.g., reel and
frame number).</p>


<p style="padding-left: +20px;">(2) The submission establishing ownership must show
that the person signing the submission is a person authorized to
act on behalf of the assignee by:</p>


<p style="padding-left: +40px;">(i) Including a statement that the person signing the
submission is authorized to act on behalf of the assignee; or</p>


Reissue Patent Application Transmittal
<p style="padding-left: +40px;">(ii) Being signed by a person having apparent authority
PTO/SB/50 (04-05)
to sign on behalf of the assignee, e.g., an officer of the
Approved for use through 04/30/2007. OMB 0651-0033
assignee.</p>
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
REISSUE PATENT APPLICATION TRANSMITTAL
Attorney Docket No.
First Named Inventor
Original Patent Number
Original Patent Issue Date
(Month/Day/Year)
Address to:
Mail Stop Reissue
Commissioner for Patents
P.O. Box 1450
Alexandria, VA 22313-1450Express Mail Label No.
APPLICATION FOR REISSUE OF:
(Check applicable box)
Utility Patent Design Patent Plant Patent
APPLICATION ELEMENTS (37 CFR 1.173) ACCOMPANYING APPLICATION PARTS
Statement of status and support for all
10. changes to the claims. See 37 CFR 1.173(c).
11. Foreign Priority Claim (35 U.S.C. 119)
(if applicable)
12. Information Disclosure Statement (IDS)
PTO/SB/08 or PTO-1449
Copies of foreign patent documents,
publications & other information
13. English Translation of Reissue Oath/Declaration
(if applicable)
14. Preliminary Amendment
Return Receipt Postcard (MPEP 503)
15. (Should be specifically itemized)
16. Other:
1. Fee Transmittal Form (PTO/SB/56)(Submit a duplicate copy)
2. Applicant claims small entity status. See 37 CFR 1.27.
3. Specification and Claims in double column copy of patent format
(amended, if appropriate)
4. Drawing(s) (proposed amendments, if appropriate)
5. Reissue Oath/Declaration (original or copy)
(37 C.F.R. 1.175) (PTO/SB/51 or 52)
6. Power of Attorney7. Original U.S. Patent currently assigned? Yes No
(If Yes, check applicable box(es))
Written Consent of all Assignees (PTO/SB/53)
37 CFR 3.73(b) Statement (PTO/SB/96)
8. CD-ROM or CD-R in duplicate, Computer Program (Appendix)
or large table
Landscape Table on CD
9. Nucleotide and/or Amino Acid Sequence Submission
(if applicable, items a. – c. are required))
a. Computer Readable Form (CRF)
b. Specification Sequence Listing on:
i CD-ROM (2 copies) or CD-R (2 copies); or
ii paper
c. Statements verifying identity of above copies17. CORRESPONDENCE ADDRESS
The address associated withCustomer Number: OR Correspondence address below
Name
Address
City State Zip Code
Country Telephone Email
Signature Date
Name (Print/Type) Registration No. (Attorney/Agent)
This collection of information is required by 37 CFR 1.173. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO
to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 12 minutes to complete,
including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on  
the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
ADDRESS. SEND TO: Mail Stop Reissue,Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
Doc Code:


(c) For patent matters only:


<p style="padding-left: +20px;">(1) Establishment of ownership by the assignee must be
submitted prior to, or at the same time as, the paper requesting or
taking action is submitted.</p>


<p style="padding-left: +20px;">(2) If the submission under this section is by an assignee
of less than the entire right, title and interest, such assignee must
indicate the extent (by percentage) of its ownership interest, or the
Office may refuse to accept the submission as an establishment of
ownership.</p>
|}




The reissue oath must be signed and sworn to by all
the inventors, or declaration made by all the inventors,
except as otherwise provided in 37 CFR 1.42,
1.43, and 1.47 (see MPEP § 409). Pursuant to 37 CFR
1.172, where the reissue application does not seek to
enlarge the scope of any of the claims of the original
patent, the reissue oath may be made and sworn to, or
declaration made, by the assignee of the entire interest.
Depending on the circumstances, either Form
PTO/SB/51, Reissue Application Declaration by the
Inventor, or Form PTO/SB/52, Reissue Application
Declaration by the Assignee, may be used to prepare a
declaration in a reissue application. These forms are
reproduced in MPEP § 1414.


Privacy Act Statment
If an inventor is to be added in a reissue application,  
Privacy Act Statement
a proper reissue oath or declaration including the  
ThePrivacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection
signatures of all of the inventors is required. If one or  
with your submission of the attached form related to a patent application or patent. Accordingly,
more inventors are being deleted in a reissue application,  
pursuant to the requirements of the Act, please be advised that: (1) the general authority for the
an oath or declaration must be supplied over the  
collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary;
signatures of the remaining inventors. Note that
and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
although an inventor being deleted in a reissue application
Office is to process and/or examine your submission related to a patent application or patent. If you do
need not sign the oath or declaration, if that
not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
inventor to be deleted has any ownership interest in  
process and/or examine your submission, which may result in termination of proceedings or
the patent (e.g., that inventor did not assign away his/
abandonment of the application or expiration of the patent.
her rights to the patent), the signature of that inventor
The information provided by you in this form will be subject to the following routine uses:
must be supplied in the consent to filing the reissue
1. The information on this form will be treated confidentially to the extent allowed under the
application. See MPEP § 1412.04 as to correction of  
Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from
inventorship via reissue.
this system of records may be disclosed to the Department of Justice to determine whether
disclosure of these records is required by the Freedom of Information Act.  
2. A record from this system of records may be disclosed, as a routine use, in the course of
presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to
opposing counsel in the course of settlement negotiations.
3. A record in this system of records may be disclosed, as a routine use, to a Member of
Congress submitting a request involving an individual, to whom the record pertains, when the  
individual has requested assistance from the Member with respect to the subject matter of the  
record.  
4. A record in this system of records may be disclosed, as a routine use, to a contractor of the
Agency having need for the information in order to perform a contract. Recipients of
information shall be required to comply with the requirements of the Privacy Act of 1974, as
amended, pursuant to 5 U.S.C. 552a(m).
5. A record related to an International Application filed under the Patent Cooperation Treaty in
this system of records may be disclosed, as a routine use, to the International Bureau of the
World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
6. A record in this system of records may be disclosed, as a routine use, to another federal
agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to
the Atomic Energy Act (42 U.S.C. 218(c)).  
7. A record from this system of records may be disclosed, as a routine use, to the Administrator,
General Services, or his/her designee, during an inspection of records conducted by GSA as
part of that agency’s responsibility to recommend improvements in records management
practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
be made in accordance with the GSA regulations governing inspection of records for this
purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not
be used to make determinations about individuals.
8. A record from this system of records may be disclosed, as a routine use, to the public after
either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
CFR 1.14, as a routine use, to the public if the record was filed in an application which
became abandoned or in which the proceedings were terminated and which application is
referenced by either a published application, an application open to public inspection or an
issued patent.  
9. A record from this system of records may be disclosed, as a routine use, to a Federal, State,
or local law enforcement agency, if the USPTO becomes aware of a violation or potential
violation of law or regulation.  


I.CONSENT TO THE REISSUE


Where no assignee exists, applicant should affirmatively
state that fact. This can be done by simply
checking the “NO” box of item 7 of Form PTO/SB/50
(which form may be signed by the inventors, or by a
registered practitioner). If the file record is silent as to
the existence of an assignee, it will be presumed that
an assignee does exist. This presumption should be
set forth by the examiner in the first Office action
alerting applicant to the requirement. It should be
noted that the mere filing of a written assertion of
small entity status in no way relieves applicant of the
requirement to affirmatively state that no assignee
exists.


Where a written assertion of small entity status, or
other paper in file indicates that the application/patent
is assigned, and there is no consent by the assignee
named in the written assertion of small entity, the
examiner should make inquiry into the matter in an
Office action, even if the record otherwise indicates
that the application/patent is not assigned.


The reissue oath or declaration must be accompanied
by the written consent of all assignees. 35 U.S.C.
111(a) and 37 CFR 1.53(b) provide, however, for
according an application a filing date if filed with a
specification, including claim(s), and any required
drawings. Thus, where an application is filed without
an oath or declaration, or without the consent of all
assignees, if the application otherwise complies with
37 CFR 1.53(b) and the reissue rules, the Office of
Initial Patent Examination (OIPE) will accord a filing
date and send out a notice of missing parts setting a
period of time for filing the missing part and for payment
of any surcharge required under 37 CFR 1.53(f)
and 1.16(f). If the reissue oath or declaration is filed
but the assignee consent is lacking, the surcharge is
required because, until the consent is filed, the reissue
oath or declaration is defective, since it is not apparent
that the signatures thereon are proper absent an indication
that the assignees have consented to the filing.


The consent of assignee must be signed by a party
authorized to act on behalf of the assignee. See MPEP
§ 324 for a discussion of parties authorized to act on
behalf of the assignee.


Where the written consent of all the assignees to the
filing of the reissue application cannot be obtained,
applicant may under appropriate circumstances petition
to the Office of Petitions (MPEP § 1002.02(b))
for a waiver under 37 CFR 1.183 of the requirement
of 37 CFR 1.172, to permit the acceptance of the filing
of the reissue application. The petition fee under
37 CFR 1.17(f) must be included with the petition.


The reissue application can then be examined, but
 
will not be allowed or issued without the consent of
1410.01Reissue Applicant, Oath or  
all the assignees as required by 37 CFR 1.172. See
Declaration, and Consent of all  
Baker Hughes Inc. v. Kirk, 921 F.Supp. 801, 809,
Assignees [R-5]
38 USPQ2d 1885, 1892 (D.D.C. 1995), N. B. Fassett,  
 
1877 C.D. 32, 11 O.G. 420 (Comm’r Pat. 1877);
37 CFR 1.172. Applicants, assignees.
James D. Wright, 1876 C.D. 217, 10 O.G. 587
 
(Comm’r Pat. 1876).
(a)A reissue oath must be signed and sworn to or declaration
made by the inventor or inventors except as otherwise provided
(see
§§
1.42, 1.43, 1.47), and must be accompanied by the
written consent of all assignees, if any, owning an undivided interest
in the patent, but a reissue oath may be made and sworn to or
declaration made by the assignee of the entire interest if the application
does not seek to enlarge the scope of the claims of the original
patent. All assignees consenting to the reissue must establish
their ownership interest in the patent by filing in the reissue application
a submission in accordance with the provisions of §
3.73(b)  
of this chapter.
 
(b)A reissue will be granted to the original patentee, his
legal representatives or assigns as the interest may appear.
 
37 CFR 3.73. Establishing right of assignee to take action.
 
 


(b)(1) In order to request or take action in a patent or trademark
Where a continuation reissue application is filed
matter, the assignee must establish its ownership of the  
with a copy of the assignee consent from the parent
patent or trademark property of paragraph (a) of this section to the  
reissue application, and the parent reissue application
satisfaction of the Director. The establishment of ownership by
is not to be abandoned, the copy of the consent should
the assignee may be combined with the paper that requests or  
not be accepted. Where a divisional reissue application
takes the action. Ownership is established by submitting to the
is filed with a copy of the assignee consent from
Office a signed statement identifying the assignee, accompanied
the parent reissue application, regardless of whether
by either:
or not the parent reissue application is to be abandoned,
the copy of the consent should not be
accepted. The copy of the consent from the parent
does not indicate that the assignee has consented to
the addition of the new invention of the divisional
reissue application to the original patent, or to the
addition of the new error correction of the continuation
reissue application. (Presumably, a new correction
has been added via the continuation, since the
parent is still pending.) As noted above, OIPE will
accord a filing date and send out a notice of missing
parts stating that there is no proper consent and setting
a period of time for filing the missing part and for
payment of any surcharge required under 37 CFR
1.53(f) and 1.16(f)


Where a continuation reissue application is filed
with a copy of the assignee consent from the parent
reissue application, and the parent reissue application
is, or will be abandoned, the copy of the consent
should be accepted by the Office.


II.PROOF OF OWNERSHIP OF ASSIGNEE


(i) Documentary evidence of a chain of title from the
The assignee that consents to the filing of the reissue
original owner to the assignee (e.g., copy of an executed assignment).  
application (as discussed above) must also establish
For trademark matters only, the documents submitted to
that it is the assignee, i.e., the owner, of the
establish ownership may be required to be recorded pursuant to §
patent. See 37 CFR 1.172. Accordingly, a 37 CFR
3.11 in the assignment records of the Office as a condition to permitting
3.73(b) paper establishing the ownership of the  
the assignee to take action in a matter pending before the  
assignee should be submitted at the time of filing the  
Office. For patent matters only, the submission of the documentary
reissue application, in order to support the consent of  
evidence must be accompanied by a statement affirming that
the assignee. The assignee must establish its ownership
the documentary evidence of the chain of title from the original
in accordance with 37 CFR 3.73(b) by:
owner to the assignee was or concurrently is being submitted for
recordation pursuant to § 3.11; or


(ii) A statement specifying where documentary evidence  
(A) filing in the reissue application documentary  
of a chain of title from the original owner to the assignee is
evidence of a chain of title from the original owner to  
recorded in the assignment records of the Office (e.g., reel and
the assignee; or
frame number).


(2)The submission establishing ownership must show
(B) specifying in the record of the reissue application
that the person signing the submission is a person authorized to
where such evidence is recorded in the Office
act on behalf of the assignee by:
(e.g., reel and frame number, etc.).


(i)Including a statement that the person signing the  
Compliance with 37
submission is authorized to act on behalf of the assignee; or
CFR 3.73(b) may be provided
as part of the same paper in which the consent by
assignee is provided.


(ii)Being signed by a person having apparent authority
In connection with option (A) above, the submission
to sign on behalf of the assignee, e.g., an officer of the
of the documentary evidence to establish ownership
assignee.
must be accompanied by a statement affirming
that the documentary evidence of the chain of title
from the original owners to the assignee was, or concurrently
is, submitted for recordation pursuant to 37
CFR 3.11. Thus, when filing a 37 CFR
3.73(b) statement
to establish ownership, an applicant or patent
owner must also submit the relied-upon assignment
document(s) to the Office for recordation, unless such
a submission has already been previously made. If the
37 CFR 3.73(b) statement is not accompanied by a
statement affirming that the documentary evidence
was, or concurrently is, submitted for recordation pursuant
to 37 CFR 3.11, then the 37 CFR
3.73(b) statement will not be accepted, and the assignee(s) will not
have established the right to take action in the patent
application or the patent for which the 37
CFR 3.73(b) statement was submitted. This could
result, for example, in an incomplete response, where
a party stated to be the “assignee” signs a consent to
the reissue to obviate a requirement for submission of  
assignee consent made in an Office action.


(c)For patent matters only:
Upon initial receipt of a reissue application, the
examiner should inspect the application to determine
whether the submission under 37 CFR 1.172 and
37 CFR 3.73(b) establishing the ownership of the
assignee is present and sufficient.


(1)Establishment of ownership by the assignee must be  
If an assignment document is attached with the
submitted prior to, or at the same time as, the paper requesting or
37 CFR 3.73(b) submission, the assignment should be  
taking action is submitted.
reviewed to ensure that the named assignee is the
same for the assignment document and the 37 CFR
3.73(b) statement, and that the assignment document
is an assignment of the patent to be reissued to the  
assignee. If an assignment document is not attached
with the 37 CFR 3.73(b) statement, but rather the reel
and frame number where the assignment document is
recorded in the USPTO is referenced in the 37 CFR
3.73(b) statement, it will be presumed that the assignment
recorded in the USPTO supports the statement
identifying the assignee. It will not be necessary
for the examiner to obtain a copy of the recorded
assignment document.


(2)If the submission under this section is by an assignee
Just as the consent of assignee must be signed by a
of less than the entire right, title and interest, such assignee must  
party authorized to act on behalf of the assignee, the
indicate the extent (by percentage) of its ownership interest, or the  
submission with respect to 37 CFR 3.73(b) to establish
Office may refuse to accept the submission as an establishment of
ownership must be signed by a party authorized
ownership.
to act on behalf of the assignee. The signature of an
attorney or agent registered to practice before the  
Office is not sufficient, unless that attorney or agent is
authorized to act on behalf of the assignee.  


The reissue oath must be signed and sworn to by all
Where the submission establishes the assignee’s
the inventors, or declaration made by all the inventors,  
ownership as to the patent, ownership as to the reissue
except as otherwise provided in 37 CFR 1.42,
application will be presumed. Accordingly, a submission
1.43, and 1.47 (see MPEP § 409). Pursuant to 37 CFR
as to the ownership of the patent will be construed
1.172, where the reissue application does not seek to
to satisfy the 37  
enlarge the scope of any of the claims of the original
CFR1.172 (and 37 CFR
patent, the reissue oath may be made and sworn to, or
3.73(b)) requirements for establishing ownership of
declaration made, by the assignee of the entire interest.  
the application. Thus, a terminal disclaimer can be
Depending on the circumstances, either Form
filed in a reissue application where ownership of the  
PTO/SB/51, Reissue Application Declaration by the  
patent has been established, without the need for a
Inventor, or Form PTO/SB/52, Reissue Application
separate submission under 37 CFR 3.73(b) showing
Declaration by the Assignee, may be used to prepare a
ownership of the reissue application.
declaration in a reissue application. These forms are
reproduced in MPEP § 1414.


If an inventor is to be added in a reissue application,
Even if the submission states that it is establishing
a proper reissue oath or declaration including the
ownership of the reissue application (rather than the  
signatures of all of the inventors is required. If one or
patent), the submission should be accepted by the  
more inventors are being deleted in a reissue application,
examiner as also establishing ownership in the patent.  
an oath or declaration must be supplied over the  
The documentation in the submission establishing
signatures of the remaining inventors. Note that
ownership of the reissue application must, of necessity,
although an inventor being deleted in a reissue application
include chain of title as to the patent.
need not sign the oath or declaration, if that
inventor to be deleted has any ownership interest in  
the patent (e.g., that inventor did not assign away his/
her rights to the patent), the signature of that inventor
must be supplied in the consent to filing the reissue  
application. See MPEP § 1412.04 as to correction of
inventorship via reissue.


I.CONSENT TO THE REISSUE
III.COMPARISON OF ASSIGNEE THAT
 
CONSENTS TO ASSIGNEE SET FORTH
Where no assignee exists, applicant should affirmatively
IN SUBMISSION ESTABLISHING OWNERSHIP
state that fact. This can be done by simply
INTEREST
checking the “NO” box of item 7 of Form PTO/SB/50
(which form may be signed by the inventors, or by a
registered practitioner). If the file record is silent as to
the existence of an assignee, it will be presumed that


The examiner must inspect both the consent and
documentary evidence of ownership to determine
whether the requirements of 37 CFR 1.172 have been
met. The assignee identified by the documentary evidence
must be the same assignee which signed the
consent. Also, the person who signs the consent for
the assignee and the person who signs the submission
of evidence of ownership for the assignee must both
be persons having authority to do so. See also MPEP
§ 324.


The reissue patent will be granted to the original
patentee, his or her legal representatives or assigns as
the interest may appear.


==1411 Form of Specification==


{{Statute|37 CFR 1.173. Reissue specification, drawings, and amendments.}}
(a) Contents of a reissue application. An application for
reissue must contain the entire specification, including the claims,
and the drawings of the patent. No new matter shall be introduced
into the application. No reissue patent shall be granted enlarging
the scope of the claims of the original patent unless applied for
within two years from the grant of the original patent, pursuant to
35 U.S.C. 251.


an assignee does exist. This presumption should be
<p style="padding-left: +20px;">(1) Specification, including claims. The entire specification,
set forth by the examiner in the first Office action
including the claims, of the patent for which reissue is
alerting applicant to the requirement. It should be  
requested must be furnished in the form of a copy of the printed
noted that the mere filing of a written assertion of  
patent, in double column format, each page on only one side of a
small entity status in no way relieves applicant of the  
single sheet of paper. If an amendment of the reissue application is
requirement to affirmatively state that no assignee
to be included, it must be made pursuant to paragraph (b) of this
exists.
section. The formal requirements for papers making up the reissue
application other than those set forth in this section are set out in §
1.52. Additionally, a copy of any disclaimer (§ 1.321), certificate
of correction (§§ 1.322 through 1.324), or reexamination certificate
(§ 1.570) issued in the patent must be included. (See also
§ 1.178).</p>


Where a written assertion of small entity status, or
<p style="padding-left: +20px;">(2) Drawings. Applicant must submit a clean copy of  
other paper in file indicates that the application/patent  
each drawing sheet of the printed patent at the time the reissue
is assigned, and there is no consent by the assignee
application is filed. If such copy complies with § 1.84, no further
named in the written assertion of small entity, the  
drawings will be required. Where a drawing of the reissue application
examiner should make inquiry into the matter in an
is to include any changes relative to the patent being reissued,  
Office action, even if the record otherwise indicates
the changes to the drawing must be made in accordance with
that the application/patent is not assigned.
paragraph (b)(3) of this section. The Office will not transfer the  
drawings from the patent file to the reissue application.</p>
|}


The reissue oath or declaration must be accompanied
by the written consent of all assignees. 35 U.S.C.
111(a) and 37 CFR 1.53(b) provide, however, for
according an application a filing date if filed with a
specification, including claim(s), and any required
drawings. Thus, where an application is filed without
an oath or declaration, or without the consent of all
assignees, if the application otherwise complies with
37 CFR 1.53(b) and the reissue rules, the Office of
Initial Patent Examination (OIPE) will accord a filing
date and send out a notice of missing parts setting a
period of time for filing the missing part and for payment
of any surcharge required under 37 CFR 1.53(f)
and 1.16(f). If the reissue oath or declaration is filed
but the assignee consent is lacking, the surcharge is
required because, until the consent is filed, the reissue
oath or declaration is defective, since it is not apparent
that the signatures thereon are proper absent an indication
that the assignees have consented to the filing.


The consent of assignee must be signed by a party
The file wrappers of all /08 and earlier series reissue
authorized to act on behalf of the assignee. See MPEP
applications are stamped “REISSUE” above the
§ 324 for a discussion of parties authorized to act on  
application number on the front of the file. “Reissue”
behalf of the assignee. The consent to the reissue
also appears below the application number on the
application may use language such as:
printed label on the file wrapper of the application
with 08/ and earlier series.


The XYZ Corporation, assignee of U.S. Patent No.
Reissue applications filed after July of 1998 (09/  
9,999,999, consents to the filing of reissue application No.
series and later) are placed in an orange and white
09/999,999 (or the present application, if filed with the
striped file wrapper and can be easily identified as
initial application papers) for the reissue of U.S. Patent
reissue applications. (For IFW Processing, see IFW
No. 9,999,999.
Manual.)


Reissue applications filed prior to November 7,
2000 should be furnished in the form of cut-up soft
copies of the original patent, with only a single column
of the printed patent securely mounted on a separate
sheet of paper.


_______________
For reissue applications filed on or after November
7, 2000, 37 CFR 1.173(a)(1) requires that the application
specification, including the claims, must be furnished
in the form of a copy of the printed patent in
double column format (so that the patent can be simply
copied without cutting). Applicants are required to
submit a clean copy of each drawing sheet of the
printed patent at the time the reissue application is
filed (37 CFR 1.173(a)(2)). Any changes to the drawings must be made in accordance with 37 CFR
1.173(b)(3). Thus, a full copy of the printed patent
(including the front page) is used to provide the
abstract, drawings, specification, and claims of the
patent for the reissue application. Each page of the
patent must appear on only one side of each individual
page of the specification of the reissue application;
a two-sided copy of the patent is not proper. It
should be noted that a re-typed specification is not
acceptable in a reissue application; the full copy of the
printed patent must be used. If, however, the changes
to be made to the patent are so extensive/numerous
that reading and understanding the specification is
extremely difficult and error-prone, a clean copy of
the specification may be submitted if accompanied by
a grantable petition under 37 CFR 1.183 for waiver of
37 CFR 1.125(d) and 37 CFR 1.173(a)(1).


Pursuant to 37 CFR 1.173(b), amendments may be
made at the time of filing of a reissue application.
The amendment may be made either by:


Lilly M. Schor
(A) physically incorporating the changes within
the specification by cutting the column of the printed
patent and inserting the added material and rejoining
the remainder of the column and then joining the
resulting modified column to the other column of the
printed patent. Markings pursuant to 37 CFR 1.173(d)
must be used to show the changes. The columnar
structure of the printed patent must be preserved, and
the physically modified page must comply with 37
CFR 1.52(a)(1). As to compliance with 37 CFR
1.52(a)(1)(iv), the “written either by a typewriter or
machine printer in permanent dark ink or its equivalent”
requirement is deemed to be satisfied where a
caret and line are drawn from a position within the
text to a newly added phrase, clause, sentence, etc.
typed legibly in the margin; or


(B) providing a preliminary amendment (a separate
amendment paper) directing that specified
changes be made to the copy of the printed patent.


Vice President,
The presentation of the insertions or deletions as
part of the original reissue specification is an amendment
under 37 CFR 1.173(b). An amendment of the
reissue application made at the time of filing of the
reissue application must be made in accordance with
37 CFR 1.173(b)-(e) and (g); see MPEP § 1453. Thus,  
as required by 37 CFR 1.173(c), an amendment of the
claims made at the time of filing of a reissue application
must include a separate paper setting forth the
status of all claims (i.e., pending or canceled), and an
explanation of the support in the disclosure of the
patent for the changes made to the claims.


If a chart, table, or chemical formula is amended
and it spans two columns of the patent, it should not
be split. Rather, the chart, table, or chemical formula
should be provided in its entirety as part of the column
of the patent to which it pertains, in order to provide
a continuity of the description. When doing so,
the chart, table, or chemical formula may extend
beyond the width of the column. Change in only a part
of a word or chemical formula is not permitted. Entire
words or chemical formulas must be shown as being
changed. Deletion of a chemical formula should be
shown by brackets which are substantially larger and
darker than any in the formula.


XYZ Corporation
Where a terminal disclaimer was filed in the application
for the patent to be reissued, a copy of that terminal
disclaimer is not needed in the reissue
application file. For a reissue application that is
maintained in a paper file, the face of the file wrapper
should be marked to indicate that a terminal disclaimer
has been filed for the patent. For a reissue
application that is maintained in IFW, the “Final
SPRE Review” form will be filled in.


Where the written consent of all the assignees to the
Twice reissued patent:
filing of the reissue application cannot be obtained,
applicant may under appropriate circumstances petition
to the Office of Petitions (MPEP § 1002.02(b))
for a waiver under 37 CFR 1.183 of the requirement
of 37 CFR 1.172, to permit the acceptance of the filing
of the reissue application. The petition fee under
37 CFR 1.17(f) must be included with the petition.


The reissue application can then be examined, but
Examples of the form for a twice-reissued patent
will not be allowed or issued without the consent of  
are found in Re. 23,558 and Re. 28,488. Double
all the assignees as required by 37 CFR 1.172. See
underlining and double bracketing are used in the second
Baker Hughes Inc. v. Kirk, 921 F.Supp. 801, 809,
reissue application, while bold-faced type and
38
double bracketing appear in the printed patent (the
USPQ2d 1885, 1892 (D.D.C. 1995), N. B. Fassett,
second reissue patent) to indicate further insertions
1877 C.D. 32, 11 O.G. 420 (Comm’r Pat. 1877);
and deletions, respectively, in the second reissue
James D. Wright, 1876 C.D. 217, 10 O.G. 587
patent.
(Comm’r Pat. 1876).


Where a continuation reissue application is filed
When a copy of a first reissue patent is used as the  
with a copy of the assignee consent from the parent
specification of a second reissue application (filed as
reissue application, and the parent reissue application
a reissue of a reissue), additions made by the first reissue  
is not to be abandoned, the copy of the consent should
will already be printed in italics, and should  
not be accepted. Where a divisional reissue application  
remain in such format. Thus, applicants need only
is filed with a copy of the assignee consent from
present additions to the specification/claims in the  
the parent reissue application, regardless of whether
second reissue application as double underlined text.  
or not the parent reissue application is to be abandoned,  
Subject matter to be deleted from the first reissue  
the copy of the consent should not be
patent should be presented in the second reissue application  
accepted. The copy of the consent from the parent
within sets of double brackets.  
does not indicate that the assignee has consented to
the addition of the new invention of the divisional
reissue application to the original patent, or to the  
addition of the new error correction of the continuation
reissue application. (Presumably, a new correction
has been added via the continuation, since the
parent is still pending.) As noted above, OIPE will
accord a filing date and send out a notice of missing
parts stating that there is no proper consent and setting
a period of time for filing the missing part and for
payment of any surcharge required under 37 CFR
1.53(f) and 1.16(f)
 
Where a continuation reissue application is filed
with a copy of the assignee consent from the parent
reissue application, and the parent reissue application  
is, or will be abandoned, the copy of the consent
should be accepted by the Office.


===1411.01 Certificate of Correction or Disclaimer in Original Patent===


The applicant should include any changes, additions,
or deletions that were made by a Certificate of
Correction to the original patent grant in the reissue
application without underlining or bracketing. The
examiner should  make certain that all Certificate of
Correction changes in the patent have been properly
incorporated into the reissue application.


Certificate of Correction changes and disclaimer of
claim(s) under 37 CFR 1.321(a) should be made without
using underlining or brackets. Since these are part
of the original patent and were made before the reissue
was filed, they should show up in the printed reissue
patent document as part of the original patent,
i.e., not in italics or bracketed. If the changes are
extensive and/or applicant has submitted them
improperly with underlining and brackets, a clean
copy of the specification with the Certificate of Correction
changes in it may be requested by the examiner.
In order for the clean copy to be entered as a
substitute specification, the reissue applicant must file
a grantable petition under 37 CFR 1.183 for waiver of
37 CFR 1.125(d) and 37 CFR 1.173(a)(1). The examiner’
s request for the clean copy will generally serve
as sufficient basis for granting the petition.


===1411.02 New Matter===


Form paragraph 14.15 may be used to indicate that  
New matter, that is, matter not present in the patent
the consent of the assignee is lacking.
sought to be reissued, is excluded from a reissue
application in accordance with 35 U.S.C. 251.


¶ 14.15 Consent of Assignee to Reissue Lacking
The claims in the reissue application must be for
subject matter which the applicant had the right to
claim in the original patent. Any change in the patent
made via the reissue application should be checked to
ensure that it does not introduce new matter. Note that
new matter may exist by virtue of the omission of a
feature or of a step in a method. See United States
Industrial Chemicals, Inc. v. Carbide & Carbon
Chemicals Corp., 315 U.S. 668, 53 USPQ 6 (1942).


This application is objected to under 37 CFR 1.172(a) as lacking
==1412 Content of Claims==
the written consent of all assignees owning an undivided interest
in the patent. The consent of the assignee must be in
compliance with 37 CFR 1.172. See MPEP § 1410.01.


A proper assent of the assignee in compliance with 37 CFR
The content of claims in a reissue application is
1.172 and 3.73 is required in reply to this Office action.
somewhat limited, as is indicated in MPEP § 1412.01through MPEP § 1412.03.


Examiner Note:
1412.01Reissue Claims Must Be for
Same General Invention [R-2]


1.This form paragraph may be used in an Office action which
The reissue claims must be for the same invention
rejects any of the claims on other grounds.
as that disclosed as being the invention in the
original patent, as required by 35 U.S.C. 251. This  
does not mean that the invention claimed in the reissue
must have been claimed in the original patent,
although this is evidence that applicants considered it
their invention. The entire disclosure, not just the
claim(s), is considered in determining what the patentee
objectively intended as his or her invention. The
proper test as to whether reissue claims are for the
same invention as that disclosed as being the invention
in the original patent is “an essentially factual
inquiry confined to the objective intent manifested by
the original patent.” In re Amos, 953 F.2d 613, 618,
21 USPQ2d 1271, 1274 (Fed. Cir. 1991) (quoting In
re Rowand, 526 F.2d 558, 560, 187 USPQ 487, 489
(CCPA 1975)) (emphasis added). See also In re Mead,
581 F.2d 257, 198 USPQ 412 (CCPA 1978). The
“original patent” requirement of 35 U.S.C. 251 must
be understood in light of In re Amos, supra, where the
Court of Appeals for the Federal Circuit stated:


2.If a consent document/statement has been submitted but is
We conclude that, under both Mead and Rowand, a claim
insufficient (e.g., not by all the assignees) or is otherwise ineffective
submitted in reissue may be rejected under the “original
(e.g., a conditional consent, or a copy of the consent from the
patent” clause if the original specification demonstrates,
parent reissue application was filed in this continuation reissue
to one skilled in the art, an absence of disclosure sufficient
application and the parent reissue application is not being abandoned),
to indicate that a patentee could have claimed the subject
an explanation of such is to be included following this
matter. Merely finding that the subject matter was “not
form paragraph.
originally claimed, not an object of the original patent,
and not depicted in the drawing,” does not answer the
essential inquiry under the “original patent” clause of §
251, which is whether one skilled in the art, reading the


3.If the case is otherwise ready for allowance, this form paragraph
should be followed by form paragraph 7.51 (insert the
phrase --See above-- in bracket 1 of form paragraph 7.51).


II.PROOF OF OWNERSHIP OF ASSIGNEE


The assignee that consents to the filing of the reissue
application (as discussed above) must also establish
that it is the assignee, i.e., the owner, of the
patent. See 37 CFR 1.172. Accordingly, a 37 CFR
3.73(b) paper establishing the ownership of the
assignee should be submitted at the time of filing the
reissue application, in order to support the consent of
the assignee. The assignee must establish its ownership
in accordance with 37 CFR 3.73(b) by:


(A)filing in the reissue application documentary
evidence of a chain of title from the original owner to
the assignee; or


(B)specifying in the record of the reissue application
specification, would identify the subject matter of the new
where such evidence is recorded in the Office
claims as invented and disclosed by the patentees. In
(e.g., reel and frame number, etc.).  
short, the absence of an “intent,” even if objectively evident
from the earlier claims, the drawings, or the original
objects of the invention is simply not enough to establish
that the new claims are not drawn to the invention disclosed
in the original patent.
 
953 F.2d at 618-19, 21 USPQ2d at 1275. Claims presented
in a reissue application are considered to satisfy
the requirement of 35 U.S.C. 251 that the claims
be “for the invention disclosed in the original patent”
where:


Compliance with 37
(A)the claims presented in the reissue application
CFR 3.73(b) may be provided
are described in the original patent specification and
as part of the same paper in which the consent by  
enabled by the original patent specification such that
assignee is provided.
35 U.S.C. 112 first paragraph is satisfied; and


In connection with option (A) above, the submission
(B)nothing in the original patent specification
of the documentary evidence to establish ownership
indicates an intent not to claim the subject matter of
must be accompanied by a statement affirming
the claims presented in the reissue application.
that the documentary evidence of the chain of title
from the original owners to the assignee was, or concurrently
is, submitted for recordation pursuant to 37
CFR
3.11. Thus, when filing a 37 CFR
3.73(b) statement
to establish ownership, an applicant or patent
owner must also submit the relied-upon assignment
document(s) to the Office for recordation, unless such
a submission has already been previously made. If the
37 CFR
3.73(b) statement is not accompanied by a
statement affirming that the documentary evidence
was, or concurrently is, submitted for recordation pursuant
to 37 CFR
3.11, then the 37 CFR
3.73(b) statement
will not be accepted, and the assignee(s) will not
have established the right to take action in the patent
application or the patent for which the 37
CFR
3.73(b) statement was submitted. This could
result, for example, in an incomplete response, where
a party stated to be the “assignee” signs a consent to
the reissue to obviate a requirement for submission of
assignee consent made in an Office action.


Upon initial receipt of a reissue application, the  
The presence of some disclosure (description
examiner should inspect the application to determine
and enablement) in the original patent should evidence
whether the submission under 37 CFR 1.172 and
that applicant intended to claim or that applicant
37
considered the material now claimed to be his or
CFR 3.73(b) establishing the ownership of the
her invention.  
assignee is present and sufficient.  


If an assignment document is attached with the
The original patent specification would indicate an  
37
intent not to claim the subject matter of the claims
CFR 3.73(b) submission, the assignment should be
presented in the reissue application in a situation analogous
reviewed to ensure that the named assignee is the
to the following:
same for the assignment document and the 37 CFR
3.73(b) statement, and that the assignment document
is an assignment of the patent to be reissued to the
assignee. If an assignment document is not attached
with the 37 CFR 3.73(b) statement, but rather the reel
and frame number where the assignment document is
recorded in the USPTO is referenced in the 37 CFR
3.73(b) statement, it will be presumed that the assignment
recorded in the USPTO supports the statement
identifying the assignee. It will not be necessary
for
the examiner to obtain a copy of the recorded
assignment document. If the submission under
37
CFR 1.172 and 37 CFR 3.73(b) is not present,
form paragraph 14.16 may be used to indicate that the  
assignee has not provided evidence of ownership.


¶ 14.16 Failure of Assignee To Establish Ownership
The original patent specification discloses that
composition X is not suitable (or not satisfactory) for
molding an item because composition X fails to provide
quick drying. After the patent issues, it is found
that composition X would be desirable for the molding
in spite of the failure to provide quick drying,
because of some other newly recognized benefit from
composition X. A claim to composition X or a method
of use thereof would not be permitted in a reissue
application, because the original patent specification
contained an explicit statement of intent not to claim
composition X or a method of use thereof.


This application is objected to under 37 CFR 1.172(a) as the  
In most instances, however, the mere failure to  
assignee has not established its ownership interest in the patent for  
claim a disclosed embodiment in the original patent
which reissue is being requested. An assignee must establish its
(absent an explicit statement in the original patent  
ownership interest in order to support the consent to a reissue  
specification of unsuitability of the embodiment)
application required by 37 CFR 1.172(a). The assignee’s ownership
would not be grounds for prohibiting a claim to that
interest is established by:
embodiment in the reissue.


FAILURE TO TIMELY FILE A DIVISIONAL
APPLICATION PRIOR TO ISSUANCE OF
ORIGINAL PATENT


Where a restriction requirement was made in an
application and applicant permitted the elected invention
to issue as a patent without the filing of a divisional
application on the non-elected invention(s), the
non-elected invention(s) cannot be recovered by filing
a reissue application. A reissue applicant’ s failure to
timely file a divisional application covering the non-
elected invention(s) in response to a restriction
requirement is not considered to be error causing a
patent granted on the elected claims to be partially
inoperative by reason of claiming less than the applicant
had a right to claim. Accordingly, such error is
not correctable by reissue of the original patent under
35 U.S.C. 251. In re Watkinson, 900 F.2d 230, 14
USPQ2d 1407 (Fed. Cir. 1990); In re Orita, 550 F.2d
1277, 1280, 193 USPQ 145, 148 (CCPA 1977). See
also In re Mead, 581 F.2d 251, 198 USPQ 412 (CCPA
1978). In this situation, the reissue claims should be
rejected under 35 U.S.C. 251 for lack of defect in the
original patent and lack of error in obtaining the original
patent. Compare with In re Doyle, 293 F.3d 1355,
63 USPQ2d 1161 (Fed. Cir. 2002) where the court
permitted the patentee to file a reissue application to
present a so-called linking claim, a claim broad
enough to read on or link the invention elected (and
patented) together with the invention not elected. The
non-elected invention(s) were inadvertently not filed
as a divisional application.


1412.02Recapture of Canceled SubjectMatter [R-5]


A reissue will not be granted to “recapture” claimed
subject matter which was surrendered in an application
to obtain the original patent. North American
Container, Inc. v. Plastipak Packaging, Inc., 415 F.3d
1335, 75 USPQ2d 1545 (Fed. Cir. 2005, Pannu v.
Storz Instruments Inc., 258 F.3d 1366, 59 USPQ2d
1597 (Fed. Cir. 2001); Hester Industries, Inc. v. Stein,
Inc., 142 F.3d 1472, 46 USPQ2d 1641 (Fed. Cir.
1998); In re Clement, 131 F.3d 1464, 45 USPQ2d
1161 (Fed. Cir. 1997); Ball Corp. v. United States, 729
F.2d 1429, 1436, 221 USPQ 289, 295 (Fed. Cir.
1984); In re Wadlinger, 496 F.2d 1200, 181 USPQ
826 (CCPA 1974); In re Richman, 409 F.2d 269, 276,


(a) filing in the reissue application evidence of a chain of title
from the original owner to the assignee, or


(b) specifying in the record of the reissue application where
such evidence is recorded in the Office (e.g., reel and frame number,
etc.).


The submission with respect to (a) and (b) to establish ownership
must be signed by a party authorized to act on behalf of the
assignee. See MPEP § 1410.01.


An appropriate paper satisfying the requirements of 37 CFR
3.73 must be submitted in reply to this Office action.


Examiner Note:
161 USPQ 359, 363-364 (CCPA 1969); In re Willingham,
282
F.2d 353, 127 USPQ 211 (CCPA 1960).


1.This form paragraph may be used in an Office action which
I.THREE STEP TEST FOR RECAPTURE:
rejects any of the claims on other grounds.


2.If otherwise ready for allowance, this form paragraph should
In Clement, 131 F.3d at 1468-70, 45 USPQ2d at
be followed by form paragraph 7.51 (insert the phrase --See
1164-65, the Court of Appeals for the Federal Circuit
above-- in bracket 1 of form paragraph 7.51).
set forth a three step test for recapture analysis. In
Pannu, 258 F.3d at 1371, 59 USPQ2d at 1600, the
court restated this test as follows:


Just as the consent of assignee must be signed by a
Application of the recapture rule is a three-step process.
party authorized to act on behalf of the assignee, the
submission with respect to 37 CFR 3.73(b) to establish
ownership must be signed by a party authorized
to act on behalf of the assignee. The signature of an
attorney or agent registered to practice before the
Office is not sufficient, unless that attorney or agent is
authorized to act on behalf of the assignee.  


If the submission under 37 CFR 3.73(b) to establish
ownership is not signed by a party authorized to act
on behalf of the assignee, the appropriate paragraphs
of form paragraphs 14.16.01 through 14.16.06 may be
used.


The first step is to ‘determine whether and in what aspect
the reissue claims are broader than the patent claims.’....


‘The second step is to determine whether the broader
aspects of the reissued claim related to surrendered subject
matter’ ....


¶ 14.16.01 Establishment of Ownership Not Signed by
Finally, the court must determine whether the reissued
Appropriate Party
claims were materially narrowed in other respects to avoid
the recapture rule. [Emphasis added]


This application is objected to under 37 CFR 1.172(a) as the
A.The First Step - Was There Broadening?
assignee has not established its ownership interest in the patent for
which reissue is being requested. An assignee must establish its
ownership interest in order to support the consent to a reissue
application required by 37 CFR 1.172(a). The submission establishing
the ownership interest of the assignee is informal. There is
no indication of record that the party who signed the submission is
an appropriate party to sign on behalf of the assignee. 37 CFR
3.73(b)


A proper submission establishing ownership interest in the  
In every reissue application, the examiner must first
patent, pursuant to 37 CFR 1.172(a), is required in response to this
review each claim for the presence of broadening, as
action.
compared with the scope of the claims of the patent to
be reissued. A reissue claim is broadened where some
limitation of the patent claims is no longer required in  
the reissue claim; see MPEP § 1412.03 for guidance
as to the nature of a “broadening claim.” If the reissue
claim is not broadened in any respect as compared to  
the patent claims, the analysis ends; there is no recapture.


Examiner Note:


1.This form paragraph should be followed: by one of form
B.The Second Step - Does Any Broadening
paragraphs 14.16.02 through 14.16.04, and then optionally by
Aspect of the Reissued Claim Relate to
form paragraph 14.16.06.
Surrendered Subject Matter?


2.See MPEP § 1410.01.
Where a claim in a reissue application is broadened
 
in some respect as compared to the patent claims, the
 
examiner must next determine whether the broadening
 
aspect(s) of that reissue claim relate(s) to subject
¶ 14.16.02 Failure To State Capacity To Sign
matter that applicant previously surrendered during
 
the prosecution of the original application (which
The person who signed the submission establishing ownership
became the patent to be reissued). Each limitation of
interest has failed to state his/her capacity to sign for the corporation
the patent claims, which is omitted or broadened in
or other business entity, and he/she has not been established
the reissue claim, must be reviewed for this determination.  
as being authorized to act on behalf of the assignee. See MPEP §
This involves two sub-steps:
324.


Examiner Note:
1.The Two Sub-Steps:


1.This form paragraph is to be used when the person signing
(A)It must first be determined whether there was
the submission establishing ownership interest does not state his/
any surrender of subject matter made in the prosecution
her capacity (e.g., as a recognized officer) to sign for the assignee,
of the original application which became the  
and is not established as being authorized to act on behalf of the
patent to be reissued.
assignee.


2.Use form paragraph 14.16.06 to explain how an official,
If an original patent claim limitation now being
other than a recognized officer, may properly sign a submission
omitted or broadened in the present reissue application
establishing ownership interest.  
was originally relied upon by applicant in the
original application to make the claims allowable over
the art, the omitted limitation relates to subject matter
previously surrendered by applicant. The reliance by
applicant to define the original patent claims over the
art can be by way of presentation of new/amended
claims to define over the art, or an argument/statement
by applicant that a limitation of the claim(s)
defines over the art. To determine whether such reliance
occurred, the examiner must review the prosecution
history of the original application file (of the
patent to be reissued) for recapture. The prosecution
history includes the rejections and applicant’s arguments
made therein.


¶ 14.16.03 Lack of Capacity To Sign
If there was no surrender of subject matter made
in the prosecution of the original application, again
the analysis ends and there is no recapture.


The person who signed the submission establishing ownership
(B)If there was a surrender of subject matter in
interest is not recognized as an officer of the assignee, and he/she
the original application prosecution, it must then be
has not been established as being authorized to act on behalf of the  
determined whether any of the broadening of the reissue
assignee. See MPEP § 324.
claims is in the area of the surrendered subject
matter. All of the broadening aspects of reissue claims
must be analyzed to determine if any of the omitted/
broadened limitation(s) are directed to limitations
relied upon by applicant in the original application to
make the claims allowable over the art.


¶ 14.16.04 Attorney/Agent of Record Signs
2.Examples of the Pannu Second Step Analysis:


The submission establishing ownership interest was signed by
applicant’s [1]. An attorney or agent of record is not authorized to
sign a submission establishing ownership interest, unless he/she
has been established as being authorized to act on behalf of the
assignee. See MPEP § 324.


Examiner Note:
(A)Example (1) - Argument without amendment:


1.This form paragraph is to be used when the person signing
In Hester, supra, the Federal Circuit held that the  
the submission establishing ownership interest is an attorney or
surrender which forms the basis for impermissible
agent of record who is not an authorized officer as defined in  
recapture “can occur through arguments alone”.
MPEP § 324 and has not been established as being authorized to  
142
act on behalf of the assignee.
F.3d at 1482, 46 USPQ2d at 1649. For example,
assume that limitation A of the patent claims is omitted
in the reissue claims. This omission provides a
broadening aspect in the reissue claims, as compared
to the claims of the patent. If the omitted limitation A
was argued in the original application to make the
application claims allowable over the art in the appli


2.Use form paragraph 14.16.06 to explain how an official,
other than a recognized officer, may properly sign a submission
establishing ownership interest.
3.In bracket 1, insert either --attorney-- or --agent--.
¶ 14.16.06 Criteria To Accept When Signed by a Non-
Recognized Officer
It would be acceptable for a person, other than a recognized
officer, to sign a submission establishing ownership interest, provided
the record for the application includes a duly signed statement
that the person is empowered to sign a submission
establishing ownership interest and/or act on behalf of the
assignee.
Accordingly, a new submission establishing ownership interest
which includes such a statement above, will be considered to be
signed by an appropriate official of the assignee. A separately
filed paper referencing the previously filed submission establishing
ownership interest and containing a proper empowerment
statement would also be acceptable.
Examiner Note:
1.This form paragraph MUST be preceded by form paragraphs
14.16.02, 14.16.03 or 14.16.04.




Line 1,349: Line 1,447:
   
   


2.When one of form paragraphs 14.16.02, 14.16.03 or 14.16.04is used to indicate that a submission establishing ownership interest
cation, then the omitted limitation relates to subject
is not proper because it was not signed by a recognized officer,  
matter previously surrendered in the original application,
this form paragraph should be used to point out one way to correct
and recapture will exist. Accordingly, where
the problem.
claims are broadened in a reissue application, the
examiner should review the prosecution history of the
original patent file for recapture, even where the
claims were never amended during the prosecution of
the application which resulted in the patent.


3.While an indication of the person’s title is desirable, its inclusion
Note: The argument that the claim limitation
is not mandatory when this option is employed.
defined over the rejection must have been specific as
to the limitation relied upon, rather than a general
statement regarding the claims as a whole. A general
'boiler plate' sentence in the original application will
not, by itself, be sufficient to establish surrender and
recapture.


Where the submission establishes the assignee’s
An example of a general “boiler plate” sentence of
ownership as to the patent, ownership as to the reissue
argument is:
application will be presumed. Accordingly, a submission
 
as to the ownership of the patent will be construed
“In closing, it is argued that the limitations of claims 1-7
to satisfy the 37
distinguish the claims from the teachings of the prior art,  
CFR1.172 (and 37 CFR
and claims 1-7 are thus patentable.
3.73(b)) requirements for establishing ownership of
the application. Thus, a terminal disclaimer can be
filed in a reissue application where ownership of the  
patent has been established, without the need for a
separate submission under 37 CFR 3.73(b) showing
ownership of the reissue application.


Even if the submission states that it is establishing
An argument that merely states that all the limitations
ownership of the reissue application (rather than the  
of the claims define over the prior art will also
patent), the submission should be accepted by the
not, by itself, be sufficient to establish surrender and
examiner as also establishing ownership in the patent.
recapture. An example is:
The documentation in the submission establishing
ownership of the reissue application must, of necessity,  
include chain of title as to the patent.


III.COMPARISON OF ASSIGNEE THAT
“Claims 1-5 set forth a power-train apparatus which comprises
CONSENTS TO ASSIGNEE SET FORTH
the combination of A+B+C+D+E. The prior art of
IN SUBMISSION ESTABLISHING OWNERSHIP
record does not disclose or render obvious a motivation to
INTEREST
provide for a material-transfer apparatus as defined by the
limitations of claim 1, including an A member and a B
member, both connected to a C member, with all three
being aligned with the D and E members.”


The examiner must inspect both the consent and
This statement is simply a restatement of the  
documentary evidence of ownership to determine
entirety of claim 1 as allowed. No measure of surrender
whether the requirements of 37 CFR 1.172 have been
could be gleaned from such a statement of reasons
met. The assignee identified by the documentary evidence
for allowance. See Ex parte Yamaguchi, 61 USPQ2d
must be the same assignee which signed the  
1043 (Bd. Pat. App. & Inter. 2001)(reported but
consent. Also, the person who signs the consent for
unpublished, precedential).
the assignee and the person who signs the submission
 
of evidence of ownership for the assignee must both
In both of the above examples, the argument does
be persons having authority to do so. See also MPEP
not provide an indication of what specific limitations,
§ 324.
e.g., specific element or step of the claims, cooperative
effect, or other aspect of the claims, are being
relied upon for patentability. Thus, applicant has not
surrendered anything.


The reissue patent will be granted to the original
(B)Example (2) - Amendment of the claims without
patentee, his or her legal representatives or assigns as
argument:
the interest may appear.


1411Form of Specification [R-3]
The limitation omitted in the reissue claim(s) was
added in the original application claims for the purpose
of making the application claims allowable over
a rejection or objection made in the application. Even
though applicant made no argument on the record that
the limitation was added to obviate the rejection, the
nature of the addition to the claim can show that the
limitation was added in direct reply to the rejection.
This too will establish the omitted limitation as relating
to subject matter previously surrendered. To illustrate
this, note the following example:


37 CFR 1.173. Reissue specification, drawings, and
The original application claims recite limitations A+B+C,
amendments.
and the Office action rejection combines two references to
show A+B+C. In the amendment replying to the Office
action, applicant adds limitation D to A+B+C in the
claims, but makes no argument as to that addition. The
examiner then allows the claims. Even though there is no
argument as to the addition of limitation D, it must be presumed
that the D limitation was added to obviate the
rejection. The subsequent deletion of (omission of) limitation
D in the reissue claims would be presumed to be a
broadening in an aspect of the reissue claims related to
surrendered subject matter. Accordingly, the reissued
claims would be barred by the recapture doctrine.


(a)Contents of a reissue application. An application for
The above result would be the same whether the  
reissue must contain the entire specification, including the claims,
addition of limitation D in the original application  
and the drawings of the patent. No new matter shall be introduced
was by way of applicant’s amendment or by way of an
into the application. No reissue patent shall be granted enlarging
examiner’s amendment with authorization by applicant.
the scope of the claims of the original patent unless applied for
within two years from the grant of the original patent, pursuant to
35 U.S.C. 251.


(1)Specification, including claims. The entire specification,
including the claims, of the patent for which reissue is
requested must be furnished in the form of a copy of the printed
patent, in double column format, each page on only one side of a
single sheet of paper. If an amendment of the reissue application is
to be included, it must be made pursuant to paragraph (b) of this
section. The formal requirements for papers making up the reissue
application other than those set forth in this section are set out in §
1.52. Additionally, a copy of any disclaimer (§ 1.321), certificate
of correction (§§ 1.322 through 1.324), or reexamination certificate
(§ 1.570) issued in the patent must be included. (See also
§
1.178).


(2)Drawings. Applicant must submit a clean copy of
(C)Example (3) - Who can make the surrendering
each drawing sheet of the printed patent at the time the reissue
argument?
application is filed. If such copy complies with § 1.84, no further
drawings will be required. Where a drawing of the reissue application
is to include any changes relative to the patent being reissued,
the changes to the drawing must be made in accordance with
paragraph (b)(3) of this section. The Office will not transfer the  
drawings from the patent file to the reissue application.


Assume that the limitation A omitted in the reissue
claims was present in the claims of the original application.
The examiner’s reasons for allowance in the
original application stated that it was that limitation A
which distinguished over a potential combination of
references X and Y. Applicant did not present on the
record a counter statement or comment as to the
examiner’s reasons for allowance, and permitted the
claims to issue.


 
Ex parte Yamaguchi, supra, held that a surrender of  
The file wrappers of all /08 and earlier series reissue
claimed subject matter cannot be based solely upon an  
applications are stamped “REISSUE” above the
applicant’s failure to respond to, or failure to challenge,  
application number on the front of the file. “Reissue”
an examiner’s statement made during the prosecution
also appears below the application number on the
of an application. Applicant is bound only by
printed label on the file wrapper of the application
applicant’s revision of the application claims or a positive
with 08/ and earlier series.
argument/statement by applicant. An applicant’s
 
failure to present on the record a counter statement or
Reissue applications filed after July of 1998 (09/
series and later) are placed in an orange and white
striped file wrapper and can be easily identified as
reissue applications. (For IFW Processing, see IFW
Manual.)
 
Reissue applications filed prior to November 7,  
2000 should be furnished in the form of cut-up soft
copies of the original patent, with only a single column
of the printed patent securely mounted on a separate
sheet of paper.
 
For reissue applications filed on or after November
7, 2000, 37 CFR 1.173(a)(1) requires that the application  
specification, including the claims, must be furnished
in the form of a copy of the printed patent in
double column format (so that the patent can be simply
copied without cutting). Applicants are required to  
submit a clean copy of each drawing sheet of the
printed patent at the time the reissue application is
filed (37 CFR 1.173(a)(2)). Any changes to the draw
 




Line 1,472: Line 1,560:
   
   


ings must be made in accordance with 37 CFR
comment as to an examiner’s reasons for allowance
1.173(b)(3). Thus, a full copy of the printed patent
does not give rise to any implication that applicant
(including the front page) is used to provide the  
agreed with or acquiesced in the examiner’s reasoning
abstract, drawings, specification, and claims of the
for allowance. Thus, the failure to present a counter
patent for the reissue application. Each page of the
statement or comment as to the examiner’s statement
patent must appear on only one side of each individual
of reasons for allowance does not give rise to any
page of the specification of the reissue application;
finding of surrender. The examiner’s statement of  
a two-sided copy of the patent is not proper. It
reasons for allowance in the original application  
should be noted that a re-typed specification is not
cannot, by itself, provide the basis for establishing
acceptable in a reissue application; the full copy of the
surrender and recapture.  
printed patent must be used. If, however, the changes
to be made to the patent are so extensive/numerous
that reading and understanding the specification is
extremely difficult and error-prone, a clean copy of
the specification may be submitted if accompanied by
a grantable petition under 37 CFR 1.183 for waiver of
37 CFR 1.125(d) and 37 CFR 1.173(a)(1).  


Pursuant to 37 CFR 1.173(b), amendments may be
It is only in the situation where applicant does file
made at the time of filing of a reissue application.  
comments on the statement of reasons for allowance,
The amendment may be made either by:
that surrender may have occurred. Note the following
two scenarios in which an applicant files comments:


(A)physically incorporating the changes within
Scenario 1- There is Surrender: The examiner’s statement
the specification by cutting the column of the printed
of reasons for allowance in the original application stated
patent and inserting the added material and rejoining
that it was limitation C (of the combination of ABC)
the remainder of the column and then joining the
which distinguished over a potential combining of references
resulting modified column to the other column of the
X and Y, in that limitation C provided increased
printed patent. Markings pursuant to 37 CFR 1.173(d)
speed to the process. Applicant filed comments on the  
must be used to show the changes. The columnar
examiner’s statement of reasons for allowance essentially
structure of the printed patent must be preserved, and
supporting the examiner’ s reasons. The limitation C is
the physically modified page must comply with 37
thus established as relating to subject matter previously
CFR 1.52(a)(1). As to compliance with 37 CFR
surrendered.
1.52(a)(1)(iv), the “written either by a typewriter or
machine printer in permanent dark ink or its equivalent”
requirement is deemed to be satisfied where a
caret and line are drawn from a position within the
text to a newly added phrase, clause, sentence, etc.  
typed legibly in the margin; or


(B)providing a preliminary amendment (a separate
Scenario 2- There is No Surrender: On the other hand, if
amendment paper) directing that specified
applicant’s comments on the examiner’s statement of reasons
changes be made to the copy of the printed patent.
for allowance contain a counter statement that it is limitation
B (of the combination of ABC), rather than C, which
distinguishes the claims over the art, then limitation B  
would constitute surrendered subject matter, and limitation
C has not been surrendered.
 
C.The Third Step - Were the reissued claims
materially narrowed in other respects to  
compensate for the broadening in the area of  
surrender, and thus avoid the recapture rule?


The presentation of the insertions or deletions as
As pointed out above, the third prong of the recapture
part of the original reissue specification is an amendment
determination set forth in Pannu is directed to
under 37 CFR 1.173(b). An amendment of the  
analysis of the broadening and narrowing effected via
reissue application made at the time of filing of the  
the reissue claims, and of the significance of the claim
reissue application must be made in accordance with
limitations added and deleted, using the prosecution
37 CFR 1.173(b)-(e) and (g); see MPEP § 1453. Thus,
history of the patent (to be reissued), to determine
as required by 37 CFR 1.173(c), an amendment of the  
whether the reissue claims should be barred as recapture.
claims made at the time of filing of a reissue application
must include a separate paper setting forth the  
status of all claims (i.e., pending or canceled), and an
explanation of the support in the disclosure of the
patent for the changes made to the claims.


If a chart, table, or chemical formula is amended
and it spans two columns of the patent, it should not
be split. Rather, the chart, table, or chemical formula
should be provided in its entirety as part of the column
of the patent to which it pertains, in order to provide
a continuity of the description. When doing so,
the chart, table, or chemical formula may extend
beyond the width of the column. Change in only a part
of a word or chemical formula is not permitted. Entire
words or chemical formulas must be shown as being
changed. Deletion of a chemical formula should be
shown by brackets which are substantially larger and
darker than any in the formula.


Where a terminal disclaimer was filed in the application
The following discussion addresses analyzing the  
for the patent to be reissued, a copy of that terminal
reissue claims, and which claims are to be compared
disclaimer is not needed in the reissue  
to the reissue claims in determining the issue of surrender
application file. For a reissue application that is
(for reissue recapture).
maintained in a paper file, the face of the file wrapper
should be marked to indicate that a terminal disclaimer
has been filed for the patent. For a reissue  
application that is maintained in IFW, the “Final
SPRE Review” form will be filled in.


Twice reissued patent:
When analyzing a reissue claim for the possibility
of impermissible recapture, there are two different
types of analysis that must be performed. If the reissue
claim “fails” either analysis, recapture exists.


Examples of the form for a twice-reissued patent
First, the reissue claim must be compared to any
are found in Re. 23,558 and Re. 28,488. Double
claims canceled or amended during prosecution of the  
underlining and double bracketing are used in the second
original application. It is impermissible recapture for  
reissue application, while bold-faced type and
a reissue claim to be as broad or broader in scope than
double bracketing appear in the printed patent (the  
any claim that was canceled or amended in the original
second reissue patent) to indicate further insertions
prosecution to define over the art. Claim scope
and deletions, respectively, in the second reissue  
that was canceled or amended is deemed surrendered
patent.
and therefore barred from reissue. In re Clement,  
supra.
 
Second, it must be determined whether the reissue
claim entirely omits any limitation that was added/
argued during the original prosecution to overcome an
art rejection. Such an omission in a reissue claim,  
even if it includes other limitations making the reissue
claim narrower than the patent claim in other aspects,
is impermissible recapture. Pannu v. Storz Instruments
Inc., supra. However, if the reissue claim
recites a broader form of the key limitation added/
argued during original prosecution to overcome an art
rejection (and therefore not entirely removing that key
limitation), then the reissue claim may not be rejected
under the recapture doctrine. Ex Parte Eggert,
67
USPQ2d 1716 (Bd. Pat. App. & Inter. 2003) (precedential).
For example, if the key limitation added to  
overcome an art rejection was “an orange peel,” and  
the reissue claim instead recites “a citrus fruit peel”,  
the reissue claim may not be rejected on recapture
grounds.
 
The following discussion is provided for analyzing
the reissue claims.
 
1.Comparison of Reissue Claims Narrowed/
Broadened Vis-à-vis the Canceled Claims


When a copy of a first reissue patent is used as the  
DEFINITION: “Canceled claims,” in the context of  
specification of a second reissue application (filed as
recapture case law, are claims canceled from the original
a reissue of a reissue), additions made by the first reissue
application to obtain the patent for which reissue  
will already be printed in italics, and should
is now being sought. The claims
remain in such format. Thus, applicants need only
present additions to the specification/claims in the  
second reissue application as double underlined text.
Subject matter to be deleted from the first reissue
patent should be presented in the second reissue application
within sets of double brackets.  


(A)can simply be canceled and not replaced by
others, or


(B)can be canceled and replaced by other claims
which are more specific than the canceled claims in at
least one aspect (to thereby define over the art of
record). The “replacement claims” can be new claims
which are narrower than the canceled claims, or can






1411.01Certificate of Correction or Disclaimer
in Original Patent [R-2]


The applicant should include any changes, additions,
   
or deletions that were made by a Certificate of
Correction to the original patent grant in the reissue
application without underlining or bracketing. The
examiner should make certain that all Certificate of
Correction changes in the patent have been properly
incorporated into the reissue application.


Certificate of Correction changes and disclaimer of
be the same claims amended to be narrower than the  
claim(s) under 37 CFR 1.321(a) should be made without
canceled version of the claims.
using underlining or brackets. Since these are part
of the original patent and were made before the reissue
was filed, they should show up in the printed reissue
patent document as part of the original patent,
i.e., not in italics or bracketed. If the changes are
extensive and/or applicant has submitted them
improperly with underlining and brackets, a clean
copy of the specification with the Certificate of Correction
changes in it may be requested by the examiner.
In order for the clean copy to be entered as a
substitute specification, the reissue applicant must file
a grantable petition under 37 CFR 1.183 for waiver of  
37 CFR 1.125(d) and 37 CFR 1.173(a)(1). The examiner’
s request for the clean copy will generally serve
as sufficient basis for granting the petition.


1411.02New Matter
(a)Reissue Claims are Same or Broader in
Scope Than Canceled Claims in All Aspects:


New matter, that is, matter not present in the patent
The recapture rule bars the patentee from acquiring,  
sought to be reissued, is excluded from a reissue
through reissue, claims that are in all aspects (A) of
application in accordance with 35 U.S.C. 251.
the same scope as, or (B) broader in scope than, those
claims canceled from the original application to
obtain a patent. In re Ball Corp. v. United States,
729
F.2d at 1436, 221 USPQ at 295.  


The claims in the reissue application must be for
(b)Reissue Claims are Narrower in Scope Than
subject matter which the applicant had the right to
Canceled Claims in at Least One Aspect:
claim in the original patent. Any change in the patent
made via the reissue application should be checked to
ensure that it does not introduce new matter. Note that
new matter may exist by virtue of the omission of a
feature or of a step in a method. See United States
Industrial Chemicals, Inc. v. Carbide & Carbon
Chemicals Corp., 315 U.S. 668, 53 USPQ 6 (1942).


Form paragraph 14.22.01 may be used where new
If the reissue claims are equal in scope to, or narrower
matter has been added anywhere in “the application
than, the claims of the original patent (as
for reissue” as prohibited by 35 U.S.C. 251.
opposed to the claims “canceled from the application”)
in all aspects, then there can never be recapture.  
The discussion that follows is not directed to that situation.  
It is rather directed to the situation where the
reissue claims are narrower than the claims 'canceled'
from the application in some aspect, but are broader
than the claims of the original patent in some other
aspect.


¶ 14.22.01 Rejection, 35 U.S.C. 251, New Matter
If the reissue claims are narrower in scope than the
 
claims canceled from the original application by
Claim [1] rejected under 35 U.S.C. 251 as being based upon
inclusion of the limitation added to define the original
new matter added to the patent for which reissue is sought. The
application claims over the art, there will be no recapture,  
added material which is not supported by the prior patent is as follows:
even if the reissue claims are broader than the
[2]
canceled claims in some other aspect (i.e., an aspect
not related to the surrender made in the original application).


Examiner Note:


1.In bracket 2, fill in the applicable page and line numbers and  
Assume combination AB was originally presented
provide an explanation of your position, as appropriate.
in the application, and was amended in response to an
art rejection to add element C and thus provide ABC
(after which the patent issued). The reissue claims are
then directed to combination ABbroadenedC. The
ABbroadenedC claims are narrower in scope when
compared with the canceled claim subject matter AB
in respect to the addition of C (which was added in the
application to overcome the art), and there is no
recapture.


2.A rejection under 35 U.S.C. 112, first paragraph, should also
As another example, assume combination ABZ was
be made if the new matter is added to the claims or is added to the  
originally presented in the application, and was
specification and affects the claims. If new matter is added to the
amended in response to an art rejection to add element
specification and does not affect the claims, an objection should
C and thus provide ABZC (after which the patent
be made based upon 35
issued). The reissue claims are then directed to combination
U.S.C. 132 using form paragraph 7.28.
ABC (i.e., element Z is deleted from the canceled
claims, while element C remains present). The
ABC claims of the reissue are narrower in scope as
compared to the canceled-from-the-original-application
claim subject matter ABZ in respect to the addition
of C (which was added in the application to  
overcome the art), and there is thus no recapture.


1412Content of Claims  
2.Comparison of Reissue Claims Narrowed/
Broadened Via-à-vis the Patent Claims


The content of claims in a reissue application is  
The “patent claims,” in the context of recapture
somewhat limited, as is indicated in MPEP § 1412.01through MPEP § 1412.03.
case law, are claims which issued in the original
patent for which reissue is now being sought. As
pointed out above, where the reissue claims are narrower
than the claims of the original patent in all
aspects, then there can never be recapture. If reissue  
claims are equal in scope to the patent claims, there is  
no recapture as to those reissue claims. Where, however,
reissue claims are both broadened and narrowedas compared with the original patent claims, the
nature of the broadening and narrowing must be
examined to determine whether the reissue claims are
barred as being recapture of surrendered subject matter.
If the claims are 'broader than they are narrower in  
a manner directly pertinent to the subject matter... surrendered
during prosecution' (Clement, 131 F.3d at
1471, 45 USPQ2d at 1166), then recapture will bar the
claims. This narrowing/broadening vis-à-vis the
patent is broken down into four possibilities that will
now be addressed.


1412.01Reissue Claims Must Be for
The “limitation” presented, argued, or stated to
Same General Invention [R-2]
make the claims patentable over the art (in the application)
 
“generates” the surrender of claimed subject
The reissue claims must be for the same invention
matter. For the sake of simplification, this limitation
as that disclosed as being the invention in the  
will be referred to throughout this section as the surrender-
original patent, as required by 35 U.S.C. 251. This
generating limitation. If a claim is presented in  
does not mean that the invention claimed in the reissue
a reissue application that omits, in its entirety, the surrender-
must have been claimed in the original patent,  
generating limitation, that claim impermissibly
although this is evidence that applicants considered it
recaptures what was previously surrendered, and that
their invention. The entire disclosure, not just the
claim is barred under 35 U.S.C. 251. This terminology
claim(s), is considered in determining what the patentee
will be used in the discussion of the four categories
objectively intended as his or her invention. The
of narrowing/broadening vis-à-vis the patent that  
proper test as to whether reissue claims are for the
follows.
same invention as that disclosed as being the invention
in the original patent is “an essentially factual
inquiry confined to the objective intent manifested by
the original patent.” In re Amos, 953 F.2d 613, 618,  
21 USPQ2d 1271, 1274 (Fed. Cir. 1991) (quoting In
re Rowand, 526 F.2d 558, 560, 187 USPQ 487, 489
(CCPA 1975)) (emphasis added). See also In re Mead,
581 F.2d 257, 198 USPQ 412 (CCPA 1978). The
“original patent” requirement of 35 U.S.C. 251 must
be understood in light of In re Amos, supra, where the  
Court of Appeals for the Federal Circuit stated:
 
We conclude that, under both Mead and Rowand, a claim
submitted in reissue may be rejected under the “original
patent” clause if the original specification demonstrates,
to one skilled in the art, an absence of disclosure sufficient
to indicate that a patentee could have claimed the subject
matter. Merely finding that the subject matter was “not
originally claimed, not an object of the original patent,
and not depicted in the drawing,” does not answer the
essential inquiry under the “original patent” clause of §
251, which is whether one skilled in the art, reading the




Line 1,693: Line 1,778:
   
   


specification, would identify the subject matter of the new
(a)Reissue Claims are Narrower in Scope Than
claims as invented and disclosed by the patentees. In
Patent Claims, in Area Not Directed to
short, the absence of an “intent,” even if objectively evident
Amendment/Argument Made to Overcome
from the earlier claims, the drawings, or the original
Art Rejection in Original Prosecution; are  
objects of the invention is simply not enough to establish
Broader in Scope by Omitting Limitation(s)
that the new claims are not drawn to the invention disclosed
Added/Argued To Overcome Art Rejection
in the original patent.
in Original Prosecution:


953 F.2d at 618-19, 21 USPQ2d at 1275. Claims presented
In this case, there is recapture.  
in a reissue application are considered to satisfy
the requirement of 35 U.S.C. 251 that the claims
be “for the invention disclosed in the original patent”
where:


(A)the claims presented in the reissue application
This situation is where the patent claims are
are described in the original patent specification and  
directed to combination ABC and the reissue claims
enabled by the original patent specification such that  
are directed to ABD. Element C was either a limitation
35 U.S.C. 112 first paragraph is satisfied; and
added to AB to obtain allowance of the original  
patent, or was argued by applicant to define over the
art (or both). Thus, addition of C (and/or argument as
to C) has resulted in the surrender of any combination
of A & B that does not include C; this is the surrendered
subject matter. Element D, on the other hand, is
not related to the surrendered subject matter. Thus, the
reissue claim, which no longer contains C, is broadened
in an area related to the surrender, and the narrowing
via the addition of D does not save the claim
from recapture since D is not related to the surrendered
subject matter.


(B)nothing in the original patent specification
Reissue claims that are broader than the original
indicates an intent not to claim the subject matter of  
patent claims by not including the surrender-generating
the claims presented in the reissue application.
limitation (element C, in the example given) will
be barred by the recapture rule even though there is
narrowing of the claims not related to the surrender-
generating limitation. As stated in the decision of In re
Clement, 131 F.3d at 1470, 45 USPQ2d at 1165, if the  
reissue claim is broader in an aspect germane to a
prior art rejection, but narrower in another aspect
completely unrelated to the rejection, the recapture
rule bars the claim. Pannu v. Storz Instruments Inc.,
supra, then brings home the point by providing an
actual fact situation in which this scenario was held to
be recapture.


The presence of some disclosure (description
(b)Reissue Claims are Narrower or Equal in
and enablement) in the original patent should evidence
Scope, in Area Directed to Amendment/
that applicant intended to claim or that applicant
Argument Made to Overcome Art Rejection
considered the material now claimed to be his or
in Original Prosecution; are Broader in
her invention.
Scope in Area Not Directed to Amendment/
Argument:


The original patent specification would indicate an
In this case, there is no recapture.
intent not to claim the subject matter of the claims
presented in the reissue application in a situation analogous
to the following:


The original patent specification discloses that
This situation is where the patent claims are
composition X is not suitable (or not satisfactory) for
directed to combination ABCDE and the reissue
molding an item because composition X fails to provide
claims are directed to ABDE (element C is omitted).
quick drying. After the patent issues, it is found
Assume that the combination of ABCD was present in
that composition X would be desirable for the molding
the original application as it was filed, and element E
in spite of the failure to provide quick drying,  
was later added to define over that art. No argument
because of some other newly recognized benefit from
was ever presented as to elements A-C defining over
composition X. A claim to composition X or a method
the art.
of use thereof would not be permitted in a reissue
 
application, because the original patent specification
In this situation, the ABCDE combination of the  
contained an explicit statement of intent not to claim  
patent can be broadened (in the reissue application) to  
composition X or a method of use thereof.  
omit element C, and thereby claim the combination of
ABDE, where element E (the surrender generating
limitation) is not omitted. There would be no recapture
in this instance. (If an argument had been presented
as to element C defining over the art, in  
addition to the addition of element E, then the  
ABCDE combination could not be broadened to omit
element C and thereby claim combination of ABDE.
This would be recapture; see the above discussion as
to surrender and recapture based upon argument.)


In most instances, however, the mere failure to  
Additionally, the reissue claims are certainly permitted
claim a disclosed embodiment in the original patent  
to recite combination ABDEspecific (where surrender-
(absent an explicit statement in the original patent
generating element E is narrowed). The patent  
specification of unsuitability of the embodiment)  
claims have been broadened in an area not directed to
would not be grounds for prohibiting a claim to that
the surrender (by omitting element C) and narrowed
embodiment in the reissue.
in the area of surrender (by narrowing element E to  
Especific). This is clearly permitted.


FAILURE TO TIMELY FILE A DIVISIONAL
As another example, assume limitation C was
APPLICATION PRIOR TO ISSUANCE OF
added to application claims AB to obtain the patent to
ORIGINAL PATENT
ABC, and now the reissue application presents claims
to AC or ABbroadC. Such reissue claims avoid the
effect of the recapture rule because they are broader in
a way that does not attempt to reclaim what was surrendered
earlier. Mentor Corp. v. Coloplast, Inc., 998
F.2d 992, 994, 27 USPQ2d 1521, 1525 (Fed. Cir.
1993). Such claims are considered to be broader in an
aspect not 'germane to a prior art rejection,' and thus
are not barred by recapture. Note In re Clement,
131
F.3d at 1470, 45 USPQ2d at 1165.


Where a restriction requirement was made in an
Reissue claims that are broader than the original
application and applicant permitted the elected invention
patent claims by deletion of a limitation or claim
to issue as a patent without the filing of a divisional
requirement other than the “surrender-generating limitation”
application on the non-elected invention(s), the  
will avoid the effect of the recapture rule,  
non-elected invention(s) cannot be recovered by filing
regardless of the nature of the narrowing in the  
a reissue application. A reissue applicant’ s failure to
claims, and even if the claims are not narrowed at all
timely file a divisional application covering the non-
from the scope of the patent claims.
elected invention(s) in response to a restriction
requirement is not considered to be error causing a
patent granted on the elected claims to be partially
inoperative by reason of claiming less than the applicant
had a right to claim. Accordingly, such error is
not correctable by reissue of the original patent under
35 U.S.C. 251. In re Watkinson, 900 F.2d 230, 14
USPQ2d 1407 (Fed. Cir. 1990); In re Orita, 550 F.2d
1277, 1280, 193 USPQ 145, 148 (CCPA 1977). See
also In re Mead, 581 F.2d 251, 198 USPQ 412 (CCPA
1978). In this situation, the reissue claims should be
rejected under 35 U.S.C. 251 for lack of defect in the  
original patent and lack of error in obtaining the original
patent. Compare with In re Doyle, 293 F.3d 1355,
63 USPQ2d 1161 (Fed. Cir. 2002) where the court
permitted the patentee to file a reissue application to
present a so-called linking claim, a claim broad
enough to read on or link the invention elected (and  
patented) together with the invention not elected. The
non-elected invention(s) were inadvertently not filed
as a divisional application.
 
1412.02Recapture of Canceled SubjectMatter [R-5]
 
A reissue will not be granted to “recapture” claimed
subject matter which was surrendered in an application
to obtain the original patent. North American
Container, Inc. v. Plastipak Packaging, Inc., 415 F.3d
1335, 75 USPQ2d 1545 (Fed. Cir. 2005, Pannu v.
Storz Instruments Inc., 258 F.3d 1366, 59 USPQ2d
1597 (Fed. Cir. 2001); Hester Industries, Inc. v. Stein,
Inc., 142 F.3d 1472, 46 USPQ2d 1641 (Fed. Cir.
1998); In re Clement, 131 F.3d 1464, 45 USPQ2d
1161 (Fed. Cir. 1997); Ball Corp. v. United States, 729
F.2d 1429, 1436, 221 USPQ 289, 295 (Fed. Cir.
1984); In re Wadlinger, 496 F.2d 1200, 181 USPQ
826 (CCPA 1974); In re Richman, 409 F.2d 269, 276,




Line 1,801: Line 1,885:
   
   


161 USPQ 359, 363-364 (CCPA 1969); In re Willingham,
(c)Reissue Claims are Narrower in Scope in
282
Area Not Directed to Amendment/Argument
F.2d 353, 127 USPQ 211 (CCPA 1960).
Made to Overcome Art Rejection in Original
Prosecution; are Broader in Scope in Area
Not Directed to the Amendment/Argument:


I.THREE STEP TEST FOR RECAPTURE:
In this instance, there is clearly no recapture. In the
reissue application, there has been no change in the
claims related to the matter surrendered in the original
application for the patent.


In Clement, 131 F.3d at 1468-70, 45 USPQ2d at
In this instance, element C was added to the AB
1164-65, the Court of Appeals for the Federal Circuit
combination to provide ABC and define over the art,  
set forth a three step test for recapture analysis. In
and the patent was issued. The reissue omits element
Pannu, 258 F.3d at 1371, 59 USPQ2d at 1600, the
B and adds element Z, to thus claim ACZ. There is no
court restated this test as follows:
recapture since the surrender generating element C
has not been modified in any way. (Note, however,
that if, when element C was added to AB, applicant
argued that the association of newly added C with B
provides a synergistic (unexpected) result to thus
define over the art, then neither B nor C could be
omitted in the reissue application.)


Application of the recapture rule is a three-step process.
(d)Reissue Claims Broader in Scope in Area
Directed to Amendment/Argument Made to
Overcome Art Rejection in Original
Prosecution; but Reissue Claims Retain, in
Broadened Form, the Limitation(s) Argued/
Added to Overcome Art Rejection in
Original Prosecution:


Assume the combination AB was originally
claimed in the application, and was amended in reply
to an art rejection to add element C and thus provide
the combination ABC (after which the patent issued).
A reissue application is then filed, and the reissue
application claims are directed to the combination
ABCbroadened. The ABCbroadened claims are narrowed
in scope when compared with the canceled claim subject
matter AB, because of the addition of Cbroadened.
Thus, the claims retain, in broadened form, the limitation
argued/added to overcome art rejection in original
prosecution. There is no recapture, since
ABCbroadened is narrower than canceled claim subject
matter AB in an area related to the surrender. This is
so, because it was element C that was added in the
application to overcome the art. See Ex Parte Eggert,
supra.


The first step is to ‘determine whether and in what aspect
II.REISSUE TO TAKE ADVANTAGE OF
the reissue claims are broader than the patent claims.’....
35
U.S.C. 103(b):


‘The second step is to determine whether the broader
A patentee may file a reissue application to permit
aspects of the reissued claim related to surrendered subject
consideration of process claims which qualify for
matter’ ....
35
U.S.C. 103(b) treatment if a patent is granted on an
application entitled to the benefit of 35 U.S.C. 103(b),
without an election having been made as a result of..
error without deceptive intent. See MPEP
§
706.02(n). This is not to be considered a recapture.
The addition of process claims, however, will
generally be considered to be a broadening of the  
invention (Ex parte Wikdahl, 10 USPQ2d 1546 (Bd.
Pat. App. & Inter. 1989)), and such addition must be
applied for within two years of the grant of the original
patent. See also MPEP § 1412.03 as to broadened
claims.


Finally, the court must determine whether the reissued
III.REISSUE FOR ARTICLE CLAIMS
claims were materially narrowed in other respects to avoid
WHICH ARE FUNCTIONAL DESCRIPTIVE
the recapture rule. [Emphasis added]
MATERIAL STORED ON A COMPUTER-
READABLE MEDIUM:


A.The First Step - Was There Broadening?
A patentee may file a reissue application to permit
consideration of article of manufacture claims which
are functional descriptive material stored on a computer-
readable medium, where these article claims
correspond to the process or machine claims which
have been patented. The error in not presenting claims
to this statutory category of invention (the “article”
claims) must have been made as a result of error without
deceptive intent. The addition of these “article”
claims will generally be considered to be a broadening
of the invention (Ex parte Wikdahl, 10 USPQ2d
1546 (Bd. Pat. App. & Inter. 1989)), and such addition
must be applied for within two years of the grant of
the original patent. See also MPEP § 1412.03 as to
broadened claims.
 
IV.REJECTION BASED UPON RECAPTURE:
 
 
Reissue claims which recapture surrendered subject
matter should be rejected using form paragraph 14.17.


In every reissue application, the examiner must first
¶ 14.17 Rejection, 35 U.S.C. 251, Recapture
review each claim for the presence of broadening, as
compared with the scope of the claims of the patent to
be reissued. A reissue claim is broadened where some
limitation of the patent claims is no longer required in
the reissue claim; see MPEP § 1412.03 for guidance
as to the nature of a “broadening claim.” If the reissue
claim is not broadened in any respect as compared to
the patent claims, the analysis ends; there is no recapture.


Claim[1] rejected under 35 U.S.C. 251 as being an improper
recapture of broadened claimed subject matter surrendered in the
application for the patent upon which the present reissue is based.
See Pannu v. Storz Instruments Inc., 258 F.3d 1366, 59 USPQ2d
1597 (Fed. Cir. 2001); Hester Industries, Inc. v. Stein, Inc., 142
F.3d 1472, 46 USPQ2d 1641 (Fed. Cir. 1998); In re Clement, 131


B.The Second Step - Does Any Broadening
Aspect of the Reissued Claim Relate to
Surrendered Subject Matter?


Where a claim in a reissue application is broadened
in some respect as compared to the patent claims, the
examiner must next determine whether the broadening
aspect(s) of that reissue claim relate(s) to subject
matter that applicant previously surrendered during
the prosecution of the original application (which
became the patent to be reissued). Each limitation of
the patent claims, which is omitted or broadened in
the reissue claim, must be reviewed for this determination.
This involves two sub-steps:


1.The Two Sub-Steps:


(A)It must first be determined whether there was
any surrender of subject matter made in the prosecution
of the original application which became the
patent to be reissued.


If an original patent claim limitation now being
F.3d 1464, 45 USPQ2d 1161 (Fed. Cir. 1997); Ball Corp. v.
omitted or broadened in the present reissue application
United States, 729 F.2d 1429, 1436, 221 USPQ 289, 295 (Fed. Cir.
was originally relied upon by applicant in the  
1984). A broadening aspect is present in the reissue which was not
original application to make the claims allowable over
present in the application for patent. The record of the application
the art, the omitted limitation relates to subject matter  
for the patent shows that the broadening aspect (in the reissue)
previously surrendered by applicant. The reliance by
relates to claim subject matter that applicant previously surrendered  
applicant to define the original patent claims over the  
during the prosecution of the application. Accordingly, the  
art can be by way of presentation of new/amended
narrow scope of the claims in the patent was not an error within
claims to define over the art, or an argument/statement
the meaning of 35 U.S.C. 251, and the broader scope of claim subject
by applicant that a limitation of the claim(s)
matter surrendered in the application for the patent cannot be  
defines over the art. To determine whether such reliance
recaptured by the filing of the present reissue application.
occurred, the examiner must review the prosecution
history of the original application file (of the  
patent to be reissued) for recapture. The prosecution
history includes the rejections and applicant’s arguments
made therein.


If there was no surrender of subject matter made
[2]
in the prosecution of the original application, again
the analysis ends and there is no recapture.


(B)If there was a surrender of subject matter in
Examiner Note:
the original application prosecution, it must then be
determined whether any of the broadening of the reissue
claims is in the area of the surrendered subject
matter. All of the broadening aspects of reissue claims
must be analyzed to determine if any of the omitted/
broadened limitation(s) are directed to limitations
relied upon by applicant in the original application to
make the claims allowable over the art.


2.Examples of the Pannu Second Step Analysis:
In bracket 2, the examiner should explain the specifics of why
recapture exists, including an identification of the omitted/broadened
claim limitations in the reissue which provide the “broadening
aspect” to the claim(s), and where in the original application
the narrowed claim scope was presented/argued to obviate a rejection/
objection. See MPEP §
1412.02.


See the recapture-analysis flow chart which follows
for assistance in determining whether recapture is
present, consistent with the case law discussed above.


(A)Example (1) - Argument without amendment:


In Hester, supra, the Federal Circuit held that the
surrender which forms the basis for impermissible
recapture “can occur through arguments alone”.
142
F.3d at 1482, 46 USPQ2d at 1649. For example,
assume that limitation A of the patent claims is omitted
in the reissue claims. This omission provides a
broadening aspect in the reissue claims, as compared
to the claims of the patent. If the omitted limitation A
was argued in the original application to make the
application claims allowable over the art in the appli






Flowchart - Reissue Recapture - Determining its presence or absence






cation, then the omitted limitation relates to subject
matter previously surrendered in the original application,
and recapture will exist. Accordingly, where
claims are broadened in a reissue application, the
examiner should review the prosecution history of the
original patent file for recapture, even where the
claims were never amended during the prosecution of
the application which resulted in the patent.


Note: The argument that the claim limitation
defined over the rejection must have been specific as
to the limitation relied upon, rather than a general
statement regarding the claims as a whole. A general
'boiler plate' sentence in the original application will
not, by itself, be sufficient to establish surrender and
recapture.


An example of a general “boiler plate” sentence of
argument is:


“In closing, it is argued that the limitations of claims 1-7
1412.03Broadening Reissue Claims
distinguish the claims from the teachings of the prior art,
[R-3]
and claims 1-7 are thus patentable.”


An argument that merely states that all the limitations
35 U.S.C. 251 prescribes a 2-year limit for filing
of the claims define over the prior art will also
applications for broadening reissues:
not, by itself, be sufficient to establish surrender and
recapture. An example is:


“Claims 1-5 set forth a power-train apparatus which comprises
No reissue patent shall be granted enlarging the scope of  
the combination of A+B+C+D+E. The prior art of  
the original patent unless applied for within two years
record does not disclose or render obvious a motivation to
from the grant of the original patent.  
provide for a material-transfer apparatus as defined by the  
limitations of claim 1, including an A member and a B
member, both connected to a C member, with all three
being aligned with the D and E members.


This statement is simply a restatement of the
entirety of claim 1 as allowed. No measure of surrender
could be gleaned from such a statement of reasons
for allowance. See Ex parte Yamaguchi, 61 USPQ2d
1043 (Bd. Pat. App. & Inter. 2001)(reported but
unpublished, precedential).


In both of the above examples, the argument does
not provide an indication of what specific limitations,
e.g., specific element or step of the claims, cooperative
effect, or other aspect of the claims, are being
relied upon for patentability. Thus, applicant has not
surrendered anything.


(B)Example (2) - Amendment of the claims without
I. MEANING OF “BROADENED REISSUE
argument:
CLAIM”


The limitation omitted in the reissue claim(s) was
A broadened reissue claim is a claim which
added in the original application claims for the purpose
enlarges the scope of the claims of the patent, i.e., a
of making the application claims allowable over
claim which is greater in scope than each and every
a rejection or objection made in the application. Even
claim of the original patent. If a disclaimer is filed in
though applicant made no argument on the record that  
the patent prior to the filing of a reissue application,
the limitation was added to obviate the rejection, the  
the disclaimed claims are not part of the “original
nature of the addition to the claim can show that the  
patent” under 35 U.S.C. 251. The Court in Vectra Fitness
limitation was added in direct reply to the rejection.  
Inc. v. TNWK Corp., 49 USPQ2d 1144, 1147,
This too will establish the omitted limitation as relating
162 F.3d 1379, 1383 (Fed. Cir. 1998) held that a reissue
to subject matter previously surrendered. To illustrate
application violated the statutory prohibition
this, note the following example:
under 35 U.S.C. 251 against broadening the scope of
the patent more than 2 years after its grant because the
reissue claims are broader than the claims that remain
after the disclaimer, even though the reissue claims
are narrower than the claims that were disclaimed by
the patentee before reissue. The reissue application
was bounded by the claims remaining in the patent
after a disclaimer is filed.A claim of a reissue application
enlarges the scope of the claims of the patent if it
is broader in at least one respect, even though it may
be narrower in other respects.  


The original application claims recite limitations A+B+C,
A claim in the reissue which includes subject matter
and the Office action rejection combines two references to
not covered by the patent claims enlarges the scope
show A+B+C. In the amendment replying to the Office
of the patent claims. For example, if any amended or
action, applicant adds limitation D to A+B+C in the  
newly added claim in the reissue contains within its
claims, but makes no argument as to that addition. The
scope any conceivable product or process which
examiner then allows the claims. Even though there is no
would not have infringed the patent, then that reissue
argument as to the addition of limitation D, it must be presumed
claim would be broader than the patent claims. Tillotson,
that the D limitation was added to obviate the
Ltd. v. Walbro Corp., 831 F.2d 1033, 1037 n.2,
rejection. The subsequent deletion of (omission of) limitation
4
D in the reissue claims would be presumed to be a  
USPQ2d 1450, 1453 n.2 (Fed. Cir. 1987); In re
broadening in an aspect of the reissue claims related to  
Ruth, 278 F.2d 729, 730, 126 USPQ 155, 156 (CCPA
surrendered subject matter. Accordingly, the reissued
1960); In re Rogoff, 261 F.2d 601, 603, 120 USPQ
claims would be barred by the recapture doctrine.
185, 186 (CCPA 1958). A claim which reads on
something which the original claims do not is a broadened
claim. A claim would be considered a broadening
claim if the patent owner would be able to sue any
party for infringement who previously could not have
been sued for infringement. Thus, where the original
patent claims only the process, and the reissue application
adds (for the first time) product claims, the
scope of the claims has been broadened since a party
could not be sued for infringement of the product
based on the claims of the original patent.


The above result would be the same whether the  
The addition of combination claims in a reissue
addition of limitation D in the original application  
application where only subcombination claims were
was by way of applicant’s amendment or by way of an
present in the original patent could be a broadening of
examiner’s amendment with authorization by applicant.
the invention. The question which must be resolved in
this case is whether the combination claims added in
the reissue would be for “the invention as claimed” in
the original patent. See Ex parte Wikdahl, 10 USPQ2d
at 1549. The newly added combination claims should
be analyzed to determine whether they contain every
limitation of the subcombination of any claim of the  
original patent. If the combination claims (added in
the reissue) contain every limitation of the subcombination
(which was claimed in the original application),
then infringement of the combination must also
result in infringement of the subcombination. Accordingly,
the patent owner could not, if a reissue patent
issues with the combination claims, sue any new
party for infringement who could not have been sued
for infringement of the original patent. Therefore,
broadening does not exist, in spite of the addition of
the combination.




(C)Example (3) - Who can make the surrendering
argument?


Assume that the limitation A omitted in the reissue
II. SCOPE OF DEPENDENT CLAIM
claims was present in the claims of the original application.  
ENLARGED-NOT BROADENING
The examiner’s reasons for allowance in the
original application stated that it was that limitation A
which distinguished over a potential combination of
references X and Y. Applicant did not present on the
record a counter statement or comment as to the
examiner’s reasons for allowance, and permitted the
claims to issue.


Ex parte Yamaguchi, supra, held that a surrender of  
As pointed out above, a claim will be considered a
claimed subject matter cannot be based solely upon an
broadened reissue claim when it is greater in scope
applicant’s failure to respond to, or failure to challenge,  
than each and every claim of the patent to be reissued.
an examiner’s statement made during the prosecution
A corollary of this is that a claim which has
of an application. Applicant is bound only by
been broadened in a reissue as compared to its scope
applicant’s revision of the application claims or a positive
in the patent is not a broadened reissue claim if it is
argument/statement by applicant. An applicant’s
narrower than, or equal in scope to, any other claim
failure to present on the record a counter statement or
which appears in the patent. A common example of
this is where dependent claim 2 is broadened via the  
reissue (other than the addition of a process step to
convert an intermediate to a final product as discussed
in the preceding subsection), but independent claim 1
on which it is based is not broadened. Since a dependent
claim is construed to contain all the limitations of
the claim upon which it depends, claim 2 must be at




Line 2,029: Line 2,148:
   
   


comment as to an examiner’s reasons for allowance
least as narrow as claim 1 and is thus not a broadened
does not give rise to any implication that applicant
reissue claim.
agreed with or acquiesced in the examiner’s reasoning
for allowance. Thus, the failure to present a counter
statement or comment as to the examiner’s statement
of reasons for allowance does not give rise to any
finding of surrender. The examiner’s statement of
reasons for allowance in the original application
cannot, by itself, provide the basis for establishing
surrender and recapture.  


It is only in the situation where applicant does file
comments on the statement of reasons for allowance,
that surrender may have occurred. Note the following
two scenarios in which an applicant files comments:


Scenario 1- There is Surrender: The examiner’s statement
of reasons for allowance in the original application stated
that it was limitation C (of the combination of ABC)
which distinguished over a potential combining of references
X and Y, in that limitation C provided increased
speed to the process. Applicant filed comments on the
examiner’s statement of reasons for allowance essentially
supporting the examiner’ s reasons. The limitation C is
thus established as relating to subject matter previously
surrendered.


Scenario 2- There is No Surrender: On the other hand, if
III. NEW CATEGORY OF INVENTION
applicant’s comments on the examiner’s statement of reasons
ADDED IN REISSUE - GENERALLY
for allowance contain a counter statement that it is limitation
IS BROADENING
B (of the combination of ABC), rather than C, which
distinguishes the claims over the art, then limitation B
would constitute surrendered subject matter, and limitation
C has not been surrendered.


C.The Third Step - Were the reissued claims  
The addition of process claims as a new category of
materially narrowed in other respects to
invention to be claimed in the patent (i.e., where there
compensate for the broadening in the area of  
were no method claims present in the original patent)
surrender, and thus avoid the recapture rule?
is generally considered as being a broadening of the
invention. See Ex parte Wikdahl, 10 USPQ2d 1546
(Bd. Pat. App. & Inter. 1989). A situation may arise,
however, where the reissue application adds a limitation
(or limitations) to process A of making the product
A claimed in the original patent claims. For
example:


As pointed out above, the third prong of the recapture
(1)a process of using the product A (made by the  
determination set forth in Pannu is directed to
process of the original patent) to make a product B,  
analysis of the broadening and narrowing effected via
disclosed but not claimed in the original patent; or
the reissue claims, and of the significance of the claim
limitations added and deleted, using the prosecution
history of the patent (to be reissued), to determine
whether the reissue claims should be barred as recapture.


(2)a process of using the product A to carry out a
process B disclosed but not claimed in the original
patent.


The following discussion addresses analyzing the  
Although this amendment of the claims adds a
reissue claims, and which claims are to be compared
method of making product B or adds a method of
to the reissue claims in determining the issue of surrender
using product A, this is not broadening (i.e., this is not
(for reissue recapture).
an enlargement of the scope of the original patent)
because the “newly claimed invention” contains all
the limitations of the original patent claim(s).


When analyzing a reissue claim for the possibility
of impermissible recapture, there are two different
types of analysis that must be performed. If the reissue
claim “fails” either analysis, recapture exists.


First, the reissue claim must be compared to any
claims canceled or amended during prosecution of the
original application. It is impermissible recapture for
a reissue claim to be as broad or broader in scope than
any claim that was canceled or amended in the original
prosecution to define over the art. Claim scope
that was canceled or amended is deemed surrendered
and therefore barred from reissue. In re Clement,
supra.


Second, it must be determined whether the reissue
IV. WHEN A BROADENED CLAIM CAN BE
claim entirely omits any limitation that was added/
PRESENTED
argued during the original prosecution to overcome an
art rejection. Such an omission in a reissue claim,
even if it includes other limitations making the reissue
claim narrower than the patent claim in other aspects,
is impermissible recapture. Pannu v. Storz Instruments
Inc., supra. However, if the reissue claim
recites a broader form of the key limitation added/
argued during original prosecution to overcome an art
rejection (and therefore not entirely removing that key
limitation), then the reissue claim may not be rejected
under the recapture doctrine. Ex Parte Eggert,
67
USPQ2d 1716 (Bd. Pat. App. & Inter. 2003) (precedential).
For example, if the key limitation added to
overcome an art rejection was “an orange peel,” and
the reissue claim instead recites “a citrus fruit peel”,
the reissue claim may not be rejected on recapture
grounds.


The following discussion is provided for analyzing
A broadened claim can be presented within two
the reissue claims.
years from the grant of the original patent in a reissue  
 
application. In addition, a broadened claim can be
1.Comparison of Reissue Claims Narrowed/
presented after two years from the grant of the original
Broadened Vis-à-vis the Canceled Claims
patent in a broadening reissue application
 
which was filed within two years from the grant.  
DEFINITION: “Canceled claims,in the context of
Where any intent to broaden is indicated in the reissue
recapture case law, are claims canceled from the original
application within the two years from the patent grant,
application to obtain the patent for which reissue  
a broadened claim can subsequently be presented in
is now being sought. The claims
the reissue after the two year period. Thus, a broadened
claim may be presented in a reissue application
after the two years, even though the broadened claim
presented after the two years is different than the
broadened claim presented within the two years.
Finally, if intent to broaden is indicated in a parent
reissue application within the two years, a broadened
claim can be presented in a continuing (continuation
or divisional) reissue application after the two year
period. In any other situation, a broadened claim cannot
be presented, and the examiner should check carefully
for the improper presentation of broadened
claims.
 
A reissue application filed on the 2-year anniversary
date from the patent grant is considered to be
filed within 2 years of the patent grant. See Switzer v.
Sockman, 333 F.2d 935, 142 USPQ 226 (CCPA 1964)
for a similar rule in interferences.


(A)can simply be canceled and not replaced by
See also the following cases which pertain to
others, or
broadened reissues:


(B)can be canceled and replaced by other claims  
In re Graff, 111 F.3d 874, 877, 42 USPQ2d 1471,
which are more specific than the canceled claims in at
1473-74 (Fed. Cir. 1997) (Broadened claims in a continuing
least one aspect (to thereby define over the art of  
reissue application were properly rejected
record). The “replacement claims” can be new claims  
under 35 U.S.C. 251 because the proposal for broadened
which are narrower than the canceled claims, or can
claims was not made (in the parent reissue application)
within two years from the grant of the original
patent and the public was not notified that broadened
claims were being sought until after the two-year
period elapsed.);


In re Fotland, 779 F.2d 31, 228 USPQ 193 (Fed.
Cir. 1985), cert. denied, 476 U.S. 1183 (1986) (The
failure by an applicant to include an oath or declaration
indicating a desire to seek broadened claimswithin two years of the patent grant will bar a subsequent
attempt to broaden the claims after the two year
limit. Under the former version of 37 CFR 1.175 (the
former 37 CFR 1.175(a)(4)), applicant timely sought
a “no-defect” reissue, but the Court did not permit an
attempt made beyond the two year limit to convert the
reissue into a broadening reissue. In this case, applicant
did not indicate any intent to broaden within the
two years.);


In re Bennett, 766 F.2d 524, 528, 226 USPQ 413,
416 (Fed. Cir. 1985) (en banc) (A reissue application
with broadened claims was filed within two years of
the patent grant; however, the declaration was executed
by the assignee rather than the inventor. The
Federal Circuit permitted correction of the improperly
executed declaration to be made more than two years
after the patent grant.);


In re Doll, 419 F.2d 925, 928, 164 USPQ 218, 220
(CCPA 1970) (If the reissue application is timely filed
within two years of the original patent grant and the




be the same claims amended to be narrower than the
canceled version of the claims.


(a)Reissue Claims are Same or Broader in
Scope Than Canceled Claims in All Aspects:


The recapture rule bars the patentee from acquiring,
through reissue, claims that are in all aspects (A) of
the same scope as, or (B) broader in scope than, those
claims canceled from the original application to
obtain a patent. In re Ball Corp. v. United States,
729
F.2d at 1436, 221 USPQ at 295.


(b)Reissue Claims are Narrower in Scope Than
applicant indicates in the oath or declaration that the
Canceled Claims in at Least One Aspect:
claims will be broadened, then applicant may subsequently
broaden the claims in the pending reissue
prosecution even if the additional broadening occurs
beyond the two year limit.).


If the reissue claims are equal in scope to, or narrower
Form paragraphs 14.12 and 14.13 may be used in
than, the claims of the original patent (as
rejections based on improper broadened reissue  
opposed to the claims “canceled from the application”)
claims.
in all aspects, then there can never be recapture.  
The discussion that follows is not directed to that situation.  
It is rather directed to the situation where the
reissue claims are narrower than the claims 'canceled'
from the application in some aspect, but are broader
than the claims of the original patent in some other
aspect.


If the reissue claims are narrower in scope than the
¶ 14.12 Rejection, 35 U.S.C. 251, Broadened Claims After
claims canceled from the original application by
Two Years
inclusion of the limitation added to define the original
application claims over the art, there will be no recapture,
even if the reissue claims are broader than the
canceled claims in some other aspect (i.e., an aspect
not related to the surrender made in the original application).


Claim [1] rejected under 35 U.S.C. 251 as being broadened in
a reissue application filed outside the two year statutory period.
[2] A claim is broader in scope than the original claims if it contains
within its scope any conceivable product or process which
would not have infringed the original patent. A claim is broadened
if it is broader in any one respect even though it may be narrower
in other respects.


Assume combination AB was originally presented
Examiner Note:
in the application, and was amended in response to an
art rejection to add element C and thus provide ABC
(after which the patent issued). The reissue claims are
then directed to combination ABbroadenedC. The
ABbroadenedC claims are narrower in scope when
compared with the canceled claim subject matter AB
in respect to the addition of C (which was added in the
application to overcome the art), and there is no
recapture.


As another example, assume combination ABZ was
The claim limitations that broaden the scope should be identified
originally presented in the application, and was
and explained in bracket 2. See MPEP §§ 706.03(x) and  
amended in response to an art rejection to add element
1412.03.
C and thus provide ABZC (after which the patent
issued). The reissue claims are then directed to combination
ABC (i.e., element Z is deleted from the canceled
claims, while element C remains present). The
ABC claims of the reissue are narrower in scope as
compared to the canceled-from-the-original-application
claim subject matter ABZ in respect to the addition
of C (which was added in the application to
overcome the art), and there is thus no recapture.


2.Comparison of Reissue Claims Narrowed/
¶ 14.13 Rejection, 35 U.S.C. 251, Broadened Claims Filed
Broadened Via-à-vis the Patent Claims
by Assignee


The “patent claims,” in the context of recapture
Claim [1] rejected under 35 U.S.C. 251 as being improperly
case law, are claims which issued in the original
broadened in a reissue application made and sworn to by the  
patent for which reissue is now being sought. As
assignee and not the patentee. [2]A claim is broader in scope than  
pointed out above, where the reissue claims are narrower
the original claims if it contains within its scope any conceivable
than the claims of the original patent in all
product or process which would not have infringed the original
aspects, then there can never be recapture. If reissue
patent. A claim is broadened if it is broader in any one respecteven though it may be narrower in other respects.
claims are equal in scope to the patent claims, there is
no recapture as to those reissue claims. Where, however,
reissue claims are both broadened and narrowedas compared with the original patent claims, the  
nature of the broadening and narrowing must be
examined to determine whether the reissue claims are
barred as being recapture of surrendered subject matter.  
If the claims are 'broader than they are narrower in
a manner directly pertinent to the subject matter... surrendered
during prosecution' (Clement, 131 F.3d at
1471, 45 USPQ2d at 1166), then recapture will bar the  
claims. This narrowing/broadening vis-à-vis the
patent is broken down into four possibilities that will
now be addressed.


The “limitation” presented, argued, or stated to
Examiner Note:
make the claims patentable over the art (in the application)
“generates” the surrender of claimed subject
matter. For the sake of simplification, this limitation
will be referred to throughout this section as the surrender-
generating limitation. If a claim is presented in
a reissue application that omits, in its entirety, the surrender-
generating limitation, that claim impermissibly
recaptures what was previously surrendered, and that
claim is barred under 35 U.S.C. 251. This terminology
will be used in the discussion of the four categories
of narrowing/broadening vis-à-vis the patent that
follows.


The claim limitations that broaden the scope should be identified
and explained in bracket 2. See MPEP §§ 706.03(x) and
1412.03.






V. BROADENING REISSUE - OATH/
DECLARATION REQUIREMENTS


(a)Reissue Claims are Narrower in Scope Than
A broadening reissue application must be applied
Patent Claims, in Area Not Directed to  
for by all of the inventors (patentees), that is, the original
Amendment/Argument Made to Overcome
reissue oath or declaration must be signed by all
Art Rejection in Original Prosecution; are
of the inventors. See also MPEP § 1414. If a supplemental
Broader in Scope by Omitting Limitation(s)  
oath or declaration in a broadening reissue
Added/Argued To Overcome Art Rejection
application is needed in the application in order to fulfill
in Original Prosecution:
the requirements of 37 CFR 1.175, the supplemental
reissue oath or declaration must be signed by all of
the inventors. See In re Hayes, 53 USPQ2d 1222
(Comm’r Pat. 1999) and MPEP § 1414.01.


In this case, there is recapture.  
1412.04Correction of Inventorship [R-5]


This situation is where the patent claims are
The correction of misjoinder of inventors has been
directed to combination ABC and the reissue claims
held to be a ground for reissue. See Ex parte Scudder,
are directed to ABD. Element C was either a limitation
169 USPQ 814, 815 (Bd. App. 1971) wherein the  
added to AB to obtain allowance of the original
Board held that 35 U.S.C. 251 authorizes reissue
patent, or was argued by applicant to define over the  
applications to correct misjoinder of inventors where35 U.S.C. 256 is inadequate. See also A.F. Stoddard &  
art (or both). Thus, addition of C (and/or argument as
Co. v. Dann, 564 F.2d 556, 567 n.16, 195 USPQ 97,  
to C) has resulted in the surrender of any combination
106 n.16 (D.C. Cir. 1977) wherein correction of
of A & B that does not include C; this is the surrendered
inventorship from sole inventor A to sole inventor B
subject matter. Element D, on the other hand, is
was permitted in a reissue application. The court
not related to the surrendered subject matter. Thus, the
noted that reissue by itself is a vehicle for correcting
reissue claim, which no longer contains C, is broadened
inventorship in a patent.
in an area related to the surrender, and the narrowing
via the addition of D does not save the claim
from recapture since D is not related to the surrendered
subject matter.


Reissue claims that are broader than the original
I.CERTIFICATE OF CORRECTION AS A
patent claims by not including the surrender-generating
VEHICLE FOR CORRECTING INVEN-
limitation (element C, in the example given) will
TORSHIP
be barred by the recapture rule even though there is
narrowing of the claims not related to the surrender-
generating limitation. As stated in the decision of In re
Clement, 131 F.3d at 1470, 45 USPQ2d at 1165, if the
reissue claim is broader in an aspect germane to a
prior art rejection, but narrower in another aspect
completely unrelated to the rejection, the recapture
rule bars the claim. Pannu v. Storz Instruments Inc.,
supra, then brings home the point by providing an
actual fact situation in which this scenario was held to
be recapture.


(b)Reissue Claims are Narrower or Equal in  
While reissue is a vehicle for correcting inventorship
Scope, in Area Directed to Amendment/
in a patent, correction of inventorship should be
Argument Made to Overcome Art Rejection
effected under the provisions of 35 U.S.C. 256 and
in Original Prosecution; are Broader in
37
Scope in Area Not Directed to Amendment/
CFR 1.324 by filing a request for a Certificate of
Argument:
Correction if:


In this case, there is no recapture.
(A)the only change being made in the patent is to
correct the inventorship; and


This situation is where the patent claims are  
(B)all parties are in agreement and the inventorship
directed to combination ABCDE and the reissue
issue is not contested.
claims are directed to ABDE (element C is omitted).
Assume that the combination of ABCD was present in
the original application as it was filed, and element E
was later added to define over that art. No argument
was ever presented as to elements A-C defining over
the art.  


In this situation, the ABCDE combination of the
See MPEP § 1481 for the procedure to be followed
patent can be broadened (in the reissue application) to  
to obtain a Certificate of Correction for correction of  
omit element C, and thereby claim the combination of
inventorship.
ABDE, where element E (the surrender generating
limitation) is not omitted. There would be no recapture
in this instance. (If an argument had been presented
as to element C defining over the art, in
addition to the addition of element E, then the
ABCDE combination could not be broadened to omit
element C and thereby claim combination of ABDE.
This would be recapture; see the above discussion as
to surrender and recapture based upon argument.)


Additionally, the reissue claims are certainly permitted
II.REISSUE AS A VEHICLE FOR CORRECTING
to recite combination ABDEspecific (where surrender-
INVENTORSHIP
generating element E is narrowed). The patent
claims have been broadened in an area not directed to
the surrender (by omitting element C) and narrowed
in the area of surrender (by narrowing element E to
Especific). This is clearly permitted.


As another example, assume limitation C was
Where the provisions of 35 U.S.C. 256 and
added to application claims AB to obtain the patent to
37
ABC, and now the reissue application presents claims
CFR 1.324 do not apply, a reissue application is
to AC or ABbroadC. Such reissue claims avoid the  
the appropriate vehicle to correct inventorship. The
effect of the recapture rule because they are broader in
failure to name the correct inventive entity is an error
a way that does not attempt to reclaim what was surrendered
in the patent which is correctable under 35 U.S.C.  
earlier. Mentor Corp. v. Coloplast, Inc., 998
251. The reissue oath or declaration pursuant to  
F.2d 992, 994, 27 USPQ2d 1521, 1525 (Fed. Cir.
37
1993). Such claims are considered to be broader in an
CFR 1.175 must state that the applicant believes
aspect not 'germane to a prior art rejection,' and thus
the original patent to be wholly or partly inoperative
are not barred by recapture. Note In re Clement,
or invalid through error of a person being incorrectly
131
named in an issued patent as the inventor, or through
F.3d at 1470, 45 USPQ2d at 1165.
error of an inventor incorrectly not named in an
 
issued
Reissue claims that are broader than the original  
patent, and that such error arose without any
patent claims by deletion of a limitation or claim
deceptive intention on the part of the applicant. The
requirement other than the “surrender-generating limitation”
will avoid the effect of the recapture rule,  
regardless of the nature of the narrowing in the
claims, and even if the claims are not narrowed at all
from the scope of the patent claims.




Line 2,354: Line 2,380:
   
   


(c)Reissue Claims are Narrower in Scope in
reissue oath or declaration must, as stated in 37 CFR
Area Not Directed to Amendment/Argument
1.175, also comply with 37CFR 1.63.
Made to Overcome Art Rejection in Original
Prosecution; are Broader in Scope in Area
Not Directed to the Amendment/Argument:


In this instance, there is clearly no recapture. In the  
The correction of inventorship does not enlarge the
reissue application, there has been no change in the  
scope of the patent claims. Where a reissue application
claims related to the matter surrendered in the original
does not seek to enlarge the scope of the claims of
application for the patent.
the original patent, the reissue oath may be made and
 
sworn to, or the declaration made, by the assignee of
In this instance, element C was added to the AB
the entire interest under 37 CFR 1.172. An assignee of
combination to provide ABC and define over the art,  
part interest may not file a reissue application to correct
and the patent was issued. The reissue omits element
inventorship where the other co-owner did not
B and adds element Z, to thus claim ACZ. There is no
join in the reissue application and has not consented
recapture since the surrender generating element C
to the reissue proceeding. See Baker Hughes Inc. v.
has not been modified in any way. (Note, however,  
Kirk, 921 F. Supp. 801, 809, 38 USPQ2d 1885, 1892
that if, when element C was added to AB, applicant
(D.D.C. 1995). See 35 U.S.C. 251, third paragraph.
argued that the association of newly added C with B
Thus, the signatures of the inventors are not needed
provides a synergistic (unexpected) result to thus
on the reissue oath or declaration where the assignee
define over the art, then neither B nor C could be
of the entire interest signs the reissue oath/declaration.
omitted in the reissue application.)
Accordingly, an assignee of the entire interest can add
or delete the name of an inventor by reissue (e.g., correct
inventorship from inventor A to inventors A and
B) without the original inventor’s consent. See also 37
CFR 3.71(a) (“One or more assignees as defined in  
paragraph (b) of this section may, after becoming of
record pursuant to paragraph (c) of this section, conduct
prosecution of a national patent application or
reexamination proceeding to the exclusion of either
the inventive entity, or the assignee(s) previously
entitled to conduct prosecution.” Emphasis added).  
Thus, the assignee of the entire interest can file a reissue
to change the inventorship to one which the
assignee believes to be correct, even though an inventor
might disagree. The protection of the assignee’s
property rights in the application and patent are statutorily
based in 35 U.S.C. 118.
 
Where the name of an inventor X is to be deleted in
a reissue application to correct inventorship in a
patent, and inventor X has not assigned his/her rights
to the patent, inventor X has an ownership interest in
the patent. Inventor X must consent to the reissue  
(37
CFR 1.172(a)), even though inventor X’s name is
being deleted as an inventor and need not sign the
reissue oath or declaration. If inventor X has assigned
his/her rights to the patent, then inventor X’s assignee
must consent. In addition to providing the consent,
even though inventor X does not sign the reissue oath
or declaration as an inventor (since the correction of
inventorship does not enlarge the scope of the patent
claims), the assignee of the entire interest must sign
the reissue oath or declaration as assignee (37 CFR
1.172(a)). Thus, if inventor X has not assigned his/her
patent rights, inventor X’s signature must be included
in the reissue oath or declaration as the assignee. If
inventor X has assigned his/her patent rights, inventor
X’s assignee must sign the reissue oath or declaration
as the assignee. For example, a patent to inventors X
and Y has no assignee. A reissue application is filed
by inventor Y to delete the name of inventor X as an
inventor. 37 CFR 1.172(a) provides that a reissue oath
or declaration may be made by the assignee/owners of
the entire interest, rather than by the inventors, where
the scope of the claims is not to be enlarged. However,
since inventor X has not assigned his/her patent
rights, inventor X must sign the reissue oath or declaration
as one of the owners, and consent to the filing
of the reissue application by inventor Y. See MPEP
§
1410.01.
 
Where a reissue to correct inventorship also
changes the claims to enlarge the scope of the patent
claims, the signature of all the inventors is needed.
However, if an inventor refuses to sign the reissue
oath or declaration because he or she believes the
change in inventorship (to be effected) is not correct,
the reissue application can still be filed with a petition
under 37 CFR 1.47 without that inventor’s signature
provided the written consent of all owners/assignees
as required by 37 CFR 1.172(a) is also submitted. In
the situation where a patent to inventors X and Y has
no assignee and a reissue application is filed by inventor
Y to delete the name of inventor X as an inventor
and to broaden the patent. Inventor X refuses to sign
the reissue oath or declaration and refuses to provide
the consent as required by 37 CFR 1.172(a). In this
instance, a 37 CFR 1.47 petition would not be appropriate
to permit the filing of the reissue application
since the consent requirement of 37 CFR 1.172(a) for
each owner/assignee is not met. Resort to the courts
would be required to delete the name of inventor X as
an inventor where X will not consent to the filing of a
reissue application. As stated in the second paragraph
of 35 U.S.C. 256, “[t]he court before which such matter
is called in question may order correction of the
patent on notice and hearing of all parties concerned
and the Director shall issue a certificate accordingly.”
 
The reissue application with its reissue oath or declaration
under 37 CFR 1.175 provides a complete
mechanism to correct inventorship. See A.F. Stoddard


(d)Reissue Claims Broader in Scope in Area
Directed to Amendment/Argument Made to
Overcome Art Rejection in Original
Prosecution; but Reissue Claims Retain, in
Broadened Form, the Limitation(s) Argued/
Added to Overcome Art Rejection in
Original Prosecution:


Assume the combination AB was originally
claimed in the application, and was amended in reply
to an art rejection to add element C and thus provide
the combination ABC (after which the patent issued).
A reissue application is then filed, and the reissue
application claims are directed to the combination
ABCbroadened. The ABCbroadened claims are narrowed
in scope when compared with the canceled claim subject
matter AB, because of the addition of Cbroadened.
Thus, the claims retain, in broadened form, the limitation
argued/added to overcome art rejection in original
prosecution. There is no recapture, since
ABCbroadened is narrower than canceled claim subject
matter AB in an area related to the surrender. This is
so, because it was element C that was added in the
application to overcome the art. See Ex Parte Eggert,
supra.


II.REISSUE TO TAKE ADVANTAGE OF
35
U.S.C. 103(b):


A patentee may file a reissue application to permit
consideration of process claims which qualify for
35
U.S.C. 103(b) treatment if a patent is granted on an
application entitled to the benefit of 35 U.S.C. 103(b),
without an election having been made as a result of..
error without deceptive intent. See MPEP
§
   
   
706.02(n). This is not to be considered a recapture.
The addition of process claims, however, will
generally be considered to be a broadening of the
invention (Ex parte Wikdahl, 10 USPQ2d 1546 (Bd.
Pat. App. & Inter. 1989)), and such addition must be
applied for within two years of the grant of the original
patent. See also MPEP § 1412.03 as to broadened
claims.


III.REISSUE FOR ARTICLE CLAIMS
& Co. v. Dann, 564 F.2d at 567, 195 USPQ at 106. A
WHICH ARE FUNCTIONAL DESCRIPTIVE
request under 37
MATERIAL STORED ON A COMPUTER-
CFR 1.48 or a petition under 37 CFR
READABLE MEDIUM:
1.324 cannot be used to correct the inventorship of a
reissue application. If a request under 37 CFR 1.48 or
a petition under 37 CFR 1.324 is filed in a reissue
application, the request or petition should be dismissed
and the processing or petition fee refunded.
The material submitted with the request or petition
should then be considered to determine if it complies
with 37 CFR 1.175. If the material submitted with the
request or petition does comply with the requirements
of 37 CFR 1.175 (and the reissue application is otherwise
in order), the correction of inventorship will be
permitted as a correction of an error in the patent
under 35 U.S.C. 251.
 
Where a reissue application seeks to correct inventorship
in the patent and the inventors are required to
sign the reissue oath or declaration (rather than an
assignee of the entire interest under 37 CFR 1.172)
due to a broadening of any claims of the original
patent, the correct inventive entity must sign the reissue
oath or declaration. Where an inventor is being
added in a reissue application to correct inventorship
in a patent, the inventor being added must sign the
reissue oath or declaration together with the inventors
previously designated on the patent. For example, a
reissue application is filed to correct the inventorship
from inventors A and B (listed as inventors on the
patent) to inventors A, B, and C. Inventor C is the
inventor being added. In such a case, A, B, and C are
the correct inventors, and accordingly, each of A, B,
and C must sign the reissue oath or declaration.
Where an inventor is being deleted in a reissue application
to correct inventorship in a patent and the
inventors are required to sign the oath or declaration
due to a broadening of any claims of the original
patent, the inventor being deleted need not sign the
reissue oath or declaration. The reissue oath or declaration
must be signed by the correct inventive entity.
For example, a reissue application is filed to correct
inventorship from inventors A, B, and C (listed as
inventors on the patent) to inventors A and B. Inventor
C is being deleted as a named inventor. In such a
case, A and B are the correct inventors, and accordingly,
inventors A and B must sign the reissue oath or
declaration but inventor C need not sign the reissue
oath or declaration.
 
==1413 Drawings==


A patentee may file a reissue application to permit
37 CFR 1.173. Reissue specification, drawings, and  
consideration of article of manufacture claims which
amendments.
are functional descriptive material stored on a computer-
readable medium, where these article claims
correspond to the process or machine claims which
have been patented. The error in not presenting claims
to this statutory category of invention (the “article”
claims) must have been made as a result of error without
deceptive intent. The addition of these “article”
claims will generally be considered to be a broadening
of the invention (Ex parte Wikdahl, 10 USPQ2d
1546 (Bd. Pat. App. & Inter. 1989)), and such addition
must be applied for within two years of the grant of
the original patent. See also MPEP § 1412.03 as to
broadened claims.


IV.REJECTION BASED UPON RECAPTURE:




Reissue claims which recapture surrendered subject
(a)(2) Drawings. Applicant must submit a clean copy of each
matter should be rejected using form paragraph 14.17.
drawing sheet of the printed patent at the time the reissue application
is filed. If such copy complies with § 1.84, no further drawings
will be required. Where a drawing of the reissue application
is to include any changes relative to the patent being reissued, the
changes to the drawing must be made in accordance with paragraph  
(b)(3) of this section. The Office will not transfer the drawings
from the patent file to the reissue application.
 


¶ 14.17 Rejection, 35 U.S.C. 251, Recapture


Claim[1] rejected under 35 U.S.C. 251 as being an improper
A clean copy (e.g., good quality photocopies free of
recapture of broadened claimed subject matter surrendered in the  
any extraneous markings) of each drawing sheet of  
application for the patent upon which the present reissue is based.  
the printed patent must be supplied by the applicant at
See Pannu v. Storz Instruments Inc., 258 F.3d 1366, 59 USPQ2d
the time of filing of the reissue application. If the copies
1597 (Fed. Cir. 2001); Hester Industries, Inc. v. Stein, Inc., 142
meet the requirements of 37 CFR 1.84, no further
F.3d 1472, 46 USPQ2d 1641 (Fed. Cir. 1998); In re Clement, 131
formal drawings will be required. New drawing sheets
are not to be submitted, unless some change is made
in the original patent drawings. Such changes must be
made in accordance with 37 CFR 1.173(b)(3).


The prior reissue practice of transferring drawings
from the patent file has been eliminated, since clean
photocopies of the printed patent drawings are acceptable
for use in the printing of the reissue patent.


AMENDMENT OF DRAWINGS


37 CFR 1.173. Reissue specification, drawings, and
amendments.




F.3d 1464, 45 USPQ2d 1161 (Fed. Cir. 1997); Ball Corp. v.
United States, 729 F.2d 1429, 1436, 221 USPQ 289, 295 (Fed. Cir.
1984). A broadening aspect is present in the reissue which was not
present in the application for patent. The record of the application
for the patent shows that the broadening aspect (in the reissue)
relates to claim subject matter that applicant previously surrendered
during the prosecution of the application. Accordingly, the
narrow scope of the claims in the patent was not an error within
the meaning of 35 U.S.C. 251, and the broader scope of claim subject
matter surrendered in the application for the patent cannot be
recaptured by the filing of the present reissue application.


[2]


Examiner Note:


In bracket 2, the examiner should explain the specifics of why
(b)(3) Drawings. One or more patent drawings shall be
recapture exists, including an identification of the omitted/broadened
amended in the following manner: Any changes to a patent drawing
claim limitations in the reissue which provide the “broadening
must be submitted as a replacement sheet of drawings which
aspect” to the claim(s), and where in the original application
shall be an attachment to the amendment document. Any replacement
the narrowed claim scope was presented/argued to obviate a rejection/
sheet of drawings must be in compliance with § 1.84 and
objection. See MPEP §
shall include all of the figures appearing on the original version of  
the sheet, even if only one figure is amended. Amended figures
1412.02.  
must be identified as “Amended,” and any added figure must be
identified as “New.” In the event that a figure is canceled, the figure
must be surrounded by brackets and identified as “Canceled.”
All changes to the drawing(s) shall be explained, in detail, beginning
on a separate sheet accompanying the papers including the  
amendment to the drawings.


See the recapture-analysis flow chart which follows
for assistance in determining whether recapture is
present, consistent with the case law discussed above.




The provisions of 37 CFR
1.173(b)(3) govern the
manner of making amendments (changes) to the






Flowchart - Reissue Recapture - Determining its presence or absence




drawings in a reissue application. The following guidance
is provided as to the procedure for amending
drawings:


(A)Amending the original or printed patent drawing
sheets by physically changing or altering them is
not permitted. Any request to do so should be denied.


(B)Where a change to the drawings is desired,
applicant must submit a replacement sheet for each
sheet of drawings containing a Figure to be revised.
Any replacement sheet must comply with 37 CFR
1.84 and include all of the figures appearing on the
original version of the sheet, even if only one figure is
being amended. Each figure that is amended must be
identified by placing the word “Amended” at the bottom
of that figure. Any added figure must be identified
as “New.” In the event that a figure is canceled,
the figure must be identified as “Canceled” and also
surrounded by brackets. All changes to the figure(s)
must be explained, in detail, beginning on a separate
sheet which accompanies the papers including the
amendment to the drawings.


(C)If desired, applicant may include a marked-up
copy of any amended drawing figure, including annotations
indicating the changes made. Such a marked-
up copy must be clearly labeled as “Annotated
Marked-up Drawings”, and it must be presented in the
amendment or remarks section that explains the
change to the drawings.


1412.03Broadening Reissue Claims
In addition, the examiner may desire a marked-up
[R-3]
copy of any amended drawing figure, and so state in
 
an Office action. A marked-up copy of any amended
35 U.S.C. 251 prescribes a 2-year limit for filing
drawing figure, including annotations indicating the
applications for broadening reissues:
changes made, must be provided when required by the
examiner.
 
(D)For each proper new drawing sheet being
added, the new sheet should be inserted after the
existing drawing sheets. For each proper  drawing
sheet being added which replaces an existing drawing
sheet, the existing sheet should be canceled by
placing the sheet face down in the file and placing a
large “X” on the back of the sheet. The new sheet
should be inserted in place of the turned over existing
sheet.


No reissue patent shall be granted enlarging the scope of  
(E)If any drawing change  is not  approved,
the original patent unless applied for within two years
or if any submitted sheet of formal drawings is not
from the grant of the original patent.  
entered, the examiner will so inform the reissue applicant
in the next Office action, and the examiner will
set forth the reasons for same.


==1414 Content of Reissue Oath/Declaration==


37 CFR 1.175. Reissue oath or declaration.


I. MEANING OF “BROADENED REISSUE
(a)The reissue oath or declaration in addition to complying
CLAIM”
with the requirements of § 1.63, must also state that:


A broadened reissue claim is a claim which
(1)The applicant believes the original patent to be wholly
enlarges the scope of the claims of the patent, i.e., a
or partly inoperative or invalid by reason of a defective specification
claim which is greater in scope than each and every
or drawing, or by reason of the patentee claiming more or less
claim of the original patent. If a disclaimer is filed in
than the patentee had the right to claim in the patent, stating at
the patent prior to the filing of a reissue application,
least one error being relied upon as the basis for reissue; and
the disclaimed claims are not part of the “original
patent” under 35 U.S.C. 251. The Court in Vectra Fitness
Inc. v. TNWK Corp., 49 USPQ2d 1144, 1147,
162 F.3d 1379, 1383 (Fed. Cir. 1998) held that a reissue
application violated the statutory prohibition
under 35 U.S.C. 251 against broadening the scope of  
the patent more than 2 years after its grant because the
reissue claims are broader than the claims that remain
after the disclaimer, even though the reissue claims
are narrower than the claims that were disclaimed by
the patentee before reissue. The reissue application
was bounded by the claims remaining in the patent  
after a disclaimer is filed.A claim of a reissue application
enlarges the scope of the claims of the patent if it
is broader in at least one respect, even though it may
be narrower in other respects.


A claim in the reissue which includes subject matter
(2)All errors being corrected in the reissue application up
not covered by the patent claims enlarges the scope
to the time of filing of the oath or declaration under this paragraph
of the patent claims. For example, if any amended or
arose without any deceptive intention on the part of the applicant.
newly added claim in the reissue contains within its
scope any conceivable product or process which
would not have infringed the patent, then that reissue
claim would be broader than the patent claims. Tillotson,
Ltd. v. Walbro Corp., 831 F.2d 1033, 1037 n.2,
4
USPQ2d 1450, 1453 n.2 (Fed. Cir. 1987); In re
Ruth, 278 F.2d 729, 730, 126 USPQ 155, 156 (CCPA
1960); In re Rogoff, 261 F.2d 601, 603, 120 USPQ
185, 186 (CCPA 1958). A claim which reads on
something which the original claims do not is a broadened
claim. A claim would be considered a broadening
claim if the patent owner would be able to sue any
party for infringement who previously could not have
been sued for infringement. Thus, where the original
patent claims only the process, and the reissue application  
adds (for the first time) product claims, the
scope of the claims has been broadened since a party
could not be sued for infringement of the product
based on the claims of the original patent.


The addition of combination claims in a reissue
(b)(1) For any error corrected, which is not covered by the  
application where only subcombination claims were
oath or declaration submitted under paragraph (a) of this section,  
present in the original patent could be a broadening of
applicant must submit a supplemental oath or declaration stating
the invention. The question which must be resolved in
that every such error arose without any deceptive intention on the  
this case is whether the combination claims added in
part of the applicant. Any supplemental oath or declaration
the reissue would be for “the invention as claimed” in
required by this paragraph must be submitted before allowance
the original patent. See Ex parte Wikdahl, 10 USPQ2d
and may be submitted:
at 1549. The newly added combination claims should
be analyzed to determine whether they contain every
limitation of the subcombination of any claim of the
original patent. If the combination claims (added in
the reissue) contain every limitation of the subcombination
(which was claimed in the original application),  
then infringement of the combination must also
result in infringement of the subcombination. Accordingly,
the patent owner could not, if a reissue patent
issues with the combination claims, sue any new
party for infringement who could not have been sued
for infringement of the original patent. Therefore,
broadening does not exist, in spite of the addition of
the combination.


(i) With any amendment prior to allowance; or


(ii) In order to overcome a rejection under 35
U.S.C. 251
made by the examiner where it is indicated that the submission of
a supplemental oath or declaration as required by this paragraph
will overcome the rejection.


II. SCOPE OF DEPENDENT CLAIM
(2)For any error sought to be corrected after allowance, a
ENLARGED-NOT BROADENING
supplemental oath or declaration must accompany the requested
correction stating that the error(s) to be corrected arose without
any deceptive intention on the part of the applicant.  


As pointed out above, a claim will be considered a
(c)Having once stated an error upon which the reissue is  
broadened reissue claim when it is greater in scope
based, as set forth in paragraph (a)(1), unless all errors previously
than each and every claim of the patent to be reissued.
stated in the oath or declaration are no longer being corrected, a
A corollary of this is that a claim which has
subsequent oath or declaration under paragraph (b) of this section
been broadened in a reissue as compared to its scope
need not specifically identify any other error or errors being corrected.
in the patent is not a broadened reissue claim if it is  
narrower than, or equal in scope to, any other claim
which appears in the patent. A common example of
this is where dependent claim 2 is broadened via the
reissue (other than the addition of a process step to
convert an intermediate to a final product as discussed
in the preceding subsection), but independent claim 1
on which it is based is not broadened. Since a dependent
claim is construed to contain all the limitations of
the claim upon which it depends, claim 2 must be at




(d)The oath or declaration required by paragraph (a) of this
section may be submitted under the provisions of § 1.53(f).


(e)The filing of any continuing reissue application which
does not replace its parent reissue application must include an
oath or declaration which, pursuant to paragraph (a)(1) of this section,
identifies at least one error in the original patent which has
not been corrected by the parent reissue application or an earlier
reissue application. All other requirements relating to oaths or
declarations must also be met.


The reissue oath/declaration is an essential part of a
reissue application and must be filed with the application,
or within the time period set under 37 CFR
1.53(f) along with the required surcharge as set forth
in 37 CFR 1.16(f) in order to avoid abandonment.


least as narrow as claim 1 and is thus not a broadened
The question of the sufficiency of the reissue oath/
reissue claim.
declaration filed under 37 CFR 1.175 must in each
case be reviewed and decided personally by the primary
examiner.






III. NEW CATEGORY OF INVENTION
ADDED IN REISSUE - GENERALLY
IS BROADENING


The addition of process claims as a new category of
invention to be claimed in the patent (i.e., where there
were no method claims present in the original patent)
is generally considered as being a broadening of the
invention. See Ex parte Wikdahl, 10 USPQ2d 1546
(Bd. Pat. App. & Inter. 1989). A situation may arise,
however, where the reissue application adds a limitation
(or limitations) to process A of making the product
A claimed in the original patent claims. For
example:


(1)a process of using the product A (made by the
Reissue oaths or declarations must contain the following:
process of the original patent) to make a product B,
disclosed but not claimed in the original patent; or


(2)a process of using the product A to carry out a
process B disclosed but not claimed in the original
patent.


Although this amendment of the claims adds a
(A)A statement that the applicant believes the  
method of making product B or adds a method of
original patent to be wholly or partly inoperative or
using product A, this is not broadening (i.e., this is not
invalid—
an enlargement of the scope of the original patent)
because the “newly claimed invention” contains all
the limitations of the original patent claim(s).


(1)by reason of a defective specification or
drawing, or


(2)by reason of the patentee claiming more or
less than patentee had the right to claim in the patent;


IV. WHEN A BROADENED CLAIM CAN BE
(B)A statement of at least one error which is
PRESENTED
relied upon to support the reissue application, i.e., as
the basis for the reissue;


A broadened claim can be presented within two
(C)A statement that all errors which are being
years from the grant of the original patent in a reissue
corrected in the reissue application up to the time of
application. In addition, a broadened claim can be
filing of the oath/declaration arose without any deceptive
presented after two years from the grant of the original
intention on the part of the applicant; and
patent in a broadening reissue application
which was filed within two years from the grant.
Where any intent to broaden is indicated in the reissue  
application within the two years from the patent grant,
a broadened claim can subsequently be presented in
the reissue after the two year period. Thus, a broadened
claim may be presented in a reissue application
after the two years, even though the broadened claim
presented after the two years is different than the
broadened claim presented within the two years.
Finally, if intent to broaden is indicated in a parent
reissue application within the two years, a broadened
claim can be presented in a continuing (continuation
or divisional) reissue application after the two year
period. In any other situation, a broadened claim cannot
be presented, and the examiner should check carefully
for the improper presentation of broadened
claims.


A reissue application filed on the 2-year anniversary
(D)The information required by 37 CFR 1.63.
date from the patent grant is considered to be
filed within 2 years of the patent grant. See Switzer v.
Sockman, 333 F.2d 935, 142 USPQ 226 (CCPA 1964)  
for a similar rule in interferences.


See also the following cases which pertain to
These elements will now be discussed:
broadened reissues:


In re Graff, 111 F.3d 874, 877, 42 USPQ2d 1471,
I.A STATEMENT THAT THE APPLICANT
1473-74 (Fed. Cir. 1997) (Broadened claims in a continuing
BELIEVES THE ORIGINAL PATENT TO
reissue application were properly rejected
BE WHOLLY OR PARTLY INOPERATIVE
under 35 U.S.C. 251 because the proposal for broadened
OR INVALID BY REASON OF A DEFECTIVE
claims was not made (in the parent reissue application)
SPECIFICATION OR DRAWING,
within two years from the grant of the original
OR BY REASON OF THE PATENTEE
patent and the public was not notified that broadened
CLAIMING MORE OR LESS THAN PATENTEE
claims were being sought until after the two-year
HAD THE RIGHT TO CLAIM IN
period elapsed.);
THE PATENT.


In re Fotland, 779 F.2d 31, 228 USPQ 193 (Fed.
In order to satisfy this requirement, a declaration
Cir. 1985), cert. denied, 476 U.S. 1183 (1986) (The
can state as for example:
failure by an applicant to include an oath or declaration
indicating a desire to seek broadened claimswithin two years of the patent grant will bar a subsequent
attempt to broaden the claims after the two year
limit. Under the former version of 37 CFR 1.175 (the
former 37 CFR 1.175(a)(4)), applicant timely sought
a “no-defect” reissue, but the Court did not permit an
attempt made beyond the two year limit to convert the
reissue into a broadening reissue. In this case, applicant
did not indicate any intent to broaden within the
two years.);


In re Bennett, 766 F.2d 524, 528, 226 USPQ 413,
416 (Fed. Cir. 1985) (en banc) (A reissue application
with broadened claims was filed within two years of
the patent grant; however, the declaration was executed
by the assignee rather than the inventor. The
Federal Circuit permitted correction of the improperly
executed declaration to be made more than two years
after the patent grant.);


In re Doll, 419 F.2d 925, 928, 164 USPQ 218, 220
(CCPA 1970) (If the reissue application is timely filed
within two years of the original patent grant and the


1. “Applicant believes the original patent to be
partly inoperative or invalid by reason of a defective
specification or drawing.”






2. “Applicant believes the original patent to be
partly inoperative or invalid by reason of the patentee
claiming more than patentee had a right to claim in
the patent.”


applicant indicates in the oath or declaration that the
claims will be broadened, then applicant may subsequently
broaden the claims in the pending reissue
prosecution even if the additional broadening occurs
beyond the two year limit.).


Form paragraphs 14.12 and 14.13 may be used in
rejections based on improper broadened reissue
claims.


¶ 14.12 Rejection, 35 U.S.C. 251, Broadened Claims After
3. “Applicant believes the original patent to be
Two Years
partly inoperative or invalid by reason of the patentee
claiming less than patentee had a right to claim in the
patent.


Claim [1] rejected under 35 U.S.C. 251 as being broadened in  
Where the specification or drawing is defective andpatentee claimed both more and less than patentee had
a reissue application filed outside the two year statutory period.  
the right to claim in the patent, then all three statements
[2] A claim is broader in scope than the original claims if it contains
should be included in the reissue oath/declaration.  
within its scope any conceivable product or process which
A statement that the original patent is “wholly
would not have infringed the original patent. A claim is broadened
or partly inoperative or invalid” (emphasis added) by
if it is broader in any one respect even though it may be narrower
reason of the patentee “claiming more or less than the
in other respects.
patentee had the right to claim in the patent” (emphasis
added) is improper since a claim cannot claim
“more or less” at the same time. Where, however, a
given independent claim is considered to be overly
broad, and another independent claim is considered to
be overly narrow, patentee has claimed both more andless than he or she had a right to claim. In such an
instance, both the second and third above-quoted
statements would be used. See MPEP § 1412.04 for
an exemplary declaration statement when the error
being corrected is an error in inventorship.
 
The above examples will be sufficient to satisfy this
requirement without any further statement.


Examiner Note:
It should be noted that the reissue oath/declaration
must also satisfy the requirement for a statement of at
least one error being relied upon as the basis for reissue,
in the manner set forth in subsection II. below.


The claim limitations that broaden the scope should be identified
Form paragraph 14.01 may be used where the reissue
and explained in bracket 2. See MPEP §§ 706.03(x) and
oath/declaration does not provide the required
1412.03.
statement as to applicant’s belief that the original
patent is wholly or partly inoperative or invalid.  


¶ 14.13 Rejection, 35 U.S.C. 251, Broadened Claims Filed
¶ 14.01 Defective Reissue Oath/Declaration, 37 CFR
by Assignee
1.175(a)(1) - No Statement of Defect in the Patent


Claim [1] rejected under 35 U.S.C. 251 as being improperly
The reissue oath/declaration filed with this application is
broadened in a reissue application made and sworn to by the  
defective because it fails to contain the statement required under
assignee and not the patentee. [2]A claim is broader in scope than
37 CFR 1.175(a)(1) as to applicant’s belief that the original patent
the original claims if it contains within its scope any conceivable
is wholly or partly inoperative or invalid. See 37 CFR 1.175(a)(1)
product or process which would not have infringed the original
and see MPEP §
patent. A claim is broadened if it is broader in any one respecteven though it may be narrower in other respects.
1414. [1]


Examiner Note:
Examiner Note:


The claim limitations that broaden the scope should be identified
1.Use this form paragraph when applicant: (a) fails to allege
and explained in bracket 2. See MPEP §§ 706.03(x) and  
that the original patent is inoperative or invalid and/or (b) fails to
1412.03.
state the reason of a defective specification or drawing, or of patentee
claiming more or less than patentee had the right to claim in  
the patent . In bracket 1, point out the specific defect to applicant
by using the language of (a) and/or (b), as it is appropriate.


2.Form paragraph 14.14 must follow this form paragraph.


II.A STATEMENT OF AT LEAST ONE ERROR
WHICH IS RELIED UPON TO SUPPORT
THE REISSUE APPLICATION (I.E.,
THE BASIS FOR THE REISSUE).


V. BROADENING REISSUE - OATH/
(A)A reissue applicant must acknowledge the
DECLARATION REQUIREMENTS
existence of an error in the specification, drawings, or
claims, which error causes the original patent to be


A broadening reissue application must be applied
for by all of the inventors (patentees), that is, the original
reissue oath or declaration must be signed by all
of the inventors. See also MPEP § 1414. If a supplemental
oath or declaration in a broadening reissue
application is needed in the application in order to fulfill
the requirements of 37 CFR 1.175, the supplemental
reissue oath or declaration must be signed by all of
the inventors. See In re Hayes, 53 USPQ2d 1222
(Comm’r Pat. 1999) and MPEP § 1414.01.


1412.04Correction of Inventorship [R-5]


The correction of misjoinder of inventors has been
held to be a ground for reissue. See Ex parte Scudder,
169 USPQ 814, 815 (Bd. App. 1971) wherein the
Board held that 35 U.S.C. 251 authorizes reissue
applications to correct misjoinder of inventors where35 U.S.C. 256 is inadequate. See also A.F. Stoddard &
Co. v. Dann, 564 F.2d 556, 567 n.16, 195 USPQ 97,
106 n.16 (D.C. Cir. 1977) wherein correction of
inventorship from sole inventor A to sole inventor B
was permitted in a reissue application. The court
noted that reissue by itself is a vehicle for correcting
inventorship in a patent.


I.CERTIFICATE OF CORRECTION AS A
VEHICLE FOR CORRECTING INVEN-
TORSHIP


While reissue is a vehicle for correcting inventorship
defective. In re Wilder, 736 F.2d 1516, 222 USPQ 369
in a patent, correction of inventorship should be
(Fed. Cir. 1984). A change or departure from the original
effected under the provisions of 35 U.S.C. 256 and
specification or claims represents an “error” in  
37
the original patent under 35 U.S.C. 251. See MPEP
CFR 1.324 by filing a request for a Certificate of
§
Correction if:
1402 for a discussion of grounds for filing a reissue
that may constitute the “error” required by 35 U.S.C.
251. Not all changes with respect to the patent constitute
the “error” required by 35 U.S.C. 251.


(A)the only change being made in the patent is to
(B)Applicant need only specify in the reissue
correct the inventorship; and
oath/declaration one of the errors upon which reissue
is based. Where applicant specifies one such error,
this requirement of a reissue oath/declaration is satisfied.
Applicant may specify more than one error.


(B)all parties are in agreement and the inventorship
Where more than one error is specified in the
issue is not contested.
oath/declaration and some of the designated “errors”
 
are found to not be “errors” under 35 U.S.C. 251, any
See MPEP § 1481 for the procedure to be followed
remaining error which is an error under 35 U.S.C. 251will still support the reissue.
to obtain a Certificate of Correction for correction of
 
inventorship.
The “at least one error” which is relied upon to
 
support the reissue application must be set forth in the  
II.REISSUE AS A VEHICLE FOR CORRECTING
oath/declaration. It is not necessary, however, to point
INVENTORSHIP
out how (or when) the error arose or occurred. Further,
 
it is not necessary to point out how (or when) the
Where the provisions of 35 U.S.C. 256 and  
error was discovered. If an applicant chooses to point
37
out these matters, the statements directed to these
CFR 1.324 do not apply, a reissue application is  
matters will not be reviewed by the examiner, and the
the appropriate vehicle to correct inventorship. The
applicant should be so informed in the next Office
failure to name the correct inventive entity is an error
action. All that is needed for the oath/declaration
in the patent which is correctable under 35 U.S.C.  
statement as to error is the identification of “at least
251. The reissue oath or declaration pursuant to  
one error” relied upon.
37  
 
CFR 1.175 must state that the applicant believes
In identifying the error, it is sufficient that the
the original patent to be wholly or partly inoperative
reissue oath/declaration identify a single word,
or invalid through error of a person being incorrectly
phrase, or expression in the specification or in an original
named in an issued patent as the inventor, or through
claim, and how it renders the original patent
error of an inventor incorrectly not named in an
wholly or partly inoperative or invalid. The corresponding
issued
corrective action which has been taken to
patent, and that such error arose without any
correct the original patent need not be identified in the
deceptive intention on the part of the applicant. The
oath/declaration. If the initial reissue oath/declaration
“states at least one error” in the original patent, and, in
addition, recites the specific corrective action taken in
the reissue application, the oath/declaration would be
considered acceptable, even though the corrective
action statement is not required.
 
(C)It is not sufficient for an oath/declaration to
merely state “this application is being filed to correct
errors in the patent which may be noted from the
changes made in the disclosure.” Rather, the oath/declaration
must specifically identify an error. In addition,
it is not sufficient to merely reproduce the claims
with brackets and underlining and state that such will
identify the error. See In re Constant, 827 F.2d 728,
729, 3 USPQ2d 1479 (Fed. Cir.), cert. denied, 484
U.S. 894 (1987). Any error in the claims must be
identified by reference to the specific claim(s) and the
specific claim language wherein lies the error.
 
A statement of “…failure to include a claim
directed to…” and then presenting a newly added
claim, would not be considered a sufficient “error”
statement since applicant has not pointed out what the
other claims lacked that the newly added claim has, or
vice versa. Such a statement would be no better than
saying in the reissue oath or declaration that “this
application is being filed to correct errors in the patent
which may be noted from the change made by adding
new claim 10.” In both cases, the error has not been
identified.
 
(D)Where a continuation reissue application is
filed with a copy of the reissue oath/declaration from
the parent reissue application, and the parent reissue
application is not to be abandoned, the reissue oath/
declaration should be accepted by the Office of Initial
Patent Examination without further evaluation, since
it is an oath/declaration, albeit improper under
35
U.S.C. 251. The examiner should, however, reject
the claims of the continuation reissue application
under 35 U.S.C. 251 as being based on an oath/declaration
that does not identify an error being corrected
by the continuation reissue application, and should
require a new oath/declaration. 37 CFR 1.175(e)
states that “the filing of any continuing reissue application
which does not replace its parent reissue application
must include an oath or declaration, which
pursuant to [37 CFR 1.175(a)(1)], identifies at least
one error in the original patent which has not been
corrected by the parent reissue application or an earlier
reissue application.” One of form paragraphs
14.01.01 through 14.01.03 may be used.
 
Where a continuation reissue application is filed
with a copy of the reissue oath/declaration from the
parent reissue application, and the parent reissue
application is, or will be abandoned, the copy of the
reissue oath/declaration should be accepted by OIPE,
and the examiner should check to ensure that the oath/
declaration identifies an error which is still being corrected
in the continuation application. If a preliminary
amendment was filed with the continuation reissue




Line 2,849: Line 2,970:
   
   


reissue oath or declaration must, as stated in 37 CFR  
application, the examiner should check for the need of
1.175, also comply with 37CFR 1.63.
a supplemental reissue oath/declaration. Pursuant to
37 CFR 1.175 (b)(1), for any error corrected via the
preliminary amendment which is not covered by the
oath or declaration submitted in the parent reissue
application, applicant must submit a supplemental
oath/declaration stating that such error arose without
any deceptive intention on the part of the applicant.
See MPEP § 1414.01.


The correction of inventorship does not enlarge the
Where a divisional reissue application is filed
scope of the patent claims. Where a reissue application  
with a copy of the reissue oath/declaration from
does not seek to enlarge the scope of the claims of
the  
the original patent, the reissue oath may be made and
parent reissue application, the reissue oath/declaration
sworn to, or the declaration made, by the assignee of  
should be accepted by OIPE, since it is an oath/
the entire interest under 37 CFR 1.172. An assignee of  
declaration, though it may be improper under
part interest may not file a reissue application to correct
35
inventorship where the other co-owner did not  
U.S.C. 251. The examiner should check the copy
join in the reissue application and has not consented
of the oath/declaration to ensure that it identifies an
to the reissue proceeding. See Baker Hughes Inc. v.
error being corrected by the divisional reissue application.  
Kirk, 921 F. Supp. 801, 809, 38 USPQ2d 1885, 1892
The copy of the oath/declaration from the parent
(D.D.C. 1995). See 35 U.S.C. 251, third paragraph.
reissue application may or may not cover an error
Thus, the signatures of the inventors are not needed
being corrected by the divisional reissue application  
on the reissue oath or declaration where the assignee
since the divisional reissue application is (by definition)
of the entire interest signs the reissue oath/declaration.
directed to a new invention. If it does not, the
Accordingly, an assignee of the entire interest can add
examiner should reject the claims of the divisional
or delete the name of an inventor by reissue (e.g., correct
reissue application under 35 U.S.C. 251 as being
inventorship from inventor A to inventors A and
based on an oath/declaration that does not identify an
B) without the original inventor’s consent. See also 37
error being corrected by the divisional reissue application,
CFR 3.71(a) (“One or more assignees as defined in
and require a new oath/declaration. If the copy of
paragraph (b) of this section may, after becoming of
the reissue oath/declaration from the parent reissue
record pursuant to paragraph (c) of this section, conduct
application does in fact cover an error being corrected
prosecution of a national patent application or
in the divisional reissue application, no such rejection
reexamination proceeding to the exclusion of either
should be made. However, since a new invention is
the inventive entity, or the assignee(s) previously
being added by the filing of the divisional reissue
entitled to conduct prosecution.” Emphasis added).  
application, a supplemental reissue oath/declaration
Thus, the assignee of the entire interest can file a reissue
pursuant to 37 CFR 1.175 (b)(1) will be required. See
to change the inventorship to one which the  
MPEP § 1414.01.
assignee believes to be correct, even though an inventor
 
might disagree. The protection of the assignee’s
Form paragraph 14.01.01 may be used where the  
property rights in the application and patent are statutorily
reissue oath/declaration does not identify an error.
based in 35 U.S.C. 118.


Where the name of an inventor X is to be deleted in
¶ 14.01.01 Defective Reissue Oath/Declaration, 37 CFR  
a reissue application to correct inventorship in a
1.175(a)(1) - No Statement of a Specific Error
patent, and inventor X has not assigned his/her rights
to the patent, inventor X has an ownership interest in
the patent. Inventor X must consent to the reissue
(37
CFR 1.172(a)), even though inventor X’s name is
being deleted as an inventor and need not sign the
reissue oath or declaration. If inventor X has assigned
his/her rights to the patent, then inventor X’s assignee
must consent. In addition to providing the consent,
even though inventor X does not sign the reissue oath
or declaration as an inventor (since the correction of
inventorship does not enlarge the scope of the patent
claims), the assignee of the entire interest must sign
the reissue oath or declaration as assignee (37 CFR  
1.172(a)). Thus, if inventor X has not assigned his/her
patent rights, inventor X’s signature must be included
in the reissue oath or declaration as the assignee. If
inventor X has assigned his/her patent rights, inventor
X’s assignee must sign the reissue oath or declaration
as the assignee. For example, a patent to inventors X
and Y has no assignee. A reissue application is filed
by inventor Y to delete the name of inventor X as an
inventor. 37 CFR 1.172(a) provides that a reissue oath
or declaration may be made by the assignee/owners of
the entire interest, rather than by the inventors, where
the scope of the claims is not to be enlarged. However,
since inventor X has not assigned his/her patent
rights, inventor X must sign the reissue oath or declaration
as one of the owners, and consent to the filing
of the reissue application by inventor Y. See MPEP
§
1410.01.


Where a reissue to correct inventorship also
The reissue oath/declaration filed with this application is  
changes the claims to enlarge the scope of the patent
defective because it fails to identify at least one error which is  
claims, the signature of all the inventors is needed.
relied upon to support the reissue application. See 37 CFR  
However, if an inventor refuses to sign the reissue
1.175(a)(1) and MPEP § 1414.
oath or declaration because he or she believes the
change in inventorship (to be effected) is not correct,
the reissue application can still be filed with a petition
under 37 CFR 1.47 without that inventor’s signature
provided the written consent of all owners/assignees
as required by 37 CFR 1.172(a) is also submitted. In
the situation where a patent to inventors X and Y has
no assignee and a reissue application is filed by inventor
Y to delete the name of inventor X as an inventor
and to broaden the patent. Inventor X refuses to sign
the reissue oath or declaration and refuses to provide
the consent as required by 37 CFR 1.172(a). In this
instance, a 37 CFR 1.47 petition would not be appropriate
to permit the filing of the reissue application
since the consent requirement of 37 CFR 1.172(a) for
each owner/assignee is not met. Resort to the courts
would be required to delete the name of inventor X as
an inventor where X will not consent to the filing of a
reissue application. As stated in the second paragraph
of 35 U.S.C. 256, “[t]he court before which such matter
is called in question may order correction of the
patent on notice and hearing of all parties concerned
and the Director shall issue a certificate accordingly.


The reissue application with its reissue oath or declaration
Examiner Note:
under 37 CFR 1.175 provides a complete
mechanism to correct inventorship. See A.F. Stoddard


1.Use this form paragraph when the reissue oath or declaration
does not contain any statement of an error which is relied upon to
support the reissue application.


2.This form paragraph can be used where the reissue oath or
declaration does not even mention error. It can also can be used
where the reissue oath or declaration contains some discussion of
the concept of error but never in fact identifies a specific error to
be relied upon. For example, it is not sufficient for an oath or declaration
to merely state “this application is being filed to correct
errors in the patent which may be noted from the changes made in
the disclosure.”


3.Form paragraph 14.14 must follow this form paragraph.


Where the reissue oath/declaration does identify an
error or errors, the oath/declaration must be checked
carefully to ensure that at least one of the errors identified
is indeed an “error” which will support the filing
of a reissue, i.e., an “error” that will provide
grounds for reissue of the patent. See MPEP § 1402.
If the error identified in the oath/declaration is not an
appropriate error upon which a reissue can be based,
then the oath/declaration must be indicated to be
defective in the examiner’s Office action.
 
Form paragraphs 14.01.02 and 14.01.03 may be
used where the reissue oath/declaration fails to provide
at least one error upon which a reissue can be
based.


& Co. v. Dann, 564 F.2d at 567, 195 USPQ at 106. A
¶ 14.01.02 Defective Reissue Oath/Declaration, 37 CFR  
request under 37
1.175(a)(1)-The Identified “Error” Is Not Appropriate
CFR 1.48 or a petition under 37 CFR  
Error
1.324 cannot be used to correct the inventorship of a  
reissue application. If a request under 37 CFR 1.48 or
a petition under 37 CFR 1.324 is filed in a reissue
application, the request or petition should be dismissed
and the processing or petition fee refunded.
The material submitted with the request or petition
should then be considered to determine if it complies
with 37 CFR 1.175. If the material submitted with the
request or petition does comply with the requirements
of 37 CFR 1.175 (and the reissue application is otherwise
in order), the correction of inventorship will be
permitted as a correction of an error in the patent
under 35 U.S.C. 251.


Where a reissue application seeks to correct inventorship
The reissue oath/declaration filed with this application is
in the patent and the inventors are required to
defective because the error which is relied upon to support the  
sign the reissue oath or declaration (rather than an
reissue application is not an error upon which a reissue can be
assignee of the entire interest under 37 CFR 1.172)
based. See 37 CFR 1.175(a)(1) and MPEP § 1414.
due to a broadening of any claims of the original
 
patent, the correct inventive entity must sign the reissue
Examiner Note:
oath or declaration. Where an inventor is being
added in a reissue application to correct inventorship
in a patent, the inventor being added must sign the  
reissue oath or declaration together with the inventors
previously designated on the patent. For example, a
reissue application is filed to correct the inventorship
from inventors A and B (listed as inventors on the
patent) to inventors A, B, and C. Inventor C is the
inventor being added. In such a case, A, B, and C are
the correct inventors, and accordingly, each of A, B,
and C must sign the reissue oath or declaration.
Where an inventor is being deleted in a reissue application
to correct inventorship in a patent and the
inventors are required to sign the oath or declaration
due to a broadening of any claims of the original
patent, the inventor being deleted need not sign the
reissue oath or declaration. The reissue oath or declaration
must be signed by the correct inventive entity.  
For example, a reissue application is filed to correct
inventorship from inventors A, B, and C (listed as
inventors on the patent) to inventors A and B. Inventor
C is being deleted as a named inventor. In such a
case, A and B are the correct inventors, and accordingly,
inventors A and B must sign the reissue oath or
declaration but inventor C need not sign the reissue
oath or declaration.


1413Drawings [R-2]
1.Use this form paragraph when the reissue oath/declaration
identifies only one error which is relied upon to support the reissue
application, and that one error is not an appropriate error upon
which a reissue can be based.


37 CFR 1.173. Reissue specification, drawings, and
2.Form paragraph 14.14 must follow this form paragraph.  
amendments.


¶ 14.01.03 Defective Reissue Oath/Declaration, 37 CFR
1.175(a)(1) - Multiple Identified “Errors” Not Appropriate
Errors


The reissue oath/declaration filed with this application is
defective because none of the errors which are relied upon to support
the reissue application are errors upon which a reissue can be
based. See 37 CFR 1.175(a)(1) and MPEP § 1414.


(a)(2) Drawings. Applicant must submit a clean copy of each
Examiner Note:
drawing sheet of the printed patent at the time the reissue application
is filed. If such copy complies with § 1.84, no further drawings
will be required. Where a drawing of the reissue application
is to include any changes relative to the patent being reissued, the
changes to the drawing must be made in accordance with paragraph
(b)(3) of this section. The Office will not transfer the drawings
from the patent file to the reissue application.


1.Use this form paragraph when the reissue oath/declaration
identifies more than one error relied upon to support the reissue
application, and none of the errors are appropriate errors upon
which a reissue can be based.


2.Note that if the reissue oath/declaration identifies more than
one error relied upon, and at least one of the errors is an error
upon which reissue can be based, this form paragraph should not
be used, despite the additional reliance by applicant on “errors”


A clean copy (e.g., good quality photocopies free of
any extraneous markings) of each drawing sheet of
the printed patent must be supplied by the applicant at
the time of filing of the reissue application. If the copies
meet the requirements of 37 CFR 1.84, no further
formal drawings will be required. New drawing sheets
are not to be submitted, unless some change is made
in the original patent drawings. Such changes must be
made in accordance with 37 CFR 1.173(b)(3).


The prior reissue practice of transferring drawings
from the patent file has been eliminated, since clean
photocopies of the printed patent drawings are acceptable
for use in the printing of the reissue patent.


AMENDMENT OF DRAWINGS


37 CFR 1.173. Reissue specification, drawings, and
amendments.


which do not support the reissue. Only one appropriate error is
needed to support a reissue.


3.Form paragraph 14.14 must follow this form paragraph.


III.A STATEMENT THAT ALL ERRORS
WHICH ARE BEING CORRECTED IN
THE REISSUE APPLICATION UP TO
THE TIME OF SIGNING OF THE OATH/
DECLARATION AROSE WITHOUT ANY
DECEPTIVE INTENTION ON THE PART
OF THE APPLICANT.


In order to satisfy this requirement, the following
statement may be included in an oath or declaration:


(b)(3) Drawings. One or more patent drawings shall be
“All errors in the present reissue application up to the time
amended in the following manner: Any changes to a patent drawing
of signing of this oath/declaration, or errors which are
must be submitted as a replacement sheet of drawings which  
being corrected by a paper filed concurrently with this
shall be an attachment to the amendment document. Any replacement
oath/declaration which correction of errors I/we have
sheet of drawings must be in compliance with § 1.84 and
reviewed, arose without any deceptive intention on the  
shall include all of the figures appearing on the original version of  
part of the applicant.
the sheet, even if only one figure is amended. Amended figures
must be identified as “Amended,” and any added figure must be
identified as “New.” In the event that a figure is canceled, the figure
must be surrounded by brackets and identified as “Canceled.”
All changes to the drawing(s) shall be explained, in detail, beginning
on a separate sheet accompanying the papers including the  
amendment to the drawings.


Nothing more is required. The examiner will determine
only whether the reissue oath/declaration contains
the required averment; the examiner will not
make any comment as to whether it appears that there
was in fact deceptive intention (see MPEP § 2022.05).
It is noted that a reissue oath/declaration will not be
effective for any errors which are corrected by a filing
made after the execution of the reissue oath/declaration,
unless it is clear from the record that the parties
executing the document were aware of the nature of
the correction when they executed the document. Further,
a reissue oath/declaration with an early date of
execution cannot be filed after a correction made later
in time, to cover the correction made after the execution
date. This is so, even if the reissue oath/declaration
states that all errors up to the filing of the oath/
declaration arose without any deceptive intention on
the part of the applicant.


Form paragraph 14.01.04 may be used where the
reissue oath/declaration does not provide the required
statement as to “without any deceptive intention on
the part of the applicant.”
¶ 14.01.04 Defective Reissue Oath/Declaration, 37 CFR
1.175- Lack of Statement of “Without Any Deceptive
Intention”


The provisions of 37 CFR  
The reissue oath/declaration filed with this application is
1.173(b)(3) govern the
defective because it fails to contain a statement that all errors
manner of making amendments (changes) to the
which are being corrected in the reissue application up to the time
of filing of the oath/declaration arose without any deceptive intention
on the part of the applicant. See 37 CFR 1.175 and MPEP §
1414.


Examiner Note:


1.Use this form paragraph when the reissue oath/declaration
does not contain the statement required by 37 CFR 1.175 that all
errors being corrected in the reissue application arose without any
deceptive intention on the part of the applicant.


2.This form paragraph is appropriate to use for a failure by
applicant to comply with the requirement, as to any of 37 CFR
1.175(a)(2), 37 CFR 1.175(b)(1), or 37 CFR 1.175(b)(2).


3.Form paragraph 14.14 must follow.


drawings in a reissue application. The following guidance
IV.THE REISSUE OATH/DECLARATION
is provided as to the procedure for amending
MUST COMPLY WITH 37 CFR 1.63.
drawings:


(A)Amending the original or printed patent drawing
The reissue oath/declaration must include the averments
sheets by physically changing or altering them is
required by 37 CFR 1.63(a) and (b), e.g., that
not permitted. Any request to do so should be denied.  
applicants for reissue


(B)Where a change to the drawings is desired,
(A)have reviewed and understand the contents of  
applicant must submit a replacement sheet for each
the specification, including the claims, as amended by  
sheet of drawings containing a Figure to be revised.
any amendment specifically referred to in the oath/
Any replacement sheet must comply with 37 CFR
declaration;
1.84 and include all of the figures appearing on the
original version of the sheet, even if only one figure is
being amended. Each figure that is amended must be
identified by placing the word “Amended” at the bottom
of that figure. Any added figure must be identified
as “New.” In the event that a figure is canceled,
the figure must be identified as “Canceled” and also
surrounded by brackets. All changes to the figure(s)
must be explained, in detail, beginning on a separate
sheet which accompanies the papers including the  
amendment to the drawings.


(C)If desired, applicant may include a marked-up
(B)believe the named inventor or inventors to be
copy of any amended drawing figure, including annotations
the original and the first inventor or inventors of the
indicating the changes made. Such a marked-
subject matter which is claimed and for which a  
up copy must be clearly labeled as “Annotated
patent is sought; and
Marked-up Drawings”, and it must be presented in the  
 
amendment or remarks section that explains the  
(C)acknowledge the duty to disclose to the  
change to the drawings.  
Office all information known to the person to be
material to patentability as defined in 37 CFR 1.56.
See also the discussion regarding the requirements of
an oath/declaration beginning at MPEP § 602.


In addition, the examiner may desire a marked-up
The examiner should check carefully to ensure that
copy of any amended drawing figure, and so state in  
all the requirements of 37 CFR 1.63 are met. Form
an Office action. A marked-up copy of any amended
paragraph 14.01.05 should be used in conjunction
drawing figure, including annotations indicating the  
with the content of form paragraphs 6.05 through
changes made, must be provided when required by the  
6.05.20 as appropriate, where the reissue oath/declaration
examiner.
fails to comply with the requirements of 37
CFR 1.63.


(D)For each proper new drawing sheet being
¶ 14.01.05 Defective Reissue Oath/Declaration, 37 CFR
added, the new sheet should be inserted after the
1.175 - General
existing drawing sheets. For each proper  drawing
sheet being added which replaces an existing drawing
sheet, the existing sheet should be canceled by
placing the sheet face down in the file and placing a
large “X” on the back of the sheet. The new sheet
should be inserted in place of the turned over existing
sheet.  


(E)If any drawing change  is not  approved,
The reissue oath/declaration filed with this application is
or if any submitted sheet of formal drawings is not
defective (see 37 CFR 1.175 and MPEP § 1414) because of the  
entered, the examiner will so inform the reissue applicant
following:
in the next Office action, and the examiner will
set forth the reasons for same.


1414Content of Reissue Oath/Declaration
Examiner Note:
[R-5]


37 CFR 1.175. Reissue oath or declaration.
1.Use this form paragraph when the reissue oath/declaration
does not comply with 37 CFR 1.175, and none of form paragraphs
14.01 - 14.01.04 or 14.05.02 apply.


(a)The reissue oath or declaration in addition to complying
2.This form paragraph must be followed by an explanation of
with the requirements of § 1.63, must also state that:
why the reissue oath/declaration is defective.  


(1)The applicant believes the original patent to be wholly
or partly inoperative or invalid by reason of a defective specification
or drawing, or by reason of the patentee claiming more or less
than the patentee had the right to claim in the patent, stating at
least one error being relied upon as the basis for reissue; and


(2)All errors being corrected in the reissue application up
to the time of filing of the oath or declaration under this paragraph
arose without any deceptive intention on the part of the applicant.


(b)(1) For any error corrected, which is not covered by the
oath or declaration submitted under paragraph (a) of this section,
applicant must submit a supplemental oath or declaration stating
that every such error arose without any deceptive intention on the
part of the applicant. Any supplemental oath or declaration
required by this paragraph must be submitted before allowance
and may be submitted:


(i) With any amendment prior to allowance; or
 
3.Form paragraph 14.14 must follow the explanation of the
defect.
 
See MPEP § 1414.01 for a discussion of the
requirements for a supplemental reissue oath/declaration.
 
 
Depending on the circumstances, either form PTO/
SB/51, Reissue Application Declaration By The
Inventor, or form PTO/SB/52, Reissue Application
Declaration By The Assignee may be used to prepare
a declaration in a reissue application.


(ii) In order to overcome a rejection under 35
U.S.C. 251
made by the examiner where it is indicated that the submission of
a supplemental oath or declaration as required by this paragraph
will overcome the rejection.


(2)For any error sought to be corrected after allowance, a
supplemental oath or declaration must accompany the requested
correction stating that the error(s) to be corrected arose without
any deceptive intention on the part of the applicant.


(c)Having once stated an error upon which the reissue is
based, as set forth in paragraph (a)(1), unless all errors previously
stated in the oath or declaration are no longer being corrected, a
subsequent oath or declaration under paragraph (b) of this section
need not specifically identify any other error or errors being corrected.




(d)The oath or declaration required by paragraph (a) of this
section may be submitted under the provisions of § 1.53(f).


(e)The filing of any continuing reissue application which
does not replace its parent reissue application must include an
oath or declaration which, pursuant to paragraph (a)(1) of this section,
identifies at least one error in the original patent which has
not been corrected by the parent reissue application or an earlier
reissue application. All other requirements relating to oaths or
declarations must also be met.


The reissue oath/declaration is an essential part of a
Reissue Application Declaration by the Inventor
reissue application and must be filed with the application,
or within the time period set under 37 CFR
1.53(f) along with the required surcharge as set forth
in 37 CFR 1.16(f) in order to avoid abandonment.


The question of the sufficiency of the reissue oath/
declaration filed under 37 CFR 1.175 must in each
case be reviewed and decided personally by the primary
examiner.




Line 3,203: Line 3,248:
   
   


Reissue oaths or declarations must contain the following:
Reissue Application Declaration by the Inventor (page 2)




(A)A statement that the applicant believes the
original patent to be wholly or partly inoperative or
invalid—


(1)by reason of a defective specification or
drawing, or


(2)by reason of the patentee claiming more or
less than patentee had the right to claim in the patent;


(B)A statement of at least one error which is
relied upon to support the reissue application, i.e., as
the basis for the reissue;


(C)A statement that all errors which are being
Privacy Act Statment
corrected in the reissue application up to the time of
filing of the oath/declaration arose without any deceptive
intention on the part of the applicant; and


(D)The information required by 37 CFR 1.63.


These elements will now be discussed:


I.A STATEMENT THAT THE APPLICANT
BELIEVES THE ORIGINAL PATENT TO
BE WHOLLY OR PARTLY INOPERATIVE
OR INVALID BY REASON OF A DEFECTIVE
SPECIFICATION OR DRAWING,
OR BY REASON OF THE PATENTEE
CLAIMING MORE OR LESS THAN PATENTEE
HAD THE RIGHT TO CLAIM IN
THE PATENT.


In order to satisfy this requirement, a declaration
can state as for example:




Reissue Application Declaration by the Assognee


1. “Applicant believes the original patent to be
partly inoperative or invalid by reason of a defective
specification or drawing.”






2. “Applicant believes the original patent to be
partly inoperative or invalid by reason of the patentee
claiming more than patentee had a right to claim in
the patent.”




Reissue Application Declaration by the Assognee (page 2)


3. “Applicant believes the original patent to be
partly inoperative or invalid by reason of the patentee
claiming less than patentee had a right to claim in the
patent.”


Where the specification or drawing is defective andpatentee claimed both more and less than patentee had
the right to claim in the patent, then all three statements
should be included in the reissue oath/declaration.
A statement that the original patent is “wholly
or partly inoperative or invalid” (emphasis added) by
reason of the patentee “claiming more or less than the
patentee had the right to claim in the patent” (emphasis
added) is improper since a claim cannot claim
“more or less” at the same time. Where, however, a
given independent claim is considered to be overly
broad, and another independent claim is considered to
be overly narrow, patentee has claimed both more andless than he or she had a right to claim. In such an
instance, both the second and third above-quoted
statements would be used. See MPEP § 1412.04 for
an exemplary declaration statement when the error
being corrected is an error in inventorship.


The above examples will be sufficient to satisfy this
requirement without any further statement.


It should be noted that the reissue oath/declaration
must also satisfy the requirement for a statement of at
least one error being relied upon as the basis for reissue,
in the manner set forth in subsection II. below.


Form paragraph 14.01 may be used where the reissue
oath/declaration does not provide the required
statement as to applicant’s belief that the original
patent is wholly or partly inoperative or invalid.


¶ 14.01 Defective Reissue Oath/Declaration, 37 CFR
Privacy Act Statment
1.175(a)(1) - No Statement of Defect in the Patent


The reissue oath/declaration filed with this application is
defective because it fails to contain the statement required under
37 CFR 1.175(a)(1) as to applicant’s belief that the original patent
is wholly or partly inoperative or invalid. See 37 CFR 1.175(a)(1)
and see MPEP §
1414. [1]


Examiner Note:


1.Use this form paragraph when applicant: (a) fails to allege
that the original patent is inoperative or invalid and/or (b) fails to
state the reason of a defective specification or drawing, or of patentee
claiming more or less than patentee had the right to claim in
the patent . In bracket 1, point out the specific defect to applicant
by using the language of (a) and/or (b), as it is appropriate.


2.Form paragraph 14.14 must follow this form paragraph.


II.A STATEMENT OF AT LEAST ONE ERROR
WHICH IS RELIED UPON TO SUPPORT
THE REISSUE APPLICATION (I.E.,
THE BASIS FOR THE REISSUE).


(A)A reissue applicant must acknowledge the
existence of an error in the specification, drawings, or
claims, which error causes the original patent to be




1414.01Supplemental Reissue Oath/
Declaration [R-5]


If additional defects or errors are corrected in the
reissue after the filing of the application and the original
reissue oath or declaration, a supplemental reissue
oath/declaration must be filed, unless all additional
errors corrected are spelling, grammar, typographical,
editorial or clerical errors which are not errors under
35 U.S.C. 251 (see MPEP § 1402). In other words, a
supplemental oath/declaration is required where any
“error” under 35 U.S.C. 251 has been corrected and
the error was not identified in the original reissue
oath/declaration.


   
  The supplemental reissue oath/declaration must
state that every error which was corrected in the reissue
application not covered by the prior oath(s)/declaration(
s) submitted in the application arose without
any deceptive intention on the part of the applicant.


defective. In re Wilder, 736 F.2d 1516, 222 USPQ 369
An example of acceptable language is as follows:
(Fed. Cir. 1984). A change or departure from the original
specification or claims represents an “error” in
the original patent under 35 U.S.C. 251. See MPEP
§
1402 for a discussion of grounds for filing a reissue
that may constitute the “error” required by 35 U.S.C.
251. Not all changes with respect to the patent constitute
the “error” required by 35 U.S.C. 251.


(B)Applicant need only specify in the reissue  
“Every error in the patent which was corrected in the  
oath/declaration one of the errors upon which reissue
present reissue application, and is not covered by the prior
is based. Where applicant specifies one such error,
declaration submitted in this application, arose without
this requirement of a reissue oath/declaration is satisfied.
any deceptive intention on the part of the applicant.
Applicant may specify more than one error.


Where more than one error is specified in the  
A supplemental reissue oath/declaration will not be
oath/declaration and some of the designated “errors”
effective for any errors which are corrected by a filing
are found to not be “errors” under 35 U.S.C. 251, any
made after the execution of the supplemental reissue
remaining error which is an error under 35 U.S.C. 251will still support the reissue.
oath/declaration, unless it is clear from the record that
the parties executing the document were aware of the  
nature of the correction when they executed the document.  
Further, a supplemental reissue oath/declaration
with an early date of execution cannot be filed after a
correction made later in time, to cover the correction
made after the execution date. This is so, even if the
supplemental reissue oath/declaration states that all
errors up to the filing of the supplemental reissue  
oath/declaration oath or declaration arose without
any deceptive intention on the part of the applicant.


The “at least one error” which is relied upon to
support the reissue application must be set forth in the
oath/declaration. It is not necessary, however, to point
out how (or when) the error arose or occurred. Further,
it is not necessary to point out how (or when) the
error was discovered. If an applicant chooses to point
out these matters, the statements directed to these
matters will not be reviewed by the examiner, and the
applicant should be so informed in the next Office
action. All that is needed for the oath/declaration
statement as to error is the identification of “at least
one error” relied upon.


In identifying the error, it is sufficient that the
reissue oath/declaration identify a single word,
phrase, or expression in the specification or in an original
claim, and how it renders the original patent
wholly or partly inoperative or invalid. The corresponding
corrective action which has been taken to
correct the original patent need not be identified in the
oath/declaration. If the initial reissue oath/declaration
“states at least one error” in the original patent, and, in
addition, recites the specific corrective action taken in
the reissue application, the oath/declaration would be
considered acceptable, even though the corrective
action statement is not required.


(C)It is not sufficient for an oath/declaration to
Form PTO/SB/51S, “Supplemental Declaration For
merely state “this application is being filed to correct
Reissue Patent Application To Correct ‘Errors’ Statement
errors in the patent which may be noted from the  
(37 CFR 1.175),” may be used to prepare a supplemental
changes made in the disclosure.” Rather, the oath/declaration  
reissue declaration. Form PTO/SB/51S
must specifically identify an error. In addition,
serves to indicate that every error in the patent that
it is not sufficient to merely reproduce the claims
was corrected in the reissue application, but was not  
with brackets and underlining and state that such will
covered by a prior reissue oath/declaration submitted
identify the error. See In re Constant, 827 F.2d 728,  
in the reissue application, arose without any deceptive
729, 3 USPQ2d 1479 (Fed. Cir.), cert. denied, 484
intention on the part of the applicant.
U.S. 894 (1987). Any error in the claims must be  
 
identified by reference to the specific claim(s) and the  
In the event that the applicant for a reissue applicant
specific claim language wherein lies the error.
is required to file a supplemental reissue oath/
declaration that also includes a specific statement of
the error being corrected by reissue in accordance
with 37 CFR 1.175(c), as discussed in subsection I.
below, applicant must also include in the supplemental
declaration language equivalent to the “Every error
…” language in the example of acceptable language
set forth above. Therefore, if either form PTO/SB/51,
“Reissue Application Declaration By The Inventor,”  
or form PTO/SB/52, “Declaration By The Assignee”
(see MPEP § 1414) is used for the purpose of filing
such supplemental reissue oath/declaration, the form
must be completed so that it is clear that the supplemental
reissue oath/declaration addresses all errors
corrected subsequent to the date upon which the last
previously reissue oath/declaration (whether original
or supplemental) was filed. For example, the form
could be completed by specifying the date upon
which the reissue application was originally filed, the
reissue application number, and the date(s) of every
amendment filed subsequent to the date upon which
the last reissue oath/declaration (whether original or
supplemental) was filed. Any manner of completing
the form so that affiant/declarant unambiguously
states that every error corrected subsequent to the filing
of the last filed reissue oath/declaration (whether
original or supplemental) arose without deceptive
intent will be acceptable. It will not be acceptable for
the new (“catch-up”) oath/declaration to simply refer
to the reissue application as filed, even though the  
new oath/declaration may be submitted after an
amendment.


A statement of “…failure to include a claim
I.WHEN AN ERROR MUST BE STATED IN
directed to…” and then presenting a newly added
THE SUPPLEMENTAL OATH/
claim, would not be considered a sufficient “error”
DECLARATION
statement since applicant has not pointed out what the
other claims lacked that the newly added claim has, or
vice versa. Such a statement would be no better than
saying in the reissue oath or declaration that “this
application is being filed to correct errors in the patent
which may be noted from the change made by adding
new claim 10.” In both cases, the error has not been
identified.


(D)Where a continuation reissue application is
In the supplemental reissue oath/declaration, there
filed with a copy of the reissue oath/declaration from
is no need to state an error which is relied upon to
the parent reissue application, and the parent reissue
support the reissue application if:
application is not to be abandoned, the reissue oath/
 
declaration should be accepted by the Office of Initial
(A)an error to support a reissue has been previously
Patent Examination without further evaluation, since
and properly stated in a reissue oath/declaration  
it is an oath/declaration, albeit improper under
in the application; and
35
U.S.C. 251. The examiner should, however, reject
the claims of the continuation reissue application  
under 35 U.S.C. 251 as being based on an oath/declaration
that does not identify an error being corrected
by the continuation reissue application, and should
require a new oath/declaration. 37 CFR 1.175(e)
states that “the filing of any continuing reissue application
which does not replace its parent reissue application
must include an oath or declaration, which
pursuant to [37 CFR 1.175(a)(1)], identifies at least
one error in the original patent which has not been
corrected by the parent reissue application or an earlier
reissue application.” One of form paragraphs
14.01.01 through 14.01.03 may be used.


Where a continuation reissue application is filed
(B)that error is still being corrected in the reissue
with a copy of the reissue oath/declaration from the
application.  
parent reissue application, and the parent reissue
application is, or will be abandoned, the copy of the
reissue oath/declaration should be accepted by OIPE,
and the examiner should check to ensure that the oath/
declaration identifies an error which is still being corrected  
in the continuation application. If a preliminary
amendment was filed with the continuation reissue




Line 3,440: Line 3,399:
   
   


application, the examiner should check for the need of  
If applicant chooses to state any further error at this
a supplemental reissue oath/declaration. Pursuant to
point (even though such is not needed), the examiner  
37 CFR 1.175 (b)(1), for any error corrected via the
should not review the statement of the further error.
preliminary amendment which is not covered by the  
 
oath or declaration submitted in the parent reissue
The supplemental reissue oath/declaration muststate an error which is relied upon to support the reissue
application, applicant must submit a supplemental
application only where one of the following is
oath/declaration stating that such error arose without
true:
any deceptive intention on the part of the applicant.
 
See MPEP § 1414.01.
(A)the prior reissue oath/declaration failed to
state an error;


Where a divisional reissue application is filed
(B)the prior reissue oath/declaration attempted to  
with a copy of the reissue oath/declaration from
state an error but did not do so properly; or
the
parent reissue application, the reissue oath/declaration  
should be accepted by OIPE, since it is an oath/
declaration, though it may be improper under
35
U.S.C. 251. The examiner should check the copy
of the oath/declaration to ensure that it identifies an
error being corrected by the divisional reissue application.
The copy of the oath/declaration from the parent
reissue application may or may not cover an error  
being corrected by the divisional reissue application
since the divisional reissue application is (by definition)
directed to a new invention. If it does not, the
examiner should reject the claims of the divisional
reissue application under 35 U.S.C. 251 as being
based on an oath/declaration that does not identify an
error being corrected by the divisional reissue application,
and require a new oath/declaration. If the copy of
the reissue oath/declaration from the parent reissue
application does in fact cover an error being corrected
in the divisional reissue application, no such rejection
should be made. However, since a new invention is
being added by the filing of the divisional reissue
application, a supplemental reissue oath/declaration
pursuant to 37 CFR 1.175 (b)(1) will be required. See
MPEP § 1414.01.


Form paragraph 14.01.01 may be used where the  
(C)all errors under 35 U.S.C. 251 stated in the  
reissue oath/declaration does not identify an error.
prior reissue oath(s)/declaration(s) are no longer being
corrected in the reissue application.


¶ 14.01.01 Defective Reissue Oath/Declaration, 37 CFR
II.WHEN A SUPPLEMENTAL OATH/DE-
1.175(a)(1) - No Statement of a Specific Error
CLARATION MUST BE SUBMITTED


The reissue oath/declaration filed with this application is
The supplemental oath/declaration in accordance
defective because it fails to identify at least one error which is
with 37 CFR 1.175(b)(1) must be submitted before
relied upon to support the reissue application. See 37 CFR  
allowance. See MPEP § 1444 for a discussion of the
1.175(a)(1) and MPEP § 1414.
action to be taken by the examiner to obtain the supplemental
oath/declaration in accordance with 37  
CFR 1.175(b)(1), where such is needed.


Examiner Note:
Where applicant seeks to correct an error after
allowance of the reissue application, a supplemental
reissue oath/declaration must accompany the
requested correction stating that the error(s) to be corrected
arose without any deceptive intention on the
part of the applicant. The supplemental reissue oath/
declaration submitted after allowance will be directed
to the error applicant seeks to correct after allowance.
This supplemental oath/declaration need not cover
any earlier errors, since all earlier errors should have
been covered by a reissue oath/declaration submitted
prior to allowance.


1.Use this form paragraph when the reissue oath or declaration
III.SUPPLEMENTAL OATH/DECLARA-
does not contain any statement of an error which is relied upon to
TION IN BROADENING REISSUE
support the reissue application.


2.This form paragraph can be used where the reissue oath or
A broadening reissue application must be applied
declaration does not even mention error. It can also can be used
for by all of the inventors (patentees), that is, the original
where the reissue oath or declaration contains some discussion of  
reissue oath/declaration must be signed by all of
the concept of error but never in fact identifies a specific error to
the inventors. See MPEP § 1414. If a supplemental
be relied upon. For example, it is not sufficient for an oath or declaration  
oath/declaration in a broadening reissue application is
to merely state “this application is being filed to correct
subsequently needed in the application in order to fulfill
errors in the patent which may be noted from the changes made in
the requirements of 37 CFR 1.175, the supplemental
the disclosure.”  
reissue oath/declaration must be signed by all of  
the inventors. In re Hayes, 53 USPQ2d 1222, 1224
(Comm’r Pat. 1999) (“37 CFR 1.175(b)(1), taken in  
conjunction with Section 1.172, requires a supplemental
declaration be signed by all of the inventors.  
This is because all oaths or declarations necessary to
fulfill the rule requirements in a reissue application
are taken together collectively as a single oath or declaration.
Thus, each oath and declaration must bear
the appropriate signatures of all the inventors.”).


3.Form paragraph 14.14 must follow this form paragraph.
If a joint inventor refuses or cannot be found or
reached to sign a supplemental oath/declaration, a
supplemental oath/declaration listing all the inventors,
and signed by all the available inventors may be filed
provided it is accompanied by a petition under 37
CFR 1.183 along with the petition fee, requesting
waiver of the signature requirement of the nonsigning
inventor.


Where the reissue oath/declaration does identify an
 
error or errors, the oath/declaration must be checked
carefully to ensure that at least one of the errors identified
is indeed an “error” which will support the filing
of a reissue, i.e., an “error” that will provide
grounds for reissue of the patent. See MPEP § 1402.
If the error identified in the oath/declaration is not an
appropriate error upon which a reissue can be based,
then the oath/declaration must be indicated to be
defective in the examiner’s Office action.


Form paragraphs 14.01.02 and 14.01.03 may be
used where the reissue oath/declaration fails to provide
at least one error upon which a reissue can be
based.


¶ 14.01.02 Defective Reissue Oath/Declaration, 37 CFR
1.175(a)(1)-The Identified “Error” Is Not Appropriate
Error


The reissue oath/declaration filed with this application is
defective because the error which is relied upon to support the
reissue application is not an error upon which a reissue can be
based. See 37 CFR 1.175(a)(1) and MPEP § 1414.


Examiner Note:


1.Use this form paragraph when the reissue oath/declaration
identifies only one error which is relied upon to support the reissue
application, and that one error is not an appropriate error upon
which a reissue can be based.


2.Form paragraph 14.14 must follow this form paragraph.


¶ 14.01.03 Defective Reissue Oath/Declaration, 37 CFR  
SUPPLEMENTAL DECLARATION FOR REISSUE PATENT APPLICATION TO CORRECT “ERRORS” STATEMENT (37 CFR 1.175)
1.175(a)(1) - Multiple Identified “Errors” Not Appropriate
PTO/SB/51S (09-04)
Errors
Approved for use through 04/30/2007. OMB 0651-0033
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
Attorney Docket Number
First Named Inventor
COMPLETE if known
Application Number
Filing Date
Art Unit
SUPPLEMENTAL DECLARATION
FOR REISSUE
PATENT APPLICATION
TO CORRECT “ERRORS” STATEMENT
(37 CFR 1.175)
Examiner Name
I/We hereby declare that:
Every error in the patent which was corrected in the present reissue application, and which is not covered by the
prior oath(s) and/or declaration(s) submitted in this application, arose without any deceptive intention on the part of
the applicant.
I/We hereby declare that all statements made herein of my/our own knowledge are true and that all statements made
on information and belief are believed to be true; and further that these statements were made with the knowledge
that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C.
1001 and that such willful false statements may jeopardize the validity of the application or any patent issued
thereon.
Name of Sole or First Inventor: A petition has been filed for this unsigned inventor
Given Name (first and middle [if any]) Family Name or Surname
Inventor’s
SignatureDate
Name of Second Inventor: A petition has been filed for this unsigned inventor
Given Name (first and middle [if any]) Family Name or Surname
Inventor’s
SignatureDate
Name of Third Inventor: A petition has been filed for this unsigned inventor
Given Name (first and middle [if any]) Family Name or Surname
Inventor’s
SignatureDate
Name of Fourth Inventor: A petition has been filed for this unsigned inventor
Given Name (first and middle [if any]) Family Name or SurnameInventor’s
SignatureDate
Additional inventors or legal representatives(s) are being named on the __________ supplemental sheets PTO/SB/02A or 02LR attached hereto.
This collection of information is required by 37 CFR 1.175. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO
to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 1.8 minutes to complete,
including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on
the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
ADDRESS. SEND TO:Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
Doc Code:
 


The reissue oath/declaration filed with this application is
defective because none of the errors which are relied upon to support
the reissue application are errors upon which a reissue can be
based. See 37 CFR 1.175(a)(1) and MPEP § 1414.


Examiner Note:


1.Use this form paragraph when the reissue oath/declaration
identifies more than one error relied upon to support the reissue
application, and none of the errors are appropriate errors upon
which a reissue can be based.


2.Note that if the reissue oath/declaration identifies more than
one error relied upon, and at least one of the errors is an error
upon which reissue can be based, this form paragraph should not
be used, despite the additional reliance by applicant on “errors”






==1415 Reissue Application and Issue Fees==


I.BASIC REISSUE APPLICATION FILING,
SEARCH, AND EXAMINATION FEES


which do not support the reissue. Only one appropriate error is
The Consolidated Appropriations Act, 2005 (Consolidated
needed to support a reissue.
Appropriations Act), effective December 8,
2004, provides for a separate reissue application filing
fee, search fee, and examination fee during fiscal
years 2005 and 2006. For reissue applications filed on
or after December 8, 2004, the following fees are
required: basic filing fee as set forth in 37 CFR
1.16(e)(1); search fee as set forth in 37 CFR 1.16(n);
examination fee as set forth in 37 CFR 1.16(r); application
size fee, if applicable (see subsection II.  
below); and excess claims fees, if applicable (see subsection
III. below).  


3.Form paragraph 14.14 must follow this form paragraph.  
For reissue applications filed prior to December 8,
2004, the following fees are required: basic filing fee
as set forth in 37 CFR 1.16(e)(2); and excess claims
fees, if applicable (see subsection III below). No
search and examination fees are required for reissue
applications filed before December 8, 2004.


III.A STATEMENT THAT ALL ERRORS
The basic filing, search and examination fees are
WHICH ARE BEING CORRECTED IN
due on filing of the reissue application. These fees
THE REISSUE APPLICATION UP TO
may be paid on a date later than the filing date of the
THE TIME OF SIGNING OF THE OATH/
reissue application provided they are paid within the
DECLARATION AROSE WITHOUT ANY
time period set forth in 37 CFR 1.53(f) and include
DECEPTIVE INTENTION ON THE PART
the surcharge set forth in 37 CFR 1.16(f). For reissue
OF THE APPLICANT.
applications filed on or after December 8, 2004 but
prior to July 1, 2005, which have been accorded a filing
date under 37 CFR 1.53(b), if the search and/or
examination fees are paid on a date later than the filing
date of the reissue application, the surcharge
under 37 CFR 1.16(f) is not required. For reissue
applications filed on or after July 1, 2005, which have
been accorded a filing date under 37 CFR 1.53(b), if
any of the basic filing fee, the search fee, or the examination
fee are paid on a date later than the filing date
of the reissue application, the surcharge under 37 CFR
1.16(f) is required.  


In order to satisfy this requirement, the following
For reissue applications filed on or after December
statement may be included in an oath or declaration:
8, 2004, in which a petition under 37 CFR
1.138(d) to expressly abandon the application was
filed on or after March 10, 2006, applicant may file a
request for refund of the search fee and excess claims
fee paid in the application. See MPEP § 711.01.


“All errors in the present reissue application up to the time
II.APPLICATION SIZE FEE
of signing of this oath/declaration, or errors which are
being corrected by a paper filed concurrently with this
oath/declaration which correction of errors I/we have
reviewed, arose without any deceptive intention on the
part of the applicant.


Nothing more is required. The examiner will determine
The Consolidated Appropriations Act also provides
only whether the reissue oath/declaration contains
for an application size fee. 37 CFR 1.16(s) sets forth
the required averment; the examiner will not
the application size fee for reissue applications filed
make any comment as to whether it appears that there
on or after December 8, 2004, the specification and
was in fact deceptive intention (see MPEP § 2022.05).  
drawings of which, excluding a sequence listing or
It is noted that a reissue oath/declaration will not be
computer program listing filed in an electronic
effective for any errors which are corrected by a filing
medium in compliance with the rules (see 37 CFR
made after the execution of the reissue oath/declaration,
1.52(f)), exceed 100 sheets of paper. The application
unless it is clear from the record that the parties
size fee does not apply to reissue applications filed
executing the document were aware of the nature of
before December 8, 2004. The application size fee
the correction when they executed the document. Further,  
applies for each additional 50 sheets or fraction
a reissue oath/declaration with an early date of
thereof over 100 sheets of paper. Any sequence listing
execution cannot be filed after a correction made later
in an electronic medium in compliance with 37 CFR
in time, to cover the correction made after the execution
1.52(e) and 37 CFR 1.821(c) or (e), and any computer
date. This is so, even if the reissue oath/declaration
program listing filed in an electronic medium in compliance
states that all errors up to the filing of the oath/
with 37 CFR 1.52(e) and 1.96, will be
declaration arose without any deceptive intention on
excluded when determining the application size fee
the part of the applicant.  
required by 37 CFR 1.16(s). See also MPEP § 607.


Form paragraph 14.01.04 may be used where the
III.EXCESS CLAIMS FEES
reissue oath/declaration does not provide the required
statement as to “without any deceptive intention on
the part of the applicant.”


¶ 14.01.04 Defective Reissue Oath/Declaration, 37 CFR  
37 CFR 1.16(h) sets forth the excess claims fee for
1.175- Lack of Statement of “Without Any Deceptive
each independent claim in excess of three. 37 CFR  
Intention”
1.16(i) sets forth the excess claims fee for each claim
 
(whether independent or dependent) in excess of  
The reissue oath/declaration filed with this application is
twenty. The access claims fees specified in 37 CFR
defective because it fails to contain a statement that all errors
1.16(h) and (i) apply to all reissue applications pending
which are being corrected in the reissue application up to the time
on or after December 8, 2004. The excess claims
of filing of the oath/declaration arose without any deceptive intention
fees specified in 37 CFR 1.16(h) and (i) apply to any
on the part of the applicant. See 37 CFR 1.175 and MPEP §  
excess claims fee paid on or after December 8, 2004,
1414.
regardless of the filing date of the reissue application
and regardless of the date on which the claim necessitating
the excess claims fee payment was added to the  
reissue application.  
 
For reissue applications filed on or after December
8, 2004, in which a petition under 37 CFR  
1.138(d) to expressly abandon the application was
filed on or after March 10, 2006, applicant may file a
request for refund of the search fee and excess claims
fee paid in the application. See MPEP § 711.01.


Examiner Note:
Under 35 U.S.C. 41(a)(2) as amended by the Consolidated
Appropriations Act, the claims in the original
patent are not taken into account in determining
the excess claims fee for a reissue application.


1.Use this form paragraph when the reissue oath/declaration
Example 1:
does not contain the statement required by 37 CFR 1.175 that all
errors being corrected in the reissue application arose without any
deceptive intention on the part of the applicant.


2.This form paragraph is appropriate to use for a failure by
Applicant filed a reissue application before
applicant to comply with the requirement, as to any of 37 CFR
December 8, 2004, with the same number of  
1.175(a)(2), 37 CFR 1.175(b)(1), or 37 CFR 1.175(b)(2).


3.Form paragraph 14.14 must follow.


IV.THE REISSUE OATH/DECLARATION
MUST COMPLY WITH 37 CFR 1.63.


The reissue oath/declaration must include the averments
required by 37 CFR 1.63(a) and (b), e.g., that
applicants for reissue


(A)have reviewed and understand the contents of
the specification, including the claims, as amended by
any amendment specifically referred to in the oath/
declaration;


(B)believe the named inventor or inventors to be
claims as in the patent. The patent has more than 3
the original and the first inventor or inventors of the  
independent claims and more than 20 total claims.
subject matter which is claimed and for which a
If applicant added one more independent claim in
patent is sought; and
the reissue application by filing an amendment
before December 8, 2004, but did not pay for the  
excess claims fees prior to December 8, 2004, on
or after December 8, 2004, applicant will have to
pay for one additional independent claim per the  
fee set forth in 37 CFR 1.16(h) and one additional
total claim per the fee set forth in 37 CFR 1.16(i).


(C)acknowledge the duty to disclose to the
Example 2:
Office all information known to the person to be
material to patentability as defined in 37 CFR 1.56.
See also the discussion regarding the requirements of
an oath/declaration beginning at MPEP § 602.


The examiner should check carefully to ensure that
Applicant filed a reissue application on or after
all the requirements of 37 CFR 1.63 are met. Form
December 8, 2004, with the same number of
paragraph 14.01.05 should be used in conjunction
claims as in the patent. The patent has 4 independent
with the content of form paragraphs 6.05 through
claims and 21 total claims. Excess claims fees
6.05.20 as appropriate, where the reissue oath/declaration
for the 4th independent claim (one additional independent
fails to comply with the requirements of 37
claim per the fee set forth in 37 CFR
CFR 1.63.
1.16(h)) and the 21st claim (one additional total
claim per the fee set forth in 37 CFR 1.16(i)) are  
required. Under 35 U.S.C. 41(a)(2) as amended by
the Consolidated Appropriations Act, the claims in
the original patent are not taken into account in
determining the excess claims fees for a reissue
application.


¶ 14.01.05 Defective Reissue Oath/Declaration, 37 CFR  
The excess claims fees, if any, due with an amendment
1.175 - General
are required prior to any consideration of the
amendment by the examiner. Upon submission of an
amendment (whether entered or not) affecting the
claims, payment of fees for those claims in excess of
the number previously paid for is required. The additional
fees, if any, due with an amendment are calculated
on the basis of the claims (total and
independent) which would be present, if the amendment
were entered. If an amendment is limited to
revising the existing claims and it does not result in
the addition of any new claim, there is no excess
claim fee. Excess claims fees apply only to the addition
of claims. It is to be noted that where excess
claims fees have been previously paid, a later amendment
affecting the claims cannot serve as the basis for
granting any refund. See 37 CFR 1.26(a).


The reissue oath/declaration filed with this application is
Amendments filed before a first Office action, or
defective (see 37 CFR 1.175 and MPEP § 1414) because of the
otherwise not filed in reply to an Office action, presenting
following:
additional claims in excess of the number
already paid for, not accompanied by the full additional
claims fee due, will not be entered in whole or
in part and applicant will be so notified. Such amendments
filed in reply to an Office action will be
regarded as being non-responsive to the Office action
and the practice set forth in MPEP § 714.03 will be
followed.


Examiner Note:
An amendment canceling claims accompanying the
 
papers constituting the reissue application will be
1.Use this form paragraph when the reissue oath/declaration
effective to diminish the number of claims to be considered
does not comply with 37 CFR 1.175, and none of form paragraphs
in calculating the filing fees to be paid. A preliminary
14.01 - 14.01.04 or 14.05.02 apply.
amendment filed concurrently with a reply to
a Notice To File Missing Parts of Application that
required the filing fees, which preliminary amendment
cancels or adds claims, will be taken into
account in determining the appropriate filing fees due
in response to the Notice To File Missing Parts of  
Application. However, no refund will be made for
claims being canceled in the reply that have already
been paid for.


2.This form paragraph must be followed by an explanation of
After a requirement for restriction, non-elected
why the reissue oath/declaration is defective.  
claims will be included in determining the fees due in
connection with a subsequent amendment unless such
claims are canceled.


IV.ISSUE FEE


The issue fee for issuing each reissue patent is set
forth in 37 CFR 1.18(a).


V.REISSUE APPLICATION FEE TRANS-
MITTAL FORM


The Office has prepared Form PTO/SB/56, Reissue  
 
Application Fee Transmittal Form which is designed
3.Form paragraph 14.14 must follow the explanation of the
to assist in the correct calculation of reissue filing
defect.
fees.
 
See MPEP § 1414.01 for a discussion of the
requirements for a supplemental reissue oath/declaration.
 
 
Depending on the circumstances, either form PTO/
SB/51, Reissue Application Declaration By The
Inventor, or form PTO/SB/52, Reissue Application  
Declaration By The Assignee may be used to prepare
a declaration in a reissue application.




Line 3,708: Line 3,741:
   
   


 
Reissue Application Fee Transmittal Form
 
Reissue Application Declaration by the Inventor
 
 
 
 
 
 
Reissue Application Declaration by the Inventor (page 2)




Line 3,727: Line 3,750:


Privacy Act Statment
Privacy Act Statment
Privacy Act Statement
ThePrivacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection
with your submission of the attached form related to a patent application or patent. Accordingly,
pursuant to the requirements of the Act, please be advised that: (1) the general authority for the
collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary;
and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
Office is to process and/or examine your submission related to a patent application or patent. If you do
not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
process and/or examine your submission, which may result in termination of proceedings or
abandonment of the application or expiration of the patent.
The information provided by you in this form will be subject to the following routine uses:
1. The information on this form will be treated confidentially to the extent allowed under the
Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from
this system of records may be disclosed to the Department of Justice to determine whether
disclosure of these records is required by the Freedom of Information Act.
2. A record from this system of records may be disclosed, as a routine use, in the course of
presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to
opposing counsel in the course of settlement negotiations.
3. A record in this system of records may be disclosed, as a routine use, to a Member of
Congress submitting a request involving an individual, to whom the record pertains, when the
individual has requested assistance from the Member with respect to the subject matter of the
record.
4. A record in this system of records may be disclosed, as a routine use, to a contractor of the
Agency having need for the information in order to perform a contract. Recipients of
information shall be required to comply with the requirements of the Privacy Act of 1974, as
amended, pursuant to 5 U.S.C. 552a(m).
5. A record related to an International Application filed under the Patent Cooperation Treaty in
this system of records may be disclosed, as a routine use, to the International Bureau of the
World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
6. A record in this system of records may be disclosed, as a routine use, to another federal
agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to
the Atomic Energy Act (42 U.S.C. 218(c)).
7. A record from this system of records may be disclosed, as a routine use, to the Administrator,
General Services, or his/her designee, during an inspection of records conducted by GSA as
part of that agency’s responsibility to recommend improvements in records management
practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
be made in accordance with the GSA regulations governing inspection of records for this
purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not
be used to make determinations about individuals.
8. A record from this system of records may be disclosed, as a routine use, to the public after
either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
CFR 1.14, as a routine use, to the public if the record was filed in an application which
became abandoned or in which the proceedings were terminated and which application is
referenced by either a published application, an application open to public inspection or an
issued patent.
9. A record from this system of records may be disclosed, as a routine use, to a Federal, State,
or local law enforcement agency, if the USPTO becomes aware of a violation or potential
violation of law or regulation.




Line 3,734: Line 3,806:
   
   


Reissue Application Declaration by the Assognee
1415.01Maintenance Fees on the Original
 
Patent [R-5]
 
 
 
 
 
Reissue Application Declaration by the Assognee (page 2)
 


The filing of a reissue application does not alter the
schedule of payments of maintenance fees on the
original patent. If maintenance fees have not been
paid on the original patent as required by 35 U.S.C.
41(b) and 37 CFR 1.20, and the patent has expired, no
reissue patent can be granted. 35 U.S.C. 251, first
paragraph, only authorizes the granting of a reissue
patent for the unexpired term of the original patent.
Once a patent has expired, the Director of the USPTO
no longer has the authority under 35 U.S.C. 251 to
reissue the patent. See In re Morgan, 990 F.2d 1230,
26
USPQ2d 1392 (Fed. Cir. 1993).


The examiner should determine whether all
required maintenance fees have been paid prior to
conducting an examination of a reissue application. In
addition, during the process of preparing the reissue
application for issue, the examiner should again determine
whether all required maintenance fees have been
paid up to date.


The history of maintenance fees is determined by
the following, all of which should be used (to provide
a check on the search made):


(A)Go to the USPTO Intranet (http://ptoweb/ptointranet/
index.htm) and select the PALM screen, then
the “General Information” screen, type in the patent
number and then select the “Fees” screen.


Privacy Act Statment
(B)Go to the USPTO Intranet and then the “Revenue
Accounting and Management” screen, then the
“File History” screen. Then type in the patent number.


(C)Go to the USPTO Internet Site (http://
www.uspto.gov) and select “eBusiness”, then the
“Patent Electronic Business Center” screen, then the
“Patent Application Information Retrieval (PAIR)”
screen (http://pair.uspto.gov/cgi-bin/final/home.pl),
and type in the patent number and select the “view
Maint. Statement” screen.


If the window for the maintenance fee due has
closed (maintenance fees are due by the day of the
4th, 8th and 12th year anniversary of the grant of the
patent), but the maintenance fee has not been paid,
the Office of Patent Legal Administration (OPLA)
should be contacted by the Technology Center
(TC) Special Program Examiner (SPRE) for instructions
as to what appropriate action to take.


PAYMENT OF MAINTENANCE FEES WHERE
THE PATENT HAS BEEN REISSUED


Pursuant to 37 CFR 1.362(b), maintenance fees are
not required for a reissue patent if the original patent
that was reissued did not require maintenance fees.


Where the original patent that was reissued did
require maintenance fees, the schedule of payments of
maintenance fees on the original patent will continue
for the reissue patent. 37 CFR 1.362(h). Once an original
patent reissues, maintenance fees are no longer
due in the original patent, but rather the maintenance
fees are due in the reissue patent. This is because upon
the issuance of the reissue patent, the original patent is
surrendered and ceases to exist.


In some instances, more than one reissue patents
will be granted to replace a single original patent. The
issuance of more than one reissue patent does not alter
the schedule of payments of maintenance fees on the
original patent. The existence of multiple reissue patents
for one original patent can arise where multiple
divisional reissue applications are filed for the same
patent, and the multiple applications issue as reissue
patents (all to replace the same original patent). In
addition, a divisional application or continuation
application of an existing reissue application may be
filed, and both may then issue as reissue patents. In
such instances, 35 U.S.C. 41 does not provide for the
charging of more than one maintenance fee for the
multiple reissues. Thus, no payment of additional
maintenance fees is required for the second or subsequent
reissue patents, i.e., continuation or divisional
reissues, which are derived from a first reissue patent
which has issued. The maintenance fee must be
directed to the first reissue patent that has issued. This
is unlike the instance where there is a reissue of a reissue
patent, and the maintenance fee must be directed
to the reissue of the reissue patent.
See MPEP Chapter 2500 for additional information
pertaining to maintenance fees.
==1416 No Physical Surrender of Original Patent==


37 CFR 1.178. Original patent; continuing duty of  
 
applicant.
1414.01Supplemental Reissue Oath/
Declaration [R-5]
 
If additional defects or errors are corrected in the
reissue after the filing of the application and the original
reissue oath or declaration, a supplemental reissue
oath/declaration must be filed, unless all additional
errors corrected are spelling, grammar, typographical,
editorial or clerical errors which are not errors under
35 U.S.C. 251 (see MPEP § 1402). In other words, a
supplemental oath/declaration is required where any
“error” under 35 U.S.C. 251 has been corrected and
the error was not identified in the original reissue
oath/declaration.
 
The supplemental reissue oath/declaration must
state that every error which was corrected in the reissue
application not covered by the prior oath(s)/declaration(
s) submitted in the application arose without
any deceptive intention on the part of the applicant.  


An example of acceptable language is as follows:
(a)The application for reissue of a patent shall constitute
an offer to surrender that patent, and the surrender shall take effect


“Every error in the patent which was corrected in the
present reissue application, and is not covered by the prior
declaration submitted in this application, arose without
any deceptive intention on the part of the applicant.”


A supplemental reissue oath/declaration will not be
effective for any errors which are corrected by a filing
made after the execution of the supplemental reissue
oath/declaration, unless it is clear from the record that
the parties executing the document were aware of the
nature of the correction when they executed the document.
Further, a supplemental reissue oath/declaration
with an early date of execution cannot be filed after a
correction made later in time, to cover the correction
made after the execution date. This is so, even if the
supplemental reissue oath/declaration states that all
errors up to the filing of the supplemental reissue
oath/declaration oath or declaration arose without
any deceptive intention on the part of the applicant.






Form PTO/SB/51S, “Supplemental Declaration For
upon reissue of the patent. Until a reissue application is granted,  
Reissue Patent Application To Correct ‘Errors’ Statement
the original patent shall remain in effect.
(37 CFR 1.175),” may be used to prepare a supplemental
reissue declaration. Form PTO/SB/51S
serves to indicate that every error in the patent that
was corrected in the reissue application, but was not
covered by a prior reissue oath/declaration submitted
in the reissue application, arose without any deceptive
intention on the part of the applicant.
 
In the event that the applicant for a reissue applicant
is required to file a supplemental reissue oath/
declaration that also includes a specific statement of
the error being corrected by reissue in accordance
with 37 CFR 1.175(c), as discussed in subsection I.
below, applicant must also include in the supplemental
declaration language equivalent to the “Every error
…” language in the example of acceptable language
set forth above. Therefore, if either form PTO/SB/51,
“Reissue Application Declaration By The Inventor,”
or form PTO/SB/52, “Declaration By The Assignee”
(see MPEP § 1414) is used for the purpose of filing
such supplemental reissue oath/declaration, the form
must be completed so that it is clear that the supplemental
reissue oath/declaration addresses all errors
corrected subsequent to the date upon which the last
previously reissue oath/declaration (whether original
or supplemental) was filed. For example, the form
could be completed by specifying the date upon
which the reissue application was originally filed, the
reissue application number, and the date(s) of every
amendment filed subsequent to the date upon which
the last reissue oath/declaration (whether original or
supplemental) was filed. Any manner of completing
the form so that affiant/declarant unambiguously
states that every error corrected subsequent to the filing
of the last filed reissue oath/declaration (whether
original or supplemental) arose without deceptive
intent will be acceptable. It will not be acceptable for
the new (“catch-up”) oath/declaration to simply refer
to the reissue application as filed, even though the
new oath/declaration may be submitted after an
amendment.


I.WHEN AN ERROR MUST BE STATED IN
THE SUPPLEMENTAL OATH/
DECLARATION


In the supplemental reissue oath/declaration, there
is no need to state an error which is relied upon to
support the reissue application if:


(A)an error to support a reissue has been previously
37 CFR 1.178(a) was amended, effective October
and properly stated in a reissue oath/declaration
21, 2004, to eliminate the requirement for physical
in the application; and
surrender of the original letters patent (i.e., the
“ribbon copy” of the original patent) in a reissue  
application, and to make surrender of the original
patent automatic upon the grant of the reissue patent.


(B)that error is still being corrected in the reissue
Amended 37 CFR 1.178(a) applies retroactively to
application.  
all pending applications. For those applications with
an outstanding requirement for the physical surrender
of the original letters patent, a reissue applicant must
timely reply that the requirement is moot in view of
the implementation of the amended rule. Such a reply
will be considered a complete reply to any requirement
directed toward the surrender of the original letters
patent. It is to be noted that the Office will not
conduct a search to withdraw Office actions where the
only outstanding requirement is compliance with the  
physical surrender of the original letters patent.


Example 1:


An Office action issues prior to the effective date
of the amendment to 37 CFR 1.178 with only a
requirement for a return of the original letters
patent to the Office. A two-month period for reply
is set in the Office action. Applicant fails to timely
reply to the Office action, relying on the amendment
to 37 CFR 1.178 as mooting the requirement
for physical surrender of the original letters patent.
The six-month full statutory period for reply
expires. In this instance, the reissue application
would be abandoned (as of the day after the last
day of the two-month period set in the Office
action) for failure to timely reply to the Office
action, because no reply was timely filed.


Example 2:


An Office action issues prior to the effective date
of the amendment to 37 CFR 1.178 with the only
requirement for a return of the original letters
patent to the Office. Applicant fails to reply to the
Office action within the two-month period set in
the Office action, relying on the amendment to
37
CFR 1.178 as mooting the requirement for
physical surrender of the original letters patent. In
reviewing the reissue application in connection
with a related application, the examiner notes the
omission prior to the expiration of the six-month
full statutory period for reply. In this instance, the
examiner may telephone the applicant, and remind
the applicant of the need to file a timely reply.


If applicant chooses to state any further error at this
Example 3:
point (even though such is not needed), the examiner
should not review the statement of the further error.


The supplemental reissue oath/declaration muststate an error which is relied upon to support the reissue
An Office action issues prior to the effective date
application only where one of the following is  
of the amendment to 37 CFR 1.178 with the only  
true:
requirement being a return of the original letters
patent to the Office. Applicant timely replies to the
Office that it should vacate/withdraw the requirement,
or otherwise indicates that return of the original
letters patent is now unnecessary. In this
instance, a complete reply would have been filed,
and the requirement would be withdrawn and the
application passed to issue.


(A)the prior reissue oath/declaration failed to
Example 4:
state an error;


(B)the prior reissue oath/declaration attempted to  
An Office action issues prior to the effective date
state an error but did not do so properly; or
of the amendment to 37 CFR 1.178 with both (a) a
requirement to return the original letters patent to
the Office, and (b) a rejection of the claims under
35 U.S.C. 103. Applicant timely replies to the
Office action addressing only the rejection under
35 U.S.C. 103 (but not the need for physical surrender
of the original letters patent). In this
instance, the reply would be accepted as complete,
and the Office would withdraw the requirement for
physical surrender of the original letters patent.
(The requirement was proper when made, so the
Office would not vacate the action in regard to
submission of the original letters patent.).
 
Where the patentee has submitted the original letters
patent in a reissue application subject to
37
CFR 1.178 as it is now amended, the Office
may, in response to a timely request, return the
original letters patent, when it can be readily
retrieved from where it is stored, namely, the paper
application file, or the artifact storage area for an
Image File Wrapper (IFW) file. Any request for
return of the letters patent which is submitted after
the issue fee has been paid will require a petition
pursuant to 37 CFR 1.59(b) to expunge from the
file and return the original letters patent. Where
the original letters patent cannot be readily
retrieved, or in the rare instance that it has been
subsequently misplaced, the Office will not be able


(C)all errors under 35 U.S.C. 251 stated in the
prior reissue oath(s)/declaration(s) are no longer being
corrected in the reissue application.


II.WHEN A SUPPLEMENTAL OATH/DE-
CLARATION MUST BE SUBMITTED


The supplemental oath/declaration in accordance
with 37 CFR 1.175(b)(1) must be submitted before
allowance. See MPEP § 1444 for a discussion of the
action to be taken by the examiner to obtain the supplemental
oath/declaration in accordance with 37
CFR 1.175(b)(1), where such is needed.


Where applicant seeks to correct an error after
allowance of the reissue application, a supplemental
reissue oath/declaration must accompany the
requested correction stating that the error(s) to be corrected
arose without any deceptive intention on the
part of the applicant. The supplemental reissue oath/
declaration submitted after allowance will be directed
to the error applicant seeks to correct after allowance.
This supplemental oath/declaration need not cover
any earlier errors, since all earlier errors should have
been covered by a reissue oath/declaration submitted
prior to allowance.


III.SUPPLEMENTAL OATH/DECLARA-
to return the original letters patent and will not create
TION IN BROADENING REISSUE
a new one.


A broadening reissue application must be applied
Example 5:
for by all of the inventors (patentees), that is, the original
reissue oath/declaration must be signed by all of
the inventors. See MPEP § 1414. If a supplemental
oath/declaration in a broadening reissue application is
subsequently needed in the application in order to fulfill
the requirements of 37 CFR 1.175, the supplemental
reissue oath/declaration must be signed by all of
the inventors. In re Hayes, 53 USPQ2d 1222, 1224
(Comm’r Pat. 1999) (“37 CFR 1.175(b)(1), taken in
conjunction with Section 1.172, requires a supplemental
declaration be signed by all of the inventors.
This is because all oaths or declarations necessary to
fulfill the rule requirements in a reissue application
are taken together collectively as a single oath or declaration.
Thus, each oath and declaration must bear
the appropriate signatures of all the inventors.”).


If a joint inventor refuses or cannot be found or
In an application filed after the effective date of
reached to sign a supplemental oath/declaration, a
the amendment to 37 CFR 1.178, applicant has
supplemental oath/declaration listing all the inventors,
mistakenly submitted the original letters patent
and signed by all the available inventors may be filed
and later seeks its return. In this instance, provided  
provided it is accompanied by a petition under 37
applicant timely requests the return of the original
CFR 1.183 along with the petition fee, requesting
letters patent, the Office would return the patent,
waiver of the signature requirement of the nonsigning
provided it can be readily retrieved.
inventor.


 
Example 6:


A reissue application was pending at the time of
the effective date of the amendment to 37 CFR
1.178, and an original letters patent was submitted.
Applicant requests return of the original letters
patent, although the application is abandoned at
the time the request for return is made. In this
instance, the Office would return the original letters
patent if it is readily retrievable. Even where
the reissue application was already abandoned at
the time of the effective date of the amendment to
37 CFR 1.178, the Office would also return the
original letters patent.


Example 7:


A reissue application is pending at the time of the
effective date of the amendment to 37 CFR 1.178.
An original letters patent was submitted, and the
issue fee has been paid for the reissue application
at the time the request for return of the original letters
patent is made. In this instance, the Office may
similarly return the original letters patent, but only
if the request is accompanied by a grantable petition
under 37 CFR 1.59(b).


Example 8:
 
 
 
SUPPLEMENTAL DECLARATION FOR REISSUE PATENT APPLICATION TO CORRECT “ERRORS” STATEMENT (37 CFR 1.175)
PTO/SB/51S (09-04)
Approved for use through 04/30/2007. OMB 0651-0033
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
Attorney Docket Number
First Named Inventor
COMPLETE if known
Application Number
Filing Date
Art Unit
SUPPLEMENTAL DECLARATION
FOR REISSUE
PATENT APPLICATION
TO CORRECT “ERRORS” STATEMENT
(37 CFR 1.175)
Examiner Name
I/We hereby declare that:
Every error in the patent which was corrected in the present reissue application, and which is not covered by the
prior oath(s) and/or declaration(s) submitted in this application, arose without any deceptive intention on the part of
the applicant.
I/We hereby declare that all statements made herein of my/our own knowledge are true and that all statements made
on information and belief are believed to be true; and further that these statements were made with the knowledge
that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C.
1001 and that such willful false statements may jeopardize the validity of the application or any patent issued
thereon.
Name of Sole or First Inventor: A petition has been filed for this unsigned inventor
Given Name (first and middle [if any]) Family Name or Surname
Inventor’s
SignatureDate
Name of Second Inventor: A petition has been filed for this unsigned inventor
Given Name (first and middle [if any]) Family Name or Surname
Inventor’s
SignatureDate
Name of Third Inventor: A petition has been filed for this unsigned inventor
Given Name (first and middle [if any]) Family Name or Surname
Inventor’s
SignatureDate
Name of Fourth Inventor: A petition has been filed for this unsigned inventor
Given Name (first and middle [if any]) Family Name or SurnameInventor’s
SignatureDate
Additional inventors or legal representatives(s) are being named on the __________ supplemental sheets PTO/SB/02A or 02LR attached hereto.
This collection of information is required by 37 CFR 1.175. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO
to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 1.8 minutes to complete,
including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on
the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
ADDRESS. SEND TO:Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
Doc Code:  
 
 


A reissue application was pending at the time of
the effective date of the amendment to 37 CFR
1.178. An original letters patent was submitted,
and the reissue application then issued as a reissue
patent. After the reissue patent issues, the request
for return of the original letters patent is made.
Once again, the Office may return the original letters
patent, but only if the request is accompanied
by a grantable petition under 37 CFR 1.59(b).
Example 9:
A reissue application issued as a reissue patent
prior to the effective date of the amendment to
37
CFR 1.178. The reissue applicant, now the patentee,
requests return of the original letters patent
that was submitted in the reissue application. In
this instance, the Office will not return the original
letters patent. The original letters patent was submitted
in reply to a requirement that was in effect
throughout the pendency of the reissue application.








==1417 Claim for Benefit Under 35 U.S.C. 119(a)-(d)==


1415Reissue Application and Issue Fees
PRIORITY UNDER 35 U.S.C. 119(a)-(d) WAS
[R-5]
PERFECTED IN THE ORIGINAL PATENT


I.BASIC REISSUE APPLICATION FILING,  
A “claim” for the benefit of an earlier filing date in
SEARCH, AND EXAMINATION FEES
a foreign country under 35 U.S.C. 119(a)-(d) must be
made in a reissue application, even though such a
claim was previously made in the application for the
original patent to be reissued. However, no additional
certified copy of the foreign application is necessary.
The procedure is similar to that for “Continuing
Applications” in MPEP § 201.14(b).
 
In addition, 37 CFR 1.63 requires that in any application
in which a claim for foreign priority is made
pursuant to 37 CFR 1.55, the oath or declaration must
identify the foreign application for patent or inventors’
certificate on which priority is claimed unless
supplied on an application data sheet (37 CFR 1.76),
and any foreign applications having a filing date
before that of the application on which priority is
claimed, by specifying:


The Consolidated Appropriations Act, 2005 (Consolidated
(A)the application number of the foreign application;
Appropriations Act), effective December 8,
2004, provides for a separate reissue application filing
fee, search fee, and examination fee during fiscal
years 2005 and 2006. For reissue applications filed on
or after December 8, 2004, the following fees are
required: basic filing fee as set forth in 37 CFR
1.16(e)(1); search fee as set forth in 37 CFR 1.16(n);
examination fee as set forth in 37 CFR 1.16(r); application  
size fee, if applicable (see subsection II.
below); and excess claims fees, if applicable (see subsection
III. below).


For reissue applications filed prior to December 8,
2004, the following fees are required: basic filing fee
as set forth in 37 CFR 1.16(e)(2); and excess claims
fees, if applicable (see subsection III below). No
search and examination fees are required for reissue
applications filed before December 8, 2004.


The basic filing, search and examination fees are
(B)the foreign country or intellectual property
due on filing of the reissue application. These fees
authority; and
may be paid on a date later than the filing date of the
reissue application provided they are paid within the
time period set forth in 37 CFR 1.53(f) and include
the surcharge set forth in 37 CFR 1.16(f). For reissue
applications filed on or after December 8, 2004 but
prior to July 1, 2005, which have been accorded a filing
date under 37 CFR 1.53(b), if the search and/or
examination fees are paid on a date later than the filing
date of the reissue application, the surcharge
under 37 CFR 1.16(f) is not required. For reissue
applications filed on or after July 1, 2005, which have
been accorded a filing date under 37 CFR 1.53(b), if
any of the basic filing fee, the search fee, or the examination
fee are paid on a date later than the filing date
of the reissue application, the surcharge under 37 CFR
1.16(f) is required.


For reissue applications filed on or after December
(C)the day, month, and year of the filing of the  
8, 2004, in which a petition under 37 CFR
foreign application.
1.138(d) to expressly abandon the application was
filed on or after March 10, 2006, applicant may file a
request for refund of the search fee and excess claims
fee paid in the application. See MPEP § 711.01.


II.APPLICATION SIZE FEE


The Consolidated Appropriations Act also provides
for an application size fee. 37 CFR 1.16(s) sets forth
the application size fee for reissue applications filed
on or after December 8, 2004, the specification and
drawings of which, excluding a sequence listing or
computer program listing filed in an electronic
medium in compliance with the rules (see 37 CFR
1.52(f)), exceed 100 sheets of paper. The application
size fee does not apply to reissue applications filed
before December 8, 2004. The application size fee
applies for each additional 50 sheets or fraction
thereof over 100 sheets of paper. Any sequence listing
in an electronic medium in compliance with 37 CFR
1.52(e) and 37 CFR 1.821(c) or (e), and any computer
program listing filed in an electronic medium in compliance
with 37 CFR 1.52(e) and 1.96, will be
excluded when determining the application size fee
required by 37 CFR 1.16(s). See also MPEP § 607.


III.EXCESS CLAIMS FEES


37 CFR 1.16(h) sets forth the excess claims fee for
each independent claim in excess of three. 37 CFR
1.16(i) sets forth the excess claims fee for each claim
(whether independent or dependent) in excess of
twenty. The access claims fees specified in 37 CFR
1.16(h) and (i) apply to all reissue applications pending
on or after December 8, 2004. The excess claims
fees specified in 37 CFR 1.16(h) and (i) apply to any
excess claims fee paid on or after December 8, 2004,
regardless of the filing date of the reissue application
and regardless of the date on which the claim necessitating
the excess claims fee payment was added to the
reissue application.


For reissue applications filed on or after December
The examiner should note that the heading on  
8, 2004, in which a petition under 37 CFR
printed copies of the patent will not be carried forward
1.138(d) to expressly abandon the application was
to the reissue from the original patent. Therefore,  
filed on or after March 10, 2006, applicant may file a
it is important that the bibliographic data sheet
request for refund of the search fee and excess claims
(or the front face of the reissue file wrapper for series
fee paid in the application. See MPEP § 711.01.
08/ and earlier paper applications) be endorsed by the  
examiner under “FOREIGN APPLICATIONS.” For
an IFW reissue file, a copy of the bibliographic data
sheet should be printed from the IFW file history. The
printed copy should be annotated by the examiner and  
then the annotated copy should be scanned into the  
IFW.
 
PRIORITY UNDER 35 U.S.C. 119(a)-(d) IS
NEWLY PERFECTED IN THE REISSUE APPLICATION


Under 35 U.S.C. 41(a)(2) as amended by the Consolidated
Appropriations Act, the claims in the original
patent are not taken into account in determining
the excess claims fee for a reissue application.


Example 1:
A reissue was granted in Brenner v. State of Israel,
400 F.2d 789, 158 USPQ 584 (D.C. Cir. 1968), where
the only ground urged was failure to file a certified
copy of the original foreign application to obtain the
right of foreign priority under 35 U.S.C. 119(a)-(d)
before the patent was granted. In Brenner, the claim
for priority had been made in the prosecution of the
original patent, and it was only necessary to submit a
certified copy of the priority document in the reissue
application to perfect priority (the claim for priority
must be repeated in the reissue application). Reissue
is also available to correct the “error” in failing to take
any steps to obtain the right of foreign priority under
35 U.S.C. 119(a)-(d) before the original patent was
granted. See Fontijn v. Okamoto, 518 F.2d 610, 622,
186 USPQ 97, 106 (CCPA 1975) (“a patent may be
reissued for the purpose of establishing a claim to priority
which was not asserted, or which was not perfected
during the prosecution of the original
application”) In a situation where it is necessary to
submit for the first time both the claim for priority and
the certified copy of the priority document in the reissue
application and the patent to be reissued resulted
from a utility or plant application filed on or after
November 29, 2000, the reissue applicant will have to
file a petition for an unintentionally delayed priority
claim under 37 CFR 1.55(c) in addition to filing a
reissue application. See MPEP §
201.14(a).


Applicant filed a reissue application before
==1418 Notification of Prior/Concurrent Proceedings and Decisions Thereon, and of Information Known to be Material to Patentability==
December 8, 2004, with the same number of  


37 CFR 1.178. Original patent; continuing duty of
applicant.






(b)In any reissue application before the Office, the applicant
must call to the attention of the Office any prior or concurrent proceedings
in which the patent (for which reissue is requested) is or
was involved, such as interferences, reissues, reexaminations, or
litigations and the results of such proceedings (see also
§
   
   
1.173(a)(1)).
37 CFR 1.178(b) requires reissue applicants to call
to the attention of the Office any prior or concurrent
proceeding in which the patent (for which reissue is
requested) is or was involved and the results of such
proceedings. These proceedings would include interferences,
reissues, reexaminations, and litigations.
Litigation would encompass any papers filed in the
court or issued by the court, which may include, for
example, motions, pleadings, and court decisions.
This duty to submit information is continuing, and
runs from the time the reissue application is filed until
the reissue application is abandoned or issues as a
reissue patent.
In addition, a reissue application is subject to the
same duty of disclosure requirements as is any other
nonprovisional application. The provisions of 37 CFR
1.63 require acknowledgment in the reissue oath or
declaration of the “duty to disclose to the Office all
information known to the [applicants] to be material
to patentability as defined in §
1.56.” Note that the
Office imposes no responsibility on a reissue applicant
to resubmit, in a reissue application, all the “References
Cited” in the patent for which reissue is
sought. Rather, applicant has a continuing duty under
37 CFR 1.56 to timely apprise the Office of any information
which is material to the patentability of the
claims under consideration in the reissue application.
37 CFR 1.97 and 37 CFR 1.98 provide a mechanism
to submit information known to applicants to be
material to patentability. Information submitted in
compliance with 37 CFR 1.97 and 37 CFR 1.98 will
be considered by the Office. See MPEP § 609.
Although a reissue applicant may utilize 37 CFR 1.97and 37 CFR 1.98 to comply with the duty of disclo


claims as in the patent. The patent has more than 3
independent claims and more than 20 total claims.
If applicant added one more independent claim in
the reissue application by filing an amendment
before December 8, 2004, but did not pay for the
excess claims fees prior to December 8, 2004, on
or after December 8, 2004, applicant will have to
pay for one additional independent claim per the
fee set forth in 37 CFR 1.16(h) and one additional
total claim per the fee set forth in 37 CFR 1.16(i).


Example 2:


Applicant filed a reissue application on or after
December 8, 2004, with the same number of
claims as in the patent. The patent has 4 independent
claims and 21 total claims. Excess claims fees
for the 4th independent claim (one additional independent
claim per the fee set forth in 37 CFR
1.16(h)) and the 21st claim (one additional total
claim per the fee set forth in 37 CFR 1.16(i)) are
required. Under 35 U.S.C. 41(a)(2) as amended by
the Consolidated Appropriations Act, the claims in
the original patent are not taken into account in
determining the excess claims fees for a reissue
application.


The excess claims fees, if any, due with an amendment
are required prior to any consideration of the
amendment by the examiner. Upon submission of an
amendment (whether entered or not) affecting the
claims, payment of fees for those claims in excess of
the number previously paid for is required. The additional
fees, if any, due with an amendment are calculated
on the basis of the claims (total and
independent) which would be present, if the amendment
were entered. If an amendment is limited to
revising the existing claims and it does not result in
the addition of any new claim, there is no excess
claim fee. Excess claims fees apply only to the addition
of claims. It is to be noted that where excess
claims fees have been previously paid, a later amendment
affecting the claims cannot serve as the basis for
granting any refund. See 37 CFR 1.26(a).


Amendments filed before a first Office action, or
sure required by 37 CFR 1.56, this does not relieve
otherwise not filed in reply to an Office action, presenting
applicant of the duties under 37 CFR 1.175 of, for  
additional claims in excess of the number
example, stating “at least one error being relied
already paid for, not accompanied by the full additional
upon.
claims fee due, will not be entered in whole or
in part and applicant will be so notified. Such amendments
filed in reply to an Office action will be
regarded as being non-responsive to the Office action
and the practice set forth in MPEP § 714.03 will be
followed.  


An amendment canceling claims accompanying the  
While 37 CFR 1.97(b) provides for the filing of an
papers constituting the reissue application will be  
information disclosure statement within 3 months of
effective to diminish the number of claims to be considered
the filing of an application or before the mailing date
in calculating the filing fees to be paid. A preliminary
of a first Office action, reissue applicants are encouraged
amendment filed concurrently with a reply to  
to file information disclosure statements at the  
a Notice To File Missing Parts of Application that
time of filing of the reissue application so that such
required the filing fees, which preliminary amendment
statements will be available to the public during the 2-
cancels or adds claims, will be taken into
month period provided in MPEP § 1441. Form paragraph
account in determining the appropriate filing fees due
14.11.01 may be used to remind applicant of the
in response to the Notice To File Missing Parts of
duties to timely make the Office aware of (A) any
Application. However, no refund will be made for
prior or concurrent proceeding (e.g., litigation or
claims being canceled in the reply that have already
Office proceedings) in which the patent to be reissued
been paid for.
is or was involved, and (B) any information which is
material to patentability of the claims in the reissue
application.


After a requirement for restriction, non-elected
¶ 14.11.01 Reminder of Duties Imposed by 37 CFR
claims will be included in determining the fees due in
1.178(b) and 37 CFR 1.56
connection with a subsequent amendment unless such
claims are canceled.


IV.ISSUE FEE
Applicant is reminded of the continuing obligation under 37
CFR 1.178(b), to timely apprise the Office of any prior or concurrent
proceeding in which Patent No. [1] is or was involved. These
proceedings would include interferences, reissues, reexaminations,
and litigation.  


The issue fee for issuing each reissue patent is set
Applicant is further reminded of the continuing obligation
forth in 37 CFR 1.18(a).
under 37 CFR 1.56, to timely apprise the Office of any information
which is material to patentability of the claims under consideration
in this reissue application.


V.REISSUE APPLICATION FEE TRANS-
These obligations rest with each individual associated with the
MITTAL FORM
filing and prosecution of this application for reissue. See also
MPEP §§ 1404, 1442.01 and 1442.04.


The Office has prepared Form PTO/SB/56, Reissue
Examiner Note:
Application Fee Transmittal Form which is designed
to assist in the correct calculation of reissue filing
fees.


1.This form paragraph is to be used in the first action in a reissue
application.


2.In bracket [1], insert the patent number of the original patent
for which reissue is requested.


==1430 Reissue Files Open to the Public and, Notice of Filing Reissue Announced in, Official Gazette==


37 CFR 1.11. Files open to the public.


Reissue Application Fee Transmittal Form




(b)All reissue applications, all applications in which the
Office has accepted a request to open the complete application to
inspection by the public, and related papers in the application file,
are open to inspection by the public, and copies may be furnished
upon paying the fee therefor. The filing of reissue applications,
other than continued prosecution applications under § 1.53(d) of
reissue applications, will be announced in the Official Gazette.
The announcement shall include at least the filing date, reissue
application and original patent numbers, title, class and subclass,
name of the inventor, name of the owner of record, name of the
attorney or agent of record, and examining group to which the
reissue application is assigned.






   
Under 37 CFR 1.11(b) all reissue applications filed
after March 1, 1977, are open to inspection by the
general public, and copies may be furnished upon
paying the fee therefor. The filing of reissue applications
(except for continued prosecution applications
(CPA’s) filed under 37
CFR 1.53(d)) will be
announced in the Official Gazette. The announcement
gives interested members of the public an opportunity
to submit to the examiner information pertinent to the
patentability of the reissue application. The announcement
includes the filing date, reissue application and
original patent numbers, title, class and subclass,
name of the inventor, name of the owner of record,
name of the attorney or agent of record, and the Technology
Center (TC) to which the reissue application is
initially assigned. A TC Director or other appropriate
Office official may, under appropriate circumstances,
postpone access to or the making of copies of a
paper reissue application file, such as, for example,
to avoid interruption of the examination or other
review of the application by an examiner.  


Privacy Act Statment
IFW reissue application files are open to inspection
Privacy Act Statement
by the general public by way of Public PAIR via
ThePrivacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection
the USPTO Internet site. In viewing the images of the  
with your submission of the attached form related to a patent application or patent. Accordingly,
files, members of the public will be able to view the  
pursuant to the requirements of the Act, please be advised that: (1) the general authority for the
entire content of the reissue application file history.  
collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary;
To access Public PAIR, a member of the public would
and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
(A) go to the USPTO web site at http://
Office is to process and/or examine your submission related to a patent application or patent. If you do
www.uspto.gov, (B) click on “Patents”, (C) under
not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
“Check Status, View Papers…” click on “Status &
process and/or examine your submission, which may result in termination of proceedings or
IFW,and (D) under “Patent Application Information
abandonment of the application or expiration of the patent.
Retrieval” enter the reissue application number.
The information provided by you in this form will be subject to the following routine uses:
1. The information on this form will be treated confidentially to the extent allowed under the
Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from
this system of records may be disclosed to the Department of Justice to determine whether
disclosure of these records is required by the Freedom of Information Act.
2. A record from this system of records may be disclosed, as a routine use, in the course of  
presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to
opposing counsel in the course of settlement negotiations.
3. A record in this system of records may be disclosed, as a routine use, to a Member of
Congress submitting a request involving an individual, to whom the record pertains, when the  
individual has requested assistance from the Member with respect to the subject matter of the  
record.  
4. A record in this system of records may be disclosed, as a routine use, to a contractor of the  
Agency having need for the information in order to perform a contract. Recipients of
information shall be required to comply with the requirements of the Privacy Act of 1974, as
amended, pursuant to 5 U.S.C. 552a(m).
5. A record related to an International Application filed under the Patent Cooperation Treaty in
this system of records may be disclosed, as a routine use, to the International Bureau of the
World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.  
6. A record in this system of records may be disclosed, as a routine use, to another federal
agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to
the Atomic Energy Act (42 U.S.C. 218(c)).
7. A record from this system of records may be disclosed, as a routine use, to the Administrator,
General Services, or his/her designee, during an inspection of records conducted by GSA as
part of that agency’s responsibility to recommend improvements in records management
practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
be made in accordance with the GSA regulations governing inspection of records for this
purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not
be used to make determinations about individuals.
8. A record from this system of records may be disclosed, as a routine use, to the public after
either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
CFR 1.14, as a routine use, to the public if the record was filed in an application which
became abandoned or in which the proceedings were terminated and which application is
referenced by either a published application, an application open to public inspection or an
issued patent.
9. A record from this system of records may be disclosed, as a routine use, to a Federal, State,
or local law enforcement agency, if the USPTO becomes aware of a violation or potential
violation of law or regulation.  


A notice of a reissue application in the Official
Gazette should be published prior to any examination
of the application. If an inadvertent failure to publish
notice of the filing of the reissue application in the
Official Gazette is recognized later in the examination,
action should be taken to have the notice published
as quickly as possible, and action on the
application may be delayed until two months after the




Line 4,277: Line 4,361:
   
   


1415.01Maintenance Fees on the Original
publication, allowing for any protests to be filed. For
Patent [R-5]
a discussion of protests, see MPEP Chapter 1900.


The filing of a reissue application does not alter the
The filing of a continued prosecution application  
schedule of payments of maintenance fees on the
(CPA) under 37 CFR 1.53(d) of a reissue application
original patent. If maintenance fees have not been
will not be announced in the Official Gazette.
paid on the original patent as required by 35 U.S.C.
Although the filing of a CPA of a reissue application
41(b) and 37 CFR 1.20, and the patent has expired, no
constitutes the filing of a reissue application, the  
reissue patent can be granted. 35 U.S.C. 251, first
announcement of the filing of such CPA would be
paragraph, only authorizes the granting of a reissue  
redundant in view of the announcement of the filing
patent for the unexpired term of the original patent.
of the prior reissue application in the Official Gazetteand the fact that the same application number and file
Once a patent has expired, the Director of the USPTO
will continue to be used for the CPA.
no longer has the authority under 35 U.S.C. 251 to
reissue the patent. See In re Morgan, 990 F.2d 1230,
26
USPQ2d 1392 (Fed. Cir. 1993).  


The examiner should determine whether all
If applicant files a Request for Continued Examination
required maintenance fees have been paid prior to
(RCE) of the reissue application under 37 CFR
conducting an examination of a reissue application. In
1.114 (which can be filed on or after May 29, 2000 for
addition, during the process of preparing the reissue  
a reissue application filed on or after June 8, 1995),
application for issue, the examiner should again determine
such filing will not be announced in the Official
whether all required maintenance fees have been
Gazette. An RCE continues prosecution of the existing
paid up to date.
reissue application and is not a filing of a new
application.


The history of maintenance fees is determined by
the following, all of which should be used (to provide
a check on the search made):


(A)Go to the USPTO Intranet (http://ptoweb/ptointranet/
index.htm) and select the PALM screen, then
the “General Information” screen, type in the patent
number and then select the “Fees” screen.


(B)Go to the USPTO Intranet and then the “Revenue
The filing of all reissue applications, except for
Accounting and Management” screen, then the
CPAs filed under 37 CFR 1.53(d), (note that effective
“File History” screen. Then type in the patent number.
July 14, 2003, CPA practice has been eliminated as to  
utility and plant application) will be announced in the  
Official Gazette and will include certain identifying
data as specified in 37 CFR 1.11(b). Access to a reissue
application that is maintained in paper must be
obtained from the area of the Office having jurisdiction
over the reissue application file.  


(C)Go to the USPTO Internet Site (http://
For reissue application files that are maintained in
www.uspto.gov) and select “eBusiness”, then the  
paper, the following access procedure will be
“Patent Electronic Business Center” screen, then the
observed:
“Patent Application Information Retrieval (PAIR)”
screen (http://pair.uspto.gov/cgi-bin/final/home.pl),
and type in the patent number and select the “view
Maint. Statement” screen.


If the window for the maintenance fee due has
(A) Any member of the general public may
closed (maintenance fees are due by the day of the  
request access to a particular reissue application filed
4th, 8th and 12th year anniversary of the grant of the
after March 1, 1977.  Since no record of such
patent), but the maintenance fee has not been paid,  
request is intended to be kept, an oral request will suffice.
the Office of Patent Legal Administration (OPLA)
Reissue applications already on file prior to
should be contacted by the Technology Center
March 1, 1977 are not automatically open to inspection,  
(TC) Special Program Examiner (SPRE) for instructions
but a liberal policy is followed by the Office of  
as to what appropriate action to take.
Patent Legal Administration and by the Board of
Patent Appeals and Interferences (see MPEP
§
1002.02(b)) in granting petitions for access to such
applications.  


PAYMENT OF MAINTENANCE FEES WHERE
(B)Paper reissue application files will be
THE PATENT HAS BEEN REISSUED
maintained in the TCs and inspection thereof will be
supervised by TC personnel. Although no general
limit is placed on the amount of time spent reviewing
the files, the Office may impose limitations, if necessary,
e.g., where the application is actively being processed.


Pursuant to 37 CFR 1.362(b), maintenance fees are
not required for a reissue patent if the original patent
that was reissued did not require maintenance fees.


Where the original patent that was reissued did
(C)Where the reissue application file has left
require maintenance fees, the schedule of payments of
the TC for administrative processing, requests for
maintenance fees on the original patent will continue
access should be directed to the appropriate supervisory
for the reissue patent. 37 CFR 1.362(h). Once an original
personnel where the application is currently
patent reissues, maintenance fees are no longer
located.  
due in the original patent, but rather the maintenance
fees are due in the reissue patent. This is because upon
the issuance of the reissue patent, the original patent is  
surrendered and ceases to exist.


In some instances, more than one reissue patents
(D)Requests for copies of papers in the reissue  
will be granted to replace a single original patent. The
application file must be in writing and addressed to
issuance of more than one reissue patent does not alter
the Mail Stop Document Services, Director of the
the schedule of payments of maintenance fees on the  
United States Patent and Trademark Office, P.O. Box
original patent. The existence of multiple reissue patents
1450, Alexandria, VA 22313-1450. Such requests
for one original patent can arise where multiple
may be either mailed or delivered to the Office Customer
divisional reissue applications are filed for the same
Service Window (See MPEP § 502). The price
patent, and the multiple applications issue as reissue
for copies made by the Office is set forth in 37 CFR
patents (all to replace the same original patent). In
1.19.
addition, a divisional application or continuation
 
application of an existing reissue application may be
==1440 Examination of Reissue Application==
filed, and both may then issue as reissue patents. In
such instances, 35 U.S.C. 41 does not provide for the
charging of more than one maintenance fee for the
multiple reissues. Thus, no payment of additional
maintenance fees is required for the second or subsequent
reissue patents, i.e., continuation or divisional
reissues, which are derived from a first reissue patent
which has issued. The maintenance fee must be  
directed to the first reissue patent that has issued. This
is unlike the instance where there is a reissue of a reissue
patent, and the maintenance fee must be directed
to the reissue of the reissue patent.


See MPEP Chapter 2500 for additional information
37 CFR 1.176. Examination of reissue.
pertaining to maintenance fees.


1416No Physical Surrender of Original
(a)A reissue application will be examined in the same manner
Patent [R-3]
as a non-reissue, non-provisional application, and will be subject
to all the requirements of the rules related to non-reissue
applications. Applications for reissue will be acted on by the
examiner in advance of other applications.


37 CFR 1.178. Original patent; continuing duty of  
(b)Restriction between subject matter of the original patent
claims and previously unclaimed subject matter may be required
(restriction involving only subject matter of the original patent
claims will not be required). If restriction is required, the subject
matter of the original patent claims will be held to be constructively
elected unless a disclaimer of all the patent claims is filed in
the reissue application, which disclaimer cannot be withdrawn by
applicant.
applicant.


(a)The application for reissue of a patent shall constitute
37 CFR 1.176 provides that an original claim, if re-
an offer to surrender that patent, and the surrender shall take effect
presented in a reissue application, will be fully examined
 
in the same manner, and subject to the same rules
 
as if being presented for the first time in an original
 
non-reissue, nonprovisional application, except that
 
division will not be required by the examiner. See
MPEP § 1450 and § 1451. Reissue applications are
normally examined by the same examiner who issued
the patent for which reissue is requested. In addition,  
the application will be examined with respect to compliance
with 37 CFR 1.171-1.178 relating specifically
to reissue applications, for example, the reissue
oath or declaration will be carefully reviewed for
compliance with 37 CFR 1.175. See MPEP § 1444 for
handling applications in which the oath or declaration


upon reissue of the patent. Until a reissue application is granted,
the original patent shall remain in effect.






37 CFR 1.178(a) was amended, effective October
21, 2004, to eliminate the requirement for physical
surrender of the original letters patent (i.e., the
“ribbon copy” of the original patent) in a reissue
application, and to make surrender of the original
patent automatic upon the grant of the reissue patent.


Amended 37 CFR 1.178(a) applies retroactively to
lacks compliance with 37 CFR 1.175. Reissue applications  
all pending applications. For those applications with  
with related litigation will be acted on by the  
an outstanding requirement for the physical surrender
examiner before any other special applications, and
of the original letters patent, a reissue applicant must
will be acted on immediately by the examiner, subject
timely reply that the requirement is moot in view of
only to a 2-month delay after publication for examining
the implementation of the amended rule. Such a reply
reissue applications; see MPEP § 1441.
will be considered a complete reply to any requirement
directed toward the surrender of the original letters
patent. It is to be noted that the Office will not
conduct a search to withdraw Office actions where the
only outstanding requirement is compliance with the
physical surrender of the original letters patent.


Example 1:
The original patent file wrapper /file history should
always be obtained and reviewed when examining a
reissue application thereof.


An Office action issues prior to the effective date
==1441 Two-Month Delay Period==
of the amendment to 37 CFR 1.178 with only a
requirement for a return of the original letters
patent to the Office. A two-month period for reply
is set in the Office action. Applicant fails to timely
reply to the Office action, relying on the amendment
to 37 CFR 1.178 as mooting the requirement
for physical surrender of the original letters patent.
The six-month full statutory period for reply
expires. In this instance, the reissue application
would be abandoned (as of the day after the last
day of the two-month period set in the Office
action) for failure to timely reply to the Office
action, because no reply was timely filed.


Example 2:
37 CFR 1.176 provides that reissue applications
 
will be acted on by the examiner in advance of other
An Office action issues prior to the effective date
applications, i.e., “special.” Generally, a reissue application
of the amendment to 37 CFR 1.178 with the only
will not be acted on sooner than 2 months after
requirement for a return of the original letters
announcement of the filing of the reissue has
patent to the Office. Applicant fails to reply to the  
appeared in the Official Gazette. The 2-month delay is
Office action within the two-month period set in
provided in order that members of the public may
the Office action, relying on the amendment to
have time to review the reissue application and submit
37  
pertinent information to the Office before the examiner’s
CFR 1.178 as mooting the requirement for  
action. The pertinent information is submitted
physical surrender of the original letters patent. In
in the form of a protest under 37 CFR 1.291(a). For a
reviewing the reissue application in connection
discussion as to protests under 37 CFR 1.291(a) in
with a related application, the examiner notes the  
reissue applications, see MPEP § 1441.01. As set
omission prior to the expiration of the six-month  
forth in MPEP § 1901.04, the public should be aware
full statutory period for reply. In this instance, the  
that such submissions should be made as
examiner may telephone the applicant, and remind
early as possible,
the applicant of the need to file a timely reply.
since, under certain circumstances, the 2-month
delay period will not be employed. For example, the  
Office may act on a continuation or a divisional reissue
application prior to the expiration of the 2-month  
period after announcement. Additionally, the Office  
will entertain a petition under 37 CFR 1.182 which is
accompanied by the required petition fee (37  
CFR  
1.17(f)) to act on a reissue application without
delaying for 2 months. Accordingly, protestors to reissue
applications (see MPEP § 1441.01) cannot automatically
assume that a full 2-month delay period will
always be available. Appropriate reasons for requesting
that the 2-month delay period not be employed
include that litigation involving a patent has been
stayed to permit the filing of an application for the
reissue of the patent. Where the basis for the petition
is ongoing litigation, the petition must clearly
identify the litigation, and detail the specifics of the  
litigation that call for prompt action on the reissue
application prior to the expiration of the 2-month  
delay period. Such petitions are decided by the  
Office of Patent Legal Administration.


Example 3:
1441.01Protest in Reissue Applications[R-3]


An Office action issues prior to the effective date  
A protest pursuant to 37 CFR 1.291 may be
of the amendment to 37 CFR 1.178 with the only
filed throughout the pendency of a reissue application,
requirement being a return of the original letters
prior to the date of mailing of a notice of allowance,
patent to the Office. Applicant timely replies to the
subject to the timing constraints of the examination,
Office that it should vacate/withdraw the requirement,
as set forth in MPEP § 1901.04. While a reissue application
or otherwise indicates that return of the original
is not published under 37 CFR 1.211, the reissue
letters patent is now unnecessary. In this
application is published pursuant to 35 U.S.C.  
instance, a complete reply would have been filed,
122(b)(1)(A) via an announcement in the Official
and the requirement would be withdrawn and the
Gazette (and public availability of the file content) per
application passed to issue.
37 CFR 1.11(b). Such a publication does not preclude
the filing of a protest. 35 U.S.C. 122(c) states:


Example 4:
“(c) PROTEST AND PRE-ISSUANCE OPPOSITION-
The Director shall establish appropriate procedures to
ensure that no protest or other form of pre-issuance
opposition to the grant of a patent on an application may be
initiated after publication of the application without the
express written consent of the applicant.” [Emphasis
added.]


An Office action issues prior to the effective date
A protest is precluded after publication for an application
of the amendment to 37 CFR 1.178 with both (a) a  
for an original patent, as a “form of pre-issuance
requirement to return the original letters patent to  
opposition.” A reissue application is a post-
the Office, and (b) a rejection of the claims under
issuance proceeding. A protest filed in a reissue application
35 U.S.C. 103. Applicant timely replies to the  
is not a “form of pre-issuance opposition to the  
Office action addressing only the rejection under  
grant of a patent” since the patent to be reissued has
35 U.S.C. 103 (but not the need for physical surrender
already been granted. Thus, the prohibition against
of the original letters patent). In this
the filing of a protest after publication of an application
instance, the reply would be accepted as complete,
under 35 U.S.C. 122(c) is not applicable to a reissue
and the Office would withdraw the requirement for
application and a protest is permitted after
physical surrender of the original letters patent.
publication of the reissue application.
(The requirement was proper when made, so the
Office would not vacate the action in regard to
submission of the original letters patent.).


Where the patentee has submitted the original letters
A protest with regard to a reissue application
patent in a reissue application subject to
should be filed within the 2-month period following
the announcement of the filing of the reissue application
in the Official Gazette. If the protest of a reissue  
application cannot be filed within the 2-month delay
period, the
protest can be submitted at a later time.
Where the protest is submitted after the 2-month
period, no petition for entry of the protest under
37  
37  
CFR 1.178 as it is now amended, the Office
CFR 1.182 is needed with respect to the protest
may, in response to a timely request, return the
being submitted after the 2 months, unless a final
original letters patent, when it can be readily
rejection has been issued or prosecution on the merits
retrieved from where it is stored, namely, the paper
has been otherwise closed for the reissue application.
application file, or the artifact storage area for an
 
Image File Wrapper (IFW) file. Any request for  
 
return of the letters patent which is submitted after
A potential protestor should be aware that reissue
the issue fee has been paid will require a petition
applications are taken up “special” and a protest
pursuant to 37 CFR 1.59(b) to expunge from the
filed outside the 2-month delay period may be  
file and return the original letters patent. Where
the original letters patent cannot be readily
retrieved, or in the rare instance that it has been
subsequently misplaced, the Office will not be able




Line 4,502: Line 4,589:
   
   


to return the original letters patent and will not create
received after action by the examiner. Once the
a new one.
first
Office action is mailed (after the 2-month
period), a member of the public may still submit pertinent
information in the form of a protest under
37
CFR 1.291, and the examiner will consider the
information submitted in the next Office action, to the
extent that such consideration is appropriate.
Where a final rejection has been issued or the
prosecution on the merits has been otherwise closed, a
petition under 37 CFR 1.182 along with the required
petition fee (37 CFR 1.17(f)) for entry of the protest
are required. The petition must include an explanation
as to why the additional time was necessary and the
nature of the protest intended. A copy of the petition
must be served upon the applicant in accordance with
37 CFR 1.248. The petition should be directed to the
Office of Petitions.


Example 5:
If the protest of a reissue application cannot be filed
within the 2-month delay period, the protestor may
petition to request (A) an extension of the 2-month
period following the announcement in the Official
Gazette, and (B) a delay of the examination until the
extended period expires. Such a request will be considered
only if filed in the form of a petition under
37
CFR 1.182 and accompanied by the petition fee set
forth in 37 CFR 1.17(f). The petition under 37 CFR
1.182 and the petition fee must be filed prior to the
expiration of the 2-month period following the
announcement of the filing of the reissue application
in the Official Gazette. The petition must explain why
the additional time is necessary and the nature of the
protest intended. A copy of the petition must be
served upon applicant in accordance with 37 CFR
1.248. The petition should be directed to the appropriate
Technology Center (TC) which will forward the
petition to the Office of Patent Legal Administration.


In an application filed after the effective date of
If the protest is a “REISSUE LITIGATION” protest,
the amendment to 37 CFR 1.178, applicant has
it is particularly important that it be filed early if
mistakenly submitted the original letters patent
protestor wishes it considered at the time the Office
and later seeks its return. In this instance, provided
first acts on the reissue application. Protestors should
applicant timely requests the return of the original
be aware that the Office will entertain petitions from
letters patent, the Office would return the patent,
the reissue applicants under 37 CFR 1.182 to waive
provided it can be readily retrieved.
the 2-month delay period in appropriate circumstances.
Accordingly, protestors to reissue applications
cannot automatically assume that the full 2-
month delay period will always be available.


Example 6:
The Technology Center (TC) to which the reissue
application is assigned is listed in the Official Gazettenotice of filing of the reissue application. Accordingly,
the indicated TC should retain jurisdiction
over the reissue application file for 2 months after
the date of the Official Gazette notice before transferring
the reissue application under the procedure set
forth in MPEP §
903.08(d).


A reissue application was pending at the time of
The publication of a notice of a reissue application  
the effective date of the amendment to 37 CFR
in the Official Gazette should be done prior to any
1.178, and an original letters patent was submitted.
examination of the reissue application. If an inadvertent
Applicant requests return of the original letters
failure to publish notice of the filing of the reissue
patent, although the application is abandoned at
application in the Official Gazette is recognized later
the time the request for return is made. In this
in the examination, action should be taken to have the  
instance, the Office would return the original letters
notice published as quickly as possible, and action on
patent if it is readily retrievable. Even where
the reissue application may be delayed until 2 months
the reissue application was already abandoned at
after the publication, allowing for any protests to be
the time of the effective date of the amendment to  
filed.
37 CFR 1.178, the Office would also return the
original letters patent.


Example 7:
See MPEP § 1901.06 for general procedures on
examiner treatment of protests in reissue applications.


A reissue application is pending at the time of the
==1442 Special Status==
effective date of the amendment to 37 CFR 1.178.
An original letters patent was submitted, and the
issue fee has been paid for the reissue application
at the time the request for return of the original letters
patent is made. In this instance, the Office may
similarly return the original letters patent, but only
if the request is accompanied by a grantable petition
under 37 CFR 1.59(b).


Example 8:
All reissue applications are taken up “special,” and
remain “special” even though applicant does not
respond promptly.


A reissue application was pending at the time of  
All reissue applications, except those under suspension
the effective date of the amendment to 37 CFR
because of litigation, will be taken up for action
1.178. An original letters patent was submitted,  
ahead of other “special” applications; this means that
and the reissue application then issued as a reissue  
all issues not deferred will be treated and responded to  
patent. After the reissue patent issues, the request
immediately. Furthermore, reissue applications
for return of the original letters patent is made.
involved in litigation will be taken up for action in
Once again, the Office may return the original letters
advance of other reissue applications.
patent, but only if the request is accompanied
by a grantable petition under 37 CFR 1.59(b).


Example 9:
1442.01Litigation-Related Reissues [R-5]


A reissue application issued as a reissue patent
During initial review, the examiner should determine
prior to the effective date of the amendment to  
whether the patent for which the reissue has
37
been filed is involved in litigation, and if so, the status
CFR 1.178. The reissue applicant, now the patentee,
of that litigation. If the examiner becomes aware of  
requests return of the original letters patent
litigation involving the patent sought to be reissued
that was submitted in the reissue application. In
during examination of the reissue application, and
this instance, the Office will not return the original
applicant has not made the details regarding that litigation
letters patent. The original letters patent was submitted
of record in the reissue application, the examiner,
in reply to a requirement that was in effect
in the next Office action, will inquire regarding
throughout the pendency of the reissue application.
the specific details of the litigation.  


Form paragraph 14.06 may be used for such an
inquiry.


¶ 14.06 Litigation-Related Reissue


The patent sought to be reissued by this application [1]
involved in litigation. Any documents and/or materials which


1417Claim for Benefit Under 35 U.S.C.
119(a)-(d) [R-5]


PRIORITY UNDER 35 U.S.C. 119(a)-(d) WAS
PERFECTED IN THE ORIGINAL PATENT


A “claim” for the benefit of an earlier filing date in
a foreign country under 35 U.S.C. 119(a)-(d) must be
made in a reissue application, even though such a
claim was previously made in the application for the
original patent to be reissued. However, no additional
certified copy of the foreign application is necessary.
The procedure is similar to that for “Continuing
Applications” in MPEP § 201.14(b).


In addition, 37 CFR 1.63 requires that in any application
in which a claim for foreign priority is made
pursuant to 37 CFR 1.55, the oath or declaration must
identify the foreign application for patent or inventors’
certificate on which priority is claimed unless
supplied on an application data sheet (37 CFR 1.76),
and any foreign applications having a filing date
before that of the application on which priority is
claimed, by specifying:


(A)the application number of the foreign application;
would be material to patentability of this reissue application are
required to be made of record in response to this action.


Due to the related litigation status of this application, EXTENSIONS
OF TIME UNDER THE PROVISIONS OF 37 CFR
1.136(a) WILL NOT BE PERMITTED DURING THE PROSECUTION
OF THIS APPLICATION.


(B)the foreign country or intellectual property
Examiner Note:
authority; and


(C)the day, month, and year of the filing of the
In bracket 1, insert either —is— or —has been—.  
foreign application.


If additional details of the litigation appear to be
material to examination of the reissue application, the
examiner may make such additional inquiries as necessary
and appropriate.


For reissue application files that are maintained in
paper, if the existence of litigation has not already
been noted, the examiner should place a prominent
notation on the application file to indicate the litigation
(1) at the bottom of the face of the file in the box
just to the right of the box for the retention label, and
(2) on the pink Reissue Notice Card form. For reissue
application files that are maintained in the Image
File Wrapper (IFW) system, if the existence of litigation
has not already been noted, the examiner should
print out a copy of the bibliographic data sheet from
the IFW file history and annotate the printed bibliographic
data sheet such that adequate notice is provided
of the existence of the litigation. The examiner
should place the annotation in a prominent place. The
annotated sheet should be scanned into IFW.


Applicants will normally be given 1 month to reply
to Office actions in all reissue applications which are
being examined during litigation, or after litigation
had been stayed, dismissed, etc., to allow for consideration
of the reissue by the Office. This 1-month
period may be extended only upon a showing of clear
justification pursuant to 37 CFR 1.136(b). The Office
action will inform applicant that the provisions of
37
CFR 1.136(a) are not available. Of course, up to
3
months may be set for reply if the examiner determines
such a period is clearly justified.


===1442.02 Concurrent Litigation===


The examiner should note that the heading on
In order to avoid duplication of effort, action in
printed copies of the patent will not be carried forward
reissue applications in which there is an indication of  
to the reissue from the original patent. Therefore,  
concurrent litigation will be suspended automatically
it is important that the bibliographic data sheet
unless and until it is evident to the examiner, or the  
(or the front face of the reissue file wrapper for series
applicant indicates, that any one of the following
08/ and earlier paper applications) be endorsed by the
applies:
examiner under “FOREIGN APPLICATIONS.” For
an IFW reissue file, a copy of the bibliographic data
sheet should be printed from the IFW file history. The
printed copy should be annotated by the examiner and
then the annotated copy should be scanned into the
IFW.


PRIORITY UNDER 35 U.S.C. 119(a)-(d) IS
(A)a stay of the litigation is in effect;
NEWLY PERFECTED IN THE REISSUE APPLICATION


(B)the litigation has been terminated;


A reissue was granted in Brenner v. State of Israel,
(C)there are no significant overlapping issues
400 F.2d 789, 158 USPQ 584 (D.C. Cir. 1968), where
between the application and the litigation; or  
the only ground urged was failure to file a certified
copy of the original foreign application to obtain the
right of foreign priority under 35 U.S.C. 119(a)-(d)
before the patent was granted. In Brenner, the claim
for priority had been made in the prosecution of the
original patent, and it was only necessary to submit a
certified copy of the priority document in the reissue
application to perfect priority (the claim for priority
must be repeated in the reissue application). Reissue
is also available to correct the “error” in failing to take
any steps to obtain the right of foreign priority under
35 U.S.C. 119(a)-(d) before the original patent was
granted. See Fontijn v. Okamoto, 518 F.2d 610, 622,
186 USPQ 97, 106 (CCPA 1975) (“a patent may be
reissued for the purpose of establishing a claim to priority
which was not asserted, or which was not perfected
during the prosecution of the original
application”) In a situation where it is necessary to
submit for the first time both the claim for priority and
the certified copy of the priority document in the reissue
application and the patent to be reissued resulted
from a utility or plant application filed on or after
November 29, 2000, the reissue applicant will have to
file a petition for an unintentionally delayed priority
claim under 37 CFR 1.55(c) in addition to filing a
reissue application. See MPEP §
201.14(a).


1418Notification of Prior/Concurrent
(D)it is applicant’s desire that the application be
Proceedings and Decisions There-
examined at that time.
on, and of Information Known to
be Material to Patentability [R-3]


37 CFR 1.178. Original patent; continuing duty of  
Where any of (A) - (D) above apply, form paragraphs
applicant.
14.08-14.10 may be used to deny a suspension
of action in the reissue, i.e., to deny a stay of the reissue
proceeding.


Where none of (A) through (D) above apply, action
in the reissue application in which there is an indication
of concurrent litigation will be suspended by the
examiner. The examiner should consult with the
Technology Center Special Program Examiner
prior to suspending action in the reissue. Form paragraph
14.11 may be used to suspend action, i.e., stay
action, in a reissue application with concurrent litigation.


An ex parte reexamination proceeding will not be
stayed where there is litigation. See Ethicon v. Quigg,
849 F.2d 1422, 7 USPQ2d 1152 (Fed. Cir. 1988).
Thus, where a reissue application has been merged
with an ex parte reexamination proceeding, the
merged proceeding will not be stayed where there is
litigation. In a merged ex parte reexamination/reissue
proceeding, the ex parte reexamination will control
because of the statutory (35 U.S.C. 305) requirement
that ex parte reexamination proceedings be conducted
with special dispatch. See MPEP § 2285 and § 2286.
As to a stay or suspension where reissue proceedings
are merged with inter partes reexamination proceedings,
see 37 CFR 1.937 and MPEP § 2686.


(b)In any reissue application before the Office, the applicant
===1442.03 Litigation Stayed===
must call to the attention of the Office any prior or concurrent proceedings
in which the patent (for which reissue is requested) is or
was involved, such as interferences, reissues, reexaminations, or
litigations and the results of such proceedings (see also
§
1.173(a)(1)).
 
37 CFR 1.178(b) requires reissue applicants to call
to the attention of the Office any prior or concurrent
proceeding in which the patent (for which reissue is
requested) is or was involved and the results of such
proceedings. These proceedings would include interferences,
reissues, reexaminations, and litigations.
Litigation would encompass any papers filed in the
court or issued by the court, which may include, for
example, motions, pleadings, and court decisions.
This duty to submit information is continuing, and
runs from the time the reissue application is filed until
the reissue application is abandoned or issues as a
reissue patent.


In addition, a reissue application is subject to the
All reissue applications, except those under suspension
same duty of disclosure requirements as is any other
because of litigation, will be taken up for action
nonprovisional application. The provisions of 37 CFR
ahead of other “special” applications; this means that
1.63 require acknowledgment in the reissue oath or
all issues not deferred will be treated and responded to  
declaration of the “duty to disclose to the Office all  
immediately. Furthermore, reissue applications
information known to the [applicants] to be material
involved in “stayed litigation” will be taken up for
to patentability as defined in §
action in advance of other reissue applications. Great
emphasis is placed on the expedited processing of
1.56.” Note that the
such reissue applications. The courts are especially
Office imposes no responsibility on a reissue applicant
interested in expedited processing in the Office where
to resubmit, in a reissue application, all the “References
litigation is stayed.
Cited” in the patent for which reissue is  
sought. Rather, applicant has a continuing duty under
37 CFR 1.56 to timely apprise the Office of any information
which is material to the patentability of the
claims under consideration in the reissue application.


37 CFR 1.97 and 37 CFR 1.98 provide a mechanism
In reissue applications with “stayed litigation,” the
to submit information known to applicants to be
Office will entertain petitions under 37 CFR 1.182,
material to patentability. Information submitted in  
which are accompanied by the fee under 37 CFR  
compliance with 37 CFR 1.97 and 37 CFR 1.98 will
1.17(f), to not apply the 2-month delay period
be considered by the Office. See MPEP § 609.  
stated in MPEP § 1441. Such petitions are decided by
Although a reissue applicant may utilize 37 CFR 1.97and 37 CFR 1.98 to comply with the duty of disclo
the Office of Patent Legal Administration.


Time-monitoring systems have been put into effect
which will closely monitor the time used by applicants,
protestors, and examiners in processing reissue
applications of patents involved in litigation in which
the court has stayed further action. Monthly reports on
the status of reissue applications with related litigation
are required from each Technology Center (TC).
Delays in reissue processing are to be followed up.
The TC Special Program Examiner is responsible for
oversight of reissue applications with related litigation.


The purpose of these procedures and those deferring
consideration of certain issues, until all other
issues are resolved or the application is otherwise
ready for consideration by the Board of Patent
Appeals and Interferences (note MPEP § 1448), is to
reduce the time between filing of the reissue application
and final action thereon, while still giving all parties
sufficient time to be heard.


===1442.04 Litigation Involving Patent===


37 CFR 1.178. Original patent; continuing duty of
applicant.


(b)In any reissue application before the Office, the applicant
must call to the attention of the Office any prior or concurrent proceedings
in which the patent (for which reissue is requested) is or
was involved, such as interferences, reissues, reexaminations, or
litigations and the results of such proceedings (see also
§ 1.173(a)(1)).


sure required by 37 CFR 1.56, this does not relieve
Where the patent for which reissue is being sought
applicant of the duties under 37 CFR 1.175 of, for
is, or has been, involved in litigation, the applicant
example, stating “at least one error being relied
should bring the existence of such litigation to the
upon.
attention of the Office. 37 CFR 1.178(b). This should
be done at the time of, or shortly after, the applicant
files the application, either in the reissue oath or declaration,
or in a separate paper, preferably accompanying
the application as filed. Litigation begun after
filing of the reissue application also should be
promptly brought to the attention of the Office.  


While 37 CFR 1.97(b) provides for the filing of an
Litigation encompasses any papers filed in the
information disclosure statement within 3 months of  
court or issued by the court. This may include, for  
the filing of an application or before the mailing date
example, motions, pleadings, and court decisions, as
of a first Office action, reissue applicants are encouraged
well as the results of such proceedings. When applicant
to file information disclosure statements at the
notifies the Office of the existence of the litigation,  
time of filing of the reissue application so that such
enough information should be submitted so that  
statements will be available to the public during the 2-
the Office can reasonably evaluate the need for asking
month period provided in MPEP § 1441. Form paragraph
for further materials in the litigation. Note that the
14.11.01 may be used to remind applicant of the
existence of supporting materials which may substantiate
duties to timely make the Office aware of (A) any
allegations of invalidity should, at least, be fully
prior or concurrent proceeding (e.g., litigation or
described, and preferably submitted. The Office is not
Office proceedings) in which the patent to be reissued
interested in receiving voluminous litigation materials
is or was involved, and (B) any information which is  
which are not relevant to the Office’s consideration of
material to patentability of the claims in the reissue  
the reissue application. The status of the litigation
application.
should be updated in the reissue application as soon as
significant events happen in the litigation.  


14.11.01 Reminder of Duties Imposed by 37 CFR
When a reissue application is filed, the examiner
1.178(b) and 37 CFR 1.56
should determine whether the original patent has been
adjudicated by a court. The decision(s) of the court,
and also other papers in the suit, may provide information
essential to the examination of the reissue.
Examiners should inform the applicant of the duty to
supply information as to litigation involving the
patent. Form paragraph 14.11.01 may be used for this
purpose. See MPEP § 1418.  


Applicant is reminded of the continuing obligation under 37
Additionally, the patented file will contain notices
CFR 1.178(b), to timely apprise the Office of any prior or concurrent
of the filing and termination of infringement suits on
proceeding in which Patent No. [1] is or was involved. These
the patent. Such notices are required by law to be filed
proceedings would include interferences, reissues, reexaminations,  
by the clerks of the Federal District Courts. These
and litigation.  
notices do not indicate if there was an opinion by the
court, nor whether a decision was published. Shepard’s
Federal Citations and the cumulative digests of
the United States Patents Quarterly, both of which are
in the Lutrelle F. Parker, Sr., Memorial Law Library,  
contain tables of patent numbers giving the citation of
published decisions concerning the patent.  


Applicant is further reminded of the continuing obligation
A litigation computer search by the Scientific and
under 37 CFR 1.56, to timely apprise the Office of any information
Technical Information Center (STIC) should be
which is material to patentability of the claims under consideration
requested by the examiner to determine whether the
in this reissue application.
patent has been, or is, involved in litigation. For
reissue application files that are maintained in paper,
the “Search Notes” box on the application file wrapper
is then  completed to indicate that the review
was conducted. A copy of the STIC search should be
hole-punched and placed in the reissue file. For
IFW reissue application files, the “Search Notes” box
on the OACS “Search Notes” page is annotated to  
indicate that the review was conducted, and the  
OACS “Search Notes” page is then scanned into the  
reissue application file history.  


These obligations rest with each individual associated with the  
Additional information or guidance as to making a
filing and prosecution of this application for reissue. See also
litigation search may be obtained from the library of
MPEP §§ 1404, 1442.01 and 1442.04.  
the Office of the Solicitor. Where papers are not otherwise
conveniently obtainable, the applicant may be
requested to supply copies of papers and records in
suits, or the Office of the Solicitor may be requested
to obtain them from the court. The information thus
obtained should be carefully considered for its bearing
on the proposed claims of the reissue, particularly
when the reissue application was filed in view of the
holding of a court.


Examiner Note:
If the examiner becomes aware of litigation involving
the patent sought to be reissued during examination
of the reissue application, and applicant has not
made the details regarding that litigation of record in
the reissue application, the examiner, in the next
Office action, should inquire regarding the same.
Form paragraph 14.06 may be used for such an
inquiry. See MPEP § 1442.01.


1.This form paragraph is to be used in the first action in a reissue  
If the additional details of the litigation appear to be  
application.
material to patentability of the reissue application, the
examiner may make such additional inquiries as necessary
and appropriate.


2.In bracket [1], insert the patent number of the original patent
===1442.05 Court Ordered Filing of Reissue Application===
for which reissue is requested.


1430Reissue Files Open to the Public
In most instances, the reissue-examination procedure
and, Notice of Filing Reissue Announced
is instituted by a patent owner who voluntarily
in, Official Gazette [R-3]
files a reissue application as a consequence of related
patent litigation. Some Federal district courts in
earlier decisions have required a patentee-litigant to  
file a reissue application as a consequence of the  
patent litigation. However, the Court of Appeals for
the Federal Circuit held in Green v. The Rich Iron Co.,
944 F.2d 852, 853, 20 USPQ2d 1075, 1076 (Fed. Cir.
1991) that a Federal district court in an infringement
case could not compel a patentee to seek reissue
by the USPTO.


37 CFR 1.11. Files open to the public.
It is to be noted that only a patentee or his or her
assignee may file a reissue patent application. An
order by a court for a different party to file a reissue
will not be binding on the Office.


==1443 Initial Examiner Review==


As part of an examiner’s preparation for the examination
of a reissue application, the Examiner Reissue
Guide and Checklist should be consulted for basic
guidance and suggestions for handling the prosecution.
The Technology Center (TC) Special Program
Examiners (SPREs) should make the Guide and
Checklist available at the time a reissue application is
docketed to an examiner.


(b)All reissue applications, all applications in which the  
On initial receipt of a reissue application, the examiner
Office has accepted a request to open the complete application to  
should inspect the submission under 37 CFR
inspection by the public, and related papers in the application file,
1.172 as to documentary evidence of a chain of title
are open to inspection by the public, and copies may be furnished
from the original owner to the assignee to determine
upon paying the fee therefor. The filing of reissue applications,  
whether the consent requirement of 37 CFR 1.172 has
other than continued prosecution applications under § 1.53(d) of
been met. The examiner will compare the consent and  
reissue applications, will be announced in the Official Gazette.
documentary evidence of ownership; the assignee
The announcement shall include at least the filing date, reissue
indicated by the documentary evidence must be the
application and original patent numbers, title, class and subclass,
same assignee which signed the consent. Also, the
name of the inventor, name of the owner of record, name of the  
person who signs the consent for the assignee and the
attorney or agent of record, and examining group to which the
person who signs the submission of evidence of ownership
reissue application is assigned.
for the assignee must both be persons having
authority to do so. See also MPEP § 324.  


Where the application is assigned, and there is no
submission under 37 CFR 1.172 as to documentary
evidence in the application, the examiner should
require the submission using form paragraph 14.16.
Once the submission under 37 CFR 1.172 as to documentary
evidence is received, it must be compared
with the consent to determine whether the assignee
indicated by the documentary evidence is the same
assignee which signed the consent. See MPEP
§ 1410.01 for further discussion as to the required
consent and documentary evidence.


Where there is a statement of record that the application
is not assigned, there should be no submission
under 37
CFR 1.172 as to documentary evidence of
ownership in the application, and none should be
required by the examiner.


Under 37 CFR 1.11(b) all reissue applications filed
The filing of all reissue applications, except for  
after March 1, 1977, are open to inspection by the
continued prosecution applications (CPAs) filed under  
general public, and copies may be furnished upon
37 CFR 1.53(d), must be announced in the Official  
paying the fee therefor. The filing of reissue applications  
Gazette. Accordingly, for any reissue application
(except for continued prosecution applications  
other than a CPA, the examiner should determine if
(CPA’s) filed under 37  
the filing of the reissue application has been
CFR 1.53(d)) will be  
announced in the Official Gazette as provided in
announced in the Official Gazette. The announcement
37 CFR 1.11(b). The contents entry on the PALM
gives interested members of the public an opportunity
Intranet Contents screen should be checked for the  
to submit to the examiner information pertinent to the
presence of “NRE” and “NOTICE OF REISSUE
patentability of the reissue application. The announcement
PUBLISHED IN OFFICIAL GAZETTE” entries in
includes the filing date, reissue application and  
the contents, and the date of publication. Where the
original patent numbers, title, class and subclass,  
reissue application is maintained in a paper file, the
name of the inventor, name of the owner of record,  
date of the Official Gazette notice can usually be
name of the attorney or agent of record, and the Technology
found on the pink “REISSUE” tag which protrudes
Center (TC) to which the reissue application is
from the top of the application file of 08/ or earlier
initially assigned. A TC Director or other appropriate
series.  For 09/ and later series reissue applications,  
Office official may, under appropriate circumstances,
the Official Gazette publication date appears on the
postpone access to or the making of copies of a
face of the file wrapper.  If the filing of the reissue
paper reissue application file, such as, for example,
application has not been announced in the Official
to avoid interruption of the examination or other
Gazette, the reissue application should be returned to
review of the application by an examiner.
the Office of Initial Patent Examination (Special Processing)
to handle the announcement. The examiner
should not further act on the reissue until 2 months
after announcement of the filing of the reissue has
appeared in the Official Gazette. See MPEP § 1440.


IFW reissue application files are open to inspection
The examiner should determine if there is concurrent
by the general public by way of Public PAIR via
litigation, and if so, the status thereof (MPEP
the USPTO Internet site. In viewing the images of the
§ 1442.01), and whether the reissue file wrapper
files, members of the public will be able to view the
(for reissue application files maintained in paper) or
entire content of the reissue application file history.
file history (for IFW reissue applications) has been
To access Public PAIR, a member of the public would
appropriately marked. Note MPEP § 1404.  
(A) go to the USPTO web site at http://
www.uspto.gov, (B) click on “Patents”, (C) under
“Check Status, View Papers…” click on “Status &
IFW,” and (D) under “Patent Application Information
Retrieval” enter the reissue application number.


A notice of a reissue application in the Official
The examiner should determine if a protest has
Gazette should be published prior to any examination
been filed, and if so, it should be handled as set forth
of the application. If an inadvertent failure to publish
in MPEP § 1901.06. For a discussion of protests
notice of the filing of the reissue application in the
under 37 CFR 1.291 in reissue applications, see
Official Gazette is recognized later in the examination,  
MPEP § 1441.01.
action should be taken to have the notice published
as quickly as possible, and action on the
application may be delayed until two months after the


The examiner should determine whether the patent
is involved in an interference, and if so, should refer
to MPEP § 1449.01 before taking any action on the
reissue application.


The examiner should verify that all Certificate of
Correction changes have been properly incorporated
into the reissue application. See MPEP § 1411.01.


The examiner should verify that the patent on
which the reissue application is based has not expired,
either because its term has run or because required
maintenance fees have not been paid. Once a patent
has expired, the Director of the USPTO no longer has
the authority under 35 U.S.C. 251 to
reissue the patent. See In re Morgan, 990 F.2d 1230, 26 USPQ2d
1392 (Fed. Cir. 1992). See also MPEP § 1415.01.


==1444 Review of Reissue Oath/Declaration==


publication, allowing for any protests to be filed. For
In accordance with 37 CFR 1.175, the following is
a discussion of protests, see MPEP Chapter 1900.
required in the reissue oath/declaration:


The filing of a continued prosecution application
(A)A statement that the applicant believes the  
(CPA) under 37 CFR 1.53(d) of a reissue application
original patent to be wholly or partly inoperative or
will not be announced in the Official Gazette.
invalid-
Although the filing of a CPA of a reissue application
constitutes the filing of a reissue application, the
announcement of the filing of such CPA would be  
redundant in view of the announcement of the filing
of the prior reissue application in the Official Gazetteand the fact that the same application number and file
will continue to be used for the CPA.


If applicant files a Request for Continued Examination
(1)by reason of a defective specification or
(RCE) of the reissue application under 37 CFR
drawing, or
1.114 (which can be filed on or after May 29, 2000 for
a reissue application filed on or after June 8, 1995),
such filing will not be announced in the Official
Gazette. An RCE continues prosecution of the existing
reissue application and is not a filing of a new
application.


(2)by reason of the patentee claiming more or
less than patentee had the right to claim in the patent;


(B)A statement of at least one error which is
relied upon to support the reissue application, i.e.,
which provides a basis for the reissue;


The filing of all reissue applications, except for
(C)A statement that all errors which are being
CPAs filed under 37 CFR 1.53(d), (note that effective
corrected in the reissue application up to the time of
July 14, 2003, CPA practice has been eliminated as to
filing of the oath/declaration arose without any deceptive
utility and plant application) will be announced in the  
intention on the part of the applicant; and
Official Gazette and will include certain identifying
data as specified in 37 CFR 1.11(b). Access to a reissue  
application that is maintained in paper must be
obtained from the area of the Office having jurisdiction
over the reissue application file.


For reissue application files that are maintained in
(D)The information required by 37 CFR 1.63.
paper, the following access procedure will be
observed:


(A) Any member of the general public may
MPEP § 1414 contains a discussion of each of the  
request access to a particular reissue application filed
above elements (i.e., requirements of a reissue oath/
after March 1, 1977. Since no record of such
declaration). The examiner should carefully review
request is intended to be kept, an oral request will suffice.
the reissue oath/declaration in conjunction with that
Reissue applications already on file prior to  
discussion, in order to ensure that each element is provided
March 1, 1977 are not automatically open to inspection,
in the oath/declaration. If the examiner’s review
but a liberal policy is followed by the Office of  
of the oath/declaration reveals a lack of compliance
Patent Legal Administration and by the Board of  
with any of the requirements of 37 CFR 1.175, a
Patent Appeals and Interferences (see MPEP
rejection of all the claims under 35
§
U.S.C. 251 should
be made on the basis that the reissue oath/declaration
1002.02(b)) in granting petitions for access to such
is insufficient.
applications.  


(B)Paper reissue application files will be
In preparing an Office action, the examiner should
maintained in the TCs and inspection thereof will be
use form paragraphs 14.01 through 14.01.04 to state
supervised by TC personnel. Although no general
the objection(s) to the oath/declaration, i.e., the
limit is placed on the amount of time spent reviewing
defects in the oath/declaration. These form paragraphs
the files, the Office may impose limitations, if necessary,
are reproduced in MPEP § 1414. The examiner should
e.g., where the application is actively being processed.  
then use form paragraph 14.14 to reject the claims
under 35 U.S.C. 251, based upon the improper oath/
declaration.  


A lack of signature on a reissue oath/declaration
(except as otherwise provided in 37 CFR 1.42, 1.43,
and 1.47 and in 37 CFR 1.172) would be considered a
lack of compliance with 37 CFR 1.175(a) and result in
a rejection, including final rejection, of all the claims
on the basis that the reissue oath/declaration is insufficient.
If the unsigned reissue oath/declaration is submitted
as part of a reply which is otherwise properly
signed and responsive to the outstanding Office
action, the reply should be accepted by the examiner
as proper and responsive, and the oath/declaration
considered fully in the next Office action. The reply
should not be treated as an unsigned or improperly
signed amendment (see MPEP § 714.01(a)), nor do
the holdings of Ex parte Quayle apply in this situation.
The lack of signature, along with any other oath/
declaration deficiencies, should be noted in the next
Office action rejecting the claims as being based upon
an insufficient reissue oath/declaration.


(C)Where the reissue application file has left
I.HANDLING OF THE REISSUE OATH/
the TC for administrative processing, requests for
DECLARATION DURING THE REISSUE
access should be directed to the appropriate supervisory
PROCEEDING
personnel where the application is currently
located.


(D)Requests for copies of papers in the reissue  
An initial reissue oath/declaration is submitted with
application file must be in writing and addressed to  
the reissue application (or within the time period set
the Mail Stop Document Services, Director of the  
for filing the oath/declaration in a Notice To File
United States Patent and Trademark Office, P.O. Box
Missing Parts under 37 CFR 1.53(f)). Where the reissue  
1450, Alexandria, VA 22313-1450. Such requests
oath/declaration fails to comply with 37 CFR
may be either mailed or delivered to the Office Customer
1.175(a), the examiner will so notify the applicant in
Service Window (See MPEP § 502). The price
an Office action, rejecting the claims under 35 U.S.C.  
for copies made by the Office is set forth in 37 CFR
251 as discussed above. In reply to the Office action, a
1.19.
supplemental reissue oath/declaration should be submitted
dealing with the noted defects in the reissue
oath/declaration.


1440Examination of Reissue Application
Where the initial reissue oath/declaration (1) failed
[R-3]
to provide any error statement, or (2) attempted to
provide an error statement, but failed to identify any
error under 35 U.S.C. 251 upon which reissue can be
based (see MPEP § 1402), the examiner should reject
all the claims as being based upon a defective reissue
oath/declaration under 35 U.S.C. 251. To support the
rejection, the examiner should specifically point out
the failure of the initial oath/declaration to comply
with 37 CFR 1.175 because an “error” under
35 U.S.C. 251 upon which reissue can be based was
not identified therein. In reply to the rejection under
35 U.S.C. 251, a supplemental reissue oath/declaration
must be submitted stating an error under
35 U.S.C. 251 which can be relied upon to support the
reissue application. Submission of this supplemental
reissue oath/declaration to obviate the rejection cannot
be deferred by applicant until the application is
otherwise in condition for allowance. In this instance,
a proper statement of error was never provided in the
initial reissue oath/declaration, thus a supplemental
oath/declaration is required in reply to the Office
action in order to properly establish grounds for reissue.


37 CFR 1.176. Examination of reissue.
A different situation may arise where the initial
reissue oath/declaration does properly identify one or
more errors under 35 U.S.C. 251 as being the basis for
reissue, however, because of changes or amendments
made during prosecution, none of the identified errors
are relied upon any more. A supplemental oath/declaration
will be needed to identify at least one error nowbeing relied upon as the basis for reissue, even though
the prior oath/declaration was earlier found proper by
the examiner. The supplemental oath/declaration need
not also indicate that the error(s) identified in the prior
oath(s)/declaration(s) is/are no longer being corrected.  
In this instance, applicant’s submission of the supplemental
reissue oath/declaration to obviate the rejection
under 35 U.S.C. 251 can, at applicant’s option, be
deferred until the application is otherwise in condition
for allowance. The submission can be deferred
because a proper statement of error was provided in
the initial reissue oath/declaration. Applicant need
only request that submission of the supplemental reissue  
oath/declaration be deferred until allowance, and
such a request will be considered a complete reply to
the rejection.


(a)A reissue application will be examined in the same manner
II.SUPPLEMENTAL REISSUE OATH/DECLARATION UNDER 37 CFR 1.175(b)(1):
as a non-reissue, non-provisional application, and will be subject
to all the requirements of the rules related to non-reissue
applications. Applications for reissue will be acted on by the
examiner in advance of other applications.


(b)Restriction between subject matter of the original patent  
Once the reissue oath/declaration is found to comply
claims and previously unclaimed subject matter may be required
with 37 CFR 1.175(a), it is not required, nor is it
(restriction involving only subject matter of the original patent  
suggested, that a new reissue oath/declaration be submitted
claims will not be required). If restriction is required, the subject
together with each new amendment and correction
matter of the original patent claims will be held to be constructively
of error in the patent. During the prosecution of a
elected unless a disclaimer of all the patent claims is filed in  
reissue application, amendments are often made
the reissue application, which disclaimer cannot be withdrawn by
and additional errors in the patent are corrected. A
applicant.
supplemental oath/declaration need not be submitted
with each amendment and additional correction.  
Rather, it is suggested that the reissue applicant wait
until the case is in condition for allowance, and then
submit a cumulative supplemental reissue oath/declaration
pursuant to 37 CFR 1.175(b)(1).


37 CFR 1.176 provides that an original claim, if re-
See MPEP § 1414.01 for a discussion of the  
presented in a reissue application, will be fully examined
required content of a supplemental reissue oath/declaration  
in the same manner, and subject to the same rules
under 37 CFR 1.175(b)(1).
as if being presented for the first time in an original
non-reissue, nonprovisional application, except that
division will not be required by the examiner. See  
MPEP § 1450 and § 1451. Reissue applications are
normally examined by the same examiner who issued
the patent for which reissue is requested. In addition,
the application will be examined with respect to compliance
with 37 CFR 1.171-1.178 relating specifically
to reissue applications, for example, the reissue  
oath or declaration will be carefully reviewed for
compliance with 37 CFR 1.175. See MPEP § 1444 for
handling applications in which the oath or declaration


A supplemental oath/declaration under 37 CFR
1.175(b)(1) must be submitted before allowance. It
may be submitted with any reply prior to allowance. It
may be submitted to overcome a rejection under
35
U.S.C. 251 made by the examiner, where it is indicated
that the submission of the supplemental oath/
declaration will overcome the rejection.


A supplemental oath/declaration under 37 CFR
1.175(b)(1) will be required where:


(A)the application is otherwise (other than the
need for this supplemental oath/declaration) in condition
for allowance;


(B)amendments or other corrections of errors in
the patent have been made subsequent to the last oath/
declaration filed in the application; and


lacks compliance with 37 CFR 1.175. Reissue applications
(C)at least one of the amendments or other corrections
with related litigation will be acted on by the  
corrects an error under 35 U.S.C. 251.
examiner before any other special applications, and
will be acted on immediately by the examiner, subject
only to a 2-month delay after publication for examining
reissue applications; see MPEP § 1441.


The original patent file wrapper /file history should
When a supplemental oath/declaration under
always be obtained and reviewed when examining a
37 CFR 1.175(b)(1) directed to the amendments or
reissue application thereof.
other corrections of error is required, the examiner is  
 
encouraged to telephone the applicant and request the  
1441Two-Month Delay Period [R-3]
submission of the supplemental oath/declaration by
 
fax. If the circumstances do not permit making a telephone
37 CFR 1.176 provides that reissue applications
call, or if applicant declines or is unable to
will be acted on by the examiner in advance of other
promptly submit the oath/declaration, the examiner
applications, i.e., “special.” Generally, a reissue application
should issue a final Office action (final rejection) and
will not be acted on sooner than 2 months after
use form paragraph 14.05.02 where the action issued
announcement of the filing of the reissue has
is a second or subsequent action on the merits.
appeared in the Official Gazette. The 2-month delay is  
provided in order that members of the public may
have time to review the reissue application and submit
pertinent information to the Office before the examiner’s
action. The pertinent information is submitted
in the form of a protest under 37 CFR 1.291(a). For a
discussion as to protests under 37 CFR 1.291(a) in
reissue applications, see MPEP § 1441.01. As set
forth in MPEP § 1901.04, the public should be aware
that such submissions should be made as
early as possible,
since, under certain circumstances, the 2-month
delay period will not be employed. For example, the
Office may act on a continuation or a divisional reissue
application prior to the expiration of the 2-month
period after announcement. Additionally, the Office
will entertain a petition under 37 CFR 1.182 which is
accompanied by the required petition fee (37
CFR
1.17(f)) to act on a reissue application without
delaying for 2 months. Accordingly, protestors to reissue
applications (see MPEP § 1441.01) cannot automatically
assume that a full 2-month delay period will
always be available. Appropriate reasons for requesting
that the 2-month delay period not be employed
include that litigation involving a patent has been
stayed to permit the filing of an application for the
reissue of the patent. Where the basis for the petition
is ongoing litigation, the petition must clearly
identify the litigation, and detail the specifics of the
litigation that call for prompt action on the reissue
application prior to the expiration of the 2-month
delay period. Such petitions are decided by the
Office of Patent Legal Administration.


1441.01Protest in Reissue Applications[R-3]
As noted above, the examiner will issue a final
Office action where the application is otherwise in
condition for allowance, and amendments or other
corrections of error in the patent have been made subsequent
to the last oath/declaration filed in the application.  
The examiner will be introducing (via form
paragraph 14.05.02) a rejection into the case for the
first time in the prosecution, when the claims have
been determined to be otherwise allowable. This
introduction of a new ground of rejection under
35
U.S.C. 251 will not prevent the action from being
made final on a second or subsequent action because
of the following factors:


A protest pursuant to 37 CFR 1.291 may be
(A)The finding of the case in condition for allowance  
filed throughout the pendency of a reissue application,
is the first opportunity that the examiner has to  
prior to the date of mailing of a notice of allowance,
make the rejection;
subject to the timing constraints of the examination,
as set forth in MPEP § 1901.04. While a reissue application
is not published under 37 CFR 1.211, the reissue
application is published pursuant to 35 U.S.C.
122(b)(1)(A) via an announcement in the Official
Gazette (and public availability of the file content) per
37 CFR 1.11(b). Such a publication does not preclude
the filing of a protest. 35 U.S.C. 122(c) states:


(c) PROTEST AND PRE-ISSUANCE OPPOSITION-
(B)The rejection is being made in reply to, i.e.,
The Director shall establish appropriate procedures to  
was caused by, an amendment of the application (to
ensure that no protest or other form of pre-issuance
correct errors in the patent);
opposition to the grant of a patent on an application may be
initiated after publication of the application without the
express written consent of the applicant.” [Emphasis
added.]


A protest is precluded after publication for an application
(C)All applicants are on notice that this rejection
for an original patent, as a “form of pre-issuance
will be made upon finding of the case otherwise in
opposition.” A reissue application is a post-
condition for allowance where errors have been corrected
issuance proceeding. A protest filed in a reissue application
subsequent to the last oath/declaration filed in  
is not a “form of pre-issuance opposition to the  
the case, so that the rejection should have been  
grant of a patent” since the patent to be reissued has
expected by applicant; and  
already been granted. Thus, the prohibition against
the filing of a protest after publication of an application
under 35 U.S.C. 122(c) is not applicable to a reissue
application and a protest is permitted after
publication of the reissue application.


A protest with regard to a reissue application
(D)The rejection will not prevent applicant from
should be filed within the 2-month period following
exercising any rights to cure the rejection, since applicant
the announcement of the filing of the reissue application
need only submit a supplemental oath/declaration
in the Official Gazette. If the protest of a reissue
with the above-described language, and it will be  
application cannot be filed within the 2-month delay
entered to cure the rejection.
period, the
protest can be submitted at a later time.
Where the protest is submitted after the 2-month
period, no petition for entry of the protest under
37
CFR 1.182 is needed with respect to the protest
being submitted after the 2 months, unless a final
rejection has been issued or prosecution on the merits
has been otherwise closed for the reissue application.


Where the application is in condition for allowance
and no amendments or other corrections of error
in the patent have been made subsequent to the
last oath/declaration filed in the application, a supplemental
reissue oath/declaration under 37 CFR
1.175(b)(1) should not be required by the examiner.
Instead, the examiner should issue a Notice of
Allowability indicating allowance of the claims.
III.AFTER ALLOWANCE
Where applicant seeks to correct an error after
allowance of the application, any amendment of the
patent correcting the error must be submitted in accordance
with 37 CFR 1.312. As set forth in 37 CFR
1.312, no amendment may be made as a matter of
right in an application after the mailing of the notice
of allowance. An amendment filed under 37 CFR
1.312 must be filed before or with the payment of the
issue fee and may be entered on the recommendation
of the primary examiner, and approved by the supervisory
patent examiner, without withdrawing the case
from issue.


A potential protestor should be aware that reissue
Because the amendment seeks to correct an error in
applications are taken up “special” and a protest
the patent, the amendment will affect the disclosure,
filed outside the 2-month delay period may be
the scope of a claim, or add a claim. Thus, in accordance
 
with MPEP § 714.16, the remarks accompanying
the amendment must fully and clearly state:


(A)why the amendment is needed;


(B)why the proposed amended or new claims
require no additional search or examination;


(C)why the claims are patentable; and


received after action by the examiner. Once the
(D)why they were not presented earlier.
first
Office action is mailed (after the 2-month
period), a member of the public may still submit pertinent
information in the form of a protest under
37
CFR 1.291, and the examiner will consider the
information submitted in the next Office action, to the
extent that such consideration is appropriate.
Where a final rejection has been issued or the
prosecution on the merits has been otherwise closed, a
petition under 37 CFR 1.182 along with the required
petition fee (37 CFR 1.17(f)) for entry of the protest
are required. The petition must include an explanation
as to why the additional time was necessary and the
nature of the protest intended. A copy of the petition
must be served upon the applicant in accordance with
37 CFR 1.248. The petition should be directed to the
Office of Petitions.


If the protest of a reissue application cannot be filed
A supplemental reissue oath/declaration must
within the 2-month delay period, the protestor may
accompany the amendment. The supplemental reissue  
petition to request (A) an extension of the 2-month
oath/declaration must state that the error(s) to be corrected
period following the announcement in the Official
arose without any deceptive intention on the  
Gazette, and (B) a delay of the examination until the  
part of the applicant. The supplemental reissue oath/
extended period expires. Such a request will be considered
declaration submitted after allowance must be
only if filed in the form of a petition under
directed to the error(s) applicant seeks to correct after
allowance. This oath/declaration need not cover any
earlier errors, since all earlier errors should have been
covered by a reissue oath/declaration submitted prior
to allowance.
 
Occasionally correcting an error after allowance
does not include an amendment of the specification or
claims of the patent. For example, the correction of
the error could be the filing of a certified copy of the  
original foreign application (prior to the payment of
the issue fee - see 37 CFR 1.55(a)(2)) to obtain the
right of foreign priority under 35 U.S.C. 119 (see
Brenner v. State of Israel, 400 F.2d 789, 158 USPQ
584 (D.C. Cir. 1968)) where the claim for foreign priority
had been timely made in the application for the
original patent. In such a case, the requirements of  
37  
37  
CFR 1.182 and accompanied by the petition fee set
CFR 1.312 must still be met. This is so, because
forth in 37 CFR 1.17(f). The petition under 37 CFR
the correction of the patent is an amendment of the  
1.182 and the petition fee must be filed prior to the
patent, even though no amendment is physically
expiration of the 2-month period following the  
entered into the case. Thus, for a reissue oath/declaration
announcement of the filing of the reissue application
submitted after allowance to correct an additional  
in the Official Gazette. The petition must explain why
error (or errors), the reissue applicant must comply
the additional time is necessary and the nature of the
with 37 CFR 1.312 in the manner discussed above.
protest intended. A copy of the petition must be
served upon applicant in accordance with 37 CFR  
1.248. The petition should be directed to the appropriate
Technology Center (TC) which will forward the  
petition to the Office of Patent Legal Administration.  


If the protest is a “REISSUE LITIGATION” protest,
==1445 Reissue Application Examined in Same Manner as Original Application==
it is particularly important that it be filed early if
protestor wishes it considered at the time the Office
first acts on the reissue application. Protestors should
be aware that the Office will entertain petitions from
the reissue applicants under 37 CFR 1.182 to waive
the 2-month delay period in appropriate circumstances.
Accordingly, protestors to reissue applications
cannot automatically assume that the full 2-
month delay period will always be available.


The Technology Center (TC) to which the reissue  
As stated in 37 CFR 1.176, a reissue application,
application is assigned is listed in the Official Gazettenotice of filing of the reissue application. Accordingly,  
including all the claims therein, is subject to “be
the indicated TC should retain jurisdiction
examined in the same manner as a non-reissue, non-
over the reissue application file for 2 months after
provisional application.Accordingly, the claims in a
the date of the Official Gazette notice before transferring
reissue application are subject to any and all rejections
the reissue application under the procedure set
which the examiner deems appropriate. It does
forth in MPEP §
not matter whether the claims are identical to those of
the patent or changed from those in the patent. It also
903.08(d).  
does not matter that a rejection was not made in the  
prosecution of the patent, or could have been made, or
was in fact made and dropped during prosecution of
the patent; the prior action in the prosecution of the
patent does not prevent that rejection from being
made in the reissue application. Claims in a reissue
application enjoy no “presumption of validity.” In re
Doyle, 482 F.2d 1385, 1392, 179 USPQ 227, 232-233
(CCPA 1973); In re Sneed, 710 F.2d 1544, 1550 n.4,
218 USPQ 385, 389 n.4 (Fed. Cir. 1983). Likewise,
the fact that during prosecution of the patent the
examiner considered, may have considered, or should
have considered information such as, for example, a
specific prior art document, does not have any bearing
on, or prevent, its use as prior art during prosecution
of the reissue application.


The publication of a notice of a reissue application
==1448 Fraud, Inequitable Conduct, or Duty of Disclosure Issues==
in the Official Gazette should be done prior to any
examination of the reissue application. If an inadvertent
failure to publish notice of the filing of the reissue
application in the Official Gazette is recognized later
in the examination, action should be taken to have the
notice published as quickly as possible, and action on
the reissue application may be delayed until 2 months
after the publication, allowing for any protests to be
filed.


See MPEP § 1901.06 for general procedures on
The Office no longer investigates and rejects reissue
examiner treatment of protests in reissue applications.
applications under 37 CFR 1.56. The Office will
not comment upon duty of disclosure issues which are
brought to the attention of the Office in reissue applications
except to note in the application, in appropriate
circumstances, that such issues are no longer
considered by the Office during its examination of
patent applications. Examination as to the lack of  
deceptive intent requirement in reissue applications  
will continue but without any investigation of fraud,
inequitable conduct, or duty of disclosure issues.
Applicant’s statement in the reissue oath or declaration
of lack of deceptive intent will be accepted as dispositive
except in special circumstances such as an
admission or judicial determination of fraud, inequitable
conduct, or violation of the duty of disclosure.  


1442Special Status
ADMISSION OR JUDICIAL DETERMINATION


All reissue applications are taken up “special,” and
An admission or judicial determination of fraud,  
remain “special” even though applicant does not
inequitable conduct, or violation of the duty of disclosure
respond promptly.
is a special circumstance, because no investigation
need be made. Accordingly, after consulting with
the Technology Center (TC) Special Program Examiner
(SPRE), a rejection should be made using the
appropriate one of form paragraphs 14.21.09 or 14.22as reproduced below.


All reissue applications, except those under suspension
Any admission of fraud, inequitable conduct or violation
because of litigation, will be taken up for action
of the duty of disclosure must be explicit,  
ahead of other “special” applications; this means that  
unequivocal, and not subject to other interpretation.
all issues not deferred will be treated and responded to  
Where a rejection is made based upon such an admission and applicant
immediately. Furthermore, reissue applications
responds with any reasonable interpretation of the
involved in litigation will be taken up for action in
facts that would not lead to a conclusion of fraud,
advance of other reissue applications.
inequitable conduct or violation of the duty of disclosure,
the rejection should be withdrawn. Alternatively,  
if applicant argues that the admission noted by the
examiner was not in fact an admission, the rejection
should also be withdrawn.


1442.01Litigation-Related Reissues [R-5]
See MPEP § 2012 for additional discussion as to
fraud, inequitable conduct or violation of duty of disclosure
in a reissue application.


During initial review, the examiner should determine
==1449 Protest Filed in Reissue Where Patent Is in Interference==
whether the patent for which the reissue has
been filed is involved in litigation, and if so, the status
of that litigation. If the examiner becomes aware of
litigation involving the patent sought to be reissued
during examination of the reissue application, and
applicant has not made the details regarding that litigation
of record in the reissue application, the examiner,
in the next Office action, will inquire regarding
the specific details of the litigation.


Form paragraph 14.06 may be used for such an
If a protest (see MPEP Chapter 1900) is filed in a
inquiry.
reissue application related to a patent involved in a
pending interference proceeding, the reissue application
should be referred to the Office of Patent Legal
Administration (OPLA) before considering the protest
and acting on the reissue application.  


¶ 14.06 Litigation-Related Reissue
The OPLA will check to see that:


The patent sought to be reissued by this application [1]
(A)all parties to the interference are aware of the
involved in litigation. Any documents and/or materials which
filing of the reissue; and


(B)the Office does not allow claims in the reissue
which are unpatentable over the pending interference
count(s), or found unpatentable in the interference
proceeding. After the reissue application has been
reviewed by the OPLA, the reissue application with
the protest will be returned to the examiner. See
MPEP § 1441.01 for a discussion as to protests under
37 CFR 1.291 in reissue applications.


===1449.01 Concurrent Office Proceedings===


I.CONCURRENT REEXAMINATION PROCEEDINGS:


37 CFR 1.565(d) provides that if “a reissue application
 
and an ex parte reexamination proceeding on
would be material to patentability of this reissue application are  
which an order pursuant to 37 CFR 1.525 has been
required to be made of record in response to this action.
mailed are pending concurrently on a patent, a decision
 
will normally be made to merge the two proceedings
Due to the related litigation status of this application, EXTENSIONS
or to suspend one of the two proceedings.”
OF TIME UNDER THE PROVISIONS OF 37 CFR
37 CFR 1.991 provides that if “a reissue application  
1.136(a) WILL NOT BE PERMITTED DURING THE PROSECUTION
and an inter partes reexamination proceeding on
OF THIS APPLICATION.
which an order pursuant to 37 CFR 1.931 has been
mailed are pending concurrently on a patent, a decision
may be made to merge the two proceedings or to
suspend one of the two proceedings”. If an examiner
becomes aware that a reissue application and an ex
parte or inter partes reexamination proceeding are
both pending for the same patent, he or she should
immediately inform the Technology Center (TC)
or Central Reexamination Unit (CRU) Special Program
Examiner (SPRE).


Examiner Note:
Pursuant to 37 CFR 1.177, a patent owner may file
more than one reissue application for the same patent.
If an examiner becomes aware that multiple reissue
applications are pending for the same patent, and an
ex parte or inter partes reexamination proceeding is
pending for the same patent, he or she should immediately
inform the TC SPRE.


In bracket 1, insert either —is— or —has been—.  
Where a reissue application and a reexamination
proceeding are pending concurrently on a patent, and
an order granting reexamination has been issued for
the reexamination proceeding, the Office of Patent
Legal Administration (OPLA) must be notified that
the proceedings are ready for a decision as to whether
to merge the reissue and the reexamination, or stay
one of the two. See MPEP § 2285 for the
procedure of
notifying OPLA and general guidance, if a reissue
application and an ex parte reexamination proceeding
are both pending for the same patent, and
an inter
partes reexamination proceeding is not involved. See
MPEP § 2686.03 where a reissue application and an
inter partes reexamination proceeding are both pending
for the same patent, regardless of whether an ex
parte reexamination proceeding is also pending.


If additional details of the litigation appear to be
Where a reissue application and a reexamination
material to examination of the reissue application, the
proceeding are pending concurrently on a patent, the
examiner may make such additional inquiries as necessary
patent owner, i.e., the reissue applicant, has a responsibility
and appropriate.  
to notify the Office of the concurrent proceeding.
 
37 CFR § 1.178(b), 37 CFR 1.565(a), and
For reissue application files that are maintained in
37
paper, if the existence of litigation has not already
CFR 1.985(a). The patent owner should file in the
been noted, the examiner should place a prominent
reissue application, as early as possible, a Notification
notation on the application file to indicate the litigation
of Concurrent Proceedings pursuant to 37 CFR
(1) at the bottom of the face of the file in the box
1.178(b) in order to alert the Office of the existence of  
just to the right of the box for the retention label, and
the reexamination proceeding on the same patent. See
(2) on the pink Reissue Notice Card form. For reissue
MPEP § 1418. In addition, the patent owner should
application files that are maintained in the Image
file in the reexamination proceeding, as early as possible,
File Wrapper (IFW) system, if the existence of litigation
a Notification of Concurrent Proceedings pursuant
has not already been noted, the examiner should
to 37 CFR 1.565(a) or 1.985(a) (depending on
print out a copy of the bibliographic data sheet from
whether the reexamination proceeding is an ex partereexamination proceeding or an inter partes reexamination
the IFW file history and annotate the printed bibliographic
proceeding) to provide a notification to the  
data sheet such that adequate notice is provided
Office in the reexamination proceeding of the existence  
of the existence of the litigation. The examiner
of the two concurrent proceedings.
should place the annotation in a prominent place. The
annotated sheet should be scanned into IFW.


Applicants will normally be given 1 month to reply
The patent owner may file a petition under 37 CFR
to Office actions in all reissue applications which are
1.182 in a reissue application to merge the reissue  
being examined during litigation, or after litigation
application with the reexamination proceeding, or to  
had been stayed, dismissed, etc., to allow for consideration
stay one of the proceedings because of the other. This  
of the reissue by the Office. This 1-month
petition must be filed after the issuance of the order to
period may be extended only upon a showing of clear
reexamine (37 CFR 1.525, 37 CFR 1.931) in the reexamination
justification pursuant to 37 CFR 1.136(b). The Office
proceeding. If the petition is filed prior to
action will inform applicant that the provisions of
the reexamination order, it will not be considered, and
37  
will be returned to the patent owner by the TC or
CFR 1.136(a) are not available. Of course, up to  
CRU Director. If the petition is filed after the issuance
3
of the order to reexamine, the petition and the
months may be set for reply if the examiner determines
files for the reissue application and the reexamination
such a period is clearly justified.
proceeding will be forwarded to OPLA for decision.


1442.02Concurrent Litigation [R-5]
II.CONCURRENT INTERFERENCE PROCEEDINGS


In order to avoid duplication of effort, action in  
If the original patent is involved in an interference,  
reissue applications in which there is an indication of
the examiner must consult the administrative patent
concurrent litigation will be suspended automatically
judge in charge of the interference before taking any
unless and until it is evident to the examiner, or the
action on the reissue application. It is particularly
applicant indicates, that any one of the following
important that the reissue application not be granted
applies:
without the administrative patent judge’s approval.
See MPEP Chapter 2300.


(A)a stay of the litigation is in effect;
III.CONCURRENT REISSUE PROCEEDINGS


(B)the litigation has been terminated;
Where more than one reissue applications are pending
concurrently on the same patent, see MPEP
§§
1450 and 1451.


(C)there are no significant overlapping issues
1449.02Interference in Reissue [R-5]
between the application and the litigation; or


(D)it is applicant’s desire that the application be
37 CFR 41.8. Mandatory notices.
examined at that time.  


Where any of (A) - (D) above apply, form paragraphs
(a)In an appeal brief (§§ 41.37, 41.67, or 41.68) or at the
14.08-14.10 may be used to deny a suspension
initiation of a contested case (§ 41.101), and within 20 days of any
of action in the reissue, i.e., to deny a stay of the reissue
change during the proceeding, a party must identify:
proceeding.


¶ 14.08 Action in Reissue Not Stayed — Related Litigation
(1)Its real party-in-interest, and
Terminated


Since the litigation related to this reissue application is terminated
(2)Each judicial or administrative proceeding that could
and final, action in this reissue application will NOT be  
affect, or be affected by, the Board proceeding.
stayed. Due to the related litigation status of this reissue application,
EXTENSIONS OF TIME UNDER THE PROVISIONS OF
37 CFR 1.136(a) WILL NOT BE PERMITTED.


¶ 14.09 Action in Reissue Not Stayed — Related Litigation
(b)For contested cases, a party seeking judicial review of a
Not Overlapping
Board proceeding must file a notice with the Board of the judicial
review within 20 days of the filing of the complaint or the notice
of appeal. The notice to the Board must include a copy of the
complaint or notice of appeal. See also §§ 1.301 to 1.304 of this
title.


While there is concurrent litigation related to this reissue application,
37 CFR 41.202. Suggesting an interference.
action in this reissue application will NOT be stayed
because there are no significant overlapping issues between the
application and that litigation. Due to the related litigation status
of this reissue application, EXTENSIONS OF TIME UNDER
THE PROVISIONS OF 37 CFR 1.136(a) WILL NOT BE PERMITTED.


(a)Applicant. An applicant, including a reissue applicant,
may suggest an interference with another application or a patent.
The suggestion must:


¶ 14.10 Action in Reissue Not Stayed — Applicant’s
(1)Provide sufficient information to identify the application
Request
or patent with which the applicant seeks an interference,


While there is concurrent litigation related to this reissue application,  
(2)Identify all claims the applicant believes interfere,  
action in this reissue application will NOT be stayed
propose one or more counts, and show how the claims correspond
because of applicant's request that the application be examined at
to one or more counts,
this time. Due to the related litigation status of this reissue application,  
EXTENSIONS OF TIME UNDER THE PROVISIONS
OF 37 CFR 1.136(a) WILL NOT BE PERMITTED.


Where none of (A) through (D) above apply, action
(3)For each count, provide a claim chart comparing at
in the reissue application in which there is an indication
least one claim of each party corresponding to the count and show
of concurrent litigation will be suspended by the  
why the claims interfere within the meaning of § 41.203(a),
examiner. The examiner should consult with the  
Technology Center Special Program Examiner
prior to suspending action in the reissue. Form paragraph
14.11 may be used to suspend action, i.e., stay
action, in a reissue application with concurrent litigation.


(4)Explain in detail why the applicant will prevail on priority,


¶ 14.11 Action in Reissue Stayed - Related Litigation
(5)If a claim has been added or amended to provoke an
interference, provide a claim chart showing the written description
for each claim in the applicant’s specification, and


In view of concurrent litigation, and in order to avoid duplication
(6)For each constructive reduction to practice for which
of effort between the two proceedings, action in this reissue
the applicant wishes to be accorded benefit, provide a chart showing
application is STAYED until such time as it is evident to the  
where the disclosure provides a constructive reduction to practice
examiner that (1) a stay of the litigation is in effect, (2) the litigation
within the scope of the interfering subject matter.
has been terminated, (3) there are no significant overlapping
issues between the application and the litigation, or (4) applicant
requests that the application be examined.


(c)Examiner. An examiner may require an applicant to add
a claim to provoke an interference. Failure to satisfy the requirement
within a period (not less than one month) the examiner sets
will operate as a concession of priority for the subject matter of
the claim. If the interference would be with a patent, the applicant
must also comply with paragraphs (a)(2) through (a)(6) of this
section. The claim the examiner proposes to have added must,
apart from the question of priority under 35 U.S.C. 102 (g):


(1)Be patentable to the applicant, and


(2)Be drawn to patentable subject matter claimed by
another applicant or patentee.


In appropriate circumstances, a reissue application  
 
may be placed into interference with a patent or pending
An ex parte reexamination proceeding will not be
application. A patentee may provoke an interference
stayed where there is litigation. See Ethicon v. Quigg,
with a patent or pending application by filing a
849 F.2d 1422, 7 USPQ2d 1152 (Fed. Cir. 1988).
reissue application, if the reissue application includes
Thus, where a reissue application has been merged
an appropriate reissue error as required by 35 U.S.C.  
with an ex parte reexamination proceeding, the
251. Reissue error must be based upon applicant
merged proceeding will not be stayed where there is
error; a reissue cannot be based solely on the error of
litigation. In a merged ex parte reexamination/reissue  
the Office for failing to declare an interference or to
proceeding, the ex parte reexamination will control
suggest copying claims for the purpose of establishing
because of the statutory (35 U.S.C. 305) requirement
an interference. See In re Keil, 808 F.2d 830,  
that ex parte reexamination proceedings be conducted
1  
with special dispatch. See MPEP §
USPQ2d 1427 (Fed. Cir. 1987); In re Dien, 680 F.2d
151, 214 USPQ 10 (CCPA 1982); In re Bostwick, 102
2285 and § 2286.
F.2d 886, 888, 41 USPQ 279, 281 (CCPA 1939); and  
As to a stay or suspension where reissue proceedings
In re Guastavino, 83 F.2d 913, 916, 29 USPQ 532,  
are merged with inter partes reexamination proceedings,  
535 (CCPA 1936). See also Slip Track Systems, Inc. v.  
see 37 CFR 1.937 and MPEP § 2686.
Metal Lite, Inc., 159 F.3d 1337, 48 USPQ2d 1055
 
(Fed. Cir. 1998) (Two patents issued claiming the  
1442.03Litigation Stayed [R-3]
same patentable subject matter, and the patentee with
 
the earlier filing date requested reexamination of the
All reissue applications, except those under suspension
patent with the later filing date (Slip Track’s patent).
because of litigation, will be taken up for action
A stay of litigation in a priority of invention suit under
ahead of other “special” applications; this means that
35 U.S.C. 291, pending the outcome of the reexamination,
all issues not deferred will be treated and responded to
was reversed. The suit under 35 U.S.C. 291was the only option available to Slip Track to determine
immediately. Furthermore, reissue applications
priority of invention. Slip Track could not file a
involved in “stayed litigation” will be taken up for
reissue application solely to provoke an interference
action in advance of other reissue applications. Great
proceeding before the Office because it did not assert
emphasis is placed on the expedited processing of
that there was any error as required by 35 U.S.C. 251in the patent.). A reissue application can be employed
such reissue applications. The courts are especially
to provoke an interference if the reissue application:
interested in expedited processing in the Office where
litigation is stayed.
 
In reissue applications with “stayed litigation,” the
Office will entertain petitions under 37 CFR 1.182,  
which are accompanied by the fee under 37 CFR
1.17(f), to not apply the 2-month delay period
stated in MPEP § 1441. Such petitions are decided by
the Office of Patent Legal Administration.
 
Time-monitoring systems have been put into effect
which will closely monitor the time used by applicants,
protestors, and examiners in processing reissue
applications of patents involved in litigation in which
the court has stayed further action. Monthly reports on
the status of reissue applications with related litigation
are required from each Technology Center (TC).  
Delays in reissue processing are to be followed up.
The TC Special Program Examiner is responsible for
oversight of reissue applications with related litigation.


(A)adds copied claims which are not present in
the original patent;


The purpose of these procedures and those deferring
(B)amends claims to correspond to those of the
consideration of certain issues, until all other
patent or application with which an interference is  
issues are resolved or the application is otherwise
sought; or
ready for consideration by the Board of Patent
Appeals and Interferences (note MPEP § 1448), is to
reduce the time between filing of the reissue application
and final action thereon, while still giving all parties
sufficient time to be heard.


Requests for stays or suspension of action in reissues
(C)contains at least one error (not directed to
where litigation has been stayed may be
provoking an interference) appropriate for the reissue.
answered with form paragraph 14.07.


¶ 14.07 Action in Reissue Not Stayed or Suspended —
In the first two situations, the reissue oath/declaration
Related Litigation Stayed
must assert that applicant erred in failing to
include claims of the proper scope to provoke an
interference in the original patent application. Note
that in In re Metz, 173 F.3d 433 (Fed. Cir. 1998)
(table), the Federal Circuit permitted a patentee to file
a reissue application to copy claims from a patent in  
order to provoke an interference with that patent. Furthermore,
the subject matter of the copied or amended
claims in the reissue application must be supported by
the disclosure of the original patent under 35 U.S.C.
112, first paragraph. See In re Molins, 368 F.2d 258,
261, 151 USPQ 570, 572
(CCPA 1966) and In re
Spencer, 273 F.2d 181, 124 USPQ 175 (CCPA 1959).


While there is a stay of the concurrent litigation related to this
A reissue applicant cannot present added or
reissue application, action in this reissue application will NOT be
amended claims to provoke an interference, if the
stayed or suspended because a stay of that litigation is in effect for  
claims were deliberately omitted from the patent. If
the purpose of awaiting the outcome of these reissue proceedings.  
there is evidence that the claims were not inadvertently
Due to the related litigation status of this reissue application,
omitted from the original patent, e.g., the subject
EXTENSIONS OF TIME UNDER THE PROVISIONS OF 37
matter was described in the original patent as being
CFR 1.136(a) WILL NOT BE PERMITTED.
undesirable, the reissue application may lack proper
basis for the reissue. See In re Bostwick, 102 F.2d at
889, 41 USPQ at 282 (CCPA 1939)(reissue lacked a
proper basis because the original patent pointed out
the disadvantages of the embodiment that provided
support for the copied claims).  


1442.04Litigation Involving Patent [R-3]
The issue date of the patent, or the publication date
of the application publication (whichever is applicable
under 35 U.S.C. 135(b)), with which an interference
is sought must be less than 1 year prior to the presentation
of the copied or amended claims in the reissue
application. See 35 U.S.C. 135(b) and MPEP § 715.05and MPEP Chapter 2300. If the reissue application
includes broadened claims, the reissue application
must be filed within two years from the issue date of
the original patent. See 35 U.S.C. 251 and MPEP §
1412.03.


37 CFR 1.178. Original patent; continuing duty of  
An examiner may, pursuant to 37 CFR 41.202(c),
applicant.
require a reissue applicant to add a claim to provoke
an interference, unless the reissue applicant cannot
present the added claim to provoke an interference
based upon the provisions of the reissue statute and
rules, e.g., if the claim was deliberately omitted from
the patent, or if the claim enlarges the scope of the
claims of the original patent and was not “applied for
within two years from the grant of the original
patent.” Failure to satisfy the requirement within a
period (not less than one month) the examiner sets
will operate as a concession of priority for the subject
matter of the claim. If the interference would be with
a patent, the reissue applicant must also comply with
37 CFR 41.202(a)(2) through (a)(6). The claim the
examiner proposes to have added must, apart from the
question of priority under 35 U.S.C. 102(g), be patentable
to the reissue applicant, and be drawn to patentable
subject matter claimed by another applicant or
patentee.


REISSUE APPLICATION FILED WHILE
PATENT IS IN INTERFERENCE


If a reissue application is filed while the original
patent is in an interference proceeding, the reissue
applicant must promptly notify the Board of Patent
Appeals and Interferences of the filing of the reissue
application within 20 days from the filing date. See 37
CFR 41.8 and MPEP Chapter 2300.


(b)In any reissue application before the Office, the applicant
==1450 Restriction and Election of Species Made in Reissue Application==
must call to the attention of the Office any prior or concurrent proceedings
in which the patent (for which reissue is requested) is or
was involved, such as interferences, reissues, reexaminations, or
litigations and the results of such proceedings (see also
§
1.173(a)(1)).


Where the patent for which reissue is being sought
37 CFR 1.176. Examination of reissue.
is, or has been, involved in litigation, the applicant
should bring the existence of such litigation to the
attention of the Office. 37 CFR 1.178(b). This should
be done at the time of, or shortly after, the applicant
files the application, either in the reissue oath or declaration,
or in a separate paper, preferably accompanying
the application as filed. Litigation begun after
filing of the reissue application also should be
promptly brought to the attention of the Office.  


Litigation encompasses any papers filed in the  
(a)A reissue application will be examined in the same manner
court or issued by the court. This may include, for
as a non-reissue, non-provisional application, and will be subject
example, motions, pleadings, and court decisions, as
to all the requirements of the rules related to non-reissue
well as the results of such proceedings. When applicant
applications. Applications for reissue will be acted on by the  
notifies the Office of the existence of the litigation,
examiner in advance of other applications.
enough information should be submitted so that
the Office can reasonably evaluate the need for asking
for further materials in the litigation. Note that the
existence of supporting materials which may substantiate
allegations of invalidity should, at least, be fully
described, and preferably submitted. The Office is not
interested in receiving voluminous litigation materials


(b)Restriction between subject matter of the original patent
claims and previously unclaimed subject matter may be required
(restriction involving only subject matter of the original patent
claims will not be required). If restriction is required, the subject
matter of the original patent claims will be held to be constructively
elected unless a disclaimer of all the patent claims is filed in
the reissue application, which disclaimer cannot be withdrawn by
applicant.


37 CFR 1.176(b) permits the examiner to require
restriction in a reissue application between claims
newly added in a reissue application and the original
patent claims, where the added claims are directed to
an invention which is separate and distinct from the
invention(s) defined by the original patent claims. The
criteria for making a restriction requirement in a reissue
application between the newly added claims and
the original claims are the same as that applied in a
non-reissue application. See MPEP §§ 806 through
806.05(i). The authority to make a “restriction”
requirement under 37 CFR 1.176(b) extends to and
includes the authority to make an election of species.


Where a restriction requirement is made by the
examiner, the original patent claims will be held to be
constructively elected (except for the limited situation
where a disclaimer is filed as discussed in the next
paragraph). Thus, the examiner will issue an Office
action in the reissue application (1) providing notification
of the restriction requirement, (2) holding the
added claims to be constructively non-elected and
withdrawn from consideration,  (3) treating the original
patent claims on the merits, and (4) informing
applicant that if the original claims are found allowable,
and a divisional application has been filed for
the non-elected claims, further action in the application
will be suspended, pending resolution of the divisional
application..


If a disclaimer of all the original patent claims is
 
filed in the reissue application containing newly
which are not relevant to the Office’s consideration of  
added claims that are separate and distinct from the
the reissue application. The status of the litigation
original patent claims, only the newly added claims
should be updated in the reissue application as soon as
will be present for examination. In this situation, the
significant events happen in the litigation.  
examiner’s Office action will treat the newly added
claims in the reissue application on the merits. The
disclaimer of all the original patent claims must be
filed in the reissue application prior to the issuance of  
the examiner’s Office action containing the restriction
requirement, in order for the newly added claims to be
treated on the merits. Once the examiner has issued
the Office action providing notification of the restriction
requirement and treating the patent claims on the
merits, it is too late to obtain an examination on
the added claims in the reissue application by filing a
disclaimer of all the original patent claims. If reissue
applicant wishes to have the newly added claims be
treated on the merits, a divisional reissue application
must be filed to obtain examination of the added
claims. Reissue applicants should carefully note that
once a disclaimer of the patent claims is filed, it cannot
be withdrawn. It does not matter whether the reissue  
application is still pending, or whether the reissue
application has been abandoned or issued as a reissue
patent. For all these situations, 37 CFR 1.176(b) states
that the disclaimer cannot be withdrawn; the disclaimer
will be given effect.


When a reissue application is filed, the examiner
Claims elected pursuant to a restriction requirement
should determine whether the original patent has been
will receive a complete examination on the merits,  
adjudicated by a court. The decision(s) of the court,  
while the non-elected claims (to any added invention(s)) will be held in abeyance in a withdrawn status,  
and also other papers in the suit, may provide information
and will only be examined if filed in a divisional
essential to the examination of the reissue.  
reissue application. If the reissue application containing
Examiners should inform the applicant of the duty to  
only original unamended claims becomes allowable
supply information as to litigation involving the  
first (and no “error” under 35 U.S.C. 251exists),
patent. Form paragraph 14.11.01 may be used for this
purpose. See MPEP § 1418.
further action in that reissue application will
 
be suspended to await examination in the divisional
Additionally, the patented file will contain notices
reissue application(s) containing the added claims.
of the filing and termination of infringement suits on
Multiple suspensions (usually six-month periods)
the patent. Such notices are required by law to be filed
may be necessary. The Office will not  permit
by the clerks of the Federal District Courts. These
claims to issue in a reissue application which
notices do not indicate if there was an opinion by the  
application does not correct any error in the original
court, nor whether a decision was published. Shepard’s
patent. Once a divisional reissue application containing
Federal Citations and the cumulative digests of  
the added claims is examined and becomes
the United States Patents Quarterly, both of which are
allowable,  the examiner will issue a requirement
in the Lutrelle F. Parker, Sr., Memorial Law Library,
under 37 CFR 1.177(c) for applicant to merge the
contain tables of patent numbers giving the citation of  
claims of the suspended first reissue application with
published decisions concerning the patent.  
the allowable claims of the divisional reissue application
into a single application, by placing all of the  
claims in one of the applications and expressly abandoning
the other. The Office action making this
requirement will set a two-month period for compliance
with the requirement. If applicant fails to timely
respond to the Office action, or otherwise refuses to  
comply with the requirement made, then the divisional
reissue application (claiming the invention
which was non-elected in the now-suspended first
reissue application) will be passed to issue alone,  
since the claims of the divisional reissue application,  
by themselves, do correct an error in the original
patent. Prosecution will be reopened in the suspended
first reissue application, and a rejection based on a
lack of error under 35
U.S.C. 251 will then be made.
This rejection may be made final, since applicant is on
notice of the consequences of not complying with the
merger requirement.


A litigation computer search by the Scientific and
If the divisional reissue application becomes abandoned,
Technical Information Center (STIC) should be  
prosecution will be reopened in the suspended
requested by the examiner to determine whether the  
first reissue application, and a rejection based on a
patent has been, or is, involved in litigation. For
lack of error under 35 U.S.C. 251 will then be made in
reissue application files that are maintained in paper,  
the first reissue application. Since no error in the original
the “Search Notes” box on the application file wrapper
patent is being corrected in the first reissue application,  
is then completed to indicate that the review
no reissue patent will issue.
was conducted. A copy of the STIC search should be  
hole-punched and placed in the reissue file. For
IFW reissue application files, the “Search Notes” box
on the OACS “Search Notes” page is annotated to
indicate that the review was conducted, and the
OACS “Search Notes” page is then scanned into the
reissue application file history.  


Additional information or guidance as to making a
As stated in 37 CFR 1.176(b), the examiner is not
litigation search may be obtained from the library of  
permitted to require restriction among original
the Office of the Solicitor. Where papers are not otherwise
claims of the patent (i.e., among claims that were in  
conveniently obtainable, the applicant may be
the patent prior to filing the reissue application). Even
requested to supply copies of papers and records in  
where the original patent contains claims to different
suits, or the Office of the Solicitor may be requested
inventions which the examiner considers independent
to obtain them from the court. The information thus
or distinct, and the reissue application claims the same
obtained should be carefully considered for its bearing
inventions, a restriction requirement would be
on the proposed claims of the reissue, particularly
improper. If such a restriction requirement is made, it
when the reissue application was filed in view of the  
must be withdrawn.
holding of a court.


If the examiner becomes aware of litigation involving
Restriction between multiple inventions recited in
the patent sought to be reissued during examination
the newly added claims will be permitted provided
of the reissue application, and applicant has not
the added claims are drawn to several separate and
made the details regarding that litigation of record in
distinct inventions. In such a situation, the original
the reissue application, the examiner, in the next
patent claims would be examined in the first reissue  
Office action, should inquire regarding the same.
application, and applicant is permitted to file a divisional
Form paragraph 14.06 may be used for such an
reissue application for each of the several separate
inquiry. See MPEP § 1442.01.
and distinct inventions identified in the  
examiner’s restriction requirement.


If the additional details of the litigation appear to be
A situation will sometimes arise where the examiner
material to patentability of the reissue application, the  
makes an election of species requirement
examiner may make such additional inquiries as necessary
between the species claimed in the original patent
and appropriate.
claims and a species of claims added in the reissue  
application. In such a situation, if (1) the non-elected
claims to the added species depend from (or otherwise
include all limitations of) a generic claim which
embraces all species claims, and (2) the generic claim
is found allowable, then the non-elected claims of the
added species must be rejoined with the elected
claims of the original patent. See MPEP §
821.04(a).  


1442.05Court Ordered Filing of Reissue  
==1451 Divisional Reissue Applications;Continuation Reissue Applications Where the Parent is Pending==
Application [R-3]


In most instances, the reissue-examination procedure
35 U.S.C. 251. Reissue of defective patents.
is instituted by a patent owner who voluntarily
files a reissue application as a consequence of related
patent litigation. Some Federal district courts in
earlier decisions have required a patentee-litigant to
file a reissue application as a consequence of the
patent litigation. However, the Court of Appeals for
the Federal Circuit held in Green v. The Rich Iron Co.,
944 F.2d 852, 853, 20 USPQ2d 1075, 1076 (Fed. Cir.
1991) that a Federal district court in an infringement
case could not compel a patentee to seek reissue
by the USPTO.


It is to be noted that only a patentee or his or her
The Director may issue several reissued patents for distinct and
assignee may file a reissue patent application. An
separate parts of the thing patented, upon demand of the applicant,
order by a court for a different party to file a reissue  
and upon payment of the required fee for a reissue for each of
will not be binding on the Office.
such reissued patents.


1443Initial Examiner Review [R-3]
37 CFR 1.177. Issuance of multiple reissue patents.


As part of an examiner’s preparation for the examination
(a)The Office may reissue a patent as multiple reissue patents.
of a reissue application, the Examiner Reissue
If applicant files more than one application for the reissue of
Guide and Checklist should be consulted for basic
a single patent, each such application must contain or be amended
guidance and suggestions for handling the prosecution.  
to contain in the first sentence of the specification a notice stating
The Technology Center (TC) Special Program
that more than one reissue application has been filed and identifying
Examiners (SPREs) should make the Guide and
each of the reissue applications by relationship, application
Checklist available at the time a reissue application is
number and filing date. The Office may correct by certificate of
docketed to an examiner.
correction under § 1.322 any reissue patent resulting from an application to which this paragraph applies that does not contain the required notice.


On initial receipt of a reissue application, the examiner
(b)If applicant files more than one application for the reissue
should inspect the submission under 37 CFR
of a single patent, each claim of the patent being reissued must
1.172 as to documentary evidence of a chain of title
be presented in each of the reissue applications as an amended,
from the original owner to the assignee to determine
unamended, or canceled (shown in brackets) claim, with each
whether the consent requirement of 37 CFR 1.172 has
such claim bearing the same number as in the patent being reissued.
The same claim of the patent being reissued may not be presented
in its original unamended form for examination in more
than one of such multiple reissue applications. The numbering of  
any added claims in any of the multiple reissue applications must
follow the number of the highest numbered original patent claim.


(c)If any one of the several reissue applications by itself
fails to correct an error in the original patent as required by 35
U.S.C. 251 but is otherwise in condition for allowance, the Office
may suspend action in
the allowable application until all issues
are resolved as to at least one of the remaining reissue applications.
The Office may also merge two or more of the multiple reissue
applications into a single reissue application. No reissue
application containing only unamended patent claims and not correcting
an error in the original patent will be passed to issue by
itself.


The court in In re Graff, 111 F.3d 874, 876-77,
42 USPQ2d 1471, 1473 (Fed. Cir. 1997) stated that
“[t]he statute does not prohibit divisional or continuation
reissue applications, and does not place stricter
limitations on such applications when they are presented
by reissue, provided of course that the statutory
requirements specific to reissue applications are met.”
Following the decision in Graff, the Office has
adopted a policy of treating continuations and divisionals
of reissue applications, to the extent possible,
in the same manner as continuations and divisionals
of non-reissue applications.


Questions relating to the propriety of divisional
reissue applications and continuation reissue applications
should be referred via the Technology Center
(TC) Special Program Examiner to the Office of
Patent Legal Administration.


I. DIVISIONAL REISSUE APPLICATIONS


been met. The examiner will compare the consent and  
37 CFR 1.176(b) permits the examiner to require
documentary evidence of ownership; the assignee
restriction in a reissue application between the original
indicated by the documentary evidence must be the  
claims of the patent and any newly added claims
same assignee which signed the consent. Also, the  
which are directed to a separate and distinct invention(
person who signs the consent for the assignee and the  
s). See also MPEP § 1450. As a result of such a
person who signs the submission of evidence of ownership
restriction requirement, divisional applications may
for the assignee must both be persons having
be filed for each of the inventions identified in the  
authority to do so. See also MPEP § 324.  
restriction requirement.  
 
In addition, applicant may initiate a division of the  
claims by filing more than one reissue application in
accordance with 37 CFR 1.177. The multiple reissue
applications which are filed may contain different
groups of claims from among the original patent
claims, or some of the reissue applications may contain
newly added groups (not present in the original
patent). There is no requirement that the claims of the
multiple reissue applications be independent and distinct
from one another; if they are not independent
and distinct from one another, the examiner must  
apply the appropriate double patenting rejections.


Where the application is assigned, and there is no
There is no requirement that a family of divisional
submission under 37 CFR 1.172 as to documentary
reissue applications issue at the same time; however,  
evidence in the application, the examiner should
it is required that they contain a cross reference to
require the submission using form paragraph 14.16.
each other in the specification. 37 CFR 1.177(a)
Once the submission under 37 CFR 1.172 as to documentary
requires that all multiple reissue applications resulting
evidence is received, it must be compared
from a single patent must include as the first sentence
with the consent to determine whether the assignee
of their respective specifications a cross reference to  
indicated by the documentary evidence is the same
the other reissue application(s). Accordingly, the first
assignee which signed the consent. See MPEP
sentence of each reissue specification must provide
§
notice stating that more than one reissue application
has been filed, and it must identify each of the reissue
1410.01 for further discussion as to the required
applications and their relationship within the family
consent and documentary evidence.
of reissue applications, and to the original patent. An
example of the suggested language to be inserted is as  
follows:


Where there is a statement of record that the application  
Notice: More than one reissue application has
is not assigned, there should be no submission
been filed for the reissue of Patent No. 9,999,999. The
under 37
reissue applications are application numbers 09/
CFR 1.172 as to documentary evidence of
999,994 (the present application), 09/999,995, and 09/
ownership in the application, and none should be
999,998, all of which are divisional reissues of Patent
required by the examiner.
No. 9,999,999.  


The filing of all reissue applications, except for
The examiner should object to the specification
continued prosecution applications (CPAs) filed under
and require an appropriate amendment if applicant
37 CFR 1.53(d), must be announced in the Official
fails to include such a cross reference to the other reissue  
Gazette. Accordingly, for any reissue application
applications in the first sentence of the specification
other than a CPA, the examiner should determine if
of each of the reissue applications.
the filing of the reissue application has been
announced in the Official Gazette as provided in
37
CFR 1.11(b). The contents entry on the PALM
Intranet Contents screen should be checked for the
presence of “NRE” and “NOTICE OF REISSUE
PUBLISHED IN OFFICIAL GAZETTE” entries in
the contents, and the date of publication. Where the
reissue application is maintained in a paper file, the
date of the Official Gazette notice can usually be
found on the pink “REISSUE” tag which protrudes
from the top of the application file of 08/ or earlier
series.  For 09/ and later series reissue applications,
the Official Gazette publication date appears on the
face of the file wrapper.  If the filing of the reissue
application has not been announced in the Official
Gazette, the reissue application should be returned to
the Office of Initial Patent Examination (Special Processing)
to handle the announcement. The examiner
should not further act on the reissue until 2 months
after announcement of the filing of the reissue has
appeared in the Official Gazette. See MPEP §
1440.


The examiner should determine if there is concurrent
In addition to the amendment to the first sentence
litigation, and if so, the status thereof (MPEP
of the specification, the reissue application cross references
§
will also be reflected in the file. For an
IFW reissue application file, a copy of the bibliographic
1442.01), and whether the reissue file wrapper
data sheet from the IFW file history should be
(for reissue application files maintained in paper) or  
printed and the examiner should annotate the printed
file history (for IFW reissue applications) has been  
sheet such that adequate notice is provided that more
appropriately marked. Note MPEP § 1404.  
than one reissue application has been filed for a single
original patent. The annotated sheet should be
scanned into IFW. For reissue application files that are
maintained in paper, the bibliographic data sheet
should be reprinted (for 09/ and later series), or  
the front face of the reissue file wrapper should be
marked (for 08/ and earlier series), for all the multiple
reissue applications, so that adequate notice is provided
that more than one reissue application has been  
filed for a single original patent.  


The examiner should determine if a protest has
Pursuant to 37 CFR 1.177(b) all of the claims of the
been filed, and if so, it should be handled as set forth
patent to be reissued must be presented in each reissue
in MPEP §
application in some form, i.e., as amended, as  
unamended or as canceled. Further,  any added
1901.06. For a discussion of protests
claims must be numbered beginning with the next
under 37 CFR 1.291 in reissue applications, see
highest number following the last patent claim. It is
MPEP § 1441.01.
noted that the same claim of the patent cannot be presented
 
for examination in more than one of the divisional
The examiner should determine whether the patent  
reissue applications, as a pending claim, in
is involved in an interference, and if so, should refer
either its original or amended versions. Once a claim
to MPEP § 1449.01 before taking any action on the  
in the patent has been reissued, it does not exist in the
reissue application.
original patent; thus, it cannot be reissued from the  
original patent in another reissue application. If the
same claim of the patent, e.g., patent claim 1 is presented
for examination in more than one of the reissue
applications, in different amended versions, the following
rejections should be made in the reissue applications
with that patent claim:


A rejection under 35 U.S.C. 251, in that the reissue
application is not correcting an error in the original
patent, because original claim 1 would be superseded
by the reissuance of claim 1 in the other reissue application.


A rejection under 35 U.S.C. 112, in that claim 1 is
indefinite because the invention of claim 1 is not particularly
pointed out and distinctly claimed. Claim 1
presents one coverage in divisional reissue application
X and another in the present reissue application. This
is inconsistent.


The examiner should verify that all Certificate of
The reissue applicant should then be advised to follow
Correction changes have been properly incorporated
a procedure similar to the following example:
into the reissue application. See MPEP § 1411.01.


The examiner should verify that the patent on
If there are patent claims 1 – 10 in two divisional
which the reissue application is based has not expired,  
reissue applications and an applicant wishes to revise
either because its term has run or because required
claim 1, which is directed to AB (for example) to
maintenance fees have
ABC in one divisional reissue application, and to
not been paid. Once a patent
ABD in a second divisional reissue application, applicant
has expired, the Director of the USPTO no longer has
should do the following: Claim 1 in the first divisional
the authority under 35 U.S.C. 251 to  
reissue application can be revised to recite
reissue the  
ABC. Claim 1 in the second divisional reissue application
patent. See In re Morgan, 990 F.2d 1230, 26 USPQ2d
would be canceled, and new claim 11 would be
1392 (Fed. Cir. 1992). See also MPEP §
added to recite ABD. The physical cancellation of
claim 1 in the second divisional reissue application
1415.01.  
will not prejudice applicant’s rights in the amended
version of claim 1 since those rights are retained via
the first reissue application. Claim 1 continues to exist
in the first reissue application, and both the first and
second reissue applications taken together make up
the totality of the correction of the original patent.


1444Review of Reissue Oath/Declaration
If the same or similar claims are presented in more
[R-5]
than one of the multiple reissue applications, the possibility
 
of statutory double patenting (35 U.S.C. 101)
In accordance with 37 CFR 1.175, the following is
or non-statutory (judicially created doctrine) double
required in the reissue oath/declaration:
patenting should be considered by the examiner during
 
examination, and the appropriate rejections made.
(A)A statement that the applicant believes the  
A terminal disclaimer may be filed to overcome an
original patent to be wholly or partly inoperative or
obviousness type double patenting rejection. The terminal
invalid-
disclaimer is necessary in order to ensure common
ownership of the reissue patents throughout the
remainder of the unexpired term of the original patent.
Whenever a divisional reissue application is filed with  
a copy of the oath/declaration and assignee consent
from the parent reissue application, the copy of the
assignee consent from the parent reissue application
should not be accepted. The copy of the consent from
the parent reissue application does not indicate that
the assignee has consented to the addition of the new
invention of the divisional reissue application to the
original patent. The Office of Initial Patent Examination
(OIPE) should accord a filing date and send out a
notice of missing parts stating that there is no proper
consent and setting a period of time for filing the
missing part and for payment of any surcharge
required under 37 CFR 1.53(f) and 1.16(f). See
MPEP § 1410.01. The copy of the reissue oath/declaration
should be accepted by OIPE, since it is an oath/
declaration, even though it may be improper under
35 U.S.C. 251. The examiner should check the copy
of the oath/declaration to ensure that it identifies an
error being corrected by the divisional reissue application.
The copy of the oath/declaration from the parent
reissue application may or may not cover the error
being corrected by the divisional reissue application
since the divisional reissue application is (by definition)  
directed to a new invention. If it does not, the
examiner should reject the claims of the divisional
reissue application under 35 U.S.C. 251 as being
based on an oath/declaration that does not identify an
error being corrected by the divisional reissue application,
and require a new oath/declaration. See MPEP §
1414. If the copy of the reissue oath/declaration from
the parent reissue application does in fact cover an
error being corrected in the divisional reissue application,
no such rejection should be made. However,
since a new invention is being added by the filing of
the divisional reissue application, a supplemental reissue
oath/declaration pursuant to 37 CFR 1.175 (b)(1)
will be required. See MPEP § 1414.01.


(1)by reason of a defective specification or  
Situations yielding divisional reissues occur infrequently
drawing, or
and usually involve only two such files. It
should be noted, however, that in rare instances in the
past, there have been more than two (and as many as
five) divisional reissues of a
patent. For treatment of a
plurality of divisional reissue applications resulting
from a requirement to restrict to distinct inventions or  
a requirement to elect species, see MPEP § 1450.


(2)by reason of the patentee claiming more or
II. CONTINUATION REISSUE APPLI-
less than patentee had the right to claim in the patent;
CATIONS


(B)A statement of at least one error which is  
A continuation of a reissue is not ordinarily filed
relied upon to support the reissue application, i.e.,
“for distinct and separate parts of the thing patented”
which provides a basis for the reissue;
as called for in the second paragraph of 35 U.S.C.
251. The decision of In re Graff, 111 F.3d 874,  
42 USPQ2d 1471 (Fed. Cir. 1997) interprets
35 U.S.C. 251 to permit multiple reissue patents to
issue even where the multiple reissue patents are not
for “distinct and separate parts of the thing patented.”
The court stated:


(C)A statement that all errors which are being
Section 251[2] is plainly intended as enabling, not as limiting.
corrected in the reissue application up to the time of  
Section 251[2] has the effect of assuring that a different
burden is not placed on divisional or continuation
reissue applications, compared with divisions and continuations
of original applications, by codifying the Supreme
Court decision which recognized that more than one
patent can result from a reissue proceeding. Thus § 251[2]
places no greater burden on Mr. Graff’s continuation reissue  
application than upon a continuation of an original
application; § 251[2] neither overrides, enlarges, nor limits the statement in § 251[3] that the provisions of Title 5 apply to reissues.


111 F.3d at 877, 42 USPQ2d at 1473. Accordingly,
prosecution of a continuation of a reissue application
will be permitted (despite the existence of the pending
parent reissue application) where the continuation
complies with the rules for reissue.


The parent and the continuation reissue applications
should be examined together if possible. In
order that the parent-continuation relationship of the
reissue applications be specifically identified and
notice be provided of both reissue applications for
both the parent and the continuation reissue applications,
the following is done:


(A) An appropriate amendment to the continuing
data entries must be made to the first sentence of
the specification, (see the discussion above under the
heading “Divisional Reissue Applications”).


(B)For an IFW reissue application file, a copy of
the bibliographic data sheet from the IFW file history
should be printed and the examiner should annotate
the printed sheet such that adequate notice is provided
that more than one reissue application has been filed
for a single original patent. The annotated sheet
should be scanned into IFW. For reissue application
files that are maintained in paper, the bibliographic
data sheet should be reprinted (for 09/ and later
series), or the front face of the reissue file wrapper
should be marked (for 08/ and earlier series), for all
the multiple reissue applications, so that adequate
notice is provided that more than one reissue application
has been filed for a single original patent.


filing of the oath/declaration arose without any deceptive
As is true for the case of multiple divisional reissue
intention on the part of the applicant; and
applications, all of the claims of the patent to be reissued
must be presented in both the parent reissue
application and the continuation reissue application in
some form, i.e., as amended, as unamended, or as canceled.
The same claim of the patent cannot, however
be presented for examination in both the parent reissue
application and the continuation reissue application,
as a pending claim, in either its original or
amended versions. See the discussion in subsection I.
above for treatment of this situation. Further, any
added claims must be numbered beginning with the
next highest number following the past patent
claims.


(D)The information required by 37 CFR 1.63.
Where the parent reissue application issues prior to  
 
the examination of the continuation, the claims of the  
MPEP § 1414 contains a discussion of each of the  
continuation should be carefully reviewed for double
above elements (i.e., requirements of a reissue oath/
patenting over the claims of the parent. Where the  
declaration). The examiner should carefully review
parent and the continuation reissue applications are  
the reissue oath/declaration in conjunction with that
examined together, a provisional double patenting
discussion, in order to ensure that each element is provided
rejection should be made in both cases as to any overlapping
in the oath/declaration. If the examiner’s review
claims. See MPEP § 804 - §
of the oath/declaration reveals a lack of compliance
with any of the requirements of 37 CFR 1.175, a
rejection of all the claims under 35
U.S.C. 251 should  
be made on the basis that the reissue oath/declaration
is insufficient.
 
In preparing an Office action, the examiner should
use form paragraphs 14.01 through 14.01.04 to state
the objection(s) to the oath/declaration, i.e., the  
defects in the oath/declaration. These form paragraphs
are reproduced in MPEP § 1414. The examiner should
then use form paragraph 14.14 to reject the claims
under 35 U.S.C. 251, based upon the improper oath/
declaration.
 
¶ 14.14 Rejection, Defective Reissue Oath or Declaration
 
Claim [1] rejected as being based upon a defective reissue [2]
under 35 U.S.C. 251 as set forth above. See 37 CFR 1.175.
 
The nature of the defect(s) in the [3] is set forth in the discussion
above in this Office action.
 
Examiner Note:
 
1.In bracket 1, list all claims in the reissue application. See  
MPEP §
   
   
706.03(x).
804.04 as to double
patenting rejections. Any terminal disclaimer filed
to obviate an obviousness-type double patenting
rejection ensures common ownership of the reissue
patents throughout the remainder of the unexpired
term of the original patent.


2.This paragraph should be preceded by at least one of the  
If the parent reissue application issues without any
paragraphs 14.01 to 14.01.04.
cross reference to the continuation, amendment of the
parent
reissue patent to include a cross-reference to
the continuation must be effected at the time of allowance
of the continuation application by Certificate of
Correction. See the discussion above under the heading
“Divisional Reissue Applications” as to how the
Certificate of Correction is to be provided.


3.In brackets 2 and 3, insert either --oath-- or --declaration--.
Again, the examiner should make reference in the
pending divisional reissue application to the fact that
an actual request for a Certificate of Correction has
been generated in the first reissue patent pursuant to
37 CFR 1.177(a), e.g., by an entry in the search notes
or in an examiner’s amendment.


A lack of signature on a reissue oath/declaration  
Where a continuation reissue application is filed
(except as otherwise provided in 37 CFR 1.42, 1.43,
with a copy of the oath/declaration and assignee consent
and 1.47 and in 37 CFR 1.172) would be considered a
from the parent reissue application, and the parent
lack of compliance with 37 CFR 1.175(a) and result in
reissue application is not to be abandoned, the
a rejection, including final rejection, of all the claims  
copy of the consent of the parent reissue application
on the basis that the reissue oath/declaration is insufficient.
should not be accepted. The copy of the consent of the
If the unsigned reissue oath/declaration is submitted
parent reissue application does not indicate that the
as part of a reply which is otherwise properly
assignee has consented to the addition of the new
signed and responsive to the outstanding Office
error correction of the continuation reissue application
action, the reply should be accepted by the examiner  
to the original patent. Presumably, a new correction
as proper and responsive, and the oath/declaration  
has been added, since the parent reissue
considered fully in the next Office action. The reply
application is still pending. OIPE should accord a filing
should not be treated as an unsigned or improperly
date and send out a notice of missing parts stating
signed amendment (see MPEP § 714.01(a)), nor do
that there is no proper consent and setting a period of
the holdings of Ex parte Quayle apply in this situation.
time for filing the missing part and for payment of any
The lack of signature, along with any other oath/
surcharge required under 37 CFR 1.53(f) and
declaration deficiencies, should be noted in the next
1.16(f). See MPEP § 1410.01. The copy of the
Office action rejecting the claims as being based upon
reissue oath/declaration should be accepted by OIPE,
an insufficient reissue oath/declaration.
since it is a oath/declaration, albeit improper under
35 U.S.C. 251. The examiner should reject the claims  
of the continuation reissue application under 35 U.S.C. 251 as being based on an oath/declaration  
that does not identify an error being corrected by the  
continuation reissue application, and should require a
new oath/declaration. See 37 CFR 1.175(e). One of
form paragraphs 14.01.01 through 14.01.03 may be
used. See MPEP § 1414.
 
Where a continuation reissue application is filed
with a copy of the oath/declaration and assignee consent
from the parent reissue application, and the parent
reissue application is, or will be abandoned, the  
copy of the consent should be accepted by both OIPE
and the examiner. The reissue oath/declaration should
be accepted by OIPE, and the examiner should check
to ensure that the oath/declaration identifies an error
that is being corrected in the continuation reissue
application. See MPEP § 1414. If a preliminary
amendment was filed with the continuation reissue
application, the examiner should check for the need of
a supplemental reissue oath/declaration. Pursuant to
37 CFR 1.175 (b)(1), for any error corrected via the
preliminary amendment which is not covered by the  
oath or declaration submitted in the parent reissue
application, applicant must submit a supplemental
oath/declaration stating that every such error arose
without any deceptive intention on the part of the
applicant. See MPEP § 1414 and § 1414.01.  


I.HANDLING OF THE REISSUE OATH/
==1452 Request for Continued Examination of Reissue Application==
DECLARATION DURING THE REISSUE
PROCEEDING


An initial reissue oath/declaration is submitted with
A request for continued examination (RCE) under
the reissue application (or within the time period set
37 CFR 1.114 is available for a reissue application.
for filing the oath/declaration in a Notice To File
Effective May 29, 2000, an applicant in a reissue
Missing Parts under 37 CFR 1.53(f)). Where the reissue
application may file a request for continued examination
oath/declaration fails to comply with 37 CFR  
of the reissue application, if the reissue application
1.175(a), the examiner will so notify the applicant in  
was filed on or after June 8, 1995. This applies
an Office action, rejecting the claims under 35 U.S.C.  
even where the application, which resulted in the original
251 as discussed above. In reply to the Office action, a
patent, was filed prior to June 8, 1995.
supplemental reissue oath/declaration should be submitted
dealing with the noted defects in the reissue
oath/declaration.


Where the initial reissue oath/declaration (1) failed
An RCE continues the prosecution of the existing
to provide any error statement, or (2) attempted to
reissue application and is not a filing of a new reissue  
provide an error statement, but failed to identify any
application. Thus, the filing of an RCE will not be  
error under 35 U.S.C. 251 upon which reissue can be
announced in the Official Gazette. Additionally, if a  
based (see MPEP § 1402), the examiner should reject
reissue application is merged with a reexamination
all the claims as being based upon a defective reissue  
proceeding (see MPEP § 1449.01), the filing of an
oath/declaration under 35 U.S.C. 251. To support the
RCE will not dissolve the merger, since the reissue
rejection, the examiner should specifically point out
application does not become abandoned.
the failure of the initial oath/declaration to comply
with 37 CFR 1.175 because an “error” under
35
U.S.C. 251 upon which reissue can be based was
not identified therein. In reply to the rejection under
35 U.S.C. 251, a supplemental reissue oath/declaration
must be submitted stating an error under
35
U.S.C. 251 which can be relied upon to support the
reissue application. Submission of this supplemental
reissue oath/declaration to obviate the rejection cannot
be deferred by applicant until the application is  
otherwise in condition for allowance. In this instance,  
a proper statement of error was never provided in the  
initial reissue oath/declaration, thus a supplemental
oath/declaration is required in reply to the Office
action in order to properly establish grounds for reissue.


==1453 Amendments to Reissue Applications==


A different situation may arise where the initial
37 CFR 1.121. Manner of making amendments in
reissue oath/declaration does properly identify one or
application.
more errors under 35 U.S.C. 251 as being the basis for
reissue, however, because of changes or amendments  
made during prosecution, none of the identified errors


(i)Amendments in reissue applications. Any amendment to
the description and claims in reissue applications must be made in
accordance with § 1.173.


37 CFR 1.173. Reissue specification, drawings, and
amendments.


(b)Making amendments in a reissue application. An amendment
in a reissue application is made either by physically incorporating
the changes into the specification when the application is
filed, or by a separate amendment paper. If amendment is made by
incorporation, markings pursuant to paragraph (d) of this section
must be used. If amendment is made by an amendment paper, the
paper must direct that specified changes be made, as follows:


(1)Specification other than the claims. Changes to the
specification, other than to the claims, must be made by submission
of the entire text of an added or rewritten paragraph, including
markings pursuant to paragraph (d) of this section, except that
an entire paragraph may be deleted by a statement deleting the
paragraph without presentation of the text of the paragraph. The
precise point in the specification must be identified where any
added or rewritten paragraph is located. This paragraph applies
whether the amendment is submitted on paper or compact disc
(see §§ 1.52(e)(1) and 1.821(c), but not for discs submitted under
§ 1.821(e)).


are relied upon any more. A supplemental oath/declaration
(2)Claims. An amendment paper must include the entire
will be needed to identify at least one error nowbeing relied upon as the basis for reissue, even though
text of each claim being changed by such amendment paper and of
the prior oath/declaration was earlier found proper by  
each claim being added by such amendment paper. For any claim
the examiner. The supplemental oath/declaration need
changed by the amendment paper, a parenthetical expression
not also indicate that the error(s) identified in the prior
“amended,” “twice amended,” etc., should follow the claim number.
oath(s)/declaration(s) is/are no longer being corrected.  
Each changed patent claim and each added claim must
In this instance, applicant’s submission of the supplemental
include markings pursuant to paragraph (d) of this section, except
reissue oath/declaration to obviate the rejection
that a patent claim or added claim should be canceled by a statement  
under 35 U.S.C. 251 can, at applicant’s option, be
canceling the claim without presentation of the text of the  
deferred until the application is otherwise in condition
claim.
for allowance. The submission can be deferred
because a proper statement of error was provided in
the initial reissue oath/declaration. Applicant need
only request that submission of the supplemental reissue
oath/declaration be deferred until allowance, and
such a request will be considered a complete reply to
the rejection.


II.SUPPLEMENTAL REISSUE OATH/DECLARATION
(3)Drawings. One or more patent drawings shall be
UNDER 37 CFR 1.175(b)(1):
amended in the following manner: Any changes to a patent drawing
must be submitted as a replacement sheet of drawings which
shall be an attachment to the amendment document. Any replacement
sheet of drawings must be in compliance with § 1.84 and
shall include all of the figures appearing on the original version of
the sheet, even if only one figure is amended. Amended figures
must be identified as “Amended,” and any added figure must be
identified as “New.” In the event that a figure is canceled, the figure
must be surrounded by brackets and identified as “Canceled.”
All changes to the drawing(s) shall be explained, in detail, beginning on a separate sheet accompanying the papers including the
amendment to the drawings.


Once the reissue oath/declaration is found to comply
(i)A marked-up copy of any amended drawing figure,  
with 37 CFR 1.175(a), it is not required, nor is it
including annotations indicating the changes made, may be  
suggested, that a new reissue oath/declaration be submitted
included. The marked-up copy must be clearly labeled as “Annotated
together with each new amendment and correction
Marked-up Drawings” and must be presented in the amendment  
of error in the patent. During the prosecution of a
or remarks section that explains the change to the drawings.  
reissue application, amendments are often made
and  
additional errors in the patent are corrected. A
supplemental oath/declaration need not be submitted
with each amendment and additional correction.
Rather, it is suggested that the reissue applicant wait
until the case is in condition for allowance, and then
submit a cumulative supplemental reissue oath/declaration
pursuant to 37 CFR 1.175(b)(1).


See MPEP § 1414.01 for a discussion of the  
(ii)A marked-up copy of any amended drawing figure,
required content of a supplemental reissue oath/declaration
including annotations indicating the changes made, must be
under 37 CFR 1.175(b)(1).
provided when required by the examiner.


A supplemental oath/declaration under 37 CFR
(c)Status of claims and support for claim changes. Whenever
1.175(b)(1) must be submitted before allowance. It
there is an amendment to the claims pursuant to paragraph
may be submitted with any reply prior to allowance. It
(b) of this section, there must also be supplied, on pages separate
may be submitted to overcome a rejection under
from the pages containing the changes, the status (i.e., pending or
35
canceled), as of the date of the amendment, of all patent claims
U.S.C. 251 made by the examiner, where it is indicated
and of all added claims, and an explanation of the support in the
that the submission of the supplemental oath/
disclosure of the patent for the changes made to the claims.
declaration will overcome the rejection.


A supplemental oath/declaration under 37 CFR
(d)Changes shown by markings. Any changes relative to the
1.175(b)(1) will be required where:
patent being reissued which are made to the specification, including
the claims, upon filing, or by an amendment paper in the reissue
application, must include the following markings:


(A)the application is otherwise (other than the
(1)The matter to be omitted by reissue must be enclosed
need for this supplemental oath/declaration) in condition
in brackets; and
for allowance;


(B)amendments or other corrections of errors in
(2)The matter to be added by reissue must be underlined,
the patent have been made subsequent to the last oath/
except for amendments submitted on compact discs (§§ 1.96 and
declaration filed in the application; and
1.821(c)). Matter added by reissue on compact discs must be preceded
with “U” and end with “/U” to properly identify the  
material being added.


(C)at least one of the amendments or other corrections
(e)Numbering of patent claims preserved. Patent claims
corrects an error under 35 U.S.C. 251.
may not be renumbered. The numbering of any claim added in the  
reissue application must follow the number of the highest numbered
patent claim.


When a supplemental oath/declaration under
(f)Amendment of disclosure may be required. The disclosure
37
must be amended, when required by the Office, to correct
CFR 1.175(b)(1) directed to the amendments or
inaccuracies of description and definition, and to secure substantial
other corrections of error is required, the examiner is
correspondence between the claims, the remainder of the specification,
encouraged to telephone the applicant and request the
and the drawings.
submission of the supplemental oath/declaration by
fax. If the circumstances do not permit making a telephone
call, or if applicant declines or is unable to  
promptly submit the oath/declaration, the examiner
should issue a final Office action (final rejection) and  
use form paragraph 14.05.02 where the action issued
is a second or subsequent action on the merits.


(g)Amendments made relative to the patent. All amendments
must be made relative to the patent specification, including
the claims, and drawings, which are in effect as of the date of filing
of the reissue application.


The provisions of 37 CFR 1.173(b)-(g) and those of
37 CFR 1.121(i) apply to amendments in reissue
applications. Any amendments submitted in a reissue
application must comply with 37 CFR 1.173(b).


¶ 14.05.02 Supplemental Oath or Declaration Required
Amendments submitted in a reissue application,
Prior to Allowance
including preliminary amendments (i.e., amendments
filed as a separate paper to accompany the filing of a
reissue application), must comply with the practice
outlined below in this section; however, for examiner’s
amendments to the specification and claims,
37
CFR 1.121(g) provides certain exceptions to that
practice in the interest of expediting prosecution. The
exceptions set forth in 37 CFR 1.121(g) also apply in
reissue applications.


In accordance with 37 CFR 1.175(b)(1), a supplemental reissue  
Pursuant to 37 CFR 1.173(a), no amendment in a  
oath/declaration under 37 CFR 1.175(b)(1) must be received
reissue application may enlarge the scope of the
before this reissue application can be allowed.
claims, unless “applied for within two years from the
grant of the original patent.” Further, the amendment
may not introduce new matter. See MPEP § 1412.03for further discussion as to the time limitation on
enlarging the scope of the patent claims in a reissue  
application.  


Claim [1] rejected as being based upon a defective reissue [2]
All amendment changes must be made relative to
under 35 U.S.C. 251. See 37 CFR 1.175. The nature of the defect
the patent to be reissued. Pursuant to 37 CFR  
is set forth above.
1.173(d), any such changes which are made to the
specification, including the claims, must be shown by
employing the following “markings:”


Receipt of an appropriate supplemental oath/declaration under
(A)The matter to be omitted by reissue must be
37 CFR 1.175(b)(1) will overcome this rejection under 35 U.S.C.
enclosed in brackets; and
251. An example of acceptable language to be used in the supplemental
oath/declaration is as follows:


“Every error in the patent which was corrected in the
(B)The matter to be added by reissue must be
present reissue application, and is not covered by a prior
underlined, except for amendments submitted on
oath/declaration submitted in this application, arose without
compact discs (pursuant to 37 CFR 1.96 for computer
any deceptive intention on the part of the applicant.
printouts or programs, and 37 CFR 1.825 for
sequence listings). Matter added by reissue on compact
discs must be preceded with “U” and end with
/U” to properly identify the material being added.


See MPEP § 1414.01.
I.THE SPECIFICATION


Examiner Note:
37 CFR 1.173(b)(1) relates to the manner of making
amendments to the specification other than the
claims. It is not to be used for making amendments to
the claims or the drawings.


1.In bracket 1, list all claims in the reissue application.
All amendments which include any deletions or
additions must be made by submission of the entire
text of each added or rewritten paragraph with markings
(as defined above), except that an entire paragraph
of specification text may be deleted by a
statement deleting the paragraph without presentation
of the text of the paragraph. Applicant must indicate
the precise point where each amendment is made. All
bracketing and underlining is made in comparison to
the original patent, not in comparison to any prior
amendment in the reissue application. Thus, all paragraphs
which are newly added to the specification of
the original patent must be submitted as completely
underlined each time they are re-submitted in the reissue  
application.  


2.In bracket 2, insert either --oath-- or --declaration--.
II.THE CLAIMS


3.This form paragraph is used in an Office action to: (a) remind
37 CFR 1.173(b)(2) relates to the manner of making
applicant of the requirement for submission of the supplemental
amendments to the claims in reissue applications.
reissue oath/declaration under 37 CFR 1.175(b)(1) before allowance
It is not to be used for making amendments to the
and (b) at the same time, reject all the claims since the reissue  
remainder of the specification or to the drawings. 37
application is defective until the supplemental oath/
CFR 1.173(b)(2) requires that:
declaration is submitted.


4.Do not use this form paragraph if no amendments (or other
(A)For each claim that is being amended by the
corrections of the patent) have been made subsequent to the last
amendment being submitted (the current amendment),
oath/declaration filed in the case; instead allow the case.
the entire text of the claim must be presented with
markings as defined above;


(B)For each new claim added to the reissue by
the amendment being submitted (the current amendment),
the entire text of the added claim must be presented
completely underlined;


(C)A patent claim should be canceled by a direction
to cancel that claim, there is no need to present
the patent claim surrounded by brackets; and


(D)A new claim (previously added in the reissue)
should be canceled by a direction to cancel that claim.


Original patent claims are never to be renumbered;
see 37 CFR 1.173(e). A patent claim retains its number
even if it is canceled in the reissue proceeding,
and the numbering of any added claims must begin
after the last original patent claim.


5.This form paragraph cannot be used in an Ex parte Quayleaction to require the supplemental oath/declaration, because the  
Pursuant to 37 CFR 1.173(c), each amendment submitted
rejection under 35 U.S.C. 251 is more than a matter of form.  
must set forth the status of all patent claims
and all added claims as of the date of the submission.
The status to be set forth is whether the claim is pending
or canceled. The failure to submit the claim status
will generally result in a notification to applicant that
the amendment prior to final rejection is not completely
responsive (see 37 CFR 1.135(c)). Such an
amendment after final rejection will not be entered.


6.Do not use this form paragraph in an examiner’s amendment.  
Also pursuant to 37 CFR 1.173(c), each claim
The supplemental oath/declaration must be filed prior to mailing
amendment must be accompanied by an explanation
of the Notice of Allowability.
of the support in the disclosure of the patent for the
amendment (i.e., support for all changes made in the
claim(s), whether insertions or deletions). The failure
to submit an explanation will generally result in a
notification to applicant that the amendment prior to  
final rejection is not completely responsive (see
37
CFR 1.135(c)). Such an amendment after final
rejection will not be entered.


III.THE DRAWINGS


37 CFR 1.173(a)(2) states that amendments to the
original patent drawings are not permitted, and that
any change to the drawings must be by way of
37
CFR 1.173(b)(3). See MPEP § 1413 for the manner
of making amendments to the drawings in a reissue
application.


As noted above, the examiner will issue a final
IV.ALL CHANGES ARE MADE VIS-À-VISTHE PATENT TO BE REISSUED
Office action where the application is otherwise in
condition for allowance, and amendments or other
corrections of error in the patent have been made subsequent
to the last oath/declaration filed in the application.  
The examiner will be introducing (via form
paragraph 14.05.02) a rejection into the case for the
first time in the prosecution, when the claims have
been determined to be otherwise allowable. This
introduction of a new ground of rejection under
35
U.S.C. 251 will not prevent the action from being
made final on a second or subsequent action because
of the following factors:
 
(A)The finding of the case in condition for allowance
is the first opportunity that the examiner has to
make the rejection;


(B)The rejection is being made in reply to, i.e.,  
When a reissue patent is printed, all underlined
was caused by, an amendment of the application (to  
matter is printed in italics and all brackets are printed
correct errors in the patent);
as inserted in the application, in order to show exactly
which additions and deletions have been made to
the
patent being reissued. Therefore, all underlining
and bracketing in the reissue application should be
made relative to the text of the patent, as follows. In
accordance with 37 CFR 1.173(g), all amendments in  
the reissue application must be made relative to (i.e.,  
vis-à-vis) the patent specification in effect as of the
date of the filing of the reissue application. The patent
specification includes the claims and drawings. If
there was a prior change to the patent (made via a
prior concluded reexamination certificate, reissue of
the patent, certificate of correction, etc.), the first
amendment of the subject reissue application must be
made relative to the patent specification as changed
by the prior proceeding or other mechanism for
changing the patent. All amendments subsequent to
the first amendment must also be made relative to the
patent specification in effect as of the date of the filing
of the reissue application, and not relative to the prior
amendment.


(C)All applicants are on notice that this rejection
The Subject Patent Already Has Underlining or
will be made upon finding of the case otherwise in
Bracketing
condition for allowance where errors have been corrected
subsequent to the last oath/declaration filed in
the case, so that the rejection should have been
expected by applicant; and


(D)The rejection will not prevent applicant from
If the original (or previously changed) patent
exercising any rights to cure the rejection, since applicant
includes a formula or equation already having underlining
need only submit a supplemental oath/declaration
or bracketing therein as part of the formula or
with the above-described language, and it will be  
equation, any amendment of such formula or equation
entered to cure the rejection.
should be made by bracketing the entire formula and
rewriting and totally underlining the amended formula
in the re-presented paragraph of the specification or
rewritten claim in which the changed formula or
equation appears. Amendments of segments of a formula
or equation should not be made. If the original
patent includes bracketing and underlining from an
earlier reexamination or reissue, double brackets and  
double underlining should be used in the subject reissue
application to identify and distinguish the present
changes being made. The subject reissue, when
printed, would include double brackets (indicating
deletions made in the subject reissue) and boldface
type (indicating material added in the subject reissue).


Where the application is in condition for allowance
V.EXAMPLES OF PROPER AMENDMENTS
and no amendments or other corrections of error
in the patent have been made subsequent to the
last oath/declaration filed in the application, a supplemental
reissue oath/declaration under 37 CFR
1.175(b)(1) should not be required by the examiner.
Instead, the examiner should issue a Notice of
Allowability indicating allowance of the claims.


III.AFTER ALLOWANCE
A substantial number of problems arise in the
Office because of improper submission of amendments
in reissue applications. The following examples
are provided to assist in preparation of proper amendments
to reissue applications.


Where applicant seeks to correct an error after
A.Original Patent Description or Patent Claim
allowance of the application, any amendment of the
Amended
patent correcting the error must be submitted in accordance
with 37 CFR 1.312. As set forth in 37 CFR
1.312, no amendment may be made as a matter of
right in an application after the mailing of the notice
of allowance. An amendment filed under 37 CFR
1.312 must be filed before or with the payment of the
issue fee and may be entered on the recommendation
of the primary examiner, and approved by the supervisory
patent examiner, without withdrawing the case
from issue.


Because the amendment seeks to correct an error in
'''Example (1)'''
the patent, the amendment will affect the disclosure,
the scope of a claim, or add a claim. Thus, in accordance
with MPEP § 714.16, the remarks accompanying
the amendment must fully and clearly state:


(A)why the amendment is needed;
If it is desired to change the specification at column
4 line 23, to replace “is” with --are--, submit a
copy of the entire paragraph of specification of the
patent being amended with underlining and bracketing,
and point out where the paragraph is located,
e.g.,


(B)why the proposed amended or new claims
<code>Replace the paragraph beginning at column 4, line 23
require no additional search or examination;
with the following:</code>


(C)why the claims are patentable; and
<code>Scanning [is] <u>are</u> controlled by clocks which are, in turn,
controlled from the display tube line synchronization. The
signals resulting from scanning the scope of the character
are delivered in parallel, then converted into serial mode
through a shift register wherein the shift signal frequency is
controlled by a clock that is, in turn, controlled from the display
tube line synchronization.</code>
 
'''Example (2)'''
 
For changes to the claims, one must submit a copy
of the entire patent claim with the amendments
shown by underlining and bracketing, e.g.,
 
<code>Amend claim 6 as follows:</code>


(D)why they were not presented earlier.
<code>Claim 6 (Amended). The apparatus of claim [5] <u>1</u> wherein
the [first] <u>second</u> piezoelectric element is parallel to the
[second] <u>third</u> piezoelectric element.</code>


A supplemental reissue oath/declaration must
If the dependency of any original patent claim is to  
accompany the amendment. The supplemental reissue
be changed by amendment, it is proper to make
oath/declaration must state that the error(s) to be corrected
that original patent claim dependent upon a later
arose without any deceptive intention on the
filed higher numbered claim.
part of the applicant. The supplemental reissue oath/
declaration submitted after allowance must be  
directed to the error(s) applicant seeks to correct after
allowance. This oath/declaration need not cover any
earlier errors, since all earlier errors should have been
covered by a reissue oath/declaration submitted prior
to allowance.


Occasionally correcting an error after allowance
B.Cancellation of Claim(s)
does not include an amendment of the specification or
claims of the patent. For example, the correction of
the error could be the filing of a certified copy of the
original foreign application (prior to the payment of
the issue fee - see 37 CFR 1.55(a)(2)) to obtain the
right of foreign priority under 35 U.S.C. 119 (see
Brenner v. State of Israel, 400 F.2d 789, 158 USPQ
584 (D.C. Cir. 1968)) where the claim for foreign priority
had been timely made in the application for the
original patent. In such a case, the requirements of
37
CFR 1.312 must still be met. This is so, because
the correction of the patent is an amendment of the


'''Example (3)'''


To cancel an original patent claim, in writing,
direct cancellation of the patent claim, e.g.,


<code>Cancel claim 6.</code>


'''Example (4)'''


patent, even though no amendment is physically
To cancel a new claim (previously added in the
entered into the case. Thus, for a reissue oath/declaration
reissue), in writing, direct cancellation of the new
submitted after allowance to correct an additional
claim, e.g.,
error (or errors), the reissue applicant must comply
with 37 CFR 1.312 in the manner discussed above.


1445Reissue Application Examined in
<code>Cancel claim 15.</code>
Same Manner as Original Application


C.Presentation of New Claims


As stated in 37 CFR 1.176, a reissue application,
'''Example (5)'''
including all the claims therein, is subject to “be
 
examined in the same manner as a non-reissue, non-
Each new claim (i.e., a claim not found in the  
provisional application.” Accordingly, the claims in a
patent, that is newly presented in the reissue application)
reissue application are subject to any and all rejections
should be presented with underlining
which the examiner deems appropriate. It does
throughout the claim, e.g.,
not matter whether the claims are identical to those of
the patent or changed from those in the patent. It also
does not matter that a rejection was not made in the  
prosecution of the patent, or could have been made, or
was in fact made and dropped during prosecution of
the patent; the prior action in the prosecution of the
patent does not prevent that rejection from being
made in the reissue application. Claims in a reissue
application enjoy no “presumption of validity.” In re
Doyle, 482 F.2d 1385, 1392, 179 USPQ 227, 232-233
(CCPA 1973); In re Sneed, 710 F.2d 1544, 1550 n.4,
218 USPQ 385, 389 n.4 (Fed. Cir. 1983). Likewise,
the fact that during prosecution of the patent the
examiner considered, may have considered, or should
have considered information such as, for example, a
specific prior art document, does not have any bearing
on, or prevent, its use as prior art during prosecution
of the reissue application.


1448Fraud, Inequitable Conduct, or
<code>Add claim 7 as follows:</code>
Duty of Disclosure Issues [R-2]


The Office no longer investigates and rejects reissue
<code><u>Claim 7. The apparatus of claim 5 further comprising
applications under 37 CFR 1.56. The Office will
electrodes attaching to said opposite faces of the first and
not comment upon duty of disclosure issues which are
second piezoelectric elements.</u></code>
brought to the attention of the Office in reissue applications
except to note in the application, in appropriate
circumstances, that such issues are no longer
considered by the Office during its examination of
patent applications. Examination as to the lack of
deceptive intent requirement in reissue applications
will continue but without any investigation of fraud,
inequitable conduct, or duty of disclosure issues.
Applicant’s statement in the reissue oath or declaration
of lack of deceptive intent will be accepted as dispositive
except in special circumstances such as an
admission or judicial determination of fraud, inequitable
conduct, or violation of the duty of disclosure.  


ADMISSION OR JUDICIAL DETERMINATION
Even though original claims may have been canceled,
the numbering of the original claims does
not change. Accordingly, any added claims are
numbered beginning with the number next higher
than the number of claims in the original patent. If
new claims have been added to the reissue application
which are later canceled prior to issuance of
the reissue patent, the examiner will renumber any
remaining new claims in numerical order to follow
the number of claims in the original patent.


An admission or judicial determination of fraud,
D.Amendment of New Claims
inequitable conduct, or violation of the duty of disclosure
is a special circumstance, because no investigation
need be made. Accordingly, after consulting with
the Technology Center (TC) Special Program Examiner
(SPRE), a rejection should be made using the
appropriate one of form paragraphs 14.21.09 or 14.22as reproduced below.


Any admission of fraud, inequitable conduct or violation
An amendment of a “new claim” (i.e., a claim not
of the duty of disclosure must be explicit,
found in the patent, that was previously presented
unequivocal, and not subject to other interpretation.  
in
Where a rejection is made based upon such an admission
the reissue application) must be done by presenting
(see form paragraph 14.22 below) and applicant
the amended “new claim” containing the amendatory
responds with any reasonable interpretation of the  
material, and completely underlining the claim. The
facts that would not lead to a conclusion of fraud,  
presentation cannot contain any bracketing or other  
inequitable conduct or violation of the duty of disclosure,  
indication of what was in the previous version of
the rejection should be withdrawn. Alternatively,  
the
if applicant argues that the admission noted by the  
claim. This is because all changes in the
examiner was not in fact an admission, the rejection
reissue
should also be withdrawn.
are
made vis-à-vis the original patent, and not
in comparison to the prior amendment. Although the
presentation of the amended claim does not contain
any indication of  
what is changed from the previous
version of the claim, applicant must point out what is
changed in the “Remarks” portion of the amendment.
Also, per 37 CFR 1.173(c), each change made in the
claim must be accompanied by an explanation of the  
support in the disclosure of the patent for the change.


Form paragraph 14.21.09 should be used where the
E.Amendment of Original Patent Claims More
examiner becomes aware of a judicial determination
Than Once
of fraud, inequitable conduct or violation of the duty
of disclosure on the part of the applicant independently
of the record of the case, i.e., the examiner
has external knowledge of the judicial determination.


Form paragraph 14.22 should be used where, in the
The following illustrates proper claim amendment
application record, there is (a) an explicit, unequivocal
of original patent claims in reissue applications:
admission by applicant of fraud, inequitable conduct
or violation of the duty of disclosure which is not
subject to other interpretation, or (b) information as to
a judicial determination of fraud, inequitable conduct
or violation of the duty of disclosure on the part of the
applicant. External information which the examiner
believes to be an admission by applicant should never
be used by the examiner, and such external information
should never be made of record in the reissue  
application.


A. Patent claim.


<code>Claim 1. A cutting means having a handle portion
and a blade portion.</code>


B. Proper first amendment format.


<code>Claim 1 (Amended). A [cutting means] <u>knife</u> having
a <u>bone</u> handle portion and a <u>notched</u> blade portion.</code>


¶ 14.21.09 Rejection, 35 U.S.C. 251, No Error Without
C. Proper second amendment format.
Deceptive Intention - External Knowledge


Claims [1] rejected under 35 U.S.C. 251 since error “without
<code>Claim 1 (Twice Amended). A [cutting means]  
any
<u>knife</u> having a handle portion and a <u>serrated</u> blade
deceptive intention” has not been established. In view of the
portion.</code>
judicial determination in [2] of [3] on the part of applicant, a conclusion
that any error was “without deceptive intention” cannot be
supported. [4]


Examiner Note:
Note that the second amendment must include the
changes previously presented in the first amendment,
i.e., [cutting means] <u>knife</u>, as well as the new changes
presented in the second amendment, i.e., <u>serrated</u>.


1.In bracket 1, list all claims in the reissue application.  
The word <u>bone</u> was presented in the first amendment
and is now to be deleted in the second amendment.
The word "bone" is NOT to be shown in
brackets in the second amendment. Rather, the word
"bone" is simply omitted from the claim, since "bone"
never appeared in the patent. An explanation of the
deletion should appear in the remarks.


2.In bracket 2, list the Court or administrative body which
The word <u>notched</u> which was presented in the first
made the determination of fraud or inequitable conduct on the  
amendment is replaced by the word serrated in the
part of applicant.  
second amendment. The word <u>notched</u> is being
deleted in the second amendment and did not appear
in the patent; accordingly, "notched" is not shown in
any form in the claim. The word <u>serrated</u> is being
added in the second amendment, and accordingly
"serrated" is added to the claim and is underlined.


3.In bracket 3, insert --fraud--, --inequitable conduct-- and/or -
In the second amendment, the deletions of
-violation of duty of disclosure--.  
"notched" and "bone" are not changes from the original
patent claim text and therefore are not shown in
brackets in the second amendment. In both the first
and the second amendments, the entire claim is presented
only with the changes from the <u>original patent
text</u>.  


4.In bracket 4, point out where in the opinion (or holding) of
VI.ADDITIONAL EXAMPLES
the Court or administrative body the determination of fraud, inequitable
conduct or violation of duty of disclosure is set forth. Page
number, column number, and paragraph information should be
given as to the opinion (or holding) of the Court or administrative
body. The examiner may add explanatory comments.


(A)For a reissue application, where the patent
was previously reissued:


As per MPEP § 1411, double underlining and
double bracketing are used in the second reissue
application to show amendments made relative to the
first reissued patent


¶ 14.22 Rejection, 35 U.S.C. 251, No Error Without
(B)For a reissue application, where the patent
Deceptive Intention-Evidence in the Application
was previously reexamined and a reexamination certificate
has issued for the patent:


Claims [1] rejected under 35 U.S.C. 251 since error “without
An amendment in the reissue application must be
any deceptive intention” has not been established. In view of the  
presented as if the changes made to the original patent
reply filed on [2], a conclusion that any error was “without deceptive
text via the reexamination certificate are a part of the
intention” cannot be supported.
original patent. Thus, all italicized text of the reexamination
 
certificate is presented in the amendment
[3]
(made in the reissue application) without italics. Further,
 
any text found in brackets in the reexamination
Examiner Note:
certificate is omitted in the amendment (made in the
reissue application).


1.In bracket 1, list all claims in the reissue application.
(C)For a reissue application, where a certificate
of correction has issued for the patent:


2.In bracket 2, insert the filing date of the reply which provides
An amendment in the reissue application must be
an admission of fraud, inequitable conduct or violation of duty of  
presented as if the changes made to the original patent
disclosure, or that there was a judicial determination of same.
text via the certificate of correction are a part of the
original patent. Thus, all text added by certificate of
correction is presented in the amendment (made in the  
reissue application) without italics. Further, any text
deleted by certificate of correction is entirely omitted
in the amendment (made in the reissue application).
 
(D)For a reissue application, where a statutory
disclaimer has issued for the patent:


3.In bracket 3, insert a statement that there has been an admission
Any claim statutorily disclaimed is no longer in
or a judicial determination of fraud, inequitable conduct or
the patent, and such a claim cannot be amended. The
violation of duty of disclosure which provide circumstances why
statutorily disclaimed claim(s) should be lined
applicant’s statement in the oath or declaration of lack of deceptive
through, and not surrounded by brackets.
intent should not be taken as dispositive. Any admission of
fraud, inequitable conduct or violation of duty of disclosure must
be explicit, unequivocal, and not subject to other interpretation.  


==1454 Appeal Brief==


The requirements for an appeal brief are set forth in
37 CFR 41.37 and MPEP § 1206, and they apply
to a reissue application in the same manner that they
apply to a non-reissue application. There is, however,
a difference in practice as to presentation of the copy
of the claims in the appeal brief for a reissue application.
The claims on appeal presented in an appeal
brief for a reissue application should include all
underlining and bracketing necessary to reflect the
changes made to the patent claims during the prosecution
of the reissue application. In addition, any new
claims added in the reissue application should be
completely underlined.


See MPEP § 2012 for additional discussion as to
==1455 Allowance and Issue==
fraud, inequitable conduct or violation of duty of disclosure
in a reissue application.


1449Protest Filed in Reissue Where
I.ISSUE CLASSIFICATION SHEET
Patent Is in Interference [R-3]


If a protest (see MPEP Chapter 1900) is filed in a
For IFW reissue applications:
reissue application related to a patent involved in a
pending interference proceeding, the reissue application
should be referred to the Office of Patent Legal
Administration (OPLA) before considering the protest
and acting on the reissue application.


The OPLA will check to see that:
The examiner completes the Issue Classification
sheet in the same manner as for a non-reissue application.
In addition, a copy of the “Final SPRE Review”
form must also be completed.


(A)all parties to the interference are aware of the
For reissue application files that are maintained in
filing of the reissue; and
paper:


(B)the Office does not allow claims in the reissue
In all reissue applications prepared for issue where
which are unpatentable over the pending interference
a blue slip is needed (i.e., 08/ and earlier series), the
count(s), or found unpatentable in the interference
patent number of the original patent which is being
proceeding. After the reissue application has been
reissued should be placed in the box provided therefor
reviewed by the OPLA, the reissue application with
below the box for the applicant’s name on the blue
the protest will be returned to the examiner. See
Issue Classification Slip (form PTO-270) or design
MPEP § 1441.01 for a discussion as to protests under
Issue Classification Slip (form PTO-328). Otherwise,  
37 CFR 1.291 in reissue applications.
the Issue Classification Slip is prepared in the same
manner as for a non-reissue application.  


1449.01Concurrent Office Proceedings
II. CHANGES TO THE ORIGINAL
[R-5]
PATENT


I.CONCURRENT REEXAMINATION PROCEEDINGS:
The specifications of reissue patents will be printed
in such a manner as to show the changes over the
original patent text by enclosing any material omitted
by the reissue in heavy brackets [ ] and printing material
added by the
reissue in italics. 37 CFR 1.173 (see
MPEP § 1411) requires the specification of a reissue
application to be presented in a specified form, specifically
designed to facilitate this different manner of
printing, as well as for other reasons.  


The printed reissue patent specification will carry
the following heading, which will be added by the
Publishing Division of the Office of Patent Publication:


37 CFR 1.565(d) provides that if “a reissue application
“Matter enclosed in heavy brackets [ ] appears in the original
and an ex parte reexamination proceeding on
patent but forms no part of this reissue specification;
which an order pursuant to 37 CFR 1.525 has been
matter printed in italics indicates the additions made by
mailed are pending concurrently on a patent, a decision
reissue.
will normally be made to merge the two proceedings
or to suspend one of the two proceedings.”
37
CFR 1.991 provides that if “a reissue application
and an inter partes reexamination proceeding on
which an order pursuant to 37 CFR 1.931 has been
mailed are pending concurrently on a patent, a decision
may be made to merge the two proceedings or to
suspend one of the two proceedings”. If an examiner
becomes aware that a reissue application and an ex
parte or inter partes reexamination proceeding are
both pending for the same patent, he or she should
immediately inform the Technology Center (TC)
or Central Reexamination Unit (CRU) Special Program
Examiner (SPRE).


Pursuant to 37 CFR 1.177, a patent owner may file
The examiners should see that the specification is
more than one reissue application for the same patent.  
in proper form for printing. Examiners should carefully check the entry of all amendments to ensure that
If an examiner becomes aware that multiple reissue
the changes directed by applicant will be accurately
applications are pending for the same patent, and an
printed in any reissue patent that may ultimately issue.  
ex parte or inter partes reexamination proceeding is  
Matter appearing in the original patent which is omitted
pending for the same patent, he or she should immediately
by reissue should be enclosed in brackets, while
inform the TC SPRE.
matter added by reissue should be underlined.  


Where a reissue application and a reexamination
Any material added by amendment in the reissue  
proceeding are pending concurrently on a patent, and  
application (as underlined text) which is later canceled
an order granting reexamination has been issued for
should be crossed through, and not bracketed.
the reexamination proceeding, the Office of Patent
Material cancelled from the original patent should be
enclosed in brackets, and not lined through.


All the claims of the original patent should appear
in the reissue patent, with canceled patent claims
being enclosed in brackets.


III. CLAIM NUMBERING


No renumbering of the original patent claims is permitted,
even if the dependency of a dependent patent
claim is changed by reissue so that it is to be dependent
on a subsequent higher numbered claim.


When a dependent claim in a reissue application
depends upon a claim which has been canceled, and
the dependent claim is not thereafter made dependent
upon a pending claim, such a dependent claim must
be rewritten in independent form.


Legal Administration (OPLA) must be notified that
New claims added during the prosecution of the
the proceedings are ready for a decision as to whether
reissue application should follow the number of the
to merge the reissue and the reexamination, or stay
highest numbered patent claim and should be completely
one of the two. See MPEP § 2285 for the  
underlined to indicate they are to be printed in
procedure of  
italics on the printed patent. Often, as a result of the  
notifying OPLA and general guidance, if a reissue
prosecution and examination, some new claims are
application and an ex parte reexamination proceeding
canceled while other new claims remain. When the  
are both pending for the same patent, and
reissue application is allowed, any claims remaining
an inter
which are additional to the patent claims (i.e., claims
partes reexamination proceeding is not involved. See
added via the reissue application) should be renumbered
MPEP § 2686.03 where a reissue application and an
in sequence starting with the number next
inter partes reexamination proceeding are both pending
higher than the number of the last claim in the original
for the same patent, regardless of whether an ex
patent (the printed patent). Therefore, the number of
parte reexamination proceeding is also pending.
claims allowed will not necessarily correspond to the
number of the last claim in the reissue application, as
allowed. The number of claims appearing in the
“Total Claims Allowed” box on the Issue Classification
sheet (or for reissue application files that are
maintained in paper, the “CLAIMS ALLOWED -
Total Claims” box on the lower right of the file wrapper
face) at the time of allowance should be consistent
with the number of claims indicated as allowable
on the Notice of Allowability (Form PTOL-37).  


Where a reissue application and a reexamination
IV. CLAIM DESIGNATED FOR PRINTING
proceeding are pending concurrently on a patent, the
patent owner, i.e., the reissue applicant, has a responsibility
to notify the Office of the concurrent proceeding.
37 CFR § 1.178(b), 37 CFR 1.565(a), and
37
CFR 1.985(a). The patent owner should file in the
reissue application, as early as possible, a Notification
of Concurrent Proceedings pursuant to 37 CFR
1.178(b) in order to alert the Office of the existence of
the reexamination proceeding on the same patent. See
MPEP § 1418. In addition, the patent owner should
file in the reexamination proceeding, as early as possible,
a Notification of Concurrent Proceedings pursuant
to 37 CFR 1.565(a) or 1.985(a) (depending on
whether the reexamination proceeding is an ex partereexamination proceeding or an inter partes reexamination
proceeding) to provide a notification to the
Office in the reexamination proceeding of the existence
of the two concurrent proceedings.


The patent owner may file a petition under 37 CFR
At least one claim of an allowable reissue application  
1.182 in a reissue application to merge the reissue
must be designated for printing in the Official
application with the reexamination proceeding, or to
Gazette. Whenever at least one claim has been
stay one of the proceedings because of the other. This
amended or added in the reissue, the claim (claims)
petition must be filed after the issuance of the order to
designated for printing must be (or include) a claim
reexamine (37 CFR 1.525, 37 CFR 1.931) in the reexamination
which has been changed or added by the reissue. A
proceeding. If the petition is filed prior to
canceled claim is not to be designated as the claim for
the reexamination order, it will not be considered, and
the Official Gazette.
will be returned to the patent owner by the TC or
CRU Director. If the petition is filed after the issuance
of the order to reexamine, the petition and the  
files for the reissue application and the reexamination
proceeding will be forwarded to OPLA for decision.


II.CONCURRENT INTERFERENCE PROCEEDINGS
If there is no change in the claims of the allowable
reissue application (i.e., when they are the same as the
claims of the original patent) or, if the only change in
the claims is the cancellation of claims, then the most
representative pending allowed claim is designated
for printing in the Official Gazette.


V. PROVIDING PROPER FORMAT


If the original patent is involved in an interference,  
Where a reissue application has not been prepared
the examiner must consult the administrative patent
in the above-indicated manner, the examiner may
judge in charge of the interference before taking any
obtain from the applicant a clean copy of the reissue
action on the reissue application. It is particularly
specification prepared in the indicated form, or a
important that the reissue application not be granted
proper submission of a previously improperly submitted
without the administrative patent judge’s approval.
amendment. However, if the deletions from the  
See MPEP Chapter 2300.
original patent are small, the reissue application can
be prepared for issue by putting the bracketed inserts
at the appropriate places and suitably numbering the  
added claims.  


III.CONCURRENT REISSUE PROCEEDINGS
When applicant submits a clean copy of the reissue
specification, or a proper submission of a previous
improper amendment, a supplemental reissue declaration
should not be provided to address this submission,
because the correction of format does not correct
a 35 U.S.C. 251 error in the patent.  


VI. PARENT APPLICATION DATA


Where more than one reissue applications are pending
All parent application data on the bibliographic
concurrently on the same patent, see MPEP
data sheet of the original patent file (or front face of
§§
the original patent file wrapper if the original patent is
a paper file) should be present on the bibliographic
1450 and 1451.
data sheet of the reissue application.


1449.02Interference in Reissue [R-5]
It sometimes happens that the reissue is a continuation
of another reissue application, and there is also
original-patent parent application data. The examiner
should ensure that the parent application data on the
original patent is properly combined with the parent
application data of the reissue, in the text of the specification
and on the bibliographic data sheet (or
on the front face of the reissue file wrapper for 08/
and earlier series applications).  The combined
statement as to parent application data should be
checked carefully for proper bracketing and underlining.


37 CFR 41.8. Mandatory notices.
VII. REFERENCES CITED AND PRINTED


(a)In an appeal brief (§§ 41.37, 41.67, or 41.68) or at the  
The list of references to be printed in the reissue
initiation of a contested case (§ 41.101), and within 20 days of any  
patent includes all the references cited during the  
change during the proceeding, a party must identify:
prosecution of the reissue application. It is noted that
the Office will not print in the reissue patent “References
Cited” section any reference cited in the patent
but not again cited in the reissue application. A patent
cannot be reissued solely for the purpose of adding
citations of additional prior art.


(1)Its real party-in-interest, and
VIII. EXAMINER'S AMENDMENT AND SUP-
PLEMENTAL DECLARATION


(2)Each judicial or administrative proceeding that could
When it is necessary to amend the reissue application
affect, or be affected by, the Board proceeding.
in order to place the application in condition for
allowance, the examiner may:


(b)For contested cases, a party seeking judicial review of a
(A)request that applicant provide the amendments
Board proceeding must file a notice with the Board of the judicial
(e.g., by facsimile transmission or by hand-
review within 20 days of the filing of the complaint or the notice
carry); or  
of appeal. The notice to the Board must include a copy of the
complaint or notice of appeal. See also §§ 1.301 to 1.304 of this
title.


37 CFR 41.202. Suggesting an interference.
(B)make the amendments, with the applicant’s
approval, by a formal examiner’s amendment.


(a)Applicant. An applicant, including a reissue applicant,
If the changes are made by a formal examiner’s
may suggest an interference with another application or a patent.  
amendment, the entire paragraph(s) or claim(s) being
The suggestion must:
amended need not be presented in rewritten form for
any deletions or additions. Changes to the specification
including the claims of an application made by
the Office in an examiner’s amendment may be made
by specific instructions to insert or delete subject matter
set forth in the examiner’s amendment by identifying
the precise point in the specification or the
claim(s) where the insertion or deletion is to be made.  
37 CFR 1.121(g).


(1)Provide sufficient information to identify the application  
If it is necessary to amend a claim or the specification
or patent with which the applicant seeks an interference,
in order to correct an “error” under 35 U.S.C. 251and thereby place the application in condition for
allowance, then a supplemental oath or declaration
will be required. See MPEP § 1444. The examiner
should telephone applicant and request the supplemental
oath or declaration, which must be filed before
the application can be counted as an allowance.


(2)Identify all claims the applicant believes interfere,
IX. FINAL REVIEW OF THE REISSUE
propose one or more counts, and show how the claims correspond
APPLICATION BY THE EXAMINER
to one or more counts,


(3)For each count, provide a claim chart comparing at
Prior to forwarding a reissue application to the
least one claim of each party corresponding to the count and show
Technology Center (TC) Special Program Examiner
why the claims interfere within the meaning of § 41.203(a),
(SPRE) for final review, the examiner should complete
and initial an Examiner Reissue Checklist. A
copy of the checklist should be available from the
SPRE or from the Paralegal Specialist of the TC.


(4)Explain in detail why the applicant will prevail on priority,
==1456 Reissue Review==
 
 
(5)If a claim has been added or amended to provoke an
interference, provide a claim chart showing the written description
for each claim in the applicant’s specification, and
 
(6)For each constructive reduction to practice for which
the applicant wishes to be accorded benefit, provide a chart showing
where the disclosure provides a constructive reduction to practice
within the scope of the interfering subject matter.


All reissue applications are monitored and
reviewed in the Technology Centers (TCs) by the
Office of TC Special Program Examiners (which
includes TC SPREs, paralegals or other technical support
who might be assigned as backup) at several
stages during the prosecution. The review by the
Office of the TC SPREs is made to check that practice
and procedure unique to reissue has been carried out
for the reissue application. In addition to the SPRE
review of the reissue applications, a patentability
review is made in a sample of reissue applications by
the TC Quality Assurance Specialist (QAS) in the
manner previously carried out by the former Office of
Patent Quality Review. In order to ensure that SPREs
are aware of the reissue applications in their TCs, a
pair of terminal-specific PALM flags have been created
which must be set by the SPRE before certain
PALM transactions can be completed. First, when a
new reissue application enters the TC, a SPRE must
set a PALM “flag” by entering the reissue application
number in an Office-wide computer grouping before a
docketing transaction will be accepted. By having to
set this first flag, the SPRE is made aware of the
assignment of the reissue application to the TC and
can take steps, as may be appropriate, to instruct the
examiner on reissue-specific procedures before the
examination process begins, as well as throughout the
period that the examiner is handling the reissue application.
Second, the SPRE must remove the above-
described PALM “flag” before a Notice of Allowance
can be generated or the PALM transaction for an issue
revision can be entered, thereby ensuring that the
SPRE is made aware of when the reissue application
is being allowed so that the SPRE may be able to conduct
a final review of the reissue application, if appropriate.


When the reissue application has been reviewed
and is ready to be released to issue, the TC SPRE
should do the following:


== 1457 Design Reissue Applications and Patents==


A reissue application can be filed for a design
patent in the same manner that a reissue application is
filed for a utility patent. There are, however, a few
aspects of a design reissue application that are
addressed as follows:


I.EXPEDITED EXAMINATION PROCE-
DURE


Design reissue applications requesting expedited
examination and complying with the requirements of
37 CFR 1.155 are examined with priority and undergo
expedited processing throughout the entire course of
prosecution in the Office, including appeal, if any, to
the Board of Patent Appeals and Interferences. All
processing is expedited from the date the request is
granted.


(c)Examiner. An examiner may require an applicant to add
Design reissue applicants seeking expedited examination
a claim to provoke an interference. Failure to satisfy the requirement
may file a design reissue application in the  
within a period (not less than one month) the examiner sets
Office together with a corresponding request under 37
will operate as a concession of priority for the subject matter of
CFR 1.155 pursuant to the guidelines set forth in
the claim. If the interference would be with a patent, the applicant
MPEP § 1504.30.
must also comply with paragraphs (a)(2) through (a)(6) of this
section. The claim the examiner proposes to have added must,
apart from the question of priority under 35 U.S.C. 102 (g):


(1)Be patentable to the applicant, and
The design reissue application and the request are
 
processed by the Office of Initial Patent Examination
(2)Be drawn to patentable subject matter claimed by
(OIPE). OIPE enters the appropriate information
another applicant or patentee.
into PALM specifying when notice of the design
reissue application will be published in the Official
Gazette (see MPEP § 1441).  After processing in
OIPE, the design reissue application and the request
are forwarded to the Design TC Director’s Office.
Upon a decision by the Design TC Director to grant
the request for expedited examination, fees are immediately
processed, and the application papers are
promptly assigned an application number. The design
reissue application file is then forwarded to the Office
of Patent Legal Administration (OPLA) for a decision
under 37 CFR 1.182 to sua sponte waive the requirement
for delaying action in the application until 2  
months after announcement of the design reissue
application filing is published in the Official Gazette(see MPEP § 1441). Once the decision under 37 CFR
1.182 is mailed, the design reissue application file
will be returned to the Design TC Director’s Office. In
accordance with the waiver, the Design Group will
begin expedited examination of the application under
37 CFR 1.155 promptly after the return of the design
reissue application file from OPLA, rather than delay
examination until after 2 months from the date the
announcement is published in the Official Gazette and
the applicant will be notified that examination is
being expedited. The decision under 37 CFR 1.182will require that no Notice of Allowance be mailed in
the design reissue application until after 2 months
from the date the announcement is published in the
Official Gazette. For example, if the design reissue






In appropriate circumstances, a reissue application
may be placed into interference with a patent or pending
application. A patentee may provoke an interference
with a patent or pending application by filing a
reissue application, if the reissue application includes
an appropriate reissue error as required by 35 U.S.C.
251. Reissue error must be based upon applicant
error; a reissue cannot be based solely on the error of
the Office for failing to declare an interference or to
suggest copying claims for the purpose of establishing
an interference. See In re Keil, 808 F.2d 830,
1
USPQ2d 1427 (Fed. Cir. 1987); In re Dien, 680 F.2d
151, 214 USPQ 10 (CCPA 1982); In re Bostwick, 102
F.2d 886, 888, 41 USPQ 279, 281 (CCPA 1939); and
In re Guastavino, 83 F.2d 913, 916, 29 USPQ 532,
535 (CCPA 1936). See also Slip Track Systems, Inc. v.
Metal Lite, Inc., 159 F.3d 1337, 48 USPQ2d 1055
(Fed. Cir. 1998) (Two patents issued claiming the
same patentable subject matter, and the patentee with
the earlier filing date requested reexamination of the
patent with the later filing date (Slip Track’s patent).
A stay of litigation in a priority of invention suit under
35 U.S.C. 291, pending the outcome of the reexamination,
was reversed. The suit under 35 U.S.C. 291was the only option available to Slip Track to determine
priority of invention. Slip Track could not file a
reissue application solely to provoke an interference
proceeding before the Office because it did not assert
that there was any error as required by 35 U.S.C. 251in the patent.). A reissue application can be employed
to provoke an interference if the reissue application:


(A)adds copied claims which are not present in
the original patent;


(B)amends claims to correspond to those of the  
application is allowed on the first Office action, then
patent or application with which an interference is
jurisdiction over the reissue application will be
sought; or
retained in the TC, and the Notice of Allowance
will not be mailed until the expiration of 2 months
after publication of the filing of the design reissue
application in the Official Gazette (plus time for
matching any protest filed with the application). (For
IFW processing, see IFW Manual.) The examiner will
check  the PALM contents to ascertain when publication
actually occurred. The delay in the mailing of  
the Notice of Allowance is to ensure that any potential
protests complying with 37 CFR 1.291 submitted
within the 2-month delay period will be considered by
the Office. (see MPEP § 1441.01).


(C)contains at least one error (not directed to
The expedited examination procedure under
provoking an interference) appropriate for the reissue.
37
CFR 1.155 occurs through initial examination processing
and throughout the entire prosecution in the
Office. Once a request for expedited examination is
granted, prosecution of the design reissue application
will proceed according to the procedure under
37
CFR 1.155, and there is no provision for “withdrawal”
from expedited examination procedure.


In the first two situations, the reissue oath/declaration
II.DESIGN REISSUE FEE
must assert that applicant erred in failing to
include claims of the proper scope to provoke an
interference in the original patent application. Note
that in In re Metz, 173 F.3d 433 (Fed. Cir. 1998)
(table), the Federal Circuit permitted a patentee to file
a reissue application to copy claims from a patent in
order to provoke an interference with that patent. Furthermore,
the subject matter of the copied or amended
claims in the reissue application must be supported by
the disclosure of the original patent under 35 U.S.C.
112, first paragraph. See In re Molins, 368 F.2d 258,
261, 151 USPQ 570, 572
(CCPA 1966) and In re
Spencer, 273 F.2d 181, 124 USPQ 175 (CCPA 1959).  


A reissue applicant cannot present added or  
The design reissue application fee is set forth for in
amended claims to provoke an interference, if the
37 CFR 1.16(e). For design reissue applications
claims were deliberately omitted from the patent. If
filed on or after December 8, 2004, a search fee
there is evidence that the claims were not inadvertently
(37
omitted from the original patent, e.g., the subject
CFR 1.16(n)) and an examination fee (37 CFR
matter was described in the original patent as being
1.16(r)) are also required. The additional fees in  
undesirable, the reissue application may lack proper
37
basis for the reissue. See In re Bostwick, 102 F.2d at
CFR 1.16(h) and 37 CFR 1.16(i) do not
889, 41 USPQ at 282 (CCPA 1939)(reissue lacked a  
apply for a design reissue application since more than
proper basis because the original patent pointed out
one claim in not permitted in a design application pursuant
the disadvantages of the embodiment that provided
to the last sentence of 37 CFR 1.153(a).
support for the copied claims).  


The issue date of the patent, or the publication date
The fee for issuing a design reissue patent is set
of the application publication (whichever is applicable
forth in 37 CFR 1.18(a).
under 35 U.S.C. 135(b)), with which an interference
is sought must be less than 1 year prior to the presentation
of the copied or amended claims in the reissue
application. See 35 U.S.C. 135(b) and MPEP § 715.05and MPEP Chapter 2300. If the reissue application
includes broadened claims, the reissue application
must be filed within two years from the issue date of
the original patent. See 35 U.S.C. 251 and MPEP §
1412.03.


An examiner may, pursuant to 37 CFR 41.202(c),
III.MULTIPLE DESIGN REISSUE APPLICATIONS
require a reissue applicant to add a claim to provoke
an interference, unless the reissue applicant cannot
present the added claim to provoke an interference
based upon the provisions of the reissue statute and
rules, e.g., if the claim was deliberately omitted from
the patent, or if the claim enlarges the scope of the
claims of the original patent and was not “applied for
within two years from the grant of the original




The design reissue application can be filed based on
the “error” of failing to include a design for a patentably
distinct segregable part of the design claimed in
the original patent or a patentably distinct subcombination
of the claimed design. A reissue design application
claiming both the entire article and the
patentably distinct subcombination or segregable part
would be proper under 35 U.S.C. 251, if such a reissue
application is filed within two years of the issuance
of the design patent, since it is considered a
broadening of the scope of the patent claim. Restriction
will be required under 37 CFR 1.176(b) in such a
reissue design application, and the added design to the
segregable part or subcombination will be held to be
constructively non-elected and withdrawn from consideration.
See MPEP § 1450. In the Office action
containing the restriction requirement, the examiner
should suggest to the applicant that a divisional
design reissue application directed to the constructively
non-elected segregable part or subcombination
subject matter may be filed. The claim to the patented
design for the entire article will then be examined and,
if found allowable without change from the patent, a
rejection will be made under 35 U.S.C. 251 based on
the fact that there is no “error” in the non-amended
original patent claim. In the Office action making this
rejection, applicant should be advised that a proper
response to the rejection must include (A) a request to
suspend action in this original reissue application
pending completion of examination of a divisional
reissue application directed to the constructively non-
elected segregable part or subcombination subject
matter, (B) the filing of the divisional reissue application,
or a statement that one has already been filed
(identifying it at least by application number), and (C)
an argument that a complete response to the rejection
has been made based upon the filing of the divisional
reissue application and the request for suspension.
Action in the original design reissue application will
then be suspended, and the divisional will be examined.




If, after examination, the divisional design reissue
 
application is also determined to be allowable, a  
patent.” Failure to satisfy the requirement within a  
requirement must be made in the divisional design
period (not less than one month) the examiner sets
reissue application to submit a petition under 37 CFR
will operate as a concession of priority for the subject
1.183 requesting waiver of 37 CFR 1.153 in order to
matter of the claim. If the interference would be with
permit the rejoining of the designs to the entire article
a patent, the reissue applicant must also comply with
(of the original application) and the segregable part or  
37 CFR 41.202(a)(2) through (a)(6). The claim the  
subcombination (of the divisional) under a single
examiner proposes to have added must, apart from the  
claim into a single design reissue application for issuance,  
question of priority under 35 U.S.C. 102(g), be patentable
the single application being the first design reissue  
to the reissue applicant, and be drawn to patentable
application.
subject matter claimed by another applicant or  
patentee.
 
REISSUE APPLICATION FILED WHILE
PATENT IS IN INTERFERENCE
 
If a reissue application is filed while the original
patent is in an interference proceeding, the reissue
applicant must promptly notify the Board of Patent
Appeals and Interferences of the filing of the reissue  
application within 20 days from the filing date. See 37
CFR 41.8 and MPEP Chapter 2300.
 
1450Restriction and Election of Species
Made in Reissue Application
[R-2]


37 CFR 1.176. Examination of reissue.
It should be noted that the filing of a design reissue
application would not be proper if applicant did in
fact include the design for a segregable part or subcombination
thereof in the original design patent
application, a restriction was thus made, and then
applicant failed to file a divisional reissue application
for a non-elected invention that was canceled in view
of a restriction requirement (prior to issue of the original
application. See In re Watkinson, 900 F.2d 230,
14
USPQ2d 1407 (Fed. Cir. 1990); In re Orita,
550
F.2d 1277, 1280, 193 USPQ 145, 148 (CCPA
1977).


(a)A reissue application will be examined in the same manner
IV.CONVERSION TO UTILITY PATENT
as a non-reissue, non-provisional application, and will be subject
to all the requirements of the rules related to non-reissue
applications. Applications for reissue will be acted on by the
examiner in advance of other applications.


(b)Restriction between subject matter of the original patent  
A design patent cannot be converted to a utility
claims and previously unclaimed subject matter may be required
patent via reissue.
(restriction involving only subject matter of the original patent  
 
claims will not be required). If restriction is required, the subject
Converting a design patent to a utility patent will,  
matter of the original patent claims will be held to be constructively
in most instances, involve the introduction of new
elected unless a disclaimer of all the patent claims is filed in
matter into the patent. The disclosure of a design
the reissue application, which disclaimer cannot be withdrawn by
patent is not directed to how the invention is made
applicant.
and used, and the introduction of new matter is
required to bridge this gap and provide support for the  
utility patent. Accordingly, the examiner should consider
rejections based on the introduction of new matter
under 35 U.S.C. 251, first paragraph, and lack of
enablement and/or description under 35 U.S.C. 112,
first paragraph, when a reissue application is filed to
convert a design patent to a utility patent.  


37 CFR 1.176(b) permits the examiner to require
Further, the term of a design patent may not be
restriction in a reissue application between claims
extended by reissue. Ex parte Lawrence, 70 USPQ
newly added in a reissue application and the original
326 (Comm’r Pat. 1946). Thus, any reissue application  
patent claims, where the added claims are directed to
filed to convert a design patent to a utility patent,  
an invention which is separate and distinct from the  
which conversion would thereby extend the term of
invention(s) defined by the original patent claims. The
the patent, should be rejected as failing to comply
criteria for making a restriction requirement in a reissue  
with 35 U.S.C. 251, first paragraph, which permits
application between the newly added claims and
reissue only “for the unexpired part of the term of the  
the original claims are the same as that applied in a
original patent.The statute requires that the reissued
non-reissue application. See MPEP §§ 806 through
patent shall not extend the term of the original patent.
806.05(i). The authority to make a “restriction”
requirement under 37 CFR 1.176(b) extends to and
includes the authority to make an election of species.


Where a restriction requirement is made by the
==1460 Effect of Reissue==
examiner, the original patent claims will be held to be
constructively elected (except for the limited situation
where a disclaimer is filed as discussed in the next
paragraph). Thus, the examiner will issue an Office
action in the reissue application (1) providing notification
of the restriction requirement, (2) holding the
added claims to be constructively non-elected and
withdrawn from consideration,  (3) treating the original
patent claims on the merits, and (4) informing
applicant that if the original claims are found allowable,
and a divisional application has been filed for
the non-elected claims, further action in the application
will be suspended, pending resolution of the divisional
application..


If a disclaimer of all the original patent claims is
35 U.S.C. 252. Effect of reissue.
filed in the reissue application containing newly
added claims that are separate and distinct from the
original patent claims, only the newly added claims
will be present for examination. In this situation, the
examiner’s Office action will treat the newly added
claims in the reissue application on the merits. The
disclaimer of all the original patent claims must be
filed in the reissue application prior to the issuance of
the examiner’s Office action containing the restriction
requirement, in order for the newly added claims to be
treated on the merits. Once the examiner has issued
the Office action providing notification of the restriction
requirement and treating the patent claims on the
merits, it is too late to obtain an examination on
the
added claims in the reissue application by filing a
disclaimer of all the original patent claims. If reissue
applicant wishes to have the newly added claims be
treated on the merits, a divisional reissue application
must be filed to obtain examination of the added
claims. Reissue applicants should carefully note that
once a disclaimer of the patent claims is filed, it cannot
be withdrawn. It does not matter whether the reissue  
application is still pending, or whether the reissue
application has been abandoned or issued as a reissue
patent. For all these situations, 37 CFR 1.176(b) states
that the disclaimer cannot be withdrawn; the disclaimer
will be given effect.


Claims elected pursuant to a restriction requirement
The surrender of the original patent shall take effect upon the
will receive a complete examination on the merits,  
issue of the reissued patent, and every reissued patent shall have
while the non-elected claims (to any added inven
the same effect and operation in law, on the trial of actions for
causes thereafter arising, as if the same had been originally
granted in such amended form, but in so far as the claims of the
original and reissued patents are substantially identical, such surrender
shall not affect any action then pending nor abate any cause
of action then existing, and the reissued patent, to the extent that
its claims are substantially identical with the original patent, shall
constitute a continuation thereof and have effect continuously
from the date of the original patent.


A reissued patent shall not abridge or affect the right of any
person or that person’s successors in business who, prior to the
grant of a reissue, made, purchased, offered to sell, or used within
the United States, or imported into the United States, anything patented
by the reissued patent, to continue the use of, to offer to sell,
or to sell to others to be used, offered for sale, or sold, the specific
thing so made, purchased, offered for sale, used, or imported
unless the making, using, offering for sale, or selling of such thing
infringes a valid claim of the reissued patent which was in the
original patent. The court before which such matter is in question
may provide for the continued manufacture, use, offer for sale, or
sale of the thing made, purchased, offered for sale, used, or
imported as specified, or for the manufacture, use, offer for sale,
or sale in the United States of which substantial preparation was
made before the grant of the reissue, and the court may also provide
for the continued practice of any process patented by the reissue
that is practiced, or for the practice of which substantial
preparation was made, before the grant of the reissue, to the extent
and under such terms as the court deems equitable for the protection
of investments made or business commenced before the grant
of the reissue.


The effect of the reissue of a patent is stated in
35
U.S.C. 252. With respect to the Office treatment of
the reissued patent, the reissued patent will be viewed
as if the original patent had been originally granted in
the amended form provided by the reissue. With
respect to intervening rights resulting from the reissue
of an original patent, the second paragraph of 35
U.S.C. 252 provides for two separate and distinct
defenses to patent infringement under the doctrine of
intervening rights:


“Absolute” intervening rights are available for a
party that “prior to the grant of a reissue, made, purchased,
offered to sell, or used within the United
States, or imported into the United States, anything
patented by the reissued patent,” and “equitable”
intervening rights may be provided where “substantial
preparation was made before the grant of the reissue.”
See BIC Leisure Prods., Inc., v. Windsurfing Int’l,
Inc., 1 F.3d 1214, 1220, 27 USPQ2d 1671, 1676 (Fed.
Cir. 1993).
==1470 Public Access of Reissue Applications==
37 CFR 1.11(b) opens all reissue applications filed
after March 1, 1977, to inspection by the general public.
37 CFR 1.11(b) also provides for announcement
of the filings of reissue applications in the Official
Gazette (except for continued prosecution applications
filed under 37 CFR 1.53(d)). This announcement
will give interested members of the public an
opportunity to submit to the examiner information
pertinent to patentability of the reissue application.


The filing of a continued prosecution application
under 37 CFR 1.53(d) of a reissue application will notbe announced in the Official Gazette. Although the
filing of a continued prosecution application of a reissue
application constitutes the filing of a reissue
application, the announcement of the filing of such
continued prosecution application would be redundant
in view of the announcement of the filing of the prior
reissue application in the Official Gazette.


37 CFR 1.11(b) is applicable to all reissue
applications filed on or after March 1, 1977. Those
reissue applications previously on file will not be
automatically open to inspection but a liberal policy
will be followed in granting petitions for access to
such applications.


tion(s)) will be held in abeyance in a withdrawn status,
IFW reissue application files are open to
and will only be examined if filed in a divisional
inspection by the general public by way of Public
reissue application. If the reissue application containing
PAIR via the USPTO Internet site. In viewing the  
only original unamended claims becomes allowable
images of the files, members of the public will be able
first (and no “error” under 35 U.S.C. 251exists),
to view the entire content of the reissue application  
file history. To access Public PAIR, a member of the  
further action in that reissue application will
public would (A) go to the USPTO web site at http://
be suspended to await examination in the divisional
www.uspto.gov, (B) click on “Patents,(C) under
reissue application(s) containing the added claims.  
“Check Status, View Papers…” click on “Status &
Multiple suspensions (usually six-month periods)
IFW,” and (D) under “Patent Application Information
may be necessary. The Office will not  permit
Retrieval” enter the reissue application number.
claims to issue in a reissue application which
application does not correct any error in the original
patent. Once a divisional reissue application containing
the added claims is examined and becomes
allowable, the examiner will issue a requirement
under 37 CFR 1.177(c) for applicant to merge the  
claims of the suspended first reissue application with
the allowable claims of the divisional reissue application
into a single application, by placing all of the  
claims in one of the applications and expressly abandoning
the other. The Office action making this
requirement will set a two-month period for compliance
with the requirement. If applicant fails to timely
respond to the Office action, or otherwise refuses to
comply with the requirement made, then the divisional
reissue application (claiming the invention
which was non-elected in the now-suspended first
reissue application) will be passed to issue alone,
since the claims of the divisional reissue application,  
by themselves, do correct an error in the original
patent. Prosecution will be reopened in the suspended
first reissue application, and a rejection based on a
lack of error under 35
U.S.C. 251 will then be made.
This rejection may be made final, since applicant is on
notice of the consequences of not complying with the
merger requirement.


If the divisional reissue application becomes abandoned,
Access to a reissue application that is maintained in
prosecution will be reopened in the suspended
paper must be obtained from the area of the Office
first reissue application, and a rejection based on a
having jurisdiction over the file. The following access
lack of error under 35 U.S.C. 251 will then be made in
procedure will be observed for reissue application  
the first reissue application. Since no error in the original
files that are maintained in paper:
patent is being corrected in the first reissue application,
no reissue patent will issue.


As stated in 37 CFR 1.176(b), the examiner is not
(A)Any member of the general public may
permitted to require restriction among original
request access to a particular reissue application filed
claims of the patent (i.e., among claims that were in
after March 1, 1977. Since no record of such request
the patent prior to filing the reissue application). Even
is intended to be kept, an oral request will suffice.  
where the original patent contains claims to different
(Reissue applications already on file prior to March 1,
inventions which the examiner considers independent
1977 are not automatically open to inspection, but a
or distinct, and the reissue application claims the same
liberal policy is followed by the Office of Patent
inventions, a restriction requirement would be
Legal Administration (OPLA) and by the Board of
improper. If such a restriction requirement is made, it
Patent Appeals and Interferences in granting petitions
must be withdrawn.
for access to such applications.);


Restriction between multiple inventions recited in
(B)Paper reissue application files will be maintained
the newly added claims will be permitted provided
in the TCs and inspection thereof will be supervised
the added claims are drawn to several separate and  
by TC personnel. A TC Director or other
distinct inventions. In such a situation, the original
appropriate Office official may, under appropriate circumstances,  
patent claims would be examined in the first reissue
postpone access to or the making of copies
application, and applicant is permitted to file a divisional
of a paper reissue application file, in order, for
reissue application for each of the several separate
example, to avoid interruption of the examination or
and distinct inventions identified in the  
other review of the application by an examiner. In
examiner’s restriction requirement.
addition, though no general limit is placed on the
amount of time spent reviewing the files, the Office
may impose limitations, if necessary, e.g., where the  
application is actively being processed;


A situation will sometimes arise where the examiner
(C)In any instance where the reissue application  
makes an election of species requirement
file has left the TC for administrative processing,  
between the species claimed in the original patent
requests for access should be directed to the appropriate
claims and a species of claims added in the reissue  
supervisory personnel where the application is
application. In such a situation, if (1) the non-elected
currently located;
claims to the added species depend from (or otherwise
include all limitations of) a generic claim which
embraces all species claims, and (2) the generic claim
is found allowable, then the non-elected claims of the
added species must be rejoined with the elected
claims of the original patent. See MPEP §
821.04(a).


(D)A paper reissue application file is not
available to the public once the reissue application file
has been released and forwarded by the TC for publication
of the reissue patent. This would include any
reissue application files which have been selected for
a post-allowance screening at OPLA. Unless
prosecution is reopened pursuant to the screening, the
reissue application files are not available to the public
until the reissue patent issues. This is because the reissue
application file has been put into a special format
for printing purposes and public access at this stage
would disrupt the publication process;


(E)Requests for copies of papers in the reissue
application file must be in writing addressed to Mail
Stop Document Services, Director of the U.S. Patent
and Trademark Office, P.O. Box 1450, Alexandria,
VA 22313-1450. Such requests may be either mailed
or delivered to the Customer Service Window. The
price for a copy of an application as filed is set forth
in 37 CFR 1.19(b)(1). Since no useful purpose is seen
for retaining such written requests for copies of
papers in reissue applications, the request(s) should be
destroyed after the order has been completed.


1451Divisional Reissue Applications;
See also MPEP § 103.
Continuation Reissue ApplicationsWhere the Parent is Pending [R-3]
 
35 U.S.C. 251. Reissue of defective patents.
 
 


The Director may issue several reissued patents for distinct and
==1480 Certificates of Correction — Office Mistake==
separate parts of the thing patented, upon demand of the applicant,
and upon payment of the required fee for a reissue for each of
such reissued patents.


35 U.S.C. 254. Certificate of correction of Patent and
Trademark Office mistake.


Whenever a mistake in a patent, incurred through the fault of
the Patent and Trademark Office, is clearly disclosed by the
records of the Office, the Director may issue a certificate of correction
stating the fact and nature of such mistake, under seal,
without charge, to be recorded in the records of patents. A printed
copy thereof shall be attached to each printed copy of the patent,
and such certificate shall be considered as part of the original
patent. Every such patent, together with such certificate, shall
have the same effect and operation in law on the trial of actions
for causes thereafter arising as if the same had been originally
issued in such corrected form. The Director may issue a corrected
patent without charge in lieu of and with like effect as a certificate
of correction.
37 CFR 1.322. Certificate of correction of Office mistake.


37 CFR 1.177. Issuance of multiple reissue patents.
(a)(1) The Director may issue a certificate of correction pursuant
to 35 U.S.C. 254 to correct a mistake in a patent, incurred
through the fault of the Office, which mistake is clearly disclosed
in the records of the Office:


(a)The Office may reissue a patent as multiple reissue patents.
(i)At the request of the patentee or the patentee’s
If applicant files more than one application for the reissue of  
assignee;
a single patent, each such application must contain or be amended
to contain in the first sentence of the specification a notice stating
that more than one reissue application has been filed and identifying
each of the reissue applications by relationship, application
number and filing date. The Office may correct by certificate of
correction under §
1.322 any reissue patent resulting from an


(ii)Acting sua sponte for mistakes that the Office discovers;
or


(iii)Acting on information about a mistake supplied by a
third party.


(2)(i) There is no obligation on the Office to act on or
respond to a submission of information or request to issue a certificate
of correction by a third party under paragraph (a)(1)(iii) of
this section.


(ii)Papers submitted by a third party under this section
will not be made of record in the file that they relate to nor be
retained by the Office.


application to which this paragraph applies that does not contain
(3)If the request relates to a patent involved in an
the required notice.
interference, the request must comply with the requirements of
this section and be accompanied by a motion under § 41.121(a)(2)
or § 41.121(a)(3) of this title.


(b)If applicant files more than one application for the reissue
(4)The Office will not issue a certificate of correction
of a single patent, each claim of the patent being reissued must
under this section without first notifying the patentee (including
be presented in each of the reissue applications as an amended,
any assignee of record) at the correspondence address of record as  
unamended, or canceled (shown in brackets) claim, with each
specified in § 1.33(a) and affording the patentee or an assignee an
such claim bearing the same number as in the patent being reissued.
opportunity to be heard.
The same claim of the patent being reissued may not be presented
in its original unamended form for examination in more
than one of such multiple reissue applications. The numbering of
any added claims in any of the multiple reissue applications must
follow the number of the highest numbered original patent claim.


(c)If any one of the several reissue applications by itself
(b)If the nature of the mistake on the part of the Office is
fails to correct an error in the original patent as required by 35
such that a certificate of correction is deemed inappropriate in  
U.S.C. 251 but is otherwise in condition for allowance, the Office
form, the Director may issue a corrected patent in lieu thereof as a
may suspend action in  
more appropriate form for certificate of correction, without
the allowable application until all issues
expense to the patentee.
are resolved as to at least one of the remaining reissue applications.
The Office may also merge two or more of the multiple reissue
applications into a single reissue application. No reissue
application containing only unamended patent claims and not correcting
an error in the original patent will be passed to issue by
itself.


The court in In re Graff, 111 F.3d 874, 876-77,  
Mistakes incurred through the fault of the Office
42
may be the subject of Certificates of Correction under
USPQ2d 1471, 1473 (Fed. Cir. 1997) stated that
37 CFR 1.322. The Office, however, has discretion
“[t]he statute does not prohibit divisional or continuation
under 35 U.S.C. 254 to decline to issue a Certificate
reissue applications, and does not place stricter
of Correction even though an Office mistake exists. If
limitations on such applications when they are presented
Office mistakes are of such a nature that the meaning
by reissue, provided of course that the statutory
intended is obvious from the context, the Office may
requirements specific to reissue applications are met.”
decline to issue a certificate and merely place the correspondence
Following the decision in Graff, the Office has
in the patented file, where it serves to
adopted a policy of treating continuations and divisionals
call attention to the matter in case any question as to it
of reissue applications, to the extent possible,  
subsequently arises. Such is the case, even where a
in the same manner as continuations and divisionals
correction is requested by the patentee or patentee’s
of non-reissue applications.
assignee.


Questions relating to the propriety of divisional
In order to expedite all proper requests, a Certificate
reissue applications and continuation reissue applications
of Correction should be requested only for errors
should be referred via the Technology Center
of consequence. Instead of a request for a Certificate
(TC) Special Program Examiner to the Office of  
of Correction, letters making errors of record should  
Patent Legal Administration.  
be utilized whenever possible. Thus, where errors are
of a minor typographical nature, or are readily apparent
to one skilled in the art, a letter making the error(s)  
of record can be submitted in lieu of a request for a
Certificate of Correction. There is no fee for the submission
of such a letter.


It is strongly advised that the text of the correction
requested be submitted on a Certificate of Correction
form, PTO/SB/44 (also referred to as PTO 1050). Submission
of this form in duplicate is not necessary. The
location of the error in the printed patent should be
identified on form PTO/SB/44 by column and line
number or claim and line number. See MPEP § 1485for a discussion of the preparation and submission of
a request for a Certificate of Correction.


I. THIRD PARTY INFORMATION ON
MISTAKES IN PATENT


I. DIVISIONAL REISSUE APPLICATIONS
Third parties do not have standing to demand that
the Office issue, or refuse to issue, a Certificate of
Correction. See Hallmark Cards, Inc. v. Lehman, 959
F. Supp. 539, 543-44, 42 USPQ2d 1134, 1138 (D.D.C.
1997). 37 CFR 1.322(a)(2) makes it clear that third
parties do not have standing to demand that the Office
act on, respond to, issue, or refuse to issue a Certificate
of Correction. The Office is, however, cognizant
of the need for the public to have correct information
about published patents and may therefore accept
information about mistakes in patents from third parties.
37 CFR 1.322(a)(1)(iii). Where appropriate, the
Office may issue certificates of correction based on
information supplied by third parties, whether or not
such information is accompanied by a specific request
for issuance of a Certificate of Correction.  


37 CFR 1.176(b) permits the examiner to require
While third parties are permitted to submit information
restriction in a reissue application between the original
about mistakes in patents which information
claims of the patent and any newly added claims
will be reviewed, the Office need not act on that information
which are directed to a separate and distinct invention(
nor deny any accompanying request for issuance
s). See also MPEP § 1450. As a result of such a
of a Certificate of Correction. Accordingly, a fee
restriction requirement, divisional applications may
for submission of the information by a third party has
be filed for each of the inventions identified in the  
not been imposed. The Office may, however, choose
restriction requirement.  
to issue a Certificate of Correction on its own initiative
based on the information supplied by a third
party, if it desires to do so. Regardless of whether the
third party information is acted upon, the information
will not be made of record in the file that it relates to,
nor be retained by the Office. 37 CFR 1.322(a)(2)(ii).


In addition, applicant may initiate a division of the  
When such third party information (about mistakes
claims by filing more than one reissue application in
in patents) is received by the Office, the Office will
accordance with 37 CFR 1.177. The multiple reissue
not correspond with third parties about the information
applications which are filed may contain different
they submitted either (1) to inform the third parties
groups of claims from among the original patent
of whether it intends to issue a Certificate of
claims, or some of the reissue applications may contain
Correction, or (2) to issue a denial of any request for
newly added groups (not present in the original
issuance of a Certificate of Correction that may  
patent). There is no requirement that the claims of the  
accompany the information. The Office will confirm
multiple reissue applications be independent and distinct
to the party submitting such information that the  
from one another; if they are not independent
Office has in fact received the information if a
and distinct from one another, the examiner must
stamped, self-addressed post card has been submitted.
apply the appropriate double patenting rejections.
See MPEP § 503.


There is no requirement that a family of divisional
II. PUBLICATION IN THE OFFICIAL
reissue applications issue at the same time; however,
GAZETTE
it is required that they contain a cross reference to
each other in the specification. 37 CFR 1.177(a)
requires that all multiple reissue applications resulting
from a single patent must include as the first sentence
of their respective specifications a cross reference to
the other reissue application(s). Accordingly, the first
sentence of each reissue specification must provide
notice stating that more than one reissue application
has been filed, and it must identify each of the reissue
applications and their relationship within the family
of reissue applications, and to the original patent. An
example of the suggested language to be inserted is as
follows:


Notice: More than one reissue application has
Each issue of the Official Gazette (patents section)
been
numerically lists all United States patents having Certificates
filed for the reissue of Patent No. 9,999,999. The  
of Correction. The list appears under the  
reissue applications are application numbers 09/
heading “Certificates of Correction for the week of  
999,994 (the present application), 09/999,995, and 09/
(date).
999,998, all of which are divisional reissues of Patent
No. 9,999,999.  


The examiner should object to the specification
===1480.01 Expedited Issuance of Certificates of Correction - Error Attributable to Office===
and require an appropriate amendment if applicant
fails to include such a cross reference to the other reissue
applications in the first sentence of the specification
of each of the reissue applications.


Where one of the divisional applications of the
In an effort to reduce the overall time required in
family has issued without the required cross reference
processing and granting Certificate of Correction
to the other reissue application(s), the examiner will
requests, the Office will expedite processing and
refer the matter to his/her Supervisory Patent Examiner
granting of patentee requests where such requests are
(SPE). The SPE will initiate a certificate of correction
accompanied by evidence to show that the error is
under 37 CFR 1.322 to include the appropriate
attributable solely to the Office (i.e., requests filed
cross reference in the already issued first reissue
pursuant to 37 CFR 1.322 only).
patent before passing the pending reissue application
to issue. Form paragraph 10.19 may be used for such
purpose. After the SPE prepares the memorandum as


The following requirements must be met for consideration
of expedited issuance of Certificates of
Correction:


The text of the correction requested should be submitted
on a Certificate of Correction form, PTO/SB/
44 (also referred to as PTO 1050). Submission of this
form in duplicate is not necessary. The location of the
error in the printed patent should be identified on
form PTO/SB/44 by column and line number or claim
and line number. See also MPEP § 1485.


Where the correction requested was incurred
through the fault of the Office, and the matter is
clearly disclosed in the records of the Office, and is
accompanied by documentation that unequivocally
supports the patentee’s assertion(s), a Certificate of
Correction will be expeditiously issued. Such supporting
documentation can consist of relevant photocopied
receipts, manuscript pages, correspondence dated
and received by the Office, photocopies of Examiners’
responses regarding entry of amendments, or any
other validation that supports the patentee’s request so
that the request can be processed without the patent
file.


Where only part of a request can be approved, the
 
appropriate modifications will be made on the form
per form paragraph 10.19, the patent file with the
PTO/SB/44 and the patentee then notified by mail.  
memorandum should be forwarded to the Certificates
Further consideration will be given to initially
of Correction Branch for issuance of a certificate. The
rejected requests upon a request for reconsideration.  
examiner should make a reference in the pending
In this instance, however, or in the case where it is
divisional reissue application to the fact that an actual
determined that the Office was not responsible for the  
request for a Certificate of Correction has been initiated
error(s) cited by the patentee, accelerated issuance of
in the first reissue patent pursuant to 37 CFR
Certificates of Correction cannot be anticipated
1.177(a), e.g., by an entry in the search notes or in an
(although the Office will make every effort to process
examiner’s amendment.
the request expeditiously).
 
¶ 10.19 Memorandum - Certificate of Correction (Cross-
Reference to Other Reissues in Family)


DATE: [1]
==1481 Certificates of Correction - Applicant’s Mistake==


TO: Certificates of Correction Branch
35 U.S.C. 255. Certificate of correction of applicant’s
mistake.


FROM: [2], SPE, Art Unit [3]
Whenever a mistake of a clerical or typographical nature, or of
minor character, which was not the fault of the Patent and Trademark
Office, appears in a patent and a showing has been made that
such mistake occurred in good faith, the Director may, upon payment
of the required fee, issue a certificate of correction, if the
correction does not involve such changes in the patent as would
constitute new matter or would require reexamination. Such
patent, together with the certificate, shall have the same effect and
operation in law on the trial of actions for causes thereafter
arising as if the same had been originally issued in such corrected
form.


SUBJECT: Request for Certificate of Correction
37 CFR 1.323. Certificate of correction of applicant’s
mistake.


Please issue a Certificate of Correction in U. S. Letters Patent
The Office may issue a certificate of correction under the
No. [4] as specified on the attached Certificate.  
conditions specified in 35 U.S.C. 255 at the request of the patentee
or the patentee’s assignee, upon payment of the fee set forth in
§ 1.20(a). If the request relates to a patent involved in an interference,
the request must comply with the requirements of this section
and be accompanied by a motion under § 41.121(a)(2) or
§ 41.121(a)(3) of this title.


______________________
37 CFR 1.323 relates to the issuance of Certificates
of Correction for the correction of errors which were
not the fault of the Office. Mistakes in a patent which
are not correctable by Certificate of Correction may
be correctable via filing a reissue application (see
MPEP § 1401 - § 1460). See Novo Industries, L.P. v.
Micro Molds Corporation, 350 F.3d 1348,
69 USPQ2d 1128 (Fed. Cir. 2003) (The Federal Circuit
stated that when Congress in 1952 defined
USPTO authority to make corrections with prospective
effect, it did not deny correction authority to the
district courts. A court, however, can correct only if
“(1) the correction is not subject to reasonable debate
based on consideration of the claim language and the
specification and (2) the prosecution history does not
suggest a different interpretation...”).


[5], SPE
In re Arnott, 19 USPQ2d 1049, 1052 (Comm’r Pat.
1991) specifies the criteria of 35 U.S.C. 255 (for a
Certificate of Correction) as follows:


Art Unit [6]
Two separate statutory requirements must be met
 
before a Certificate of Correction for an applicant’s mistake
UNITED STATES PATENT AND TRADEMARK OFFICE
may issue. The first statutory requirement concerns
CERTIFICATE
the nature, i.e., type, of the mistake for which a correction
 
is sought. The mistake must be:
Patent No. [7]


Patented: [8]
(1) of a clerical nature,


The present reissue patent issued from an application that is
(2) of a typographical nature, or
one of a family of divisional reissue applications resulting from
Patent No. [9]. The present reissue patent has issued without the
cross reference to the other reissue application(s) of the family
which is required pursuant to 37 CFR 1.177(a). Accordingly,  
insert in the first sentence of the specification as follows:


Notice: More than one reissue application has been filed for the
(3) a mistake of minor character.
reissue of patent [9]. The reissue applications are [10].


_________________________
The second statutory requirement concerns the nature
of the proposed correction. The correction must not
involve changes which would:


[11], Supervisory Patent Examiner
(1) constitute new matter or


Art Unit [12]
(2) require reexamination.


Examiner Note:
If the above criteria are not satisfied, then a Certificate
of Correction for an applicant’s mistake will not issue,
and reissue must be employed as the vehicle to “correct”
the patent. Usually, any mistake affecting claim
scope must be corrected by reissue.
 
A mistake is not considered to be of the “minor”
character required for the issuance of a Certificate of
Correction if the requested change would materially
affect the scope or meaning of the patent. See also
MPEP § 1412.04 as to correction of inventorship via
certificate of correction or reissue.
 
The fee for providing a correction of applicant’s
mistake, other than inventorship, is set forth in
37 CFR 1.20(a). The fee for correction of inventorship
in a patent is set forth in 37 CFR 1.20(b).
 
===1481.01 Correction of Assignees’ Names===
 
The Fee(s) Transmittal Form portion (PTOL-
85B) of the Notice of Allowance provides a space
(item 3) for assignment data which should be completed
in order to comply with 37 CFR 3.81. Unless
an assignee’s name and
address are identified in the
appropriate space for
specifying the assignee, (i.e.,
item 3 of the Fee(s) Transmittal Form PTOL-
85B), the patent will issue to the applicant. Assignment
data printed on the patent will be based solely on
the information so supplied.


1In bracket 9, insert the patent number of the patent for which
Any request for the issuance of an application
multiple reissue divisional applications have been filed.
in the name of the assignee submitted after the date of
payment of the issue fee, and any request for a patent  
to be corrected to state the name of the assignee must:


2This is an internal memo and must not be mailed to the applicant.
(A)state that the assignment was submitted for
This memo should accompany the patented file to the Certificates
recordation as set forth in 37 CFR 3.11 before issuance
of Correction Branch as noted in form paragraphs 10.13 and
of the patent;
10.14.


3.In brackets 5 and 11, insert the name of SPE and provide the  
(B)include a request for a certificate of correction
signature of the SPE above each line.
under 37 CFR 1.323 along with the fee set forth in
37 CFR 1.20(a); and


4.In brackets 6 and 12, insert the Art Unit number.
(C)include the processing fee set forth in 37 CFR
1.17(i).


5.Two separate pages of USPTO letterhead will be printed
See 37 CFR 3.81(b).
when using this form paragraph.


6.In bracket 10, identify each of the reissue applications
===1481.02 Correction of Inventors’ Names===
(including the present application) and their relationship within
the family of reissue applications, and to the original patent.


In addition to the amendment to the first sentence
35 U.S.C. 256. Correction of named inventor.
of the specification, the reissue application cross references
will also be reflected in the file. For an
IFW reissue application file, a copy of the bibliographic
data sheet from the IFW file history should be
printed and the examiner should annotate the printed
sheet such that adequate notice is provided that more
than one reissue application has been filed for a single
original patent. The annotated sheet should be
scanned into IFW. For reissue application files that are
maintained in paper, the bibliographic data sheet
should be reprinted (for 09/ and later series), or
the front face of the reissue file wrapper should be
marked (for 08/ and earlier series), for all the multiple
reissue applications, so that adequate notice is provided
that more than one reissue application has been
filed for a single original patent.  


Pursuant to 37 CFR 1.177(b) all of the claims of the
Whenever through error a person is named in an issued patent  
patent to be reissued must be presented in each reissue
as the inventor, or through error an inventor is not named in an
application in some form, i.e., as amended, as
issued patent and such error arose without any deceptive intention
unamended or as canceled. Further,  any added
on his part, the Director may, on application of all the parties and
claims must be numbered beginning with the next
assignees, with proof of the facts and such other requirements as
highest number following the last patent claim. It is  
may be imposed, issue a certificate correcting such error.
noted that the same claim of the patent cannot be presented
for examination in more than one of the divisional
reissue applications, as a pending claim, in
either its original or amended versions. Once a claim
in the patent has been reissued, it does not exist in the  
original patent; thus, it cannot be reissued from the
original patent in another reissue application. If the  
same claim of the patent, e.g., patent claim 1 is presented
for examination in more than one of the reissue
applications, in different amended versions, the following
rejections should be made in the reissue applications
with that patent claim:


A rejection under 35 U.S.C. 251, in that the reissue
The error of omitting inventors or naming persons who are not
application is not correcting an error in the original
inventors shall not invalidate the patent in which such error  
patent, because original claim 1 would be superseded
occurred if it can be corrected as provided in this section. The
by the reissuance of claim 1 in the other reissue application.
court before which such matter is called in question may order
correction of the patent on notice and hearing of all parties concerned
and the Director shall issue a certificate accordingly.


In requesting the Office to effectuate a court order
correcting inventorship in a patent pursuant to
35 U.S.C. 256, a copy of the court order and a Certificate
of Correction under 37 CFR 1.323 should be submitted
to the Certificates of Corrections Branch.


A rejection under 35 U.S.C. 112, in that claim 1 is
37 CFR 1.324. Correction of inventorship in patent,
indefinite because the invention of claim 1 is not particularly
pursuant to 35 U.S.C. 256.
pointed out and distinctly claimed. Claim 1
presents one coverage in divisional reissue application
X and another in the present reissue application. This
is inconsistent.
 
The reissue applicant should then be advised to follow
a procedure similar to the following example:


(a)Whenever through error a person is named in an
issued patent as the inventor, or through error an inventor is not
named in an issued patent and such error arose without any deceptive
intention on his or her part, the Director, pursuant to 35
U.S.C. 256, may, on application of all the parties and assignees, or
on order of a court before which such matter is called in question,
issue a certificate naming only the actual inventor or inventors. A
petition to correct inventorship of a patent involved in an interference
must comply with the requirements of this section and must
be accompanied by a motion under § 41.121(a)(2) or §
41.121(a)(3) of this title.


(b)Any request to correct inventorship of a patent pursuant
to paragraph (a) of this section must be accompanied by:


(1)Where one or more persons are being added, a statement
from each person who is being added as an inventor that the
inventorship error occurred without any deceptive intention on his
or her part;


(2)A statement from the current named inventors who
have not submitted a statement under paragraph (b)(1) of this section
either agreeing to the change of inventorship or stating that
they have no disagreement in regard to the requested change;
 
(3)A statement from all assignees of the parties submitting
a statement under paragraphs (b)(1) and (b)(2) of this section
agreeing to the change of inventorship in the patent, which statement
must comply with the requirements of § 3.73(b) of this chapter;
and
 
(4)The fee set forth in § 1.20(b).
 
(c)For correction of inventorship in an application, see
§§ 1.48 and 1.497.


If there are patent claims 1 – 10 in two divisional
(d)In a contested case before the Board of Patent Appeals
reissue applications and an applicant wishes to revise
and Interferences under part 41, subpart D, of this title, a request
claim 1, which is directed to AB (for example) to
for correction of a patent must be in the form of a motion under
ABC in one divisional reissue application, and to
§ 41.121(a)(2) or § 41.121(a)(3) of this title.
ABD in a second divisional reissue application, applicant
should do the following: Claim 1 in the first divisional
reissue application can be revised to recite
ABC. Claim 1 in the second divisional reissue application
would be canceled, and new claim 11 would be
added to recite ABD. The physical cancellation of  
claim 1 in the second divisional reissue application
will not prejudice applicant’s rights in the amended
version of claim 1 since those rights are retained via
the first reissue application. Claim 1 continues to exist
in the first reissue application, and both the first and
second reissue applications taken together make up
the totality of the correction of the original patent.


If the same or similar claims are presented in more
The petition to correct inventorship under 37 CFR  
than one of the multiple reissue applications, the possibility
1.324 must include the statements and fee required by  
of statutory double patenting (35 U.S.C. 101)
37 CFR 1.324(b).
or non-statutory (judicially created doctrine) double
patenting should be considered by the examiner during
examination, and the appropriate rejections made.
A terminal disclaimer may be filed to overcome an
obviousness type double patenting rejection. The terminal
disclaimer is necessary in order to ensure common
ownership of the reissue patents throughout the
remainder of the unexpired term of the original patent.
Whenever a divisional reissue application is filed with
a copy of the oath/declaration and assignee consent
from the parent reissue application, the copy of the
assignee consent from the parent reissue application
should not be accepted. The copy of the consent from
the parent reissue application does not indicate that
the assignee has consented to the addition of the new
invention of the divisional reissue application to the
original patent. The Office of Initial Patent Examination
(OIPE) should accord a filing date and send out a
notice of missing parts stating that there is no proper
consent and setting a period of time for filing the
missing part and for payment of any surcharge
required under 37 CFR 1.53(f) and 1.16(f). See
MPEP § 1410.01. The copy of the reissue oath/declaration
should be accepted by OIPE, since it is an oath/
declaration, even though it may be improper under
35
U.S.C. 251. The examiner should check the copy
of the oath/declaration to ensure that it identifies an
error being corrected by the divisional reissue application.
The copy of the oath/declaration from the parent
reissue application may or may not cover the error
being corrected by the divisional reissue application
since the divisional reissue application is (by definition)
directed to a new invention. If it does not, the
examiner should reject the claims of the divisional
reissue application under 35 U.S.C. 251 as being
based on an oath/declaration that does not identify an
error being corrected by the divisional reissue application,
and require a new oath/declaration. See MPEP §
1414. If the copy of the reissue oath/declaration from
the parent reissue application does in fact cover an
error being corrected in the divisional reissue application,
no such rejection should be made. However,
since a new invention is being added by the filing of
the divisional reissue application, a supplemental reissue
oath/declaration pursuant to 37 CFR 1.175 (b)(1)
will be required. See MPEP § 1414.01.


Situations yielding divisional reissues occur infrequently
Under 37 CFR 1.324(b)(1), a statement is required
and usually involve only two such files. It
from each person who is being added as an inventor
should be noted, however, that in rare instances in the
that the inventorship error occurred without any
past, there have been more than two (and as many as  
deceptive intention on their part. In order to satisfy
five) divisional reissues of a
this, a statement such as the following is sufficient:
patent. For treatment of a
plurality of divisional reissue applications resulting
from a requirement to restrict to distinct inventions or
a requirement to elect species, see MPEP § 1450.


“The inventorship error of failing to include John Smith
as an inventor of the patent occurred without any deceptive
intention on the part of John Smith.”


Nothing more is required. The examiner will determine
only whether the statement contains the required
language; the examiner will not make any commentas to whether or not it appears that there was in fact
deceptive intention (see MPEP § 2022.05).


II. CONTINUATION REISSUE APPLI-
Under 37 CFR 1.324(b)(2), all current inventors
CATIONS
who did not submit a statement under 37 CFR
1.324(b)(1) must submit a statement either agreeing to
the change of inventorship, or stating that they have
no disagreement with regard to the requested change.
“Current inventors” include the inventor(s) being
retained as such and the inventor(s) to be deleted.
These current inventors need not make a statement as
to whether the inventorship error occurred without
deceptive intention.


A continuation of a reissue is not ordinarily filed
If an inventor is not available, or refuses, to submit
“for distinct and separate parts of the thing patented”
a statement, the assignee of the patent may wish to
as called for in the second paragraph of 35 U.S.C.
consider filing a reissue application to correct inventorship,
251. The decision of In re Graff, 111 F.3d 874,
since the inventor’s statement is not required
42
for a non-broadening reissue application to correct
USPQ2d 1471 (Fed. Cir. 1997) interprets
inventorship. See MPEP § 1412.04.
35
U.S.C. 251 to permit multiple reissue patents to  
issue even where the multiple reissue patents are not  
for “distinct and separate parts of the thing patented.
The court stated:


Section 251[2] is plainly intended as enabling, not as limiting.
Under 37 CFR 1.324(b)(3), a statement is required
Section 251[2] has the effect of assuring that a different
from the assignee(s) of the patent agreeing to the
burden is not placed on divisional or continuation
change of inventorship in the patent. The assignee
reissue applications, compared with divisions and continuations
statement agreeing to the change of inventorship must
of original applications, by codifying the Supreme
be accompanied by a proper statement under 37 CFR
Court decision which recognized that more than one
3.73(b) establishing ownership, unless a proper 37
patent can result from a reissue proceeding. Thus § 251[2]
CFR 3.73(b) statement is already in the file. See
places no greater burden on Mr. Graff’s continuation reissue
MPEP § 324 as to the requirements of a statement
application than upon a continuation of an original
under 37 CFR 3.73(b).
application; § 251[2] neither overrides, enlarges, nor lim


While a request under 37 CFR 1.48 is appropriate
to correct inventorship in a nonprovisional application,
a petition under 37 CFR 1.324 is the appropriate
vehicle to correct inventorship in a patent. If a request
under 37 CFR 1.48(a), (b), or (c) is inadvertently filed
in a patent, the request may be treated as a petition
under 37 CFR 1.324, and if it is grantable, form paragraph
10.14 set forth below should be used.


Similarly, if a request under 37 CFR 1.48(a), (b), or
(c) is filed in a pending application but not acted upon
until after the application becomes a patent, the
request may be treated as a petition under 37 CFR 1.324, and if it is grantable, form paragraph 10.14 set
forth below should be used.


The statutory basis for correction of inventorship
in a patent under 37 CFR 1.324 is 35 U.S.C. 256. It is
important to recognize that 35 U.S.C. 256 is stricter
than 35 U.S.C. 116, the statutory basis for corrections
of inventorship in applications under 37 CFR 1.48.
35 U.S.C. 256 requires “on application of all the parties
and assignees,” while 35 U.S.C. 116 does not
have the same requirement. Under 35 U.S.C. 116 and
37 CFR 1.48, waiver requests under 37 CFR 1.183may be submitted (see, e.g., MPEP § 201.03, under
the heading “Statement of Lack of Deceptive Intention”).
This is not possible under 35 U.S.C. 256 and
37 CFR 1.324. In correction of inventorship in a nonprovisional
application under 37 CFR 1.48(a), the
requirement for a statement by each originally named
inventor may be waived pursuant to 37 CFR 1.183;
however, correction of inventorship in a patent under
37 CFR 1.324 requires petition of all the parties, i.e.,
originally named inventors and assignees, in accordance
with statute (35 U.S.C. 256) and thus the
requirement cannot be waived.


===1481.03 Correction of 35 U.S.C. 119 and 35 U.S.C. 120 Benefits===


I.CORRECTION TO PERFECT CLAIM
 
FOR 35 U.S.C. 119 (a)-(d) AND (f) BENEFITS
its the statement in § 251[3] that the provisions of Title 5
apply to reissues.
 
111 F.3d at 877, 42 USPQ2d at 1473. Accordingly,
prosecution of a continuation of a reissue application
will be permitted (despite the existence of the pending
parent reissue application) where the continuation
complies with the rules for reissue.
 
The parent and the continuation reissue applications
should be examined together if possible. In
order that the parent-continuation relationship of the
reissue applications be specifically identified and
notice be provided of both reissue applications for
both the parent and the continuation reissue applications,
the following is done:


(A) An appropriate amendment to the continuing
See MPEP § 201.16 for a discussion of when
data entries must be made to the first sentence of  
35 U.S.C. 119 (a)-(d) and (f) benefits can be perfected
the specification, (see the discussion above under the
by certificate of correction.
heading “Divisional Reissue Applications”).


(B)For an IFW reissue application file, a copy of
II.CORRECTION AS TO 35 U.S.C. 120 AND
the bibliographic data sheet from the IFW file history
35 U.S.C. 119(e) BENEFITS
should be printed and the examiner should annotate
the printed sheet such that adequate notice is provided
that more than one reissue application has been filed
for a single original patent. The annotated sheet
should be scanned into IFW. For reissue application
files that are maintained in paper, the bibliographic
data sheet should be reprinted (for 09/ and later
series), or the front face of the reissue file wrapper
should be marked (for 08/ and earlier series), for all
the multiple reissue applications, so that adequate
notice is provided that more than one reissue application
has been filed for a single original patent.


As is true for the case of multiple divisional reissue
A.For Applications Filed Prior to November 29, 2000
applications, all of the claims of the patent to be reissued
must be presented in both the parent reissue
application and the continuation reissue application in
some form, i.e., as amended, as unamended, or as canceled.
The same claim of the patent cannot, however
be presented for examination in both the parent reissue
application and the continuation reissue application,
as a pending claim, in either its original or
amended versions. See the discussion in subsection I.
above for treatment of this situation. Further, any
added claims must be numbered beginning with the
next highest number following the past patent
claims.


Where the parent reissue application issues prior to  
For applications filed prior to November 29, 2000,
the examination of the continuation, the claims of the
it is the version of 37 CFR 1.78, which was in effect
continuation should be carefully reviewed for double
as of November 29, 2000, that applies. The pre-
patenting over the claims of the parent. Where the
November 29, 2000 version reads as follows:
parent and the continuation reissue applications are
 
examined together, a provisional double patenting
37 CFR 1.78. Claiming benefit of earlier filing date andcross-references to other applications.  
rejection should be made in both cases as to any overlapping
 
claims. See MPEP § 804 - §
(a)(1) A nonprovisional application may claim an invention
disclosed in one or more prior filed copending nonprovisional
804.04 as to double
applications or copending international applications designating
patenting rejections. Any terminal disclaimer filed  
the United States of America. In order for a nonprovisional application
to obviate an obviousness-type double patenting
to claim the benefit of a prior filed copending nonprovisional
rejection ensures common ownership of the reissue
application or copending international application
patents throughout the remainder of the unexpired
designating the United States of America, each prior application
term of the original patent.
must name as an inventor at least one inventor named in the later
filed nonprovisional application and disclose the named inventor’s
invention claimed in at least one claim of the later filed nonprovisional
application in the manner provided by the first
paragraph of 35 U.S.C. 112. In addition, each prior application
must be:
 
(i)An international application entitled to a filing date in
accordance with PCT Article 11 and designating the United States
of America; or


If the parent reissue application issues without any
(ii)Complete as set forth in § 1.51(b); or
cross reference to the continuation, amendment of the
parent
reissue patent to include a cross-reference to
the continuation must be effected at the time of allowance
of the continuation application by Certificate of
Correction. See the discussion above under the heading
“Divisional Reissue Applications” as to how the
Certificate of Correction is to be provided.


Again, the examiner should make reference in the
(iii)Entitled to a filing date as set forth in § 1.53(b) or
pending divisional reissue application to the fact that
§ 1.53(d) and include the basic filing fee set forth in § 1.16; or
an actual request for a Certificate of Correction has
been generated in the first reissue patent pursuant to
37 CFR 1.177(a), e.g., by an entry in the search notes
or in an examiner’s amendment.


Where a continuation reissue application is filed
(iv)Entitled to a filing date as set forth in § 1.53(b) and
with a copy of the oath/declaration and assignee consent
have paid therein the processing and retention fee set forth in
from the parent reissue application, and the parent
§ 1.21(l) within the time period set forth in § 1.53(f).
reissue application is not to be abandoned, the  
 
copy of the consent of the parent reissue application  
(2)Except for a continued prosecution application filed
should not be accepted. The copy of the consent of the  
under §
parent reissue application does not indicate that the
assignee has consented to the addition of the new
1.53(d), any nonprovisional application claiming the benefit
error correction of the continuation reissue application  
of one or more prior filed copending nonprovisional applications
to the original patent. Presumably, a new correction
or international applications designating the United States of  
has been added, since the parent reissue
America must contain a reference to each such prior application,
application is still pending. OIPE should accord a filing
identifying it by application number (consisting of the series code
date and send out a notice of missing parts stating
and serial number) or international application number and international
that there is no proper consent and setting a period of
filing date and indicating the relationship of the applications.
time for filing the missing part and for payment of any
Unless the reference required by this paragraph is included
surcharge required under 37 CFR 1.53(f) and
in an application data sheet (§ 1.76), the specification must contain
1.16(f). See MPEP § 1410.01. The copy of the  
or be amended to contain such reference in the first sentence
reissue oath/declaration should be accepted by OIPE,
following any title. The request for a continued prosecution application
since it is a oath/declaration, albeit improper under
under § 1.53(d) is the specific reference required by  
35  
35  
U.S.C. 251. The examiner should reject the claims
U.S.C. 120 to the prior application. The identification of an
of the continuation reissue application under
application by application number under this section is the specific
reference required by 35 U.S.C. 120 to every application
assigned that application number. Cross-references to other
related applications may be made when appropriate (see
§ 1.14(a)).


(3)A nonprovisional application other than for a design
patent may claim an invention disclosed in one or more prior filed
copending provisional applications. In order for a nonprovisional
application to claim the benefit of one or more prior filed copending
provisional applications, each prior provisional application
must name as an inventor at least one inventor named in the later
filed nonprovisional application and disclose the named inventor's
invention claimed in at least one claim of the later filed nonprovisional
application in the manner provided by the first paragraph of
35 U.S.C. 112. In addition, each prior provisional application
must be entitled to a filing date as set forth in § 1.53(c), have any
required English-language translation filed therein within the time
period set forth in § 1.52(d), and have paid therein the basic filing
fee set forth in § 1.16(k) within the time period set forth in
§ 1.53(g).


(4)Any nonprovisional application claiming the benefit
of one or more prior filed copending provisional applications must
contain a reference to each such prior provisional application,
identifying it as a provisional application, and including the provisional
application number (consisting of series code and serial
number). Unless the reference required by this paragraph is
included in an application data sheet (§ 1.76), the specification
must contain or be amended to contain such reference in the first
sentence following any title.


Under certain conditions specified below, a Certificate
of Correction can be used, with respect to
35
U.S.C. 120 and 119(e) priority, to correct:


(A)the failure to make reference to a prior
copending application pursuant to 37 CFR 1.78(a)(2)
and (a)(4); or


35
(B)an incorrect reference to a prior copending
U.S.C. 251 as being based on an oath/declaration
application pursuant to 37 CFR 1.78(a)(2) and (a)(4).
that does not identify an error being corrected by the
continuation reissue application, and should require a
new oath/declaration. See 37 CFR 1.175(e). One of
form paragraphs 14.01.01 through 14.01.03 may be
used. See MPEP § 1414.


Where a continuation reissue application is filed
For all situations other than where priority is based
with a copy of the oath/declaration and assignee consent
upon 35 U.S.C. 365(c), the conditions are as follows:
from the parent reissue application, and the parent
reissue application is, or will be abandoned, the
copy of the consent should be accepted by both OIPE
and the examiner. The reissue oath/declaration should
be accepted by OIPE, and the examiner should check
to ensure that the oath/declaration identifies an error
that is being corrected in the continuation reissue
application. See MPEP § 1414. If a preliminary
amendment was filed with the continuation reissue
application, the examiner should check for the need of
a supplemental reissue oath/declaration. Pursuant to
37 CFR 1.175 (b)(1), for any error corrected via the  
preliminary amendment which is not covered by the
oath or declaration submitted in the parent reissue
application, applicant must submit a supplemental
oath/declaration stating that every such error arose
without any deceptive intention on the part of the
applicant. See MPEP § 1414 and § 1414.01.


1452Request for Continued Examination
(A)for 35 U.S.C. 120 priority, all requirements
of Reissue Application
set forth in 37 CFR 1.78(a)(1) must have been met in
the application which became the patent to be corrected;


A request for continued examination (RCE) under
(B)for 35 U.S.C. 119(e) priority, all requirements
37 CFR 1.114 is available for a reissue application.
set forth in 37 CFR 1.78(a)(3) must have been met in  
Effective May 29, 2000, an applicant in a reissue
the application which became the patent to be corrected;
application may file a request for continued examination
and
of the reissue application, if the reissue application  
was filed on or after June 8, 1995. This applies
even where the application, which resulted in the original
patent, was filed prior to June 8, 1995.


An RCE continues the prosecution of the existing
(C)it must be clear from the record of the patent
reissue application and is not a filing of a new reissue
and the parent application(s) that priority is appropriate.
application. Thus, the filing of an RCE will not be
See MPEP § 201.1l for requirements under
announced in the Official Gazette. Additionally, if a
35 U.S.C. 119(e) and 120.
reissue application is merged with a reexamination
proceeding (see MPEP § 1449.01), the filing of an
RCE will not dissolve the merger, since the reissue
application does not become abandoned.


1453Amendments to Reissue Applications
Where 35 U.S.C. 120 and 365(c) priority based on
[R-5]
an international application is to be asserted or corrected
 
in a patent via a Certificate of Correction, the
37 CFR 1.121. Manner of making amendments in
following conditions must be satisfied:
application.


(A)all requirements set forth in 37 CFR
1.78(a)(1) must have been met in the application
which became the patent to be corrected;


(B)it must be clear from the record of the patent
and the parent application(s) that priority is appropriate
(see MPEP § 201.11); and


(i)Amendments in reissue applications. Any amendment to  
(C)the patentee must submit with the request for
the description and claims in reissue applications must be made in
the certificate copies of documentation showing designation
accordance with § 1.173.
of states and any other information needed to
make it clear from the record that the 35 U.S.C. 120priority is appropriate. See MPEP § 201.13(b) as to  
the requirements for 35
U.S.C. 120 priority based on
an international application.


If all the above-stated conditions are satisfied, a
Certificate of Correction can be used to amend the
patent to make reference to a prior copending application,
or to correct an incorrect reference to the prior
copending application. Note In re Schuurs, 218 USPQ
443 (Comm’r Pat. 1983) which suggests that a Certificate
of Correction is an appropriate remedy for correcting,
in a patent, reference to a prior copending
application. Also, note In re Lambrech, 202 USPQ
620 (Comm’r Pat. 1976), citing In re Van Esdonk,
187
USPQ 671 (Comm’r Pat. 1975).


If any of the above-stated conditions is not satisfied,
the filing of a reissue application (see MPEP
§ 1401 - § 1460) would be appropriate to pursue the
desired correction of the patent.


37 CFR 1.173. Reissue specification, drawings, and
B.For Applications Filed on or After November
amendments.
29, 2000


For applications filed on or after November 29,
2000, the version of 37 CFR 1.78 reproduced below
applies (note that amendments to 37 CFR 1.78 took
effect on November 29, 2000, December 28, 2001,
May 1, 2003, January 21, 2004, September 21, 2004,
December 8, 2004,  July 1, 2005, and November
25, 2005).


37 CFR 1.78. Claiming benefit of earlier filing date and
cross-references to other applications.


(b)Making amendments in a reissue application. An amendment
(a)(1)A nonprovisional application or international application  
in a reissue application is made either by physically incorporating
designating the United States of America may claim an
the changes into the specification when the application is
invention disclosed in one or more prior-filed copending nonprovisional
filed, or by a separate amendment paper. If amendment is made by
applications or international applications designating the
incorporation, markings pursuant to paragraph (d) of this section
United States of America. In order for an application to claim the  
must be used. If amendment is made by an amendment paper, the
benefit of a prior-filed copending nonprovisional application or  
paper must direct that specified changes be made, as follows:
international application designating the United States of America,  
 
each prior-filed application must name as an inventor at least
(1)Specification other than the claims. Changes to the
one inventor named in the later-filed application and disclose the  
specification, other than to the claims, must be made by submission
named inventor’s invention claimed in at least one claim of the  
of the entire text of an added or rewritten paragraph, including
later-filed application in the manner provided by the first paragraph
markings pursuant to paragraph (d) of this section, except that
of 35 U.S.C. 112. In addition, each prior-filed application
an entire paragraph may be deleted by a statement deleting the
must be:
paragraph without presentation of the text of the paragraph. The
precise point in the specification must be identified where any
added or rewritten paragraph is located. This paragraph applies
whether the amendment is submitted on paper or compact disc
(see §§ 1.52(e)(1) and 1.821(c), but not for discs submitted under
§ 1.821(e)).
 
(2)Claims. An amendment paper must include the entire
text of each claim being changed by such amendment paper and of
each claim being added by such amendment paper. For any claim
changed by the amendment paper, a parenthetical expression
“amended,” “twice amended,” etc., should follow the claim number.
Each changed patent claim and each added claim must
include markings pursuant to paragraph (d) of this section, except
that a patent claim or added claim should be canceled by a statement
canceling the claim without presentation of the text of the  
claim.
 
(3)Drawings. One or more patent drawings shall be
amended in the following manner: Any changes to a patent drawing
must be submitted as a replacement sheet of drawings which
shall be an attachment to the amendment document. Any replacement
sheet of drawings must be in compliance with § 1.84 and
shall include all of the figures appearing on the original version of
the sheet, even if only one figure is amended. Amended figures
must be identified as “Amended,” and any added figure must be
identified as “New.In the event that a figure is canceled, the figure
must be surrounded by brackets and identified as “Canceled.”
All changes to the drawing(s) shall be explained, in detail, begin


(i) An international application entitled to a filing date
in accordance with PCT Article 11 and designating the United
States of America; or


(ii) Entitled to a filing date as set forth in § 1.53(b) or §
1.53(d) and have paid therein the basic filing fee set forth in § 1.16within the pendency of the application.


(2)(i)Except for a continued prosecution application
filed under § 1.53(d), any nonprovisional application or international
application designating the United States of America claiming
the benefit of one or more prior-filed copending
nonprovisional applications or international applications designating
the United States of America must contain or be amended to
contain a reference to each such prior-filed application, identifying
it by application number (consisting of the series code and
serial number) or international application number and international
filing date and indicating the relationship of the applications.
Cross references to other related applications may be made
when appropriate (see § 1.14).


(ii)This reference must be submitted during the pendency
of the later-filed application. If the later-filed application is
an application filed under 35
U.S.C. 111(a), this reference must
also be submitted within the later of four months from the actual
filing date of the later-filed application or sixteen months from the
filing date of the prior-filed application. If the later-filed application
is a nonprovisional application which entered the national
stage from an international application after compliance with
35
U.S.C. 371, this reference must also be submitted within the
later of four months from the date on which the national stage
commenced under 35 U.S.C. 371 (b) or (f) in the later-filed international
application or sixteen months from the filing date of the
prior-filed application. These time periods are not extendable.
Except as provided in paragraph (a)(3) of this section, the failure
to timely submit the reference required by 35 U.S.C. 120 and
paragraph (a)(2)(i) of this section is considered a waiver of any
benefit under 35
U.S.C. 120, 121, or 365(c) to such prior-filed
application. The time periods in this paragraph do not apply if the
later-filed application is:


(A)An application for a design patent;


ning on a separate sheet accompanying the papers including the
(B)An application filed under 35 U.S.C. 111 (a)
amendment to the drawings.
before November 29, 2000; or


(i)A marked-up copy of any amended drawing figure,
(C)A nonprovisional application which entered the  
including annotations indicating the changes made, may be
national stage after compliance with 35 U.S.C. 371 from an international
included. The marked-up copy must be clearly labeled as “Annotated
application filed under 35 U.S.C. 363 before November
Marked-up Drawings” and must be presented in the amendment
29, 2000.
or remarks section that explains the change to the drawings.  


(ii)A marked-up copy of any amended drawing figure,  
(iii)If the later-filed application is a nonprovisional
including annotations indicating the changes made, must be  
application, the reference required by this paragraph must be
provided when required by the examiner.
included in an application data sheet (§ 1.76), or the specification
must contain or be amended to contain such reference in the first
sentence(s) following the title.


(c)Status of claims and support for claim changes. Whenever
(iv)The request for a continued prosecution application
there is an amendment to the claims pursuant to paragraph
under § 1.53(d) is the specific reference required by
(b) of this section, there must also be supplied, on pages separate
35 U.S.C. 120 to the prior-filed application. The identification of  
from the pages containing the changes, the status (i.e., pending or
an application by application number under this section is the  
canceled), as of the date of the amendment, of all patent claims
identification of every application assigned that application number
and of all added claims, and an explanation of the support in the  
necessary for a specific reference required by 35 U.S.C. 120 to  
disclosure of the patent for the changes made to the claims.
every such application assigned that application number.


(d)Changes shown by markings. Any changes relative to the  
(3)If the reference required by 35 U.S.C. 120 and paragraph
patent being reissued which are made to the specification, including
(a)(2) of this section is presented after the time period provided
the claims, upon filing, or by an amendment paper in the reissue
by paragraph (a)(2)(ii) of this section, the claim under
application, must include the following markings:
35 U.S.C. 120, 121, or 365(c) for the benefit of a prior-filed
copending nonprovisional application or international application
designating the United States of America may be accepted if the
reference identifying the prior-filed application by application
number or international application number and international filing
date was unintentionally delayed. A petition to accept an unintentionally
delayed claim under 35 U.S.C. 120, 121, or 365(c) for
the benefit of a prior-filed application must be accompanied by:


(1)The matter to be omitted by reissue must be enclosed
(i)The reference required by 35 U.S.C. 120 and paragraph
in brackets; and
(a)(2) of this section to the prior-filed application, unless
previously submitted;


(2)The matter to be added by reissue must be underlined,
(ii)The surcharge set forth in § 1.17(t); and
except for amendments submitted on compact discs (§§ 1.96 and
1.821(c)). Matter added by reissue on compact discs must be preceded
with “U” and end with “/U” to properly identify the
material being added.


(e)Numbering of patent claims preserved. Patent claims
(iii)A statement that the entire delay between the date
may not be renumbered. The numbering of any claim added in the
the claim was due under paragraph (a)(2)(ii) of this section and
reissue application must follow the number of the highest numbered
the date the claim was filed was unintentional. The Director may
patent claim.
require additional information where there is a question whether
the delay was unintentional.


(f)Amendment of disclosure may be required. The disclosure
(4)A nonprovisional application, other than for a design
must be amended, when required by the Office, to correct
patent, or an international application designating the United
inaccuracies of description and definition, and to secure substantial
States of America may claim an invention disclosed in one or
correspondence between the claims, the remainder of the specification,  
more prior-filed provisional applications. In order for an application
and the drawings.
to claim the benefit of one or more prior-filed provisional
applications, each prior-filed provisional application must name
as an inventor at least one inventor named in the later-filed application
and disclose the named inventor’s invention claimed in at
least one claim of the later-filed application in the manner provided
by the first paragraph of 35
U.S.C. 112. In addition, each
prior-filed provisional application must be entitled to a filing date
as set forth in § 1.53(c), and the basic filing fee set forth in
§ 1.16(d) must be paid within the time period set forth in
§ 1.53(g).


(g)Amendments made relative to the patent. All amendments
(5)(i) Any nonprovisional application or international
must be made relative to the patent specification, including
application designating the United States of America claiming the  
the claims, and drawings, which are in effect as of the date of filing
benefit of one or more prior-filed provisional applications must  
of the reissue application.
contain or be amended to contain a reference to each such prior-
filed provisional application, identifying it by the provisional
application number (consisting of series code and serial number).  


The provisions of 37 CFR 1.173(b)-(g) and those of  
(ii)This reference must be submitted during the pendency
37 CFR 1.121(i) apply to amendments in reissue
of the later-filed application. If the later-filed application is
applications. Any amendments submitted in a reissue
an application filed under 35
application must comply with 37 CFR 1.173(b).
U.S.C. 111(a), this reference must
also be submitted within the later of four months from the actual
filing date of the later-filed application or sixteen months from the
filing date of the prior-filed provisional application. If the later-
filed application is a nonprovisional application which entered the
national stage from an international application after compliance
with 35 U.S.C. 371, this reference must also be submitted within
the later of four months from the date on which the national stage
commenced under 35
U.S.C. 371(b) or (f) in the later-filed international
application or sixteen months from the filing date of the
prior-filed provisional application. These time periods are not
extendable. Except as provided in paragraph(a)(6) of this section,
the failure to timely submit the reference is considered a waiver of
any benefit under 35 U.S.C. 119(e) to such prior-filed provisional
application. The time periods in this paragraph do not apply if the
later-filed application is:


Amendments submitted in a reissue application,
(A)An application filed under 35 U.S.C. 111(a)  
including preliminary amendments (i.e., amendments
before November 29, 2000; or
filed as a separate paper to accompany the filing of a
reissue application), must comply with the practice
outlined below in this section; however, for examiner’s
amendments to the specification and claims,
37
CFR 1.121(g) provides certain exceptions to that
practice in the interest of expediting prosecution. The
exceptions set forth in 37 CFR 1.121(g) also apply in
reissue applications.


Pursuant to 37 CFR 1.173(a), no amendment in a
(B)A nonprovisional application which entered the  
reissue application may enlarge the scope of the  
national stage after compliance with 35 U.S.C. 371 from an international
claims, unless “applied for within two years from the
application filed under 35 U.S.C. 363 before November
grant of the original patent.” Further, the amendment
29, 2000.
may not introduce new matter. See MPEP § 1412.03for further discussion as to the time limitation on
enlarging the scope of the patent claims in a reissue
application.  


All amendment changes must be made relative to
(iii)If the later-filed application is a nonprovisional
the patent to be reissued. Pursuant to 37 CFR
application, the reference required by this paragraph must be  
1.173(d), any such changes which are made to the  
included in an application data sheet (§ 1.76), or the specification
specification, including the claims, must be shown by
must contain or be amended to contain such reference in the first
employing the following “markings:”
sentence(s) following the title.


(A)The matter to be omitted by reissue must be
(iv)If the prior-filed provisional application was filed
enclosed in brackets; and
in a language other than English and both an English-language
 
translation of the prior-filed provisional application and a statement
(B)The matter to be added by reissue must be
that the translation is accurate were not previously filed in
underlined, except for amendments submitted on
the prior-filed provisional application, applicant will be notified
compact discs (pursuant to 37 CFR 1.96 for computer
and given a period of time within which to file, in the prior-filed
printouts or programs, and 37 CFR 1.825 for
provisional application, the translation and the statement. If the
sequence listings). Matter added by reissue on compact
notice is mailed in a pending nonprovisional application, a timely
discs must be preceded with “U” and end with
reply to such a notice must include the filing in the nonprovisional
“/U” to properly identify the material being added.
application of either a confirmation that the translation and statement
were filed in the provisional application, or an amendment
or Supplemental Application Data Sheet withdrawing the benefit
claim, or the nonprovisional application will be abandoned. The
translation and statement may be filed in the provisional application,
even if the provisional application has become abandoned.


I.THE SPECIFICATION
(6)If the reference required by 35 U.S.C. 119(e) and
paragraph (a)(5) of this section is presented in a nonprovisional
application after the time period provided by paragraph (a)(5)(ii)
of this section, the claim under 35
U.S.C. 119(e) for the benefit of
a prior filed provisional application may be accepted during the
pendency of the later-filed application if the reference identifying
the prior-filed application by provisional application number was
unintentionally delayed. A petition to accept an unintentionally
delayed claim under 35
U.S.C. 119(e) for the benefit of a prior
filed provisional application must be accompanied by:


37 CFR 1.173(b)(1) relates to the manner of making
(i)The reference required by 35 U.S.C. 119(e) and
amendments to the specification other than the
paragraph (a)(5) of this section to the prior-filed provisional application,
claims. It is not to be used for making amendments to
unless previously submitted;
the claims or the drawings.


All amendments which include any deletions or
(ii)The surcharge set forth in § 1.17(t); and
additions must be made by submission of the entire
text of each added or rewritten paragraph with markings
(as defined above), except that an entire paragraph
of specification text may be deleted by a
statement deleting the paragraph without presentation
of the text of the paragraph. Applicant must indicate
the precise point where each amendment is made. All
bracketing and underlining is made in comparison to
the original patent, not in comparison to any prior
amendment in the reissue application. Thus, all paragraphs
which are newly added to the specification of
the original patent must be submitted as completely
underlined each time they are re-submitted in the reissue
application.


(iii)A statement that the entire delay between the date
the claim was due under paragraph (a)(5)(ii) of this section and
the date the claim was filed was unintentional. The Director may
require additional information where there is a question whether
the delay was unintentional.


(b)Where two or more applications filed by the same applicant
contain conflicting claims, elimination of such claims from
all but one application may be required in the absence of good and
sufficient reason for their retention during pendency in more than
one application.


(c)If an application or a patent under reexamination and at
least one other application naming different inventors are owned
by the same person and contain conflicting claims, and there is no
statement of record indicating that the claimed inventions were
commonly owned or subject to an obligation of assignment to the
same person at the time the later invention was made, the Office
may require the assignee to state whether the claimed inventions
were commonly owned or subject to an obligation of assignment
to the same person at the time the later invention was made, and if
not, indicate which named inventor is the prior inventor. Even if
the claimed inventions were commonly owned, or subject to an
obligation of assignment to the same person, at the time the later
invention was made, the conflicting claims may be rejected under
the doctrine of double patenting in view of such commonly owned
or assigned applications or patents under reexamination.


Under no circumstances can a Certificate of Correction
 
be employed to correct an applicant’s mistake
II.THE CLAIMS
by adding or correcting a priority claim under
35
U.S.C. 119(e) for an application filed on or after
November 29, 2000.  


37 CFR 1.173(b)(2) relates to the manner of making
Section 4503 of the American Inventors Protection
amendments to the claims in reissue applications.
Act of 1999 (AIPA) amended 35 U.S.C. 119(e)(1) to
It is not to be used for making amendments to the  
state that:
remainder of the specification or to the drawings. 37
CFR 1.173(b)(2) requires that:


(A)For each claim that is being amended by the  
No application shall be entitled to the benefit of an earlier
amendment being submitted (the current amendment),  
filed provisional application under this subsection
the entire text of the claim must be presented with
unless an amendment containing the specific reference to
markings as defined above;
the earlier filed provisional application is submitted at such
time during the pendency of the application as required by  
the Director. The Director may consider the failure to submit
such an amendment within that time period as a waiver
of any benefit under this subsection. The Director may
establish procedures, including the payment of a surcharge,  
to accept an unintentionally delayed submission of an
amendment under this section during the pendency of the  
application. (emphasis added)


(B)For each new claim added to the reissue by
A Certificate of Correction is NOT a
the amendment being submitted (the current amendment),
valid mechanism for adding or correcting a priority
the entire text of the added claim must be presented
claim under 35
completely underlined;
U.S.C. 119(e) after a patent has been
granted on an application filed on or after November
29, 2000.


(C)A patent claim should be canceled by a direction
Under certain conditions as specified below, however,
to cancel that claim, there is no need to present
a Certificate of Correction can still be used, with
the patent claim surrounded by brackets; and
respect to 35 U.S.C. 120 priority, to correct:


(D)A new claim (previously added in the reissue)
(A)the failure to make reference to a prior
should be canceled by a direction to cancel that claim.
copending application pursuant to 37 CFR 1.78(a)(2);
or


Original patent claims are never to be renumbered;
(B)an incorrect reference to a prior copending
see 37 CFR 1.173(e). A patent claim retains its number
application pursuant to 37 CFR 1.78(a)(2).
even if it is canceled in the reissue proceeding,
and the numbering of any added claims must begin
after the last original patent claim.  


Pursuant to 37 CFR 1.173(c), each amendment submitted
Where priority is based upon 35 U.S.C. 120 to a  
must set forth the status of all patent claims
national application, the following conditions must
and all added claims as of the date of the submission.  
be satisfied:
The status to be set forth is whether the claim is pending
or canceled. The failure to submit the claim status
will generally result in a notification to applicant that
the amendment prior to final rejection is not completely
responsive (see 37 CFR 1.135(c)). Such an
amendment after final rejection will not be entered.


Also pursuant to 37 CFR 1.173(c), each claim
(A)all requirements set forth in 37 CFR  
amendment must be accompanied by an explanation
1.78(a)(1) must have been met in the application
of the support in the disclosure of the patent for the
which became the patent to be corrected;
amendment (i.e., support for all changes made in the
claim(s), whether insertions or deletions). The failure
to submit an explanation will generally result in a
notification to applicant that the amendment prior to  
final rejection is not completely responsive (see
37
CFR 1.135(c)). Such an amendment after final
rejection will not be entered.


III.THE DRAWINGS
(B) it must be clear from the record of the patent
and the parent application(s) that priority is appropriate
(see MPEP § 201.11); and


37 CFR 1.173(a)(2) states that amendments to the
(C)a grantable petition to accept an unintentionally
original patent drawings are not permitted, and that
delayed claim for the benefit of a prior application
any change to the drawings must be by way of
must be filed, including a surcharge as set forth in
37  
37 CFR 1.17(t), as required by 37 CFR 1.78(a)(3).
CFR 1.173(b)(3). See MPEP § 1413 for the manner
of making amendments to the drawings in a reissue
application.


Form paragraph 14.20.01 may be used to advise
Where 35 U.S.C. 120 and 365(c) priority based on
applicant of the proper manner of making amendments
an international application is to be asserted or corrected
in a reissue application.
in a patent via a Certificate of Correction, the  
following conditions must be satisfied:


(A)all requirements set forth in 37 CFR
1.78(a)(1) must have been met in the application
which became the patent to be corrected;


(B)it must be clear from the record of the patent
and the parent application(s) that priority is appropriate
(see MPEP § 201.11);


¶ 14.20.01 Amendments To Reissue-37 CFR 1.173(b)
(C)the patentee must submit together with the
request for the certificate, copies of documentation
showing designation of states and any other information
needed to make it clear from the record that the
35 U.S.C. 120 priority is appropriate (see MPEP
§ 201.13(b) as to the requirements for 35 U.S.C. 120priority based on an international application; and


Applicant is notified that any subsequent amendment to the  
(D)a grantable petition to accept an unintentionally
specification and/or claims must comply with 37 CFR 1.173(b).
delayed claim for the benefit of a prior application
In addition, when any substantive amendment is filed in the reissue
must be filed, including a surcharge as set forth in
application, which amendment otherwise places the reissue
37 CFR 1.17(t), as required by 37 CFR 1.78(a)(3).
application in condition for allowance, a supplemental oath/declaration
will be required. See MPEP § 1414.01.


Examiner Note:
If all the above-stated conditions are satisfied, a
Certificate of Correction can be used to amend the
patent to make reference to a prior copending application,
or to correct an incorrect reference to the prior
copending application, for benefit claims under
35 U.S.C. 120 and 365(c).


This form paragraph may be used in the first Office action to
If any of the above-stated conditions is not satisfied,
advise applicant of the proper manner of making amendments,
the filing of a reissue application (see MPEP
and to notify applicant of the need to file a supplemental oath/declaration
§ 1401 - § 1460) may be appropriate to pursue the
before the application can be allowed.
desired correction of the patent for benefit claims
under 35 U.S.C. 120 and 365(c).  


==1485 Handling of Request for Certificates of Correction==


A request for a Certificate of Correction should be
addressed to:


Form paragraph 14.21.01 may be used to notify
Commissioner for Patents
applicant that proposed amendments filed prior to
final rejection in the reissue application do not comply
with 37 CFR 1.173(b).


¶ 14.21.01 Improper Amendment To Reissue - 37 CFR
Office of Patent Publication
1.173(b)


The amendment filed [1] proposes amendments to [2] that do
ATTN: Certificate of Correction Branch
not comply with 37 CFR 1.173(b), which sets forth the manner of  
making amendments in reissue applications. A supplemental
paper correctly amending the reissue application is required.


A shortened statutory period for reply to this letter is set to
P.O. Box 1450
expire ONE MONTH or THIRTY DAYS, whichever is longer,
from the mailing date of this letter.


Examiner Note:
Alexandria, VA 22313-1450


1.This form paragraph may be used for any 37 CFR 1.173(b)
Requests for Certificates of Correction will be forwarded
informality as to an amendment submitted in a reissue application
to the Certificate of Correction Branch of the
prior to final rejection. After final rejection, applicant should be
Office of Patent Publication, where they will be listed
informed that the amendment will not be entered by way of an
in a permanent record book.
Advisory Office action.


2.In bracket 2, specify the proposed amendments that are not in  
If the patent is involved in an interference, a Certificate
compliance.
of Correction under 37 CFR 1.324 will not be
 
issued unless a corresponding motion under 37 CFR
Note that if an informal amendment is submitted
41.121(a)(2) or 41.121(a)(3) has been granted by the
after final rejection, form paragraph 14.21.01 should
administrative patent judge. Otherwise, determination
not be used. Rather, an advisory Office action should
as to whether an error has been made, the responsibility
be issued using Form PTO-303 indicating that the  
for the error, if any, and whether the error is of
amendment was not entered because it does not comply
such a nature as to justify the issuance of a Certificate
with 37 CFR 1.173(b), which sets forth the manner
of Correction will be made by the Certificate of Correction
of making amendments in reissue applications.
Branch. If a report is necessary in making such
determination, the case will be forwarded to the
appropriate group with a request that the report be furnished.  
If no certificate is to issue, the party making
the request is so notified and the request, report, if  
any, and copy of the communication to the person
making the request are placed in the file wrapper (for
a paper file) or entered into the file history (for an  
IFW file), and entered into the “Contents” for the file
by the Certificate of Correction Branch. The case is
then returned to the patented files. If a certificate is to
issue, it will be prepared and forwarded to the person
making the request by the Office of Patent Publication.  
In that case, the request, the report, if any, and a
copy of the letter transmitting the Certificate of Correction
to the person making the request will be  
placed in the file wrapper (for a paper file) or entered  
into the file history (for an IFW file), and entered into
the “Contents” for the file.


Applicants, or their attorneys or agents, are urged to
submit the text of the correction on a special Certificate
of Correction form, PTO/SB/44 (also referred to
as Form PTO-1050), which can serve as the camera
copy for use in direct offset printing of the Certificate
of Correction.


Where only a part of a request can be approved, or
where the Office discovers and includes additional
corrections, the appropriate alterations are made on
the form PTO/SB/44 by the Office. The patentee is
notified of the changes on the Notification of
Approval-in-part form PTOL-404. The certificate is
issued approximately 6 weeks thereafter.


Form PTO/SB/44 should be used exclusively
regardless of the length or complexity of the subject
matter. Intricate chemical formulas or page of specification
or drawings may be reproduced and mounted
on a blank copy of PTO/SB/44. Failure to use the
form has frequently delayed issuance since the
text
must be retyped by the Office onto a PTO/SB/44.


The exact page and line number where the errors
occur in the application file should be identified on
the request. However, on form PTO/SB/44, only the
column and line number in the printed patent should
be used.


IV.ALL CHANGES ARE MADE VIS-À-VISTHE PATENT TO BE REISSUED
The patent grant should be retained by the patentee.
The Office does not attach the Certificate of Correction
to patentee’s copy of the patent. The patent grant
will be returned to the patentee if submitted.


When a reissue patent is printed, all underlined
Below is a sample form illustrating a variety of corrections
matter is printed in italics and all brackets are printed
and the suggested manner of setting out the  
as inserted in the application, in order to show exactly
format. Particular attention is directed to:
which additions and deletions have been made to
the
patent being reissued. Therefore, all underlining
and bracketing in the reissue application should be
made relative to the text of the patent, as follows. In
accordance with 37 CFR 1.173(g), all amendments in
the reissue application must be made relative to (i.e.,
vis-à-vis) the patent specification in effect as of the
date of the filing of the reissue application. The patent
specification includes the claims and drawings. If
there was a prior change to the patent (made via a  
prior concluded reexamination certificate, reissue of  
the patent, certificate of correction, etc.), the first
amendment of the subject reissue application must be
made relative to the patent specification as changed
by the prior proceeding or other mechanism for
changing the patent. All amendments subsequent to
the first amendment must also be made relative to the
patent specification in effect as of the date of the filing
of the reissue application, and not relative to the prior
amendment.


The Subject Patent Already Has Underlining or  
(A)Identification of the exact point of error by
Bracketing
reference to column and line number of the printed
patent for changes in the specification or to claim
number and line where a claim is involved.


If the original (or previously changed) patent
(B)Conservation of space on the form by typing
includes a formula or equation already having underlining
single space, beginning two lines down from the  
or bracketing therein as part of the formula or
printed message.
equation, any amendment of such formula or equation
should be made by bracketing the entire formula and
rewriting and totally underlining the amended formula
in the re-presented paragraph of the specification or
rewritten claim in which the changed formula or
equation appears. Amendments of segments of a formula
or equation should not be made. If the original
patent includes bracketing and underlining from an
earlier reexamination or reissue, double brackets and
double underlining should be used in the subject reissue
application to identify and distinguish the present
changes being made. The subject reissue, when
printed, would include double brackets (indicating
deletions made in the subject reissue) and boldface
type (indicating material added in the subject reissue).


V.EXAMPLES OF PROPER AMEND-
(C)Starting the correction to each separate column
MENTS
as a sentence, and using semicolons to separate
corrections within the same column, where possible.


A substantial number of problems arise in the  
(D)Leaving a two-inch space blank at bottom of  
Office because of improper submission of amendments
the last sheet for the signature of the attesting officer.
in reissue applications. The following examples
are provided to assist in preparation of proper amendments
to reissue applications.


A.Original Patent Description or Patent Claim
(E)Using quotation marks to enclose the exact
Amended
subject matter to be deleted or corrected; using double
hyphens (-- --) to enclose subject matter to be added,
except for formulas.


Example (1)
(F)Where a formula is involved, setting out
only
that portion thereof which is to be corrected or,
if
necessary, pasting a photocopy onto form PTO/SB/
44.


If it is desired to change the specification at column
ELECTRONIC PUBLICATION OF CERTIFICATES
4 line 23, to replace “is” with --are--, submit a
OF CORRECTION WITH LATER LISTING
copy of the entire paragraph of specification of the
IN THE OFFICIAL GAZETTE
patent being amended with underlining and bracketing,
and point out where the paragraph is located,
e.g.,


Replace the paragraph beginning at column 4, line 23
Effective August 2001, the U.S. Patent and Trademark
with the following:
Office (USPTO) publishes on the USPTO web
site at http://www.uspto.gov/web/patents/certofcorrect
a listing by patent number of the patents for
which certificates of correction are being issued.


Scanning [is] are controlled by clocks which are, in turn,
The USPTO is now automating the publication
controlled from the display tube line synchronization. The
process for certificates of correction. This new process
signals resulting from scanning the scope of the character
will result in certificates of correction being published
are delivered in parallel, then converted into serial mode
quicker electronically on the USPTO’s web site
through a shift register wherein the shift signal frequency is
as compared to their paper publication and the listing
controlled by a clock that is, in turn, controlled from the display
of the certificates of correction in the Official Gazette.  
tube line synchronization.
Under the newly automated process, each issue of certificates
of correction will be electronically published
on the USPTO web site at http://www.uspto.gov/web/
patents/certofcorrect, and will also subsequently be
listed in the Official Gazette (and in the Official
Gazette Notices posted at http://www.uspto.gov/web/
offices/com/sol/og) approximately three weeks thereafter.
The listing of certificates of correction in the  
Official Gazette will include the certificate’s date of
issuance.  


Example (2)
On the date on which the listing of certificates of
correction is electronically published on the USPTO
web site: (A) the certificate of correction will be
entered into the file wrapper of a paper-file patent, or
entered into the file history of an IFW-file patent and
will be available to the public; (B) a printed copy of
the certificate of correction will be mailed to the patentee
or the patent’s assignee; and (C) an image of the
printed certificate of correction will be added to the
image of the patent on the patent database at http://
www.uspto.gov.patft. Dissemination of all other paper
copies of the certificate of correction will occur
shortly thereafter.


For changes to the claims, one must submit a copy
The date on which the USPTO makes the certificate
of the entire patent claim with the amendments
of correction available to the public (e.g., by adding
shown by underlining and bracketing, e.g.,
the certificate of correction to the file wrapper/file
history) will be regarded as the date of issuance of the  
certificate of correction, not the date of the certificate
of correction appearing in the Official Gazette. (For
IFW processing, see IFW Manual.) Certificates of
correction published in the above-described manner
will provide the public with prompt notice and access,  
and this is consistent with the legislative intent behind
the American Inventors Protection Act of 1999. See


Amend claim 6 as follows:
35 U.S.C. 10(a) (authorizing the USPTO to publish in electronic form).


Claim 6 (Amended). The apparatus of claim [5] 1 wherein
The listing of certificates of correction can be electronically
the [first] second piezoelectric element is parallel to the  
accessed on the day of issuance at http://
[second] third piezoelectric element.
www.uspto.gov/web/patents/certofcorrect. The electronic
image of the printed certificate of correction
can be accessed on the patent database at http://
www.uspto.gov/patft and the listing of the certificates
of correction, as published in the Official Gazettethree weeks later, will be electronically accessible at
http://www.uspto.gov/web/offices/com/sol/og.


If the dependency of any original patent claim is to
==1490 Disclaimers==
be changed by amendment, it is proper to make
that original patent claim dependent upon a later
filed higher numbered claim.


B.Cancellation of Claim(s)
35 U.S.C. 253. Disclaimer.


Example (3)
Whenever, without any deceptive intention, a claim of a patent
 
is invalid the remaining claims shall not thereby be rendered
To cancel an original patent claim, in writing,  
invalid. A patentee, whether of the whole or any sectional interest
direct cancellation of the patent claim, e.g.,
therein, may, on payment of the fee required by law, make disclaimer
 
of any complete claim, stating therein the extent of his
Cancel claim 6.
interest in such patent. Such disclaimer shall be in writing, and
recorded in the Patent and Trademark Office; and it shall thereafter
be considered as part of the original patent to the extent of the
interest possessed by the disclaimant and by those claiming under
him.


In like manner any patentee or applicant may disclaim or dedicate
to the public the entire term, or any terminal part of the term,
of the patent granted or to be granted.


37 CFR 1.321. Statutory disclaimers, including terminal
disclaimers.


(a)A patentee owning the whole or any sectional interest in
a patent may disclaim any complete claim or claims in a patent. In
like manner any patentee may disclaim or dedicate to the public
the entire term, or any terminal part of the term, of the patent
granted. Such disclaimer is binding upon the grantee and its successors
or assigns. A notice of the disclaimer is published in the
Official Gazette and attached to the printed copies of the specification.
The disclaimer, to be recorded in the Patent and Trademark
Office, must:


(1)be signed by the patentee, or an attorney or agent of
record;


Example (4)
(2)identify the patent and complete claim or claims, or
term being disclaimed. A disclaimer which is not a disclaimer of a
complete claim or claims, or term, will be refused recordation;


To cancel a new claim (previously added in the  
(3)state the present extent of patentee’s ownership interest
reissue), in writing, direct cancellation of the new
in the patent; and
claim, e.g.,


Cancel claim 15.
(4)be accompanied by the fee set forth in § 1.20(d).


C.Presentation of New Claims
(b)An applicant or assignee may disclaim or dedicate to the
public the entire term, or any terminal part of the term, of a patent
to be granted. Such terminal disclaimer is binding upon the
grantee and its successors or assigns. The terminal disclaimer, to
be recorded in the Patent and Trademark Office, must:


Example (5)  
(1)be signed:


Each new claim (i.e., a claim not found in the
(i)by the applicant, or
patent, that is newly presented in the reissue application)  
should be presented with underlining
throughout the claim, e.g.,


Add claim 7 as follows:
(ii)if there is an assignee of record of an undivided
part interest, by the applicant and such assignee, or


Claim 7. The apparatus of claim 5 further comprising
(iii)if there is an assignee of record of the entire interest,
electrodes attaching to said opposite faces of the first and
by such assignee, or
second piezoelectric elements.


Even though original claims may have been canceled,
(iv)by an attorney or agent of record;
the numbering of the original claims does
not change. Accordingly, any added claims are
numbered beginning with the number next higher
than the number of claims in the original patent. If
new claims have been added to the reissue application
which are later canceled prior to issuance of
the reissue patent, the examiner will renumber any
remaining new claims in numerical order to follow
the number of claims in the original patent.


D.Amendment of New Claims
(2)specify the portion of the term of the patent being disclaimed;


An amendment of a “new claim” (i.e., a claim not
found in the patent, that was previously presented
in
the reissue application) must be done by presenting
the amended “new claim” containing the amendatory
material, and completely underlining the claim. The
presentation cannot contain any bracketing or other
indication of what was in the previous version of
the
claim. This is because all changes in the
reissue
are
made vis-à-vis the original patent, and not
in comparison to the prior amendment. Although the
presentation of the amended claim does not contain
any indication of
what is changed from the previous
version of the claim,
applicant must point out what is
changed in the “Remarks” portion of the amendment.
Also, per 37 CFR 1.173(c), each change made in the
claim must be accompanied by an explanation of the
support in the disclosure of the patent for the change.


E.Amendment of Original Patent Claims More
(3)state the present extent of applicant’s or assignee’s
Than Once
ownership interest in the patent to be granted; and


The following illustrates proper claim amendment
(4)be accompanied by the fee set forth in § 1.20(d).
of original patent claims in reissue applications:


A. Patent claim.
(c)A terminal disclaimer, when filed to obviate judicially
created double patenting in a patent application or in a reexamination
proceeding except as provided for in paragraph (d) of this
section, must:


Claim 1. A cutting means having a handle portion
(1)Comply with the provisions of paragraphs (b)(2)
and a blade portion.
through (b)(4) of this section;


B. Proper first amendment format.
(2)Be signed in accordance with paragraph (b)(1) of this
section if filed in a patent application or in accordance with paragraph
(a)(1) of this section if filed in a reexamination proceeding;
and


Claim 1 (Amended). A [cutting means] knife having
(3)Include a provision that any patent granted on that
a bone handle portion and a notched blade portion.
application or any patent subject to the reexamination proceeding
shall be enforceable only for and during such period that said
patent is commonly owned with the application or patent which
formed the basis for the judicially created double patenting.


(d)A terminal disclaimer, when filed in a patent application
or in a reexamination proceeding to obviate double patenting
based upon a patent or application that is not commonly owned
but was disqualified under 35 U.S.C. 103(c) as resulting from
activities undertaken within the scope of a joint research agreement,
must:


C. Proper second amendment format.
(1)Comply with the provisions of paragraphs (b)(2)
through (b)(4) of this section;


Claim 1 (Twice Amended). A [cutting means]
(2)Be signed in accordance with paragraph (b)(1) of this
knife having a handle portion and a serrated blade
section if filed in a patent application or be signed in accordance
portion.
with paragraph (a)(1) of this section if filed in a reexamination
proceeding;


Note that the second amendment must include the  
(3)Include a provision waiving the right to separately
changes previously presented in the first amendment,
enforce any patent granted on that application or any patent subject
i.e., [cutting means] knife, as well as the new changes
to the reexamination proceeding and the patent or any patent
presented in the second amendment, i.e., serrated.
granted on the application which formed the basis for the double
 
patenting, and that any patent granted on that application or any
The word bone was presented in the first amendment
patent subject to the reexamination proceeding shall be enforceable
and is now to be deleted in the second amendment.
only for and during such period that said patent and the  
The word “bone” is NOT to be shown in
patent, or any patent granted on the application, which formed the  
brackets in the second amendment. Rather, the word
basis for the double patenting are not separately enforced.
“bone” is simply omitted from the claim, since “bone”
never appeared in the patent. An explanation of the  
deletion should appear in the remarks.


The word notched which was presented in the first
A disclaimer is a statement filed by an owner (in
amendment is replaced by the word serrated in the  
part or in entirety) of a patent or of a patent to be
second amendment. The word notched is being
granted (i.e., an application), in which said owner
deleted in the second amendment and did not appear
relinquishes certain legal rights to the patent. There
in the patent; accordingly, “notched” is not shown in
are two types of disclaimers: a statutory disclaimer
any form in the claim. The word serrated is being
and a terminal disclaimer. The owner of a patent or an
added in the second amendment, and accordingly
application is the original inventor(s) or the assignee
“serrated” is added to the claim and is underlined.
of the original inventor(s). The patent or application is  
assigned by one assignment or by multiple assignments
which establish a chain of title from the inventor(
s) to the assignee(s). The owner of the patent or
application can sign a disclaimer, and a person
empowered by the owner to sign the disclaimer can
also sign it. Per 37 CFR 1.321(b)(1)(iv), an attorney
or agent of record is permitted to sign the disclaimer.
A registered practitioner acting in a representative
capacity under 37 CFR 1.34 is not permitted to sign
the disclaimer. For a disclaimer to be accepted, it must
be signed by the proper party as follows:


In the second amendment, the deletions of
(A)A disclaimer filed in an application must be
“notched” and “bone” are not changes from the original
signed by
patent claim text and therefore are not shown in
brackets in the second amendment. In both the first
and the second amendments, the entire claim is presented
only with the changes from the original patent
text.


VI.ADDITIONAL EXAMPLES
(1)the applicant where the application has not
been assigned,


(A)For a reissue application, where the patent
(2)the applicant and the assignee where each
was previously reissued:
owns a part interest in the application,  


As per MPEP § 1411, double underlining and
(3)the assignee where assignee owns the
double bracketing are used in the second reissue
entire interest in the application, or


(4)an attorney or agent of record.


(B)A disclaimer filed in a patent or a reexamination
proceeding must be signed by either


(1)the patentee (the assignee, the inventor(s) if
the patent is not assigned, or the assignee and the
inventors if the patent is assigned-in-part), or


(2)an attorney or agent of record.


application to show amendments made relative to the  
(C)Where the assignee (of an application or of a
first reissued patent
patent being reexamined or to be reissued) signs the
disclaimer, there is a requirement to comply with
37
CFR 3.73(b) in order to satisfy 37 CFR 1.321,
unless an attorney or agent of record signs the disclaimer.
In order to comply with 37 CFR 3.73(b), the
assignee’s ownership interest must be established by:


(B)For a reissue application, where the patent
(1)filing in the application or patent evidence
was previously reexamined and a reexamination certificate
of a chain of title from the original owner to the  
has issued for the patent:
assignee and a statement affirming that the documentary
evidence of the chain of title from the original
owner to the assignee was, or concurrently is
being, submitted for recordation pursuant to 37 CFR
3.11, or


An amendment in the reissue application must be
(2)specifying in the record of the application
presented as if the changes made to the original patent
or patent where such evidence is recorded in the  
text via the reexamination certificate are a part of the  
Office (e.g., reel and frame number, etc.).  
original patent. Thus, all italicized text of the reexamination
certificate is presented in the amendment
(made in the reissue application) without italics. Further,  
any text found in brackets in the reexamination
certificate is omitted in the amendment (made in the
reissue application).


(C)For a reissue application, where a certificate
The submission with respect to 37 CFR 3.73(b)
of correction has issued for the patent:
to establish ownership must be signed by a party
authorized to act on behalf of the assignee. See also
MPEP § 324 as to compliance with 37 CFR 3.73(b).
A copy of the “Statement Under 37 CFR 3.73 (b),
which is reproduced in MPEP § 324, may be sent by
the examiner to applicant to provide an acceptable
way to comply with the requirements of 37 CFR 3.73(b).


An amendment in the reissue application must be
(D)Where the attorney or agent of record signs
presented as if the changes made to the original patent
the disclaimer, there is no need to comply with
text via the certificate of correction are a part of the
37
original patent. Thus, all text added by certificate of
CFR 3.73(b).
correction is presented in the amendment (made in the
reissue application) without italics. Further, any text
deleted by certificate of correction is entirely omitted
in the amendment (made in the reissue application).


(D)For a reissue application, where a statutory
(E)The signature on the disclaimer need not be
disclaimer has issued for the patent:
an original signature. Pursuant to 37 CFR
1.4(d)(1)(ii), the submitted disclaimer can be a copy,  
such as a photocopy or facsimile transmission of an
original disclaimer.


Any claim statutorily disclaimed is no longer in
I.STATUTORY DISCLAIMERS
the patent, and such a claim cannot be amended. The
statutorily disclaimed claim(s) should be lined
through, and not surrounded by brackets.


1454Appeal Brief [R-3]
Under 37 CFR 1.321(a) the owner of a patent may
disclaim a complete claim or claims of his or her
patent. This may result from a lawsuit or because he
or she has reason to believe that the claim or claims
are too broad or otherwise invalid. If the patent is
involved in an interference, see 37 CFR 41.121(a).


The requirements for an appeal brief are set forth in
As noted above, a statutory disclaimer is a statement
37
in which a patent owner relinquishes legal rights
CFR 41.37 and MPEP § 1206, and they apply
to one or more claims of a patent. A statutory disclaimer
to a reissue application in the same manner that they
is not, however, a vehicle for adding or
apply to a non-reissue application. There is, however,  
amending claims, since there is no provision for such
a difference in practice as to presentation of the copy
in the statute (35 U.S.C. 253) nor the rules (37 CFR
of the claims in the appeal brief for a reissue application.  
1.321). Thus, claims of a patent cannot be disclaimed
The claims on appeal presented in an appeal
in favor of new claims to be added to the patent or an
brief for a reissue application should include all
amendment to existing claims.
underlining and bracketing necessary to reflect the
changes made to the patent claims during the prosecution
of the reissue application. In addition, any new  
claims added in the reissue application should be
completely underlined.  


1455Allowance and Issue [R-3]
II.TERMINAL DISCLAIMERS


37 CFR 1.321(a) also provides for the filing by an
applicant or patentee of a terminal disclaimer which
disclaims or dedicates to the public the entire term or
any portion of the term of a patent or patent to be
granted.


37 CFR 1.321(c) specifically provides for the filing
of a terminal disclaimer in an application or a reexamination
proceeding for the purpose of overcoming
a
nonstatutory double patenting rejection. See MPEP
§ 804.02.


I.ISSUE CLASSIFICATION SHEET
37 CFR 1.321(d) specifically provides for the filing
of a terminal disclaimer in an application or a reexamination
proceeding for the purpose of overcoming a
nonstatutory double patenting rejection based on a
U.S. patent or application that is not commonly
owned but was disqualified under 35 U.S.C. 103(c).


For IFW reissue applications:
III.PROCESSING


The examiner completes the Issue Classification
Certificate of Correction Branch
sheet in the same manner as for a non-reissue application.
In addition, a copy of the “Final SPRE Review”
form must also be completed.


For reissue application files that are maintained in
The Certificate of Correction Branch is responsible
paper:
for the handling of all statutory disclaimers filed
 
under the first paragraph of 35 U.S.C. 253, whether
In all reissue applications prepared for issue where
the case is pending or patented, and all terminal disclaimers
a blue slip is needed (i.e., 08/ and earlier series), the
(filed under the second paragraph of
patent number of the original patent which is being
35
reissued should be placed in the box provided therefor
U.S.C. 253) except for those filed in an application
below the box for the applicant’s name on the blue
or reexamination proceeding pending in a Technology
Issue Classification Slip (form PTO-270) or design
Center (TC). This involves:
Issue Classification Slip (form PTO-328). Otherwise,
the Issue Classification Slip is prepared in the same
manner as for a non-reissue application.


For 09/ and later series applications, the patent
(A)Determining the compliance of the disclaimer
number of the original patent which is being reissued
with 35 U.S.C. 253 and 37 CFR 1.321 and 3.73;
should be placed on the face of the file wrapper above
the box “PREPARED AND APPROVED FOR
ISSUE” just after “(Exr. Initials)” in the line reading
“SURRENDER OF ORIGINAL PATENT________
(Exr. Initials).


(B)Notifying applicant or patentee when the disclaimer
is informal and thus not acceptable;


(C)Recording the disclaimers in the record of the
application file; and


II. CHANGES TO THE ORIGINAL
(D)Providing the disclaimer data for printing in
PATENT
the Official Gazette.


The specifications of reissue patents will be printed
IV.TERMINAL DISCLAIMER IN PENDING APPLICATION PRACTICE IN THE TECHNOLOGY CENTERS
in such a manner as to show the changes over the
original patent text by enclosing any material omitted
by the reissue in heavy brackets [ ] and printing material
added by the
reissue in italics. 37 CFR 1.173 (see
MPEP § 1411) requires the specification of a reissue
application to be presented in a specified form, specifically
designed to facilitate this different manner of
printing, as well as for other reasons.  


The printed reissue patent specification will carry
Where a terminal disclaimer is filed in an application
the following heading, which will be added by the  
pending in a TC, it will be processed by the paralegal
Publishing Division of the Office of Patent Publication:
of the Office of the Special Program Examiner
of the TC having responsibility for the application.
The paralegal will:


(A)Determine compliance with 35 U.S.C. 253and 37
CFR 1.321 and 3.73, and ensure that the
appropriate terminal disclaimer fee set forth in
37
CFR 1.20(d) is/was applied;


“Matter enclosed in heavy brackets [ ] appears in the original
(B)Notify the examiner having charge of the
patent but forms no part of this reissue specification;
application whether the terminal disclaimer is acceptable
matter printed in italics indicates the additions made by
or not;
reissue.”


The examiners should see that the specification is
(C)Where the terminal disclaimer is not acceptable,
in proper form for printing. Examiners should care
indicate the nature of the informalities so that the  
examiner can inform applicant in the next Office
action. For an IFW application, complete the IFW terminal
disclaimer form by checking the “Disapproved”
box and have the form scanned into IFW;


(D)Where the terminal disclaimer is acceptable,
record the terminal disclaimer in the record of the
application as set forth below.


The paralegal will record an acceptable terminal
disclaimer as being present in an application by:
For IFW applications:


(A)Completing the IFW terminal disclaimer form
by checking the “Approved” box and having the form
scanned into IFW; and


(B)Entering the terminal disclaimer into PALM
for the application.


For application files that are maintained in paper:


fully check the entry of all amendments to ensure that
For paper applications with 08/ and earlier series
the changes directed by applicant will be accurately
code
printed in any reissue patent that may ultimately issue.
Matter appearing in the original patent which is omitted
by reissue should be enclosed in brackets, while
matter added by reissue should be underlined.


Any material added by amendment in the reissue
(A)Attaching a green label to the file wrapper;
application (as underlined text) which is later canceled
should be crossed through, and not bracketed.
Material cancelled from the original patent should be
enclosed in brackets, and not lined through.


All the claims of the original patent should appear
(B)Stamping a notice on the file of the term
in the reissue patent, with canceled patent claims
which has been disclaimed (note that the blanks on
being enclosed in brackets.
the stamped notice for entering information on the
patent(s) being disclaimed are no longer filled in);


(C)Endorsing the paper containing the terminal
disclaimer submission on the “Contents” flap of the
application file; and


(D)Entering the terminal disclaimer into the
PALM system records, for the application.


III. CLAIM NUMBERING
For paper applications with 09/ and later series
code


No renumbering of the original patent claims is permitted,
(A)Checking a box on the file wrapper which
even if the dependency of a dependent patent  
states that the terminal disclaimer has been filed (Any
claim is changed by reissue so that it is to be dependent
blanks for entering information on the patent(s) being
on a subsequent higher numbered claim.
disclaimed are no longer filled in. Note that applications
with 10/ and later series codes no longer have
such blanks to complete);


When a dependent claim in a reissue application
(B)Endorsing the paper containing the terminal
depends upon a claim which has been canceled, and
disclaimer submission on the “Contents” flap of the  
the dependent claim is not thereafter made dependent
application file; and
upon a pending claim, such a dependent claim must
be rewritten in independent form.


New claims added during the prosecution of the
(C)Entering the terminal disclaimer into the  
reissue application should follow the number of the
PALM system records, for the application.  
highest numbered patent claim and should be completely
underlined to indicate they are to be printed in
italics on the printed patent. Often, as a result of the
prosecution and examination, some new claims are
canceled while other new claims remain. When the
reissue application is allowed, any claims remaining
which are additional to the patent claims (i.e., claims
added via the reissue application) should be renumbered
in sequence starting with the number next
higher than the number of the last claim in the original
patent (the printed patent). Therefore, the number of
claims allowed will not necessarily correspond to the  
number of the last claim in the reissue application, as
allowed. The number of claims appearing in the
“Total Claims Allowed” box on the Issue Classification
sheet (or for reissue application files that are
maintained in paper, the “CLAIMS ALLOWED -
Total Claims” box on the lower right of the file wrapper
face) at the time of allowance should be consistent
with the number of claims indicated as allowable
on the Notice of Allowability (Form PTOL-37).  


The paralegal completes a Terminal Disclaimer
Informal Memo to notify the examiner of the nature
of any informalities in the terminal disclaimer. The
examiner should notify the applicant of the informalities
in the next Office action, or by interview with
applicant if such will expedite prosecution of the
application. Further, the examiner should initial and
date the Terminal Disclaimer Informal Memo and
return it to the paralegal to indicate that the examiner
has appropriately notified applicant about the terminal
disclaimer. The paralegal will then discard the Terminal
Disclaimer Informal Memo.


V.OTHER MATTERS DIRECTED TO TERMINAL DISCLAIMERS


IV. CLAIM DESIGNATED FOR PRINTING
A.Requirements of Terminal Disclaimers


At least one claim of an allowable reissue application  
A proper terminal disclaimer must disclaim the terminal
must be designated for printing in the Official
part of the statutory term of any patent granted
Gazette. Whenever at least one claim has been
on the application being examined which would
amended or added in the reissue, the claim (claims)
extend beyond the expiration date of the full statutory
designated for printing must be (or include) a claim
term, shortened by any terminal disclaimer, of the  
which has been changed or added by the reissue. A
patent (or of any patent granted on the application) to
canceled claim is not to be designated as the claim for
which the disclaimer is directed. Note the exculpatory
the Official Gazette.
language in the second paragraph of the sample terminal
disclaimer forms, PTO/SB/25 and PTO/SB/26,
provided at the end of this Chapter. That language
(“In making the above disclaimer, the owner does not
disclaim...”) is permissible in a terminal disclaimer.


If there is no change in the claims of the allowable
A terminal disclaimer filed to obviate a nonstatutory
reissue application (i.e., when they are the same as the  
double patenting rejection based on a commonly
claims of the original patent) or, if the only change in
owned patent or application must comply with the  
the claims is the cancellation of claims, then the most
requirements of 37 CFR 1.321(c). The terminal disclaimer
representative pending allowed claim is designated
must state that any patent granted on the  
for printing in the Official Gazette.
application being examined will be enforceable only
for and during the period that it and the patent to
which the disclaimer is directed or the patent granted
on the application to which the disclaimer is directed
are commonly owned. See MPEP § 706.02(1)(2) for  
examples of common ownership, or lack thereof.


A terminal disclaimer filed to obviate a nonstatutory
double patenting rejection based on a non-commonly
owned patent or application disqualified under
35 U.S.C. 103(c) as a result of activities undertaken
within the scope of a joint research agreement under
35 U.S.C. 103(c)(2) and (3) must comply with 37
CFR 1.321(d), which sets forth signature, waiver
rights and enforceability requirements.


The terminal disclaimer must include a provision:


V. PROVIDING PROPER FORMAT
(1)waiving the right to separately enforce (a) any
patent granted on that application or the patent being
reexamined and (b) the reference patent, or any patent
granted on the reference application which formed the
basis for the double patenting; and


Where a reissue application has not been prepared
(2)agreeing that any patent granted on that application  
in the above-indicated manner, the examiner may
or patent being reexamined shall be enforceable
obtain from the applicant a clean copy of the reissue
only for and during such period that said patent
specification prepared in the indicated form, or a
and the reference patent, or any patent granted on the  
proper submission of a previously improperly submitted
reference application, which formed the basis for the  
amendment. However, if the deletions from the  
double patenting are not separately enforced.
original patent are small, the reissue application can
be prepared for issue by putting the bracketed inserts
at the appropriate places and suitably numbering the
added claims.  


When applicant submits a clean copy of the reissue
A terminal disclaimer must state that the agreement
specification, or a proper submission of a previous
is to run with any patent granted on the application
improper amendment, a supplemental reissue declaration
being examined and is to be binding upon the grantee,  
should not be provided to address this submission,  
its successors, or assigns.
because the correction of format does not correct
a 35 U.S.C. 251 error in the patent.  


A statement of assignee interest in a terminal disclaimer
that “A and B are the owners of 100% of the
instant application...” is sufficient to satisfy the
37
CFR 1.321(b)(3) requirement that a terminal disclaimer
“state the present extent of applicant’s or
assignee’s ownership interest in the patent to be
granted.” Although the quoted statement does not
identify what specific percentage is owned by A and
what specific percentage is owned by B, the statement
does provide consent to the terminal disclaimer by the
entirety of the ownership of the application (A and B
own all of the invention, regardless of the individual
percentages they own).


The appropriate one of form paragraphs 14.27.04to 14.27.08 (reproduced below) may be used to provide
applicant or patent owner with an example of
acceptable terminal disclaimer language. Additionally,
copies of forms PTO/SB/25 and PTO/SB/26 (provided
at the end of this Chapter) may be attached to
the Office action to provide sample terminal disclaimers.


VI. PARENT APPLICATION DATA
Pursuant to the last sentence of 35 U.S.C. 253, “any
 
patentee or applicant may disclaim or dedicate to the  
All parent application data on the bibliographic
public... any terminal part of the term, of the patent  
data sheet of the original patent file (or front face of  
granted or to be granted”. Accordingly, the disclaimer
the original patent file wrapper if the original patent is
must be of a terminal portion of the term of the entire
a paper file) should be present on the bibliographic
patent to be granted. A disclaimer of a terminal portion
data sheet of the reissue application.
of the term of an individual claim, or individual
 
claims will not be accepted. It is further noted that a
It sometimes happens that the reissue is a continuation
disclaimer of the term of individual claims would not
of another reissue application, and there is also
be appropriate since the claims of a pending application  
 
or proceeding are subject to cancelation, amendment,
or renumbering. The statute does not provide
for conditional disclaimers and accordingly, a proposed
disclaimer which is made contingent on the
allowance of certain claims cannot be accepted. The
disclaimer should identify the disclaimant and his or
her interest in the application and should specify the
date when the disclaimer is to become effective.


B.Effect of Disclaimers in Continuing Applications
and in Reissues


A terminal disclaimer filed to obviate a double patenting
rejection is effective only with respect to the
application identified in the disclaimer unless by its
terms it extends to continuing applications. For example,
a terminal disclaimer filed in a parent application
normally has no effect on a continuing application
claiming filing date benefits of the parent application
under 35 U.S.C. 120. A terminal disclaimer filed in a
parent application to obviate a double patenting rejection
does, however, carry over to a continued prosecution
application (CPA) filed under 37 CFR 1.53(d)
(effective July 14, 2003, CPAs are only available in
design applications). The terminal disclaimer filed in
the parent application carries over because the CPA
retains the same application number as the parent
application, i.e., the application number to which the
previously filed terminal disclaimer is directed. If
applicant does not want the terminal disclaimer to
carry over to the CPA, applicant must file a petition
under 37 CFR 1.182, along with the required petition
fee, requesting the terminal disclaimer filed in the parent
application not be carried over to the CPA; see
below “Withdrawing a Terminal Disclaimer” (paragraph
“A. Before Issuance of Patent”). If applicant
files a Request for Continued Examination (RCE) of
an application under 37 CFR 1.114 (which can be
filed on or after May 29, 2000 for an application filed
on or after June 8, 1995), any terminal disclaimer
present will continue to operate, since a new application
has not been filed, but rather prosecution has
been continued in the existing application. A petition
under 37 CFR 1.182, along with the required petition
fee, may be filed, if withdrawal of the terminal disclaimer
is to be requested.


Reissue applications: Where a terminal disclaimer
 
was filed in an original application, a copy of that terminal
original-patent parent application data. The examiner
disclaimer is not required be filed by applicant
should ensure that the parent application data on the
in the reissue.  
original patent is properly combined with the parent
application data of the reissue, in the text of the specification
and on the bibliographic data sheet (or
on the front face of the reissue file wrapper for 08/
and earlier series applications).  The combined
statement as to parent application data should be
checked carefully for proper bracketing and underlining.
 


For reissue application files that are maintained in
paper:


The face of the file wrapper of the reissue application
should, however, be marked by the examiner in
order to indicate that a terminal disclaimer has been
filed for the patent (and will be effective for the patent
as it will be reissued). Further, a copy of the terminal
disclaimer should be placed in the reissue application
file by the Technology Center.


VII. REFERENCES CITED AND PRINTED
For IFW reissue applications:


The list of references to be printed in the reissue
The “Final SPRE Review” form will be filled in to
patent includes all the references cited during the
indicate that a terminal disclaimer has been filed for
prosecution of the reissue application. It is noted that  
the patent (and will be effective for the patent as it
the Office will not print in the reissue patent “References
will be reissued). Further, a copy of the terminal disclaimer
Cited” section any reference cited in the patent
should be scanned into the reissue application  
but not again cited in the reissue application. A patent
file history by the Technology Center.
cannot be reissued solely for the purpose of adding
citations of additional prior art.


C.Disclaimer Identifies the Wrong Target
Application or Patent


In some instances a terminal disclaimer filed to
obviate an obviousness type double patenting rejection
will identify the wrong target application or
patent (i.e., an application or patent which is not the
basis for the double patenting rejection). In these
instances, a replacement terminal disclaimer identifying
the correct target application or patent would be
required by the examiner. Once a correct replacement
terminal disclaimer is received, the next Office action
should make it clear that “the second terminal disclaimer
replaces the first terminal disclaimer, and the
first terminal disclaimer is thus void.” A second terminal
disclaimer fee should not be assessed/charged,
since the first fee is applied to the second terminal disclaimer.


VIII. EXAMINER'S AMENDMENT AND SUP-
D.Two or More Copending Applications
PLEMENTAL DECLARATION
 
When it is necessary to amend the reissue application
in order to place the application in condition for
allowance, the examiner may:
 
(A)request that applicant provide the amendments
(e.g., by facsimile transmission or by hand-
carry); or  


(B)make the amendments, with the applicant’s
If two (or more) pending applications are filed, in
approval, by a formal examiner’s amendment.
each of which a rejection of one claimed invention
over the other on the ground of provisional obviousness-
type double patenting (ODP) is proper, the ODP
rejection will be made in each application. If the ODP
rejection is the only rejection remaining in the earlier
filed of the two pending applications, (but the later-
filed application is rejectable on other grounds),
the examiner should then withdraw that rejection
and permit the earlier-filed application to issue as a
patent without a terminal disclaimer. If the ODP rejection
is the only rejection remaining in the later-filed
application, (while the earlier-filed application is
rejectable on other grounds), a terminal disclaimer
must be required in the later-filed application, before
the ODP rejection can be withdrawn.


If the changes are made by a formal examiner’s
If the ODP rejections in both applications are the
amendment, the entire paragraph(s) or claim(s) being
only rejections remaining in those applications, the  
amended need not be presented in rewritten form for
examiner should then withdraw the ODP rejection in  
any deletions or additions. Changes to the specification
the earlier filed application thereby permitting that
including the claims of an application made by
application to issue without need of a terminal disclaimer.
the Office in an examiner’s amendment may be made
A terminal disclaimer must be required in the  
by specific instructions to insert or delete subject matter
later-filed application before the ODP rejection can be
set forth in the examiner’s amendment by identifying
withdrawn and the application be permitted to issue.
the precise point in the specification or the
claim(s) where the insertion or deletion is to be made.
37 CFR 1.121(g).


If it is necessary to amend a claim or the specification
If both applications are filed on the same day, the  
in order to correct an “error” under 35 U.S.C. 251and thereby place the application in condition for
examiner should determine which application claims
allowance, then a supplemental oath or declaration
the base invention and which application claims the
will be required. See MPEP § 1444. The examiner
improvement (added limitations). The ODP rejection
should telephone applicant and request the supplemental
in the base application can be withdrawn without a
oath or declaration, which must be filed before
terminal disclaimer, while the ODP rejection in the
the application can be counted as an allowance.
improvement application cannot be withdrawn without
a terminal disclaimer.


Where there are three applications containing
claims that conflict such that an ODP rejection is
made in each application based upon the other two, it
is not sufficient to file a terminal disclaimer in only
one of the applications addressing the other two applications.
Rather, an appropriate terminal disclaimer
must be filed in at least two of the applications to link
all three together. This is because a terminal disclaimer
filed to obviate a double patenting rejection is
effective only with respect to the application in which
the terminal disclaimer is filed; it is not effective to
link the other two applications to each other.


VI. WITHDRAWING A RECORDED TERMINAL DISCLAIMER


IX. FINAL REVIEW OF THE REISSUE
If timely requested, a recorded terminal disclaimer
APPLICATION BY THE EXAMINER
may be withdrawn before the application in which it
is filed issues as a patent, or in a reexamination proceeding,
before the reexamination certificate issues.  
After a patent or reexamination certificate issues, it is
unlikely that a recorded terminal disclaimer will be
nullified.


Prior to forwarding a reissue application to the
A. Before Issuance Of Patent
Technology Center (TC) Special Program Examiner
(SPRE) for final review, the examiner should complete
and initial an Examiner Reissue Checklist. A  
copy of the checklist should be available from the
SPRE or from the Paralegal Specialist of the TC.


1456Reissue Review [R-3]
While the filing and recordation of an unnecessary
terminal disclaimer has been characterized as an
“unhappy circumstance” in In re Jentoft, 392 F.2d
633, 157 USPQ 363 (CCPA 1968), there is no statutory
prohibition against nullifying or otherwise canceling
the effect of a recorded terminal disclaimer
which was erroneously filed before the patent issues.
Since the terminal disclaimer would not take effect
until the patent is granted, and the public has not had
the opportunity to rely on the terminal disclaimer,
relief from this unhappy circumstance may be available
by way of petition or by refiling the application
(other than by refiling it as a CPA).


All reissue applications are monitored and
Under appropriate circumstances, consistent with
reviewed in the Technology Centers (TCs) by the  
the orderly administration of the examination process, the nullification of a recorded terminal disclaimer
Office of TC Special Program Examiners (which
may be addressed by filing a petition under 37 CFR
includes TC SPREs, paralegals or other technical support
1.182 requesting withdrawal of the recorded terminal
who might be assigned as backup) at several
disclaimer. Petitions seeking to reopen the question of
stages during the prosecution. The review by the
the propriety of the double patenting rejection that
Office of the TC SPREs is made to check that practice
prompted the filing of the terminal disclaimer have  
and procedure unique to reissue has been carried out
not been favorably considered. The filing of a continuing
for the reissue application. In addition to the SPRE
application other than a CPA, while abandoning
review of the reissue applications, a patentability
the application in which the terminal disclaimer
review is made in a sample of reissue applications by
has been filed, will typically nullify the effect of a terminal
the TC Quality Assurance Specialist (QAS) in the  
disclaimer. The filing of a Request for Continued
manner previously carried out by the former Office of
Examination (RCE) of an application under
Patent Quality Review. In order to ensure that SPREs
37
are aware of the reissue applications in their TCs, a
CFR 1.114 will not nullify the effect of a terminal
pair of terminal-specific PALM flags have been created
disclaimer, since a new application has not been filed,  
which must be set by the SPRE before certain
but rather prosecution has been continued in the existing
PALM transactions can be completed. First, when a  
application.
new reissue application enters the TC, a SPRE must
set a PALM “flag” by entering the reissue application  
number in an Office-wide computer grouping before a  
docketing transaction will be accepted. By having to
set this first flag, the SPRE is made aware of the
assignment of the reissue application to the TC and
can take steps, as may be appropriate, to instruct the
examiner on reissue-specific procedures before the
examination process begins, as well as throughout the  
period that the examiner is handling the reissue application.  
Second, the SPRE must remove the above-
described PALM “flag” before a Notice of Allowance
can be generated or the PALM transaction for an issue


B.After Issuance Of Patent


The mechanisms to correct a patent — Certificate
of Correction (35 U.S.C. 255), reissue (35 U.S.C.
251), and reexamination (35 U.S.C. 305) — are not
available to withdraw or otherwise nullify the effect
of a recorded terminal disclaimer. As a general principle,
public policy does not favor the restoration to the
patent owner of something that has been freely dedicated
to the public, particularly where the public interest
is not protected in some manner — e.g.,
intervening rights in the case of a reissue patent. See,
e.g., Altoona Publix Theatres v. American Tri-Ergon
Corp., 294
U.S. 477, 24 USPQ 308 (1935).


Certificates of Correction (35 U.S.C. 255) are
available for the correction of an applicant’s mistake.
The scope of this remedial provision is limited in
two
ways — by the nature of the mistake for which
correction is sought and the nature of the proposed
correction. In re Arnott, 19 USPQ2d 1049 (Comm’r
Pat. 1991). The nature of the mistake for which correction
is sought is limited to those mistakes that are:


(A)of a clerical nature,


revision can be entered, thereby ensuring that the
(B)of a typographical nature, or
SPRE is made aware of when the reissue application
is being allowed so that the SPRE may be able to conduct
a final review of the reissue application, if appropriate.


(C)of a minor character.


When the reissue application has been reviewed
The nature of the proposed correction is limited to  
and is ready to be released to issue, the TC SPRE
those situations where the correction does not involve
should do the following:
changes which would:  


For IFW reissue applications:
(A)constitute new matter, or


The SPRE should complete the “Final SPRE
(B)require reexamination.  
Review” form. The SPRE will discard any informal
papers that were forwarded to the SPRE, such as the
informal Reissue Check List that was filled out by the
examiner. The SPRE will then forward (message) the
reissue file to the Office of Patent Legal Administration
(OPLA). The file for any original paper patent
should be forwarded to OPLA.


For reissue application files that are maintained in  
A mistake in filing a terminal disclaimer does not
paper:
fall within any of the categories of mistake for which
a certificate of correction of applicant’s mistake is
permissible, and any attempt to remove or nullify the
effect of the terminal disclaimer would typically
require reexamination of the circumstances under
which it was filed.


The SPRE should initial the face of the file wrapper,  
Although the remedial nature of reissue (35 U.S.C. 251) is well recognized, reissue is not available to correct all errors. It has been the Office position that reissue is not available to withdraw or otherwise nullify the effect of a terminal disclaimer recorded in an issued patent. First, the reissue statute only authorizes the Director of the USPTO to reissue a patent “for the unexpired part of the term of the original patent.” Since the granting of a reissue patent without the
and forward the reissue file to OPLA.
effect of a recorded terminal disclaimer would result
Along with the reissue file, the file for the original
in extending the term of the original patent, reissue  
patent should be forwarded to OPLA.
under these circumstances would be contrary to the
statute. Second, the principle against recapturing
something that has been intentionally dedicated to the
public dates back to Leggett v. Avery, 101 U.S. 256
(1879). The attempt to restore that portion of the
patent term that was dedicated to the public to secure
the grant of the original patent would be contrary to
this recapture principle. Finally, applicants have the
opportunity to challenge the need for a terminal disclaimer
during the prosecution of the application that
issues as a patent. “Reissue is not a substitute for
Patent Office appeal procedures.” Ball Corp. v. United
States, 729
F.2d 1429, 1435, 221 USPQ 289, 293
(Fed. Cir. 1984). Where applicants did not challenge
the propriety of the examiner’s obvious-type double
patenting rejection, but filed a terminal disclaimer to  
avoid the rejection, the filing of the terminal disclaimer
did not constitute error within the meaning of
35 U.S.C. 251. Ex parte Anthony, 230 USPQ 467 (Bd.
App. 1982), aff’d, No. 84-1357 (Fed. Cir. June 14,
1985).  


After leaving the TC, all reissue applications go
Finally, the nullification of a recorded terminal disclaimer
through a screening process which is currently performed
would not be appropriate in a reexamination
in OPLA. The screening process which
proceeding. There is a prohibition (35 U.S.C. 305)
includes review of the reissue oath or declaration for
against enlarging the scope of a claim during a reexamination
compliance with 37 CFR 1.175, review of the presentation
proceeding. As noted by the Board in
and entry of reissue amendments for compliance
Anthony, supra, if a terminal disclaimer was nullified,  
with 37 CFR 1.173(b), and review of other
“claims would be able to be sued upon for a longer
matters to ensure adherence to current reissue practices.
period than would the claims of the original patent.  
The above identified review processes are
Therefore, the vertical scope, as opposed to the horizontal
appropriate vehicles for correcting errors, identifying
scope (where the subject matter is enlarged),
problem areas and recognizing trends, providing
would be enlarged.
information on the uniformity of practice, and providing
{{MPEP Chapter|1300|1500}}
feedback to the TC personnel responsible for processing
and examining reissue applications.
 
1457Design Reissue Applications and
Patents [R-3]
 
A reissue application can be filed for a design
patent in the same manner that a reissue application is
filed for a utility patent. There are, however, a few
aspects of a design reissue application that are
addressed as follows:
 
I.EXPEDITED EXAMINATION PROCE-
DURE
 
Design reissue applications requesting expedited
examination and complying with the requirements of
37 CFR 1.155 are examined with priority and undergo
expedited processing throughout the entire course of
prosecution in the Office, including appeal, if any, to  
the Board of Patent Appeals and Interferences. All
processing is expedited from the date the request is  
granted.
 
Design reissue applicants seeking expedited examination
may file a design reissue application in the
Office together with a corresponding request under 37
CFR 1.155 pursuant to the guidelines set forth in
MPEP § 1504.30.
 
The design reissue application and the request are
processed by the Office of Initial Patent Examination
(OIPE). OIPE enters the appropriate information
into PALM specifying when notice of the design
reissue application will be published in the Official
Gazette (see MPEP § 1441).  After processing in
OIPE, the design reissue application and the request
are forwarded to the Design TC Director’s Office.
Upon a decision by the Design TC Director to grant
the request for expedited examination, fees are immediately
processed, and the application papers are
promptly assigned an application number. The design
reissue application file is then forwarded to the Office
of Patent Legal Administration (OPLA) for a decision
under 37 CFR 1.182 to sua sponte waive the requirement
for delaying action in the application until 2
months after announcement of the design reissue
application filing is published in the Official Gazette(see MPEP § 1441). Once the decision under 37 CFR
1.182 is mailed, the design reissue application file
will be returned to the Design TC Director’s Office. In
accordance with the waiver, the Design Group will
begin expedited examination of the application under
37 CFR 1.155 promptly after the return of the design
reissue application file from OPLA, rather than delay
examination until after 2 months from the date the
announcement is published in the Official Gazette and
the applicant will be notified that examination is
being expedited. The decision under 37 CFR 1.182will require that no Notice of Allowance be mailed in
the design reissue application until after 2 months
from the date the announcement is published in the
Official Gazette. For example, if the design reissue
 
 
 
 
 
application is allowed on the first Office action, then
jurisdiction over the reissue application will be
retained in the TC, and the Notice of Allowance
will not be mailed until the expiration of 2 months
after publication of the filing of the design reissue
application in the Official Gazette (plus time for
matching any protest filed with the application). (For
IFW processing, see IFW Manual.) The examiner will
check  the PALM contents to ascertain when publication
actually occurred. The delay in the mailing of
the Notice of Allowance is to ensure that any potential
protests complying with 37 CFR 1.291 submitted
within the 2-month delay period will be considered by
the Office. (see MPEP § 1441.01).
 
The expedited examination procedure under
37
CFR 1.155 occurs through initial examination processing
and throughout the entire prosecution in the
Office. Once a request for expedited examination is
granted, prosecution of the design reissue application
will proceed according to the procedure under
37
CFR 1.155, and there is no provision for “withdrawal”
from expedited examination procedure.
 
II.DESIGN REISSUE FEE
 
The design reissue application fee is set forth for in
37 CFR 1.16(e). For design reissue applications
filed on or after December 8, 2004, a search fee
(37
CFR 1.16(n)) and an examination fee (37 CFR
1.16(r)) are also required. The additional fees in
37
CFR 1.16(h) and 37 CFR 1.16(i) do not
apply for a design reissue application since more than
one claim in not permitted in a design application pursuant
to the last sentence of 37 CFR 1.153(a).
 
The fee for issuing a design reissue patent is set
forth in 37 CFR 1.18(a).
 
III.MULTIPLE DESIGN REISSUE APPLICATIONS
 
 
The design reissue application can be filed based on
the “error” of failing to include a design for a patentably
distinct segregable part of the design claimed in
the original patent or a patentably distinct subcombination
of the claimed design. A reissue design application
claiming both the entire article and the
patentably distinct subcombination or segregable part
would be proper under 35 U.S.C. 251, if such a reissue
application is filed within two years of the issuance
of the design patent, since it is considered a
broadening of the scope of the patent claim. Restriction
will be required under 37 CFR 1.176(b) in such a
reissue design application, and the added design to the
segregable part or subcombination will be held to be
constructively non-elected and withdrawn from consideration.
See MPEP § 1450. In the Office action
containing the restriction requirement, the examiner
should suggest to the applicant that a divisional
design reissue application directed to the constructively
non-elected segregable part or subcombination
subject matter may be filed. The claim to the patented
design for the entire article will then be examined and,
if found allowable without change from the patent, a
rejection will be made under 35 U.S.C. 251 based on
the fact that there is no “error” in the non-amended
original patent claim. In the Office action making this
rejection, applicant should be advised that a proper
response to the rejection must include (A) a request to
suspend action in this original reissue application
pending completion of examination of a divisional
reissue application directed to the constructively non-
elected segregable part or subcombination subject
matter, (B) the filing of the divisional reissue application,
or a statement that one has already been filed
(identifying it at least by application number), and (C)
an argument that a complete response to the rejection
has been made based upon the filing of the divisional
reissue application and the request for suspension.
Action in the original design reissue application will
then be suspended, and the divisional will be examined.
 
 
If, after examination, the divisional design reissue
application is also determined to be allowable, a
requirement must be made in the divisional design
reissue application to submit a petition under 37 CFR
1.183 requesting waiver of 37 CFR 1.153 in order to
permit the rejoining of the designs to the entire article
(of the original application) and the segregable part or
subcombination (of the divisional) under a single
claim into a single design reissue application for issuance,
the single application being the first design reissue
application.
 
It should be noted that the filing of a design reissue
application would not be proper if applicant did in
fact include the design for a segregable part or subcombination
thereof in the original design patent
application, a restriction was thus made, and then
applicant failed to file a divisional reissue application
 
 
 
 
 
for a non-elected invention that was canceled in view
of a restriction requirement (prior to issue of the original
application. See In re Watkinson, 900 F.2d 230,
14
USPQ2d 1407 (Fed. Cir. 1990); In re Orita,
550
F.2d 1277, 1280, 193 USPQ 145, 148 (CCPA
1977).
 
IV.CONVERSION TO UTILITY PATENT
 
A design patent cannot be converted to a utility
patent via reissue.
 
Converting a design patent to a utility patent will,
in most instances, involve the introduction of new
matter into the patent. The disclosure of a design
patent is not directed to how the invention is made
and used, and the introduction of new matter is
required to bridge this gap and provide support for the
utility patent. Accordingly, the examiner should consider
rejections based on the introduction of new matter
under 35 U.S.C. 251, first paragraph, and lack of
enablement and/or description under 35 U.S.C. 112,
first paragraph, when a reissue application is filed to
convert a design patent to a utility patent.
 
Further, the term of a design patent may not be
extended by reissue. Ex parte Lawrence, 70 USPQ
326 (Comm’r Pat. 1946). Thus, any reissue application
filed to convert a design patent to a utility patent,
which conversion would thereby extend the term of
the patent, should be rejected as failing to comply
with 35 U.S.C. 251, first paragraph, which permits
reissue only “for the unexpired part of the term of the
original patent.” The statute requires that the reissued
patent shall not extend the term of the original patent.
 
1460Effect of Reissue [R-2]
 
35 U.S.C. 252. Effect of reissue.
 
The surrender of the original patent shall take effect upon the
issue of the reissued patent, and every reissued patent shall have
the same effect and operation in law, on the trial of actions for
causes thereafter arising, as if the same had been originally
granted in such amended form, but in so far as the claims of the
original and reissued patents are substantially identical, such surrender
shall not affect any action then pending nor abate any cause
of action then existing, and the reissued patent, to the extent that
its claims are substantially identical with the original patent, shall
constitute a continuation thereof and have effect continuously
from the date of the original patent.
 
A reissued patent shall not abridge or affect the right of any
person or that person’s successors in business who, prior to the
grant of a reissue, made, purchased, offered to sell, or used within
the United States, or imported into the United States, anything patented
by the reissued patent, to continue the use of, to offer to sell,
or to sell to others to be used, offered for sale, or sold, the specific
thing so made, purchased, offered for sale, used, or imported
unless the making, using, offering for sale, or selling of such thing
infringes a valid claim of the reissued patent which was in the
original patent. The court before which such matter is in question
may provide for the continued manufacture, use, offer for sale, or
sale of the thing made, purchased, offered for sale, used, or
imported as specified, or for the manufacture, use, offer for sale,
or sale in the United States of which substantial preparation was
made before the grant of the reissue, and the court may also provide
for the continued practice of any process patented by the reissue
that is practiced, or for the practice of which substantial
preparation was made, before the grant of the reissue, to the extent
and under such terms as the court deems equitable for the protection
of investments made or business commenced before the grant
of the reissue.
 
The effect of the reissue of a patent is stated in
35
U.S.C. 252. With respect to the Office treatment of
the reissued patent, the reissued patent will be viewed
as if the original patent had been originally granted in
the amended form provided by the reissue. With
respect to intervening rights resulting from the reissue
of an original patent, the second paragraph of 35
U.S.C. 252 provides for two separate and distinct
defenses to patent infringement under the doctrine of
intervening rights:
 
“Absolute” intervening rights are available for a
party that “prior to the grant of a reissue, made, purchased,
offered to sell, or used within the United
States, or imported into the United States, anything
patented by the reissued patent,” and “equitable”
intervening rights may be provided where “substantial
preparation was made before the grant of the reissue.”
See BIC Leisure Prods., Inc., v. Windsurfing Int’l,
Inc., 1 F.3d 1214, 1220, 27 USPQ2d 1671, 1676 (Fed.
Cir. 1993).
 
1470Public Access of Reissue Applications
[R-3]
 
37 CFR 1.11(b) opens all reissue applications filed
after March 1, 1977, to inspection by the general public.
37 CFR 1.11(b) also provides for announcement
of the filings of reissue applications in the Official
Gazette (except for continued prosecution applications
filed under 37 CFR 1.53(d)). This announcement
will give interested members of the public an
opportunity to submit to the examiner information
pertinent to patentability of the reissue application.
 
 
 
 
 
The filing of a continued prosecution application
under 37 CFR 1.53(d) of a reissue application will notbe announced in the Official Gazette. Although the
filing of a continued prosecution application of a reissue
application constitutes the filing of a reissue
application, the announcement of the filing of such
continued prosecution application would be redundant
in view of the announcement of the filing of the prior
reissue application in the Official Gazette.
 
37 CFR 1.11(b) is applicable to all reissue
applications filed on or after March 1, 1977. Those
reissue applications previously on file will not be
automatically open to inspection but a liberal policy
will be followed in granting petitions for access to
such applications.
 
IFW reissue application files are open to
inspection by the general public by way of Public
PAIR via the USPTO Internet site. In viewing the
images of the files, members of the public will be able
to view the entire content of the reissue application
file history. To access Public PAIR, a member of the
public would (A) go to the USPTO web site at http://
www.uspto.gov, (B) click on “Patents,” (C) under
“Check Status, View Papers…” click on “Status &
IFW,” and (D) under “Patent Application Information
Retrieval” enter the reissue application number.
 
Access to a reissue application that is maintained in
paper must be obtained from the area of the Office
having jurisdiction over the file. The following access
procedure will be observed for reissue application
files that are maintained in paper:
 
(A)Any member of the general public may
request access to a particular reissue application filed
after March 1, 1977. Since no record of such request
is intended to be kept, an oral request will suffice.
(Reissue applications already on file prior to March 1,
1977 are not automatically open to inspection, but a
liberal policy is followed by the Office of Patent
Legal Administration (OPLA) and by the Board of
Patent Appeals and Interferences in granting petitions
for access to such applications.);
 
(B)Paper reissue application files will be maintained
in the TCs and inspection thereof will be supervised
by TC personnel. A TC Director or other
appropriate Office official may, under appropriate circumstances,
postpone access to or the making of copies
of a paper reissue application file, in order, for
example, to avoid interruption of the examination or
other review of the application by an examiner. In
addition, though no general limit is placed on the
amount of time spent reviewing the files, the Office
may impose limitations, if necessary, e.g., where the
application is actively being processed;
 
(C)In any instance where the reissue application
file has left the TC for administrative processing,
requests for access should be directed to the appropriate
supervisory personnel where the application is
currently located;
 
(D)A paper reissue application file is not
available to the public once the reissue application file
has been released and forwarded by the TC for publication
of the reissue patent. This would include any
reissue application files which have been selected for
a post-allowance screening at OPLA. Unless
prosecution is reopened pursuant to the screening, the
reissue application files are not available to the public
until the reissue patent issues. This is because the reissue
application file has been put into a special format
for printing purposes and public access at this stage
would disrupt the publication process;
 
(E)Requests for copies of papers in the reissue
application file must be in writing addressed to Mail
Stop Document Services, Director of the U.S. Patent
and Trademark Office, P.O. Box 1450, Alexandria,
VA 22313-1450. Such requests may be either mailed
or delivered to the Customer Service Window. The
price for a copy of an application as filed is set forth
in 37 CFR 1.19(b)(1). Since no useful purpose is seen
for retaining such written requests for copies of
papers in reissue applications, the request(s) should be
destroyed after the order has been completed.
 
See also MPEP § 103.
 
1480Certificates of Correction — OfficeMistake [R-3]
 
35 U.S.C. 254. Certificate of correction of Patent and
Trademark Office mistake.
 
Whenever a mistake in a patent, incurred through the fault of
the Patent and Trademark Office, is clearly disclosed by the
records of the Office, the Director may issue a certificate of correction
stating the fact and nature of such mistake, under seal,
without charge, to be recorded in the records of patents. A printed
copy thereof shall be attached to each printed copy of the patent,
and such certificate shall be considered as part of the original
patent. Every such patent, together with such certificate, shall
have the same effect and operation in law on the trial of actions
for causes thereafter arising as if the same had been originally
 
 
 
 
 
issued in such corrected form. The Director may issue a corrected
patent without charge in lieu of and with like effect as a certificate
of correction.
 
37 CFR 1.322. Certificate of correction of Office mistake.
 
(a)(1) The Director may issue a certificate of correction pursuant
to 35 U.S.C. 254 to correct a mistake in a patent, incurred
through the fault of the Office, which mistake is clearly disclosed
in the records of the Office:
 
(i)At the request of the patentee or the patentee’s
assignee;
 
(ii)Acting sua sponte for mistakes that the Office discovers;
or
 
(iii)Acting on information about a mistake supplied by a
third party.
 
(2)(i) There is no obligation on the Office to act on or
respond to a submission of information or request to issue a certificate
of correction by a third party under paragraph (a)(1)(iii) of
this section.
 
(ii)Papers submitted by a third party under this section
will not be made of record in the file that they relate to nor be
retained by the Office.
 
(3)If the request relates to a patent involved in an
interference, the request must comply with the requirements of
this section and be accompanied by a motion under § 41.121(a)(2)
or § 41.121(a)(3) of this title.
 
(4)The Office will not issue a certificate of correction
under this section without first notifying the patentee (including
any assignee of record) at the correspondence address of record as
specified in § 1.33(a) and affording the patentee or an assignee an
opportunity to be heard.
 
(b)If the nature of the mistake on the part of the Office is
such that a certificate of correction is deemed inappropriate in
form, the Director may issue a corrected patent in lieu thereof as a
more appropriate form for certificate of correction, without
expense to the patentee.
 
Mistakes incurred through the fault of the Office
may be the subject of Certificates of Correction under
37 CFR 1.322. The Office, however, has discretion
under 35 U.S.C. 254 to decline to issue a Certificate
of Correction even though an Office mistake exists. If
Office mistakes are of such a nature that the meaning
intended is obvious from the context, the Office may
decline to issue a certificate and merely place the correspondence
in the patented file, where it serves to
call attention to the matter in case any question as to it
subsequently arises. Such is the case, even where a
correction is requested by the patentee or patentee’s
assignee.
 
In order to expedite all proper requests, a Certificate
of Correction should be requested only for errors
of consequence. Instead of a request for a Certificate
of Correction, letters making errors of record should
be utilized whenever possible. Thus, where errors are
of a minor typographical nature, or are readily apparent
to one skilled in the art, a letter making the error(s)
of record can be submitted in lieu of a request for a
Certificate of Correction. There is no fee for the submission
of such a letter.
 
It is strongly advised that the text of the correction
requested be submitted on a Certificate of Correction
form, PTO/SB/44 (also referred to as PTO 1050). Submission
of this form in duplicate is not necessary. The
location of the error in the printed patent should be
identified on form PTO/SB/44 by column and line
number or claim and line number. See MPEP § 1485for a discussion of the preparation and submission of
a request for a Certificate of Correction.
 
A request for a Certificate of Correction should be
addressed to:
 
ATTN: Certificate of Correction Branch
 
Commissioner for Patents
 
P.O. Box 1450
 
Alexandria, VA 22313-1450
 
 
 
I. THIRD PARTY INFORMATION ON
MISTAKES IN PATENT
 
Third parties do not have standing to demand that
the Office issue, or refuse to issue, a Certificate of
Correction. See Hallmark Cards, Inc. v. Lehman, 959
F. Supp. 539, 543-44, 42 USPQ2d 1134, 1138 (D.D.C.
1997). 37 CFR 1.322(a)(2) makes it clear that third
parties do not have standing to demand that the Office
act on, respond to, issue, or refuse to issue a Certificate
of Correction. The Office is, however, cognizant
of the need for the public to have correct information
about published patents and may therefore accept
information about mistakes in patents from third parties.
37 CFR 1.322(a)(1)(iii). Where appropriate, the
Office may issue certificates of correction based on
information supplied by third parties, whether or not
such information is accompanied by a specific request
for issuance of a Certificate of Correction.
 
While third parties are permitted to submit information
about mistakes in patents which information
will be reviewed, the Office need not act on that information
nor deny any accompanying request for issuance
of a Certificate of Correction. Accordingly, a fee
for submission of the information by a third party has
not been imposed. The Office may, however, choose
 
 
 
 
 
to issue a Certificate of Correction on its own initiative
based on the information supplied by a third
party, if it desires to do so. Regardless of whether the
third party information is acted upon, the information
will not be made of record in the file that it relates to,
nor be retained by the Office. 37 CFR 1.322(a)(2)(ii).
 
When such third party information (about mistakes
in patents) is received by the Office, the Office will
not correspond with third parties about the information
they submitted either (1) to inform the third parties
of whether it intends to issue a Certificate of
Correction, or (2) to issue a denial of any request for
issuance of a Certificate of Correction that may
accompany the information. The Office will confirm
to the party submitting such information that the
Office has in fact received the information if a
stamped, self-addressed post card has been submitted.
See MPEP § 503.
 
 
 
II. PUBLICATION IN THE OFFICIAL
GAZETTE
 
Each issue of the Official Gazette (patents section)
numerically lists all United States patents having Certificates
of Correction. The list appears under the
heading “Certificates of Correction for the week of
(date).”
 
 
 
1480.01Expedited Issuance of
Certificates of Correction -
Error Attributable to Office [R-
2]
 
In an effort to reduce the overall time required in
processing and granting Certificate of Correction
requests, the Office will expedite processing and
granting of patentee requests where such requests are
accompanied by evidence to show that the error is
attributable solely to the Office (i.e., requests filed
pursuant to 37 CFR 1.322 only).
 
The following requirements must be met for consideration
of expedited issuance of Certificates of
Correction:
 
The text of the correction requested should be submitted
on a Certificate of Correction form, PTO/SB/
44 (also referred to as PTO 1050). Submission of this
form in duplicate is not necessary. The location of the
error in the printed patent should be identified on
form PTO/SB/44 by column and line number or claim
and line number. See also MPEP § 1485.
 
Where the correction requested was incurred
through the fault of the Office, and the matter is
clearly disclosed in the records of the Office, and is
accompanied by documentation that unequivocally
supports the patentee’s assertion(s), a Certificate of
Correction will be expeditiously issued. Such supporting
documentation can consist of relevant photocopied
receipts, manuscript pages, correspondence dated
and received by the Office, photocopies of Examiners’
responses regarding entry of amendments, or any
other validation that supports the patentee’s request so
that the request can be processed without the patent
file.
 
Where only part of a request can be approved, the
appropriate modifications will be made on the form
PTO/SB/44 and the patentee then notified by mail.
Further consideration will be given to initially
rejected requests upon a request for reconsideration.
In this instance, however, or in the case where it is
determined that the Office was not responsible for the
error(s) cited by the patentee, accelerated issuance of
Certificates of Correction cannot be anticipated
(although the Office will make every effort to process
the request expeditiously).
 
As in the case of a request for a Certificate of Correction,
a Request for Expedited Issuance of Certificate
of Correction should be addressed to:
 
ATTN: Certificate of Correction Branch
 
Commissioner for Patents
 
P.O. Box 1450
 
Alexandria, VA 22313-1450
 
1481Certificates of Correction - Applicant’s
Mistake [R-3]
 
35 U.S.C. 255. Certificate of correction of applicant’s
mistake.
 
Whenever a mistake of a clerical or typographical nature, or of
minor character, which was not the fault of the Patent and Trademark
Office, appears in a patent and a showing has been made that
such mistake occurred in good faith, the Director may, upon payment
of the required fee, issue a certificate of correction, if the
correction does not involve such changes in the patent as would
constitute new matter or would require reexamination. Such
patent, together with the certificate, shall have the same effect and
operation in law on the trial of actions for causes thereafter
 
 
 
 
 
arising
as if the same had been originally issued in such corrected
form.
 
37 CFR 1.323. Certificate of correction of applicant’s
mistake.
 
The Office may issue a certificate of correction under the
conditions specified in 35 U.S.C. 255 at the request of the patentee
or the patentee’s assignee, upon payment of the fee set forth in
§ 1.20(a). If the request relates to a patent involved in an interference,
the request must comply with the requirements of this section
and be accompanied by a motion under § 41.121(a)(2) or
§
41.121(a)(3) of this title.
 
37 CFR 1.323 relates to the issuance of Certificates
of Correction for the correction of errors which were
not the fault of the Office. Mistakes in a patent which
are not correctable by Certificate of Correction may
be correctable via filing a reissue application (see
MPEP § 1401 - § 1460). See Novo Industries, L.P. v.
Micro Molds Corporation, 350 F.3d 1348,
69
USPQ2d 1128 (Fed. Cir. 2003) (The Federal Circuit
stated that when Congress in 1952 defined
USPTO authority to make corrections with prospective
effect, it did not deny correction authority to the
district courts. A court, however, can correct only if
“(1) the correction is not subject to reasonable debate
based on consideration of the claim language and the
specification and (2) the prosecution history does not
suggest a different interpretation...”).
 
In re Arnott, 19 USPQ2d 1049, 1052 (Comm’r Pat.
1991) specifies the criteria of 35 U.S.C. 255 (for a
Certificate of Correction) as follows:
 
Two separate statutory requirements must be met
before a Certificate of Correction for an applicant’s mistake
may issue. The first statutory requirement concerns
the nature, i.e., type, of the mistake for which a correction
is sought. The mistake must be:
 
(1) of a clerical nature,
 
(2) of a typographical nature, or
 
(3) a mistake of minor character.
 
The second statutory requirement concerns the nature
of the proposed correction. The correction must not
involve changes which would:
 
(1) constitute new matter or
 
(2) require reexamination.
 
If the above criteria are not satisfied, then a Certificate
of Correction for an applicant’s mistake will not issue,
and reissue must be employed as the vehicle to “correct”
the patent. Usually, any mistake affecting claim
scope must be corrected by reissue.
 
A mistake is not considered to be of the “minor”
character required for the issuance of a Certificate of
Correction if the requested change would materially
affect the scope or meaning of the patent. See also
MPEP § 1412.04 as to correction of inventorship via
certificate of correction or reissue.
 
The fee for providing a correction of applicant’s
mistake, other than inventorship, is set forth in
37
CFR 1.20(a). The fee for correction of inventorship
in a patent is set forth in 37 CFR 1.20(b).
 
 
 
1481.01Correction of Assignees’ Names[R-3]
 
 
 
The Fee(s) Transmittal Form portion (PTOL-
85B) of the Notice of Allowance provides a space
(item 3) for assignment data which should be completed
in order to comply with 37 CFR 3.81. Unless
an assignee’s name and
address are identified in the
appropriate space for
specifying the assignee, (i.e.,
item 3 of the Fee(s) Transmittal Form PTOL-
85B), the patent will issue to the applicant. Assignment
data printed on the patent will be based solely on
the information so supplied.
 
Any request for the issuance of an application
in the name of the assignee submitted after the date of
payment of the issue fee, and any request for a patent
to be corrected to state the name of the assignee must:
 
(A)state that the assignment was submitted for
recordation as set forth in 37 CFR 3.11 before issuance
of the patent;
 
(B)include a request for a certificate of correction
under 37 CFR 1.323 along with the fee set forth in
37
CFR 1.20(a); and
 
(C)include the processing fee set forth in 37 CFR
1.17(i).
 
See 37 CFR 3.81(b).
 
1481.02Correction of Inventors’ Names[R-3]
 
 
 
35 U.S.C. 256. Correction of named inventor.
 
Whenever through error a person is named in an issued patent
as the inventor, or through error an inventor is not named in an
issued patent and such error arose without any deceptive intention
on his part, the Director may, on application of all the parties and
 
 
 
 
 
assignees, with proof of the facts and such other requirements as
may be imposed, issue a certificate correcting such error.
 
The error of omitting inventors or naming persons who are not
inventors shall not invalidate the patent in which such error
occurred if it can be corrected as provided in this section. The
court before which such matter is called in question may order
correction of the patent on notice and hearing of all parties concerned
and the Director shall issue a certificate accordingly.
 
In requesting the Office to effectuate a court order
correcting inventorship in a patent pursuant to
35
U.S.C. 256, a copy of the court order and a Certificate
of Correction under 37 CFR 1.323 should be submitted
to the Certificates of Corrections Branch.
 
37 CFR 1.324. Correction of inventorship in patent,
pursuant to 35 U.S.C. 256.
 
(a)Whenever through error a person is named in an
issued patent as the inventor, or through error an inventor is not
named in an issued patent and such error arose without any deceptive
intention on his or her part, the Director, pursuant to 35
U.S.C. 256, may, on application of all the parties and assignees, or
on order of a court before which such matter is called in question,
issue a certificate naming only the actual inventor or inventors. A
petition to correct inventorship of a patent involved in an interference
must comply with the requirements of this section and must
be accompanied by a motion under § 41.121(a)(2) or §
41.121(a)(3) of this title.
 
(b)Any request to correct inventorship of a patent pursuant
to paragraph (a) of this section must be accompanied by:
 
(1)Where one or more persons are being added, a statement
from each person who is being added as an inventor that the
inventorship error occurred without any deceptive intention on his
or her part;
 
(2)A statement from the current named inventors who
have not submitted a statement under paragraph (b)(1) of this section
either agreeing to the change of inventorship or stating that
they have no disagreement in regard to the requested change;
 
(3)A statement from all assignees of the parties submitting
a statement under paragraphs (b)(1) and (b)(2) of this section
agreeing to the change of inventorship in the patent, which statement
must comply with the requirements of § 3.73(b) of this chapter;
and
 
(4)The fee set forth in § 1.20(b).
 
(c)For correction of inventorship in an application, see
§§ 1.48 and 1.497.
 
(d)In a contested case before the Board of Patent Appeals
and Interferences under part 41, subpart D, of this title, a request
for correction of a patent must be in the form of a motion under
§
41.121(a)(2) or § 41.121(a)(3) of this title.
 
The petition to correct inventorship under 37 CFR
1.324 must include the statements and fee required by
37 CFR 1.324(b).
 
Under 37 CFR 1.324(b)(1), a statement is required
from each person who is being added as an inventor
that the inventorship error occurred without any
deceptive intention on their part. In order to satisfy
this, a statement such as the following is sufficient:
 
“The inventorship error of failing to include John Smith
as an inventor of the patent occurred without any deceptive
intention on the part of John Smith.”
 
Nothing more is required. The examiner will determine
only whether the statement contains the required
language; the examiner will not make any commentas to whether or not it appears that there was in fact
deceptive intention (see MPEP § 2022.05).
 
Under 37 CFR 1.324(b)(2), all current inventors
who did not submit a statement under 37 CFR
1.324(b)(1) must submit a statement either agreeing to
the change of inventorship, or stating that they have
no disagreement with regard to the requested change.
“Current inventors” include the inventor(s) being
retained as such and the inventor(s) to be deleted.
These current inventors need not make a statement as
to whether the inventorship error occurred without
deceptive intention.
 
If an inventor is not available, or refuses, to submit
a statement, the assignee of the patent may wish to
consider filing a reissue application to correct inventorship,
since the inventor’s statement is not required
for a non-broadening reissue application to correct
inventorship. See MPEP § 1412.04.
 
Under 37 CFR 1.324(b)(3), a statement is required
from the assignee(s) of the patent agreeing to the
change of inventorship in the patent. The assignee
statement agreeing to the change of inventorship must
be accompanied by a proper statement under 37 CFR
3.73(b) establishing ownership, unless a proper 37
CFR 3.73(b) statement is already in the file. See
MPEP § 324 as to the requirements of a statement
under 37 CFR 3.73(b).
 
While a request under 37 CFR 1.48 is appropriate
to correct inventorship in a nonprovisional application,
a petition under 37 CFR 1.324 is the appropriate
vehicle to correct inventorship in a patent. If a request
under 37 CFR 1.48(a), (b), or (c) is inadvertently filed
in a patent, the request may be treated as a petition
under 37 CFR 1.324, and if it is grantable, form paragraph
10.14 set forth below should be used.
 
Similarly, if a request under 37 CFR 1.48(a), (b), or
(c) is filed in a pending application but not acted upon
until after the application becomes a patent, the
request may be treated as a petition under 37 CFR
 
 
 
 
 
1.324, and if it is grantable, form paragraph 10.14 set
forth below should be used.
 
The statutory basis for correction of inventorship
in a patent under 37 CFR 1.324 is 35 U.S.C. 256. It is
important to recognize that 35 U.S.C. 256 is stricter
than 35 U.S.C. 116, the statutory basis for corrections
of inventorship in applications under 37 CFR 1.48.
35
U.S.C. 256 requires “on application of all the parties
and assignees,” while 35 U.S.C. 116 does not
have the same requirement. Under 35 U.S.C. 116 and
37 CFR 1.48, waiver requests under 37 CFR 1.183may be submitted (see, e.g., MPEP § 201.03, under
the heading “Statement of Lack of Deceptive Intention”).
This is not possible under 35 U.S.C. 256 and
37 CFR 1.324. In correction of inventorship in a nonprovisional
application under 37 CFR 1.48(a), the
requirement for a statement by each originally named
inventor may be waived pursuant to 37 CFR 1.183;
however, correction of inventorship in a patent under
37 CFR 1.324 requires petition of all the parties, i.e.,
originally named inventors and assignees, in accordance
with statute (35 U.S.C. 256) and thus the
requirement cannot be waived. Correction of inventorship
requests under 37 CFR 1.324 should be
directed to the Supervisory Patent Examiner whose
unit handles the subject matter of the patent. Form
paragraphs 10.13 through 10.18 may be used.
 
¶ 10.13 Petition Under 37 CFR 1.324, Granted
 
In re Patent No. [1]:
 
Issue Date: [2]: DECISION
 
Appl. No.: [3]: GRANTING
 
Filed: [4]: PETITION
 
For: [5]: 37 CFR 1.324
 
This is a decision on the petition filed [6] to correct inventorship
under 37 CFR 1.324.
 
The petition is granted.
 
The patented file is being forwarded to Certificate of Corrections
Branch for issuance of a certificate naming only the actual
inventor or inventors.
 
_______________________
 
[7]
 
Supervisory Patent Examiner,
 
Art Unit [8],
 
Technology Center [9]
 
[10]
 
Examiner Note:
 
1.Petitions to correct inventorship of an issued patent are
decided by the Supervisory Patent Examiner, as set forth in the
Commissioner’s memorandum dated June 2, 1989.
 
2.In bracket 10, insert the correspondence address of record.
 
3.This form paragraph is printed with the USPTO letterhead.
 
4.Prepare Certificate using form paragraph 10.15.
 
¶ 10.14 Treatment of Request Under 37 CFR 1.48 Petition
Under 37 CFR 1.324, Petition Granted
 
In re Patent No. [1]:
 
Issue Date: [2]: DECISION
 
Appl. No.: [3]: GRANTING
 
Filed: [4]: PETITION
 
For: [5]: 37 CFR 1.324
 
This is a decision on the request under 37 CFR 1.48, filed [6].
In view of the fact that the patent has already issued, the request
under 37 CFR 1.48 has been treated as a petition to correct inventorship
under 37 CFR 1.324.
 
The petition is granted.
 
The patented file is being forwarded to Certificate of Corrections
Branch for issuance of a certificate naming only the actual
inventor or inventors.
 
_______________________
 
[7]
 
Supervisory Patent Examiner,
 
Art Unit [8],
 
Technology Center [9]
 
[10]
 
Examiner Note:
 
1.Petitions to correct inventorship of an issued patent are
decided by the Supervisory Patent Examiner, as set forth in the
Commissioner’s memorandum dated June 2, 1989.
 
2.This form paragraph is printed with the USPTO letterhead.
 
3.Prepare Certificate using form paragraph 10.15.
 
4.In bracket 10, insert the correspondence address of record.
 
¶ 10.15 Memorandum - Certificate of Correction
(Inventorship)
 
DATE: [1]
 
TO: Certificates of Correction Branch
 
FROM: [2], SPE, Art Unit [3]
 
SUBJECT: Request for Certificate of Correction
 
Please issue a Certificate of Correction in U. S. Letters Patent
No. [4] as specified on the attached Certificate.
 
______________________
 
[5], SPE
 
Art Unit [6]
 
UNITED STATES PATENT AND TRADEMARK OFFICE
CERTIFICATE
 
Patent No. [7]
 
Patented: [8]
 
On petition requesting issuance of a certificate for correction of
inventorship pursuant to 35 U.S.C. 256, it has been found that the
above identified patent, through error and without deceptive
intent, improperly sets forth the inventorship. Accordingly, it is
hereby certified that the correct inventorship of this patent is:
 
[9]
 
 
 
 
 
_________________________
 
[10], Supervisory Patent Examiner
 
Art Unit [11]
 
Examiner Note:
 
1.In bracket 9, insert the full name and residence (City, State)
of each actual inventor.
 
2.This is an internal memo, not to be mailed to applicant,
which accompanies the patented file to Certificates of Correction
Branch as noted in form paragraphs 10.13 and 10.14.
 
3.In brackets 5 and 10, insert name of SPE; in brackets 6 and
11 the Art Unit and sign above each line.
 
4.Two separate pages of USPTO letterhead will be printed
when using this form paragraph.
 
¶ 10.16 Petition Under 37 CFR 1.324, Dismissed
 
In re Patent No. [1]:
 
Issue Date: [2]: DECISION
 
Appl. No.: [3]: DISMISSING
 
Filed: [4]: PETITION
 
For: [5]: 37 CFR 1.324
 
This is a decision on the petition filed [6] to correct inventorship
under 37 CFR 1.324.
 
The petition is dismissed.
 
A petition to correct inventorship as provided by 37 CFR 1.324requires (1) a statement from each person who is being added as
an inventor that the inventorship error occurred without any
deceptive intention on their part, (2) a statement from the current
named inventors (including any “inventor” being deleted) who
have not submitted a statement as per “(1)” either agreeing to the
change of inventorship or stating that they have no disagreement
in regard to the requested change, (3) a statement from all assignees
of the parties submitting a statement under “(1)” and “(2)”
agreeing to the change of inventorship in the patent; such statement
must comply with the requirements of 37 CFR 3.73(b); and
(4) the fee set forth in 37 CFR 1.20(b).This petition lacks item(s)
[7].
 
_______________________
 
[8]
 
Supervisory Patent Examiner,
 
Art Unit [9],
 
Technology Center [10]
 
[11]
 
Examiner Note:
 
1.If each of the four specified items has been submitted but one
or more is insufficient, the petition should be denied. See paragraph
10.17. However, if the above noted deficiency can be cured
by the submission of a renewed petition, a dismissal would be
appropriate.
 
2.If the petition includes a request for suspension of the rules
(37 CFR 1.183) of one or more provisions of 37 CFR 1.324 that
are required by the statute (35 U.S.C. 256), form paragraph 10.18should follow this form paragraph.
 
3.In bracket 7, pluralize as necessary and insert the item number(
s) which are missing.
 
4.In bracket 11, insert correspondence address of record.
 
5.This form paragraph is printed with the USPTO letterhead.
 
¶ 10.17 Petition Under 37 CFR 1.324, Denied
 
In re Patent No. [1]:
 
Issue Date: [2]:DECISION DENYING PETITION
 
Appl. No.: [3]:37 CFR 1.324
 
Filed: [4]:
 
For: [5]:
 
This is a decision on the petition filed [6] to correct inventorship
under 37 CFR 1.324.
 
The petition is denied.
 
[7]
 
_______________________
 
[8]
 
Supervisory Patent Examiner,
 
Art Unit [9],
 
Technology Center [10]
 
[11]
 
Examiner Note:
 
1.In bracket 7, a full explanation of the deficiency must be provided.
 
 
2.If the petition lacks one or more of the required parts set forth
in 37 CFR 1.324, it should be dismissed using form paragraph
10.14 or 10.20, rather than being denied.
 
3.In bracket 11, insert correspondence address of record.
 
4.This form paragraph is printed with the USPTO letterhead.
 
¶ 10.18 Waiver of Requirements of 37 CFR 1.324 Under 37
CFR 1.183, Dismissed
 
Suspension of the rules under 37 CFR 1.183 may be granted
for any requirement of the regulations which is not a requirement
of the statutes. In this instance, 35 U.S.C. 256 requires [1].
Accordingly, the petition under 37 CFR 1.183 is dismissed as
moot.
 
Examiner Note:
 
1. This form paragraph should follow form paragraph 10.16whenever the petition requests waiver of one or more of the provisions
of 37 CFR 1.324 that are also requirements of 35 U.S.C.
256.
 
2. If the petition requests waiver of requirements of 37 CFR
1.324 that are not specific requirements of the statute (i.e., the fee
or the oath or declaration by all inventors), the application must be
forwarded to a petitions attorney in the Office of the Deputy Commissioner
for Patent Examination Policy for decision.
 
 
 
 
 
1481.03Correction of 35 U.S.C. 119 and
35 U.S.C. 120 Benefits [R-5]
 
I.CORRECTION TO PERFECT CLAIM
FOR 35
U.S.C. 119 (a)-(d) AND (f) BENEFITS
 
 
See MPEP § 201.16 for a discussion of when
35
U.S.C. 119 (a)-(d) and (f) benefits can be perfected
by certificate of correction.
 
II.CORRECTION AS TO 35 U.S.C. 120 AND
35
U.S.C. 119(e) BENEFITS
 
A.For Applications Filed Prior to November 29,
2000
 
For applications filed prior to November 29, 2000,
it is the version of 37 CFR 1.78, which was in effect
as of November 29, 2000, that applies. The pre-
November 29, 2000 version reads as follows:
 
37 CFR 1.78. Claiming benefit of earlier filing date andcross-references to other applications.
 
(a)(1) A nonprovisional application may claim an invention
disclosed in one or more prior filed copending nonprovisional
applications or copending international applications designating
the United States of America. In order for a nonprovisional application
to claim the benefit of a prior filed copending nonprovisional
application or copending international application
designating the United States of America, each prior application
must name as an inventor at least one inventor named in the later
filed nonprovisional application and disclose the named inventor’s
invention claimed in at least one claim of the later filed nonprovisional
application in the manner provided by the first
paragraph of 35 U.S.C. 112. In addition, each prior application
must be:
 
(i)An international application entitled to a filing date in
accordance with PCT Article 11 and designating the United States
of America; or
 
(ii)Complete as set forth in § 1.51(b); or
 
(iii)Entitled to a filing date as set forth in § 1.53(b) or
§
1.53(d) and include the basic filing fee set forth in § 1.16; or
 
(iv)Entitled to a filing date as set forth in § 1.53(b) and
have paid therein the processing and retention fee set forth in
§
1.21(l) within the time period set forth in § 1.53(f).
 
(2)Except for a continued prosecution application filed
under §
1.53(d), any nonprovisional application claiming the benefit
of one or more prior filed copending nonprovisional applications
or international applications designating the United States of
America must contain a reference to each such prior application,
identifying it by application number (consisting of the series code
and serial number) or international application number and international
filing date and indicating the relationship of the applications.
Unless the reference required by this paragraph is included
in an application data sheet (§ 1.76), the specification must contain
or be amended to contain such reference in the first sentence
following any title. The request for a continued prosecution application
under § 1.53(d) is the specific reference required by
35
U.S.C. 120 to the prior application. The identification of an
application by application number under this section is the specific
reference required by 35 U.S.C. 120 to every application
assigned that application number. Cross-references to other
related applications may be made when appropriate (see
§
1.14(a)).
 
(3)A nonprovisional application other than for a design
patent may claim an invention disclosed in one or more prior filed
copending provisional applications. In order for a nonprovisional
application to claim the benefit of one or more prior filed copending
provisional applications, each prior provisional application
must name as an inventor at least one inventor named in the later
filed nonprovisional application and disclose the named inventor's
invention claimed in at least one claim of the later filed nonprovisional
application in the manner provided by the first paragraph of
35 U.S.C. 112. In addition, each prior provisional application
must be entitled to a filing date as set forth in § 1.53(c), have any
required English-language translation filed therein within the time
period set forth in § 1.52(d), and have paid therein the basic filing
fee set forth in § 1.16(k) within the time period set forth in
§
1.53(g).
 
(4)Any nonprovisional application claiming the benefit
of one or more prior filed copending provisional applications must
contain a reference to each such prior provisional application,
identifying it as a provisional application, and including the provisional
application number (consisting of series code and serial
number). Unless the reference required by this paragraph is
included in an application data sheet (§ 1.76), the specification
must contain or be amended to contain such reference in the first
sentence following any title.
 
 
 
Under certain conditions specified below, a Certificate
of Correction can be used, with respect to
35
U.S.C. 120 and 119(e) priority, to correct:
 
(A)the failure to make reference to a prior
copending application pursuant to 37 CFR 1.78(a)(2)
and (a)(4); or
 
(B)an incorrect reference to a prior copending
application pursuant to 37 CFR 1.78(a)(2) and (a)(4).
 
For all situations other than where priority is based
upon 35 U.S.C. 365(c), the conditions are as follows:
 
(A)for 35 U.S.C. 120 priority, all requirements
set forth in 37 CFR 1.78(a)(1) must have been met in
the application which became the patent to be corrected;
 
 
(B)for 35 U.S.C. 119(e) priority, all requirements
set forth in 37 CFR 1.78(a)(3) must have been met in
 
 
 
 
 
the application which became the patent to be corrected;
and
 
(C)it must be clear from the record of the patent
and the parent application(s) that priority is appropriate.
See MPEP § 201.1l for requirements under
35
U.S.C. 119(e) and 120.
 
Where 35 U.S.C. 120 and 365(c) priority based on
an international application is to be asserted or corrected
in a patent via a Certificate of Correction, the
following conditions must be satisfied:
 
(A)all requirements set forth in 37 CFR
1.78(a)(1) must have been met in the application
which became the patent to be corrected;
 
(B)it must be clear from the record of the patent
and the parent application(s) that priority is appropriate
(see MPEP § 201.11); and
 
(C)the patentee must submit with the request for
the certificate copies of documentation showing designation
of states and any other information needed to
make it clear from the record that the 35 U.S.C. 120priority is appropriate. See MPEP § 201.13(b) as to
the requirements for 35
U.S.C. 120 priority based on
an international application.
 
If all the above-stated conditions are satisfied, a
Certificate of Correction can be used to amend the
patent to make reference to a prior copending application,
or to correct an incorrect reference to the prior
copending application. Note In re Schuurs, 218 USPQ
443 (Comm’r Pat. 1983) which suggests that a Certificate
of Correction is an appropriate remedy for correcting,
in a patent, reference to a prior copending
application. Also, note In re Lambrech, 202 USPQ
620 (Comm’r Pat. 1976), citing In re Van Esdonk,
187
USPQ 671 (Comm’r Pat. 1975).
 
If any of the above-stated conditions is not satisfied,
the filing of a reissue application (see MPEP
§
1401 - § 1460) would be appropriate to pursue the
desired correction of the patent.
 
B.For Applications Filed on or After November
29, 2000
 
For applications filed on or after November 29,
2000, the version of 37 CFR 1.78 reproduced below
applies (note that amendments to 37 CFR 1.78 took
effect on November 29, 2000, December 28, 2001,
May 1, 2003, January 21, 2004, September 21, 2004,
December 8, 2004,  July 1, 2005, and November
25, 2005).
 
37 CFR 1.78. Claiming benefit of earlier filing date and
cross-references to other applications.
 
(a)(1)A nonprovisional application or international application
designating the United States of America may claim an
invention disclosed in one or more prior-filed copending nonprovisional
applications or international applications designating the
United States of America. In order for an application to claim the
benefit of a prior-filed copending nonprovisional application or
international application designating the United States of America,
each prior-filed application must name as an inventor at least
one inventor named in the later-filed application and disclose the
named inventor’s invention claimed in at least one claim of the
later-filed application in the manner provided by the first paragraph
of 35 U.S.C. 112. In addition, each prior-filed application
must be:
 
(i) An international application entitled to a filing date
in accordance with PCT Article 11 and designating the United
States of America; or
 
(ii) Entitled to a filing date as set forth in § 1.53(b) or §
1.53(d) and have paid therein the basic filing fee set forth in § 1.16within the pendency of the application.
 
(2)(i)Except for a continued prosecution application
filed under § 1.53(d), any nonprovisional application or international
application designating the United States of America claiming
the benefit of one or more prior-filed copending
nonprovisional applications or international applications designating
the United States of America must contain or be amended to
contain a reference to each such prior-filed application, identifying
it by application number (consisting of the series code and
serial number) or international application number and international
filing date and indicating the relationship of the applications.
Cross references to other related applications may be made
when appropriate (see § 1.14).
 
(ii)This reference must be submitted during the pendency
of the later-filed application. If the later-filed application is
an application filed under 35
U.S.C. 111(a), this reference must
also be submitted within the later of four months from the actual
filing date of the later-filed application or sixteen months from the
filing date of the prior-filed application. If the later-filed application
is a nonprovisional application which entered the national
stage from an international application after compliance with
35
U.S.C. 371, this reference must also be submitted within the
later of four months from the date on which the national stage
commenced under 35 U.S.C. 371 (b) or (f) in the later-filed international
application or sixteen months from the filing date of the
prior-filed application. These time periods are not extendable.
Except as provided in paragraph (a)(3) of this section, the failure
to timely submit the reference required by 35 U.S.C. 120 and
paragraph (a)(2)(i) of this section is considered a waiver of any
benefit under 35
U.S.C. 120, 121, or 365(c) to such prior-filed
application. The time periods in this paragraph do not apply if the
later-filed application is:
 
 
 
 
 
(A)An application for a design patent;
 
(B)An application filed under 35 U.S.C. 111 (a)
before November 29, 2000; or
 
(C)A nonprovisional application which entered the
national stage after compliance with 35 U.S.C. 371 from an international
application filed under 35 U.S.C. 363 before November
29, 2000.
 
(iii)If the later-filed application is a nonprovisional
application, the reference required by this paragraph must be
included in an application data sheet (§ 1.76), or the specification
must contain or be amended to contain such reference in the first
sentence(s) following the title.
 
(iv)The request for a continued prosecution application
under § 1.53(d) is the specific reference required by
35
U.S.C. 120 to the prior-filed application. The identification of
an application by application number under this section is the
identification of every application assigned that application number
necessary for a specific reference required by 35 U.S.C. 120 to
every such application assigned that application number.
 
(3)If the reference required by 35 U.S.C. 120 and paragraph
(a)(2) of this section is presented after the time period provided
by paragraph (a)(2)(ii) of this section, the claim under
35
U.S.C. 120, 121, or 365(c) for the benefit of a prior-filed
copending nonprovisional application or international application
designating the United States of America may be accepted if the
reference identifying the prior-filed application by application
number or international application number and international filing
date was unintentionally delayed. A petition to accept an unintentionally
delayed claim under 35 U.S.C. 120, 121, or 365(c) for
the benefit of a prior-filed application must be accompanied by:
 
(i)The reference required by 35 U.S.C. 120 and paragraph
(a)(2) of this section to the prior-filed application, unless
previously submitted;
 
(ii)The surcharge set forth in § 1.17(t); and
 
(iii)A statement that the entire delay between the date
the claim was due under paragraph (a)(2)(ii) of this section and
the date the claim was filed was unintentional. The Director may
require additional information where there is a question whether
the delay was unintentional.
 
(4)A nonprovisional application, other than for a design
patent, or an international application designating the United
States of America may claim an invention disclosed in one or
more prior-filed provisional applications. In order for an application
to claim the benefit of one or more prior-filed provisional
applications, each prior-filed provisional application must name
as an inventor at least one inventor named in the later-filed application
and disclose the named inventor’s invention claimed in at
least one claim of the later-filed application in the manner provided
by the first paragraph of 35
U.S.C. 112. In addition, each
prior-filed provisional application must be entitled to a filing date
as set forth in § 1.53(c), and the basic filing fee set forth in
§
1.16(d) must be paid within the time period set forth in
§
1.53(g).
 
(5)(i) Any nonprovisional application or international
application designating the United States of America claiming the
benefit of one or more prior-filed provisional applications must
contain or be amended to contain a reference to each such prior-
filed provisional application, identifying it by the provisional
application number (consisting of series code and serial number).
 
(ii)This reference must be submitted during the pendency
of the later-filed application. If the later-filed application is
an application filed under 35
U.S.C. 111(a), this reference must
also be submitted within the later of four months from the actual
filing date of the later-filed application or sixteen months from the
filing date of the prior-filed provisional application. If the later-
filed application is a nonprovisional application which entered the
national stage from an international application after compliance
with 35 U.S.C. 371, this reference must also be submitted within
the later of four months from the date on which the national stage
commenced under 35
U.S.C. 371(b) or (f) in the later-filed international
application or sixteen months from the filing date of the
prior-filed provisional application. These time periods are not
extendable. Except as provided in paragraph(a)(6) of this section,
the failure to timely submit the reference is considered a waiver of
any benefit under 35 U.S.C. 119(e) to such prior-filed provisional
application. The time periods in this paragraph do not apply if the
later-filed application is:
 
(A)An application filed under 35 U.S.C. 111(a)
before November 29, 2000; or
 
(B)A nonprovisional application which entered the
national stage after compliance with 35 U.S.C. 371 from an international
application filed under 35 U.S.C. 363 before November
29, 2000.
 
(iii)If the later-filed application is a nonprovisional
application, the reference required by this paragraph must be
included in an application data sheet (§ 1.76), or the specification
must contain or be amended to contain such reference in the first
sentence(s) following the title.
 
 
 
(iv)If the prior-filed provisional application was filed
in a language other than English and both an English-language
translation of the prior-filed provisional application and a statement
that the translation is accurate were not previously filed in
the prior-filed provisional application, applicant will be notified
and given a period of time within which to file, in the prior-filed
provisional application, the translation and the statement. If the
notice is mailed in a pending nonprovisional application, a timely
reply to such a notice must include the filing in the nonprovisional
application of either a confirmation that the translation and statement
were filed in the provisional application, or an amendment
or Supplemental Application Data Sheet withdrawing the benefit
claim, or the nonprovisional application will be abandoned. The
translation and statement may be filed in the provisional application,
even if the provisional application has become abandoned.
 
(6)If the reference required by 35 U.S.C. 119(e) and
paragraph (a)(5) of this section is presented in a nonprovisional
application after the time period provided by paragraph (a)(5)(ii)
of this section, the claim under 35
U.S.C. 119(e) for the benefit of
a prior filed provisional application may be accepted during the
pendency of the later-filed application if the reference identifying
the prior-filed application by provisional application number was
unintentionally delayed. A petition to accept an unintentionally
delayed claim under 35
U.S.C. 119(e) for the benefit of a prior
filed provisional application must be accompanied by:
 
 
 
 
 
(i)The reference required by 35 U.S.C. 119(e) and
paragraph (a)(5) of this section to the prior-filed provisional application,
unless previously submitted;
 
(ii)The surcharge set forth in § 1.17(t); and
 
(iii)A statement that the entire delay between the date
the claim was due under paragraph (a)(5)(ii) of this section and
the date the claim was filed was unintentional. The Director may
require additional information where there is a question whether
the delay was unintentional.
 
(b)Where two or more applications filed by the same applicant
contain conflicting claims, elimination of such claims from
all but one application may be required in the absence of good and
sufficient reason for their retention during pendency in more than
one application.
 
(c)If an application or a patent under reexamination and at
least one other application naming different inventors are owned
by the same person and contain conflicting claims, and there is no
statement of record indicating that the claimed inventions were
commonly owned or subject to an obligation of assignment to the
same person at the time the later invention was made, the Office
may require the assignee to state whether the claimed inventions
were commonly owned or subject to an obligation of assignment
to the same person at the time the later invention was made, and if
not, indicate which named inventor is the prior inventor. Even if
the claimed inventions were commonly owned, or subject to an
obligation of assignment to the same person, at the time the later
invention was made, the conflicting claims may be rejected under
the doctrine of double patenting in view of such commonly owned
or assigned applications or patents under reexamination.
 
Under no circumstances can a Certificate of Correction
be employed to correct an applicant’s mistake
by adding or correcting a priority claim under
35
U.S.C. 119(e) for an application filed on or after
November 29, 2000.
 
Section 4503 of the American Inventors Protection
Act of 1999 (AIPA) amended 35 U.S.C. 119(e)(1) to
state that:
 
No application shall be entitled to the benefit of an earlier
filed provisional application under this subsection
unless an amendment containing the specific reference to
the earlier filed provisional application is submitted at such
time during the pendency of the application as required by
the Director. The Director may consider the failure to submit
such an amendment within that time period as a waiver
of any benefit under this subsection. The Director may
establish procedures, including the payment of a surcharge,
to accept an unintentionally delayed submission of an
amendment under this section during the pendency of the
application. (emphasis added)
 
A Certificate of Correction is NOT a
valid mechanism for adding or correcting a priority
claim under 35
U.S.C. 119(e) after a patent has been
granted on an application filed on or after November
29, 2000.
 
Under certain conditions as specified below, however,
a Certificate of Correction can still be used, with
respect to 35 U.S.C. 120 priority, to correct:
 
(A)the failure to make reference to a prior
copending application pursuant to 37 CFR 1.78(a)(2);
or
 
(B)an incorrect reference to a prior copending
application pursuant to 37 CFR 1.78(a)(2).
 
Where priority is based upon 35 U.S.C. 120 to a
national application, the following conditions must
be satisfied:
 
(A)all requirements set forth in 37 CFR
1.78(a)(1) must have been met in the application
which became the patent to be corrected;
 
(B) it must be clear from the record of the patent
and the parent application(s) that priority is appropriate
(see MPEP § 201.11); and
 
(C)a grantable petition to accept an unintentionally
delayed claim for the benefit of a prior application
must be filed, including a surcharge as set forth in
37 CFR 1.17(t), as required by 37 CFR 1.78(a)(3).
 
Where 35 U.S.C. 120 and 365(c) priority based on
an international application is to be asserted or corrected
in a patent via a Certificate of Correction, the
following conditions must be satisfied:
 
(A)all requirements set forth in 37 CFR
1.78(a)(1) must have been met in the application
which became the patent to be corrected;
 
(B)it must be clear from the record of the patent
and the parent application(s) that priority is appropriate
(see MPEP § 201.11);
 
(C)the patentee must submit together with the
request for the certificate, copies of documentation
showing designation of states and any other information
needed to make it clear from the record that the
35 U.S.C. 120 priority is appropriate (see MPEP
§
201.13(b) as to the requirements for 35 U.S.C. 120priority based on an international application; and
 
(D)a grantable petition to accept an unintentionally
delayed claim for the benefit of a prior application
must be filed, including a surcharge as set forth in
37 CFR 1.17(t), as required by 37 CFR 1.78(a)(3).
 
 
 
 
 
If all the above-stated conditions are satisfied, a
Certificate of Correction can be used to amend the
patent to make reference to a prior copending application,
or to correct an incorrect reference to the prior
copending application, for benefit claims under
35
U.S.C. 120 and 365(c).
 
If any of the above-stated conditions is not satisfied,
the filing of a reissue application (see MPEP
§
1401 - § 1460) may be appropriate to pursue the
desired correction of the patent for benefit claims
under 35 U.S.C. 120 and 365(c).
 
1485Handling of Request for Certificates
of Correction [R-5]
 
A request for a Certificate of Correction should be
addressed to:
 
Commissioner for Patents
 
Office of Patent Publication
 
ATTN: Certificate of Correction Branch
 
 
 
P.O. Box 1450
 
Alexandria, VA 22313-1450
 
Requests for Certificates of Correction will be forwarded
to the Certificate of Correction Branch of the
Office of Patent Publication, where they will be listed
in a permanent record book.
 
If the patent is involved in an interference, a Certificate
of Correction under 37 CFR 1.324 will not be
issued unless a corresponding motion under 37 CFR
41.121(a)(2) or 41.121(a)(3) has been granted by the
administrative patent judge. Otherwise, determination
as to whether an error has been made, the responsibility
for the error, if any, and whether the error is of
such a nature as to justify the issuance of a Certificate
of Correction will be made by the Certificate of Correction
Branch. If a report is necessary in making such
determination, the case will be forwarded to the
appropriate group with a request that the report be furnished.
If no certificate is to issue, the party making
the request is so notified and the request, report, if
any, and copy of the communication to the person
making the request are placed in the file wrapper (for
a paper file) or entered into the file history (for an
IFW file), and entered into the “Contents” for the file
by the Certificate of Correction Branch. The case is
then returned to the patented files. If a certificate is to
issue, it will be prepared and forwarded to the person
making the request by the Office of Patent Publication.
In that case, the request, the report, if any, and a
copy of the letter transmitting the Certificate of Correction
to the person making the request will be
placed in the file wrapper (for a paper file) or entered
into the file history (for an IFW file), and entered into
the “Contents” for the file.
 
Applicants, or their attorneys or agents, are urged to
submit the text of the correction on a special Certificate
of Correction form, PTO/SB/44 (also referred to
as Form PTO-1050), which can serve as the camera
copy for use in direct offset printing of the Certificate
of Correction.
 
Where only a part of a request can be approved, or
where the Office discovers and includes additional
corrections, the appropriate alterations are made on
the form PTO/SB/44 by the Office. The patentee is
notified of the changes on the Notification of
Approval-in-part form PTOL-404. The certificate is
issued approximately 6 weeks thereafter.
 
Form PTO/SB/44 should be used exclusively
regardless of the length or complexity of the subject
matter. Intricate chemical formulas or page of specification
or drawings may be reproduced and mounted
on a blank copy of PTO/SB/44. Failure to use the
form has frequently delayed issuance since the
text
must be retyped by the Office onto a PTO/SB/44.
 
The exact page and line number where the errors
occur in the application file should be identified on
the request. However, on form PTO/SB/44, only the
column and line number in the printed patent should
be used.
 
The patent grant should be retained by the patentee.
The Office does not attach the Certificate of Correction
to patentee’s copy of the patent. The patent grant
will be returned to the patentee if submitted.
 
Below is a sample form illustrating a variety of corrections
and the suggested manner of setting out the
format. Particular attention is directed to:
 
(A)Identification of the exact point of error by
reference to column and line number of the printed
patent for changes in the specification or to claim
number and line where a claim is involved.
 
(B)Conservation of space on the form by typing
single space, beginning two lines down from the
printed message.
 
 
 
 
 
(C)Starting the correction to each separate column
as a sentence, and using semicolons to separate
corrections within the same column, where possible.
 
(D)Leaving a two-inch space blank at bottom of
the last sheet for the signature of the attesting officer.
 
(E)Using quotation marks to enclose the exact
subject matter to be deleted or corrected; using double
hyphens (-- --) to enclose subject matter to be added,
except for formulas.
 
(F)Where a formula is involved, setting out
only
that portion thereof which is to be corrected or,
if
necessary, pasting a photocopy onto form PTO/SB/
44.
 
UNITED STATES PATENT AND TRADEMARK
OFFICE CERTIFICATE OF CORRECTION
 
 
Patent No. :9,999,999
 
Application No. :10/999,999
 
Issue Date :May 1, 2002
 
Inventor(s) :Eli Y. Rosenthal
 
 
 
It is certified that error appears in the above-identified
patent and that said Letters Patent is hereby corrected as
shown below:
 
In the drawings, Sheet 3, Fig. 3, the reference numeral
225 should be applied to the plate element attached to the
support member 207:
 
Column 2, line 68 and column 3, lines 3, 8 and 13, for
the claim reference numeral '2', each occurrence, should
read -1-.
 
Column 7, lines 45 to 49, the left-hand formula should
appear as follows:
 
-R3 -CHF
 
Column 8, Formula XVII, that portion of the formula
reading “-CHClCH-” should read --CHFCH2 --; line 5,
“chlorine” should be changed to --fluorine--.
 
Column 10, line 29, cancel the text beginning with “12.
A sensor device” to and ending “active strips.” in column
11, line 10, and insert the following claim:
 
12. A control circuit of the character set forth in claim
4 and for an automobile having a convertible top, and
including; means for moving the top between a raised and
lowered retracted position; and control means responsive
to a sensor relay for energizing the top moving means for
moving said top from a retracted position to a raised position.
 
 
ELECTRONIC PUBLICATION OF CERTIFICATES
OF CORRECTION WITH LATER LISTING
IN THE OFFICIAL GAZETTE
 
Effective August 2001, the U.S. Patent and Trademark
Office (USPTO) publishes on the USPTO web
site at http://www.uspto.gov/web/patents/certofcorrect
a listing by patent number of the patents for
which certificates of correction are being issued.
 
The USPTO is now automating the publication
process for certificates of correction. This new process
will result in certificates of correction being published
quicker electronically on the USPTO’s web site
as compared to their paper publication and the listing
of the certificates of correction in the Official Gazette.
Under the newly automated process, each issue of certificates
of correction will be electronically published
on the USPTO web site at http://www.uspto.gov/web/
patents/certofcorrect, and will also subsequently be
listed in the Official Gazette (and in the Official
Gazette Notices posted at http://www.uspto.gov/web/
offices/com/sol/og) approximately three weeks thereafter.
The listing of certificates of correction in the
Official Gazette will include the certificate’s date of
issuance.
 
On the date on which the listing of certificates of
correction is electronically published on the USPTO
web site: (A) the certificate of correction will be
entered into the file wrapper of a paper-file patent, or
entered into the file history of an IFW-file patent and
will be available to the public; (B) a printed copy of
the certificate of correction will be mailed to the patentee
or the patent’s assignee; and (C) an image of the
printed certificate of correction will be added to the
image of the patent on the patent database at http://
www.uspto.gov.patft. Dissemination of all other paper
copies of the certificate of correction will occur
shortly thereafter.
 
The date on which the USPTO makes the certificate
of correction available to the public (e.g., by adding
the certificate of correction to the file wrapper/file
history) will be regarded as the date of issuance of the
certificate of correction, not the date of the certificate
of correction appearing in the Official Gazette. (For
IFW processing, see IFW Manual.) Certificates of
correction published in the above-described manner
will provide the public with prompt notice and access,
and this is consistent with the legislative intent behind
the American Inventors Protection Act of 1999. See
 
 
 
 
 
35 U.S.C. 10(a) (authorizing the USPTO to publish in
electronic form).
 
The listing of certificates of correction can be electronically
accessed on the day of issuance at http://
www.uspto.gov/web/patents/certofcorrect. The electronic
image of the printed certificate of correction
can be accessed on the patent database at http://
www.uspto.gov/patft and the listing of the certificates
of correction, as published in the Official Gazettethree weeks later, will be electronically accessible at
http://www.uspto.gov/web/offices/com/sol/og.
 
 
 
 
 
Certificate of Correction
PTO/SB/44 (04-05)
Approved for use through 04/30/2007. OMB 0651-0033
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
(Also Form PTO-1050)
UNITED STATES PATENT AND TRADEMARK OFFICE
CERTIFICATE OF CORRECTION
Page _____ of _____
PATENT NO. :
APPLICATION NO.:
ISSUE DATE :
INVENTOR(S) :
It is certified that an error appears or errors appear in the above-identified patent and that said Letters Patent
is hereby corrected as shown below:
MAILING ADDRESS OF SENDER (Please do not use customer number below):
This collection of information is required by 37 CFR 1.322, 1.323, and 1.324. The information is required to obtain or retain a benefit by the public which is to file
(and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 1.0 hour to
complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any
comments on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer,
U.S. Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED
FORMS TO THIS ADDRESS. SEND TO: Attention Certificate of Corrections Branch,Commissioner for Patents, P.O. Box 1450, Alexandria,
VA 22313-1450.
If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
DOC Code: COCIN
 
 
 
 
 
 
Privacy Act Statment
Privacy Act Statement
ThePrivacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection
with your submission of the attached form related to a patent application or patent. Accordingly,
pursuant to the requirements of the Act, please be advised that: (1) the general authority for the
collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary;
and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
Office is to process and/or examine your submission related to a patent application or patent. If you do
not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
process and/or examine your submission, which may result in termination of proceedings or
abandonment of the application or expiration of the patent.
The information provided by you in this form will be subject to the following routine uses:
1. The information on this form will be treated confidentially to the extent allowed under the
Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from
this system of records may be disclosed to the Department of Justice to determine whether
disclosure of these records is required by the Freedom of Information Act.
2. A record from this system of records may be disclosed, as a routine use, in the course of
presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to
opposing counsel in the course of settlement negotiations.
3. A record in this system of records may be disclosed, as a routine use, to a Member of
Congress submitting a request involving an individual, to whom the record pertains, when the
individual has requested assistance from the Member with respect to the subject matter of the
record.
4. A record in this system of records may be disclosed, as a routine use, to a contractor of the
Agency having need for the information in order to perform a contract. Recipients of
information shall be required to comply with the requirements of the Privacy Act of 1974, as
amended, pursuant to 5 U.S.C. 552a(m).
5. A record related to an International Application filed under the Patent Cooperation Treaty in
this system of records may be disclosed, as a routine use, to the International Bureau of the
World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
6. A record in this system of records may be disclosed, as a routine use, to another federal
agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to
the Atomic Energy Act (42 U.S.C. 218(c)).
7. A record from this system of records may be disclosed, as a routine use, to the Administrator,
General Services, or his/her designee, during an inspection of records conducted by GSA as
part of that agency’s responsibility to recommend improvements in records management
practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
be made in accordance with the GSA regulations governing inspection of records for this
purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not
be used to make determinations about individuals.
8. A record from this system of records may be disclosed, as a routine use, to the public after
either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
CFR 1.14, as a routine use, to the public if the record was filed in an application which
became abandoned or in which the proceedings were terminated and which application is
referenced by either a published application, an application open to public inspection or an
issued patent.
9. A record from this system of records may be disclosed, as a routine use, to a Federal, State,
or local law enforcement agency, if the USPTO becomes aware of a violation or potential
violation of law or regulation.
 
 
 
 
 
 
1490Disclaimers [R-5]
 
35 U.S.C. 253. Disclaimer.
 
Whenever, without any deceptive intention, a claim of a patent
is invalid the remaining claims shall not thereby be rendered
invalid. A patentee, whether of the whole or any sectional interest
therein, may, on payment of the fee required by law, make disclaimer
of any complete claim, stating therein the extent of his
interest in such patent. Such disclaimer shall be in writing, and
recorded in the Patent and Trademark Office; and it shall thereafter
be considered as part of the original patent to the extent of the
interest possessed by the disclaimant and by those claiming under
him.
 
In like manner any patentee or applicant may disclaim or dedicate
to the public the entire term, or any terminal part of the term,
of the patent granted or to be granted.
 
37 CFR 1.321. Statutory disclaimers, including terminal
disclaimers.
 
(a)A patentee owning the whole or any sectional interest in
a patent may disclaim any complete claim or claims in a patent. In
like manner any patentee may disclaim or dedicate to the public
the entire term, or any terminal part of the term, of the patent
granted. Such disclaimer is binding upon the grantee and its successors
or assigns. A notice of the disclaimer is published in the
Official Gazette and attached to the printed copies of the specification.
The disclaimer, to be recorded in the Patent and Trademark
Office, must:
 
(1)be signed by the patentee, or an attorney or agent of
record;
 
(2)identify the patent and complete claim or claims, or
term being disclaimed. A disclaimer which is not a disclaimer of a
complete claim or claims, or term, will be refused recordation;
 
(3)state the present extent of patentee’s ownership interest
in the patent; and
 
(4)be accompanied by the fee set forth in § 1.20(d).
 
(b)An applicant or assignee may disclaim or dedicate to the
public the entire term, or any terminal part of the term, of a patent
to be granted. Such terminal disclaimer is binding upon the
grantee and its successors or assigns. The terminal disclaimer, to
be recorded in the Patent and Trademark Office, must:
 
(1)be signed:
 
(i)by the applicant, or
 
(ii)if there is an assignee of record of an undivided
part interest, by the applicant and such assignee, or
 
(iii)if there is an assignee of record of the entire interest,
by such assignee, or
 
(iv)by an attorney or agent of record;
 
(2)specify the portion of the term of the patent being disclaimed;
 
 
(3)state the present extent of applicant’s or assignee’s
ownership interest in the patent to be granted; and
 
(4)be accompanied by the fee set forth in § 1.20(d).
 
(c)A terminal disclaimer, when filed to obviate judicially
created double patenting in a patent application or in a reexamination
proceeding except as provided for in paragraph (d) of this
section, must:
 
(1)Comply with the provisions of paragraphs (b)(2)
through (b)(4) of this section;
 
(2)Be signed in accordance with paragraph (b)(1) of this
section if filed in a patent application or in accordance with paragraph
(a)(1) of this section if filed in a reexamination proceeding;
and
 
(3)Include a provision that any patent granted on that
application or any patent subject to the reexamination proceeding
shall be enforceable only for and during such period that said
patent is commonly owned with the application or patent which
formed the basis for the judicially created double patenting.
 
 
 
(d)A terminal disclaimer, when filed in a patent application
or in a reexamination proceeding to obviate double patenting
based upon a patent or application that is not commonly owned
but was disqualified under 35 U.S.C. 103(c) as resulting from
activities undertaken within the scope of a joint research agreement,
must:
 
(1)Comply with the provisions of paragraphs (b)(2)
through (b)(4) of this section;
 
(2)Be signed in accordance with paragraph (b)(1) of this
section if filed in a patent application or be signed in accordance
with paragraph (a)(1) of this section if filed in a reexamination
proceeding;
 
(3)Include a provision waiving the right to separately
enforce any patent granted on that application or any patent subject
to the reexamination proceeding and the patent or any patent
granted on the application which formed the basis for the double
patenting, and that any patent granted on that application or any
patent subject to the reexamination proceeding shall be enforceable
only for and during such period that said patent and the
patent, or any patent granted on the application, which formed the
basis for the double patenting are not separately enforced.
 
A disclaimer is a statement filed by an owner (in
part or in entirety) of a patent or of a patent to be
granted (i.e., an application), in which said owner
relinquishes certain legal rights to the patent. There
are two types of disclaimers: a statutory disclaimer
and a terminal disclaimer. The owner of a patent or an
application is the original inventor(s) or the assignee
of the original inventor(s). The patent or application is
assigned by one assignment or by multiple assignments
which establish a chain of title from the inventor(
s) to the assignee(s). The owner of the patent or
application can sign a disclaimer, and a person
empowered by the owner to sign the disclaimer can
also sign it. Per 37 CFR 1.321(b)(1)(iv), an attorney
 
 
 
 
 
or agent of record is permitted to sign the disclaimer.
A registered practitioner acting in a representative
capacity under 37 CFR 1.34 is not permitted to sign
the disclaimer. For a disclaimer to be accepted, it must
be signed by the proper party as follows:
 
(A)A disclaimer filed in an application must be
signed by
 
(1)the applicant where the application has not
been assigned,
 
(2)the applicant and the assignee where each
owns a part interest in the application,
 
(3)the assignee where assignee owns the
entire interest in the application, or
 
(4)an attorney or agent of record.
 
(B)A disclaimer filed in a patent or a reexamination
proceeding must be signed by either
 
(1)the patentee (the assignee, the inventor(s) if
the patent is not assigned, or the assignee and the
inventors if the patent is assigned-in-part), or
 
(2)an attorney or agent of record.
 
(C)Where the assignee (of an application or of a
patent being reexamined or to be reissued) signs the
disclaimer, there is a requirement to comply with
37
CFR 3.73(b) in order to satisfy 37 CFR 1.321,
unless an attorney or agent of record signs the disclaimer.
In order to comply with 37 CFR 3.73(b), the
assignee’s ownership interest must be established by:
 
(1)filing in the application or patent evidence
of a chain of title from the original owner to the
assignee and a statement affirming that the documentary
evidence of the chain of title from the original
owner to the assignee was, or concurrently is
being, submitted for recordation pursuant to 37 CFR
3.11, or
 
(2)specifying in the record of the application
or patent where such evidence is recorded in the
Office (e.g., reel and frame number, etc.).
 
The submission with respect to 37 CFR 3.73(b)
to establish ownership must be signed by a party
authorized to act on behalf of the assignee. See also
MPEP § 324 as to compliance with 37 CFR 3.73(b).
A copy of the “Statement Under 37 CFR 3.73 (b),”
which is reproduced in MPEP § 324, may be sent by
the examiner to applicant to provide an acceptable
way to comply with the requirements of 37 CFR 3.73(b).
 
(D)Where the attorney or agent of record signs
the disclaimer, there is no need to comply with
37
CFR 3.73(b).
 
(E)The signature on the disclaimer need not be
an original signature. Pursuant to 37 CFR
1.4(d)(1)(ii), the submitted disclaimer can be a copy,
such as a photocopy or facsimile transmission of an
original disclaimer.
 
I.STATUTORY DISCLAIMERS
 
Under 37 CFR 1.321(a) the owner of a patent may
disclaim a complete claim or claims of his or her
patent. This may result from a lawsuit or because he
or she has reason to believe that the claim or claims
are too broad or otherwise invalid. If the patent is
involved in an interference, see 37 CFR 41.121(a).
 
As noted above, a statutory disclaimer is a statement
in which a patent owner relinquishes legal rights
to one or more claims of a patent. A statutory disclaimer
is not, however, a vehicle for adding or
amending claims, since there is no provision for such
in the statute (35 U.S.C. 253) nor the rules (37 CFR
1.321). Thus, claims of a patent cannot be disclaimed
in favor of new claims to be added to the patent or an
amendment to existing claims.
 
II.TERMINAL DISCLAIMERS
 
37 CFR 1.321(a) also provides for the filing by an
applicant or patentee of a terminal disclaimer which
disclaims or dedicates to the public the entire term or
any portion of the term of a patent or patent to be
granted.
 
37 CFR 1.321(c) specifically provides for the filing
of a terminal disclaimer in an application or a reexamination
proceeding for the purpose of overcoming
a
nonstatutory double patenting rejection. See MPEP
§ 804.02.
 
37 CFR 1.321(d) specifically provides for the filing
of a terminal disclaimer in an application or a reexamination
proceeding for the purpose of overcoming a
nonstatutory double patenting rejection based on a
U.S. patent or application that is not commonly
owned but was disqualified under 35 U.S.C. 103(c).
 
 
 
 
 
III.PROCESSING
 
Certificate of Correction Branch
 
The Certificate of Correction Branch is responsible
for the handling of all statutory disclaimers filed
under the first paragraph of 35 U.S.C. 253, whether
the case is pending or patented, and all terminal disclaimers
(filed under the second paragraph of
35
U.S.C. 253) except for those filed in an application
or reexamination proceeding pending in a Technology
Center (TC). This involves:
 
(A)Determining the compliance of the disclaimer
with 35 U.S.C. 253 and 37 CFR 1.321 and 3.73;
 
(B)Notifying applicant or patentee when the disclaimer
is informal and thus not acceptable;
 
(C)Recording the disclaimers in the record of the
application file; and
 
(D)Providing the disclaimer data for printing in
the Official Gazette.
 
IV.TERMINAL DISCLAIMER IN PENDING
APPLICATION PRACTICE IN THE
TECHNOLOGY CENTERS
 
Where a terminal disclaimer is filed in an application
pending in a TC, it will be processed by the paralegal
of the Office of the Special Program Examiner
of the TC having responsibility for the application.
The paralegal will:
 
(A)Determine compliance with 35 U.S.C. 253and 37
CFR 1.321 and 3.73, and ensure that the
appropriate terminal disclaimer fee set forth in
37
CFR 1.20(d) is/was applied;
 
(B)Notify the examiner having charge of the
application whether the terminal disclaimer is acceptable
or not;
 
(C)Where the terminal disclaimer is not acceptable,
indicate the nature of the informalities so that the
examiner can inform applicant in the next Office
action. For an IFW application, complete the IFW terminal
disclaimer form by checking the “Disapproved”
box and have the form scanned into IFW;
 
(D)Where the terminal disclaimer is acceptable,
record the terminal disclaimer in the record of the
application as set forth below.
 
The paralegal will record an acceptable terminal
disclaimer as being present in an application by:
 
For IFW applications:
 
(A)Completing the IFW terminal disclaimer form
by checking the “Approved” box and having the form
scanned into IFW; and
 
(B)Entering the terminal disclaimer into PALM
for the application.
 
For application files that are maintained in paper:
 
For paper applications with 08/ and earlier series
code
 
(A)Attaching a green label to the file wrapper;
 
(B)Stamping a notice on the file of the term
which has been disclaimed (note that the blanks on
the stamped notice for entering information on the
patent(s) being disclaimed are no longer filled in);
 
(C)Endorsing the paper containing the terminal
disclaimer submission on the “Contents” flap of the
application file; and
 
(D)Entering the terminal disclaimer into the
PALM system records, for the application.
 
For paper applications with 09/ and later series
code
 
(A)Checking a box on the file wrapper which
states that the terminal disclaimer has been filed (Any
blanks for entering information on the patent(s) being
disclaimed are no longer filled in. Note that applications
with 10/ and later series codes no longer have
such blanks to complete);
 
(B)Endorsing the paper containing the terminal
disclaimer submission on the “Contents” flap of the
application file; and
 
(C)Entering the terminal disclaimer into the
PALM system records, for the application.
 
The paralegal completes a Terminal Disclaimer
Informal Memo to notify the examiner of the nature
of any informalities in the terminal disclaimer. The
examiner should notify the applicant of the informalities
in the next Office action, or by interview with
applicant if such will expedite prosecution of the
application. Further, the examiner should initial and
date the Terminal Disclaimer Informal Memo and
return it to the paralegal to indicate that the examiner
has appropriately notified applicant about the terminal
disclaimer. The paralegal will then discard the Terminal
Disclaimer Informal Memo.
 
 
 
 
 
V.OTHER MATTERS DIRECTED TO
TERMINAL DISCLAIMERS
 
A.Requirements of Terminal Disclaimers
 
A proper terminal disclaimer must disclaim the terminal
part of the statutory term of any patent granted
on the application being examined which would
extend beyond the expiration date of the full statutory
term, shortened by any terminal disclaimer, of the
patent (or of any patent granted on the application) to
which the disclaimer is directed. Note the exculpatory
language in the second paragraph of the sample terminal
disclaimer forms, PTO/SB/25 and PTO/SB/26,
provided at the end of this Chapter. That language
(“In making the above disclaimer, the owner does not
disclaim...”) is permissible in a terminal disclaimer.
 
A terminal disclaimer filed to obviate a nonstatutory
double patenting rejection based on a commonly
owned patent or application must comply with the
requirements of 37 CFR 1.321(c). The terminal disclaimer
must state that any patent granted on the
application being examined will be enforceable only
for and during the period that it and the patent to
which the disclaimer is directed or the patent granted
on the application to which the disclaimer is directed
are commonly owned. See MPEP § 706.02(1)(2) for
examples of common ownership, or lack thereof.
 
 
 
A terminal disclaimer filed to obviate a nonstatutory
double patenting rejection based on a non-commonly
owned patent or application disqualified under
35 U.S.C. 103(c) as a result of activities undertaken
within the scope of a joint research agreement under
35 U.S.C. 103(c)(2) and (3) must comply with 37
CFR 1.321(d), which sets forth signature, waiver
rights and enforceability requirements.
 
 
 
The terminal disclaimer must include a provision:
 
(1)waiving the right to separately enforce (a) any
patent granted on that application or the patent being
reexamined and (b) the reference patent, or any patent
granted on the reference application which formed the
basis for the double patenting; and
 
(2)agreeing that any patent granted on that application
or patent being reexamined shall be enforceable
only for and during such period that said patent
and the reference patent, or any patent granted on the
reference application, which formed the basis for the
double patenting are not separately enforced.
 
A terminal disclaimer must state that the agreement
is to run with any patent granted on the application
being examined and is to be binding upon the grantee,
its successors, or assigns.
 
A statement of assignee interest in a terminal disclaimer
that “A and B are the owners of 100% of the
instant application...” is sufficient to satisfy the
37
CFR 1.321(b)(3) requirement that a terminal disclaimer
“state the present extent of applicant’s or
assignee’s ownership interest in the patent to be
granted.” Although the quoted statement does not
identify what specific percentage is owned by A and
what specific percentage is owned by B, the statement
does provide consent to the terminal disclaimer by the
entirety of the ownership of the application (A and B
own all of the invention, regardless of the individual
percentages they own).
 
The appropriate one of form paragraphs 14.27.04to 14.27.08 (reproduced below) may be used to provide
applicant or patent owner with an example of
acceptable terminal disclaimer language. Additionally,
copies of forms PTO/SB/25 and PTO/SB/26 (provided
at the end of this Chapter) may be attached to
the Office action to provide sample terminal disclaimers.
 
 
Pursuant to the last sentence of 35 U.S.C. 253, “any
patentee or applicant may disclaim or dedicate to the
public... any terminal part of the term, of the patent
granted or to be granted”. Accordingly, the disclaimer
must be of a terminal portion of the term of the entire
patent to be granted. A disclaimer of a terminal portion
of the term of an individual claim, or individual
claims will not be accepted. It is further noted that a
disclaimer of the term of individual claims would not
be appropriate since the claims of a pending application
or proceeding are subject to cancelation, amendment,
or renumbering. The statute does not provide
for conditional disclaimers and accordingly, a proposed
disclaimer which is made contingent on the
allowance of certain claims cannot be accepted. The
disclaimer should identify the disclaimant and his or
her interest in the application and should specify the
date when the disclaimer is to become effective.
 
 
 
 
 
B.Effect of Disclaimers in Continuing Applications
and in Reissues
 
A terminal disclaimer filed to obviate a double patenting
rejection is effective only with respect to the
application identified in the disclaimer unless by its
terms it extends to continuing applications. For example,
a terminal disclaimer filed in a parent application
normally has no effect on a continuing application
claiming filing date benefits of the parent application
under 35 U.S.C. 120. A terminal disclaimer filed in a
parent application to obviate a double patenting rejection
does, however, carry over to a continued prosecution
application (CPA) filed under 37 CFR 1.53(d)
(effective July 14, 2003, CPAs are only available in
design applications). The terminal disclaimer filed in
the parent application carries over because the CPA
retains the same application number as the parent
application, i.e., the application number to which the
previously filed terminal disclaimer is directed. If
applicant does not want the terminal disclaimer to
carry over to the CPA, applicant must file a petition
under 37 CFR 1.182, along with the required petition
fee, requesting the terminal disclaimer filed in the parent
application not be carried over to the CPA; see
below “Withdrawing a Terminal Disclaimer” (paragraph
“A. Before Issuance of Patent”). If applicant
files a Request for Continued Examination (RCE) of
an application under 37 CFR 1.114 (which can be
filed on or after May 29, 2000 for an application filed
on or after June 8, 1995), any terminal disclaimer
present will continue to operate, since a new application
has not been filed, but rather prosecution has
been continued in the existing application. A petition
under 37 CFR 1.182, along with the required petition
fee, may be filed, if withdrawal of the terminal disclaimer
is to be requested.
 
Reissue applications: Where a terminal disclaimer
was filed in an original application, a copy of that terminal
disclaimer is not required be filed by applicant
in the reissue.
 
For reissue application files that are maintained in
paper:
 
The face of the file wrapper of the reissue application
should, however, be marked by the examiner in
order to indicate that a terminal disclaimer has been
filed for the patent (and will be effective for the patent
as it will be reissued). Further, a copy of the terminal
disclaimer should be placed in the reissue application
file by the Technology Center.
 
For IFW reissue applications:
 
The “Final SPRE Review” form will be filled in to
indicate that a terminal disclaimer has been filed for
the patent (and will be effective for the patent as it
will be reissued). Further, a copy of the terminal disclaimer
should be scanned into the reissue application
file history by the Technology Center.
 
C.Disclaimer Identifies the Wrong Target
Application or Patent
 
In some instances a terminal disclaimer filed to
obviate an obviousness type double patenting rejection
will identify the wrong target application or
patent (i.e., an application or patent which is not the
basis for the double patenting rejection). In these
instances, a replacement terminal disclaimer identifying
the correct target application or patent would be
required by the examiner. Once a correct replacement
terminal disclaimer is received, the next Office action
should make it clear that “the second terminal disclaimer
replaces the first terminal disclaimer, and the
first terminal disclaimer is thus void.” A second terminal
disclaimer fee should not be assessed/charged,
since the first fee is applied to the second terminal disclaimer.
 
 
D.Two or More Copending Applications
 
If two (or more) pending applications are filed, in
each of which a rejection of one claimed invention
over the other on the ground of provisional obviousness-
type double patenting (ODP) is proper, the ODP
rejection will be made in each application. If the ODP
rejection is the only rejection remaining in the earlier
filed of the two pending applications, (but the later-
filed application is rejectable on other grounds),
the
examiner should then withdraw that rejection
and
permit the earlier-filed application to issue as a
patent without a terminal disclaimer. If the ODP rejection
is the only rejection remaining in the later-filed
application, (while the earlier-filed application is
rejectable on other grounds), a terminal disclaimer
 
 
 
 
 
must be required in the later-filed application, before
the ODP rejection can be withdrawn.
 
If the ODP rejections in both applications are the
only rejections remaining in those applications, the
examiner should then withdraw the ODP rejection in
the earlier filed application thereby permitting that
application to issue without need of a terminal disclaimer.
A terminal disclaimer must be required in the
later-filed application before the ODP rejection can be
withdrawn and the application be permitted to issue.
 
If both applications are filed on the same day, the
examiner should determine which application claims
the base invention and which application claims the
improvement (added limitations). The ODP rejection
in the base application can be withdrawn without a
terminal disclaimer, while the ODP rejection in the
improvement application cannot be withdrawn without
a terminal disclaimer.
 
Where there are three applications containing
claims that conflict such that an ODP rejection is
made in each application based upon the other two, it
is not sufficient to file a terminal disclaimer in only
one of the applications addressing the other two applications.
Rather, an appropriate terminal disclaimer
must be filed in at least two of the applications to link
all three together. This is because a terminal disclaimer
filed to obviate a double patenting rejection is
effective only with respect to the application in which
the terminal disclaimer is filed; it is not effective to
link the other two applications to each other.
 
VI.FORM PARAGRAPHS
 
The following form paragraphs may be used to
inform the applicant (or patent owner) of the status of
a submitted terminal disclaimer.
 
¶ 14.23 Terminal Disclaimer Proper
 
The terminal disclaimer filed on [1] disclaiming the terminal
portion of any patent granted on this application which would
extend beyond the expiration date of [2] has been reviewed and is
accepted. The terminal disclaimer has been recorded.
 
Examiner Note:
 
1.In bracket 1, insert the date the terminal disclaimer was filed.
 
2.In bracket 2, list the Patent Number and/or Application Number
(including series code and serial no.). Where an Application
Number is listed, it must be preceded by the phrase --any patent
granted on Application Number--.
 
3.If an assignment is submitted to support the terminal disclaimer,
also use form paragraph 14.34 to suggest that the assignment
be separately submitted for recording in the Office.
 
4.See MPEP § 1490 for discussion of requirements for a
proper terminal disclaimer.
 
5.Use form paragraph 14.23.01 for reexamination proceedings.
 
6.For improper terminal disclaimers, see form paragraphs14.24et seq.
 
¶ 14.23.01 Terminal Disclaimer Proper (Reexamination
Only)
 
The terminal disclaimer filed on [1] disclaiming the terminal
portion of the patent being reexamined which would extend
beyond the expiration date of [2] has been reviewed and is
accepted. The terminal disclaimer has been recorded.
 
Examiner Note:
 
1.In bracket 1, insert the date the terminal disclaimer was filed.
 
2.In bracket 2, list the Patent Number and/or Application Number
(including series code and serial no.). Where an Application
Number is listed, it must be preceded by the phrase --any patent
granted on Application Number--.
 
3.If an assignment is submitted to support the terminal disclaimer,
also use 14.34 to suggest that the assignment be separately
submitted for recording in the Office.
 
4.See MPEP § 1490 for discussion of requirements for a
proper terminal disclaimer.
 
5.For improper terminal disclaimers, see the form paragraphs
which follow.
 
 
 
¶ 14.24 Terminal Disclaimer Not Proper - Introductory
Paragraph
 
The terminal disclaimer filed on [1] disclaiming the terminal
portion of any patent granted on this application which would
extend beyond the expiration date of [2] has been reviewed and is
NOT accepted.
 
Examiner Note:
 
1.In bracket 1, insert the date the terminal disclaimer was filed.
 
2.In bracket 2, list the Patent Number and/or Application Number
(including series code and serial no.). Where an Application
Number is listed, it must be preceded by the phrase --any patent
granted on Application Number--.
 
3.One or more of the appropriate form paragraphs 14.26 to
14.32 MUST follow this form paragraph to indicate why the terminal
disclaimer is not accepted.
 
4.Form paragraph 14.33 includes the full text of 37 CFR 3.73and may be included in the Office action when deemed appropriate.
 
 
5.Form paragraph 14.35 may be used to inform applicant that
an additional disclaimer fee will not be required for the submission
of a replacement or supplemental terminal disclaimer.
 
6.Do not use in reexamination proceedings, use form paragraph
14.25 instead.
 
 
 
 
 
 
 
¶ 14.25 Terminal Disclaimer Not Proper - Introductory
Paragraph (Reexamination Only)
 
The terminal disclaimer filed on [1] disclaiming the terminal
portion of the patent being reexamined which would extend
beyond the expiration date of [2] has been reviewed and is NOT
accepted.
 
Examiner Note:
 
1.In bracket 1, insert the date the terminal disclaimer was filed.
 
2.In bracket 2, list the Patent Number and/or the Application
Number (including series code and serial no.). Where an Application
Number is listed, it must be preceded by the phrase --any
patent granted on Application Number--.
 
3.One or more of the appropriate form paragraphs 14.26 to
14.32 MUST follow this form paragraph to indicate why the terminal
disclaimer is not accepted.
 
4.Form paragraph 14.33 includes the full text of 37 CFR 3.73and may be included in the Office action when deemed appropriate.
 
 
5.Form paragraph 14.35 may be used to inform applicant that
an additional disclaimer fee will not be required for the submission
of a replacement or supplemental terminal disclaimer.
 
¶ 14.26 Does Not Comply With 37 CFR 1.321(b) and/or
(c) “Sub-Heading” Only
 
The terminal disclaimer does not comply with 37 CFR
1.321(b) and/or (c) because:
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 and followed by one or more of the appropriate
form paragraphs 14.26.01 to 14.27.03.
 
¶ 14.26.01 Extent of Interest Not Stated
 
The person who has signed the disclaimer has not stated the
extent of his/her interest, or the business entity’s interest, in the
application/patent. See 37 CFR 1.321(b)(3).
 
Examiner Note:
 
This form paragraph MUST be preceded by form paragraph
14.24 or 14.25 AND 14.26.
 
¶ 14.26.02 Directed to Particular Claim(s)
 
It is directed to a particular claim or claims, which is not
acceptable, since “the disclaimer must be of a terminal portion of
the term of the entire [patent or] patent to be granted.” See MPEP
§ 1490.
 
Examiner Note:
 
This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.26.
 
¶ 14.26.03 Not Signed
 
The terminal disclaimer was not signed.
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.26.
 
¶ 14.26.04 Application/Patent Not Identified
 
The application/patent being disclaimed has not been identified.
 
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.26.
 
¶ 14.26.05 Application/Patent Improperly Identified
 
The application/patent being disclaimed has been improperly
identified since the number used to identify the [1] being disclaimed
is incorrect. The correct number is [2].
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.26.
 
2.In bracket 1, insert --application-- or --patent--.
 
3.In bracket 2, insert the correct Application Number (including
series code and serial no.) or the correct Patent Number being
disclaimed.
 
4.A terminal disclaimer is acceptable if it includes the correct
Patent Number or the correct Application Number or the serial
number together with the proper filing date or the proper series
code.
 
¶ 14.26.06 Not Signed by All Owners
 
It was not signed by all owners and, therefore, supplemental
terminal disclaimers are required from the remaining owners.
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.26.
 
¶ 14.26.07 No Disclaimer Fee Submitted
 
The disclaimer fee of $ [1] in accordance with 37 CFR 1.20(d)
has not been submitted, nor is there any authorization in the application
file to charge a specified Deposit Account or credit card.
 
Examiner Note:
 
1.In bracket 1, insert the fee for a disclaimer.
 
2.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.26. If the disclaimer fee was paid for a
terminal disclaimer which was not accepted, applicant does nothave to pay another disclaimer fee when submitting a replacement
or supplemental terminal disclaimer, and this form paragraph
should not be used.
 
¶ 14.27.01 Lacks Clause of Enforceable Only During
Period of Common Ownership
 
It does not include a recitation that any patent granted shall be
enforceable only for and during such period that said patent is
commonly owned with the application(s) or patent(s) which
formed the basis for the double patenting rejection. See 37 CFR
1.321(c)(3).
 
Examiner Note:
 
This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.26.
 
 
 
 
 
 
 
¶ 14.27.011 Lacks 37 CFR 1.321(d) statement for joint
research agreement under 35 U.S.C. 103(c)(2)&(3)
 
It does not include the waiver and enforceability provisions of
37 CFR 1.321(d). The terminal disclaimer must include a provision:
 
 
(1) waiving the right to separately enforce (a) any patent
granted on that application or the patent being reexamined and (b)
the reference patent, or any patent granted on the reference application
which formed the basis of the double patenting; and
 
(2) agreeing that any patent granted on that application or
patent being reexamined shall be enforceable only for and during
such period that said patent and the reference patent, or any patent
granted on the reference application, which formed the basis for
the double patenting are not separately enforced.
 
See 37 CFR 1.321(d)(3).
 
Examiner Note:
 
This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.26, and this paragraph should be followed
by either form paragraph 14.27.07 or form paragraph 14.27.08.
 
 
 
¶ 14.27.02 Fails To Disclaim Terminal Portion of Any
Patent Granted On Subject Application
 
It fails to disclaim the terminal portion of any patent granted on
the subject application.
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraph
14.24 or 14.25 AND 14.26.
 
2.Use this form paragraph when the period disclaimed is not
the correct period or when no period is specified at all.
 
3.When using this form paragraph, give an example of proper
terminal disclaimer language using form paragraph 14.27.04 following
this or the series of statements concerning the defective
terminal disclaimer.
 
¶ 14.27.03 Fails To Disclaim Terminal Portion of Subject
Patent
 
It fails to disclaim the terminal portion of the subject patent.
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraph
14.24 or 14.25 AND 14.26.
 
2.Use this form paragraph in a reissue application or reexamination
proceeding when the period disclaimed is not the correct
period or when no period is specified at all.
 
 
 
¶ 14.27.04 Examples of Acceptable Terminal Disclaimer
Language in Patent To Be Granted
 
Examples of acceptable language for making the disclaimer of
the terminal portion of any patent granted on the subject application
follow:
 
I. If a Provisional Obviousness-Type Double Patenting
Rejection Over A Pending Application was made, use:
 
The owner, _________________________________,
of ____________ percent interest in the instant application
hereby disclaims the terminal part of the statutory term of
any patent granted on the instant application which would
extend beyond the expiration date of the full statutory term
of any patent granted on pending reference Application
Number ________________, filed on _____________, as
such term is defined in 35 U.S.C. 154 and 173, and as the
term of any patent granted on said reference application
may be shortened by any terminal disclaimer filed prior to
the grant of any patent on the pending reference application.
The owner hereby agrees that any patent so granted on
the instant application shall be enforceable only for and during
such period that it and any patent granted on the reference
application are commonly owned. This agreement
runs with any patent granted on the instant application and
is binding upon the grantee, its successors or assigns.
 
II. If an Obviousness-Type Double Patenting Rejection
Over A Prior Patent was made, use:
 
The owner, _________________________________,
of ____________ percent interest in the instant application
hereby disclaims the terminal part of the statutory term of
any patent granted on the instant application which would
extend beyond the expiration date of the full statutory term
of reference patent No. ________________ as the term of
said prior patent is defined in 35 U.S.C. 154 and 173 , and
as the term of said reference patent is presently shortened
by any terminal disclaimer. The owner hereby agrees that
any patent so granted on the instant application shall be
enforceable only for and during such period that it and the
reference patent are commonly owned. This agreement
runs with any patent granted on the instant application and
is binding upon the grantee, its successors or assigns.
 
Alternatively, Form PTO/SB/25 may be used for situation I,
and Form PTO/SB/26 may be used for situation II; a copy of each
form may be found at the end of MPEP § 1490.
 
Examiner Note:
 
1.To provide examples of acceptable terminal disclaimer language
in a patent (e.g., for a reexamination situation), other than
for a terminal disclaimer based on activities undertaken within the
scope of a joint research agreement, use form paragraph 14.27.06.
 
2.To provide examples of acceptable terminal disclaimer language
for a terminal disclaimer based on activities undertaken
within the scope of a joint research agreement, (a) use form paragraph
14.27.07 for making the disclaimer of the terminal portion
of a patent to be granted on an application (generally, an application
being examined), and (b) use form paragraph 14.27.08 for
making the disclaimer of the terminal portion of an existing patent
(e.g., for a reexamination situation).
 
 
 
 
 
 
 
¶ 14.27.06 Examples of Acceptable Terminal Disclaimer
Language in Patent (Reexamination Situation)
 
Examples of acceptable language for making the disclaimer of
the terminal portion of the patent being reexamined (or otherwise
for an existing patent) follow:
 
I. If a Provisional Obviousness-Type Double Patenting
Rejection Over A Pending Application was made, or is
otherwise believed to be applicable to the patent, use:
 
The patent owner hereby disclaims the terminal part of
the instant patent, which would extend beyond the expiration
date of the full statutory term of any patent granted on
pending Application Number ______________, filed on
______________, as such term is defined in 35 U.S.C. 154and 173, and as the term of any patent granted on said application
may be shortened by any terminal disclaimer filed
prior to the grant of any patent on the pending application.
The patent owner hereby agrees that the instant patent shall
be enforceable only for and during such period that the
instant patent and any patent granted on the above-listed
pending application are commonly owned. This agreement
is binding upon the patent owner, its successors, or assigns.
 
II. If an Obviousness-Type Double Patenting Rejection
Over A Prior Patent was made, or is otherwise believed
to be applicable to the patent, use:
 
The patent owner hereby disclaims the terminal part of
the instant patent, which would extend beyond the expiration
date of the full statutory term of reference patent No.
______________ as the term of said reference patent is
defined in 35 U.S.C. 154 and 173, and as the term of said
reference patent is presently shortened by any terminal disclaimer.
The patent owner hereby agrees that the instant
patent shall be enforceable only for and during such period
that the instant patent and the reference patent are commonly
owned. This agreement is binding upon the patent
owner, its successors, or assign.
 
Examiner Note:
 
1.To provide examples of acceptable terminal disclaimer language
in a patent to be granted on an application (generally, an
application being examined), other than for a terminal disclaimer
based on activities undertaken within the scope of a joint research
agreement, use form paragraph 14.27.04.
 
2.To provide examples of acceptable terminal disclaimer language
for a terminal disclaimer based on activities undertaken
within the scope of a joint research agreement, (a) use form paragraph
14.27.07 for making the disclaimer of the terminal portion
of a patent to be granted on an application (generally, an application
being examined), and (b) use form paragraph 14.27.08 for
making the disclaimer of the terminal portion of an existing patent
(e.g., for a reexamination situation).
 
 
 
¶ 14.27.07 Examples of Acceptable Terminal Disclaimer
Language in Patent To Be Granted (activities undertaken
within the scope of a joint research agreement)
 
Examples of acceptable language for making the disclaimer of
the terminal portion of any patent granted on the subject application
follow:
 
I. If a Provisional Obviousness-Type Double Patenting
Rejection Over A Pending Application was made, use:
 
The owner, __________________, of _______ percent
interest in the instant application hereby disclaims the terminal
part of the statutory term of any patent granted on the
instant application which would extend beyond the expiration
date of the full statutory term of any patent granted on
pending reference Application Number ______________,
filed on ______________, as such term is defined in 35
U.S.C. 154 and 173, and as the term of any patent granted
on said reference application may be shortened by any terminal
disclaimer filed prior to the grant of any patent on the
pending reference application.
 
The owner of the instant application waives the right to
separately enforce any patent granted on the instant application
and any patent granted on the reference application.
The owner of the instant application hereby agrees that any
patent granted on the instant application and any patent
granted on the reference application shall be enforceable
only for and during such period that the instant application
and the reference application are not separately enforced.
The waiver, and this agreement, run with any patent granted
on the instant application and any patent granted on the reference
application, and are binding upon the owner of the
instant application, its successors, or assigns.
 
Owner, or attorney/agent of record, of the instant application:
 
Signature:__________________________
 
Printed/Typed name:_________________
 
II. If an Obviousness-Type Double Patenting Rejection
Over A Prior Patent was made, use:
 
The owner, __________________, of _______ percent
interest in the instant application hereby disclaims the terminal
part of the statutory term of any patent granted on the
instant application which would extend beyond the expiration
date of the full statutory term of reference patent No.
_________________, as the term of said prior patent is
defined in 35 U.S.C. 154 and 173, and as the term of said
reference patent is presently shortened by any terminal disclaimer.
 
 
The owner of the instant application waives the right to
separately enforce the reference patent and any patent
granted on the instant application. The owner of the instant
application hereby agrees that the reference patent and any
patent granted on the instant application shall be enforce
 
 
 
 
 
 
able only for and during such period that the reference
patent and any patent granted on the instant application are
not separately enforced. The waiver, and this agreement, run
with any patent granted on the instant application and are
binding upon the owner of the instant application, its successors,
or assigns.
 
Owner, or attorney/agent of record, of the instant application:
 
Signature:___________________________
 
Printed/Typed name:__________________
 
Examiner Note:
 
1.To provide examples of acceptable terminal disclaimer language
in a patent (e.g., for a reexamination situation) for a terminal
disclaimer based on activities undertaken within the scope of a
joint research agreement, use form paragraph 14.27.08.
 
2.To provide examples of acceptable terminal disclaimer language
for a terminal disclaimer in a situation other than one based
on activities undertaken within the scope of a joint research agreement,
(a) use form paragraph 14.27.04 for making the disclaimer
of the terminal portion of a patent to be granted on an application
(generally, an application being examined), and (b) use form paragraph
14.27.06 for making the disclaimer of the terminal portion
of an existing patent (e.g., for a reexamination situation).
 
¶ 14.27.08 Examples of Acceptable Terminal Disclaimer
Language in Patent (Reexamination Situation; activities
undertaken within the scope of a joint research agreement)
 
Examples of acceptable language for making the disclaimer of
the terminal portion of the patent being reexamined (or otherwise
for an existing patent) follow:
 
I. If a provisional obviousness-type double patenting
rejection over a Pending Application was made, or is otherwise
believed to be applicable to the patent, use:
 
The patent owner hereby disclaims the terminal part of
the instant patent, which would extend beyond the expiration
date of the full statutory term of any patent granted on
pending Application Number ______________, filed on
______________, as such term is defined in 35 U.S.C. 154and 173, and as the term of any patent granted on said application
may be shortened by any terminal disclaimer filed
prior to the grant of any patent on the pending application.
 
The patent owner waives the right to separately enforce
the instant patent and the above-listed pending application.
The patent owner agrees that the instant patent and any
patent granted on the above-listed pending application shall
be enforceable only for and during such period that the
instant patent and the patent granted on the above-listed
pending application are not separately enforced. The
waiver, and this agreement, run with any patent granted on
the above-listed pending application, and are binding upon
the patent owner, its successors, or assigns.
 
Patent Owner, or attorney/agent of record:
 
Signature:_________________________
 
Printed/Typed name:________________
 
II. If an obviousness-type double patenting rejection
over a Reference Patent was made, or is otherwise believed
to be applicable to the patent, use:
 
The patent owner hereby disclaims the terminal part of
the instant patent, which would extend beyond the expiration
date of the full statutory term of reference patent No.
_________________, as the term of said reference patentis defined in 35 U.S.C. 154 and 173, and as the term of said
reference patent is presently shortened by any terminal disclaimer.
 
 
The patent owner waives the right to separately enforce
the instant patent and the reference patent. The patent
owner agrees that the instant patent and the reference
patent shall be enforceable only for and during such period
that the instant patent and the reference patent are not separately
enforced. The waiver, and this agreement, are binding
upon the patent owner, its successors, or assigns.
 
Patent Owner, or attorney/agent of record:
 
Signature:_________________________
 
Printed/Typed name:________________
 
Examiner Note:
 
1.To provide examples of acceptable terminal disclaimer language
in a patent to be granted on an application (generally, an
application being examined) for a terminal disclaimer based on
activities undertaken within the scope of a joint research agreement,
use form paragraph 14.27.07.
 
2.To provide examples of acceptable terminal disclaimer language
for a terminal disclaimer in a situation other than one based
on activities undertaken within the scope of a joint research agreement,
(a) use form paragraph 14.27.04 for making the disclaimer
of the terminal portion of a patent to be granted on an application
(generally, an application being examined), and (b) use form paragraph
14.27.06 for making the disclaimer of the terminal portion
of an existing patent (e.g., for a reexamination situation).
 
 
 
¶ 14.28 Failure To State Capacity To Sign
 
The person who signed the terminal disclaimer has failed to
state his/her capacity to sign for the corporation, or other business
entity or organization, and he/she has not been established as
being authorized to act on behalf of the assignee.
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraph
14.24 or 14.25 AND 14.26.
 
¶ 14.29 Not Recognized as Officer of Assignee - “Sub-
Heading” Only
 
The person who signed the terminal disclaimer is not recognized
as an officer of the assignee, and he/she has not been established
as being authorized to act on behalf of the assignee. See
MPEP § 324.
 
 
 
 
 
Examiner Note:
 
1.This form paragraph is to be used when the person signing
the terminal disclaimer is not an authorized officer as defined in
MPEP § 324.
 
2.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 and followed by form paragraphs 14.29.01 and/or
14.29.02 when appropriate. An attorney or agent of record is
always authorized to sign the terminal disclaimer, even though
there is no indication that he or she is an officer of the assignee.
 
3.Use form paragraph 14.29.02 to explain how an official,
other than a recognized officer, may properly sign a terminal disclaimer.
 
 
¶ 14.29.01 Attorney/Agent Not of Record
 
An attorney or agent, not of record, is not authorized to sign a
terminal disclaimer in the capacity as an attorney or agent acting
in a representative capacity as provided by 37 CFR 1.34 (a). See
37 CFR 1.321(b) and/or
(c).
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.29.
 
2.An attorney or agent, however, may sign a terminal disclaimer
provided he/she is an attorney or agent of record or is
established as an appropriate official of the assignee. To suggest to
the attorney or agent, not of record, how he/she may establish status
as an appropriate official of the assignee to sign a terminal disclaimer,
use form paragraph 14.29.02.
 
¶ 14.29.02 Criteria To Accept Terminal Disclaimer When
Signed by a Non-Recognized Officer
 
It would be acceptable for a person, other than a recognized
officer, to sign a terminal disclaimer, provided the record for the
application includes a statement that the person is empowered to
sign terminal disclaimers and/or act on behalf of the assignee.
 
Accordingly, a new terminal disclaimer which includes the
above empowerment statement will be considered to be signed by
an appropriate official of the assignee. A separately filed paper
referencing the previously filed terminal disclaimer and containing
a proper empowerment statement would also be acceptable.
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.29.
 
2.When form paragraph 14.29 is used to indicate that a terminal
disclaimer is denied because it was not signed by a recognized
officer nor by an attorney or agent of record, this form paragraph
should be used to point out one way to correct the problem.
 
3.While an indication of the person’s title is desirable, its inclusion
is not mandatory when this option is employed.
 
4.A sample terminal disclaimer should be sent with the Office
action.
 
 
 
¶ 14.30 No Evidence of Chain of Title to Assignee -
Application
 
The assignee has not established its ownership interest in the
application, in order to support the terminal disclaimer. There is
no submission in the record establishing the ownership interest by
either (a) providing documentary evidence of a chain of title from
the original inventor(s) to the assignee and a statement affirming
that the documentary evidence of the chain of title form the original
owner to the assignee was, or concurrently is being, submitted
for recordatoin pursuant to 37 CFR 3.11, or (b) specifying (by reel
and frame number) where such documentary evidence is recorded
in the Office (37 CFR 3.73(b)).
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraph
14.24 or 14.25.
 
2.Where an attorney or agent of record signs a terminal disclaimer,
there is no need to provide a statement under 37 CFR
3.73(b). Thus, this form paragraph should not be used.
 
3.It should be noted that the documentary evidence or the specifying
of reel and frame number may be found in the terminal disclaimer
itself or in a separate paper.
 
¶ 14.30.01 No Evidence of Chain of Title to Assignee -
Patent
 
The assignee has not established its ownership interest in the
patent, in order to support the terminal disclaimer. There is no
submission in the record establishing the ownership interest by
either (a) providing documentary evidence of a chain of title from
the original inventor(s) to the assignee and a statement affirming
that the documentary evidence of the chain of title form the original
owner to the assignee was, or concurrently is being, submitted
for recordatoin pursuant to 37 CFR 3.11, or (b) specifying (by reel
and frame number) where such documentary evidence is recorded
in the Office (37 CFR 3.73(b)).
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraph
14.24 or 14.25.
 
2.Where an attorney or agent of record signs a terminal disclaimer,
there is no need to provide a statement under 37 CFR
3.73(b). Thus, this form paragraph should not be used.
 
3.It should be noted that the documentary evidence or the specifying
of reel and frame number may be found in the terminal disclaimer
itself or in a separate paper in the application.
 
 
 
¶ 14.30.02 Evidence of Chain of Title to Assignee -
Submission Not Signed by Appropriate Party - Terminal
Disclaimer Is Thus Not Entered
 
The submission establishing the ownership interest of the
assignee is informal. There is no indication of record that the party
who signed the submission establishing the ownership interest is
authorized to sign the submission (37 CFR 3.73(b)).
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraph
14.24 or 14.25.
 
2.Where an attorney or agent of record signs a terminal disclaimer,
there is no need to provide any statement under 37 CFR
3.73(b). Thus, this form paragraph should not be used.
 
 
 
 
 
3.This form paragraph should be followed by one of form paragraphs
14.16.02 or 14.16.03. In rare situations where BOTH form
paragraphs 14.16.02 and 14.16.03 do not apply and thus cannot be
used, the examiner should instead follow this form paragraph with
a detailed statement of why the there is no authorization to sign.
 
4.Use form paragraph 14.16.06 to point out one way to correct
the problem.
 
¶ 14.32 Application/Patent Which Forms Basis for
Rejection Not Identified
 
The application/patent which forms the basis for the double
patenting rejection is not identified in the terminal disclaimer.
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraph
14.24 or 14.25.
 
2.Use this form paragraph when no information is presented. If
incorrect information is contained in the terminal disclaimer, use
form paragraphs 14.26 and 14.26.05.
 
 
 
¶ 14.33 37 CFR 3.73 - Establishing Right of Assignee To
Take Action
 
The following is a statement of 37 CFR 3.73:
 
37 CFR 3.73 Establishing right of assignee to take action.
 
(a) The inventor is presumed to be the owner of a patent
application, and any patent that may issue therefrom, unless
there is an assignment. The original applicant is presumed
to be the owner of a trademark application or registration,
unless there is an assignment.
 
(b)(1) In order to request or take action in a patent or trademark
matter, the assignee must establish its ownership of
the patent or trademark property of paragraph (a) of this section
to the satisfaction of the Director. The establishment of
ownership by the assignee may be combined with the paper
that requests or takes the action. Ownership is established
by submitting to the Office a signed statement identifying
the assignee, accompanied by either:
 
(i) Documentary evidence of a chain of title from the original
owner to the assignee (e.g., copy of an executed assignment).
For trademark matters only, the documents submitted
to establish ownership may be required to be recorded pursuant
to § 3.11 in the assignment records of the Office as a
condition to permitting the assignee to take action in a matter
pending before the Office. For patent matters only, the
submission of the documentary evidence must be accompanied
by a statement affirming that the documentary evidence
of the chain of title from the original owner to the
assignee was, or concurrently is being, submitted for recordation
pursuant to § 3.11; or
 
(ii) A statement specifying where documentary evidence of
a chain of title from the original owner to the assignee is
recorded in the assignment records of the Office (e.g., reel
and frame number).
 
(2) The submission establishing ownership must show that
the person signing the submission is a person authorized to
act on behalf of the assignee by:
 
(i) Including a statement that the person signing the submission
is authorized to act on behalf of the assignee; or
 
(ii) Being signed by a person having apparent authority to
sign on behalf of the assignee, e.g., an officer of the
assignee.
 
(c) For patent matters only:
 
(1) Establishment of ownership by the assignee must be
submitted prior to, or at the same time as, the paper requesting
or taking action is submitted.
 
(2) If the submission under this section is by an assignee of
less than the entire right, title and interest, such assignee
must indicate the extent (by percentage) of its ownership
interest, or the Office may refuse to accept the submission
as an establishment of ownership.
 
¶ 14.34 Requirement for Statement To Record Assignment
Submitted With Terminal Disclaimer
 
The assignment document filed on [1] is not acceptable as the
documentary evidence required by 37 CFR 3.73. The submission
of the documentary evidence was not accompanied by a statement
affirming that the documentary evidence of the chain of title from
the original owner to the assignee was, or concurrently is being,
submitted for recordation pursuant to 37 CFR 3.11. See 37 CFR
3.11 and MPEP § 302.
 
Examiner Note:
 
1.In bracket 1, insert the date the assignment document was
filed.
 
2.This form paragraph should be used when an assignment
document (an original, facsimile, or copy) is submitted to satisfy
37 CFR 3.73(b) was not accompanied by a statement affirming
that the documentary evidence of the chain of title from the original
owner to the assignee was, or concurrently is being, submitted
for recordation, and the documentary evidence has not been
recorded among the assignment records of the Office.
 
 
 
¶ 14.35 Disclaimer Fee Not Required Twice - Applicant
 
It should be noted that applicant is not required to pay another
disclaimer fee as set forth in 37 CFR 1.20(d) when submitting a
replacement or supplemental terminal disclaimer.
 
Examiner Note:
 
1.This form paragraph can be used to notify an applicant that
another disclaimer fee will not be required when a replacement or
supplemental terminal disclaimer is submitted.
 
2.Use form paragraph 14.35.01 for providing notification to
patent owner, rather than an applicant.
 
 
 
 
 
¶ 14.35.01 Disclaimer Fee Not Required Twice - Patent
Owner
 
It should be noted that patent owner is not required to pay
another disclaimer fee as set forth in 37 CFR 1.20(d) when submitting
a replacement or supplemental terminal disclaimer.
 
Examiner Note:
 
This form paragraph can be used to notify a patent owner that
another disclaimer fee will not be required when a replacement or
supplemental terminal disclaimer is submitted.
 
¶ 14.36 Suggestion That “Applicant” Request a Refund
 
Since the required fee for the terminal disclaimer was previously
paid, applicant’s payment of an additional terminal disclaimer
fee is not required. Applicant may request a refund of this
additional terminal disclaimer fee by submitting a written request
for a refund and a copy of this Office action to: Mail Stop 16,
Director of the United States Patent and Trademark Office, P.O.
Box 1450, Alexandria, Virginia 22313-1450.
 
Examiner Note:
 
1.This form paragraph should be used to notify applicant that a
refund can be obtained if another terminal disclaimer fee was paid
when a replacement or supplemental terminal disclaimer was submitted.
 
 
2.Note - If applicant has authorized or requested a fee refund to
be credited to a specific Deposit Account or credit card, then an
appropriate credit should be made to that Deposit Account or
credit card and this paragraph should NOT be used.
 
3.Use form paragraph 14.36.01 for providing notification to
patent owner, rather than an applicant.
 
¶ 14.36.01 Suggestion That “Patent Owner” Request a
Refund
 
Since the required fee for the terminal disclaimer was previously
paid, patent owner’s payment of an additional terminal disclaimer
fee is not required. Patent owner may request a refund of
this additional terminal disclaimer fee by submitting a written
request for a refund and a copy of this Office action to: Mail Stop
16, Director of the United States Patent and Trademark Office,
P.O. Box 1450, Alexandria, Virginia 22313-1450.
 
Examiner Note:
 
1.This form paragraph should be used to notify patent owner
that a refund can be obtained if another terminal disclaimer fee
was paid when a replacement or supplemental terminal disclaimer
was submitted.
 
2.Note - If patent owner has authorized or requested a fee
refund to be credited to a specific Deposit Account or credit card,
then an appropriate credit should be made to that Deposit Account
or credit card and this form paragraph should NOT be used.
 
 
 
¶ 14.37 Samples of a Terminal Disclaimer Over a Pending
Application and Assignee Statement Enclosed
 
Enclosed with this Office action is a sample terminal disclaimer
which is effective to overcome a provisional obviousness-
type double patenting rejection over a pending application (37
CFR 1.321(b) and (c)).
 
Also enclosed is a sample Statement Under 37 CFR 3.73(b)
(Form PTO/SB/96) which an assignee may use in order to ensure
compliance with the rule. Part A of the Statement is used when
there is a single assignment from the inventor(s). Part B of the
Statement is used when there is a chain of title. The “Copies of
assignments...” box should be checked when the assignment document(
s) (set forth in part A or part B) is/are not recorded in the
Office, and a copy of the assignment document(s) is/are attached.
When the “Copies of assignments...” box is checked, either the
part A box or the part B box, as appropriate, must be checked, and
the “Reel_____, Frame_____” entries should be left blank. If the
part B box is checked, and copies of assignments are not included,
the “From:______ To:______” blank(s) must be filled in. This
statement should be used the first time an assignee seeks to take
action in an application under 37 CFR 3.73(b), e.g., when signing
a terminal disclaimer or a power of attorney.
 
Examiner Note:
 
1.This form paragraph can be used to provide applicant samples
of a terminal disclaimer which contains the necessary clauses
to overcome a provisional obviousness-type double patenting
rejection over a pending application and a Statement to be signed
by an assignee to ensure compliance with 37 CFR 3.73(b).
 
2.Note that the requirements for compliance with 37 CFR 3.73(b) have been made more liberal, such that certain specifics of the
sample statement are no longer required. At present, in order to
comply with 37
CFR 3.73(b), the assignee’s ownership interest
must be established by (a) filing in the application or patent evidence
of a chain of title from the original owner to the assignee
and a statement affirming that the documentary evidence of the
chain of title from the original owner to the assignee was, or concurrently
is being, submitted for recordation pursuant to 37 CFR
3.11, or (b) specifying in the record of the application or patent
where such evidence is recorded in the Office (e.g., reel and frame
number, etc.). The submission with respect to (a) and (b) to establish
ownership must be signed by a party authorized to act on
behalf of the assignee.
 
(See your Technology Center Paralegal or Special Program Examiner
for copies of the sample terminal disclaimer and Statement
Under 37 CFR 3.73(b) to enclose with the Office action. Alternatively,
it is permissible to copy the sample terminal disclaimer
found after MPEP § 1490 and the Sample Statement Under 37
CFR 3.73(b) found after MPEP § 324.)
 
¶ 14.38 Samples of a Terminal Disclaimer Over a Prior
Patent and Assignee Statement Enclosed
 
Enclosed with this Office action is a sample terminal disclaimer
which is effective to overcome an obviousness-type double
patenting rejection over a prior patent (37 CFR 1.321(b) and
(c)).
 
Also enclosed is a sample Statement Under 37 CFR 3.73(b)
(Form PTO/SB/96) which an assignee may use in order to ensure
compliance with the rule. Part A of the Statement is used when
there is a single assignment from the inventor(s). Part B of the
Statement is used when there is a chain of title. The “Copies of
assignments...” box should be checked when the assignment doc
 
 
 
 
 
 
ument(s) (set forth in part A or part B) is/are not recorded in the
Office, and a copy of the assignment document(s) is/are attached.
When the “Copies of assignments...” box is checked, either the
part A box or the part B box, as appropriate, must be checked, and
the “Reel_____, Frame_____” entries should be left blank. If the
part B box is checked, and copies of assignments are not included,
the “From:______ To:______” blank(s) must be filled in. This
statement should be used the first time an assignee seeks to take
action in an application under 37 CFR 3.73(b), e.g., when signing
a terminal disclaimer or a power of attorney.
 
Examiner Note:
 
1.This form paragraph can be used to provide applicant samples
of a terminal disclaimer which contains the necessary clauses
to overcome an obviousness-type double patenting rejection over
a prior patent and a Statement to be signed by an assignee to
ensure compliance with 37 CFR 3.73(b).
 
2.Note that the requirements for compliance with 37 CFR 3.73(b) have been made more liberal, such that certain specifics of the
sample statement are no longer required. At present, in order to
comply with 37
CFR 3.73(b), the assignee’s ownership interest
must be established by (a) filing in the application or patent evidence
of a chain of title from the original owner to the assignee
and a statement affirming that the documentary evidence of the
chain of title from the original owner to the assignee was, or concurrently
is being, submitted for recordation pursuant to 37 CFR
3.11, or (b) specifying in the record of the application or patent
where such evidence is recorded in the Office (e.g., reel and frame
number, etc.). The submission with respect to (a) and (b) to establish
ownership must be signed by a party authorized to act on
behalf of the assignee.
 
(See your Technology Center Paralegal or Special Program Examiner
for copies of the sample terminal disclaimer and Statement
Under 37 CFR 3.73(b) to enclose with the Office action. Alternatively,
it is permissible to copy the sample terminal disclaimer
found after MPEP § 1490 and the Sample Statement Under 37
CFR 3.73(b) found after MPEP § 324.)
 
¶ 14.39 Sample Assignee Statement Under 37 CFR 3.73(b)
Enclosed
 
Enclosed with this Office action is a sample Statement under
37 CFR 3.73(b) which an assignee may use in order to ensure
compliance with the Rule. Part A of the Statement is used when
there is a single assignment from the inventor(s). Part B of the
Statement is used when there is a chain of title. The “Copies of
assignments...” box should be checked when the assignment document(
s) (set forth in part A or part B) is/are not recorded in the
Office, and a copy of the assignment document(s) is/are attached.
When the “Copies of assignments...” box is checked, either the
part A box or the part B box, as appropriate, must be checked, and
the “Reel_____, Frame_____” entries should be left blank. If the
part B box is checked, and copies of assignments are not included,
the “From:______ To:______” blank(s) must be filled in. This
statement should be used the first time an assignee seeks to take
action in an application under 37 CFR 3.73(b).
 
Examiner Note:
 
1.This form paragraph can be used to provide applicant a sample
of a Statement to be signed by an assignee to ensure compliance
with 37 CFR 3.73(b).
 
2.Note that the requirements for compliance with 37 CFR 3.73(b) have been made more liberal, such that certain specifics of the
sample statement are no longer required. At present, in order to
comply with 37
CFR 3.73(b), the assignee’s ownership interest
must be established by (a) filing in the application or patent evidence
of a chain of title from the original owner to the assignee
and a statement affirming that the documentary evidence of the
chain of title from the original owner to the assignee was, or concurrently
is being, submitted for recordation pursuant to 37 CFR
3.11, or (b) specifying in the record of the application or patent
where such evidence is recorded in the Office (e.g., reel and frame
number, etc.). The submission with respect to (a) and (b) to establish
ownership must be signed by a party authorized to act on
behalf of the assignee.
 
(See your Technology Center Paralegal or Special Program Examiner
for a copy of the sample Statement Under 37 CFR 3.73(b) to
enclose with the Office action. Alternatively, it is permissible to
copy the sample Statement Under 37
CFR 3.73(b) found after
MPEP § 324.)
 
 
 
VII.WITHDRAWING A RECORDED TER-
MINAL DISCLAIMER
 
If timely requested, a recorded terminal disclaimer
may be withdrawn before the application in which it
is filed issues as a patent, or in a reexamination proceeding,
before the reexamination certificate issues.
After a patent or reexamination certificate issues, it is
unlikely that a recorded terminal disclaimer will be
nullified.
 
A. Before Issuance Of Patent
 
While the filing and recordation of an unnecessary
terminal disclaimer has been characterized as an
“unhappy circumstance” in In re Jentoft, 392 F.2d
633, 157 USPQ 363 (CCPA 1968), there is no statutory
prohibition against nullifying or otherwise canceling
the effect of a recorded terminal disclaimer
which was erroneously filed before the patent issues.
Since the terminal disclaimer would not take effect
until the patent is granted, and the public has not had
the opportunity to rely on the terminal disclaimer,
relief from this unhappy circumstance may be available
by way of petition or by refiling the application
(other than by refiling it as a CPA).
 
Under appropriate circumstances, consistent with
the orderly administration of the examination process,
 
 
 
 
 
the nullification of a recorded terminal disclaimer
may be addressed by filing a petition under 37 CFR
1.182 requesting withdrawal of the recorded terminal
disclaimer. Petitions seeking to reopen the question of
the propriety of the double patenting rejection that
prompted the filing of the terminal disclaimer have
not been favorably considered. The filing of a continuing
application other than a CPA, while abandoning
the application in which the terminal disclaimer
has been filed, will typically nullify the effect of a terminal
disclaimer. The filing of a Request for Continued
Examination (RCE) of an application under
37
CFR 1.114 will not nullify the effect of a terminal
disclaimer, since a new application has not been filed,
but rather prosecution has been continued in the existing
application.
 
B.After Issuance Of Patent
 
The mechanisms to correct a patent — Certificate
of Correction (35 U.S.C. 255), reissue (35 U.S.C.
251), and reexamination (35 U.S.C. 305) — are not
available to withdraw or otherwise nullify the effect
of a recorded terminal disclaimer. As a general principle,
public policy does not favor the restoration to the
patent owner of something that has been freely dedicated
to the public, particularly where the public interest
is not protected in some manner — e.g.,
intervening rights in the case of a reissue patent. See,
e.g., Altoona Publix Theatres v. American Tri-Ergon
Corp., 294
U.S. 477, 24 USPQ 308 (1935).
 
Certificates of Correction (35 U.S.C. 255) are
available for the correction of an applicant’s mistake.
The scope of this remedial provision is limited in
two
ways — by the nature of the mistake for which
correction is sought and the nature of the proposed
correction. In re Arnott, 19 USPQ2d 1049 (Comm’r
Pat. 1991). The nature of the mistake for which correction
is sought is limited to those mistakes that are:
 
(A)of a clerical nature,
 
(B)of a typographical nature, or
 
(C)of a minor character.
 
The nature of the proposed correction is limited to
those situations where the correction does not involve
changes which would:
 
(A)constitute new matter, or
 
(B)require reexamination.
 
A mistake in filing a terminal disclaimer does not
fall within any of the categories of mistake for which
a certificate of correction of applicant’s mistake is
permissible, and any attempt to remove or nullify the
effect of the terminal disclaimer would typically
require reexamination of the circumstances under
which it was filed.
 
Although the remedial nature of reissue (35 U.S.C.
251) is well recognized, reissue is not available to correct
all errors. It has been the Office position that reissue
is not available to withdraw or otherwise nullify
the effect of a terminal disclaimer recorded in an
issued patent. First, the reissue statute only authorizes
the Director of the USPTO to reissue a patent “for the
unexpired part of the term of the original patent.”
Since the
granting of a reissue patent without the
effect of
a
recorded terminal disclaimer would result
in extending the term of the original patent, reissue
under these circumstances would be contrary to the
statute. Second, the principle against recapturing
something that has been intentionally dedicated to the
public dates back to Leggett v. Avery, 101 U.S. 256
(1879). The attempt to restore that portion of the
patent term that was dedicated to the public to secure
the grant of the original patent would be contrary to
this recapture principle. Finally, applicants have the
opportunity to challenge the need for a terminal disclaimer
during the prosecution of the application that
issues as a patent. “Reissue is not a substitute for
Patent Office appeal procedures.” Ball Corp. v. United
States, 729
F.2d 1429, 1435, 221 USPQ 289, 293
(Fed. Cir. 1984). Where applicants did not challenge
the propriety of the examiner’s obvious-type double
patenting rejection, but filed a terminal disclaimer to
avoid the rejection, the filing of the terminal disclaimer
did not constitute error within the meaning of
35 U.S.C. 251. Ex parte Anthony, 230 USPQ 467 (Bd.
App. 1982), aff’d, No. 84-1357 (Fed. Cir. June 14,
1985).
 
Finally, the nullification of a recorded terminal disclaimer
would not be appropriate in a reexamination
proceeding. There is a prohibition (35 U.S.C. 305)
against enlarging the scope of a claim during a reexamination
proceeding. As noted by the Board in
Anthony, supra, if a terminal disclaimer was nullified,
“claims would be able to be sued upon for a longer
 
 
 
 
 
period than would the claims of the original patent.
Therefore, the vertical scope, as opposed to the horizontal
scope (where the subject matter is enlarged),
would be enlarged.”
 
 
 
 
 
 
 
TERMINAL DISCLAIMER TO OBVIATE A PROVISIONAL DOUBLE PATENTING REJECTION OVER A PENDING “REFERENCE” APPLICATION
PTO/SB/25(07-06)
Approved for use through 09/30/2006. OMB 0651-0031
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
TERMINAL DISCLAIMER TO OBVIATE A PROVISIONAL DOUBLE PATENTING
REJECTION OVER A PENDING “REFERENCE” APPLICATIONDocket Number (Optional)
In re Application of:
Application No.:
Filed:
For:
The owner, ________________________________________, of ________ percent interest in the instant application hereby disclaims,
except as provided below, the terminal part of the statutory term of any patent granted on the instant application which would extend beyond
the expiration date of the full statutory term of any patent granted on pending reference Application Number ______________________, filed
on ____________________, as such term is defined in 35 U.S.C. 154 and 173, and as the term of any patent granted on said referenceapplication may be shortened by any terminal disclaimer filed prior to the grant of any patent on the pending reference application. The owner
hereby agrees that any patent so granted on the instant application shall be enforceable only for and during such period that it and any patent
granted on the reference application are commonly owned. This agreement runs with any patent granted on the instant application and is
binding upon the grantee, its successors or assigns.
In making the above disclaimer, the owner does not disclaim the terminal part of any patent granted on the instant application that would
extend to the expiration date of the full statutory term as defined in 35 U.S.C. 154 and 173 of any patent granted on said referenceapplication, “as the term of any patent granted on said reference application may be shortened by any terminal disclaimer filed prior to the
grant of any patent on the pending reference application,” in the event that: any such patent: granted on the pending reference application:
expires for failure to pay a maintenance fee, is held unenforceable, is found invalid by a court of competent jurisdiction, is statutorily disclaimed
in whole or terminally disclaimed under 37 CFR 1.321, has all claims canceled by a reexamination certificate, is reissued, or is in any manner
terminated prior to the expiration of its full statutory term as shortened by any terminal disclaimer filed prior to its grant.
Check either box 1 or 2 below, if appropriate.
1. For submissions on behalf of a business/organization (e.g., corporation, partnership, university, government agency,
etc.), the undersigned is empowered to act on behalf of the business/organization.
I hereby declare that all statements made herein of my own knowledge are true and that all statements made on information and
belief are believed to be true; and further that these statements were made with the knowledge that willful false statements and the like so
made are punishable by fine or imprisonment, or both, under Section 1001 of Title 18 of the United States Code and that such willful false
statements may jeopardize the validity of the application or any patent issued thereon.
2. The undersigned is an attorney or agent of record. Reg. No. __________________
________________________________________________________________________ _______________________
Signature Date
________________________________________________________________________________________________
Typed or printed name
_________________________________
Telephone Number
Terminal disclaimer fee under 37 CFR 1.20(d) is included.
WARNING: Information on this form may become public. Credit card information should not
be included on this form. Provide credit card information and authorizationon PTO-2038.
Statement under 37 CFR 3.73(b) is required if terminal disclaimer is signed by the assignee (owner).
Form PTO/SB/96 may be used for making this statement. See MPEP § 324.
This collection of information is required by 37 CFR 1.321. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO
to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 12 minutes to complete,
including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on
the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
ADDRESS.SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
Doc Code:
 
 
 
 
 
 
Privacy Act Statment
 
 
 
 
 
 
TERMINAL DISCLAIMER TO OBVIATE A DOUBLE PATENTING REJECTION OVER A “PRIOR” PATENT
PTO/SB/26(07-06)
Approved for use through 09/30/2006. OMB 0651-0031
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
TERMINAL DISCLAIMER TO OBVIATE A DOUBLE PATENTING
REJECTION OVER A “PRIOR” PATENTDocket Number (Optional)
In re Application of:
Application No.:
Filed:
For:
The owner, _________________________________________, of ____________ percent interest in the instant application hereby disclaims,
except as provided below, the terminal part of the statutory term of any patent granted on the instant application which would extend beyond
the expiration date of the full statutory term prior patent No. __________________ as the term of said prior patent is defined in 35 U.S.C. 154
and 173, and as the term of said prior patent is presently shortened by any terminal disclaimer. The owner hereby agrees that any patent so
granted on the instant application shall be enforceable only for and during such period that it and the prior patent are commonly owned. This
agreement runs with any patent granted on the instant application and is binding upon the grantee, its successors or assigns.
In making the above disclaimer, the owner does not disclaim the terminal part of the term of any patent granted on the instant application that
would extend to the expiration date of the full statutory term as defined in 35 U.S.C. 154 and 173 of the prior patent, “as the term of said prior
patent is presently shortened by any terminal disclaimer,” in the event that said prior patent later:
expires for failure to pay a maintenance fee;
is held unenforceable;
is found invalid by a court of competent jurisdiction;
is statutorily disclaimed in whole or terminally disclaimed under 37 CFR 1.321;
has all claims canceled by a reexamination certificate;
is reissued; or
is in any manner terminated prior to the expiration of its full statutory term as presently shortened by any terminal disclaimer.
Check either box 1 or 2 below, if appropriate.
1. For submissions on behalf of a business/organization (e.g., corporation, partnership, university, government agency,
etc.), the undersigned is empowered to act on behalf of the business/organization.
I hereby declare that all statements made herein of my own knowledge are true and that all statements made on information and
belief are believed to be true; and further that these statements were made with the knowledge that willful false statements and the like so
made are punishable by fine or imprisonment, or both, under Section 1001 of Title 18 of the United States Code and that such willful false
statements may jeopardize the validity of the application or any patent issued thereon.
2. The undersigned is an attorney or agent of record. Reg. No.___________________
_______________________________________________________________________ _____________________
Signature Date
______________________________________________________________________________________________
Typed or printed name
_______________________________
Telephone Number
Terminal disclaimer fee under 37 CFR 1.20(d) included.
WARNING: Information on this form may become public. Credit card information should not
be included on this form. Provide credit card information and authorization on PTO-2038.
Statement under 37 CFR 3.73(b) is required if terminal disclaimer is signed by the assignee (owner).
Form PTO/SB/96 may be used for making this certification. See MPEP § 324.
This collection of information is required by 37 CFR 1.321. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO
to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 12 minutes to complete,
including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments
on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent
and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
ADDRESS.SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
Doc Code:
 
 
 
 
 
 
Privacy Act StatementrPrivacy Act Statement
Privacy Act Statement
ThePrivacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection
with your submission of the attached form related to a patent application or patent. Accordingly,
pursuant to the requirements of the Act, please be advised that: (1) the general authority for the
collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary;
and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
Office is to process and/or examine your submission related to a patent application or patent. If you do
not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
process and/or examine your submission, which may result in termination of proceedings or
abandonment of the application or expiration of the patent.
The information provided by you in this form will be subject to the following routine uses:
1. The information on this form will be treated confidentially to the extent allowed under the
Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from
this system of records may be disclosed to the Department of Justice to determine whether
disclosure of these records is required by the Freedom of Information Act.
2. A record from this system of records may be disclosed, as a routine use, in the course of
presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to
opposing counsel in the course of settlement negotiations.
3. A record in this system of records may be disclosed, as a routine use, to a Member of
Congress submitting a request involving an individual, to whom the record pertains, when the
individual has requested assistance from the Member with respect to the subject matter of the
record.
4. A record in this system of records may be disclosed, as a routine use, to a contractor of the
Agency having need for the information in order to perform a contract. Recipients of
information shall be required to comply with the requirements of the Privacy Act of 1974, as
amended, pursuant to 5 U.S.C. 552a(m).
5. A record related to an International Application filed under the Patent Cooperation Treaty in
this system of records may be disclosed, as a routine use, to the International Bureau of the
World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
6. A record in this system of records may be disclosed, as a routine use, to another federal
agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to
the Atomic Energy Act (42 U.S.C. 218(c)).
7. A record from this system of records may be disclosed, as a routine use, to the Administrator,
General Services, or his/her designee, during an inspection of records conducted by GSA as
part of that agency’s responsibility to recommend improvements in records management
practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
be made in accordance with the GSA regulations governing inspection of records for this
purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not
be used to make determinations about individuals.
8. A record from this system of records may be disclosed, as a routine use, to the public after
either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
CFR 1.14, as a routine use, to the public if the record was filed in an application which
became abandoned or in which the proceedings were terminated and which application is
referenced by either a published application, an application open to public inspection or an
issued patent.
9. A record from this system of records may be disclosed, as a routine use, to a Federal, State,
or local law enforcement agency, if the USPTO becomes aware of a violation or potential
violation of law or regulation.

Latest revision as of 22:42, May 31, 2020

← MPEP 1300 ↑ MPEP Table of Contents MPEP 1500 →


Chapter 1400 Correction of Patents

1400 [No Text][edit | edit source]

1400.01Introduction[edit | edit source]

A patent may be corrected or amended in four ways, namely:

(A)by reissue,

(B)by the issuance of a certificate of correction which becomes a part of the patent,

(C)by disclaimer, and

(D)by reexamination.

The first three ways are discussed in this chapter while the fourth way (reexamination) is discussed in MPEP Chapter 2200 for ex parte reexamination and MPEP Chapter 2600 for inter partes reexamination.

1401 Reissue[edit | edit source]

35 U.S.C. 251. Reissue of defective patents.

Whenever any patent is, through error without any deceptive intention, deemed wholly or partly inoperative or invalid, by reason of a defective specification or drawing, or by reason of the patentee claiming more or less than he had a right to claim in the patent, the Director shall, on the surrender of such patent and the payment of the fee required by law, reissue the patent for the invention disclosed in the original patent, and in accordance with a new and amended application, for the unexpired part of the term of the original patent. No new matter shall be introduced into the application for reissue.

The Director may issue several reissued patents for distinct and separate parts of the thing patented, upon demand of the applicant, and upon payment of the required fee for a reissue for each of such reissued patents.

The provisions of this title relating to applications for patent shall be applicable to applications for reissue of a patent, except that application for reissue may be made and sworn to by the assignee of the entire interest if the application does not seek to enlarge the scope of the claims of the original patent.

No reissued patent shall be granted enlarging the scope of the claims of the original patent unless applied for within two years from the grant of the original patent.


The provisions of 35 U.S.C. 251 permit the reissue of a patent to correct an error in the patent made without any deceptive intention and provide criteria for the reissue. 37 CFR 1.171 through 1.178 are rules directed to reissue.

1402 Grounds for Filing[edit | edit source]

A reissue application is filed to correct an error in the patent which was made without any deceptive intention, where, as a result of the error, the patent is deemed wholly or partly inoperative or invalid. An error in the patent arises out of an error in conduct which was made in the preparation and/or prosecution of the application which became the patent.

There must be at least one error in the patent to provide grounds for reissue of the patent. If there is no error in the patent, the patent will not be reissued. The present section provides a discussion of what may be considered an error in the patent upon which to base a reissue application.

In accordance with 35 U.S.C. 251, the error upon which a reissue is based must be one which causes the patent to be “deemed wholly or partly inoperative or invalid, by reason of a defective specification or drawing, or by reason of the patentee claiming more or less than he had a right to claim in the patent.” Thus, an error under 35 U.S.C. 251 has not been presented where the correction to the patent is one of spelling, or grammar, or a typographical, editorial or clerical error which does not cause the patent to be deemed wholly or partly inoperative or invalid for the reasons specified in 35 U.S.C. 251. These corrections to a patent do not provide a basis for reissue (although these corrections may also be included in a reissue application, where a 35 U.S.C. 251 error is already present).

These corrections may be made via a certificate of correction; see MPEP § 1481.

The most common bases for filing a reissue application are:

(A)the claims are too narrow or too broad;

(B)the disclosure contains inaccuracies;

(C)applicant failed to or incorrectly claimed foreign priority; and

(D)applicant failed to make reference to or incorrectly made reference to prior copending applications.

An attorney’s failure to appreciate the full scope of the invention was held to be an error correctable through reissue in the decision of In re Wilder, 736 F.2d 1516, 222 USPQ 369 (Fed. Cir. 1984). The correction of misjoinder of inventors in divisional reissues has been held to be a ground for reissue. See Ex parte Scudder, 169 USPQ 814 (Bd. App. 1971).The Board of Appeals held in Ex parte Scudder, 169 USPQ at 815, that 35 U.S.C. 251 authorizes reissue application to correct misjoinder of inventors where 35 U.S.C. 256 is inadequate.

Reissue may no longer be necessary under the facts in Ex parte Scudder, supra, in view of 35 U.S.C. 116which provides, inter alia, that:

“Inventors may apply for a patent jointly even though . . . (3) each did not make a contribution to the subject matter of every claim in the patent.”

See also 37 CFR 1.45(b)(3).

If the only change being made in the patent is correction of the inventorship, this can be accomplished by filing a request for a certificate of correction under the provisions of 35 U.S.C. 256 and 37 CFR 1.324. See MPEP § 1412.04 and § 1481. A Certificate of Correction will be issued if all parties are in agreement and the inventorship issue is not contested.

A reissue was granted in Brenner v. State of Israel, 400 F.2d 789, 158 USPQ 584 (D.C. Cir. 1968), where the only ground urged was failure to file a certified copy of the original foreign application to obtain the right of foreign priority under 35 U.S.C. 119(a)-(d) before the patent was granted.

In Brenner, the claim for priority had been made in the prosecution of the original patent, and it was only necessary to submit a certified copy of the priority document in the reissue application to perfect priority. Reissue is also available to convert the “error” in failing to take any steps to obtain the right of foreign priority under 35 U.S.C. 119(a)-(d) before the patent was granted. See Fontijn v. Okamoto, 518 F.2d 610, 622, 186 USPQ 97, 106 (CCPA 1975) (“a patent may be reissued for the purpose of establishing a claim to priority which was not asserted, or which was not perfected during the prosecution of the original application”) In a situation where it is necessary to submit for the first time both the claim for priority and the certified copy of the priority document in the reissue application, and the patent to be reissued resulted from a utility or plant application which became the patent to be reissued was filed on or after November 29, 2000, the reissue applicant must (where it is necessary to submit for the first time the claim for priority) also file a petition for an unintentionally delayed priority claim under 37 CFR 1.55(c) in addition to filing a reissue application. See MPEP § 201.14(a).

The courts have not addressed the question of correction of the failure to adequately claim benefit under 35 U.S.C. 119(e) in the application (which became the patent to be reissued) via reissue. If the application which became the patent to be reissued was filed prior to November 29, 2000, correction as to benefit under 35 U.S.C. 119(e) would be permitted in a manner somewhat analogous to that of the priority correction discussed above. Where the application, which became the patent to be reissued, was filed on or after November 29, 2000, reissue may be employed to correct an applicant’s mistake by adding or correcting a benefit claim under 35 U.S.C. 119(e). A petition under 37 CFR 1.78(a)(6) for an unintentionally delayed claim under 35 U.S.C. 119(e) would not be required in addition to filing a reissue application..

Section 4503 of the American Inventors Protection Act of 1999 (AIPA) amended 35 U.S.C. 119(e)(1) to state that:

No application shall be entitled to the benefit of an earlier filed provisional application under this subsection unless an amendment containing the specific reference to the earlier filed provisional application is submitted at such time during the pendency of the application as required by the Director. The Director may consider the failure to submit such an amendment within that time period as a waiver of any benefit under this subsection. The Director may establish procedures, including the payment of a surcharge, to accept an unintentionally delayed submission of an amendment under this section during the pendency of the application. (Emphasis added.)

The court in Fontijn held that 35 U.S.C. 251was sufficiently broad to correct a patent where the applicant failed to assert or failed to perfect a claim for foreign priority during the prosecution of the original application even though 35 U.S.C. 119(b) at that time required a claim and a certified copy of the foreign application to be filed before the patent is granted. Similarly, the Office may grant a reissue for adding or correcting a benefit claim under 35 U.S.C.119(e) that requires the benefit claim to a provisional application be submitted during the pendency of the application..

Correction of failure to adequately claim benefit under 35 U.S.C. 120 in an earlier filed copending U.S. patent application was held a proper ground for reissue. Sampson v. Comm’r Pat., 195 USPQ 136, 137 (D.D.C. 1976). If the utility or plant application which became the patent to be reissued was filed on or after November 29, 2000, the reissue applicant must file a petition for an unintentionally delayed priority claim under 37 CFR 1.78(a)(3) in addition to filing a reissue application. See MPEP § 201.11. For treatment of an error involving disclaimer of a benefit claim under 35 U.S.C. 120, see MPEP 1405. If the utility or plant application which became the patent to be reissued was filed prior to November 29, 2000 and therefore, not subject to the eighteen-month publication (e.g., one of the categories set forth in 37 CFR 1.78(a)(2)(ii)(A) – (C)), a petition for an unintentionally delayed benefit claim under 37 CFR 1.78(a)(3) would not be required to add/correct the benefit claim in the reissue application. This is so, even if the reissue application was filed on or after November 29, 2000. On the other hand, if applicant fails to file an amendment to add a claim for benefit of a prior-filed reissue application in a later-filed reissue application within the time period set forth in 37 CFR 1.78(a)(2), then a petition for an unintentionally delayed benefit claim under 37 CFR 1.78(a)(3) along with the surcharge set forth in 37 CFR 1.17(t) would be required if the later-filed reissue application is a utility or plant application filed on or after November 29, 2000 irrespective of whether the original application which became the original patent was filed prior to November 29, 2000. This is because the benefit claim is between the later-filed reissue application and the prior-filed reissue application and the benefit claim is not being added to make a correction as to a benefit of the original patent.

A reissue applicant’s failure to timely file a divisional application covering the non-elected invention( s) following a restriction requirement is not considered to be error causing a patent granted on elected claims to be partially inoperative by reason of claiming less than the applicant had a right to claim. Thus, such applicant’s error is not correctable by reissue of the original patent under 35 U.S.C. 251. See MPEP § 1412.01.

A reissue may be based on a drawing correction that is substantive in nature, because such a correction qualifies as correcting an “error” under 35 U.S.C. 251that may properly be deemed to render the patent wholly or partly inoperative. A reissue application cannot be based on a non-substantive drawing change, such as a reference numeral correction or addition, the addition of shading, or even the addition of an additional figure merely to “clarify” the disclosure. Non- substantive drawing changes may, however, be included in a reissue application that corrects at least one substantive “error ” under 35 U.S.C. 251.

1403 Diligence in Filing[edit | edit source]

When a reissue application is filed within 2 years from the date of the original patent, a rejection on the grounds of lack of diligence or delay in filing the reissue should not normally be made. Ex parte Lafferty, 190 USPQ 202 (Bd. App. 1975); but see Rohm & Haas Co. v. Roberts Chemical Inc., 142 F. Supp. 499, 110 USPQ 93 (S.W. Va. 1956), rev’d on other grounds, 245 F.2d 693, 113 USPQ 423 (4th Cir. 1957).

The fourth paragraph of 35 U.S.C. 251 states:

“No reissued patent shall be granted enlarging the scope of the claims of the original patent unless applied for within two years from the grant of the original patent.”

Where any broadening reissue application is filed within two years from the date of the original patent, 35 U.S.C. 251 presumes diligence, and the examiner should not inquire why applicant failed to file the reissue application earlier within the two year period.

See MPEP § 1412.03 for broadening reissue practice. See also In re Graff, 111 F.3rd 874, 42 USPQ2d 1471 (Fed. Cir. 1997); In re Bennett, 766 F.2d 524, 528, 226 USPQ 413, 416 (Fed. Cir. 1985); In re Fotland, 779 F.2d 31, 228 USPQ 193 (Fed. Cir. 1985).

A reissue application that is filed on the 2-year anniversary date of the patent grant is considered as being filed within 2 years. See Switzer v. Sockman, 333 F.2d 935, 142 USPQ 226 (CCPA 1964) (a similar rule in interferences).

A reissue application can be granted a filing date without an oath or declaration, or without the basic filing fee, search fee, or examination fee being present. See 37 CFR 1.53(f). Applicant will be given a period of time to provide the missing parts and to pay the surcharge under 37 CFR 1.16(f). See MPEP § 1410.01.

1404 Submission of Papers Where Reissue Patent Is in Litigation[edit | edit source]

Marking of envelope: Applicants and protestors (see MPEP § 1901.03) submitting papers for entry in reissue applications of patents involved in litigation are requested to mark the outside envelope and the top right-hand portion of the papers with the words “REISSUE LITIGATION” and with the art unit or other area of the United States Patent and Trademark Office in which the reissue application is located, e.g., Commissioner for Patents, Board of Patent Appeals and Interferences, Office of Patent Legal Administration, Technology Center, Office of Patent Publication, etc. Marking of papers: Any “Reissue Litigation” papers mailed to the Office should be so marked. The markings preferably should be written in a bright color with a felt point marker. Papers marked “REISSUE LITIGATION” will be given special attention and expedited handling. (For IFW processing, see IFW Manual.) See MPEP § 1442.01through § 1442.04 for examination of litigation- related reissue applications. Protestor’s participation, including the submission of papers, is limited in accordance with 37 CFR 1.291(c).

1405 Reissue and Patent Term[edit | edit source]

35 U.S.C. 251 prescribes the effect of reissue on the patent term by stating that “the Director shall… reissue the patent… for the unexpired term of the original patent.”

The maximum term of the original patent is fixed at the time the patent is granted. While the term may be subsequently shortened, e.g., through the filing of a terminal disclaimer, it cannot be extended through the filing of a reissue. Accordingly, a deletion in a reissue application of an earlier-obtained benefit claim under 35 U.S.C. 120 will not operate to lengthen the term of the patent to be reissued.

When a reissue application has been filed in an attempt to delete an earlier-obtained benefit claim under 35 U.S.C. 120, it should be treated as follows:

(A)More than one “error” (as defined by 35 U.S.C. 251) is described in a reissue declaration, and one of the errors identified is the failure to delete a 35 U.S.C. 120 benefit claim in the original patent, or the erroneous making of a claim for 35 U.S.C. 120 benefit.

If one of the errors identified is the presence of the claim for 35 U.S.C. 120 benefit in the patent, and patentee (1) states a belief that this error renders the original patent wholly or partly inoperative or invalid, and (2) is seeking to eliminate this error via the reissue proceeding, the Office will permit entry of an accompanying amendment deleting the benefit claim in the continuity data, and will not object to or reject the reissue declaration. Assuming the reissue declaration appropriately identifies or describes at least one other error being corrected, the reissue declaration would not be objected to for failure to comply with the requirements of 37 CFR 1.175.

Where the reissue declaration states that the patentee is making this correction in order to extend the term of the original patent, the examiner’s Office action will merely refer to the statement in the declaration and then point out with respect to such statement that 35 U.S.C. 251 only permits reissue “... for the unexpired part of the term of the original patent.”

(B)Only one “error” (as defined by 35 U.S.C. 251) is described in a reissue declaration, and that error is the failure to delete a 35 U.S.C. 120 benefit claim in the original patent, or the erroneous making of a claim for 35 U.S.C. 120 benefit.

(1)If the only error identified in the reissue declaration is stated to be the correction or adjustment of the patent term by deleting the 35 U.S.C. 120 benefit claim, a rejection under 35 U.S.C. 251 should be made, based on the lack of an appropriate error for reissue and failure to comply with 37 CFR 1.175.

(2)If the only error identified in the reissue declaration is the need to delete a 35 U.S.C. 120 benefit claim, which the patentee seeks to now delete in the reissue application, (and no reference is made as to increasing the term of the patent), the examiner should not make a rejection under 35 U.S.C. 251based on lack of an appropriate error for reissue and failure to comply with 37 CFR 1.175. The examiner should examine the reissue application in accordance with 37 CFR 1.176 (MPEP § 1440). A statement should, however, be made in an Office action pointing out the lack of effect (of the change in the patent) on the patent term because 35 U.S.C. 251 only permits reissue “... for the unexpired part of the term of the original patent.”

1406 Citation and Consideration of References Cited in Original Patent[edit | edit source]

In a reissue application, the examiner should consider and list on a PTO-892 form all references that have been cited during the original prosecution of the patent. See MPEP § 1455. An exception to this practice might be where the references cited in the original patent may no longer be relevant, e.g., in view of a narrowing of the claim scope in the reissue application.

Should applicants wish to ensure that all of the references which were cited in the original patent are considered and cited in the reissue application, an information disclosure statement (IDS) in compliance with 37 CFR 1.97 and 1.98 should be filed in the reissue application. See MPEP § 609. The requirement for a copy of each U.S. patent or U.S. patent application publication listed in an IDS has been eliminated, unless required by the Office. 37 CFR 1.98(a)(2) requires

(A) a legible copy of each foreign patent,

(B) each publication or that portion which caused it to be listed,

(C) each pending unpublished U.S. application unless the cited pending U.S. application is stored in the Image File Wrapper (IFW) system. The requirement in 37 CFR 1.98(a)(2)(iii) for a legible copy of the specification, including the claims and drawings of each cited pending U.S. patent application (or portion of the application which caused it to be listed) is sua sponte waived where the cited pending application is stored in the Office’ s IFW system. See Waiver of the Copy Requirement in 37 CFR 1.98 for Cited Pending U.S. Patent Applications, 1287 O.G. 163 (Oct. 19, 2004),

(D) all other information or that portion which caused it to be listed.

See MPEP § 609.04(a). The Office imposes no responsibility on a reissue applicant to resubmit, in a reissue application, all the “References Cited” in the patent for which reissue is sought. Rather, applicant has a continuing duty under 37 CFR 1.56 to timely apprise the Office of any information which is material to the patentability of the claims under consideration in the reissue application. See MPEP § 1418.

Where a copy of a reference other than a U.S. patent or U.S. patent application publication is not available and cannot be obtained through any source other than the reissue applicant (who has not submitted the copy), the examiner will not indicate on PTO- 892 or PTO/SB/08 submitted by applicant that a reference has been considered.

1410 Content of Reissue Application[edit | edit source]

37 CFR 1.171. Application for reissue.

An application for reissue must contain the same parts required for an application for an original patent, complying with all the rules relating thereto except as otherwise provided, and in addition, must comply with the requirements of the rules relating to reissue applications.


37 CFR 1.173. Reissue specification, drawings, and amendments.

(a) Contents of a reissue application. An application for reissue must contain the entire specification, including the claims, and the drawings of the patent. No new matter shall be introduced into the application. No reissue patent shall be granted enlarging the scope of the claims of the original patent unless applied for within two years from the grant of the original patent, pursuant to 35 U.S.C. 251.

(1) Specification, including claims. The entire specification, including the claims, of the patent for which reissue is requested must be furnished in the form of a copy of the printed patent, in double column format, each page on only one side of a single sheet of paper. If an amendment of the reissue application is to be included, it must be made pursuant to paragraph (b) of this section. The formal requirements for papers making up the reissue application other than those set forth in this section are set out in § 1.52. Additionally, a copy of any disclaimer (§ 1.321), certificate of correction (§§ 1.322 through 1.324), or reexamination certificate (§ 1.570) issued in the patent must be included. (See also § 1.178).

(2) Drawings. Applicant must submit a clean copy of each drawing sheet of the printed patent at the time the reissue application is filed. If such copy complies with § 1.84, no further drawings will be required. Where a drawing of the reissue application is to include any changes relative to the patent being reissued, the changes to the drawing must be made in accordance with paragraph (b)(3) of this section. The Office will not transfer the drawings from the patent file to the reissue application.

.          .          .


The specification (including the claims and any drawings) of the reissue application is the copy of the printed patent for which reissue is requested that is submitted by applicant as part of the initial application papers. The copy of the printed patent must be submitted in double column format, each page of double column format being on only one side of the piece of paper. It should be noted that a re-typed specification is not acceptable in a reissue application; the full copy of the printed patent must be used. In addition, an applicant for reissue is required to file a reissue oath or declaration which, in addition to complying with 37 CFR 1.63, must comply with 37 CFR 1.175. Where the patent has been assigned, the reissue applicant must also provide a consent of assignee to the reissue and evidence of ownership. Where the patent has not been assigned, the reissue applicant should affirmatively state that the patent is not assigned.

An amendment may be submitted at the time of filing of a reissue application. The amendment may be made either by:

(A) physically incorporating the changes within the specification by cutting the column of the printed patent and inserting the added material and rejoining the remainder of the column and then joining the resulting modified column to the other column of the printed patent. Markings pursuant to 37 CFR 1.173(d) must be used to show the changes. The columnar structure of the printed patent must be preserved, and the physically modified page must comply with 37 CFR 1.52(a)(1). As to compliance with 37 CFR 1.52(a)(1)(iv), the “written either by a typewriter or machine printer in permanent dark ink or its equivalent” requirement is deemed to be satisfied where a caret and line are drawn from a position within the text to a newly added phrase, clause, sentence, etc. typed legibly in the margin; or

(B) providing a separate amendment paper with the reissue application.

In either case, the amendment must be made pursuant to 37 CFR 1.173(b) and must comply with all the provisions of 37 CFR 1.173(b)– (e) and (g).

If the changes to be made to the patent are so extensive that reading and understanding the specification is extremely difficult and error-prone, a clean, typed copy of the specification may be submitted if accompanied by a grantable petition under 37 CFR 1.183 for waiver of 37 CFR 1.125(d) and 37 CFR 1.173(a)(1).

Pursuant to 37 CFR 1.173(a)(1), applicant is required to include a copy of any disclaimer (37 CFR 1.321), certificate of correction (37 CFR 1.322 – 1.324), or reexamination certificate (37 CFR 1.520) issued in the patent for which reissue is requested. It should also be noted that 37 CFR 1.178(b) requires reissue applicants to call to the attention of the Office any prior or concurrent proceedings in which the patent (for which reissue is requested) is or was involved, such as interferences, reissues, reexaminations, or litigation (litigation covers any papers filed in the court or issued by the court, such as, for example, motions, pleadings, and court decisions including court orders) and the results of such proceedings. This duty to submit such information is a continuing duty, and runs from the time the reissue application is filed until the reissue application is abandoned or issues as a reissue patent.

It is no longer required that the reissue applicant physically surrender the original patent, see MPEP § 1416.

Where appropriate, the reissue applicant may provide a claim for priority benefit under 35 U.S.C. 119or 120, and may also file an Information Disclosure Statement.

The initial contents of a reissue application are discussed in detail in MPEP § 1410.01 through § 1418.

For expedited processing, new and continuing reissue application filings under 37 CFR 1.53(b) may be addressed to: Mail Stop REISSUE, Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450. Mail Stop REISSUE should only be used for the initial filing of reissue applications, and should not be used for any subsequently filed correspondence in reissue applications. All new reissue filings should include a copy of a completed Reissue Patent Application Transmittal Form (PTO/SB/50) to ensure that the filing of the new application will be recognized as being for a reissue application.

The oath or declaration, any matters ancillary thereto (such as the consent of assignee), and the basic filing fee, search fee, and examination fee may be submitted after the filing date pursuant to 37 CFR 1.53(f).

The requirement for the assignee to consent to filing a reissue no longer includes a requirement for applicant to order a title report with the filing of the reissue application. Rather, the assignee entity is established by a statement on behalf of all the assignees under 37 CFR 1.172(a) and 37 CFR 3.73(b). See MPEP § 1410.01.

1410.01 Reissue Applicant, Oath or Declaration, and Consent of all Assignees[edit | edit source]

37 CFR 1.172. Applicants, assignees.

(a) A reissue oath must be signed and sworn to or declaration made by the inventor or inventors except as otherwise provided (see §§ 1.42, 1.43, 1.47), and must be accompanied by the written consent of all assignees, if any, owning an undivided interest in the patent, but a reissue oath may be made and sworn to or declaration made by the assignee of the entire interest if the application does not seek to enlarge the scope of the claims of the original patent. All assignees consenting to the reissue must establish their ownership interest in the patent by filing in the reissue application a submission in accordance with the provisions of § 3.73(b) of this chapter.

(b) A reissue will be granted to the original patentee, his legal representatives or assigns as the interest may appear.


37 CFR 3.73. Establishing right of assignee to take action.
.          .          .

(b)

(1) In order to request or take action in a patent or trademark matter, the assignee must establish its ownership of the patent or trademark property of paragraph (a) of this section to the satisfaction of the Director. The establishment of ownership by the assignee may be combined with the paper that requests or takes the action. Ownership is established by submitting to the Office a signed statement identifying the assignee, accompanied by either:

(i) Documentary evidence of a chain of title from the original owner to the assignee (e.g., copy of an executed assignment). For trademark matters only, the documents submitted to establish ownership may be required to be recorded pursuant to § 3.11 in the assignment records of the Office as a condition to permitting the assignee to take action in a matter pending before the Office. For patent matters only, the submission of the documentary evidence must be accompanied by a statement affirming that the documentary evidence of the chain of title from the original owner to the assignee was or concurrently is being submitted for recordation pursuant to § 3.11; or

(ii) A statement specifying where documentary evidence of a chain of title from the original owner to the assignee is recorded in the assignment records of the Office (e.g., reel and frame number).

(2) The submission establishing ownership must show that the person signing the submission is a person authorized to act on behalf of the assignee by:

(i) Including a statement that the person signing the submission is authorized to act on behalf of the assignee; or

(ii) Being signed by a person having apparent authority to sign on behalf of the assignee, e.g., an officer of the assignee.

(c) For patent matters only:

(1) Establishment of ownership by the assignee must be submitted prior to, or at the same time as, the paper requesting or taking action is submitted.

(2) If the submission under this section is by an assignee of less than the entire right, title and interest, such assignee must indicate the extent (by percentage) of its ownership interest, or the Office may refuse to accept the submission as an establishment of ownership.


The reissue oath must be signed and sworn to by all the inventors, or declaration made by all the inventors, except as otherwise provided in 37 CFR 1.42, 1.43, and 1.47 (see MPEP § 409). Pursuant to 37 CFR 1.172, where the reissue application does not seek to enlarge the scope of any of the claims of the original patent, the reissue oath may be made and sworn to, or declaration made, by the assignee of the entire interest. Depending on the circumstances, either Form PTO/SB/51, Reissue Application Declaration by the Inventor, or Form PTO/SB/52, Reissue Application Declaration by the Assignee, may be used to prepare a declaration in a reissue application. These forms are reproduced in MPEP § 1414.

If an inventor is to be added in a reissue application, a proper reissue oath or declaration including the signatures of all of the inventors is required. If one or more inventors are being deleted in a reissue application, an oath or declaration must be supplied over the signatures of the remaining inventors. Note that although an inventor being deleted in a reissue application need not sign the oath or declaration, if that inventor to be deleted has any ownership interest in the patent (e.g., that inventor did not assign away his/ her rights to the patent), the signature of that inventor must be supplied in the consent to filing the reissue application. See MPEP § 1412.04 as to correction of inventorship via reissue.

I.CONSENT TO THE REISSUE

Where no assignee exists, applicant should affirmatively state that fact. This can be done by simply checking the “NO” box of item 7 of Form PTO/SB/50 (which form may be signed by the inventors, or by a registered practitioner). If the file record is silent as to the existence of an assignee, it will be presumed that an assignee does exist. This presumption should be set forth by the examiner in the first Office action alerting applicant to the requirement. It should be noted that the mere filing of a written assertion of small entity status in no way relieves applicant of the requirement to affirmatively state that no assignee exists.

Where a written assertion of small entity status, or other paper in file indicates that the application/patent is assigned, and there is no consent by the assignee named in the written assertion of small entity, the examiner should make inquiry into the matter in an Office action, even if the record otherwise indicates that the application/patent is not assigned.

The reissue oath or declaration must be accompanied by the written consent of all assignees. 35 U.S.C. 111(a) and 37 CFR 1.53(b) provide, however, for according an application a filing date if filed with a specification, including claim(s), and any required drawings. Thus, where an application is filed without an oath or declaration, or without the consent of all assignees, if the application otherwise complies with 37 CFR 1.53(b) and the reissue rules, the Office of Initial Patent Examination (OIPE) will accord a filing date and send out a notice of missing parts setting a period of time for filing the missing part and for payment of any surcharge required under 37 CFR 1.53(f) and 1.16(f). If the reissue oath or declaration is filed but the assignee consent is lacking, the surcharge is required because, until the consent is filed, the reissue oath or declaration is defective, since it is not apparent that the signatures thereon are proper absent an indication that the assignees have consented to the filing.

The consent of assignee must be signed by a party authorized to act on behalf of the assignee. See MPEP § 324 for a discussion of parties authorized to act on behalf of the assignee.

Where the written consent of all the assignees to the filing of the reissue application cannot be obtained, applicant may under appropriate circumstances petition to the Office of Petitions (MPEP § 1002.02(b)) for a waiver under 37 CFR 1.183 of the requirement of 37 CFR 1.172, to permit the acceptance of the filing of the reissue application. The petition fee under 37 CFR 1.17(f) must be included with the petition.

The reissue application can then be examined, but will not be allowed or issued without the consent of all the assignees as required by 37 CFR 1.172. See Baker Hughes Inc. v. Kirk, 921 F.Supp. 801, 809, 38 USPQ2d 1885, 1892 (D.D.C. 1995), N. B. Fassett, 1877 C.D. 32, 11 O.G. 420 (Comm’r Pat. 1877); James D. Wright, 1876 C.D. 217, 10 O.G. 587 (Comm’r Pat. 1876).

Where a continuation reissue application is filed with a copy of the assignee consent from the parent reissue application, and the parent reissue application is not to be abandoned, the copy of the consent should not be accepted. Where a divisional reissue application is filed with a copy of the assignee consent from the parent reissue application, regardless of whether or not the parent reissue application is to be abandoned, the copy of the consent should not be accepted. The copy of the consent from the parent does not indicate that the assignee has consented to the addition of the new invention of the divisional reissue application to the original patent, or to the addition of the new error correction of the continuation reissue application. (Presumably, a new correction has been added via the continuation, since the parent is still pending.) As noted above, OIPE will accord a filing date and send out a notice of missing parts stating that there is no proper consent and setting a period of time for filing the missing part and for payment of any surcharge required under 37 CFR 1.53(f) and 1.16(f)

Where a continuation reissue application is filed with a copy of the assignee consent from the parent reissue application, and the parent reissue application is, or will be abandoned, the copy of the consent should be accepted by the Office.

II.PROOF OF OWNERSHIP OF ASSIGNEE

The assignee that consents to the filing of the reissue application (as discussed above) must also establish that it is the assignee, i.e., the owner, of the patent. See 37 CFR 1.172. Accordingly, a 37 CFR 3.73(b) paper establishing the ownership of the assignee should be submitted at the time of filing the reissue application, in order to support the consent of the assignee. The assignee must establish its ownership in accordance with 37 CFR 3.73(b) by:

(A) filing in the reissue application documentary evidence of a chain of title from the original owner to the assignee; or

(B) specifying in the record of the reissue application where such evidence is recorded in the Office (e.g., reel and frame number, etc.).

Compliance with 37 CFR 3.73(b) may be provided as part of the same paper in which the consent by assignee is provided.

In connection with option (A) above, the submission of the documentary evidence to establish ownership must be accompanied by a statement affirming that the documentary evidence of the chain of title from the original owners to the assignee was, or concurrently is, submitted for recordation pursuant to 37 CFR 3.11. Thus, when filing a 37 CFR 3.73(b) statement to establish ownership, an applicant or patent owner must also submit the relied-upon assignment document(s) to the Office for recordation, unless such a submission has already been previously made. If the 37 CFR 3.73(b) statement is not accompanied by a statement affirming that the documentary evidence was, or concurrently is, submitted for recordation pursuant to 37 CFR 3.11, then the 37 CFR 3.73(b) statement will not be accepted, and the assignee(s) will not have established the right to take action in the patent application or the patent for which the 37 CFR 3.73(b) statement was submitted. This could result, for example, in an incomplete response, where a party stated to be the “assignee” signs a consent to the reissue to obviate a requirement for submission of assignee consent made in an Office action.

Upon initial receipt of a reissue application, the examiner should inspect the application to determine whether the submission under 37 CFR 1.172 and 37 CFR 3.73(b) establishing the ownership of the assignee is present and sufficient.

If an assignment document is attached with the 37 CFR 3.73(b) submission, the assignment should be reviewed to ensure that the named assignee is the same for the assignment document and the 37 CFR 3.73(b) statement, and that the assignment document is an assignment of the patent to be reissued to the assignee. If an assignment document is not attached with the 37 CFR 3.73(b) statement, but rather the reel and frame number where the assignment document is recorded in the USPTO is referenced in the 37 CFR 3.73(b) statement, it will be presumed that the assignment recorded in the USPTO supports the statement identifying the assignee. It will not be necessary for the examiner to obtain a copy of the recorded assignment document.

Just as the consent of assignee must be signed by a party authorized to act on behalf of the assignee, the submission with respect to 37 CFR 3.73(b) to establish ownership must be signed by a party authorized to act on behalf of the assignee. The signature of an attorney or agent registered to practice before the Office is not sufficient, unless that attorney or agent is authorized to act on behalf of the assignee.

Where the submission establishes the assignee’s ownership as to the patent, ownership as to the reissue application will be presumed. Accordingly, a submission as to the ownership of the patent will be construed to satisfy the 37 CFR1.172 (and 37 CFR 3.73(b)) requirements for establishing ownership of the application. Thus, a terminal disclaimer can be filed in a reissue application where ownership of the patent has been established, without the need for a separate submission under 37 CFR 3.73(b) showing ownership of the reissue application.

Even if the submission states that it is establishing ownership of the reissue application (rather than the patent), the submission should be accepted by the examiner as also establishing ownership in the patent. The documentation in the submission establishing ownership of the reissue application must, of necessity, include chain of title as to the patent.

III.COMPARISON OF ASSIGNEE THAT CONSENTS TO ASSIGNEE SET FORTH IN SUBMISSION ESTABLISHING OWNERSHIP INTEREST

The examiner must inspect both the consent and documentary evidence of ownership to determine whether the requirements of 37 CFR 1.172 have been met. The assignee identified by the documentary evidence must be the same assignee which signed the consent. Also, the person who signs the consent for the assignee and the person who signs the submission of evidence of ownership for the assignee must both be persons having authority to do so. See also MPEP § 324.

The reissue patent will be granted to the original patentee, his or her legal representatives or assigns as the interest may appear.

1411 Form of Specification[edit | edit source]

37 CFR 1.173. Reissue specification, drawings, and amendments.

(a) Contents of a reissue application. An application for reissue must contain the entire specification, including the claims, and the drawings of the patent. No new matter shall be introduced into the application. No reissue patent shall be granted enlarging the scope of the claims of the original patent unless applied for within two years from the grant of the original patent, pursuant to 35 U.S.C. 251.

(1) Specification, including claims. The entire specification, including the claims, of the patent for which reissue is requested must be furnished in the form of a copy of the printed patent, in double column format, each page on only one side of a single sheet of paper. If an amendment of the reissue application is to be included, it must be made pursuant to paragraph (b) of this section. The formal requirements for papers making up the reissue application other than those set forth in this section are set out in § 1.52. Additionally, a copy of any disclaimer (§ 1.321), certificate of correction (§§ 1.322 through 1.324), or reexamination certificate (§ 1.570) issued in the patent must be included. (See also § 1.178).

(2) Drawings. Applicant must submit a clean copy of each drawing sheet of the printed patent at the time the reissue application is filed. If such copy complies with § 1.84, no further drawings will be required. Where a drawing of the reissue application is to include any changes relative to the patent being reissued, the changes to the drawing must be made in accordance with paragraph (b)(3) of this section. The Office will not transfer the drawings from the patent file to the reissue application.


The file wrappers of all /08 and earlier series reissue applications are stamped “REISSUE” above the application number on the front of the file. “Reissue” also appears below the application number on the printed label on the file wrapper of the application with 08/ and earlier series.

Reissue applications filed after July of 1998 (09/ series and later) are placed in an orange and white striped file wrapper and can be easily identified as reissue applications. (For IFW Processing, see IFW Manual.)

Reissue applications filed prior to November 7, 2000 should be furnished in the form of cut-up soft copies of the original patent, with only a single column of the printed patent securely mounted on a separate sheet of paper.

For reissue applications filed on or after November 7, 2000, 37 CFR 1.173(a)(1) requires that the application specification, including the claims, must be furnished in the form of a copy of the printed patent in double column format (so that the patent can be simply copied without cutting). Applicants are required to submit a clean copy of each drawing sheet of the printed patent at the time the reissue application is filed (37 CFR 1.173(a)(2)). Any changes to the drawings must be made in accordance with 37 CFR 1.173(b)(3). Thus, a full copy of the printed patent (including the front page) is used to provide the abstract, drawings, specification, and claims of the patent for the reissue application. Each page of the patent must appear on only one side of each individual page of the specification of the reissue application; a two-sided copy of the patent is not proper. It should be noted that a re-typed specification is not acceptable in a reissue application; the full copy of the printed patent must be used. If, however, the changes to be made to the patent are so extensive/numerous that reading and understanding the specification is extremely difficult and error-prone, a clean copy of the specification may be submitted if accompanied by a grantable petition under 37 CFR 1.183 for waiver of 37 CFR 1.125(d) and 37 CFR 1.173(a)(1).

Pursuant to 37 CFR 1.173(b), amendments may be made at the time of filing of a reissue application. The amendment may be made either by:

(A) physically incorporating the changes within the specification by cutting the column of the printed patent and inserting the added material and rejoining the remainder of the column and then joining the resulting modified column to the other column of the printed patent. Markings pursuant to 37 CFR 1.173(d) must be used to show the changes. The columnar structure of the printed patent must be preserved, and the physically modified page must comply with 37 CFR 1.52(a)(1). As to compliance with 37 CFR 1.52(a)(1)(iv), the “written either by a typewriter or machine printer in permanent dark ink or its equivalent” requirement is deemed to be satisfied where a caret and line are drawn from a position within the text to a newly added phrase, clause, sentence, etc. typed legibly in the margin; or

(B) providing a preliminary amendment (a separate amendment paper) directing that specified changes be made to the copy of the printed patent.

The presentation of the insertions or deletions as part of the original reissue specification is an amendment under 37 CFR 1.173(b). An amendment of the reissue application made at the time of filing of the reissue application must be made in accordance with 37 CFR 1.173(b)-(e) and (g); see MPEP § 1453. Thus, as required by 37 CFR 1.173(c), an amendment of the claims made at the time of filing of a reissue application must include a separate paper setting forth the status of all claims (i.e., pending or canceled), and an explanation of the support in the disclosure of the patent for the changes made to the claims.

If a chart, table, or chemical formula is amended and it spans two columns of the patent, it should not be split. Rather, the chart, table, or chemical formula should be provided in its entirety as part of the column of the patent to which it pertains, in order to provide a continuity of the description. When doing so, the chart, table, or chemical formula may extend beyond the width of the column. Change in only a part of a word or chemical formula is not permitted. Entire words or chemical formulas must be shown as being changed. Deletion of a chemical formula should be shown by brackets which are substantially larger and darker than any in the formula.

Where a terminal disclaimer was filed in the application for the patent to be reissued, a copy of that terminal disclaimer is not needed in the reissue application file. For a reissue application that is maintained in a paper file, the face of the file wrapper should be marked to indicate that a terminal disclaimer has been filed for the patent. For a reissue application that is maintained in IFW, the “Final SPRE Review” form will be filled in.

Twice reissued patent:

Examples of the form for a twice-reissued patent are found in Re. 23,558 and Re. 28,488. Double underlining and double bracketing are used in the second reissue application, while bold-faced type and double bracketing appear in the printed patent (the second reissue patent) to indicate further insertions and deletions, respectively, in the second reissue patent.

When a copy of a first reissue patent is used as the specification of a second reissue application (filed as a reissue of a reissue), additions made by the first reissue will already be printed in italics, and should remain in such format. Thus, applicants need only present additions to the specification/claims in the second reissue application as double underlined text. Subject matter to be deleted from the first reissue patent should be presented in the second reissue application within sets of double brackets.

1411.01 Certificate of Correction or Disclaimer in Original Patent[edit | edit source]

The applicant should include any changes, additions, or deletions that were made by a Certificate of Correction to the original patent grant in the reissue application without underlining or bracketing. The examiner should make certain that all Certificate of Correction changes in the patent have been properly incorporated into the reissue application.

Certificate of Correction changes and disclaimer of claim(s) under 37 CFR 1.321(a) should be made without using underlining or brackets. Since these are part of the original patent and were made before the reissue was filed, they should show up in the printed reissue patent document as part of the original patent, i.e., not in italics or bracketed. If the changes are extensive and/or applicant has submitted them improperly with underlining and brackets, a clean copy of the specification with the Certificate of Correction changes in it may be requested by the examiner. In order for the clean copy to be entered as a substitute specification, the reissue applicant must file a grantable petition under 37 CFR 1.183 for waiver of 37 CFR 1.125(d) and 37 CFR 1.173(a)(1). The examiner’ s request for the clean copy will generally serve as sufficient basis for granting the petition.

1411.02 New Matter[edit | edit source]

New matter, that is, matter not present in the patent sought to be reissued, is excluded from a reissue application in accordance with 35 U.S.C. 251.

The claims in the reissue application must be for subject matter which the applicant had the right to claim in the original patent. Any change in the patent made via the reissue application should be checked to ensure that it does not introduce new matter. Note that new matter may exist by virtue of the omission of a feature or of a step in a method. See United States Industrial Chemicals, Inc. v. Carbide & Carbon Chemicals Corp., 315 U.S. 668, 53 USPQ 6 (1942).

1412 Content of Claims[edit | edit source]

The content of claims in a reissue application is somewhat limited, as is indicated in MPEP § 1412.01through MPEP § 1412.03.

1412.01Reissue Claims Must Be for Same General Invention [R-2]

The reissue claims must be for the same invention as that disclosed as being the invention in the original patent, as required by 35 U.S.C. 251. This does not mean that the invention claimed in the reissue must have been claimed in the original patent, although this is evidence that applicants considered it their invention. The entire disclosure, not just the claim(s), is considered in determining what the patentee objectively intended as his or her invention. The proper test as to whether reissue claims are for the same invention as that disclosed as being the invention in the original patent is “an essentially factual inquiry confined to the objective intent manifested by the original patent.” In re Amos, 953 F.2d 613, 618, 21 USPQ2d 1271, 1274 (Fed. Cir. 1991) (quoting In re Rowand, 526 F.2d 558, 560, 187 USPQ 487, 489 (CCPA 1975)) (emphasis added). See also In re Mead, 581 F.2d 257, 198 USPQ 412 (CCPA 1978). The “original patent” requirement of 35 U.S.C. 251 must be understood in light of In re Amos, supra, where the Court of Appeals for the Federal Circuit stated:

We conclude that, under both Mead and Rowand, a claim submitted in reissue may be rejected under the “original patent” clause if the original specification demonstrates, to one skilled in the art, an absence of disclosure sufficient to indicate that a patentee could have claimed the subject matter. Merely finding that the subject matter was “not originally claimed, not an object of the original patent, and not depicted in the drawing,” does not answer the essential inquiry under the “original patent” clause of § 251, which is whether one skilled in the art, reading the




specification, would identify the subject matter of the new claims as invented and disclosed by the patentees. In short, the absence of an “intent,” even if objectively evident from the earlier claims, the drawings, or the original objects of the invention is simply not enough to establish that the new claims are not drawn to the invention disclosed in the original patent.

953 F.2d at 618-19, 21 USPQ2d at 1275. Claims presented in a reissue application are considered to satisfy the requirement of 35 U.S.C. 251 that the claims be “for the invention disclosed in the original patent” where:

(A)the claims presented in the reissue application are described in the original patent specification and enabled by the original patent specification such that 35 U.S.C. 112 first paragraph is satisfied; and

(B)nothing in the original patent specification indicates an intent not to claim the subject matter of the claims presented in the reissue application.

The presence of some disclosure (description and enablement) in the original patent should evidence that applicant intended to claim or that applicant considered the material now claimed to be his or her invention.

The original patent specification would indicate an intent not to claim the subject matter of the claims presented in the reissue application in a situation analogous to the following:

The original patent specification discloses that composition X is not suitable (or not satisfactory) for molding an item because composition X fails to provide quick drying. After the patent issues, it is found that composition X would be desirable for the molding in spite of the failure to provide quick drying, because of some other newly recognized benefit from composition X. A claim to composition X or a method of use thereof would not be permitted in a reissue application, because the original patent specification contained an explicit statement of intent not to claim composition X or a method of use thereof.

In most instances, however, the mere failure to claim a disclosed embodiment in the original patent (absent an explicit statement in the original patent specification of unsuitability of the embodiment) would not be grounds for prohibiting a claim to that embodiment in the reissue.

FAILURE TO TIMELY FILE A DIVISIONAL APPLICATION PRIOR TO ISSUANCE OF ORIGINAL PATENT

Where a restriction requirement was made in an application and applicant permitted the elected invention to issue as a patent without the filing of a divisional application on the non-elected invention(s), the non-elected invention(s) cannot be recovered by filing a reissue application. A reissue applicant’ s failure to timely file a divisional application covering the non- elected invention(s) in response to a restriction requirement is not considered to be error causing a patent granted on the elected claims to be partially inoperative by reason of claiming less than the applicant had a right to claim. Accordingly, such error is not correctable by reissue of the original patent under 35 U.S.C. 251. In re Watkinson, 900 F.2d 230, 14 USPQ2d 1407 (Fed. Cir. 1990); In re Orita, 550 F.2d 1277, 1280, 193 USPQ 145, 148 (CCPA 1977). See also In re Mead, 581 F.2d 251, 198 USPQ 412 (CCPA 1978). In this situation, the reissue claims should be rejected under 35 U.S.C. 251 for lack of defect in the original patent and lack of error in obtaining the original patent. Compare with In re Doyle, 293 F.3d 1355, 63 USPQ2d 1161 (Fed. Cir. 2002) where the court permitted the patentee to file a reissue application to present a so-called linking claim, a claim broad enough to read on or link the invention elected (and patented) together with the invention not elected. The non-elected invention(s) were inadvertently not filed as a divisional application.

1412.02Recapture of Canceled SubjectMatter [R-5]

A reissue will not be granted to “recapture” claimed subject matter which was surrendered in an application to obtain the original patent. North American Container, Inc. v. Plastipak Packaging, Inc., 415 F.3d 1335, 75 USPQ2d 1545 (Fed. Cir. 2005, Pannu v. Storz Instruments Inc., 258 F.3d 1366, 59 USPQ2d 1597 (Fed. Cir. 2001); Hester Industries, Inc. v. Stein, Inc., 142 F.3d 1472, 46 USPQ2d 1641 (Fed. Cir. 1998); In re Clement, 131 F.3d 1464, 45 USPQ2d 1161 (Fed. Cir. 1997); Ball Corp. v. United States, 729 F.2d 1429, 1436, 221 USPQ 289, 295 (Fed. Cir. 1984); In re Wadlinger, 496 F.2d 1200, 181 USPQ 826 (CCPA 1974); In re Richman, 409 F.2d 269, 276,




161 USPQ 359, 363-364 (CCPA 1969); In re Willingham, 282 F.2d 353, 127 USPQ 211 (CCPA 1960).

I.THREE STEP TEST FOR RECAPTURE:

In Clement, 131 F.3d at 1468-70, 45 USPQ2d at 1164-65, the Court of Appeals for the Federal Circuit set forth a three step test for recapture analysis. In Pannu, 258 F.3d at 1371, 59 USPQ2d at 1600, the court restated this test as follows:

Application of the recapture rule is a three-step process.


The first step is to ‘determine whether and in what aspect the reissue claims are broader than the patent claims.’....

‘The second step is to determine whether the broader aspects of the reissued claim related to surrendered subject matter’ ....

Finally, the court must determine whether the reissued claims were materially narrowed in other respects to avoid the recapture rule. [Emphasis added]

A.The First Step - Was There Broadening?

In every reissue application, the examiner must first review each claim for the presence of broadening, as compared with the scope of the claims of the patent to be reissued. A reissue claim is broadened where some limitation of the patent claims is no longer required in the reissue claim; see MPEP § 1412.03 for guidance as to the nature of a “broadening claim.” If the reissue claim is not broadened in any respect as compared to the patent claims, the analysis ends; there is no recapture.


B.The Second Step - Does Any Broadening Aspect of the Reissued Claim Relate to Surrendered Subject Matter?

Where a claim in a reissue application is broadened in some respect as compared to the patent claims, the examiner must next determine whether the broadening aspect(s) of that reissue claim relate(s) to subject matter that applicant previously surrendered during the prosecution of the original application (which became the patent to be reissued). Each limitation of the patent claims, which is omitted or broadened in the reissue claim, must be reviewed for this determination. This involves two sub-steps:

1.The Two Sub-Steps:

(A)It must first be determined whether there was any surrender of subject matter made in the prosecution of the original application which became the patent to be reissued.

If an original patent claim limitation now being omitted or broadened in the present reissue application was originally relied upon by applicant in the original application to make the claims allowable over the art, the omitted limitation relates to subject matter previously surrendered by applicant. The reliance by applicant to define the original patent claims over the art can be by way of presentation of new/amended claims to define over the art, or an argument/statement by applicant that a limitation of the claim(s) defines over the art. To determine whether such reliance occurred, the examiner must review the prosecution history of the original application file (of the patent to be reissued) for recapture. The prosecution history includes the rejections and applicant’s arguments made therein.

If there was no surrender of subject matter made in the prosecution of the original application, again the analysis ends and there is no recapture.

(B)If there was a surrender of subject matter in the original application prosecution, it must then be determined whether any of the broadening of the reissue claims is in the area of the surrendered subject matter. All of the broadening aspects of reissue claims must be analyzed to determine if any of the omitted/ broadened limitation(s) are directed to limitations relied upon by applicant in the original application to make the claims allowable over the art.

2.Examples of the Pannu Second Step Analysis:


(A)Example (1) - Argument without amendment:

In Hester, supra, the Federal Circuit held that the surrender which forms the basis for impermissible recapture “can occur through arguments alone”. 142 F.3d at 1482, 46 USPQ2d at 1649. For example, assume that limitation A of the patent claims is omitted in the reissue claims. This omission provides a broadening aspect in the reissue claims, as compared to the claims of the patent. If the omitted limitation A was argued in the original application to make the application claims allowable over the art in the appli




cation, then the omitted limitation relates to subject matter previously surrendered in the original application, and recapture will exist. Accordingly, where claims are broadened in a reissue application, the examiner should review the prosecution history of the original patent file for recapture, even where the claims were never amended during the prosecution of the application which resulted in the patent.

Note: The argument that the claim limitation defined over the rejection must have been specific as to the limitation relied upon, rather than a general statement regarding the claims as a whole. A general 'boiler plate' sentence in the original application will not, by itself, be sufficient to establish surrender and recapture.

An example of a general “boiler plate” sentence of argument is:

“In closing, it is argued that the limitations of claims 1-7 distinguish the claims from the teachings of the prior art, and claims 1-7 are thus patentable.”

An argument that merely states that all the limitations of the claims define over the prior art will also not, by itself, be sufficient to establish surrender and recapture. An example is:

“Claims 1-5 set forth a power-train apparatus which comprises the combination of A+B+C+D+E. The prior art of record does not disclose or render obvious a motivation to provide for a material-transfer apparatus as defined by the limitations of claim 1, including an A member and a B member, both connected to a C member, with all three being aligned with the D and E members.”

This statement is simply a restatement of the entirety of claim 1 as allowed. No measure of surrender could be gleaned from such a statement of reasons for allowance. See Ex parte Yamaguchi, 61 USPQ2d 1043 (Bd. Pat. App. & Inter. 2001)(reported but unpublished, precedential).

In both of the above examples, the argument does not provide an indication of what specific limitations, e.g., specific element or step of the claims, cooperative effect, or other aspect of the claims, are being relied upon for patentability. Thus, applicant has not surrendered anything.

(B)Example (2) - Amendment of the claims without argument:

The limitation omitted in the reissue claim(s) was added in the original application claims for the purpose of making the application claims allowable over a rejection or objection made in the application. Even though applicant made no argument on the record that the limitation was added to obviate the rejection, the nature of the addition to the claim can show that the limitation was added in direct reply to the rejection. This too will establish the omitted limitation as relating to subject matter previously surrendered. To illustrate this, note the following example:

The original application claims recite limitations A+B+C, and the Office action rejection combines two references to show A+B+C. In the amendment replying to the Office action, applicant adds limitation D to A+B+C in the claims, but makes no argument as to that addition. The examiner then allows the claims. Even though there is no argument as to the addition of limitation D, it must be presumed that the D limitation was added to obviate the rejection. The subsequent deletion of (omission of) limitation D in the reissue claims would be presumed to be a broadening in an aspect of the reissue claims related to surrendered subject matter. Accordingly, the reissued claims would be barred by the recapture doctrine.

The above result would be the same whether the addition of limitation D in the original application was by way of applicant’s amendment or by way of an examiner’s amendment with authorization by applicant.


(C)Example (3) - Who can make the surrendering argument?

Assume that the limitation A omitted in the reissue claims was present in the claims of the original application. The examiner’s reasons for allowance in the original application stated that it was that limitation A which distinguished over a potential combination of references X and Y. Applicant did not present on the record a counter statement or comment as to the examiner’s reasons for allowance, and permitted the claims to issue.

Ex parte Yamaguchi, supra, held that a surrender of claimed subject matter cannot be based solely upon an applicant’s failure to respond to, or failure to challenge, an examiner’s statement made during the prosecution of an application. Applicant is bound only by applicant’s revision of the application claims or a positive argument/statement by applicant. An applicant’s failure to present on the record a counter statement or




comment as to an examiner’s reasons for allowance does not give rise to any implication that applicant agreed with or acquiesced in the examiner’s reasoning for allowance. Thus, the failure to present a counter statement or comment as to the examiner’s statement of reasons for allowance does not give rise to any finding of surrender. The examiner’s statement of reasons for allowance in the original application cannot, by itself, provide the basis for establishing surrender and recapture.

It is only in the situation where applicant does file comments on the statement of reasons for allowance, that surrender may have occurred. Note the following two scenarios in which an applicant files comments:

Scenario 1- There is Surrender: The examiner’s statement of reasons for allowance in the original application stated that it was limitation C (of the combination of ABC) which distinguished over a potential combining of references X and Y, in that limitation C provided increased speed to the process. Applicant filed comments on the examiner’s statement of reasons for allowance essentially supporting the examiner’ s reasons. The limitation C is thus established as relating to subject matter previously surrendered.

Scenario 2- There is No Surrender: On the other hand, if applicant’s comments on the examiner’s statement of reasons for allowance contain a counter statement that it is limitation B (of the combination of ABC), rather than C, which distinguishes the claims over the art, then limitation B would constitute surrendered subject matter, and limitation C has not been surrendered.

C.The Third Step - Were the reissued claims materially narrowed in other respects to compensate for the broadening in the area of surrender, and thus avoid the recapture rule?

As pointed out above, the third prong of the recapture determination set forth in Pannu is directed to analysis of the broadening and narrowing effected via the reissue claims, and of the significance of the claim limitations added and deleted, using the prosecution history of the patent (to be reissued), to determine whether the reissue claims should be barred as recapture.


The following discussion addresses analyzing the reissue claims, and which claims are to be compared to the reissue claims in determining the issue of surrender (for reissue recapture).

When analyzing a reissue claim for the possibility of impermissible recapture, there are two different types of analysis that must be performed. If the reissue claim “fails” either analysis, recapture exists.

First, the reissue claim must be compared to any claims canceled or amended during prosecution of the original application. It is impermissible recapture for a reissue claim to be as broad or broader in scope than any claim that was canceled or amended in the original prosecution to define over the art. Claim scope that was canceled or amended is deemed surrendered and therefore barred from reissue. In re Clement, supra.

Second, it must be determined whether the reissue claim entirely omits any limitation that was added/ argued during the original prosecution to overcome an art rejection. Such an omission in a reissue claim, even if it includes other limitations making the reissue claim narrower than the patent claim in other aspects, is impermissible recapture. Pannu v. Storz Instruments Inc., supra. However, if the reissue claim recites a broader form of the key limitation added/ argued during original prosecution to overcome an art rejection (and therefore not entirely removing that key limitation), then the reissue claim may not be rejected under the recapture doctrine. Ex Parte Eggert, 67 USPQ2d 1716 (Bd. Pat. App. & Inter. 2003) (precedential). For example, if the key limitation added to overcome an art rejection was “an orange peel,” and the reissue claim instead recites “a citrus fruit peel”, the reissue claim may not be rejected on recapture grounds.

The following discussion is provided for analyzing the reissue claims.

1.Comparison of Reissue Claims Narrowed/ Broadened Vis-à-vis the Canceled Claims

DEFINITION: “Canceled claims,” in the context of recapture case law, are claims canceled from the original application to obtain the patent for which reissue is now being sought. The claims

(A)can simply be canceled and not replaced by others, or

(B)can be canceled and replaced by other claims which are more specific than the canceled claims in at least one aspect (to thereby define over the art of record). The “replacement claims” can be new claims which are narrower than the canceled claims, or can




be the same claims amended to be narrower than the canceled version of the claims.

(a)Reissue Claims are Same or Broader in Scope Than Canceled Claims in All Aspects:

The recapture rule bars the patentee from acquiring, through reissue, claims that are in all aspects (A) of the same scope as, or (B) broader in scope than, those claims canceled from the original application to obtain a patent. In re Ball Corp. v. United States, 729 F.2d at 1436, 221 USPQ at 295.

(b)Reissue Claims are Narrower in Scope Than Canceled Claims in at Least One Aspect:

If the reissue claims are equal in scope to, or narrower than, the claims of the original patent (as opposed to the claims “canceled from the application”) in all aspects, then there can never be recapture. The discussion that follows is not directed to that situation. It is rather directed to the situation where the reissue claims are narrower than the claims 'canceled' from the application in some aspect, but are broader than the claims of the original patent in some other aspect.

If the reissue claims are narrower in scope than the claims canceled from the original application by inclusion of the limitation added to define the original application claims over the art, there will be no recapture, even if the reissue claims are broader than the canceled claims in some other aspect (i.e., an aspect not related to the surrender made in the original application).


Assume combination AB was originally presented in the application, and was amended in response to an art rejection to add element C and thus provide ABC (after which the patent issued). The reissue claims are then directed to combination ABbroadenedC. The ABbroadenedC claims are narrower in scope when compared with the canceled claim subject matter AB in respect to the addition of C (which was added in the application to overcome the art), and there is no recapture.

As another example, assume combination ABZ was originally presented in the application, and was amended in response to an art rejection to add element C and thus provide ABZC (after which the patent issued). The reissue claims are then directed to combination ABC (i.e., element Z is deleted from the canceled claims, while element C remains present). The ABC claims of the reissue are narrower in scope as compared to the canceled-from-the-original-application claim subject matter ABZ in respect to the addition of C (which was added in the application to overcome the art), and there is thus no recapture.

2.Comparison of Reissue Claims Narrowed/ Broadened Via-à-vis the Patent Claims

The “patent claims,” in the context of recapture case law, are claims which issued in the original patent for which reissue is now being sought. As pointed out above, where the reissue claims are narrower than the claims of the original patent in all aspects, then there can never be recapture. If reissue claims are equal in scope to the patent claims, there is no recapture as to those reissue claims. Where, however, reissue claims are both broadened and narrowedas compared with the original patent claims, the nature of the broadening and narrowing must be examined to determine whether the reissue claims are barred as being recapture of surrendered subject matter. If the claims are 'broader than they are narrower in a manner directly pertinent to the subject matter... surrendered during prosecution' (Clement, 131 F.3d at 1471, 45 USPQ2d at 1166), then recapture will bar the claims. This narrowing/broadening vis-à-vis the patent is broken down into four possibilities that will now be addressed.

The “limitation” presented, argued, or stated to make the claims patentable over the art (in the application) “generates” the surrender of claimed subject matter. For the sake of simplification, this limitation will be referred to throughout this section as the surrender- generating limitation. If a claim is presented in a reissue application that omits, in its entirety, the surrender- generating limitation, that claim impermissibly recaptures what was previously surrendered, and that claim is barred under 35 U.S.C. 251. This terminology will be used in the discussion of the four categories of narrowing/broadening vis-à-vis the patent that follows.




(a)Reissue Claims are Narrower in Scope Than Patent Claims, in Area Not Directed to Amendment/Argument Made to Overcome Art Rejection in Original Prosecution; are Broader in Scope by Omitting Limitation(s) Added/Argued To Overcome Art Rejection in Original Prosecution:

In this case, there is recapture.

This situation is where the patent claims are directed to combination ABC and the reissue claims are directed to ABD. Element C was either a limitation added to AB to obtain allowance of the original patent, or was argued by applicant to define over the art (or both). Thus, addition of C (and/or argument as to C) has resulted in the surrender of any combination of A & B that does not include C; this is the surrendered subject matter. Element D, on the other hand, is not related to the surrendered subject matter. Thus, the reissue claim, which no longer contains C, is broadened in an area related to the surrender, and the narrowing via the addition of D does not save the claim from recapture since D is not related to the surrendered subject matter.

Reissue claims that are broader than the original patent claims by not including the surrender-generating limitation (element C, in the example given) will be barred by the recapture rule even though there is narrowing of the claims not related to the surrender- generating limitation. As stated in the decision of In re Clement, 131 F.3d at 1470, 45 USPQ2d at 1165, if the reissue claim is broader in an aspect germane to a prior art rejection, but narrower in another aspect completely unrelated to the rejection, the recapture rule bars the claim. Pannu v. Storz Instruments Inc., supra, then brings home the point by providing an actual fact situation in which this scenario was held to be recapture.

(b)Reissue Claims are Narrower or Equal in Scope, in Area Directed to Amendment/ Argument Made to Overcome Art Rejection in Original Prosecution; are Broader in Scope in Area Not Directed to Amendment/ Argument:

In this case, there is no recapture.

This situation is where the patent claims are directed to combination ABCDE and the reissue claims are directed to ABDE (element C is omitted). Assume that the combination of ABCD was present in the original application as it was filed, and element E was later added to define over that art. No argument was ever presented as to elements A-C defining over the art.

In this situation, the ABCDE combination of the patent can be broadened (in the reissue application) to omit element C, and thereby claim the combination of ABDE, where element E (the surrender generating limitation) is not omitted. There would be no recapture in this instance. (If an argument had been presented as to element C defining over the art, in addition to the addition of element E, then the ABCDE combination could not be broadened to omit element C and thereby claim combination of ABDE. This would be recapture; see the above discussion as to surrender and recapture based upon argument.)

Additionally, the reissue claims are certainly permitted to recite combination ABDEspecific (where surrender- generating element E is narrowed). The patent claims have been broadened in an area not directed to the surrender (by omitting element C) and narrowed in the area of surrender (by narrowing element E to Especific). This is clearly permitted.

As another example, assume limitation C was added to application claims AB to obtain the patent to ABC, and now the reissue application presents claims to AC or ABbroadC. Such reissue claims avoid the effect of the recapture rule because they are broader in a way that does not attempt to reclaim what was surrendered earlier. Mentor Corp. v. Coloplast, Inc., 998 F.2d 992, 994, 27 USPQ2d 1521, 1525 (Fed. Cir. 1993). Such claims are considered to be broader in an aspect not 'germane to a prior art rejection,' and thus are not barred by recapture. Note In re Clement, 131 F.3d at 1470, 45 USPQ2d at 1165.

Reissue claims that are broader than the original patent claims by deletion of a limitation or claim requirement other than the “surrender-generating limitation” will avoid the effect of the recapture rule, regardless of the nature of the narrowing in the claims, and even if the claims are not narrowed at all from the scope of the patent claims.




(c)Reissue Claims are Narrower in Scope in Area Not Directed to Amendment/Argument Made to Overcome Art Rejection in Original Prosecution; are Broader in Scope in Area Not Directed to the Amendment/Argument:

In this instance, there is clearly no recapture. In the reissue application, there has been no change in the claims related to the matter surrendered in the original application for the patent.

In this instance, element C was added to the AB combination to provide ABC and define over the art, and the patent was issued. The reissue omits element B and adds element Z, to thus claim ACZ. There is no recapture since the surrender generating element C has not been modified in any way. (Note, however, that if, when element C was added to AB, applicant argued that the association of newly added C with B provides a synergistic (unexpected) result to thus define over the art, then neither B nor C could be omitted in the reissue application.)

(d)Reissue Claims Broader in Scope in Area Directed to Amendment/Argument Made to Overcome Art Rejection in Original Prosecution; but Reissue Claims Retain, in Broadened Form, the Limitation(s) Argued/ Added to Overcome Art Rejection in Original Prosecution:

Assume the combination AB was originally claimed in the application, and was amended in reply to an art rejection to add element C and thus provide the combination ABC (after which the patent issued). A reissue application is then filed, and the reissue application claims are directed to the combination ABCbroadened. The ABCbroadened claims are narrowed in scope when compared with the canceled claim subject matter AB, because of the addition of Cbroadened. Thus, the claims retain, in broadened form, the limitation argued/added to overcome art rejection in original prosecution. There is no recapture, since ABCbroadened is narrower than canceled claim subject matter AB in an area related to the surrender. This is so, because it was element C that was added in the application to overcome the art. See Ex Parte Eggert, supra.

II.REISSUE TO TAKE ADVANTAGE OF 35 U.S.C. 103(b):

A patentee may file a reissue application to permit consideration of process claims which qualify for 35 U.S.C. 103(b) treatment if a patent is granted on an application entitled to the benefit of 35 U.S.C. 103(b), without an election having been made as a result of.. error without deceptive intent. See MPEP §

706.02(n). This is not to be considered a recapture. The addition of process claims, however, will generally be considered to be a broadening of the invention (Ex parte Wikdahl, 10 USPQ2d 1546 (Bd. Pat. App. & Inter. 1989)), and such addition must be applied for within two years of the grant of the original patent. See also MPEP § 1412.03 as to broadened claims.

III.REISSUE FOR ARTICLE CLAIMS WHICH ARE FUNCTIONAL DESCRIPTIVE MATERIAL STORED ON A COMPUTER- READABLE MEDIUM:

A patentee may file a reissue application to permit consideration of article of manufacture claims which are functional descriptive material stored on a computer- readable medium, where these article claims correspond to the process or machine claims which have been patented. The error in not presenting claims to this statutory category of invention (the “article” claims) must have been made as a result of error without deceptive intent. The addition of these “article” claims will generally be considered to be a broadening of the invention (Ex parte Wikdahl, 10 USPQ2d 1546 (Bd. Pat. App. & Inter. 1989)), and such addition must be applied for within two years of the grant of the original patent. See also MPEP § 1412.03 as to broadened claims.

IV.REJECTION BASED UPON RECAPTURE:


Reissue claims which recapture surrendered subject matter should be rejected using form paragraph 14.17.

¶ 14.17 Rejection, 35 U.S.C. 251, Recapture

Claim[1] rejected under 35 U.S.C. 251 as being an improper recapture of broadened claimed subject matter surrendered in the application for the patent upon which the present reissue is based. See Pannu v. Storz Instruments Inc., 258 F.3d 1366, 59 USPQ2d 1597 (Fed. Cir. 2001); Hester Industries, Inc. v. Stein, Inc., 142 F.3d 1472, 46 USPQ2d 1641 (Fed. Cir. 1998); In re Clement, 131




F.3d 1464, 45 USPQ2d 1161 (Fed. Cir. 1997); Ball Corp. v. United States, 729 F.2d 1429, 1436, 221 USPQ 289, 295 (Fed. Cir. 1984). A broadening aspect is present in the reissue which was not present in the application for patent. The record of the application for the patent shows that the broadening aspect (in the reissue) relates to claim subject matter that applicant previously surrendered during the prosecution of the application. Accordingly, the narrow scope of the claims in the patent was not an error within the meaning of 35 U.S.C. 251, and the broader scope of claim subject matter surrendered in the application for the patent cannot be recaptured by the filing of the present reissue application.

[2]

Examiner Note:

In bracket 2, the examiner should explain the specifics of why recapture exists, including an identification of the omitted/broadened claim limitations in the reissue which provide the “broadening aspect” to the claim(s), and where in the original application the narrowed claim scope was presented/argued to obviate a rejection/ objection. See MPEP §

1412.02.

See the recapture-analysis flow chart which follows for assistance in determining whether recapture is present, consistent with the case law discussed above.




Flowchart - Reissue Recapture - Determining its presence or absence




1412.03Broadening Reissue Claims [R-3]

35 U.S.C. 251 prescribes a 2-year limit for filing applications for broadening reissues:

No reissue patent shall be granted enlarging the scope of the original patent unless applied for within two years from the grant of the original patent.


I. MEANING OF “BROADENED REISSUE CLAIM”

A broadened reissue claim is a claim which enlarges the scope of the claims of the patent, i.e., a claim which is greater in scope than each and every claim of the original patent. If a disclaimer is filed in the patent prior to the filing of a reissue application, the disclaimed claims are not part of the “original patent” under 35 U.S.C. 251. The Court in Vectra Fitness Inc. v. TNWK Corp., 49 USPQ2d 1144, 1147, 162 F.3d 1379, 1383 (Fed. Cir. 1998) held that a reissue application violated the statutory prohibition under 35 U.S.C. 251 against broadening the scope of the patent more than 2 years after its grant because the reissue claims are broader than the claims that remain after the disclaimer, even though the reissue claims are narrower than the claims that were disclaimed by the patentee before reissue. The reissue application was bounded by the claims remaining in the patent after a disclaimer is filed.A claim of a reissue application enlarges the scope of the claims of the patent if it is broader in at least one respect, even though it may be narrower in other respects.

A claim in the reissue which includes subject matter not covered by the patent claims enlarges the scope of the patent claims. For example, if any amended or newly added claim in the reissue contains within its scope any conceivable product or process which would not have infringed the patent, then that reissue claim would be broader than the patent claims. Tillotson, Ltd. v. Walbro Corp., 831 F.2d 1033, 1037 n.2, 4 USPQ2d 1450, 1453 n.2 (Fed. Cir. 1987); In re Ruth, 278 F.2d 729, 730, 126 USPQ 155, 156 (CCPA 1960); In re Rogoff, 261 F.2d 601, 603, 120 USPQ 185, 186 (CCPA 1958). A claim which reads on something which the original claims do not is a broadened claim. A claim would be considered a broadening claim if the patent owner would be able to sue any party for infringement who previously could not have been sued for infringement. Thus, where the original patent claims only the process, and the reissue application adds (for the first time) product claims, the scope of the claims has been broadened since a party could not be sued for infringement of the product based on the claims of the original patent.

The addition of combination claims in a reissue application where only subcombination claims were present in the original patent could be a broadening of the invention. The question which must be resolved in this case is whether the combination claims added in the reissue would be for “the invention as claimed” in the original patent. See Ex parte Wikdahl, 10 USPQ2d at 1549. The newly added combination claims should be analyzed to determine whether they contain every limitation of the subcombination of any claim of the original patent. If the combination claims (added in the reissue) contain every limitation of the subcombination (which was claimed in the original application), then infringement of the combination must also result in infringement of the subcombination. Accordingly, the patent owner could not, if a reissue patent issues with the combination claims, sue any new party for infringement who could not have been sued for infringement of the original patent. Therefore, broadening does not exist, in spite of the addition of the combination.


II. SCOPE OF DEPENDENT CLAIM ENLARGED-NOT BROADENING

As pointed out above, a claim will be considered a broadened reissue claim when it is greater in scope than each and every claim of the patent to be reissued. A corollary of this is that a claim which has been broadened in a reissue as compared to its scope in the patent is not a broadened reissue claim if it is narrower than, or equal in scope to, any other claim which appears in the patent. A common example of this is where dependent claim 2 is broadened via the reissue (other than the addition of a process step to convert an intermediate to a final product as discussed in the preceding subsection), but independent claim 1 on which it is based is not broadened. Since a dependent claim is construed to contain all the limitations of the claim upon which it depends, claim 2 must be at




least as narrow as claim 1 and is thus not a broadened reissue claim.


III. NEW CATEGORY OF INVENTION ADDED IN REISSUE - GENERALLY IS BROADENING

The addition of process claims as a new category of invention to be claimed in the patent (i.e., where there were no method claims present in the original patent) is generally considered as being a broadening of the invention. See Ex parte Wikdahl, 10 USPQ2d 1546 (Bd. Pat. App. & Inter. 1989). A situation may arise, however, where the reissue application adds a limitation (or limitations) to process A of making the product A claimed in the original patent claims. For example:

(1)a process of using the product A (made by the process of the original patent) to make a product B, disclosed but not claimed in the original patent; or

(2)a process of using the product A to carry out a process B disclosed but not claimed in the original patent.

Although this amendment of the claims adds a method of making product B or adds a method of using product A, this is not broadening (i.e., this is not an enlargement of the scope of the original patent) because the “newly claimed invention” contains all the limitations of the original patent claim(s).


IV. WHEN A BROADENED CLAIM CAN BE PRESENTED

A broadened claim can be presented within two years from the grant of the original patent in a reissue application. In addition, a broadened claim can be presented after two years from the grant of the original patent in a broadening reissue application which was filed within two years from the grant. Where any intent to broaden is indicated in the reissue application within the two years from the patent grant, a broadened claim can subsequently be presented in the reissue after the two year period. Thus, a broadened claim may be presented in a reissue application after the two years, even though the broadened claim presented after the two years is different than the broadened claim presented within the two years. Finally, if intent to broaden is indicated in a parent reissue application within the two years, a broadened claim can be presented in a continuing (continuation or divisional) reissue application after the two year period. In any other situation, a broadened claim cannot be presented, and the examiner should check carefully for the improper presentation of broadened claims.

A reissue application filed on the 2-year anniversary date from the patent grant is considered to be filed within 2 years of the patent grant. See Switzer v. Sockman, 333 F.2d 935, 142 USPQ 226 (CCPA 1964) for a similar rule in interferences.

See also the following cases which pertain to broadened reissues:

In re Graff, 111 F.3d 874, 877, 42 USPQ2d 1471, 1473-74 (Fed. Cir. 1997) (Broadened claims in a continuing reissue application were properly rejected under 35 U.S.C. 251 because the proposal for broadened claims was not made (in the parent reissue application) within two years from the grant of the original patent and the public was not notified that broadened claims were being sought until after the two-year period elapsed.);

In re Fotland, 779 F.2d 31, 228 USPQ 193 (Fed. Cir. 1985), cert. denied, 476 U.S. 1183 (1986) (The failure by an applicant to include an oath or declaration indicating a desire to seek broadened claimswithin two years of the patent grant will bar a subsequent attempt to broaden the claims after the two year limit. Under the former version of 37 CFR 1.175 (the former 37 CFR 1.175(a)(4)), applicant timely sought a “no-defect” reissue, but the Court did not permit an attempt made beyond the two year limit to convert the reissue into a broadening reissue. In this case, applicant did not indicate any intent to broaden within the two years.);

In re Bennett, 766 F.2d 524, 528, 226 USPQ 413, 416 (Fed. Cir. 1985) (en banc) (A reissue application with broadened claims was filed within two years of the patent grant; however, the declaration was executed by the assignee rather than the inventor. The Federal Circuit permitted correction of the improperly executed declaration to be made more than two years after the patent grant.);

In re Doll, 419 F.2d 925, 928, 164 USPQ 218, 220 (CCPA 1970) (If the reissue application is timely filed within two years of the original patent grant and the




applicant indicates in the oath or declaration that the claims will be broadened, then applicant may subsequently broaden the claims in the pending reissue prosecution even if the additional broadening occurs beyond the two year limit.).

Form paragraphs 14.12 and 14.13 may be used in rejections based on improper broadened reissue claims.

¶ 14.12 Rejection, 35 U.S.C. 251, Broadened Claims After Two Years

Claim [1] rejected under 35 U.S.C. 251 as being broadened in a reissue application filed outside the two year statutory period. [2] A claim is broader in scope than the original claims if it contains within its scope any conceivable product or process which would not have infringed the original patent. A claim is broadened if it is broader in any one respect even though it may be narrower in other respects.

Examiner Note:

The claim limitations that broaden the scope should be identified and explained in bracket 2. See MPEP §§ 706.03(x) and 1412.03.

¶ 14.13 Rejection, 35 U.S.C. 251, Broadened Claims Filed by Assignee

Claim [1] rejected under 35 U.S.C. 251 as being improperly broadened in a reissue application made and sworn to by the assignee and not the patentee. [2]A claim is broader in scope than the original claims if it contains within its scope any conceivable product or process which would not have infringed the original patent. A claim is broadened if it is broader in any one respecteven though it may be narrower in other respects.

Examiner Note:

The claim limitations that broaden the scope should be identified and explained in bracket 2. See MPEP §§ 706.03(x) and 1412.03.


V. BROADENING REISSUE - OATH/ DECLARATION REQUIREMENTS

A broadening reissue application must be applied for by all of the inventors (patentees), that is, the original reissue oath or declaration must be signed by all of the inventors. See also MPEP § 1414. If a supplemental oath or declaration in a broadening reissue application is needed in the application in order to fulfill the requirements of 37 CFR 1.175, the supplemental reissue oath or declaration must be signed by all of the inventors. See In re Hayes, 53 USPQ2d 1222 (Comm’r Pat. 1999) and MPEP § 1414.01.

1412.04Correction of Inventorship [R-5]

The correction of misjoinder of inventors has been held to be a ground for reissue. See Ex parte Scudder, 169 USPQ 814, 815 (Bd. App. 1971) wherein the Board held that 35 U.S.C. 251 authorizes reissue applications to correct misjoinder of inventors where35 U.S.C. 256 is inadequate. See also A.F. Stoddard & Co. v. Dann, 564 F.2d 556, 567 n.16, 195 USPQ 97, 106 n.16 (D.C. Cir. 1977) wherein correction of inventorship from sole inventor A to sole inventor B was permitted in a reissue application. The court noted that reissue by itself is a vehicle for correcting inventorship in a patent.

I.CERTIFICATE OF CORRECTION AS A VEHICLE FOR CORRECTING INVEN- TORSHIP

While reissue is a vehicle for correcting inventorship in a patent, correction of inventorship should be effected under the provisions of 35 U.S.C. 256 and 37 CFR 1.324 by filing a request for a Certificate of Correction if:

(A)the only change being made in the patent is to correct the inventorship; and

(B)all parties are in agreement and the inventorship issue is not contested.

See MPEP § 1481 for the procedure to be followed 

to obtain a Certificate of Correction for correction of inventorship.

II.REISSUE AS A VEHICLE FOR CORRECTING INVENTORSHIP

Where the provisions of 35 U.S.C. 256 and 

37 CFR 1.324 do not apply, a reissue application is the appropriate vehicle to correct inventorship. The failure to name the correct inventive entity is an error in the patent which is correctable under 35 U.S.C. 251. The reissue oath or declaration pursuant to 37 CFR 1.175 must state that the applicant believes the original patent to be wholly or partly inoperative or invalid through error of a person being incorrectly named in an issued patent as the inventor, or through error of an inventor incorrectly not named in an issued patent, and that such error arose without any deceptive intention on the part of the applicant. The




reissue oath or declaration must, as stated in 37 CFR 1.175, also comply with 37CFR 1.63.

The correction of inventorship does not enlarge the 

scope of the patent claims. Where a reissue application does not seek to enlarge the scope of the claims of the original patent, the reissue oath may be made and sworn to, or the declaration made, by the assignee of the entire interest under 37 CFR 1.172. An assignee of part interest may not file a reissue application to correct inventorship where the other co-owner did not join in the reissue application and has not consented to the reissue proceeding. See Baker Hughes Inc. v. Kirk, 921 F. Supp. 801, 809, 38 USPQ2d 1885, 1892 (D.D.C. 1995). See 35 U.S.C. 251, third paragraph. Thus, the signatures of the inventors are not needed on the reissue oath or declaration where the assignee of the entire interest signs the reissue oath/declaration. Accordingly, an assignee of the entire interest can add or delete the name of an inventor by reissue (e.g., correct inventorship from inventor A to inventors A and B) without the original inventor’s consent. See also 37 CFR 3.71(a) (“One or more assignees as defined in paragraph (b) of this section may, after becoming of record pursuant to paragraph (c) of this section, conduct prosecution of a national patent application or reexamination proceeding to the exclusion of either the inventive entity, or the assignee(s) previously entitled to conduct prosecution.” Emphasis added). Thus, the assignee of the entire interest can file a reissue to change the inventorship to one which the assignee believes to be correct, even though an inventor might disagree. The protection of the assignee’s property rights in the application and patent are statutorily based in 35 U.S.C. 118.

Where the name of an inventor X is to be deleted in a reissue application to correct inventorship in a patent, and inventor X has not assigned his/her rights to the patent, inventor X has an ownership interest in the patent. Inventor X must consent to the reissue (37 CFR 1.172(a)), even though inventor X’s name is being deleted as an inventor and need not sign the reissue oath or declaration. If inventor X has assigned his/her rights to the patent, then inventor X’s assignee must consent. In addition to providing the consent, even though inventor X does not sign the reissue oath or declaration as an inventor (since the correction of inventorship does not enlarge the scope of the patent claims), the assignee of the entire interest must sign the reissue oath or declaration as assignee (37 CFR 1.172(a)). Thus, if inventor X has not assigned his/her patent rights, inventor X’s signature must be included in the reissue oath or declaration as the assignee. If inventor X has assigned his/her patent rights, inventor X’s assignee must sign the reissue oath or declaration as the assignee. For example, a patent to inventors X and Y has no assignee. A reissue application is filed by inventor Y to delete the name of inventor X as an inventor. 37 CFR 1.172(a) provides that a reissue oath or declaration may be made by the assignee/owners of the entire interest, rather than by the inventors, where the scope of the claims is not to be enlarged. However, since inventor X has not assigned his/her patent rights, inventor X must sign the reissue oath or declaration as one of the owners, and consent to the filing of the reissue application by inventor Y. See MPEP §

1410.01.

Where a reissue to correct inventorship also 

changes the claims to enlarge the scope of the patent claims, the signature of all the inventors is needed. However, if an inventor refuses to sign the reissue oath or declaration because he or she believes the change in inventorship (to be effected) is not correct, the reissue application can still be filed with a petition under 37 CFR 1.47 without that inventor’s signature provided the written consent of all owners/assignees as required by 37 CFR 1.172(a) is also submitted. In the situation where a patent to inventors X and Y has no assignee and a reissue application is filed by inventor Y to delete the name of inventor X as an inventor and to broaden the patent. Inventor X refuses to sign the reissue oath or declaration and refuses to provide the consent as required by 37 CFR 1.172(a). In this instance, a 37 CFR 1.47 petition would not be appropriate to permit the filing of the reissue application since the consent requirement of 37 CFR 1.172(a) for each owner/assignee is not met. Resort to the courts would be required to delete the name of inventor X as an inventor where X will not consent to the filing of a reissue application. As stated in the second paragraph of 35 U.S.C. 256, “[t]he court before which such matter is called in question may order correction of the patent on notice and hearing of all parties concerned and the Director shall issue a certificate accordingly.”

The reissue application with its reissue oath or declaration 

under 37 CFR 1.175 provides a complete mechanism to correct inventorship. See A.F. Stoddard




& Co. v. Dann, 564 F.2d at 567, 195 USPQ at 106. A request under 37 CFR 1.48 or a petition under 37 CFR 1.324 cannot be used to correct the inventorship of a reissue application. If a request under 37 CFR 1.48 or a petition under 37 CFR 1.324 is filed in a reissue application, the request or petition should be dismissed and the processing or petition fee refunded. The material submitted with the request or petition should then be considered to determine if it complies with 37 CFR 1.175. If the material submitted with the request or petition does comply with the requirements of 37 CFR 1.175 (and the reissue application is otherwise in order), the correction of inventorship will be permitted as a correction of an error in the patent under 35 U.S.C. 251.

Where a reissue application seeks to correct inventorship in the patent and the inventors are required to sign the reissue oath or declaration (rather than an assignee of the entire interest under 37 CFR 1.172) due to a broadening of any claims of the original patent, the correct inventive entity must sign the reissue oath or declaration. Where an inventor is being added in a reissue application to correct inventorship in a patent, the inventor being added must sign the reissue oath or declaration together with the inventors previously designated on the patent. For example, a reissue application is filed to correct the inventorship from inventors A and B (listed as inventors on the patent) to inventors A, B, and C. Inventor C is the inventor being added. In such a case, A, B, and C are the correct inventors, and accordingly, each of A, B, and C must sign the reissue oath or declaration. Where an inventor is being deleted in a reissue application to correct inventorship in a patent and the inventors are required to sign the oath or declaration due to a broadening of any claims of the original patent, the inventor being deleted need not sign the reissue oath or declaration. The reissue oath or declaration must be signed by the correct inventive entity. For example, a reissue application is filed to correct inventorship from inventors A, B, and C (listed as inventors on the patent) to inventors A and B. Inventor C is being deleted as a named inventor. In such a case, A and B are the correct inventors, and accordingly, inventors A and B must sign the reissue oath or declaration but inventor C need not sign the reissue oath or declaration.

1413 Drawings[edit | edit source]

37 CFR 1.173. Reissue specification, drawings, and amendments.


(a)(2) Drawings. Applicant must submit a clean copy of each drawing sheet of the printed patent at the time the reissue application is filed. If such copy complies with § 1.84, no further drawings will be required. Where a drawing of the reissue application is to include any changes relative to the patent being reissued, the changes to the drawing must be made in accordance with paragraph (b)(3) of this section. The Office will not transfer the drawings from the patent file to the reissue application.


A clean copy (e.g., good quality photocopies free of any extraneous markings) of each drawing sheet of the printed patent must be supplied by the applicant at the time of filing of the reissue application. If the copies meet the requirements of 37 CFR 1.84, no further formal drawings will be required. New drawing sheets are not to be submitted, unless some change is made in the original patent drawings. Such changes must be made in accordance with 37 CFR 1.173(b)(3).

The prior reissue practice of transferring drawings from the patent file has been eliminated, since clean photocopies of the printed patent drawings are acceptable for use in the printing of the reissue patent.

AMENDMENT OF DRAWINGS

37 CFR 1.173. Reissue specification, drawings, and amendments.



(b)(3) Drawings. One or more patent drawings shall be amended in the following manner: Any changes to a patent drawing must be submitted as a replacement sheet of drawings which shall be an attachment to the amendment document. Any replacement sheet of drawings must be in compliance with § 1.84 and shall include all of the figures appearing on the original version of the sheet, even if only one figure is amended. Amended figures must be identified as “Amended,” and any added figure must be identified as “New.” In the event that a figure is canceled, the figure must be surrounded by brackets and identified as “Canceled.” All changes to the drawing(s) shall be explained, in detail, beginning on a separate sheet accompanying the papers including the amendment to the drawings.


The provisions of 37 CFR 1.173(b)(3) govern the manner of making amendments (changes) to the




drawings in a reissue application. The following guidance is provided as to the procedure for amending drawings:

(A)Amending the original or printed patent drawing sheets by physically changing or altering them is not permitted. Any request to do so should be denied.

(B)Where a change to the drawings is desired, applicant must submit a replacement sheet for each sheet of drawings containing a Figure to be revised. Any replacement sheet must comply with 37 CFR 1.84 and include all of the figures appearing on the original version of the sheet, even if only one figure is being amended. Each figure that is amended must be identified by placing the word “Amended” at the bottom of that figure. Any added figure must be identified as “New.” In the event that a figure is canceled, the figure must be identified as “Canceled” and also surrounded by brackets. All changes to the figure(s) must be explained, in detail, beginning on a separate sheet which accompanies the papers including the amendment to the drawings.

(C)If desired, applicant may include a marked-up copy of any amended drawing figure, including annotations indicating the changes made. Such a marked- up copy must be clearly labeled as “Annotated Marked-up Drawings”, and it must be presented in the amendment or remarks section that explains the change to the drawings.

In addition, the examiner may desire a marked-up copy of any amended drawing figure, and so state in an Office action. A marked-up copy of any amended drawing figure, including annotations indicating the changes made, must be provided when required by the examiner.

(D)For each proper new drawing sheet being added, the new sheet should be inserted after the existing drawing sheets. For each proper drawing sheet being added which replaces an existing drawing sheet, the existing sheet should be canceled by placing the sheet face down in the file and placing a large “X” on the back of the sheet. The new sheet should be inserted in place of the turned over existing sheet.

(E)If any drawing change is not approved, or if any submitted sheet of formal drawings is not entered, the examiner will so inform the reissue applicant in the next Office action, and the examiner will set forth the reasons for same.

1414 Content of Reissue Oath/Declaration[edit | edit source]

37 CFR 1.175. Reissue oath or declaration.

(a)The reissue oath or declaration in addition to complying with the requirements of § 1.63, must also state that:

(1)The applicant believes the original patent to be wholly or partly inoperative or invalid by reason of a defective specification or drawing, or by reason of the patentee claiming more or less than the patentee had the right to claim in the patent, stating at least one error being relied upon as the basis for reissue; and

(2)All errors being corrected in the reissue application up to the time of filing of the oath or declaration under this paragraph arose without any deceptive intention on the part of the applicant.

(b)(1) For any error corrected, which is not covered by the oath or declaration submitted under paragraph (a) of this section, applicant must submit a supplemental oath or declaration stating that every such error arose without any deceptive intention on the part of the applicant. Any supplemental oath or declaration required by this paragraph must be submitted before allowance and may be submitted:

(i) With any amendment prior to allowance; or

(ii) In order to overcome a rejection under 35 U.S.C. 251 made by the examiner where it is indicated that the submission of a supplemental oath or declaration as required by this paragraph will overcome the rejection.

(2)For any error sought to be corrected after allowance, a supplemental oath or declaration must accompany the requested correction stating that the error(s) to be corrected arose without any deceptive intention on the part of the applicant.

(c)Having once stated an error upon which the reissue is based, as set forth in paragraph (a)(1), unless all errors previously stated in the oath or declaration are no longer being corrected, a subsequent oath or declaration under paragraph (b) of this section need not specifically identify any other error or errors being corrected.


(d)The oath or declaration required by paragraph (a) of this section may be submitted under the provisions of § 1.53(f).

(e)The filing of any continuing reissue application which does not replace its parent reissue application must include an oath or declaration which, pursuant to paragraph (a)(1) of this section, identifies at least one error in the original patent which has not been corrected by the parent reissue application or an earlier reissue application. All other requirements relating to oaths or declarations must also be met.

The reissue oath/declaration is an essential part of a reissue application and must be filed with the application, or within the time period set under 37 CFR 1.53(f) along with the required surcharge as set forth in 37 CFR 1.16(f) in order to avoid abandonment.

The question of the sufficiency of the reissue oath/ declaration filed under 37 CFR 1.175 must in each case be reviewed and decided personally by the primary examiner.




Reissue oaths or declarations must contain the following:


(A)A statement that the applicant believes the original patent to be wholly or partly inoperative or invalid—

(1)by reason of a defective specification or drawing, or

(2)by reason of the patentee claiming more or less than patentee had the right to claim in the patent;

(B)A statement of at least one error which is relied upon to support the reissue application, i.e., as the basis for the reissue;

(C)A statement that all errors which are being corrected in the reissue application up to the time of filing of the oath/declaration arose without any deceptive intention on the part of the applicant; and

(D)The information required by 37 CFR 1.63.

These elements will now be discussed:

I.A STATEMENT THAT THE APPLICANT BELIEVES THE ORIGINAL PATENT TO BE WHOLLY OR PARTLY INOPERATIVE OR INVALID BY REASON OF A DEFECTIVE SPECIFICATION OR DRAWING, OR BY REASON OF THE PATENTEE CLAIMING MORE OR LESS THAN PATENTEE HAD THE RIGHT TO CLAIM IN THE PATENT.

In order to satisfy this requirement, a declaration can state as for example:


1. “Applicant believes the original patent to be partly inoperative or invalid by reason of a defective specification or drawing.”


2. “Applicant believes the original patent to be partly inoperative or invalid by reason of the patentee claiming more than patentee had a right to claim in the patent.”


3. “Applicant believes the original patent to be partly inoperative or invalid by reason of the patentee claiming less than patentee had a right to claim in the patent.”

Where the specification or drawing is defective andpatentee claimed both more and less than patentee had the right to claim in the patent, then all three statements should be included in the reissue oath/declaration. A statement that the original patent is “wholly or partly inoperative or invalid” (emphasis added) by reason of the patentee “claiming more or less than the patentee had the right to claim in the patent” (emphasis added) is improper since a claim cannot claim “more or less” at the same time. Where, however, a given independent claim is considered to be overly broad, and another independent claim is considered to be overly narrow, patentee has claimed both more andless than he or she had a right to claim. In such an instance, both the second and third above-quoted statements would be used. See MPEP § 1412.04 for an exemplary declaration statement when the error being corrected is an error in inventorship.

The above examples will be sufficient to satisfy this requirement without any further statement.

It should be noted that the reissue oath/declaration must also satisfy the requirement for a statement of at least one error being relied upon as the basis for reissue, in the manner set forth in subsection II. below.

Form paragraph 14.01 may be used where the reissue oath/declaration does not provide the required statement as to applicant’s belief that the original patent is wholly or partly inoperative or invalid.

¶ 14.01 Defective Reissue Oath/Declaration, 37 CFR 1.175(a)(1) - No Statement of Defect in the Patent

The reissue oath/declaration filed with this application is defective because it fails to contain the statement required under 37 CFR 1.175(a)(1) as to applicant’s belief that the original patent is wholly or partly inoperative or invalid. See 37 CFR 1.175(a)(1) and see MPEP §

1414. [1]

Examiner Note:

1.Use this form paragraph when applicant: (a) fails to allege that the original patent is inoperative or invalid and/or (b) fails to state the reason of a defective specification or drawing, or of patentee claiming more or less than patentee had the right to claim in the patent . In bracket 1, point out the specific defect to applicant by using the language of (a) and/or (b), as it is appropriate.

2.Form paragraph 14.14 must follow this form paragraph.

II.A STATEMENT OF AT LEAST ONE ERROR WHICH IS RELIED UPON TO SUPPORT THE REISSUE APPLICATION (I.E., THE BASIS FOR THE REISSUE).

(A)A reissue applicant must acknowledge the existence of an error in the specification, drawings, or claims, which error causes the original patent to be




defective. In re Wilder, 736 F.2d 1516, 222 USPQ 369 (Fed. Cir. 1984). A change or departure from the original specification or claims represents an “error” in the original patent under 35 U.S.C. 251. See MPEP §

1402 for a discussion of grounds for filing a reissue that may constitute the “error” required by 35 U.S.C. 251. Not all changes with respect to the patent constitute the “error” required by 35 U.S.C. 251.

(B)Applicant need only specify in the reissue oath/declaration one of the errors upon which reissue is based. Where applicant specifies one such error, this requirement of a reissue oath/declaration is satisfied. Applicant may specify more than one error.

Where more than one error is specified in the oath/declaration and some of the designated “errors” are found to not be “errors” under 35 U.S.C. 251, any remaining error which is an error under 35 U.S.C. 251will still support the reissue.

The “at least one error” which is relied upon to support the reissue application must be set forth in the oath/declaration. It is not necessary, however, to point out how (or when) the error arose or occurred. Further, it is not necessary to point out how (or when) the error was discovered. If an applicant chooses to point out these matters, the statements directed to these matters will not be reviewed by the examiner, and the applicant should be so informed in the next Office action. All that is needed for the oath/declaration statement as to error is the identification of “at least one error” relied upon.

In identifying the error, it is sufficient that the reissue oath/declaration identify a single word, phrase, or expression in the specification or in an original claim, and how it renders the original patent wholly or partly inoperative or invalid. The corresponding corrective action which has been taken to correct the original patent need not be identified in the oath/declaration. If the initial reissue oath/declaration “states at least one error” in the original patent, and, in addition, recites the specific corrective action taken in the reissue application, the oath/declaration would be considered acceptable, even though the corrective action statement is not required.

(C)It is not sufficient for an oath/declaration to merely state “this application is being filed to correct errors in the patent which may be noted from the changes made in the disclosure.” Rather, the oath/declaration must specifically identify an error. In addition, it is not sufficient to merely reproduce the claims with brackets and underlining and state that such will identify the error. See In re Constant, 827 F.2d 728, 729, 3 USPQ2d 1479 (Fed. Cir.), cert. denied, 484 U.S. 894 (1987). Any error in the claims must be identified by reference to the specific claim(s) and the specific claim language wherein lies the error.

A statement of “…failure to include a claim directed to…” and then presenting a newly added claim, would not be considered a sufficient “error” statement since applicant has not pointed out what the other claims lacked that the newly added claim has, or vice versa. Such a statement would be no better than saying in the reissue oath or declaration that “this application is being filed to correct errors in the patent which may be noted from the change made by adding new claim 10.” In both cases, the error has not been identified.

(D)Where a continuation reissue application is filed with a copy of the reissue oath/declaration from the parent reissue application, and the parent reissue application is not to be abandoned, the reissue oath/ declaration should be accepted by the Office of Initial Patent Examination without further evaluation, since it is an oath/declaration, albeit improper under 35 U.S.C. 251. The examiner should, however, reject the claims of the continuation reissue application under 35 U.S.C. 251 as being based on an oath/declaration that does not identify an error being corrected by the continuation reissue application, and should require a new oath/declaration. 37 CFR 1.175(e) states that “the filing of any continuing reissue application which does not replace its parent reissue application must include an oath or declaration, which pursuant to [37 CFR 1.175(a)(1)], identifies at least one error in the original patent which has not been corrected by the parent reissue application or an earlier reissue application.” One of form paragraphs 14.01.01 through 14.01.03 may be used.

Where a continuation reissue application is filed with a copy of the reissue oath/declaration from the parent reissue application, and the parent reissue application is, or will be abandoned, the copy of the reissue oath/declaration should be accepted by OIPE, and the examiner should check to ensure that the oath/ declaration identifies an error which is still being corrected in the continuation application. If a preliminary amendment was filed with the continuation reissue




application, the examiner should check for the need of a supplemental reissue oath/declaration. Pursuant to 37 CFR 1.175 (b)(1), for any error corrected via the preliminary amendment which is not covered by the oath or declaration submitted in the parent reissue application, applicant must submit a supplemental oath/declaration stating that such error arose without any deceptive intention on the part of the applicant. See MPEP § 1414.01.

Where a divisional reissue application is filed with a copy of the reissue oath/declaration from the parent reissue application, the reissue oath/declaration should be accepted by OIPE, since it is an oath/ declaration, though it may be improper under 35 U.S.C. 251. The examiner should check the copy of the oath/declaration to ensure that it identifies an error being corrected by the divisional reissue application. The copy of the oath/declaration from the parent reissue application may or may not cover an error being corrected by the divisional reissue application since the divisional reissue application is (by definition) directed to a new invention. If it does not, the examiner should reject the claims of the divisional reissue application under 35 U.S.C. 251 as being based on an oath/declaration that does not identify an error being corrected by the divisional reissue application, and require a new oath/declaration. If the copy of the reissue oath/declaration from the parent reissue application does in fact cover an error being corrected in the divisional reissue application, no such rejection should be made. However, since a new invention is being added by the filing of the divisional reissue application, a supplemental reissue oath/declaration pursuant to 37 CFR 1.175 (b)(1) will be required. See MPEP § 1414.01.

Form paragraph 14.01.01 may be used where the reissue oath/declaration does not identify an error.

¶ 14.01.01 Defective Reissue Oath/Declaration, 37 CFR 1.175(a)(1) - No Statement of a Specific Error

The reissue oath/declaration filed with this application is defective because it fails to identify at least one error which is relied upon to support the reissue application. See 37 CFR 1.175(a)(1) and MPEP § 1414.

Examiner Note:

1.Use this form paragraph when the reissue oath or declaration does not contain any statement of an error which is relied upon to support the reissue application.

2.This form paragraph can be used where the reissue oath or declaration does not even mention error. It can also can be used where the reissue oath or declaration contains some discussion of the concept of error but never in fact identifies a specific error to be relied upon. For example, it is not sufficient for an oath or declaration to merely state “this application is being filed to correct errors in the patent which may be noted from the changes made in the disclosure.”

3.Form paragraph 14.14 must follow this form paragraph.

Where the reissue oath/declaration does identify an error or errors, the oath/declaration must be checked carefully to ensure that at least one of the errors identified is indeed an “error” which will support the filing of a reissue, i.e., an “error” that will provide grounds for reissue of the patent. See MPEP § 1402. If the error identified in the oath/declaration is not an appropriate error upon which a reissue can be based, then the oath/declaration must be indicated to be defective in the examiner’s Office action.

Form paragraphs 14.01.02 and 14.01.03 may be used where the reissue oath/declaration fails to provide at least one error upon which a reissue can be based.

¶ 14.01.02 Defective Reissue Oath/Declaration, 37 CFR 1.175(a)(1)-The Identified “Error” Is Not Appropriate Error

The reissue oath/declaration filed with this application is defective because the error which is relied upon to support the reissue application is not an error upon which a reissue can be based. See 37 CFR 1.175(a)(1) and MPEP § 1414.

Examiner Note:

1.Use this form paragraph when the reissue oath/declaration identifies only one error which is relied upon to support the reissue application, and that one error is not an appropriate error upon which a reissue can be based.

2.Form paragraph 14.14 must follow this form paragraph.

¶ 14.01.03 Defective Reissue Oath/Declaration, 37 CFR 1.175(a)(1) - Multiple Identified “Errors” Not Appropriate Errors

The reissue oath/declaration filed with this application is defective because none of the errors which are relied upon to support the reissue application are errors upon which a reissue can be based. See 37 CFR 1.175(a)(1) and MPEP § 1414.

Examiner Note:

1.Use this form paragraph when the reissue oath/declaration identifies more than one error relied upon to support the reissue application, and none of the errors are appropriate errors upon which a reissue can be based.

2.Note that if the reissue oath/declaration identifies more than one error relied upon, and at least one of the errors is an error upon which reissue can be based, this form paragraph should not be used, despite the additional reliance by applicant on “errors”




which do not support the reissue. Only one appropriate error is needed to support a reissue.

3.Form paragraph 14.14 must follow this form paragraph.

III.A STATEMENT THAT ALL ERRORS WHICH ARE BEING CORRECTED IN THE REISSUE APPLICATION UP TO THE TIME OF SIGNING OF THE OATH/ DECLARATION AROSE WITHOUT ANY DECEPTIVE INTENTION ON THE PART OF THE APPLICANT.

In order to satisfy this requirement, the following statement may be included in an oath or declaration:

“All errors in the present reissue application up to the time of signing of this oath/declaration, or errors which are being corrected by a paper filed concurrently with this oath/declaration which correction of errors I/we have reviewed, arose without any deceptive intention on the part of the applicant.”

Nothing more is required. The examiner will determine only whether the reissue oath/declaration contains the required averment; the examiner will not make any comment as to whether it appears that there was in fact deceptive intention (see MPEP § 2022.05). It is noted that a reissue oath/declaration will not be effective for any errors which are corrected by a filing made after the execution of the reissue oath/declaration, unless it is clear from the record that the parties executing the document were aware of the nature of the correction when they executed the document. Further, a reissue oath/declaration with an early date of execution cannot be filed after a correction made later in time, to cover the correction made after the execution date. This is so, even if the reissue oath/declaration states that all errors up to the filing of the oath/ declaration arose without any deceptive intention on the part of the applicant.

Form paragraph 14.01.04 may be used where the reissue oath/declaration does not provide the required statement as to “without any deceptive intention on the part of the applicant.”

¶ 14.01.04 Defective Reissue Oath/Declaration, 37 CFR 1.175- Lack of Statement of “Without Any Deceptive Intention”

The reissue oath/declaration filed with this application is defective because it fails to contain a statement that all errors which are being corrected in the reissue application up to the time of filing of the oath/declaration arose without any deceptive intention on the part of the applicant. See 37 CFR 1.175 and MPEP § 1414.

Examiner Note:

1.Use this form paragraph when the reissue oath/declaration does not contain the statement required by 37 CFR 1.175 that all errors being corrected in the reissue application arose without any deceptive intention on the part of the applicant.

2.This form paragraph is appropriate to use for a failure by applicant to comply with the requirement, as to any of 37 CFR 1.175(a)(2), 37 CFR 1.175(b)(1), or 37 CFR 1.175(b)(2).

3.Form paragraph 14.14 must follow.

IV.THE REISSUE OATH/DECLARATION MUST COMPLY WITH 37 CFR 1.63.

The reissue oath/declaration must include the averments required by 37 CFR 1.63(a) and (b), e.g., that applicants for reissue

(A)have reviewed and understand the contents of the specification, including the claims, as amended by any amendment specifically referred to in the oath/ declaration;

(B)believe the named inventor or inventors to be the original and the first inventor or inventors of the subject matter which is claimed and for which a patent is sought; and

(C)acknowledge the duty to disclose to the Office all information known to the person to be material to patentability as defined in 37 CFR 1.56. See also the discussion regarding the requirements of an oath/declaration beginning at MPEP § 602.

The examiner should check carefully to ensure that all the requirements of 37 CFR 1.63 are met. Form paragraph 14.01.05 should be used in conjunction with the content of form paragraphs 6.05 through 6.05.20 as appropriate, where the reissue oath/declaration fails to comply with the requirements of 37 CFR 1.63.

¶ 14.01.05 Defective Reissue Oath/Declaration, 37 CFR 1.175 - General

The reissue oath/declaration filed with this application is defective (see 37 CFR 1.175 and MPEP § 1414) because of the following:

Examiner Note:

1.Use this form paragraph when the reissue oath/declaration does not comply with 37 CFR 1.175, and none of form paragraphs 14.01 - 14.01.04 or 14.05.02 apply.

2.This form paragraph must be followed by an explanation of why the reissue oath/declaration is defective.




3.Form paragraph 14.14 must follow the explanation of the defect.

See MPEP § 1414.01 for a discussion of the requirements for a supplemental reissue oath/declaration.


Depending on the circumstances, either form PTO/

SB/51, Reissue Application Declaration By The Inventor, or form PTO/SB/52, Reissue Application Declaration By The Assignee may be used to prepare a declaration in a reissue application.





Reissue Application Declaration by the Inventor




Reissue Application Declaration by the Inventor (page 2)




Privacy Act Statment




Reissue Application Declaration by the Assognee




Reissue Application Declaration by the Assognee (page 2)




Privacy Act Statment





1414.01Supplemental Reissue Oath/ Declaration [R-5]

If additional defects or errors are corrected in the reissue after the filing of the application and the original reissue oath or declaration, a supplemental reissue oath/declaration must be filed, unless all additional errors corrected are spelling, grammar, typographical, editorial or clerical errors which are not errors under 35 U.S.C. 251 (see MPEP § 1402). In other words, a supplemental oath/declaration is required where any “error” under 35 U.S.C. 251 has been corrected and the error was not identified in the original reissue oath/declaration.

The supplemental reissue oath/declaration must 

state that every error which was corrected in the reissue application not covered by the prior oath(s)/declaration( s) submitted in the application arose without any deceptive intention on the part of the applicant.

An example of acceptable language is as follows:

“Every error in the patent which was corrected in the present reissue application, and is not covered by the prior declaration submitted in this application, arose without any deceptive intention on the part of the applicant.”

A supplemental reissue oath/declaration will not be effective for any errors which are corrected by a filing made after the execution of the supplemental reissue oath/declaration, unless it is clear from the record that the parties executing the document were aware of the nature of the correction when they executed the document. Further, a supplemental reissue oath/declaration with an early date of execution cannot be filed after a correction made later in time, to cover the correction made after the execution date. This is so, even if the supplemental reissue oath/declaration states that all errors up to the filing of the supplemental reissue oath/declaration oath or declaration arose without any deceptive intention on the part of the applicant.


Form PTO/SB/51S, “Supplemental Declaration For Reissue Patent Application To Correct ‘Errors’ Statement (37 CFR 1.175),” may be used to prepare a supplemental reissue declaration. Form PTO/SB/51S serves to indicate that every error in the patent that was corrected in the reissue application, but was not covered by a prior reissue oath/declaration submitted in the reissue application, arose without any deceptive intention on the part of the applicant.

In the event that the applicant for a reissue applicant is required to file a supplemental reissue oath/ declaration that also includes a specific statement of the error being corrected by reissue in accordance with 37 CFR 1.175(c), as discussed in subsection I. below, applicant must also include in the supplemental declaration language equivalent to the “Every error …” language in the example of acceptable language set forth above. Therefore, if either form PTO/SB/51, “Reissue Application Declaration By The Inventor,” or form PTO/SB/52, “Declaration By The Assignee” (see MPEP § 1414) is used for the purpose of filing such supplemental reissue oath/declaration, the form must be completed so that it is clear that the supplemental reissue oath/declaration addresses all errors corrected subsequent to the date upon which the last previously reissue oath/declaration (whether original or supplemental) was filed. For example, the form could be completed by specifying the date upon which the reissue application was originally filed, the reissue application number, and the date(s) of every amendment filed subsequent to the date upon which the last reissue oath/declaration (whether original or supplemental) was filed. Any manner of completing the form so that affiant/declarant unambiguously states that every error corrected subsequent to the filing of the last filed reissue oath/declaration (whether original or supplemental) arose without deceptive intent will be acceptable. It will not be acceptable for the new (“catch-up”) oath/declaration to simply refer to the reissue application as filed, even though the new oath/declaration may be submitted after an amendment.

I.WHEN AN ERROR MUST BE STATED IN THE SUPPLEMENTAL OATH/ DECLARATION

In the supplemental reissue oath/declaration, there is no need to state an error which is relied upon to support the reissue application if:

(A)an error to support a reissue has been previously and properly stated in a reissue oath/declaration in the application; and

(B)that error is still being corrected in the reissue application.




If applicant chooses to state any further error at this point (even though such is not needed), the examiner should not review the statement of the further error.

The supplemental reissue oath/declaration muststate an error which is relied upon to support the reissue application only where one of the following is true:

(A)the prior reissue oath/declaration failed to state an error;

(B)the prior reissue oath/declaration attempted to state an error but did not do so properly; or

(C)all errors under 35 U.S.C. 251 stated in the prior reissue oath(s)/declaration(s) are no longer being corrected in the reissue application.

II.WHEN A SUPPLEMENTAL OATH/DE- CLARATION MUST BE SUBMITTED

The supplemental oath/declaration in accordance with 37 CFR 1.175(b)(1) must be submitted before allowance. See MPEP § 1444 for a discussion of the action to be taken by the examiner to obtain the supplemental oath/declaration in accordance with 37 CFR 1.175(b)(1), where such is needed.

Where applicant seeks to correct an error after allowance of the reissue application, a supplemental reissue oath/declaration must accompany the requested correction stating that the error(s) to be corrected arose without any deceptive intention on the part of the applicant. The supplemental reissue oath/ declaration submitted after allowance will be directed to the error applicant seeks to correct after allowance. This supplemental oath/declaration need not cover any earlier errors, since all earlier errors should have been covered by a reissue oath/declaration submitted prior to allowance.

III.SUPPLEMENTAL OATH/DECLARA- TION IN BROADENING REISSUE

A broadening reissue application must be applied for by all of the inventors (patentees), that is, the original reissue oath/declaration must be signed by all of the inventors. See MPEP § 1414. If a supplemental oath/declaration in a broadening reissue application is subsequently needed in the application in order to fulfill the requirements of 37 CFR 1.175, the supplemental reissue oath/declaration must be signed by all of the inventors. In re Hayes, 53 USPQ2d 1222, 1224 (Comm’r Pat. 1999) (“37 CFR 1.175(b)(1), taken in conjunction with Section 1.172, requires a supplemental declaration be signed by all of the inventors. This is because all oaths or declarations necessary to fulfill the rule requirements in a reissue application are taken together collectively as a single oath or declaration. Thus, each oath and declaration must bear the appropriate signatures of all the inventors.”).

If a joint inventor refuses or cannot be found or 

reached to sign a supplemental oath/declaration, a supplemental oath/declaration listing all the inventors, and signed by all the available inventors may be filed provided it is accompanied by a petition under 37 CFR 1.183 along with the petition fee, requesting waiver of the signature requirement of the nonsigning inventor.






SUPPLEMENTAL DECLARATION FOR REISSUE PATENT APPLICATION TO CORRECT “ERRORS” STATEMENT (37 CFR 1.175) PTO/SB/51S (09-04) Approved for use through 04/30/2007. OMB 0651-0033 U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number. Attorney Docket Number First Named Inventor COMPLETE if known Application Number Filing Date Art Unit SUPPLEMENTAL DECLARATION FOR REISSUE PATENT APPLICATION TO CORRECT “ERRORS” STATEMENT (37 CFR 1.175) Examiner Name I/We hereby declare that: Every error in the patent which was corrected in the present reissue application, and which is not covered by the prior oath(s) and/or declaration(s) submitted in this application, arose without any deceptive intention on the part of the applicant. I/We hereby declare that all statements made herein of my/our own knowledge are true and that all statements made on information and belief are believed to be true; and further that these statements were made with the knowledge that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. 1001 and that such willful false statements may jeopardize the validity of the application or any patent issued thereon. Name of Sole or First Inventor: A petition has been filed for this unsigned inventor Given Name (first and middle [if any]) Family Name or Surname Inventor’s SignatureDate Name of Second Inventor: A petition has been filed for this unsigned inventor Given Name (first and middle [if any]) Family Name or Surname Inventor’s SignatureDate Name of Third Inventor: A petition has been filed for this unsigned inventor Given Name (first and middle [if any]) Family Name or Surname Inventor’s SignatureDate Name of Fourth Inventor: A petition has been filed for this unsigned inventor Given Name (first and middle [if any]) Family Name or SurnameInventor’s SignatureDate Additional inventors or legal representatives(s) are being named on the __________ supplemental sheets PTO/SB/02A or 02LR attached hereto. This collection of information is required by 37 CFR 1.175. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 1.8 minutes to complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO:Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450. If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2. Doc Code:





1415 Reissue Application and Issue Fees[edit | edit source]

I.BASIC REISSUE APPLICATION FILING, SEARCH, AND EXAMINATION FEES

The Consolidated Appropriations Act, 2005 (Consolidated Appropriations Act), effective December 8, 2004, provides for a separate reissue application filing fee, search fee, and examination fee during fiscal years 2005 and 2006. For reissue applications filed on or after December 8, 2004, the following fees are required: basic filing fee as set forth in 37 CFR 1.16(e)(1); search fee as set forth in 37 CFR 1.16(n); examination fee as set forth in 37 CFR 1.16(r); application size fee, if applicable (see subsection II. below); and excess claims fees, if applicable (see subsection III. below).

For reissue applications filed prior to December 8, 2004, the following fees are required: basic filing fee as set forth in 37 CFR 1.16(e)(2); and excess claims fees, if applicable (see subsection III below). No search and examination fees are required for reissue applications filed before December 8, 2004.

The basic filing, search and examination fees are due on filing of the reissue application. These fees may be paid on a date later than the filing date of the reissue application provided they are paid within the time period set forth in 37 CFR 1.53(f) and include the surcharge set forth in 37 CFR 1.16(f). For reissue applications filed on or after December 8, 2004 but prior to July 1, 2005, which have been accorded a filing date under 37 CFR 1.53(b), if the search and/or examination fees are paid on a date later than the filing date of the reissue application, the surcharge under 37 CFR 1.16(f) is not required. For reissue applications filed on or after July 1, 2005, which have been accorded a filing date under 37 CFR 1.53(b), if any of the basic filing fee, the search fee, or the examination fee are paid on a date later than the filing date of the reissue application, the surcharge under 37 CFR 1.16(f) is required.

For reissue applications filed on or after December 8, 2004, in which a petition under 37 CFR 1.138(d) to expressly abandon the application was filed on or after March 10, 2006, applicant may file a request for refund of the search fee and excess claims fee paid in the application. See MPEP § 711.01.

II.APPLICATION SIZE FEE

The Consolidated Appropriations Act also provides for an application size fee. 37 CFR 1.16(s) sets forth the application size fee for reissue applications filed on or after December 8, 2004, the specification and drawings of which, excluding a sequence listing or computer program listing filed in an electronic medium in compliance with the rules (see 37 CFR 1.52(f)), exceed 100 sheets of paper. The application size fee does not apply to reissue applications filed before December 8, 2004. The application size fee applies for each additional 50 sheets or fraction thereof over 100 sheets of paper. Any sequence listing in an electronic medium in compliance with 37 CFR 1.52(e) and 37 CFR 1.821(c) or (e), and any computer program listing filed in an electronic medium in compliance with 37 CFR 1.52(e) and 1.96, will be excluded when determining the application size fee required by 37 CFR 1.16(s). See also MPEP § 607.

III.EXCESS CLAIMS FEES

37 CFR 1.16(h) sets forth the excess claims fee for each independent claim in excess of three. 37 CFR 1.16(i) sets forth the excess claims fee for each claim (whether independent or dependent) in excess of twenty. The access claims fees specified in 37 CFR 1.16(h) and (i) apply to all reissue applications pending on or after December 8, 2004. The excess claims fees specified in 37 CFR 1.16(h) and (i) apply to any excess claims fee paid on or after December 8, 2004, regardless of the filing date of the reissue application and regardless of the date on which the claim necessitating the excess claims fee payment was added to the reissue application.

For reissue applications filed on or after December 8, 2004, in which a petition under 37 CFR 1.138(d) to expressly abandon the application was filed on or after March 10, 2006, applicant may file a request for refund of the search fee and excess claims fee paid in the application. See MPEP § 711.01.

Under 35 U.S.C. 41(a)(2) as amended by the Consolidated Appropriations Act, the claims in the original patent are not taken into account in determining the excess claims fee for a reissue application.

Example 1:

Applicant filed a reissue application before December 8, 2004, with the same number of




claims as in the patent. The patent has more than 3 independent claims and more than 20 total claims. If applicant added one more independent claim in the reissue application by filing an amendment before December 8, 2004, but did not pay for the excess claims fees prior to December 8, 2004, on or after December 8, 2004, applicant will have to pay for one additional independent claim per the fee set forth in 37 CFR 1.16(h) and one additional total claim per the fee set forth in 37 CFR 1.16(i).

Example 2:

Applicant filed a reissue application on or after December 8, 2004, with the same number of claims as in the patent. The patent has 4 independent claims and 21 total claims. Excess claims fees for the 4th independent claim (one additional independent claim per the fee set forth in 37 CFR 1.16(h)) and the 21st claim (one additional total claim per the fee set forth in 37 CFR 1.16(i)) are required. Under 35 U.S.C. 41(a)(2) as amended by the Consolidated Appropriations Act, the claims in the original patent are not taken into account in determining the excess claims fees for a reissue application.

The excess claims fees, if any, due with an amendment are required prior to any consideration of the amendment by the examiner. Upon submission of an amendment (whether entered or not) affecting the claims, payment of fees for those claims in excess of the number previously paid for is required. The additional fees, if any, due with an amendment are calculated on the basis of the claims (total and independent) which would be present, if the amendment were entered. If an amendment is limited to revising the existing claims and it does not result in the addition of any new claim, there is no excess claim fee. Excess claims fees apply only to the addition of claims. It is to be noted that where excess claims fees have been previously paid, a later amendment affecting the claims cannot serve as the basis for granting any refund. See 37 CFR 1.26(a).

Amendments filed before a first Office action, or otherwise not filed in reply to an Office action, presenting additional claims in excess of the number already paid for, not accompanied by the full additional claims fee due, will not be entered in whole or in part and applicant will be so notified. Such amendments filed in reply to an Office action will be regarded as being non-responsive to the Office action and the practice set forth in MPEP § 714.03 will be followed.

An amendment canceling claims accompanying the papers constituting the reissue application will be effective to diminish the number of claims to be considered in calculating the filing fees to be paid. A preliminary amendment filed concurrently with a reply to a Notice To File Missing Parts of Application that required the filing fees, which preliminary amendment cancels or adds claims, will be taken into account in determining the appropriate filing fees due in response to the Notice To File Missing Parts of Application. However, no refund will be made for claims being canceled in the reply that have already been paid for.

After a requirement for restriction, non-elected claims will be included in determining the fees due in connection with a subsequent amendment unless such claims are canceled.

IV.ISSUE FEE

The issue fee for issuing each reissue patent is set forth in 37 CFR 1.18(a).

V.REISSUE APPLICATION FEE TRANS- MITTAL FORM

The Office has prepared Form PTO/SB/56, Reissue Application Fee Transmittal Form which is designed to assist in the correct calculation of reissue filing fees.




Reissue Application Fee Transmittal Form




Privacy Act Statment Privacy Act Statement ThePrivacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that: (1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or patent. If you do not furnish the requested information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may result in termination of proceedings or abandonment of the application or expiration of the patent. The information provided by you in this form will be subject to the following routine uses: 1. The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of records may be disclosed to the Department of Justice to determine whether disclosure of these records is required by the Freedom of Information Act. 2. A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement negotiations. 3. A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request involving an individual, to whom the record pertains, when the individual has requested assistance from the Member with respect to the subject matter of the record. 4. A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for the information in order to perform a contract. Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m). 5. A record related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty. 6. A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)). 7. A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or his/her designee, during an inspection of records conducted by GSA as part of that agency’s responsibility to recommend improvements in records management practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not be used to make determinations about individuals. 8. A record from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record was filed in an application which became abandoned or in which the proceedings were terminated and which application is referenced by either a published application, an application open to public inspection or an issued patent. 9. A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.




1415.01Maintenance Fees on the Original Patent [R-5]

The filing of a reissue application does not alter the schedule of payments of maintenance fees on the original patent. If maintenance fees have not been paid on the original patent as required by 35 U.S.C. 41(b) and 37 CFR 1.20, and the patent has expired, no reissue patent can be granted. 35 U.S.C. 251, first paragraph, only authorizes the granting of a reissue patent for the unexpired term of the original patent. Once a patent has expired, the Director of the USPTO no longer has the authority under 35 U.S.C. 251 to reissue the patent. See In re Morgan, 990 F.2d 1230, 26 USPQ2d 1392 (Fed. Cir. 1993).

The examiner should determine whether all required maintenance fees have been paid prior to conducting an examination of a reissue application. In addition, during the process of preparing the reissue application for issue, the examiner should again determine whether all required maintenance fees have been paid up to date.

The history of maintenance fees is determined by the following, all of which should be used (to provide a check on the search made):

(A)Go to the USPTO Intranet (http://ptoweb/ptointranet/ index.htm) and select the PALM screen, then the “General Information” screen, type in the patent number and then select the “Fees” screen.

(B)Go to the USPTO Intranet and then the “Revenue Accounting and Management” screen, then the “File History” screen. Then type in the patent number.

(C)Go to the USPTO Internet Site (http:// www.uspto.gov) and select “eBusiness”, then the “Patent Electronic Business Center” screen, then the “Patent Application Information Retrieval (PAIR)” screen (http://pair.uspto.gov/cgi-bin/final/home.pl), and type in the patent number and select the “view Maint. Statement” screen.

If the window for the maintenance fee due has closed (maintenance fees are due by the day of the 4th, 8th and 12th year anniversary of the grant of the patent), but the maintenance fee has not been paid, the Office of Patent Legal Administration (OPLA) should be contacted by the Technology Center (TC) Special Program Examiner (SPRE) for instructions as to what appropriate action to take.

PAYMENT OF MAINTENANCE FEES WHERE THE PATENT HAS BEEN REISSUED

Pursuant to 37 CFR 1.362(b), maintenance fees are not required for a reissue patent if the original patent that was reissued did not require maintenance fees.

Where the original patent that was reissued did require maintenance fees, the schedule of payments of maintenance fees on the original patent will continue for the reissue patent. 37 CFR 1.362(h). Once an original patent reissues, maintenance fees are no longer due in the original patent, but rather the maintenance fees are due in the reissue patent. This is because upon the issuance of the reissue patent, the original patent is surrendered and ceases to exist.

In some instances, more than one reissue patents will be granted to replace a single original patent. The issuance of more than one reissue patent does not alter the schedule of payments of maintenance fees on the original patent. The existence of multiple reissue patents for one original patent can arise where multiple divisional reissue applications are filed for the same patent, and the multiple applications issue as reissue patents (all to replace the same original patent). In addition, a divisional application or continuation application of an existing reissue application may be filed, and both may then issue as reissue patents. In such instances, 35 U.S.C. 41 does not provide for the charging of more than one maintenance fee for the multiple reissues. Thus, no payment of additional maintenance fees is required for the second or subsequent reissue patents, i.e., continuation or divisional reissues, which are derived from a first reissue patent which has issued. The maintenance fee must be directed to the first reissue patent that has issued. This is unlike the instance where there is a reissue of a reissue patent, and the maintenance fee must be directed to the reissue of the reissue patent.

See MPEP Chapter 2500 for additional information pertaining to maintenance fees.

1416 No Physical Surrender of Original Patent[edit | edit source]

37 CFR 1.178. Original patent; continuing duty of applicant.

(a)The application for reissue of a patent shall constitute an offer to surrender that patent, and the surrender shall take effect




upon reissue of the patent. Until a reissue application is granted, the original patent shall remain in effect.


37 CFR 1.178(a) was amended, effective October 21, 2004, to eliminate the requirement for physical surrender of the original letters patent (i.e., the “ribbon copy” of the original patent) in a reissue application, and to make surrender of the original patent automatic upon the grant of the reissue patent.

Amended 37 CFR 1.178(a) applies retroactively to all pending applications. For those applications with an outstanding requirement for the physical surrender of the original letters patent, a reissue applicant must timely reply that the requirement is moot in view of the implementation of the amended rule. Such a reply will be considered a complete reply to any requirement directed toward the surrender of the original letters patent. It is to be noted that the Office will not conduct a search to withdraw Office actions where the only outstanding requirement is compliance with the physical surrender of the original letters patent.

Example 1:

An Office action issues prior to the effective date of the amendment to 37 CFR 1.178 with only a requirement for a return of the original letters patent to the Office. A two-month period for reply is set in the Office action. Applicant fails to timely reply to the Office action, relying on the amendment to 37 CFR 1.178 as mooting the requirement for physical surrender of the original letters patent. The six-month full statutory period for reply expires. In this instance, the reissue application would be abandoned (as of the day after the last day of the two-month period set in the Office action) for failure to timely reply to the Office action, because no reply was timely filed.

Example 2:

An Office action issues prior to the effective date of the amendment to 37 CFR 1.178 with the only requirement for a return of the original letters patent to the Office. Applicant fails to reply to the Office action within the two-month period set in the Office action, relying on the amendment to 37 CFR 1.178 as mooting the requirement for physical surrender of the original letters patent. In reviewing the reissue application in connection with a related application, the examiner notes the omission prior to the expiration of the six-month full statutory period for reply. In this instance, the examiner may telephone the applicant, and remind the applicant of the need to file a timely reply.

Example 3:

An Office action issues prior to the effective date of the amendment to 37 CFR 1.178 with the only requirement being a return of the original letters patent to the Office. Applicant timely replies to the Office that it should vacate/withdraw the requirement, or otherwise indicates that return of the original letters patent is now unnecessary. In this instance, a complete reply would have been filed, and the requirement would be withdrawn and the application passed to issue.

Example 4:

An Office action issues prior to the effective date of the amendment to 37 CFR 1.178 with both (a) a requirement to return the original letters patent to the Office, and (b) a rejection of the claims under 35 U.S.C. 103. Applicant timely replies to the Office action addressing only the rejection under 35 U.S.C. 103 (but not the need for physical surrender of the original letters patent). In this instance, the reply would be accepted as complete, and the Office would withdraw the requirement for physical surrender of the original letters patent. (The requirement was proper when made, so the Office would not vacate the action in regard to submission of the original letters patent.).

Where the patentee has submitted the original letters patent in a reissue application subject to 37 CFR 1.178 as it is now amended, the Office may, in response to a timely request, return the original letters patent, when it can be readily retrieved from where it is stored, namely, the paper application file, or the artifact storage area for an Image File Wrapper (IFW) file. Any request for return of the letters patent which is submitted after the issue fee has been paid will require a petition pursuant to 37 CFR 1.59(b) to expunge from the file and return the original letters patent. Where the original letters patent cannot be readily retrieved, or in the rare instance that it has been subsequently misplaced, the Office will not be able




to return the original letters patent and will not create a new one.

Example 5:

In an application filed after the effective date of the amendment to 37 CFR 1.178, applicant has mistakenly submitted the original letters patent and later seeks its return. In this instance, provided applicant timely requests the return of the original letters patent, the Office would return the patent, provided it can be readily retrieved.

Example 6:

A reissue application was pending at the time of the effective date of the amendment to 37 CFR 1.178, and an original letters patent was submitted. Applicant requests return of the original letters patent, although the application is abandoned at the time the request for return is made. In this instance, the Office would return the original letters patent if it is readily retrievable. Even where the reissue application was already abandoned at the time of the effective date of the amendment to 37 CFR 1.178, the Office would also return the original letters patent.

Example 7:

A reissue application is pending at the time of the effective date of the amendment to 37 CFR 1.178. An original letters patent was submitted, and the issue fee has been paid for the reissue application at the time the request for return of the original letters patent is made. In this instance, the Office may similarly return the original letters patent, but only if the request is accompanied by a grantable petition under 37 CFR 1.59(b).

Example 8:

A reissue application was pending at the time of the effective date of the amendment to 37 CFR 1.178. An original letters patent was submitted, and the reissue application then issued as a reissue patent. After the reissue patent issues, the request for return of the original letters patent is made. Once again, the Office may return the original letters patent, but only if the request is accompanied by a grantable petition under 37 CFR 1.59(b).

Example 9:

A reissue application issued as a reissue patent prior to the effective date of the amendment to 37 CFR 1.178. The reissue applicant, now the patentee, requests return of the original letters patent that was submitted in the reissue application. In this instance, the Office will not return the original letters patent. The original letters patent was submitted in reply to a requirement that was in effect throughout the pendency of the reissue application.



1417 Claim for Benefit Under 35 U.S.C. 119(a)-(d)[edit | edit source]

PRIORITY UNDER 35 U.S.C. 119(a)-(d) WAS PERFECTED IN THE ORIGINAL PATENT

A “claim” for the benefit of an earlier filing date in a foreign country under 35 U.S.C. 119(a)-(d) must be made in a reissue application, even though such a claim was previously made in the application for the original patent to be reissued. However, no additional certified copy of the foreign application is necessary. The procedure is similar to that for “Continuing Applications” in MPEP § 201.14(b).

In addition, 37 CFR 1.63 requires that in any application in which a claim for foreign priority is made pursuant to 37 CFR 1.55, the oath or declaration must identify the foreign application for patent or inventors’ certificate on which priority is claimed unless supplied on an application data sheet (37 CFR 1.76), and any foreign applications having a filing date before that of the application on which priority is claimed, by specifying:

(A)the application number of the foreign application;


(B)the foreign country or intellectual property authority; and

(C)the day, month, and year of the filing of the foreign application.




The examiner should note that the heading on printed copies of the patent will not be carried forward to the reissue from the original patent. Therefore, it is important that the bibliographic data sheet (or the front face of the reissue file wrapper for series 08/ and earlier paper applications) be endorsed by the examiner under “FOREIGN APPLICATIONS.” For an IFW reissue file, a copy of the bibliographic data sheet should be printed from the IFW file history. The printed copy should be annotated by the examiner and then the annotated copy should be scanned into the IFW.

PRIORITY UNDER 35 U.S.C. 119(a)-(d) IS NEWLY PERFECTED IN THE REISSUE APPLICATION


A reissue was granted in Brenner v. State of Israel, 400 F.2d 789, 158 USPQ 584 (D.C. Cir. 1968), where the only ground urged was failure to file a certified copy of the original foreign application to obtain the right of foreign priority under 35 U.S.C. 119(a)-(d) before the patent was granted. In Brenner, the claim for priority had been made in the prosecution of the original patent, and it was only necessary to submit a certified copy of the priority document in the reissue application to perfect priority (the claim for priority must be repeated in the reissue application). Reissue is also available to correct the “error” in failing to take any steps to obtain the right of foreign priority under 35 U.S.C. 119(a)-(d) before the original patent was granted. See Fontijn v. Okamoto, 518 F.2d 610, 622, 186 USPQ 97, 106 (CCPA 1975) (“a patent may be reissued for the purpose of establishing a claim to priority which was not asserted, or which was not perfected during the prosecution of the original application”) In a situation where it is necessary to submit for the first time both the claim for priority and the certified copy of the priority document in the reissue application and the patent to be reissued resulted from a utility or plant application filed on or after November 29, 2000, the reissue applicant will have to file a petition for an unintentionally delayed priority claim under 37 CFR 1.55(c) in addition to filing a reissue application. See MPEP §

201.14(a).

1418 Notification of Prior/Concurrent Proceedings and Decisions Thereon, and of Information Known to be Material to Patentability[edit | edit source]

37 CFR 1.178. Original patent; continuing duty of applicant.


(b)In any reissue application before the Office, the applicant must call to the attention of the Office any prior or concurrent proceedings in which the patent (for which reissue is requested) is or was involved, such as interferences, reissues, reexaminations, or litigations and the results of such proceedings (see also §

1.173(a)(1)).

37 CFR 1.178(b) requires reissue applicants to call to the attention of the Office any prior or concurrent proceeding in which the patent (for which reissue is requested) is or was involved and the results of such proceedings. These proceedings would include interferences, reissues, reexaminations, and litigations. Litigation would encompass any papers filed in the court or issued by the court, which may include, for example, motions, pleadings, and court decisions. This duty to submit information is continuing, and runs from the time the reissue application is filed until the reissue application is abandoned or issues as a reissue patent.

In addition, a reissue application is subject to the same duty of disclosure requirements as is any other nonprovisional application. The provisions of 37 CFR 1.63 require acknowledgment in the reissue oath or declaration of the “duty to disclose to the Office all information known to the [applicants] to be material to patentability as defined in §

1.56.” Note that the Office imposes no responsibility on a reissue applicant to resubmit, in a reissue application, all the “References Cited” in the patent for which reissue is sought. Rather, applicant has a continuing duty under 37 CFR 1.56 to timely apprise the Office of any information which is material to the patentability of the claims under consideration in the reissue application.

37 CFR 1.97 and 37 CFR 1.98 provide a mechanism to submit information known to applicants to be material to patentability. Information submitted in compliance with 37 CFR 1.97 and 37 CFR 1.98 will be considered by the Office. See MPEP § 609. Although a reissue applicant may utilize 37 CFR 1.97and 37 CFR 1.98 to comply with the duty of disclo




sure required by 37 CFR 1.56, this does not relieve applicant of the duties under 37 CFR 1.175 of, for example, stating “at least one error being relied upon.”

While 37 CFR 1.97(b) provides for the filing of an information disclosure statement within 3 months of the filing of an application or before the mailing date of a first Office action, reissue applicants are encouraged to file information disclosure statements at the time of filing of the reissue application so that such statements will be available to the public during the 2- month period provided in MPEP § 1441. Form paragraph 14.11.01 may be used to remind applicant of the duties to timely make the Office aware of (A) any prior or concurrent proceeding (e.g., litigation or Office proceedings) in which the patent to be reissued is or was involved, and (B) any information which is material to patentability of the claims in the reissue application.

¶ 14.11.01 Reminder of Duties Imposed by 37 CFR 1.178(b) and 37 CFR 1.56

Applicant is reminded of the continuing obligation under 37 CFR 1.178(b), to timely apprise the Office of any prior or concurrent proceeding in which Patent No. [1] is or was involved. These proceedings would include interferences, reissues, reexaminations, and litigation.

Applicant is further reminded of the continuing obligation under 37 CFR 1.56, to timely apprise the Office of any information which is material to patentability of the claims under consideration in this reissue application.

These obligations rest with each individual associated with the filing and prosecution of this application for reissue. See also MPEP §§ 1404, 1442.01 and 1442.04.

Examiner Note:

1.This form paragraph is to be used in the first action in a reissue application.

2.In bracket [1], insert the patent number of the original patent for which reissue is requested.

1430 Reissue Files Open to the Public and, Notice of Filing Reissue Announced in, Official Gazette[edit | edit source]

37 CFR 1.11. Files open to the public.


(b)All reissue applications, all applications in which the Office has accepted a request to open the complete application to inspection by the public, and related papers in the application file, are open to inspection by the public, and copies may be furnished upon paying the fee therefor. The filing of reissue applications, other than continued prosecution applications under § 1.53(d) of reissue applications, will be announced in the Official Gazette. The announcement shall include at least the filing date, reissue application and original patent numbers, title, class and subclass, name of the inventor, name of the owner of record, name of the attorney or agent of record, and examining group to which the reissue application is assigned.


Under 37 CFR 1.11(b) all reissue applications filed after March 1, 1977, are open to inspection by the general public, and copies may be furnished upon paying the fee therefor. The filing of reissue applications (except for continued prosecution applications (CPA’s) filed under 37 CFR 1.53(d)) will be announced in the Official Gazette. The announcement gives interested members of the public an opportunity to submit to the examiner information pertinent to the patentability of the reissue application. The announcement includes the filing date, reissue application and original patent numbers, title, class and subclass, name of the inventor, name of the owner of record, name of the attorney or agent of record, and the Technology Center (TC) to which the reissue application is initially assigned. A TC Director or other appropriate Office official may, under appropriate circumstances, postpone access to or the making of copies of a paper reissue application file, such as, for example, to avoid interruption of the examination or other review of the application by an examiner.

IFW reissue application files are open to inspection by the general public by way of Public PAIR via the USPTO Internet site. In viewing the images of the files, members of the public will be able to view the entire content of the reissue application file history. To access Public PAIR, a member of the public would (A) go to the USPTO web site at http:// www.uspto.gov, (B) click on “Patents”, (C) under “Check Status, View Papers…” click on “Status & IFW,” and (D) under “Patent Application Information Retrieval” enter the reissue application number.

A notice of a reissue application in the Official Gazette should be published prior to any examination of the application. If an inadvertent failure to publish notice of the filing of the reissue application in the Official Gazette is recognized later in the examination, action should be taken to have the notice published as quickly as possible, and action on the application may be delayed until two months after the




publication, allowing for any protests to be filed. For a discussion of protests, see MPEP Chapter 1900.

The filing of a continued prosecution application (CPA) under 37 CFR 1.53(d) of a reissue application will not be announced in the Official Gazette. Although the filing of a CPA of a reissue application constitutes the filing of a reissue application, the announcement of the filing of such CPA would be redundant in view of the announcement of the filing of the prior reissue application in the Official Gazetteand the fact that the same application number and file will continue to be used for the CPA.

If applicant files a Request for Continued Examination (RCE) of the reissue application under 37 CFR 1.114 (which can be filed on or after May 29, 2000 for a reissue application filed on or after June 8, 1995), such filing will not be announced in the Official Gazette. An RCE continues prosecution of the existing reissue application and is not a filing of a new application.


The filing of all reissue applications, except for CPAs filed under 37 CFR 1.53(d), (note that effective July 14, 2003, CPA practice has been eliminated as to utility and plant application) will be announced in the Official Gazette and will include certain identifying data as specified in 37 CFR 1.11(b). Access to a reissue application that is maintained in paper must be obtained from the area of the Office having jurisdiction over the reissue application file.

For reissue application files that are maintained in paper, the following access procedure will be observed:

(A) Any member of the general public may request access to a particular reissue application filed after March 1, 1977. Since no record of such request is intended to be kept, an oral request will suffice. Reissue applications already on file prior to March 1, 1977 are not automatically open to inspection, but a liberal policy is followed by the Office of Patent Legal Administration and by the Board of Patent Appeals and Interferences (see MPEP §

1002.02(b)) in granting petitions for access to such applications.

(B)Paper reissue application files will be maintained in the TCs and inspection thereof will be supervised by TC personnel. Although no general limit is placed on the amount of time spent reviewing the files, the Office may impose limitations, if necessary, e.g., where the application is actively being processed.


(C)Where the reissue application file has left the TC for administrative processing, requests for access should be directed to the appropriate supervisory personnel where the application is currently located.

(D)Requests for copies of papers in the reissue application file must be in writing and addressed to the Mail Stop Document Services, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450. Such requests may be either mailed or delivered to the Office Customer Service Window (See MPEP § 502). The price for copies made by the Office is set forth in 37 CFR 1.19.

1440 Examination of Reissue Application[edit | edit source]

37 CFR 1.176. Examination of reissue.

(a)A reissue application will be examined in the same manner as a non-reissue, non-provisional application, and will be subject to all the requirements of the rules related to non-reissue applications. Applications for reissue will be acted on by the examiner in advance of other applications.

(b)Restriction between subject matter of the original patent claims and previously unclaimed subject matter may be required (restriction involving only subject matter of the original patent claims will not be required). If restriction is required, the subject matter of the original patent claims will be held to be constructively elected unless a disclaimer of all the patent claims is filed in the reissue application, which disclaimer cannot be withdrawn by applicant.

37 CFR 1.176 provides that an original claim, if re- presented in a reissue application, will be fully examined in the same manner, and subject to the same rules as if being presented for the first time in an original non-reissue, nonprovisional application, except that division will not be required by the examiner. See MPEP § 1450 and § 1451. Reissue applications are normally examined by the same examiner who issued the patent for which reissue is requested. In addition, the application will be examined with respect to compliance with 37 CFR 1.171-1.178 relating specifically to reissue applications, for example, the reissue oath or declaration will be carefully reviewed for compliance with 37 CFR 1.175. See MPEP § 1444 for handling applications in which the oath or declaration




lacks compliance with 37 CFR 1.175. Reissue applications with related litigation will be acted on by the examiner before any other special applications, and will be acted on immediately by the examiner, subject only to a 2-month delay after publication for examining reissue applications; see MPEP § 1441.

The original patent file wrapper /file history should always be obtained and reviewed when examining a reissue application thereof.

1441 Two-Month Delay Period[edit | edit source]

37 CFR 1.176 provides that reissue applications will be acted on by the examiner in advance of other applications, i.e., “special.” Generally, a reissue application will not be acted on sooner than 2 months after announcement of the filing of the reissue has appeared in the Official Gazette. The 2-month delay is provided in order that members of the public may have time to review the reissue application and submit pertinent information to the Office before the examiner’s action. The pertinent information is submitted in the form of a protest under 37 CFR 1.291(a). For a discussion as to protests under 37 CFR 1.291(a) in reissue applications, see MPEP § 1441.01. As set forth in MPEP § 1901.04, the public should be aware that such submissions should be made as early as possible, since, under certain circumstances, the 2-month delay period will not be employed. For example, the Office may act on a continuation or a divisional reissue application prior to the expiration of the 2-month period after announcement. Additionally, the Office will entertain a petition under 37 CFR 1.182 which is accompanied by the required petition fee (37 CFR 1.17(f)) to act on a reissue application without delaying for 2 months. Accordingly, protestors to reissue applications (see MPEP § 1441.01) cannot automatically assume that a full 2-month delay period will always be available. Appropriate reasons for requesting that the 2-month delay period not be employed include that litigation involving a patent has been stayed to permit the filing of an application for the reissue of the patent. Where the basis for the petition is ongoing litigation, the petition must clearly identify the litigation, and detail the specifics of the litigation that call for prompt action on the reissue application prior to the expiration of the 2-month delay period. Such petitions are decided by the Office of Patent Legal Administration.

1441.01Protest in Reissue Applications[R-3]

A protest pursuant to 37 CFR 1.291 may be filed throughout the pendency of a reissue application, prior to the date of mailing of a notice of allowance, subject to the timing constraints of the examination, as set forth in MPEP § 1901.04. While a reissue application is not published under 37 CFR 1.211, the reissue application is published pursuant to 35 U.S.C. 122(b)(1)(A) via an announcement in the Official Gazette (and public availability of the file content) per 37 CFR 1.11(b). Such a publication does not preclude the filing of a protest. 35 U.S.C. 122(c) states:

“(c) PROTEST AND PRE-ISSUANCE OPPOSITION- The Director shall establish appropriate procedures to ensure that no protest or other form of pre-issuance opposition to the grant of a patent on an application may be initiated after publication of the application without the express written consent of the applicant.” [Emphasis added.]

A protest is precluded after publication for an application for an original patent, as a “form of pre-issuance opposition.” A reissue application is a post- issuance proceeding. A protest filed in a reissue application is not a “form of pre-issuance opposition to the grant of a patent” since the patent to be reissued has already been granted. Thus, the prohibition against the filing of a protest after publication of an application under 35 U.S.C. 122(c) is not applicable to a reissue application and a protest is permitted after publication of the reissue application.

A protest with regard to a reissue application 

should be filed within the 2-month period following the announcement of the filing of the reissue application in the Official Gazette. If the protest of a reissue application cannot be filed within the 2-month delay period, the protest can be submitted at a later time. Where the protest is submitted after the 2-month period, no petition for entry of the protest under 37 CFR 1.182 is needed with respect to the protest being submitted after the 2 months, unless a final rejection has been issued or prosecution on the merits has been otherwise closed for the reissue application.


A potential protestor should be aware that reissue applications are taken up “special” and a protest filed outside the 2-month delay period may be




received after action by the examiner. Once the first Office action is mailed (after the 2-month period), a member of the public may still submit pertinent information in the form of a protest under 37 CFR 1.291, and the examiner will consider the information submitted in the next Office action, to the extent that such consideration is appropriate. Where a final rejection has been issued or the prosecution on the merits has been otherwise closed, a petition under 37 CFR 1.182 along with the required petition fee (37 CFR 1.17(f)) for entry of the protest are required. The petition must include an explanation as to why the additional time was necessary and the nature of the protest intended. A copy of the petition must be served upon the applicant in accordance with 37 CFR 1.248. The petition should be directed to the Office of Petitions.

If the protest of a reissue application cannot be filed within the 2-month delay period, the protestor may petition to request (A) an extension of the 2-month period following the announcement in the Official Gazette, and (B) a delay of the examination until the extended period expires. Such a request will be considered only if filed in the form of a petition under 37 CFR 1.182 and accompanied by the petition fee set forth in 37 CFR 1.17(f). The petition under 37 CFR 1.182 and the petition fee must be filed prior to the expiration of the 2-month period following the announcement of the filing of the reissue application in the Official Gazette. The petition must explain why the additional time is necessary and the nature of the protest intended. A copy of the petition must be served upon applicant in accordance with 37 CFR 1.248. The petition should be directed to the appropriate Technology Center (TC) which will forward the petition to the Office of Patent Legal Administration.

If the protest is a “REISSUE LITIGATION” protest, it is particularly important that it be filed early if protestor wishes it considered at the time the Office first acts on the reissue application. Protestors should be aware that the Office will entertain petitions from the reissue applicants under 37 CFR 1.182 to waive the 2-month delay period in appropriate circumstances. Accordingly, protestors to reissue applications cannot automatically assume that the full 2- month delay period will always be available.

The Technology Center (TC) to which the reissue application is assigned is listed in the Official Gazettenotice of filing of the reissue application. Accordingly, the indicated TC should retain jurisdiction over the reissue application file for 2 months after the date of the Official Gazette notice before transferring the reissue application under the procedure set forth in MPEP §

903.08(d).

The publication of a notice of a reissue application in the Official Gazette should be done prior to any examination of the reissue application. If an inadvertent failure to publish notice of the filing of the reissue application in the Official Gazette is recognized later in the examination, action should be taken to have the notice published as quickly as possible, and action on the reissue application may be delayed until 2 months after the publication, allowing for any protests to be filed.

See MPEP § 1901.06 for general procedures on examiner treatment of protests in reissue applications.

1442 Special Status[edit | edit source]

All reissue applications are taken up “special,” and remain “special” even though applicant does not respond promptly.

All reissue applications, except those under suspension because of litigation, will be taken up for action ahead of other “special” applications; this means that all issues not deferred will be treated and responded to immediately. Furthermore, reissue applications involved in litigation will be taken up for action in advance of other reissue applications.

1442.01Litigation-Related Reissues [R-5]

During initial review, the examiner should determine whether the patent for which the reissue has been filed is involved in litigation, and if so, the status of that litigation. If the examiner becomes aware of litigation involving the patent sought to be reissued during examination of the reissue application, and applicant has not made the details regarding that litigation of record in the reissue application, the examiner, in the next Office action, will inquire regarding the specific details of the litigation.

Form paragraph 14.06 may be used for such an inquiry.

¶ 14.06 Litigation-Related Reissue

The patent sought to be reissued by this application [1] involved in litigation. Any documents and/or materials which




would be material to patentability of this reissue application are required to be made of record in response to this action.

Due to the related litigation status of this application, EXTENSIONS OF TIME UNDER THE PROVISIONS OF 37 CFR 1.136(a) WILL NOT BE PERMITTED DURING THE PROSECUTION OF THIS APPLICATION.

Examiner Note:

In bracket 1, insert either —is— or —has been—.

If additional details of the litigation appear to be material to examination of the reissue application, the examiner may make such additional inquiries as necessary and appropriate.

For reissue application files that are maintained in paper, if the existence of litigation has not already been noted, the examiner should place a prominent notation on the application file to indicate the litigation (1) at the bottom of the face of the file in the box just to the right of the box for the retention label, and (2) on the pink Reissue Notice Card form. For reissue application files that are maintained in the Image File Wrapper (IFW) system, if the existence of litigation has not already been noted, the examiner should print out a copy of the bibliographic data sheet from the IFW file history and annotate the printed bibliographic data sheet such that adequate notice is provided of the existence of the litigation. The examiner should place the annotation in a prominent place. The annotated sheet should be scanned into IFW.

Applicants will normally be given 1 month to reply to Office actions in all reissue applications which are being examined during litigation, or after litigation had been stayed, dismissed, etc., to allow for consideration of the reissue by the Office. This 1-month period may be extended only upon a showing of clear justification pursuant to 37 CFR 1.136(b). The Office action will inform applicant that the provisions of 37 CFR 1.136(a) are not available. Of course, up to 3 months may be set for reply if the examiner determines such a period is clearly justified.

1442.02 Concurrent Litigation[edit | edit source]

In order to avoid duplication of effort, action in reissue applications in which there is an indication of concurrent litigation will be suspended automatically unless and until it is evident to the examiner, or the applicant indicates, that any one of the following applies:

(A)a stay of the litigation is in effect;

(B)the litigation has been terminated;

(C)there are no significant overlapping issues between the application and the litigation; or

(D)it is applicant’s desire that the application be examined at that time.

Where any of (A) - (D) above apply, form paragraphs 14.08-14.10 may be used to deny a suspension of action in the reissue, i.e., to deny a stay of the reissue proceeding.

Where none of (A) through (D) above apply, action in the reissue application in which there is an indication of concurrent litigation will be suspended by the examiner. The examiner should consult with the Technology Center Special Program Examiner prior to suspending action in the reissue. Form paragraph 14.11 may be used to suspend action, i.e., stay action, in a reissue application with concurrent litigation.

An ex parte reexamination proceeding will not be stayed where there is litigation. See Ethicon v. Quigg, 849 F.2d 1422, 7 USPQ2d 1152 (Fed. Cir. 1988). Thus, where a reissue application has been merged with an ex parte reexamination proceeding, the merged proceeding will not be stayed where there is litigation. In a merged ex parte reexamination/reissue proceeding, the ex parte reexamination will control because of the statutory (35 U.S.C. 305) requirement that ex parte reexamination proceedings be conducted with special dispatch. See MPEP § 2285 and § 2286. As to a stay or suspension where reissue proceedings are merged with inter partes reexamination proceedings, see 37 CFR 1.937 and MPEP § 2686.

1442.03 Litigation Stayed[edit | edit source]

All reissue applications, except those under suspension because of litigation, will be taken up for action ahead of other “special” applications; this means that all issues not deferred will be treated and responded to immediately. Furthermore, reissue applications involved in “stayed litigation” will be taken up for action in advance of other reissue applications. Great emphasis is placed on the expedited processing of such reissue applications. The courts are especially interested in expedited processing in the Office where litigation is stayed.

In reissue applications with “stayed litigation,” the Office will entertain petitions under 37 CFR 1.182, which are accompanied by the fee under 37 CFR 1.17(f), to not apply the 2-month delay period stated in MPEP § 1441. Such petitions are decided by the Office of Patent Legal Administration.

Time-monitoring systems have been put into effect which will closely monitor the time used by applicants, protestors, and examiners in processing reissue applications of patents involved in litigation in which the court has stayed further action. Monthly reports on the status of reissue applications with related litigation are required from each Technology Center (TC). Delays in reissue processing are to be followed up. The TC Special Program Examiner is responsible for oversight of reissue applications with related litigation.

The purpose of these procedures and those deferring consideration of certain issues, until all other issues are resolved or the application is otherwise ready for consideration by the Board of Patent Appeals and Interferences (note MPEP § 1448), is to reduce the time between filing of the reissue application and final action thereon, while still giving all parties sufficient time to be heard.

1442.04 Litigation Involving Patent[edit | edit source]

37 CFR 1.178. Original patent; continuing duty of applicant.

(b)In any reissue application before the Office, the applicant must call to the attention of the Office any prior or concurrent proceedings in which the patent (for which reissue is requested) is or was involved, such as interferences, reissues, reexaminations, or litigations and the results of such proceedings (see also § 1.173(a)(1)).

Where the patent for which reissue is being sought is, or has been, involved in litigation, the applicant should bring the existence of such litigation to the attention of the Office. 37 CFR 1.178(b). This should be done at the time of, or shortly after, the applicant files the application, either in the reissue oath or declaration, or in a separate paper, preferably accompanying the application as filed. Litigation begun after filing of the reissue application also should be promptly brought to the attention of the Office.

Litigation encompasses any papers filed in the court or issued by the court. This may include, for example, motions, pleadings, and court decisions, as well as the results of such proceedings. When applicant notifies the Office of the existence of the litigation, enough information should be submitted so that the Office can reasonably evaluate the need for asking for further materials in the litigation. Note that the existence of supporting materials which may substantiate allegations of invalidity should, at least, be fully described, and preferably submitted. The Office is not interested in receiving voluminous litigation materials which are not relevant to the Office’s consideration of the reissue application. The status of the litigation should be updated in the reissue application as soon as significant events happen in the litigation.

When a reissue application is filed, the examiner should determine whether the original patent has been adjudicated by a court. The decision(s) of the court, and also other papers in the suit, may provide information essential to the examination of the reissue. Examiners should inform the applicant of the duty to supply information as to litigation involving the patent. Form paragraph 14.11.01 may be used for this purpose. See MPEP § 1418.

Additionally, the patented file will contain notices of the filing and termination of infringement suits on the patent. Such notices are required by law to be filed by the clerks of the Federal District Courts. These notices do not indicate if there was an opinion by the court, nor whether a decision was published. Shepard’s Federal Citations and the cumulative digests of the United States Patents Quarterly, both of which are in the Lutrelle F. Parker, Sr., Memorial Law Library, contain tables of patent numbers giving the citation of published decisions concerning the patent.

A litigation computer search by the Scientific and Technical Information Center (STIC) should be requested by the examiner to determine whether the patent has been, or is, involved in litigation. For reissue application files that are maintained in paper, the “Search Notes” box on the application file wrapper is then completed to indicate that the review was conducted. A copy of the STIC search should be hole-punched and placed in the reissue file. For IFW reissue application files, the “Search Notes” box on the OACS “Search Notes” page is annotated to indicate that the review was conducted, and the OACS “Search Notes” page is then scanned into the reissue application file history.

Additional information or guidance as to making a litigation search may be obtained from the library of the Office of the Solicitor. Where papers are not otherwise conveniently obtainable, the applicant may be requested to supply copies of papers and records in suits, or the Office of the Solicitor may be requested to obtain them from the court. The information thus obtained should be carefully considered for its bearing on the proposed claims of the reissue, particularly when the reissue application was filed in view of the holding of a court.

If the examiner becomes aware of litigation involving the patent sought to be reissued during examination of the reissue application, and applicant has not made the details regarding that litigation of record in the reissue application, the examiner, in the next Office action, should inquire regarding the same. Form paragraph 14.06 may be used for such an inquiry. See MPEP § 1442.01.

If the additional details of the litigation appear to be material to patentability of the reissue application, the examiner may make such additional inquiries as necessary and appropriate.

1442.05 Court Ordered Filing of Reissue Application[edit | edit source]

In most instances, the reissue-examination procedure is instituted by a patent owner who voluntarily files a reissue application as a consequence of related patent litigation. Some Federal district courts in earlier decisions have required a patentee-litigant to file a reissue application as a consequence of the patent litigation. However, the Court of Appeals for the Federal Circuit held in Green v. The Rich Iron Co., 944 F.2d 852, 853, 20 USPQ2d 1075, 1076 (Fed. Cir. 1991) that a Federal district court in an infringement case could not compel a patentee to seek reissue by the USPTO.

It is to be noted that only a patentee or his or her assignee may file a reissue patent application. An order by a court for a different party to file a reissue will not be binding on the Office.

1443 Initial Examiner Review[edit | edit source]

As part of an examiner’s preparation for the examination of a reissue application, the Examiner Reissue Guide and Checklist should be consulted for basic guidance and suggestions for handling the prosecution. The Technology Center (TC) Special Program Examiners (SPREs) should make the Guide and Checklist available at the time a reissue application is docketed to an examiner.

On initial receipt of a reissue application, the examiner should inspect the submission under 37 CFR 1.172 as to documentary evidence of a chain of title from the original owner to the assignee to determine whether the consent requirement of 37 CFR 1.172 has been met. The examiner will compare the consent and documentary evidence of ownership; the assignee indicated by the documentary evidence must be the same assignee which signed the consent. Also, the person who signs the consent for the assignee and the person who signs the submission of evidence of ownership for the assignee must both be persons having authority to do so. See also MPEP § 324.

Where the application is assigned, and there is no submission under 37 CFR 1.172 as to documentary evidence in the application, the examiner should require the submission using form paragraph 14.16. Once the submission under 37 CFR 1.172 as to documentary evidence is received, it must be compared with the consent to determine whether the assignee indicated by the documentary evidence is the same assignee which signed the consent. See MPEP § 1410.01 for further discussion as to the required consent and documentary evidence.

Where there is a statement of record that the application is not assigned, there should be no submission under 37 CFR 1.172 as to documentary evidence of ownership in the application, and none should be required by the examiner.

The filing of all reissue applications, except for continued prosecution applications (CPAs) filed under 37 CFR 1.53(d), must be announced in the Official Gazette. Accordingly, for any reissue application other than a CPA, the examiner should determine if the filing of the reissue application has been announced in the Official Gazette as provided in 37 CFR 1.11(b). The contents entry on the PALM Intranet Contents screen should be checked for the presence of “NRE” and “NOTICE OF REISSUE PUBLISHED IN OFFICIAL GAZETTE” entries in the contents, and the date of publication. Where the reissue application is maintained in a paper file, the date of the Official Gazette notice can usually be found on the pink “REISSUE” tag which protrudes from the top of the application file of 08/ or earlier series. For 09/ and later series reissue applications, the Official Gazette publication date appears on the face of the file wrapper. If the filing of the reissue application has not been announced in the Official Gazette, the reissue application should be returned to the Office of Initial Patent Examination (Special Processing) to handle the announcement. The examiner should not further act on the reissue until 2 months after announcement of the filing of the reissue has appeared in the Official Gazette. See MPEP § 1440.

The examiner should determine if there is concurrent litigation, and if so, the status thereof (MPEP § 1442.01), and whether the reissue file wrapper (for reissue application files maintained in paper) or file history (for IFW reissue applications) has been appropriately marked. Note MPEP § 1404.

The examiner should determine if a protest has been filed, and if so, it should be handled as set forth in MPEP § 1901.06. For a discussion of protests under 37 CFR 1.291 in reissue applications, see MPEP § 1441.01.

The examiner should determine whether the patent is involved in an interference, and if so, should refer to MPEP § 1449.01 before taking any action on the reissue application.

The examiner should verify that all Certificate of Correction changes have been properly incorporated into the reissue application. See MPEP § 1411.01.

The examiner should verify that the patent on which the reissue application is based has not expired, either because its term has run or because required maintenance fees have not been paid. Once a patent has expired, the Director of the USPTO no longer has the authority under 35 U.S.C. 251 to reissue the patent. See In re Morgan, 990 F.2d 1230, 26 USPQ2d 1392 (Fed. Cir. 1992). See also MPEP § 1415.01.

1444 Review of Reissue Oath/Declaration[edit | edit source]

In accordance with 37 CFR 1.175, the following is required in the reissue oath/declaration:

(A)A statement that the applicant believes the original patent to be wholly or partly inoperative or invalid-

(1)by reason of a defective specification or drawing, or

(2)by reason of the patentee claiming more or less than patentee had the right to claim in the patent;

(B)A statement of at least one error which is relied upon to support the reissue application, i.e., which provides a basis for the reissue;

(C)A statement that all errors which are being corrected in the reissue application up to the time of filing of the oath/declaration arose without any deceptive intention on the part of the applicant; and

(D)The information required by 37 CFR 1.63.

MPEP § 1414 contains a discussion of each of the above elements (i.e., requirements of a reissue oath/ declaration). The examiner should carefully review the reissue oath/declaration in conjunction with that discussion, in order to ensure that each element is provided in the oath/declaration. If the examiner’s review of the oath/declaration reveals a lack of compliance with any of the requirements of 37 CFR 1.175, a rejection of all the claims under 35 U.S.C. 251 should be made on the basis that the reissue oath/declaration is insufficient.

In preparing an Office action, the examiner should use form paragraphs 14.01 through 14.01.04 to state the objection(s) to the oath/declaration, i.e., the defects in the oath/declaration. These form paragraphs are reproduced in MPEP § 1414. The examiner should then use form paragraph 14.14 to reject the claims under 35 U.S.C. 251, based upon the improper oath/ declaration.

A lack of signature on a reissue oath/declaration (except as otherwise provided in 37 CFR 1.42, 1.43, and 1.47 and in 37 CFR 1.172) would be considered a lack of compliance with 37 CFR 1.175(a) and result in a rejection, including final rejection, of all the claims on the basis that the reissue oath/declaration is insufficient. If the unsigned reissue oath/declaration is submitted as part of a reply which is otherwise properly signed and responsive to the outstanding Office action, the reply should be accepted by the examiner as proper and responsive, and the oath/declaration considered fully in the next Office action. The reply should not be treated as an unsigned or improperly signed amendment (see MPEP § 714.01(a)), nor do the holdings of Ex parte Quayle apply in this situation. The lack of signature, along with any other oath/ declaration deficiencies, should be noted in the next Office action rejecting the claims as being based upon an insufficient reissue oath/declaration.

I.HANDLING OF THE REISSUE OATH/ DECLARATION DURING THE REISSUE PROCEEDING

An initial reissue oath/declaration is submitted with the reissue application (or within the time period set for filing the oath/declaration in a Notice To File Missing Parts under 37 CFR 1.53(f)). Where the reissue oath/declaration fails to comply with 37 CFR 1.175(a), the examiner will so notify the applicant in an Office action, rejecting the claims under 35 U.S.C. 251 as discussed above. In reply to the Office action, a supplemental reissue oath/declaration should be submitted dealing with the noted defects in the reissue oath/declaration.

Where the initial reissue oath/declaration (1) failed to provide any error statement, or (2) attempted to provide an error statement, but failed to identify any error under 35 U.S.C. 251 upon which reissue can be based (see MPEP § 1402), the examiner should reject all the claims as being based upon a defective reissue oath/declaration under 35 U.S.C. 251. To support the rejection, the examiner should specifically point out the failure of the initial oath/declaration to comply with 37 CFR 1.175 because an “error” under 35 U.S.C. 251 upon which reissue can be based was not identified therein. In reply to the rejection under 35 U.S.C. 251, a supplemental reissue oath/declaration must be submitted stating an error under 35 U.S.C. 251 which can be relied upon to support the reissue application. Submission of this supplemental reissue oath/declaration to obviate the rejection cannot be deferred by applicant until the application is otherwise in condition for allowance. In this instance, a proper statement of error was never provided in the initial reissue oath/declaration, thus a supplemental oath/declaration is required in reply to the Office action in order to properly establish grounds for reissue.

A different situation may arise where the initial reissue oath/declaration does properly identify one or more errors under 35 U.S.C. 251 as being the basis for reissue, however, because of changes or amendments made during prosecution, none of the identified errors are relied upon any more. A supplemental oath/declaration will be needed to identify at least one error nowbeing relied upon as the basis for reissue, even though the prior oath/declaration was earlier found proper by the examiner. The supplemental oath/declaration need not also indicate that the error(s) identified in the prior oath(s)/declaration(s) is/are no longer being corrected. In this instance, applicant’s submission of the supplemental reissue oath/declaration to obviate the rejection under 35 U.S.C. 251 can, at applicant’s option, be deferred until the application is otherwise in condition for allowance. The submission can be deferred because a proper statement of error was provided in the initial reissue oath/declaration. Applicant need only request that submission of the supplemental reissue oath/declaration be deferred until allowance, and such a request will be considered a complete reply to the rejection.

II.SUPPLEMENTAL REISSUE OATH/DECLARATION UNDER 37 CFR 1.175(b)(1):

Once the reissue oath/declaration is found to comply with 37 CFR 1.175(a), it is not required, nor is it suggested, that a new reissue oath/declaration be submitted together with each new amendment and correction of error in the patent. During the prosecution of a reissue application, amendments are often made and additional errors in the patent are corrected. A supplemental oath/declaration need not be submitted with each amendment and additional correction. Rather, it is suggested that the reissue applicant wait until the case is in condition for allowance, and then submit a cumulative supplemental reissue oath/declaration pursuant to 37 CFR 1.175(b)(1).

See MPEP § 1414.01 for a discussion of the required content of a supplemental reissue oath/declaration under 37 CFR 1.175(b)(1).

A supplemental oath/declaration under 37 CFR 1.175(b)(1) must be submitted before allowance. It may be submitted with any reply prior to allowance. It may be submitted to overcome a rejection under 35 U.S.C. 251 made by the examiner, where it is indicated that the submission of the supplemental oath/ declaration will overcome the rejection.

A supplemental oath/declaration under 37 CFR 1.175(b)(1) will be required where:

(A)the application is otherwise (other than the need for this supplemental oath/declaration) in condition for allowance;

(B)amendments or other corrections of errors in the patent have been made subsequent to the last oath/ declaration filed in the application; and

(C)at least one of the amendments or other corrections corrects an error under 35 U.S.C. 251.

When a supplemental oath/declaration under 37 CFR 1.175(b)(1) directed to the amendments or other corrections of error is required, the examiner is encouraged to telephone the applicant and request the submission of the supplemental oath/declaration by fax. If the circumstances do not permit making a telephone call, or if applicant declines or is unable to promptly submit the oath/declaration, the examiner should issue a final Office action (final rejection) and use form paragraph 14.05.02 where the action issued is a second or subsequent action on the merits.

As noted above, the examiner will issue a final Office action where the application is otherwise in condition for allowance, and amendments or other corrections of error in the patent have been made subsequent to the last oath/declaration filed in the application. The examiner will be introducing (via form paragraph 14.05.02) a rejection into the case for the first time in the prosecution, when the claims have been determined to be otherwise allowable. This introduction of a new ground of rejection under 35 U.S.C. 251 will not prevent the action from being made final on a second or subsequent action because of the following factors:

(A)The finding of the case in condition for allowance is the first opportunity that the examiner has to make the rejection;

(B)The rejection is being made in reply to, i.e., was caused by, an amendment of the application (to correct errors in the patent);

(C)All applicants are on notice that this rejection will be made upon finding of the case otherwise in condition for allowance where errors have been corrected subsequent to the last oath/declaration filed in the case, so that the rejection should have been expected by applicant; and

(D)The rejection will not prevent applicant from exercising any rights to cure the rejection, since applicant need only submit a supplemental oath/declaration with the above-described language, and it will be entered to cure the rejection.

Where the application is in condition for allowance and no amendments or other corrections of error in the patent have been made subsequent to the last oath/declaration filed in the application, a supplemental reissue oath/declaration under 37 CFR 1.175(b)(1) should not be required by the examiner. Instead, the examiner should issue a Notice of Allowability indicating allowance of the claims.

III.AFTER ALLOWANCE

Where applicant seeks to correct an error after allowance of the application, any amendment of the patent correcting the error must be submitted in accordance with 37 CFR 1.312. As set forth in 37 CFR 1.312, no amendment may be made as a matter of right in an application after the mailing of the notice of allowance. An amendment filed under 37 CFR 1.312 must be filed before or with the payment of the issue fee and may be entered on the recommendation of the primary examiner, and approved by the supervisory patent examiner, without withdrawing the case from issue.

Because the amendment seeks to correct an error in the patent, the amendment will affect the disclosure, the scope of a claim, or add a claim. Thus, in accordance with MPEP § 714.16, the remarks accompanying the amendment must fully and clearly state:

(A)why the amendment is needed;

(B)why the proposed amended or new claims require no additional search or examination;

(C)why the claims are patentable; and

(D)why they were not presented earlier.

A supplemental reissue oath/declaration must accompany the amendment. The supplemental reissue oath/declaration must state that the error(s) to be corrected arose without any deceptive intention on the part of the applicant. The supplemental reissue oath/ declaration submitted after allowance must be directed to the error(s) applicant seeks to correct after allowance. This oath/declaration need not cover any earlier errors, since all earlier errors should have been covered by a reissue oath/declaration submitted prior to allowance.

Occasionally correcting an error after allowance does not include an amendment of the specification or claims of the patent. For example, the correction of the error could be the filing of a certified copy of the original foreign application (prior to the payment of the issue fee - see 37 CFR 1.55(a)(2)) to obtain the right of foreign priority under 35 U.S.C. 119 (see Brenner v. State of Israel, 400 F.2d 789, 158 USPQ 584 (D.C. Cir. 1968)) where the claim for foreign priority had been timely made in the application for the original patent. In such a case, the requirements of 37 CFR 1.312 must still be met. This is so, because the correction of the patent is an amendment of the patent, even though no amendment is physically entered into the case. Thus, for a reissue oath/declaration submitted after allowance to correct an additional error (or errors), the reissue applicant must comply with 37 CFR 1.312 in the manner discussed above.

1445 Reissue Application Examined in Same Manner as Original Application[edit | edit source]

As stated in 37 CFR 1.176, a reissue application, including all the claims therein, is subject to “be examined in the same manner as a non-reissue, non- provisional application.” Accordingly, the claims in a reissue application are subject to any and all rejections which the examiner deems appropriate. It does not matter whether the claims are identical to those of the patent or changed from those in the patent. It also does not matter that a rejection was not made in the prosecution of the patent, or could have been made, or was in fact made and dropped during prosecution of the patent; the prior action in the prosecution of the patent does not prevent that rejection from being made in the reissue application. Claims in a reissue application enjoy no “presumption of validity.” In re Doyle, 482 F.2d 1385, 1392, 179 USPQ 227, 232-233 (CCPA 1973); In re Sneed, 710 F.2d 1544, 1550 n.4, 218 USPQ 385, 389 n.4 (Fed. Cir. 1983). Likewise, the fact that during prosecution of the patent the examiner considered, may have considered, or should have considered information such as, for example, a specific prior art document, does not have any bearing on, or prevent, its use as prior art during prosecution of the reissue application.

1448 Fraud, Inequitable Conduct, or Duty of Disclosure Issues[edit | edit source]

The Office no longer investigates and rejects reissue applications under 37 CFR 1.56. The Office will not comment upon duty of disclosure issues which are brought to the attention of the Office in reissue applications except to note in the application, in appropriate circumstances, that such issues are no longer considered by the Office during its examination of patent applications. Examination as to the lack of deceptive intent requirement in reissue applications will continue but without any investigation of fraud, inequitable conduct, or duty of disclosure issues. Applicant’s statement in the reissue oath or declaration of lack of deceptive intent will be accepted as dispositive except in special circumstances such as an admission or judicial determination of fraud, inequitable conduct, or violation of the duty of disclosure.

ADMISSION OR JUDICIAL DETERMINATION

An admission or judicial determination of fraud, inequitable conduct, or violation of the duty of disclosure is a special circumstance, because no investigation need be made. Accordingly, after consulting with the Technology Center (TC) Special Program Examiner (SPRE), a rejection should be made using the appropriate one of form paragraphs 14.21.09 or 14.22as reproduced below.

Any admission of fraud, inequitable conduct or violation of the duty of disclosure must be explicit, unequivocal, and not subject to other interpretation. Where a rejection is made based upon such an admission and applicant responds with any reasonable interpretation of the facts that would not lead to a conclusion of fraud, inequitable conduct or violation of the duty of disclosure, the rejection should be withdrawn. Alternatively, if applicant argues that the admission noted by the examiner was not in fact an admission, the rejection should also be withdrawn.

See MPEP § 2012 for additional discussion as to fraud, inequitable conduct or violation of duty of disclosure in a reissue application.

1449 Protest Filed in Reissue Where Patent Is in Interference[edit | edit source]

If a protest (see MPEP Chapter 1900) is filed in a reissue application related to a patent involved in a pending interference proceeding, the reissue application should be referred to the Office of Patent Legal Administration (OPLA) before considering the protest and acting on the reissue application.

The OPLA will check to see that:

(A)all parties to the interference are aware of the filing of the reissue; and

(B)the Office does not allow claims in the reissue which are unpatentable over the pending interference count(s), or found unpatentable in the interference proceeding. After the reissue application has been reviewed by the OPLA, the reissue application with the protest will be returned to the examiner. See MPEP § 1441.01 for a discussion as to protests under 37 CFR 1.291 in reissue applications.

1449.01 Concurrent Office Proceedings[edit | edit source]

I.CONCURRENT REEXAMINATION PROCEEDINGS:

37 CFR 1.565(d) provides that if “a reissue application and an ex parte reexamination proceeding on which an order pursuant to 37 CFR 1.525 has been mailed are pending concurrently on a patent, a decision will normally be made to merge the two proceedings or to suspend one of the two proceedings.” 37 CFR 1.991 provides that if “a reissue application and an inter partes reexamination proceeding on which an order pursuant to 37 CFR 1.931 has been mailed are pending concurrently on a patent, a decision may be made to merge the two proceedings or to suspend one of the two proceedings”. If an examiner becomes aware that a reissue application and an ex parte or inter partes reexamination proceeding are both pending for the same patent, he or she should immediately inform the Technology Center (TC) or Central Reexamination Unit (CRU) Special Program Examiner (SPRE).

Pursuant to 37 CFR 1.177, a patent owner may file more than one reissue application for the same patent. If an examiner becomes aware that multiple reissue applications are pending for the same patent, and an ex parte or inter partes reexamination proceeding is pending for the same patent, he or she should immediately inform the TC SPRE.

Where a reissue application and a reexamination proceeding are pending concurrently on a patent, and an order granting reexamination has been issued for the reexamination proceeding, the Office of Patent Legal Administration (OPLA) must be notified that the proceedings are ready for a decision as to whether to merge the reissue and the reexamination, or stay one of the two. See MPEP § 2285 for the procedure of notifying OPLA and general guidance, if a reissue application and an ex parte reexamination proceeding are both pending for the same patent, and an inter partes reexamination proceeding is not involved. See MPEP § 2686.03 where a reissue application and an inter partes reexamination proceeding are both pending for the same patent, regardless of whether an ex parte reexamination proceeding is also pending.

Where a reissue application and a reexamination proceeding are pending concurrently on a patent, the patent owner, i.e., the reissue applicant, has a responsibility to notify the Office of the concurrent proceeding. 37 CFR § 1.178(b), 37 CFR 1.565(a), and 37 CFR 1.985(a). The patent owner should file in the reissue application, as early as possible, a Notification of Concurrent Proceedings pursuant to 37 CFR 1.178(b) in order to alert the Office of the existence of the reexamination proceeding on the same patent. See MPEP § 1418. In addition, the patent owner should file in the reexamination proceeding, as early as possible, a Notification of Concurrent Proceedings pursuant to 37 CFR 1.565(a) or 1.985(a) (depending on whether the reexamination proceeding is an ex partereexamination proceeding or an inter partes reexamination proceeding) to provide a notification to the Office in the reexamination proceeding of the existence of the two concurrent proceedings.

The patent owner may file a petition under 37 CFR 1.182 in a reissue application to merge the reissue application with the reexamination proceeding, or to stay one of the proceedings because of the other. This petition must be filed after the issuance of the order to reexamine (37 CFR 1.525, 37 CFR 1.931) in the reexamination proceeding. If the petition is filed prior to the reexamination order, it will not be considered, and will be returned to the patent owner by the TC or CRU Director. If the petition is filed after the issuance of the order to reexamine, the petition and the files for the reissue application and the reexamination proceeding will be forwarded to OPLA for decision.

II.CONCURRENT INTERFERENCE PROCEEDINGS

If the original patent is involved in an interference, the examiner must consult the administrative patent judge in charge of the interference before taking any action on the reissue application. It is particularly important that the reissue application not be granted without the administrative patent judge’s approval. See MPEP Chapter 2300.

III.CONCURRENT REISSUE PROCEEDINGS

Where more than one reissue applications are pending concurrently on the same patent, see MPEP §§

1450 and 1451.

1449.02Interference in Reissue [R-5]

37 CFR 41.8. Mandatory notices.

(a)In an appeal brief (§§ 41.37, 41.67, or 41.68) or at the initiation of a contested case (§ 41.101), and within 20 days of any change during the proceeding, a party must identify:

(1)Its real party-in-interest, and

(2)Each judicial or administrative proceeding that could affect, or be affected by, the Board proceeding.

(b)For contested cases, a party seeking judicial review of a Board proceeding must file a notice with the Board of the judicial review within 20 days of the filing of the complaint or the notice of appeal. The notice to the Board must include a copy of the complaint or notice of appeal. See also §§ 1.301 to 1.304 of this title.

37 CFR 41.202. Suggesting an interference.

(a)Applicant. An applicant, including a reissue applicant, may suggest an interference with another application or a patent. The suggestion must:

(1)Provide sufficient information to identify the application or patent with which the applicant seeks an interference,

(2)Identify all claims the applicant believes interfere, propose one or more counts, and show how the claims correspond to one or more counts,

(3)For each count, provide a claim chart comparing at least one claim of each party corresponding to the count and show why the claims interfere within the meaning of § 41.203(a),

(4)Explain in detail why the applicant will prevail on priority,

(5)If a claim has been added or amended to provoke an interference, provide a claim chart showing the written description for each claim in the applicant’s specification, and

(6)For each constructive reduction to practice for which the applicant wishes to be accorded benefit, provide a chart showing where the disclosure provides a constructive reduction to practice within the scope of the interfering subject matter.

(c)Examiner. An examiner may require an applicant to add a claim to provoke an interference. Failure to satisfy the requirement within a period (not less than one month) the examiner sets will operate as a concession of priority for the subject matter of the claim. If the interference would be with a patent, the applicant must also comply with paragraphs (a)(2) through (a)(6) of this section. The claim the examiner proposes to have added must, apart from the question of priority under 35 U.S.C. 102 (g):

(1)Be patentable to the applicant, and

(2)Be drawn to patentable subject matter claimed by another applicant or patentee.

In appropriate circumstances, a reissue application may be placed into interference with a patent or pending application. A patentee may provoke an interference with a patent or pending application by filing a reissue application, if the reissue application includes an appropriate reissue error as required by 35 U.S.C. 251. Reissue error must be based upon applicant error; a reissue cannot be based solely on the error of the Office for failing to declare an interference or to suggest copying claims for the purpose of establishing an interference. See In re Keil, 808 F.2d 830, 1 USPQ2d 1427 (Fed. Cir. 1987); In re Dien, 680 F.2d 151, 214 USPQ 10 (CCPA 1982); In re Bostwick, 102 F.2d 886, 888, 41 USPQ 279, 281 (CCPA 1939); and In re Guastavino, 83 F.2d 913, 916, 29 USPQ 532, 535 (CCPA 1936). See also Slip Track Systems, Inc. v. Metal Lite, Inc., 159 F.3d 1337, 48 USPQ2d 1055 (Fed. Cir. 1998) (Two patents issued claiming the same patentable subject matter, and the patentee with the earlier filing date requested reexamination of the patent with the later filing date (Slip Track’s patent). A stay of litigation in a priority of invention suit under 35 U.S.C. 291, pending the outcome of the reexamination, was reversed. The suit under 35 U.S.C. 291was the only option available to Slip Track to determine priority of invention. Slip Track could not file a reissue application solely to provoke an interference proceeding before the Office because it did not assert that there was any error as required by 35 U.S.C. 251in the patent.). A reissue application can be employed to provoke an interference if the reissue application:

(A)adds copied claims which are not present in the original patent;

(B)amends claims to correspond to those of the patent or application with which an interference is sought; or

(C)contains at least one error (not directed to provoking an interference) appropriate for the reissue.

In the first two situations, the reissue oath/declaration must assert that applicant erred in failing to include claims of the proper scope to provoke an interference in the original patent application. Note that in In re Metz, 173 F.3d 433 (Fed. Cir. 1998) (table), the Federal Circuit permitted a patentee to file a reissue application to copy claims from a patent in order to provoke an interference with that patent. Furthermore, the subject matter of the copied or amended claims in the reissue application must be supported by the disclosure of the original patent under 35 U.S.C. 112, first paragraph. See In re Molins, 368 F.2d 258, 261, 151 USPQ 570, 572 (CCPA 1966) and In re Spencer, 273 F.2d 181, 124 USPQ 175 (CCPA 1959).

A reissue applicant cannot present added or amended claims to provoke an interference, if the claims were deliberately omitted from the patent. If there is evidence that the claims were not inadvertently omitted from the original patent, e.g., the subject matter was described in the original patent as being undesirable, the reissue application may lack proper basis for the reissue. See In re Bostwick, 102 F.2d at 889, 41 USPQ at 282 (CCPA 1939)(reissue lacked a proper basis because the original patent pointed out the disadvantages of the embodiment that provided support for the copied claims).

The issue date of the patent, or the publication date of the application publication (whichever is applicable under 35 U.S.C. 135(b)), with which an interference is sought must be less than 1 year prior to the presentation of the copied or amended claims in the reissue application. See 35 U.S.C. 135(b) and MPEP § 715.05and MPEP Chapter 2300. If the reissue application includes broadened claims, the reissue application must be filed within two years from the issue date of the original patent. See 35 U.S.C. 251 and MPEP § 1412.03.

An examiner may, pursuant to 37 CFR 41.202(c), require a reissue applicant to add a claim to provoke an interference, unless the reissue applicant cannot present the added claim to provoke an interference based upon the provisions of the reissue statute and rules, e.g., if the claim was deliberately omitted from the patent, or if the claim enlarges the scope of the claims of the original patent and was not “applied for within two years from the grant of the original patent.” Failure to satisfy the requirement within a period (not less than one month) the examiner sets will operate as a concession of priority for the subject matter of the claim. If the interference would be with a patent, the reissue applicant must also comply with 37 CFR 41.202(a)(2) through (a)(6). The claim the examiner proposes to have added must, apart from the question of priority under 35 U.S.C. 102(g), be patentable to the reissue applicant, and be drawn to patentable subject matter claimed by another applicant or patentee.

REISSUE APPLICATION FILED WHILE PATENT IS IN INTERFERENCE

If a reissue application is filed while the original patent is in an interference proceeding, the reissue applicant must promptly notify the Board of Patent Appeals and Interferences of the filing of the reissue application within 20 days from the filing date. See 37 CFR 41.8 and MPEP Chapter 2300.

1450 Restriction and Election of Species Made in Reissue Application[edit | edit source]

37 CFR 1.176. Examination of reissue.

(a)A reissue application will be examined in the same manner as a non-reissue, non-provisional application, and will be subject to all the requirements of the rules related to non-reissue applications. Applications for reissue will be acted on by the examiner in advance of other applications.

(b)Restriction between subject matter of the original patent claims and previously unclaimed subject matter may be required (restriction involving only subject matter of the original patent claims will not be required). If restriction is required, the subject matter of the original patent claims will be held to be constructively elected unless a disclaimer of all the patent claims is filed in the reissue application, which disclaimer cannot be withdrawn by applicant.

37 CFR 1.176(b) permits the examiner to require restriction in a reissue application between claims newly added in a reissue application and the original patent claims, where the added claims are directed to an invention which is separate and distinct from the invention(s) defined by the original patent claims. The criteria for making a restriction requirement in a reissue application between the newly added claims and the original claims are the same as that applied in a non-reissue application. See MPEP §§ 806 through 806.05(i). The authority to make a “restriction” requirement under 37 CFR 1.176(b) extends to and includes the authority to make an election of species.

Where a restriction requirement is made by the examiner, the original patent claims will be held to be constructively elected (except for the limited situation where a disclaimer is filed as discussed in the next paragraph). Thus, the examiner will issue an Office action in the reissue application (1) providing notification of the restriction requirement, (2) holding the added claims to be constructively non-elected and withdrawn from consideration, (3) treating the original patent claims on the merits, and (4) informing applicant that if the original claims are found allowable, and a divisional application has been filed for the non-elected claims, further action in the application will be suspended, pending resolution of the divisional application..

If a disclaimer of all the original patent claims is filed in the reissue application containing newly added claims that are separate and distinct from the original patent claims, only the newly added claims will be present for examination. In this situation, the examiner’s Office action will treat the newly added claims in the reissue application on the merits. The disclaimer of all the original patent claims must be filed in the reissue application prior to the issuance of the examiner’s Office action containing the restriction requirement, in order for the newly added claims to be treated on the merits. Once the examiner has issued the Office action providing notification of the restriction requirement and treating the patent claims on the merits, it is too late to obtain an examination on the added claims in the reissue application by filing a disclaimer of all the original patent claims. If reissue applicant wishes to have the newly added claims be treated on the merits, a divisional reissue application must be filed to obtain examination of the added claims. Reissue applicants should carefully note that once a disclaimer of the patent claims is filed, it cannot be withdrawn. It does not matter whether the reissue application is still pending, or whether the reissue application has been abandoned or issued as a reissue patent. For all these situations, 37 CFR 1.176(b) states that the disclaimer cannot be withdrawn; the disclaimer will be given effect.

Claims elected pursuant to a restriction requirement will receive a complete examination on the merits, while the non-elected claims (to any added invention(s)) will be held in abeyance in a withdrawn status, and will only be examined if filed in a divisional reissue application. If the reissue application containing only original unamended claims becomes allowable first (and no “error” under 35 U.S.C. 251exists),

further action in that reissue application will be suspended to await examination in the divisional reissue application(s) containing the added claims. Multiple suspensions (usually six-month periods) may be necessary. The Office will not permit claims to issue in a reissue application which application does not correct any error in the original patent. Once a divisional reissue application containing the added claims is examined and becomes allowable, the examiner will issue a requirement under 37 CFR 1.177(c) for applicant to merge the claims of the suspended first reissue application with the allowable claims of the divisional reissue application into a single application, by placing all of the claims in one of the applications and expressly abandoning the other. The Office action making this requirement will set a two-month period for compliance with the requirement. If applicant fails to timely respond to the Office action, or otherwise refuses to comply with the requirement made, then the divisional reissue application (claiming the invention which was non-elected in the now-suspended first reissue application) will be passed to issue alone, since the claims of the divisional reissue application, by themselves, do correct an error in the original patent. Prosecution will be reopened in the suspended first reissue application, and a rejection based on a lack of error under 35 U.S.C. 251 will then be made. This rejection may be made final, since applicant is on notice of the consequences of not complying with the merger requirement.

If the divisional reissue application becomes abandoned, prosecution will be reopened in the suspended first reissue application, and a rejection based on a lack of error under 35 U.S.C. 251 will then be made in the first reissue application. Since no error in the original patent is being corrected in the first reissue application, no reissue patent will issue.

As stated in 37 CFR 1.176(b), the examiner is not permitted to require restriction among original claims of the patent (i.e., among claims that were in the patent prior to filing the reissue application). Even where the original patent contains claims to different inventions which the examiner considers independent or distinct, and the reissue application claims the same inventions, a restriction requirement would be improper. If such a restriction requirement is made, it must be withdrawn.

Restriction between multiple inventions recited in the newly added claims will be permitted provided the added claims are drawn to several separate and distinct inventions. In such a situation, the original patent claims would be examined in the first reissue application, and applicant is permitted to file a divisional reissue application for each of the several separate and distinct inventions identified in the examiner’s restriction requirement.

A situation will sometimes arise where the examiner makes an election of species requirement between the species claimed in the original patent claims and a species of claims added in the reissue application. In such a situation, if (1) the non-elected claims to the added species depend from (or otherwise include all limitations of) a generic claim which embraces all species claims, and (2) the generic claim is found allowable, then the non-elected claims of the added species must be rejoined with the elected claims of the original patent. See MPEP § 821.04(a).

1451 Divisional Reissue Applications;Continuation Reissue Applications Where the Parent is Pending[edit | edit source]

35 U.S.C. 251. Reissue of defective patents.

The Director may issue several reissued patents for distinct and separate parts of the thing patented, upon demand of the applicant, and upon payment of the required fee for a reissue for each of such reissued patents.

37 CFR 1.177. Issuance of multiple reissue patents.

(a)The Office may reissue a patent as multiple reissue patents. If applicant files more than one application for the reissue of a single patent, each such application must contain or be amended to contain in the first sentence of the specification a notice stating that more than one reissue application has been filed and identifying each of the reissue applications by relationship, application number and filing date. The Office may correct by certificate of correction under § 1.322 any reissue patent resulting from an application to which this paragraph applies that does not contain the required notice.

(b)If applicant files more than one application for the reissue of a single patent, each claim of the patent being reissued must be presented in each of the reissue applications as an amended, unamended, or canceled (shown in brackets) claim, with each such claim bearing the same number as in the patent being reissued. The same claim of the patent being reissued may not be presented in its original unamended form for examination in more than one of such multiple reissue applications. The numbering of any added claims in any of the multiple reissue applications must follow the number of the highest numbered original patent claim.

(c)If any one of the several reissue applications by itself fails to correct an error in the original patent as required by 35 U.S.C. 251 but is otherwise in condition for allowance, the Office may suspend action in the allowable application until all issues are resolved as to at least one of the remaining reissue applications. The Office may also merge two or more of the multiple reissue applications into a single reissue application. No reissue application containing only unamended patent claims and not correcting an error in the original patent will be passed to issue by itself.

The court in In re Graff, 111 F.3d 874, 876-77, 42 USPQ2d 1471, 1473 (Fed. Cir. 1997) stated that “[t]he statute does not prohibit divisional or continuation reissue applications, and does not place stricter limitations on such applications when they are presented by reissue, provided of course that the statutory requirements specific to reissue applications are met.” Following the decision in Graff, the Office has adopted a policy of treating continuations and divisionals of reissue applications, to the extent possible, in the same manner as continuations and divisionals of non-reissue applications.

Questions relating to the propriety of divisional reissue applications and continuation reissue applications should be referred via the Technology Center (TC) Special Program Examiner to the Office of Patent Legal Administration.

I. DIVISIONAL REISSUE APPLICATIONS

37 CFR 1.176(b) permits the examiner to require restriction in a reissue application between the original claims of the patent and any newly added claims which are directed to a separate and distinct invention( s). See also MPEP § 1450. As a result of such a restriction requirement, divisional applications may be filed for each of the inventions identified in the restriction requirement.

In addition, applicant may initiate a division of the claims by filing more than one reissue application in accordance with 37 CFR 1.177. The multiple reissue applications which are filed may contain different groups of claims from among the original patent claims, or some of the reissue applications may contain newly added groups (not present in the original patent). There is no requirement that the claims of the multiple reissue applications be independent and distinct from one another; if they are not independent and distinct from one another, the examiner must apply the appropriate double patenting rejections.

There is no requirement that a family of divisional reissue applications issue at the same time; however, it is required that they contain a cross reference to each other in the specification. 37 CFR 1.177(a) requires that all multiple reissue applications resulting from a single patent must include as the first sentence of their respective specifications a cross reference to the other reissue application(s). Accordingly, the first sentence of each reissue specification must provide notice stating that more than one reissue application has been filed, and it must identify each of the reissue applications and their relationship within the family of reissue applications, and to the original patent. An example of the suggested language to be inserted is as follows:

Notice: More than one reissue application has been filed for the reissue of Patent No. 9,999,999. The reissue applications are application numbers 09/ 999,994 (the present application), 09/999,995, and 09/ 999,998, all of which are divisional reissues of Patent No. 9,999,999.

The examiner should object to the specification and require an appropriate amendment if applicant fails to include such a cross reference to the other reissue applications in the first sentence of the specification of each of the reissue applications.

In addition to the amendment to the first sentence of the specification, the reissue application cross references will also be reflected in the file. For an IFW reissue application file, a copy of the bibliographic data sheet from the IFW file history should be printed and the examiner should annotate the printed sheet such that adequate notice is provided that more than one reissue application has been filed for a single original patent. The annotated sheet should be scanned into IFW. For reissue application files that are maintained in paper, the bibliographic data sheet should be reprinted (for 09/ and later series), or the front face of the reissue file wrapper should be marked (for 08/ and earlier series), for all the multiple reissue applications, so that adequate notice is provided that more than one reissue application has been filed for a single original patent.

Pursuant to 37 CFR 1.177(b) all of the claims of the patent to be reissued must be presented in each reissue application in some form, i.e., as amended, as unamended or as canceled. Further, any added claims must be numbered beginning with the next highest number following the last patent claim. It is noted that the same claim of the patent cannot be presented for examination in more than one of the divisional reissue applications, as a pending claim, in either its original or amended versions. Once a claim in the patent has been reissued, it does not exist in the original patent; thus, it cannot be reissued from the original patent in another reissue application. If the same claim of the patent, e.g., patent claim 1 is presented for examination in more than one of the reissue applications, in different amended versions, the following rejections should be made in the reissue applications with that patent claim:

A rejection under 35 U.S.C. 251, in that the reissue application is not correcting an error in the original patent, because original claim 1 would be superseded by the reissuance of claim 1 in the other reissue application.

A rejection under 35 U.S.C. 112, in that claim 1 is indefinite because the invention of claim 1 is not particularly pointed out and distinctly claimed. Claim 1 presents one coverage in divisional reissue application X and another in the present reissue application. This is inconsistent.

The reissue applicant should then be advised to follow a procedure similar to the following example:

If there are patent claims 1 – 10 in two divisional reissue applications and an applicant wishes to revise claim 1, which is directed to AB (for example) to ABC in one divisional reissue application, and to ABD in a second divisional reissue application, applicant should do the following: Claim 1 in the first divisional reissue application can be revised to recite ABC. Claim 1 in the second divisional reissue application would be canceled, and new claim 11 would be added to recite ABD. The physical cancellation of claim 1 in the second divisional reissue application will not prejudice applicant’s rights in the amended version of claim 1 since those rights are retained via the first reissue application. Claim 1 continues to exist in the first reissue application, and both the first and second reissue applications taken together make up the totality of the correction of the original patent.

If the same or similar claims are presented in more than one of the multiple reissue applications, the possibility of statutory double patenting (35 U.S.C. 101) or non-statutory (judicially created doctrine) double patenting should be considered by the examiner during examination, and the appropriate rejections made. A terminal disclaimer may be filed to overcome an obviousness type double patenting rejection. The terminal disclaimer is necessary in order to ensure common ownership of the reissue patents throughout the remainder of the unexpired term of the original patent. Whenever a divisional reissue application is filed with a copy of the oath/declaration and assignee consent from the parent reissue application, the copy of the assignee consent from the parent reissue application should not be accepted. The copy of the consent from the parent reissue application does not indicate that the assignee has consented to the addition of the new invention of the divisional reissue application to the original patent. The Office of Initial Patent Examination (OIPE) should accord a filing date and send out a notice of missing parts stating that there is no proper consent and setting a period of time for filing the missing part and for payment of any surcharge required under 37 CFR 1.53(f) and 1.16(f). See MPEP § 1410.01. The copy of the reissue oath/declaration should be accepted by OIPE, since it is an oath/ declaration, even though it may be improper under 35 U.S.C. 251. The examiner should check the copy of the oath/declaration to ensure that it identifies an error being corrected by the divisional reissue application. The copy of the oath/declaration from the parent reissue application may or may not cover the error being corrected by the divisional reissue application since the divisional reissue application is (by definition) directed to a new invention. If it does not, the examiner should reject the claims of the divisional reissue application under 35 U.S.C. 251 as being based on an oath/declaration that does not identify an error being corrected by the divisional reissue application, and require a new oath/declaration. See MPEP § 1414. If the copy of the reissue oath/declaration from the parent reissue application does in fact cover an error being corrected in the divisional reissue application, no such rejection should be made. However, since a new invention is being added by the filing of the divisional reissue application, a supplemental reissue oath/declaration pursuant to 37 CFR 1.175 (b)(1) will be required. See MPEP § 1414.01.

Situations yielding divisional reissues occur infrequently and usually involve only two such files. It should be noted, however, that in rare instances in the past, there have been more than two (and as many as five) divisional reissues of a patent. For treatment of a plurality of divisional reissue applications resulting from a requirement to restrict to distinct inventions or a requirement to elect species, see MPEP § 1450.

II. CONTINUATION REISSUE APPLI- CATIONS

A continuation of a reissue is not ordinarily filed “for distinct and separate parts of the thing patented” as called for in the second paragraph of 35 U.S.C. 251. The decision of In re Graff, 111 F.3d 874, 42 USPQ2d 1471 (Fed. Cir. 1997) interprets 35 U.S.C. 251 to permit multiple reissue patents to issue even where the multiple reissue patents are not for “distinct and separate parts of the thing patented.” The court stated:

Section 251[2] is plainly intended as enabling, not as limiting. Section 251[2] has the effect of assuring that a different burden is not placed on divisional or continuation reissue applications, compared with divisions and continuations of original applications, by codifying the Supreme Court decision which recognized that more than one patent can result from a reissue proceeding. Thus § 251[2] places no greater burden on Mr. Graff’s continuation reissue application than upon a continuation of an original application; § 251[2] neither overrides, enlarges, nor limits the statement in § 251[3] that the provisions of Title 5 apply to reissues.

111 F.3d at 877, 42 USPQ2d at 1473. Accordingly, prosecution of a continuation of a reissue application will be permitted (despite the existence of the pending parent reissue application) where the continuation complies with the rules for reissue.

The parent and the continuation reissue applications should be examined together if possible. In order that the parent-continuation relationship of the reissue applications be specifically identified and notice be provided of both reissue applications for both the parent and the continuation reissue applications, the following is done:

(A) An appropriate amendment to the continuing data entries must be made to the first sentence of the specification, (see the discussion above under the heading “Divisional Reissue Applications”).

(B)For an IFW reissue application file, a copy of the bibliographic data sheet from the IFW file history should be printed and the examiner should annotate the printed sheet such that adequate notice is provided that more than one reissue application has been filed for a single original patent. The annotated sheet should be scanned into IFW. For reissue application files that are maintained in paper, the bibliographic data sheet should be reprinted (for 09/ and later series), or the front face of the reissue file wrapper should be marked (for 08/ and earlier series), for all the multiple reissue applications, so that adequate notice is provided that more than one reissue application has been filed for a single original patent.

As is true for the case of multiple divisional reissue applications, all of the claims of the patent to be reissued must be presented in both the parent reissue application and the continuation reissue application in some form, i.e., as amended, as unamended, or as canceled. The same claim of the patent cannot, however be presented for examination in both the parent reissue application and the continuation reissue application, as a pending claim, in either its original or amended versions. See the discussion in subsection I. above for treatment of this situation. Further, any added claims must be numbered beginning with the next highest number following the past patent claims.

Where the parent reissue application issues prior to the examination of the continuation, the claims of the continuation should be carefully reviewed for double patenting over the claims of the parent. Where the parent and the continuation reissue applications are examined together, a provisional double patenting rejection should be made in both cases as to any overlapping claims. See MPEP § 804 - §

804.04 as to double patenting rejections. Any terminal disclaimer filed to obviate an obviousness-type double patenting rejection ensures common ownership of the reissue patents throughout the remainder of the unexpired term of the original patent.

If the parent reissue application issues without any cross reference to the continuation, amendment of the parent reissue patent to include a cross-reference to the continuation must be effected at the time of allowance of the continuation application by Certificate of Correction. See the discussion above under the heading “Divisional Reissue Applications” as to how the Certificate of Correction is to be provided.

Again, the examiner should make reference in the pending divisional reissue application to the fact that an actual request for a Certificate of Correction has been generated in the first reissue patent pursuant to 37 CFR 1.177(a), e.g., by an entry in the search notes or in an examiner’s amendment.

Where a continuation reissue application is filed with a copy of the oath/declaration and assignee consent from the parent reissue application, and the parent reissue application is not to be abandoned, the copy of the consent of the parent reissue application should not be accepted. The copy of the consent of the parent reissue application does not indicate that the assignee has consented to the addition of the new error correction of the continuation reissue application to the original patent. Presumably, a new correction has been added, since the parent reissue application is still pending. OIPE should accord a filing date and send out a notice of missing parts stating that there is no proper consent and setting a period of time for filing the missing part and for payment of any surcharge required under 37 CFR 1.53(f) and 1.16(f). See MPEP § 1410.01. The copy of the reissue oath/declaration should be accepted by OIPE, since it is a oath/declaration, albeit improper under 35 U.S.C. 251. The examiner should reject the claims of the continuation reissue application under 35 U.S.C. 251 as being based on an oath/declaration that does not identify an error being corrected by the continuation reissue application, and should require a new oath/declaration. See 37 CFR 1.175(e). One of form paragraphs 14.01.01 through 14.01.03 may be used. See MPEP § 1414.

Where a continuation reissue application is filed with a copy of the oath/declaration and assignee consent from the parent reissue application, and the parent reissue application is, or will be abandoned, the copy of the consent should be accepted by both OIPE and the examiner. The reissue oath/declaration should be accepted by OIPE, and the examiner should check to ensure that the oath/declaration identifies an error that is being corrected in the continuation reissue application. See MPEP § 1414. If a preliminary amendment was filed with the continuation reissue application, the examiner should check for the need of a supplemental reissue oath/declaration. Pursuant to 37 CFR 1.175 (b)(1), for any error corrected via the preliminary amendment which is not covered by the oath or declaration submitted in the parent reissue application, applicant must submit a supplemental oath/declaration stating that every such error arose without any deceptive intention on the part of the applicant. See MPEP § 1414 and § 1414.01.

1452 Request for Continued Examination of Reissue Application[edit | edit source]

A request for continued examination (RCE) under 37 CFR 1.114 is available for a reissue application. Effective May 29, 2000, an applicant in a reissue application may file a request for continued examination of the reissue application, if the reissue application was filed on or after June 8, 1995. This applies even where the application, which resulted in the original patent, was filed prior to June 8, 1995.

An RCE continues the prosecution of the existing reissue application and is not a filing of a new reissue application. Thus, the filing of an RCE will not be announced in the Official Gazette. Additionally, if a reissue application is merged with a reexamination proceeding (see MPEP § 1449.01), the filing of an RCE will not dissolve the merger, since the reissue application does not become abandoned.

1453 Amendments to Reissue Applications[edit | edit source]

37 CFR 1.121. Manner of making amendments in application.

(i)Amendments in reissue applications. Any amendment to the description and claims in reissue applications must be made in accordance with § 1.173.

37 CFR 1.173. Reissue specification, drawings, and amendments.

(b)Making amendments in a reissue application. An amendment in a reissue application is made either by physically incorporating the changes into the specification when the application is filed, or by a separate amendment paper. If amendment is made by incorporation, markings pursuant to paragraph (d) of this section must be used. If amendment is made by an amendment paper, the paper must direct that specified changes be made, as follows:

(1)Specification other than the claims. Changes to the specification, other than to the claims, must be made by submission of the entire text of an added or rewritten paragraph, including markings pursuant to paragraph (d) of this section, except that an entire paragraph may be deleted by a statement deleting the paragraph without presentation of the text of the paragraph. The precise point in the specification must be identified where any added or rewritten paragraph is located. This paragraph applies whether the amendment is submitted on paper or compact disc (see §§ 1.52(e)(1) and 1.821(c), but not for discs submitted under § 1.821(e)).

(2)Claims. An amendment paper must include the entire text of each claim being changed by such amendment paper and of each claim being added by such amendment paper. For any claim changed by the amendment paper, a parenthetical expression “amended,” “twice amended,” etc., should follow the claim number. Each changed patent claim and each added claim must include markings pursuant to paragraph (d) of this section, except that a patent claim or added claim should be canceled by a statement canceling the claim without presentation of the text of the claim.

(3)Drawings. One or more patent drawings shall be amended in the following manner: Any changes to a patent drawing must be submitted as a replacement sheet of drawings which shall be an attachment to the amendment document. Any replacement sheet of drawings must be in compliance with § 1.84 and shall include all of the figures appearing on the original version of the sheet, even if only one figure is amended. Amended figures must be identified as “Amended,” and any added figure must be identified as “New.” In the event that a figure is canceled, the figure must be surrounded by brackets and identified as “Canceled.” All changes to the drawing(s) shall be explained, in detail, beginning on a separate sheet accompanying the papers including the amendment to the drawings.

(i)A marked-up copy of any amended drawing figure, including annotations indicating the changes made, may be included. The marked-up copy must be clearly labeled as “Annotated Marked-up Drawings” and must be presented in the amendment or remarks section that explains the change to the drawings.

(ii)A marked-up copy of any amended drawing figure, including annotations indicating the changes made, must be provided when required by the examiner.

(c)Status of claims and support for claim changes. Whenever there is an amendment to the claims pursuant to paragraph (b) of this section, there must also be supplied, on pages separate from the pages containing the changes, the status (i.e., pending or canceled), as of the date of the amendment, of all patent claims and of all added claims, and an explanation of the support in the disclosure of the patent for the changes made to the claims.

(d)Changes shown by markings. Any changes relative to the patent being reissued which are made to the specification, including the claims, upon filing, or by an amendment paper in the reissue application, must include the following markings:

(1)The matter to be omitted by reissue must be enclosed in brackets; and

(2)The matter to be added by reissue must be underlined, except for amendments submitted on compact discs (§§ 1.96 and 1.821(c)). Matter added by reissue on compact discs must be preceded with “U” and end with “/U” to properly identify the material being added.

(e)Numbering of patent claims preserved. Patent claims may not be renumbered. The numbering of any claim added in the reissue application must follow the number of the highest numbered patent claim.

(f)Amendment of disclosure may be required. The disclosure must be amended, when required by the Office, to correct inaccuracies of description and definition, and to secure substantial correspondence between the claims, the remainder of the specification, and the drawings.

(g)Amendments made relative to the patent. All amendments must be made relative to the patent specification, including the claims, and drawings, which are in effect as of the date of filing of the reissue application.

The provisions of 37 CFR 1.173(b)-(g) and those of 37 CFR 1.121(i) apply to amendments in reissue applications. Any amendments submitted in a reissue application must comply with 37 CFR 1.173(b).

Amendments submitted in a reissue application, including preliminary amendments (i.e., amendments filed as a separate paper to accompany the filing of a reissue application), must comply with the practice outlined below in this section; however, for examiner’s amendments to the specification and claims, 37 CFR 1.121(g) provides certain exceptions to that practice in the interest of expediting prosecution. The exceptions set forth in 37 CFR 1.121(g) also apply in reissue applications.

Pursuant to 37 CFR 1.173(a), no amendment in a reissue application may enlarge the scope of the claims, unless “applied for within two years from the grant of the original patent.” Further, the amendment may not introduce new matter. See MPEP § 1412.03for further discussion as to the time limitation on enlarging the scope of the patent claims in a reissue application.

All amendment changes must be made relative to the patent to be reissued. Pursuant to 37 CFR 1.173(d), any such changes which are made to the specification, including the claims, must be shown by employing the following “markings:”

(A)The matter to be omitted by reissue must be enclosed in brackets; and

(B)The matter to be added by reissue must be underlined, except for amendments submitted on compact discs (pursuant to 37 CFR 1.96 for computer printouts or programs, and 37 CFR 1.825 for sequence listings). Matter added by reissue on compact discs must be preceded with “U” and end with “/U” to properly identify the material being added.

I.THE SPECIFICATION

37 CFR 1.173(b)(1) relates to the manner of making amendments to the specification other than the claims. It is not to be used for making amendments to the claims or the drawings.

All amendments which include any deletions or additions must be made by submission of the entire text of each added or rewritten paragraph with markings (as defined above), except that an entire paragraph of specification text may be deleted by a statement deleting the paragraph without presentation of the text of the paragraph. Applicant must indicate the precise point where each amendment is made. All bracketing and underlining is made in comparison to the original patent, not in comparison to any prior amendment in the reissue application. Thus, all paragraphs which are newly added to the specification of the original patent must be submitted as completely underlined each time they are re-submitted in the reissue application.

II.THE CLAIMS

37 CFR 1.173(b)(2) relates to the manner of making amendments to the claims in reissue applications. It is not to be used for making amendments to the remainder of the specification or to the drawings. 37 CFR 1.173(b)(2) requires that:

(A)For each claim that is being amended by the amendment being submitted (the current amendment), the entire text of the claim must be presented with markings as defined above;

(B)For each new claim added to the reissue by the amendment being submitted (the current amendment), the entire text of the added claim must be presented completely underlined;

(C)A patent claim should be canceled by a direction to cancel that claim, there is no need to present the patent claim surrounded by brackets; and

(D)A new claim (previously added in the reissue) should be canceled by a direction to cancel that claim.

Original patent claims are never to be renumbered; see 37 CFR 1.173(e). A patent claim retains its number even if it is canceled in the reissue proceeding, and the numbering of any added claims must begin after the last original patent claim.

Pursuant to 37 CFR 1.173(c), each amendment submitted must set forth the status of all patent claims and all added claims as of the date of the submission. The status to be set forth is whether the claim is pending or canceled. The failure to submit the claim status will generally result in a notification to applicant that the amendment prior to final rejection is not completely responsive (see 37 CFR 1.135(c)). Such an amendment after final rejection will not be entered.

Also pursuant to 37 CFR 1.173(c), each claim amendment must be accompanied by an explanation of the support in the disclosure of the patent for the amendment (i.e., support for all changes made in the claim(s), whether insertions or deletions). The failure to submit an explanation will generally result in a notification to applicant that the amendment prior to final rejection is not completely responsive (see 37 CFR 1.135(c)). Such an amendment after final rejection will not be entered.

III.THE DRAWINGS

37 CFR 1.173(a)(2) states that amendments to the original patent drawings are not permitted, and that any change to the drawings must be by way of 37 CFR 1.173(b)(3). See MPEP § 1413 for the manner of making amendments to the drawings in a reissue application.

IV.ALL CHANGES ARE MADE VIS-À-VISTHE PATENT TO BE REISSUED

When a reissue patent is printed, all underlined matter is printed in italics and all brackets are printed as inserted in the application, in order to show exactly which additions and deletions have been made to the patent being reissued. Therefore, all underlining and bracketing in the reissue application should be made relative to the text of the patent, as follows. In accordance with 37 CFR 1.173(g), all amendments in the reissue application must be made relative to (i.e., vis-à-vis) the patent specification in effect as of the date of the filing of the reissue application. The patent specification includes the claims and drawings. If there was a prior change to the patent (made via a prior concluded reexamination certificate, reissue of the patent, certificate of correction, etc.), the first amendment of the subject reissue application must be made relative to the patent specification as changed by the prior proceeding or other mechanism for changing the patent. All amendments subsequent to the first amendment must also be made relative to the patent specification in effect as of the date of the filing of the reissue application, and not relative to the prior amendment.

The Subject Patent Already Has Underlining or Bracketing

If the original (or previously changed) patent includes a formula or equation already having underlining or bracketing therein as part of the formula or equation, any amendment of such formula or equation should be made by bracketing the entire formula and rewriting and totally underlining the amended formula in the re-presented paragraph of the specification or rewritten claim in which the changed formula or equation appears. Amendments of segments of a formula or equation should not be made. If the original patent includes bracketing and underlining from an earlier reexamination or reissue, double brackets and double underlining should be used in the subject reissue application to identify and distinguish the present changes being made. The subject reissue, when printed, would include double brackets (indicating deletions made in the subject reissue) and boldface type (indicating material added in the subject reissue).

V.EXAMPLES OF PROPER AMENDMENTS

A substantial number of problems arise in the Office because of improper submission of amendments in reissue applications. The following examples are provided to assist in preparation of proper amendments to reissue applications.

A.Original Patent Description or Patent Claim Amended

Example (1)

If it is desired to change the specification at column 4 line 23, to replace “is” with --are--, submit a copy of the entire paragraph of specification of the patent being amended with underlining and bracketing, and point out where the paragraph is located, e.g.,

Replace the paragraph beginning at column 4, line 23 with the following:

Scanning [is] are controlled by clocks which are, in turn, controlled from the display tube line synchronization. The signals resulting from scanning the scope of the character are delivered in parallel, then converted into serial mode through a shift register wherein the shift signal frequency is controlled by a clock that is, in turn, controlled from the display tube line synchronization.

Example (2)

For changes to the claims, one must submit a copy of the entire patent claim with the amendments shown by underlining and bracketing, e.g.,

Amend claim 6 as follows:

Claim 6 (Amended). The apparatus of claim [5] 1 wherein the [first] second piezoelectric element is parallel to the [second] third piezoelectric element.

If the dependency of any original patent claim is to be changed by amendment, it is proper to make that original patent claim dependent upon a later filed higher numbered claim.

B.Cancellation of Claim(s)

Example (3)

To cancel an original patent claim, in writing, direct cancellation of the patent claim, e.g.,

Cancel claim 6.

Example (4)

To cancel a new claim (previously added in the reissue), in writing, direct cancellation of the new claim, e.g.,

Cancel claim 15.

C.Presentation of New Claims

Example (5)

Each new claim (i.e., a claim not found in the patent, that is newly presented in the reissue application) should be presented with underlining throughout the claim, e.g.,

Add claim 7 as follows:

Claim 7. The apparatus of claim 5 further comprising electrodes attaching to said opposite faces of the first and second piezoelectric elements.

Even though original claims may have been canceled, the numbering of the original claims does not change. Accordingly, any added claims are numbered beginning with the number next higher than the number of claims in the original patent. If new claims have been added to the reissue application which are later canceled prior to issuance of the reissue patent, the examiner will renumber any remaining new claims in numerical order to follow the number of claims in the original patent.

D.Amendment of New Claims

An amendment of a “new claim” (i.e., a claim not found in the patent, that was previously presented in the reissue application) must be done by presenting the amended “new claim” containing the amendatory material, and completely underlining the claim. The presentation cannot contain any bracketing or other indication of what was in the previous version of the claim. This is because all changes in the reissue are made vis-à-vis the original patent, and not in comparison to the prior amendment. Although the presentation of the amended claim does not contain any indication of what is changed from the previous version of the claim, applicant must point out what is changed in the “Remarks” portion of the amendment. Also, per 37 CFR 1.173(c), each change made in the claim must be accompanied by an explanation of the support in the disclosure of the patent for the change.

E.Amendment of Original Patent Claims More Than Once

The following illustrates proper claim amendment of original patent claims in reissue applications:

A. Patent claim.

Claim 1. A cutting means having a handle portion and a blade portion.

B. Proper first amendment format.

Claim 1 (Amended). A [cutting means] knife having a bone handle portion and a notched blade portion.

C. Proper second amendment format.

Claim 1 (Twice Amended). A [cutting means] knife having a handle portion and a serrated blade portion.

Note that the second amendment must include the changes previously presented in the first amendment, i.e., [cutting means] knife, as well as the new changes presented in the second amendment, i.e., serrated.

The word bone was presented in the first amendment and is now to be deleted in the second amendment. The word "bone" is NOT to be shown in brackets in the second amendment. Rather, the word "bone" is simply omitted from the claim, since "bone" never appeared in the patent. An explanation of the deletion should appear in the remarks.

The word notched which was presented in the first amendment is replaced by the word serrated in the second amendment. The word notched is being deleted in the second amendment and did not appear in the patent; accordingly, "notched" is not shown in any form in the claim. The word serrated is being added in the second amendment, and accordingly "serrated" is added to the claim and is underlined.

In the second amendment, the deletions of "notched" and "bone" are not changes from the original patent claim text and therefore are not shown in brackets in the second amendment. In both the first and the second amendments, the entire claim is presented only with the changes from the original patent text.

VI.ADDITIONAL EXAMPLES

(A)For a reissue application, where the patent was previously reissued:

As per MPEP § 1411, double underlining and double bracketing are used in the second reissue application to show amendments made relative to the first reissued patent

(B)For a reissue application, where the patent was previously reexamined and a reexamination certificate has issued for the patent:

An amendment in the reissue application must be presented as if the changes made to the original patent text via the reexamination certificate are a part of the original patent. Thus, all italicized text of the reexamination certificate is presented in the amendment (made in the reissue application) without italics. Further, any text found in brackets in the reexamination certificate is omitted in the amendment (made in the reissue application).

(C)For a reissue application, where a certificate of correction has issued for the patent:

An amendment in the reissue application must be presented as if the changes made to the original patent text via the certificate of correction are a part of the original patent. Thus, all text added by certificate of correction is presented in the amendment (made in the reissue application) without italics. Further, any text deleted by certificate of correction is entirely omitted in the amendment (made in the reissue application).

(D)For a reissue application, where a statutory disclaimer has issued for the patent:

Any claim statutorily disclaimed is no longer in the patent, and such a claim cannot be amended. The statutorily disclaimed claim(s) should be lined through, and not surrounded by brackets.

1454 Appeal Brief[edit | edit source]

The requirements for an appeal brief are set forth in 37 CFR 41.37 and MPEP § 1206, and they apply to a reissue application in the same manner that they apply to a non-reissue application. There is, however, a difference in practice as to presentation of the copy of the claims in the appeal brief for a reissue application. The claims on appeal presented in an appeal brief for a reissue application should include all underlining and bracketing necessary to reflect the changes made to the patent claims during the prosecution of the reissue application. In addition, any new claims added in the reissue application should be completely underlined.

1455 Allowance and Issue[edit | edit source]

I.ISSUE CLASSIFICATION SHEET

For IFW reissue applications:

The examiner completes the Issue Classification sheet in the same manner as for a non-reissue application. In addition, a copy of the “Final SPRE Review” form must also be completed.

For reissue application files that are maintained in paper:

In all reissue applications prepared for issue where a blue slip is needed (i.e., 08/ and earlier series), the patent number of the original patent which is being reissued should be placed in the box provided therefor below the box for the applicant’s name on the blue Issue Classification Slip (form PTO-270) or design Issue Classification Slip (form PTO-328). Otherwise, the Issue Classification Slip is prepared in the same manner as for a non-reissue application.

II. CHANGES TO THE ORIGINAL PATENT

The specifications of reissue patents will be printed in such a manner as to show the changes over the original patent text by enclosing any material omitted by the reissue in heavy brackets [ ] and printing material added by the reissue in italics. 37 CFR 1.173 (see MPEP § 1411) requires the specification of a reissue application to be presented in a specified form, specifically designed to facilitate this different manner of printing, as well as for other reasons.

The printed reissue patent specification will carry the following heading, which will be added by the Publishing Division of the Office of Patent Publication:

“Matter enclosed in heavy brackets [ ] appears in the original patent but forms no part of this reissue specification; matter printed in italics indicates the additions made by reissue.”

The examiners should see that the specification is in proper form for printing. Examiners should carefully check the entry of all amendments to ensure that the changes directed by applicant will be accurately printed in any reissue patent that may ultimately issue. Matter appearing in the original patent which is omitted by reissue should be enclosed in brackets, while matter added by reissue should be underlined.

Any material added by amendment in the reissue application (as underlined text) which is later canceled should be crossed through, and not bracketed. Material cancelled from the original patent should be enclosed in brackets, and not lined through.

All the claims of the original patent should appear in the reissue patent, with canceled patent claims being enclosed in brackets.

III. CLAIM NUMBERING

No renumbering of the original patent claims is permitted, even if the dependency of a dependent patent claim is changed by reissue so that it is to be dependent on a subsequent higher numbered claim.

When a dependent claim in a reissue application depends upon a claim which has been canceled, and the dependent claim is not thereafter made dependent upon a pending claim, such a dependent claim must be rewritten in independent form.

New claims added during the prosecution of the reissue application should follow the number of the highest numbered patent claim and should be completely underlined to indicate they are to be printed in italics on the printed patent. Often, as a result of the prosecution and examination, some new claims are canceled while other new claims remain. When the reissue application is allowed, any claims remaining which are additional to the patent claims (i.e., claims added via the reissue application) should be renumbered in sequence starting with the number next higher than the number of the last claim in the original patent (the printed patent). Therefore, the number of claims allowed will not necessarily correspond to the number of the last claim in the reissue application, as allowed. The number of claims appearing in the “Total Claims Allowed” box on the Issue Classification sheet (or for reissue application files that are maintained in paper, the “CLAIMS ALLOWED - Total Claims” box on the lower right of the file wrapper face) at the time of allowance should be consistent with the number of claims indicated as allowable on the Notice of Allowability (Form PTOL-37).

IV. CLAIM DESIGNATED FOR PRINTING

At least one claim of an allowable reissue application must be designated for printing in the Official Gazette. Whenever at least one claim has been amended or added in the reissue, the claim (claims) designated for printing must be (or include) a claim which has been changed or added by the reissue. A canceled claim is not to be designated as the claim for the Official Gazette.

If there is no change in the claims of the allowable reissue application (i.e., when they are the same as the claims of the original patent) or, if the only change in the claims is the cancellation of claims, then the most representative pending allowed claim is designated for printing in the Official Gazette.

V. PROVIDING PROPER FORMAT

Where a reissue application has not been prepared in the above-indicated manner, the examiner may obtain from the applicant a clean copy of the reissue specification prepared in the indicated form, or a proper submission of a previously improperly submitted amendment. However, if the deletions from the original patent are small, the reissue application can be prepared for issue by putting the bracketed inserts at the appropriate places and suitably numbering the added claims.

When applicant submits a clean copy of the reissue specification, or a proper submission of a previous improper amendment, a supplemental reissue declaration should not be provided to address this submission, because the correction of format does not correct a 35 U.S.C. 251 error in the patent.

VI. PARENT APPLICATION DATA

All parent application data on the bibliographic data sheet of the original patent file (or front face of the original patent file wrapper if the original patent is a paper file) should be present on the bibliographic data sheet of the reissue application.

It sometimes happens that the reissue is a continuation of another reissue application, and there is also original-patent parent application data. The examiner should ensure that the parent application data on the original patent is properly combined with the parent application data of the reissue, in the text of the specification and on the bibliographic data sheet (or on the front face of the reissue file wrapper for 08/ and earlier series applications). The combined statement as to parent application data should be checked carefully for proper bracketing and underlining.

VII. REFERENCES CITED AND PRINTED

The list of references to be printed in the reissue patent includes all the references cited during the prosecution of the reissue application. It is noted that the Office will not print in the reissue patent “References Cited” section any reference cited in the patent but not again cited in the reissue application. A patent cannot be reissued solely for the purpose of adding citations of additional prior art.

VIII. EXAMINER'S AMENDMENT AND SUP- PLEMENTAL DECLARATION

When it is necessary to amend the reissue application in order to place the application in condition for allowance, the examiner may:

(A)request that applicant provide the amendments (e.g., by facsimile transmission or by hand- carry); or

(B)make the amendments, with the applicant’s approval, by a formal examiner’s amendment.

If the changes are made by a formal examiner’s amendment, the entire paragraph(s) or claim(s) being amended need not be presented in rewritten form for any deletions or additions. Changes to the specification including the claims of an application made by the Office in an examiner’s amendment may be made by specific instructions to insert or delete subject matter set forth in the examiner’s amendment by identifying the precise point in the specification or the claim(s) where the insertion or deletion is to be made. 37 CFR 1.121(g).

If it is necessary to amend a claim or the specification in order to correct an “error” under 35 U.S.C. 251and thereby place the application in condition for allowance, then a supplemental oath or declaration will be required. See MPEP § 1444. The examiner should telephone applicant and request the supplemental oath or declaration, which must be filed before the application can be counted as an allowance.

IX. FINAL REVIEW OF THE REISSUE APPLICATION BY THE EXAMINER

Prior to forwarding a reissue application to the Technology Center (TC) Special Program Examiner (SPRE) for final review, the examiner should complete and initial an Examiner Reissue Checklist. A copy of the checklist should be available from the SPRE or from the Paralegal Specialist of the TC.

1456 Reissue Review[edit | edit source]

All reissue applications are monitored and reviewed in the Technology Centers (TCs) by the Office of TC Special Program Examiners (which includes TC SPREs, paralegals or other technical support who might be assigned as backup) at several stages during the prosecution. The review by the Office of the TC SPREs is made to check that practice and procedure unique to reissue has been carried out for the reissue application. In addition to the SPRE review of the reissue applications, a patentability review is made in a sample of reissue applications by the TC Quality Assurance Specialist (QAS) in the manner previously carried out by the former Office of Patent Quality Review. In order to ensure that SPREs are aware of the reissue applications in their TCs, a pair of terminal-specific PALM flags have been created which must be set by the SPRE before certain PALM transactions can be completed. First, when a new reissue application enters the TC, a SPRE must set a PALM “flag” by entering the reissue application number in an Office-wide computer grouping before a docketing transaction will be accepted. By having to set this first flag, the SPRE is made aware of the assignment of the reissue application to the TC and can take steps, as may be appropriate, to instruct the examiner on reissue-specific procedures before the examination process begins, as well as throughout the period that the examiner is handling the reissue application. Second, the SPRE must remove the above- described PALM “flag” before a Notice of Allowance can be generated or the PALM transaction for an issue revision can be entered, thereby ensuring that the SPRE is made aware of when the reissue application is being allowed so that the SPRE may be able to conduct a final review of the reissue application, if appropriate.

When the reissue application has been reviewed and is ready to be released to issue, the TC SPRE should do the following:

1457 Design Reissue Applications and Patents[edit | edit source]

A reissue application can be filed for a design patent in the same manner that a reissue application is filed for a utility patent. There are, however, a few aspects of a design reissue application that are addressed as follows:

I.EXPEDITED EXAMINATION PROCE- DURE

Design reissue applications requesting expedited examination and complying with the requirements of 37 CFR 1.155 are examined with priority and undergo expedited processing throughout the entire course of prosecution in the Office, including appeal, if any, to the Board of Patent Appeals and Interferences. All processing is expedited from the date the request is granted.

Design reissue applicants seeking expedited examination may file a design reissue application in the Office together with a corresponding request under 37 CFR 1.155 pursuant to the guidelines set forth in MPEP § 1504.30.

The design reissue application and the request are processed by the Office of Initial Patent Examination (OIPE). OIPE enters the appropriate information into PALM specifying when notice of the design reissue application will be published in the Official Gazette (see MPEP § 1441). After processing in OIPE, the design reissue application and the request are forwarded to the Design TC Director’s Office. Upon a decision by the Design TC Director to grant the request for expedited examination, fees are immediately processed, and the application papers are promptly assigned an application number. The design reissue application file is then forwarded to the Office of Patent Legal Administration (OPLA) for a decision under 37 CFR 1.182 to sua sponte waive the requirement for delaying action in the application until 2 months after announcement of the design reissue application filing is published in the Official Gazette(see MPEP § 1441). Once the decision under 37 CFR 1.182 is mailed, the design reissue application file will be returned to the Design TC Director’s Office. In accordance with the waiver, the Design Group will begin expedited examination of the application under 37 CFR 1.155 promptly after the return of the design reissue application file from OPLA, rather than delay examination until after 2 months from the date the announcement is published in the Official Gazette and the applicant will be notified that examination is being expedited. The decision under 37 CFR 1.182will require that no Notice of Allowance be mailed in the design reissue application until after 2 months from the date the announcement is published in the Official Gazette. For example, if the design reissue




application is allowed on the first Office action, then jurisdiction over the reissue application will be retained in the TC, and the Notice of Allowance will not be mailed until the expiration of 2 months after publication of the filing of the design reissue application in the Official Gazette (plus time for matching any protest filed with the application). (For IFW processing, see IFW Manual.) The examiner will check the PALM contents to ascertain when publication actually occurred. The delay in the mailing of the Notice of Allowance is to ensure that any potential protests complying with 37 CFR 1.291 submitted within the 2-month delay period will be considered by the Office. (see MPEP § 1441.01).

The expedited examination procedure under 37 CFR 1.155 occurs through initial examination processing and throughout the entire prosecution in the Office. Once a request for expedited examination is granted, prosecution of the design reissue application will proceed according to the procedure under 37 CFR 1.155, and there is no provision for “withdrawal” from expedited examination procedure.

II.DESIGN REISSUE FEE

The design reissue application fee is set forth for in 37 CFR 1.16(e). For design reissue applications filed on or after December 8, 2004, a search fee (37 CFR 1.16(n)) and an examination fee (37 CFR 1.16(r)) are also required. The additional fees in 37 CFR 1.16(h) and 37 CFR 1.16(i) do not apply for a design reissue application since more than one claim in not permitted in a design application pursuant to the last sentence of 37 CFR 1.153(a).

The fee for issuing a design reissue patent is set forth in 37 CFR 1.18(a).

III.MULTIPLE DESIGN REISSUE APPLICATIONS


The design reissue application can be filed based on the “error” of failing to include a design for a patentably distinct segregable part of the design claimed in the original patent or a patentably distinct subcombination of the claimed design. A reissue design application claiming both the entire article and the patentably distinct subcombination or segregable part would be proper under 35 U.S.C. 251, if such a reissue application is filed within two years of the issuance of the design patent, since it is considered a broadening of the scope of the patent claim. Restriction will be required under 37 CFR 1.176(b) in such a reissue design application, and the added design to the segregable part or subcombination will be held to be constructively non-elected and withdrawn from consideration. See MPEP § 1450. In the Office action containing the restriction requirement, the examiner should suggest to the applicant that a divisional design reissue application directed to the constructively non-elected segregable part or subcombination subject matter may be filed. The claim to the patented design for the entire article will then be examined and, if found allowable without change from the patent, a rejection will be made under 35 U.S.C. 251 based on the fact that there is no “error” in the non-amended original patent claim. In the Office action making this rejection, applicant should be advised that a proper response to the rejection must include (A) a request to suspend action in this original reissue application pending completion of examination of a divisional reissue application directed to the constructively non- elected segregable part or subcombination subject matter, (B) the filing of the divisional reissue application, or a statement that one has already been filed (identifying it at least by application number), and (C) an argument that a complete response to the rejection has been made based upon the filing of the divisional reissue application and the request for suspension. Action in the original design reissue application will then be suspended, and the divisional will be examined.


If, after examination, the divisional design reissue application is also determined to be allowable, a requirement must be made in the divisional design reissue application to submit a petition under 37 CFR 1.183 requesting waiver of 37 CFR 1.153 in order to permit the rejoining of the designs to the entire article (of the original application) and the segregable part or subcombination (of the divisional) under a single claim into a single design reissue application for issuance, the single application being the first design reissue application.

It should be noted that the filing of a design reissue application would not be proper if applicant did in fact include the design for a segregable part or subcombination thereof in the original design patent application, a restriction was thus made, and then applicant failed to file a divisional reissue application for a non-elected invention that was canceled in view of a restriction requirement (prior to issue of the original application. See In re Watkinson, 900 F.2d 230, 14 USPQ2d 1407 (Fed. Cir. 1990); In re Orita, 550 F.2d 1277, 1280, 193 USPQ 145, 148 (CCPA 1977).

IV.CONVERSION TO UTILITY PATENT

A design patent cannot be converted to a utility patent via reissue.

Converting a design patent to a utility patent will, in most instances, involve the introduction of new matter into the patent. The disclosure of a design patent is not directed to how the invention is made and used, and the introduction of new matter is required to bridge this gap and provide support for the utility patent. Accordingly, the examiner should consider rejections based on the introduction of new matter under 35 U.S.C. 251, first paragraph, and lack of enablement and/or description under 35 U.S.C. 112, first paragraph, when a reissue application is filed to convert a design patent to a utility patent.

Further, the term of a design patent may not be extended by reissue. Ex parte Lawrence, 70 USPQ 326 (Comm’r Pat. 1946). Thus, any reissue application filed to convert a design patent to a utility patent, which conversion would thereby extend the term of the patent, should be rejected as failing to comply with 35 U.S.C. 251, first paragraph, which permits reissue only “for the unexpired part of the term of the original patent.” The statute requires that the reissued patent shall not extend the term of the original patent.

1460 Effect of Reissue[edit | edit source]

35 U.S.C. 252. Effect of reissue.

The surrender of the original patent shall take effect upon the issue of the reissued patent, and every reissued patent shall have the same effect and operation in law, on the trial of actions for causes thereafter arising, as if the same had been originally granted in such amended form, but in so far as the claims of the original and reissued patents are substantially identical, such surrender shall not affect any action then pending nor abate any cause of action then existing, and the reissued patent, to the extent that its claims are substantially identical with the original patent, shall constitute a continuation thereof and have effect continuously from the date of the original patent.

A reissued patent shall not abridge or affect the right of any person or that person’s successors in business who, prior to the grant of a reissue, made, purchased, offered to sell, or used within the United States, or imported into the United States, anything patented by the reissued patent, to continue the use of, to offer to sell, or to sell to others to be used, offered for sale, or sold, the specific thing so made, purchased, offered for sale, used, or imported unless the making, using, offering for sale, or selling of such thing infringes a valid claim of the reissued patent which was in the original patent. The court before which such matter is in question may provide for the continued manufacture, use, offer for sale, or sale of the thing made, purchased, offered for sale, used, or imported as specified, or for the manufacture, use, offer for sale, or sale in the United States of which substantial preparation was made before the grant of the reissue, and the court may also provide for the continued practice of any process patented by the reissue that is practiced, or for the practice of which substantial preparation was made, before the grant of the reissue, to the extent and under such terms as the court deems equitable for the protection of investments made or business commenced before the grant of the reissue.

The effect of the reissue of a patent is stated in 35 U.S.C. 252. With respect to the Office treatment of the reissued patent, the reissued patent will be viewed as if the original patent had been originally granted in the amended form provided by the reissue. With respect to intervening rights resulting from the reissue of an original patent, the second paragraph of 35 U.S.C. 252 provides for two separate and distinct defenses to patent infringement under the doctrine of intervening rights:

“Absolute” intervening rights are available for a party that “prior to the grant of a reissue, made, purchased, offered to sell, or used within the United States, or imported into the United States, anything patented by the reissued patent,” and “equitable” intervening rights may be provided where “substantial preparation was made before the grant of the reissue.” See BIC Leisure Prods., Inc., v. Windsurfing Int’l, Inc., 1 F.3d 1214, 1220, 27 USPQ2d 1671, 1676 (Fed. Cir. 1993).

1470 Public Access of Reissue Applications[edit | edit source]

37 CFR 1.11(b) opens all reissue applications filed after March 1, 1977, to inspection by the general public. 37 CFR 1.11(b) also provides for announcement of the filings of reissue applications in the Official Gazette (except for continued prosecution applications filed under 37 CFR 1.53(d)). This announcement will give interested members of the public an opportunity to submit to the examiner information pertinent to patentability of the reissue application.

The filing of a continued prosecution application under 37 CFR 1.53(d) of a reissue application will notbe announced in the Official Gazette. Although the filing of a continued prosecution application of a reissue application constitutes the filing of a reissue application, the announcement of the filing of such continued prosecution application would be redundant in view of the announcement of the filing of the prior reissue application in the Official Gazette.

37 CFR 1.11(b) is applicable to all reissue applications filed on or after March 1, 1977. Those reissue applications previously on file will not be automatically open to inspection but a liberal policy will be followed in granting petitions for access to such applications.

IFW reissue application files are open to inspection by the general public by way of Public PAIR via the USPTO Internet site. In viewing the images of the files, members of the public will be able to view the entire content of the reissue application file history. To access Public PAIR, a member of the public would (A) go to the USPTO web site at http:// www.uspto.gov, (B) click on “Patents,” (C) under “Check Status, View Papers…” click on “Status & IFW,” and (D) under “Patent Application Information Retrieval” enter the reissue application number.

Access to a reissue application that is maintained in paper must be obtained from the area of the Office having jurisdiction over the file. The following access procedure will be observed for reissue application files that are maintained in paper:

(A)Any member of the general public may request access to a particular reissue application filed after March 1, 1977. Since no record of such request is intended to be kept, an oral request will suffice. (Reissue applications already on file prior to March 1, 1977 are not automatically open to inspection, but a liberal policy is followed by the Office of Patent Legal Administration (OPLA) and by the Board of Patent Appeals and Interferences in granting petitions for access to such applications.);

(B)Paper reissue application files will be maintained in the TCs and inspection thereof will be supervised by TC personnel. A TC Director or other appropriate Office official may, under appropriate circumstances, postpone access to or the making of copies of a paper reissue application file, in order, for example, to avoid interruption of the examination or other review of the application by an examiner. In addition, though no general limit is placed on the amount of time spent reviewing the files, the Office may impose limitations, if necessary, e.g., where the application is actively being processed;

(C)In any instance where the reissue application file has left the TC for administrative processing, requests for access should be directed to the appropriate supervisory personnel where the application is currently located;

(D)A paper reissue application file is not available to the public once the reissue application file has been released and forwarded by the TC for publication of the reissue patent. This would include any reissue application files which have been selected for a post-allowance screening at OPLA. Unless prosecution is reopened pursuant to the screening, the reissue application files are not available to the public until the reissue patent issues. This is because the reissue application file has been put into a special format for printing purposes and public access at this stage would disrupt the publication process;

(E)Requests for copies of papers in the reissue application file must be in writing addressed to Mail Stop Document Services, Director of the U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450. Such requests may be either mailed or delivered to the Customer Service Window. The price for a copy of an application as filed is set forth in 37 CFR 1.19(b)(1). Since no useful purpose is seen for retaining such written requests for copies of papers in reissue applications, the request(s) should be destroyed after the order has been completed.

See also MPEP § 103.

1480 Certificates of Correction — Office Mistake[edit | edit source]

35 U.S.C. 254. Certificate of correction of Patent and Trademark Office mistake.

Whenever a mistake in a patent, incurred through the fault of the Patent and Trademark Office, is clearly disclosed by the records of the Office, the Director may issue a certificate of correction stating the fact and nature of such mistake, under seal, without charge, to be recorded in the records of patents. A printed copy thereof shall be attached to each printed copy of the patent, and such certificate shall be considered as part of the original patent. Every such patent, together with such certificate, shall have the same effect and operation in law on the trial of actions for causes thereafter arising as if the same had been originally issued in such corrected form. The Director may issue a corrected patent without charge in lieu of and with like effect as a certificate of correction.

37 CFR 1.322. Certificate of correction of Office mistake.

(a)(1) The Director may issue a certificate of correction pursuant to 35 U.S.C. 254 to correct a mistake in a patent, incurred through the fault of the Office, which mistake is clearly disclosed in the records of the Office:

(i)At the request of the patentee or the patentee’s assignee;

(ii)Acting sua sponte for mistakes that the Office discovers; or

(iii)Acting on information about a mistake supplied by a third party.

(2)(i) There is no obligation on the Office to act on or respond to a submission of information or request to issue a certificate of correction by a third party under paragraph (a)(1)(iii) of this section.

(ii)Papers submitted by a third party under this section will not be made of record in the file that they relate to nor be retained by the Office.

(3)If the request relates to a patent involved in an interference, the request must comply with the requirements of this section and be accompanied by a motion under § 41.121(a)(2) or § 41.121(a)(3) of this title.

(4)The Office will not issue a certificate of correction under this section without first notifying the patentee (including any assignee of record) at the correspondence address of record as specified in § 1.33(a) and affording the patentee or an assignee an opportunity to be heard.

(b)If the nature of the mistake on the part of the Office is such that a certificate of correction is deemed inappropriate in form, the Director may issue a corrected patent in lieu thereof as a more appropriate form for certificate of correction, without expense to the patentee.

Mistakes incurred through the fault of the Office may be the subject of Certificates of Correction under 37 CFR 1.322. The Office, however, has discretion under 35 U.S.C. 254 to decline to issue a Certificate of Correction even though an Office mistake exists. If Office mistakes are of such a nature that the meaning intended is obvious from the context, the Office may decline to issue a certificate and merely place the correspondence in the patented file, where it serves to call attention to the matter in case any question as to it subsequently arises. Such is the case, even where a correction is requested by the patentee or patentee’s assignee.

In order to expedite all proper requests, a Certificate of Correction should be requested only for errors of consequence. Instead of a request for a Certificate of Correction, letters making errors of record should be utilized whenever possible. Thus, where errors are of a minor typographical nature, or are readily apparent to one skilled in the art, a letter making the error(s) of record can be submitted in lieu of a request for a Certificate of Correction. There is no fee for the submission of such a letter.

It is strongly advised that the text of the correction requested be submitted on a Certificate of Correction form, PTO/SB/44 (also referred to as PTO 1050). Submission of this form in duplicate is not necessary. The location of the error in the printed patent should be identified on form PTO/SB/44 by column and line number or claim and line number. See MPEP § 1485for a discussion of the preparation and submission of a request for a Certificate of Correction.

I. THIRD PARTY INFORMATION ON MISTAKES IN PATENT

Third parties do not have standing to demand that the Office issue, or refuse to issue, a Certificate of Correction. See Hallmark Cards, Inc. v. Lehman, 959 F. Supp. 539, 543-44, 42 USPQ2d 1134, 1138 (D.D.C. 1997). 37 CFR 1.322(a)(2) makes it clear that third parties do not have standing to demand that the Office act on, respond to, issue, or refuse to issue a Certificate of Correction. The Office is, however, cognizant of the need for the public to have correct information about published patents and may therefore accept information about mistakes in patents from third parties. 37 CFR 1.322(a)(1)(iii). Where appropriate, the Office may issue certificates of correction based on information supplied by third parties, whether or not such information is accompanied by a specific request for issuance of a Certificate of Correction.

While third parties are permitted to submit information about mistakes in patents which information will be reviewed, the Office need not act on that information nor deny any accompanying request for issuance of a Certificate of Correction. Accordingly, a fee for submission of the information by a third party has not been imposed. The Office may, however, choose to issue a Certificate of Correction on its own initiative based on the information supplied by a third party, if it desires to do so. Regardless of whether the third party information is acted upon, the information will not be made of record in the file that it relates to, nor be retained by the Office. 37 CFR 1.322(a)(2)(ii).

When such third party information (about mistakes in patents) is received by the Office, the Office will not correspond with third parties about the information they submitted either (1) to inform the third parties of whether it intends to issue a Certificate of Correction, or (2) to issue a denial of any request for issuance of a Certificate of Correction that may accompany the information. The Office will confirm to the party submitting such information that the Office has in fact received the information if a stamped, self-addressed post card has been submitted. See MPEP § 503.

II. PUBLICATION IN THE OFFICIAL GAZETTE

Each issue of the Official Gazette (patents section) numerically lists all United States patents having Certificates of Correction. The list appears under the heading “Certificates of Correction for the week of (date).”

1480.01 Expedited Issuance of Certificates of Correction - Error Attributable to Office[edit | edit source]

In an effort to reduce the overall time required in processing and granting Certificate of Correction requests, the Office will expedite processing and granting of patentee requests where such requests are accompanied by evidence to show that the error is attributable solely to the Office (i.e., requests filed pursuant to 37 CFR 1.322 only).

The following requirements must be met for consideration of expedited issuance of Certificates of Correction:

The text of the correction requested should be submitted on a Certificate of Correction form, PTO/SB/ 44 (also referred to as PTO 1050). Submission of this form in duplicate is not necessary. The location of the error in the printed patent should be identified on form PTO/SB/44 by column and line number or claim and line number. See also MPEP § 1485.

Where the correction requested was incurred through the fault of the Office, and the matter is clearly disclosed in the records of the Office, and is accompanied by documentation that unequivocally supports the patentee’s assertion(s), a Certificate of Correction will be expeditiously issued. Such supporting documentation can consist of relevant photocopied receipts, manuscript pages, correspondence dated and received by the Office, photocopies of Examiners’ responses regarding entry of amendments, or any other validation that supports the patentee’s request so that the request can be processed without the patent file.

Where only part of a request can be approved, the appropriate modifications will be made on the form PTO/SB/44 and the patentee then notified by mail. Further consideration will be given to initially rejected requests upon a request for reconsideration. In this instance, however, or in the case where it is determined that the Office was not responsible for the error(s) cited by the patentee, accelerated issuance of Certificates of Correction cannot be anticipated (although the Office will make every effort to process the request expeditiously).

1481 Certificates of Correction - Applicant’s Mistake[edit | edit source]

35 U.S.C. 255. Certificate of correction of applicant’s mistake.

Whenever a mistake of a clerical or typographical nature, or of minor character, which was not the fault of the Patent and Trademark Office, appears in a patent and a showing has been made that such mistake occurred in good faith, the Director may, upon payment of the required fee, issue a certificate of correction, if the correction does not involve such changes in the patent as would constitute new matter or would require reexamination. Such patent, together with the certificate, shall have the same effect and operation in law on the trial of actions for causes thereafter arising as if the same had been originally issued in such corrected form.

37 CFR 1.323. Certificate of correction of applicant’s mistake.

The Office may issue a certificate of correction under the conditions specified in 35 U.S.C. 255 at the request of the patentee or the patentee’s assignee, upon payment of the fee set forth in § 1.20(a). If the request relates to a patent involved in an interference, the request must comply with the requirements of this section and be accompanied by a motion under § 41.121(a)(2) or § 41.121(a)(3) of this title.

37 CFR 1.323 relates to the issuance of Certificates of Correction for the correction of errors which were not the fault of the Office. Mistakes in a patent which are not correctable by Certificate of Correction may be correctable via filing a reissue application (see MPEP § 1401 - § 1460). See Novo Industries, L.P. v. Micro Molds Corporation, 350 F.3d 1348, 69 USPQ2d 1128 (Fed. Cir. 2003) (The Federal Circuit stated that when Congress in 1952 defined USPTO authority to make corrections with prospective effect, it did not deny correction authority to the district courts. A court, however, can correct only if “(1) the correction is not subject to reasonable debate based on consideration of the claim language and the specification and (2) the prosecution history does not suggest a different interpretation...”).

In re Arnott, 19 USPQ2d 1049, 1052 (Comm’r Pat. 1991) specifies the criteria of 35 U.S.C. 255 (for a Certificate of Correction) as follows:

Two separate statutory requirements must be met before a Certificate of Correction for an applicant’s mistake may issue. The first statutory requirement concerns the nature, i.e., type, of the mistake for which a correction is sought. The mistake must be:

(1) of a clerical nature,

(2) of a typographical nature, or

(3) a mistake of minor character.

The second statutory requirement concerns the nature of the proposed correction. The correction must not involve changes which would:

(1) constitute new matter or

(2) require reexamination.

If the above criteria are not satisfied, then a Certificate of Correction for an applicant’s mistake will not issue, and reissue must be employed as the vehicle to “correct” the patent. Usually, any mistake affecting claim scope must be corrected by reissue.

A mistake is not considered to be of the “minor” character required for the issuance of a Certificate of Correction if the requested change would materially affect the scope or meaning of the patent. See also MPEP § 1412.04 as to correction of inventorship via certificate of correction or reissue.

The fee for providing a correction of applicant’s mistake, other than inventorship, is set forth in 37 CFR 1.20(a). The fee for correction of inventorship in a patent is set forth in 37 CFR 1.20(b).

1481.01 Correction of Assignees’ Names[edit | edit source]

The Fee(s) Transmittal Form portion (PTOL- 85B) of the Notice of Allowance provides a space (item 3) for assignment data which should be completed in order to comply with 37 CFR 3.81. Unless an assignee’s name and address are identified in the appropriate space for specifying the assignee, (i.e., item 3 of the Fee(s) Transmittal Form PTOL- 85B), the patent will issue to the applicant. Assignment data printed on the patent will be based solely on the information so supplied.

Any request for the issuance of an application in the name of the assignee submitted after the date of payment of the issue fee, and any request for a patent to be corrected to state the name of the assignee must:

(A)state that the assignment was submitted for recordation as set forth in 37 CFR 3.11 before issuance of the patent;

(B)include a request for a certificate of correction under 37 CFR 1.323 along with the fee set forth in 37 CFR 1.20(a); and

(C)include the processing fee set forth in 37 CFR 1.17(i).

See 37 CFR 3.81(b).

1481.02 Correction of Inventors’ Names[edit | edit source]

35 U.S.C. 256. Correction of named inventor.

Whenever through error a person is named in an issued patent as the inventor, or through error an inventor is not named in an issued patent and such error arose without any deceptive intention on his part, the Director may, on application of all the parties and assignees, with proof of the facts and such other requirements as may be imposed, issue a certificate correcting such error.

The error of omitting inventors or naming persons who are not inventors shall not invalidate the patent in which such error occurred if it can be corrected as provided in this section. The court before which such matter is called in question may order correction of the patent on notice and hearing of all parties concerned and the Director shall issue a certificate accordingly.

In requesting the Office to effectuate a court order correcting inventorship in a patent pursuant to 35 U.S.C. 256, a copy of the court order and a Certificate of Correction under 37 CFR 1.323 should be submitted to the Certificates of Corrections Branch.

37 CFR 1.324. Correction of inventorship in patent, pursuant to 35 U.S.C. 256.

(a)Whenever through error a person is named in an issued patent as the inventor, or through error an inventor is not named in an issued patent and such error arose without any deceptive intention on his or her part, the Director, pursuant to 35 U.S.C. 256, may, on application of all the parties and assignees, or on order of a court before which such matter is called in question, issue a certificate naming only the actual inventor or inventors. A petition to correct inventorship of a patent involved in an interference must comply with the requirements of this section and must be accompanied by a motion under § 41.121(a)(2) or § 41.121(a)(3) of this title.

(b)Any request to correct inventorship of a patent pursuant to paragraph (a) of this section must be accompanied by:

(1)Where one or more persons are being added, a statement from each person who is being added as an inventor that the inventorship error occurred without any deceptive intention on his or her part;

(2)A statement from the current named inventors who have not submitted a statement under paragraph (b)(1) of this section either agreeing to the change of inventorship or stating that they have no disagreement in regard to the requested change;

(3)A statement from all assignees of the parties submitting a statement under paragraphs (b)(1) and (b)(2) of this section agreeing to the change of inventorship in the patent, which statement must comply with the requirements of § 3.73(b) of this chapter; and

(4)The fee set forth in § 1.20(b).

(c)For correction of inventorship in an application, see §§ 1.48 and 1.497.

(d)In a contested case before the Board of Patent Appeals and Interferences under part 41, subpart D, of this title, a request for correction of a patent must be in the form of a motion under § 41.121(a)(2) or § 41.121(a)(3) of this title.

The petition to correct inventorship under 37 CFR 1.324 must include the statements and fee required by 37 CFR 1.324(b).

Under 37 CFR 1.324(b)(1), a statement is required from each person who is being added as an inventor that the inventorship error occurred without any deceptive intention on their part. In order to satisfy this, a statement such as the following is sufficient:

“The inventorship error of failing to include John Smith as an inventor of the patent occurred without any deceptive intention on the part of John Smith.”

Nothing more is required. The examiner will determine only whether the statement contains the required language; the examiner will not make any commentas to whether or not it appears that there was in fact deceptive intention (see MPEP § 2022.05).

Under 37 CFR 1.324(b)(2), all current inventors who did not submit a statement under 37 CFR 1.324(b)(1) must submit a statement either agreeing to the change of inventorship, or stating that they have no disagreement with regard to the requested change. “Current inventors” include the inventor(s) being retained as such and the inventor(s) to be deleted. These current inventors need not make a statement as to whether the inventorship error occurred without deceptive intention.

If an inventor is not available, or refuses, to submit a statement, the assignee of the patent may wish to consider filing a reissue application to correct inventorship, since the inventor’s statement is not required for a non-broadening reissue application to correct inventorship. See MPEP § 1412.04.

Under 37 CFR 1.324(b)(3), a statement is required from the assignee(s) of the patent agreeing to the change of inventorship in the patent. The assignee statement agreeing to the change of inventorship must be accompanied by a proper statement under 37 CFR 3.73(b) establishing ownership, unless a proper 37 CFR 3.73(b) statement is already in the file. See MPEP § 324 as to the requirements of a statement under 37 CFR 3.73(b).

While a request under 37 CFR 1.48 is appropriate to correct inventorship in a nonprovisional application, a petition under 37 CFR 1.324 is the appropriate vehicle to correct inventorship in a patent. If a request under 37 CFR 1.48(a), (b), or (c) is inadvertently filed in a patent, the request may be treated as a petition under 37 CFR 1.324, and if it is grantable, form paragraph 10.14 set forth below should be used.

Similarly, if a request under 37 CFR 1.48(a), (b), or (c) is filed in a pending application but not acted upon until after the application becomes a patent, the request may be treated as a petition under 37 CFR 1.324, and if it is grantable, form paragraph 10.14 set forth below should be used.

The statutory basis for correction of inventorship in a patent under 37 CFR 1.324 is 35 U.S.C. 256. It is important to recognize that 35 U.S.C. 256 is stricter than 35 U.S.C. 116, the statutory basis for corrections of inventorship in applications under 37 CFR 1.48. 35 U.S.C. 256 requires “on application of all the parties and assignees,” while 35 U.S.C. 116 does not have the same requirement. Under 35 U.S.C. 116 and 37 CFR 1.48, waiver requests under 37 CFR 1.183may be submitted (see, e.g., MPEP § 201.03, under the heading “Statement of Lack of Deceptive Intention”). This is not possible under 35 U.S.C. 256 and 37 CFR 1.324. In correction of inventorship in a nonprovisional application under 37 CFR 1.48(a), the requirement for a statement by each originally named inventor may be waived pursuant to 37 CFR 1.183; however, correction of inventorship in a patent under 37 CFR 1.324 requires petition of all the parties, i.e., originally named inventors and assignees, in accordance with statute (35 U.S.C. 256) and thus the requirement cannot be waived.

1481.03 Correction of 35 U.S.C. 119 and 35 U.S.C. 120 Benefits[edit | edit source]

I.CORRECTION TO PERFECT CLAIM FOR 35 U.S.C. 119 (a)-(d) AND (f) BENEFITS

See MPEP § 201.16 for a discussion of when 35 U.S.C. 119 (a)-(d) and (f) benefits can be perfected by certificate of correction.

II.CORRECTION AS TO 35 U.S.C. 120 AND 35 U.S.C. 119(e) BENEFITS

A.For Applications Filed Prior to November 29, 2000

For applications filed prior to November 29, 2000, it is the version of 37 CFR 1.78, which was in effect as of November 29, 2000, that applies. The pre- November 29, 2000 version reads as follows:

37 CFR 1.78. Claiming benefit of earlier filing date andcross-references to other applications.

(a)(1) A nonprovisional application may claim an invention disclosed in one or more prior filed copending nonprovisional applications or copending international applications designating the United States of America. In order for a nonprovisional application to claim the benefit of a prior filed copending nonprovisional application or copending international application designating the United States of America, each prior application must name as an inventor at least one inventor named in the later filed nonprovisional application and disclose the named inventor’s invention claimed in at least one claim of the later filed nonprovisional application in the manner provided by the first paragraph of 35 U.S.C. 112. In addition, each prior application must be:

(i)An international application entitled to a filing date in accordance with PCT Article 11 and designating the United States of America; or

(ii)Complete as set forth in § 1.51(b); or

(iii)Entitled to a filing date as set forth in § 1.53(b) or § 1.53(d) and include the basic filing fee set forth in § 1.16; or

(iv)Entitled to a filing date as set forth in § 1.53(b) and have paid therein the processing and retention fee set forth in § 1.21(l) within the time period set forth in § 1.53(f).

(2)Except for a continued prosecution application filed under §

1.53(d), any nonprovisional application claiming the benefit of one or more prior filed copending nonprovisional applications or international applications designating the United States of America must contain a reference to each such prior application, identifying it by application number (consisting of the series code and serial number) or international application number and international filing date and indicating the relationship of the applications. Unless the reference required by this paragraph is included in an application data sheet (§ 1.76), the specification must contain or be amended to contain such reference in the first sentence following any title. The request for a continued prosecution application under § 1.53(d) is the specific reference required by 35 U.S.C. 120 to the prior application. The identification of an application by application number under this section is the specific reference required by 35 U.S.C. 120 to every application assigned that application number. Cross-references to other related applications may be made when appropriate (see § 1.14(a)).

(3)A nonprovisional application other than for a design patent may claim an invention disclosed in one or more prior filed copending provisional applications. In order for a nonprovisional application to claim the benefit of one or more prior filed copending provisional applications, each prior provisional application must name as an inventor at least one inventor named in the later filed nonprovisional application and disclose the named inventor's invention claimed in at least one claim of the later filed nonprovisional application in the manner provided by the first paragraph of 35 U.S.C. 112. In addition, each prior provisional application must be entitled to a filing date as set forth in § 1.53(c), have any required English-language translation filed therein within the time period set forth in § 1.52(d), and have paid therein the basic filing fee set forth in § 1.16(k) within the time period set forth in § 1.53(g).

(4)Any nonprovisional application claiming the benefit of one or more prior filed copending provisional applications must contain a reference to each such prior provisional application, identifying it as a provisional application, and including the provisional application number (consisting of series code and serial number). Unless the reference required by this paragraph is included in an application data sheet (§ 1.76), the specification must contain or be amended to contain such reference in the first sentence following any title.

Under certain conditions specified below, a Certificate of Correction can be used, with respect to 35 U.S.C. 120 and 119(e) priority, to correct:

(A)the failure to make reference to a prior copending application pursuant to 37 CFR 1.78(a)(2) and (a)(4); or

(B)an incorrect reference to a prior copending application pursuant to 37 CFR 1.78(a)(2) and (a)(4).

For all situations other than where priority is based upon 35 U.S.C. 365(c), the conditions are as follows:

(A)for 35 U.S.C. 120 priority, all requirements set forth in 37 CFR 1.78(a)(1) must have been met in the application which became the patent to be corrected;

(B)for 35 U.S.C. 119(e) priority, all requirements set forth in 37 CFR 1.78(a)(3) must have been met in the application which became the patent to be corrected; and

(C)it must be clear from the record of the patent and the parent application(s) that priority is appropriate. See MPEP § 201.1l for requirements under 35 U.S.C. 119(e) and 120.

Where 35 U.S.C. 120 and 365(c) priority based on an international application is to be asserted or corrected in a patent via a Certificate of Correction, the following conditions must be satisfied:

(A)all requirements set forth in 37 CFR 1.78(a)(1) must have been met in the application which became the patent to be corrected;

(B)it must be clear from the record of the patent and the parent application(s) that priority is appropriate (see MPEP § 201.11); and

(C)the patentee must submit with the request for the certificate copies of documentation showing designation of states and any other information needed to make it clear from the record that the 35 U.S.C. 120priority is appropriate. See MPEP § 201.13(b) as to the requirements for 35 U.S.C. 120 priority based on an international application.

If all the above-stated conditions are satisfied, a Certificate of Correction can be used to amend the patent to make reference to a prior copending application, or to correct an incorrect reference to the prior copending application. Note In re Schuurs, 218 USPQ 443 (Comm’r Pat. 1983) which suggests that a Certificate of Correction is an appropriate remedy for correcting, in a patent, reference to a prior copending application. Also, note In re Lambrech, 202 USPQ 620 (Comm’r Pat. 1976), citing In re Van Esdonk, 187 USPQ 671 (Comm’r Pat. 1975).

If any of the above-stated conditions is not satisfied, the filing of a reissue application (see MPEP § 1401 - § 1460) would be appropriate to pursue the desired correction of the patent.

B.For Applications Filed on or After November 29, 2000

For applications filed on or after November 29, 2000, the version of 37 CFR 1.78 reproduced below applies (note that amendments to 37 CFR 1.78 took effect on November 29, 2000, December 28, 2001, May 1, 2003, January 21, 2004, September 21, 2004, December 8, 2004, July 1, 2005, and November 25, 2005).

37 CFR 1.78. Claiming benefit of earlier filing date and cross-references to other applications.

(a)(1)A nonprovisional application or international application designating the United States of America may claim an invention disclosed in one or more prior-filed copending nonprovisional applications or international applications designating the United States of America. In order for an application to claim the benefit of a prior-filed copending nonprovisional application or international application designating the United States of America, each prior-filed application must name as an inventor at least one inventor named in the later-filed application and disclose the named inventor’s invention claimed in at least one claim of the later-filed application in the manner provided by the first paragraph of 35 U.S.C. 112. In addition, each prior-filed application must be:

(i) An international application entitled to a filing date in accordance with PCT Article 11 and designating the United States of America; or

(ii) Entitled to a filing date as set forth in § 1.53(b) or § 1.53(d) and have paid therein the basic filing fee set forth in § 1.16within the pendency of the application.

(2)(i)Except for a continued prosecution application filed under § 1.53(d), any nonprovisional application or international application designating the United States of America claiming the benefit of one or more prior-filed copending nonprovisional applications or international applications designating the United States of America must contain or be amended to contain a reference to each such prior-filed application, identifying it by application number (consisting of the series code and serial number) or international application number and international filing date and indicating the relationship of the applications. Cross references to other related applications may be made when appropriate (see § 1.14).

(ii)This reference must be submitted during the pendency of the later-filed application. If the later-filed application is an application filed under 35 U.S.C. 111(a), this reference must also be submitted within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior-filed application. If the later-filed application is a nonprovisional application which entered the national stage from an international application after compliance with 35 U.S.C. 371, this reference must also be submitted within the later of four months from the date on which the national stage commenced under 35 U.S.C. 371 (b) or (f) in the later-filed international application or sixteen months from the filing date of the prior-filed application. These time periods are not extendable. Except as provided in paragraph (a)(3) of this section, the failure to timely submit the reference required by 35 U.S.C. 120 and paragraph (a)(2)(i) of this section is considered a waiver of any benefit under 35 U.S.C. 120, 121, or 365(c) to such prior-filed application. The time periods in this paragraph do not apply if the later-filed application is:

(A)An application for a design patent;

(B)An application filed under 35 U.S.C. 111 (a) before November 29, 2000; or

(C)A nonprovisional application which entered the national stage after compliance with 35 U.S.C. 371 from an international application filed under 35 U.S.C. 363 before November 29, 2000.

(iii)If the later-filed application is a nonprovisional application, the reference required by this paragraph must be included in an application data sheet (§ 1.76), or the specification must contain or be amended to contain such reference in the first sentence(s) following the title.

(iv)The request for a continued prosecution application under § 1.53(d) is the specific reference required by 35 U.S.C. 120 to the prior-filed application. The identification of an application by application number under this section is the identification of every application assigned that application number necessary for a specific reference required by 35 U.S.C. 120 to every such application assigned that application number.

(3)If the reference required by 35 U.S.C. 120 and paragraph (a)(2) of this section is presented after the time period provided by paragraph (a)(2)(ii) of this section, the claim under 35 U.S.C. 120, 121, or 365(c) for the benefit of a prior-filed copending nonprovisional application or international application designating the United States of America may be accepted if the reference identifying the prior-filed application by application number or international application number and international filing date was unintentionally delayed. A petition to accept an unintentionally delayed claim under 35 U.S.C. 120, 121, or 365(c) for the benefit of a prior-filed application must be accompanied by:

(i)The reference required by 35 U.S.C. 120 and paragraph (a)(2) of this section to the prior-filed application, unless previously submitted;

(ii)The surcharge set forth in § 1.17(t); and

(iii)A statement that the entire delay between the date the claim was due under paragraph (a)(2)(ii) of this section and the date the claim was filed was unintentional. The Director may require additional information where there is a question whether the delay was unintentional.

(4)A nonprovisional application, other than for a design patent, or an international application designating the United States of America may claim an invention disclosed in one or more prior-filed provisional applications. In order for an application to claim the benefit of one or more prior-filed provisional applications, each prior-filed provisional application must name as an inventor at least one inventor named in the later-filed application and disclose the named inventor’s invention claimed in at least one claim of the later-filed application in the manner provided by the first paragraph of 35 U.S.C. 112. In addition, each prior-filed provisional application must be entitled to a filing date as set forth in § 1.53(c), and the basic filing fee set forth in § 1.16(d) must be paid within the time period set forth in § 1.53(g).

(5)(i) Any nonprovisional application or international application designating the United States of America claiming the benefit of one or more prior-filed provisional applications must contain or be amended to contain a reference to each such prior- filed provisional application, identifying it by the provisional application number (consisting of series code and serial number).

(ii)This reference must be submitted during the pendency of the later-filed application. If the later-filed application is an application filed under 35 U.S.C. 111(a), this reference must also be submitted within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior-filed provisional application. If the later- filed application is a nonprovisional application which entered the national stage from an international application after compliance with 35 U.S.C. 371, this reference must also be submitted within the later of four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f) in the later-filed international application or sixteen months from the filing date of the prior-filed provisional application. These time periods are not extendable. Except as provided in paragraph(a)(6) of this section, the failure to timely submit the reference is considered a waiver of any benefit under 35 U.S.C. 119(e) to such prior-filed provisional application. The time periods in this paragraph do not apply if the later-filed application is:

(A)An application filed under 35 U.S.C. 111(a) before November 29, 2000; or

(B)A nonprovisional application which entered the national stage after compliance with 35 U.S.C. 371 from an international application filed under 35 U.S.C. 363 before November 29, 2000.

(iii)If the later-filed application is a nonprovisional application, the reference required by this paragraph must be included in an application data sheet (§ 1.76), or the specification must contain or be amended to contain such reference in the first sentence(s) following the title.

(iv)If the prior-filed provisional application was filed in a language other than English and both an English-language translation of the prior-filed provisional application and a statement that the translation is accurate were not previously filed in the prior-filed provisional application, applicant will be notified and given a period of time within which to file, in the prior-filed provisional application, the translation and the statement. If the notice is mailed in a pending nonprovisional application, a timely reply to such a notice must include the filing in the nonprovisional application of either a confirmation that the translation and statement were filed in the provisional application, or an amendment or Supplemental Application Data Sheet withdrawing the benefit claim, or the nonprovisional application will be abandoned. The translation and statement may be filed in the provisional application, even if the provisional application has become abandoned.

(6)If the reference required by 35 U.S.C. 119(e) and paragraph (a)(5) of this section is presented in a nonprovisional application after the time period provided by paragraph (a)(5)(ii) of this section, the claim under 35 U.S.C. 119(e) for the benefit of a prior filed provisional application may be accepted during the pendency of the later-filed application if the reference identifying the prior-filed application by provisional application number was unintentionally delayed. A petition to accept an unintentionally delayed claim under 35 U.S.C. 119(e) for the benefit of a prior filed provisional application must be accompanied by:

(i)The reference required by 35 U.S.C. 119(e) and paragraph (a)(5) of this section to the prior-filed provisional application, unless previously submitted;

(ii)The surcharge set forth in § 1.17(t); and

(iii)A statement that the entire delay between the date the claim was due under paragraph (a)(5)(ii) of this section and the date the claim was filed was unintentional. The Director may require additional information where there is a question whether the delay was unintentional.

(b)Where two or more applications filed by the same applicant contain conflicting claims, elimination of such claims from all but one application may be required in the absence of good and sufficient reason for their retention during pendency in more than one application.

(c)If an application or a patent under reexamination and at least one other application naming different inventors are owned by the same person and contain conflicting claims, and there is no statement of record indicating that the claimed inventions were commonly owned or subject to an obligation of assignment to the same person at the time the later invention was made, the Office may require the assignee to state whether the claimed inventions were commonly owned or subject to an obligation of assignment to the same person at the time the later invention was made, and if not, indicate which named inventor is the prior inventor. Even if the claimed inventions were commonly owned, or subject to an obligation of assignment to the same person, at the time the later invention was made, the conflicting claims may be rejected under the doctrine of double patenting in view of such commonly owned or assigned applications or patents under reexamination.

Under no circumstances can a Certificate of Correction be employed to correct an applicant’s mistake by adding or correcting a priority claim under 35 U.S.C. 119(e) for an application filed on or after November 29, 2000.

Section 4503 of the American Inventors Protection Act of 1999 (AIPA) amended 35 U.S.C. 119(e)(1) to state that:

No application shall be entitled to the benefit of an earlier filed provisional application under this subsection unless an amendment containing the specific reference to the earlier filed provisional application is submitted at such time during the pendency of the application as required by the Director. The Director may consider the failure to submit such an amendment within that time period as a waiver of any benefit under this subsection. The Director may establish procedures, including the payment of a surcharge, to accept an unintentionally delayed submission of an amendment under this section during the pendency of the application. (emphasis added)

A Certificate of Correction is NOT a valid mechanism for adding or correcting a priority claim under 35 U.S.C. 119(e) after a patent has been granted on an application filed on or after November 29, 2000.

Under certain conditions as specified below, however, a Certificate of Correction can still be used, with respect to 35 U.S.C. 120 priority, to correct:

(A)the failure to make reference to a prior copending application pursuant to 37 CFR 1.78(a)(2); or

(B)an incorrect reference to a prior copending application pursuant to 37 CFR 1.78(a)(2).

Where priority is based upon 35 U.S.C. 120 to a national application, the following conditions must be satisfied:

(A)all requirements set forth in 37 CFR 1.78(a)(1) must have been met in the application which became the patent to be corrected;

(B) it must be clear from the record of the patent and the parent application(s) that priority is appropriate (see MPEP § 201.11); and

(C)a grantable petition to accept an unintentionally delayed claim for the benefit of a prior application must be filed, including a surcharge as set forth in 37 CFR 1.17(t), as required by 37 CFR 1.78(a)(3).

Where 35 U.S.C. 120 and 365(c) priority based on an international application is to be asserted or corrected in a patent via a Certificate of Correction, the following conditions must be satisfied:

(A)all requirements set forth in 37 CFR 1.78(a)(1) must have been met in the application which became the patent to be corrected;

(B)it must be clear from the record of the patent and the parent application(s) that priority is appropriate (see MPEP § 201.11);

(C)the patentee must submit together with the request for the certificate, copies of documentation showing designation of states and any other information needed to make it clear from the record that the 35 U.S.C. 120 priority is appropriate (see MPEP § 201.13(b) as to the requirements for 35 U.S.C. 120priority based on an international application; and

(D)a grantable petition to accept an unintentionally delayed claim for the benefit of a prior application must be filed, including a surcharge as set forth in 37 CFR 1.17(t), as required by 37 CFR 1.78(a)(3).

If all the above-stated conditions are satisfied, a Certificate of Correction can be used to amend the patent to make reference to a prior copending application, or to correct an incorrect reference to the prior copending application, for benefit claims under 35 U.S.C. 120 and 365(c).

If any of the above-stated conditions is not satisfied, the filing of a reissue application (see MPEP § 1401 - § 1460) may be appropriate to pursue the desired correction of the patent for benefit claims under 35 U.S.C. 120 and 365(c).

1485 Handling of Request for Certificates of Correction[edit | edit source]

A request for a Certificate of Correction should be addressed to:

Commissioner for Patents

Office of Patent Publication

ATTN: Certificate of Correction Branch

P.O. Box 1450

Alexandria, VA 22313-1450

Requests for Certificates of Correction will be forwarded to the Certificate of Correction Branch of the Office of Patent Publication, where they will be listed in a permanent record book.

If the patent is involved in an interference, a Certificate of Correction under 37 CFR 1.324 will not be issued unless a corresponding motion under 37 CFR 41.121(a)(2) or 41.121(a)(3) has been granted by the administrative patent judge. Otherwise, determination as to whether an error has been made, the responsibility for the error, if any, and whether the error is of such a nature as to justify the issuance of a Certificate of Correction will be made by the Certificate of Correction Branch. If a report is necessary in making such determination, the case will be forwarded to the appropriate group with a request that the report be furnished. If no certificate is to issue, the party making the request is so notified and the request, report, if any, and copy of the communication to the person making the request are placed in the file wrapper (for a paper file) or entered into the file history (for an IFW file), and entered into the “Contents” for the file by the Certificate of Correction Branch. The case is then returned to the patented files. If a certificate is to issue, it will be prepared and forwarded to the person making the request by the Office of Patent Publication. In that case, the request, the report, if any, and a copy of the letter transmitting the Certificate of Correction to the person making the request will be placed in the file wrapper (for a paper file) or entered into the file history (for an IFW file), and entered into the “Contents” for the file.

Applicants, or their attorneys or agents, are urged to submit the text of the correction on a special Certificate of Correction form, PTO/SB/44 (also referred to as Form PTO-1050), which can serve as the camera copy for use in direct offset printing of the Certificate of Correction.

Where only a part of a request can be approved, or where the Office discovers and includes additional corrections, the appropriate alterations are made on the form PTO/SB/44 by the Office. The patentee is notified of the changes on the Notification of Approval-in-part form PTOL-404. The certificate is issued approximately 6 weeks thereafter.

Form PTO/SB/44 should be used exclusively regardless of the length or complexity of the subject matter. Intricate chemical formulas or page of specification or drawings may be reproduced and mounted on a blank copy of PTO/SB/44. Failure to use the form has frequently delayed issuance since the text must be retyped by the Office onto a PTO/SB/44.

The exact page and line number where the errors occur in the application file should be identified on the request. However, on form PTO/SB/44, only the column and line number in the printed patent should be used.

The patent grant should be retained by the patentee. The Office does not attach the Certificate of Correction to patentee’s copy of the patent. The patent grant will be returned to the patentee if submitted.

Below is a sample form illustrating a variety of corrections and the suggested manner of setting out the format. Particular attention is directed to:

(A)Identification of the exact point of error by reference to column and line number of the printed patent for changes in the specification or to claim number and line where a claim is involved.

(B)Conservation of space on the form by typing single space, beginning two lines down from the printed message.

(C)Starting the correction to each separate column as a sentence, and using semicolons to separate corrections within the same column, where possible.

(D)Leaving a two-inch space blank at bottom of the last sheet for the signature of the attesting officer.

(E)Using quotation marks to enclose the exact subject matter to be deleted or corrected; using double hyphens (-- --) to enclose subject matter to be added, except for formulas.

(F)Where a formula is involved, setting out only that portion thereof which is to be corrected or, if necessary, pasting a photocopy onto form PTO/SB/ 44.

ELECTRONIC PUBLICATION OF CERTIFICATES OF CORRECTION WITH LATER LISTING IN THE OFFICIAL GAZETTE

Effective August 2001, the U.S. Patent and Trademark Office (USPTO) publishes on the USPTO web site at http://www.uspto.gov/web/patents/certofcorrect a listing by patent number of the patents for which certificates of correction are being issued.

The USPTO is now automating the publication process for certificates of correction. This new process will result in certificates of correction being published quicker electronically on the USPTO’s web site as compared to their paper publication and the listing of the certificates of correction in the Official Gazette. Under the newly automated process, each issue of certificates of correction will be electronically published on the USPTO web site at http://www.uspto.gov/web/ patents/certofcorrect, and will also subsequently be listed in the Official Gazette (and in the Official Gazette Notices posted at http://www.uspto.gov/web/ offices/com/sol/og) approximately three weeks thereafter. The listing of certificates of correction in the Official Gazette will include the certificate’s date of issuance.

On the date on which the listing of certificates of correction is electronically published on the USPTO web site: (A) the certificate of correction will be entered into the file wrapper of a paper-file patent, or entered into the file history of an IFW-file patent and will be available to the public; (B) a printed copy of the certificate of correction will be mailed to the patentee or the patent’s assignee; and (C) an image of the printed certificate of correction will be added to the image of the patent on the patent database at http:// www.uspto.gov.patft. Dissemination of all other paper copies of the certificate of correction will occur shortly thereafter.

The date on which the USPTO makes the certificate of correction available to the public (e.g., by adding the certificate of correction to the file wrapper/file history) will be regarded as the date of issuance of the certificate of correction, not the date of the certificate of correction appearing in the Official Gazette. (For IFW processing, see IFW Manual.) Certificates of correction published in the above-described manner will provide the public with prompt notice and access, and this is consistent with the legislative intent behind the American Inventors Protection Act of 1999. See

35 U.S.C. 10(a) (authorizing the USPTO to publish in electronic form).

The listing of certificates of correction can be electronically accessed on the day of issuance at http:// www.uspto.gov/web/patents/certofcorrect. The electronic image of the printed certificate of correction can be accessed on the patent database at http:// www.uspto.gov/patft and the listing of the certificates of correction, as published in the Official Gazettethree weeks later, will be electronically accessible at http://www.uspto.gov/web/offices/com/sol/og.

1490 Disclaimers[edit | edit source]

35 U.S.C. 253. Disclaimer.

Whenever, without any deceptive intention, a claim of a patent is invalid the remaining claims shall not thereby be rendered invalid. A patentee, whether of the whole or any sectional interest therein, may, on payment of the fee required by law, make disclaimer of any complete claim, stating therein the extent of his interest in such patent. Such disclaimer shall be in writing, and recorded in the Patent and Trademark Office; and it shall thereafter be considered as part of the original patent to the extent of the interest possessed by the disclaimant and by those claiming under him.

In like manner any patentee or applicant may disclaim or dedicate to the public the entire term, or any terminal part of the term, of the patent granted or to be granted.

37 CFR 1.321. Statutory disclaimers, including terminal disclaimers.

(a)A patentee owning the whole or any sectional interest in a patent may disclaim any complete claim or claims in a patent. In like manner any patentee may disclaim or dedicate to the public the entire term, or any terminal part of the term, of the patent granted. Such disclaimer is binding upon the grantee and its successors or assigns. A notice of the disclaimer is published in the Official Gazette and attached to the printed copies of the specification. The disclaimer, to be recorded in the Patent and Trademark Office, must:

(1)be signed by the patentee, or an attorney or agent of record;

(2)identify the patent and complete claim or claims, or term being disclaimed. A disclaimer which is not a disclaimer of a complete claim or claims, or term, will be refused recordation;

(3)state the present extent of patentee’s ownership interest in the patent; and

(4)be accompanied by the fee set forth in § 1.20(d).

(b)An applicant or assignee may disclaim or dedicate to the public the entire term, or any terminal part of the term, of a patent to be granted. Such terminal disclaimer is binding upon the grantee and its successors or assigns. The terminal disclaimer, to be recorded in the Patent and Trademark Office, must:

(1)be signed:

(i)by the applicant, or

(ii)if there is an assignee of record of an undivided part interest, by the applicant and such assignee, or

(iii)if there is an assignee of record of the entire interest, by such assignee, or

(iv)by an attorney or agent of record;

(2)specify the portion of the term of the patent being disclaimed;


(3)state the present extent of applicant’s or assignee’s ownership interest in the patent to be granted; and

(4)be accompanied by the fee set forth in § 1.20(d).

(c)A terminal disclaimer, when filed to obviate judicially created double patenting in a patent application or in a reexamination proceeding except as provided for in paragraph (d) of this section, must:

(1)Comply with the provisions of paragraphs (b)(2) through (b)(4) of this section;

(2)Be signed in accordance with paragraph (b)(1) of this section if filed in a patent application or in accordance with paragraph (a)(1) of this section if filed in a reexamination proceeding; and

(3)Include a provision that any patent granted on that application or any patent subject to the reexamination proceeding shall be enforceable only for and during such period that said patent is commonly owned with the application or patent which formed the basis for the judicially created double patenting.

(d)A terminal disclaimer, when filed in a patent application or in a reexamination proceeding to obviate double patenting based upon a patent or application that is not commonly owned but was disqualified under 35 U.S.C. 103(c) as resulting from activities undertaken within the scope of a joint research agreement, must:

(1)Comply with the provisions of paragraphs (b)(2) through (b)(4) of this section;

(2)Be signed in accordance with paragraph (b)(1) of this section if filed in a patent application or be signed in accordance with paragraph (a)(1) of this section if filed in a reexamination proceeding;

(3)Include a provision waiving the right to separately enforce any patent granted on that application or any patent subject to the reexamination proceeding and the patent or any patent granted on the application which formed the basis for the double patenting, and that any patent granted on that application or any patent subject to the reexamination proceeding shall be enforceable only for and during such period that said patent and the patent, or any patent granted on the application, which formed the basis for the double patenting are not separately enforced.

A disclaimer is a statement filed by an owner (in part or in entirety) of a patent or of a patent to be granted (i.e., an application), in which said owner relinquishes certain legal rights to the patent. There are two types of disclaimers: a statutory disclaimer and a terminal disclaimer. The owner of a patent or an application is the original inventor(s) or the assignee of the original inventor(s). The patent or application is assigned by one assignment or by multiple assignments which establish a chain of title from the inventor( s) to the assignee(s). The owner of the patent or application can sign a disclaimer, and a person empowered by the owner to sign the disclaimer can also sign it. Per 37 CFR 1.321(b)(1)(iv), an attorney or agent of record is permitted to sign the disclaimer. A registered practitioner acting in a representative capacity under 37 CFR 1.34 is not permitted to sign the disclaimer. For a disclaimer to be accepted, it must be signed by the proper party as follows:

(A)A disclaimer filed in an application must be signed by

(1)the applicant where the application has not been assigned,

(2)the applicant and the assignee where each owns a part interest in the application,

(3)the assignee where assignee owns the entire interest in the application, or

(4)an attorney or agent of record.

(B)A disclaimer filed in a patent or a reexamination proceeding must be signed by either

(1)the patentee (the assignee, the inventor(s) if the patent is not assigned, or the assignee and the inventors if the patent is assigned-in-part), or

(2)an attorney or agent of record.

(C)Where the assignee (of an application or of a patent being reexamined or to be reissued) signs the disclaimer, there is a requirement to comply with 37 CFR 3.73(b) in order to satisfy 37 CFR 1.321, unless an attorney or agent of record signs the disclaimer. In order to comply with 37 CFR 3.73(b), the assignee’s ownership interest must be established by:

(1)filing in the application or patent evidence of a chain of title from the original owner to the assignee and a statement affirming that the documentary evidence of the chain of title from the original owner to the assignee was, or concurrently is being, submitted for recordation pursuant to 37 CFR 3.11, or

(2)specifying in the record of the application or patent where such evidence is recorded in the Office (e.g., reel and frame number, etc.).

The submission with respect to 37 CFR 3.73(b) to establish ownership must be signed by a party authorized to act on behalf of the assignee. See also MPEP § 324 as to compliance with 37 CFR 3.73(b). A copy of the “Statement Under 37 CFR 3.73 (b),” which is reproduced in MPEP § 324, may be sent by the examiner to applicant to provide an acceptable way to comply with the requirements of 37 CFR 3.73(b).

(D)Where the attorney or agent of record signs the disclaimer, there is no need to comply with 37 CFR 3.73(b).

(E)The signature on the disclaimer need not be an original signature. Pursuant to 37 CFR 1.4(d)(1)(ii), the submitted disclaimer can be a copy, such as a photocopy or facsimile transmission of an original disclaimer.

I.STATUTORY DISCLAIMERS

Under 37 CFR 1.321(a) the owner of a patent may disclaim a complete claim or claims of his or her patent. This may result from a lawsuit or because he or she has reason to believe that the claim or claims are too broad or otherwise invalid. If the patent is involved in an interference, see 37 CFR 41.121(a).

As noted above, a statutory disclaimer is a statement in which a patent owner relinquishes legal rights to one or more claims of a patent. A statutory disclaimer is not, however, a vehicle for adding or amending claims, since there is no provision for such in the statute (35 U.S.C. 253) nor the rules (37 CFR 1.321). Thus, claims of a patent cannot be disclaimed in favor of new claims to be added to the patent or an amendment to existing claims.

II.TERMINAL DISCLAIMERS

37 CFR 1.321(a) also provides for the filing by an applicant or patentee of a terminal disclaimer which disclaims or dedicates to the public the entire term or any portion of the term of a patent or patent to be granted.

37 CFR 1.321(c) specifically provides for the filing of a terminal disclaimer in an application or a reexamination proceeding for the purpose of overcoming a nonstatutory double patenting rejection. See MPEP § 804.02.

37 CFR 1.321(d) specifically provides for the filing of a terminal disclaimer in an application or a reexamination proceeding for the purpose of overcoming a nonstatutory double patenting rejection based on a U.S. patent or application that is not commonly owned but was disqualified under 35 U.S.C. 103(c).

III.PROCESSING

Certificate of Correction Branch

The Certificate of Correction Branch is responsible for the handling of all statutory disclaimers filed under the first paragraph of 35 U.S.C. 253, whether the case is pending or patented, and all terminal disclaimers (filed under the second paragraph of 35 U.S.C. 253) except for those filed in an application or reexamination proceeding pending in a Technology Center (TC). This involves:

(A)Determining the compliance of the disclaimer with 35 U.S.C. 253 and 37 CFR 1.321 and 3.73;

(B)Notifying applicant or patentee when the disclaimer is informal and thus not acceptable;

(C)Recording the disclaimers in the record of the application file; and

(D)Providing the disclaimer data for printing in the Official Gazette.

IV.TERMINAL DISCLAIMER IN PENDING APPLICATION PRACTICE IN THE TECHNOLOGY CENTERS

Where a terminal disclaimer is filed in an application pending in a TC, it will be processed by the paralegal of the Office of the Special Program Examiner of the TC having responsibility for the application. The paralegal will:

(A)Determine compliance with 35 U.S.C. 253and 37 CFR 1.321 and 3.73, and ensure that the appropriate terminal disclaimer fee set forth in 37 CFR 1.20(d) is/was applied;

(B)Notify the examiner having charge of the application whether the terminal disclaimer is acceptable or not;

(C)Where the terminal disclaimer is not acceptable, indicate the nature of the informalities so that the examiner can inform applicant in the next Office action. For an IFW application, complete the IFW terminal disclaimer form by checking the “Disapproved” box and have the form scanned into IFW;

(D)Where the terminal disclaimer is acceptable, record the terminal disclaimer in the record of the application as set forth below.

The paralegal will record an acceptable terminal disclaimer as being present in an application by:

For IFW applications:

(A)Completing the IFW terminal disclaimer form by checking the “Approved” box and having the form scanned into IFW; and

(B)Entering the terminal disclaimer into PALM for the application.

For application files that are maintained in paper:

For paper applications with 08/ and earlier series code

(A)Attaching a green label to the file wrapper;

(B)Stamping a notice on the file of the term which has been disclaimed (note that the blanks on the stamped notice for entering information on the patent(s) being disclaimed are no longer filled in);

(C)Endorsing the paper containing the terminal disclaimer submission on the “Contents” flap of the application file; and

(D)Entering the terminal disclaimer into the PALM system records, for the application.

For paper applications with 09/ and later series code

(A)Checking a box on the file wrapper which states that the terminal disclaimer has been filed (Any blanks for entering information on the patent(s) being disclaimed are no longer filled in. Note that applications with 10/ and later series codes no longer have such blanks to complete);

(B)Endorsing the paper containing the terminal disclaimer submission on the “Contents” flap of the application file; and

(C)Entering the terminal disclaimer into the PALM system records, for the application.

The paralegal completes a Terminal Disclaimer Informal Memo to notify the examiner of the nature of any informalities in the terminal disclaimer. The examiner should notify the applicant of the informalities in the next Office action, or by interview with applicant if such will expedite prosecution of the application. Further, the examiner should initial and date the Terminal Disclaimer Informal Memo and return it to the paralegal to indicate that the examiner has appropriately notified applicant about the terminal disclaimer. The paralegal will then discard the Terminal Disclaimer Informal Memo.

V.OTHER MATTERS DIRECTED TO TERMINAL DISCLAIMERS

A.Requirements of Terminal Disclaimers

A proper terminal disclaimer must disclaim the terminal part of the statutory term of any patent granted on the application being examined which would extend beyond the expiration date of the full statutory term, shortened by any terminal disclaimer, of the patent (or of any patent granted on the application) to which the disclaimer is directed. Note the exculpatory language in the second paragraph of the sample terminal disclaimer forms, PTO/SB/25 and PTO/SB/26, provided at the end of this Chapter. That language (“In making the above disclaimer, the owner does not disclaim...”) is permissible in a terminal disclaimer.

A terminal disclaimer filed to obviate a nonstatutory double patenting rejection based on a commonly owned patent or application must comply with the requirements of 37 CFR 1.321(c). The terminal disclaimer must state that any patent granted on the application being examined will be enforceable only for and during the period that it and the patent to which the disclaimer is directed or the patent granted on the application to which the disclaimer is directed are commonly owned. See MPEP § 706.02(1)(2) for examples of common ownership, or lack thereof.

A terminal disclaimer filed to obviate a nonstatutory double patenting rejection based on a non-commonly owned patent or application disqualified under 35 U.S.C. 103(c) as a result of activities undertaken within the scope of a joint research agreement under 35 U.S.C. 103(c)(2) and (3) must comply with 37 CFR 1.321(d), which sets forth signature, waiver rights and enforceability requirements.

The terminal disclaimer must include a provision:

(1)waiving the right to separately enforce (a) any patent granted on that application or the patent being reexamined and (b) the reference patent, or any patent granted on the reference application which formed the basis for the double patenting; and

(2)agreeing that any patent granted on that application or patent being reexamined shall be enforceable only for and during such period that said patent and the reference patent, or any patent granted on the reference application, which formed the basis for the double patenting are not separately enforced.

A terminal disclaimer must state that the agreement is to run with any patent granted on the application being examined and is to be binding upon the grantee, its successors, or assigns.

A statement of assignee interest in a terminal disclaimer that “A and B are the owners of 100% of the instant application...” is sufficient to satisfy the 37 CFR 1.321(b)(3) requirement that a terminal disclaimer “state the present extent of applicant’s or assignee’s ownership interest in the patent to be granted.” Although the quoted statement does not identify what specific percentage is owned by A and what specific percentage is owned by B, the statement does provide consent to the terminal disclaimer by the entirety of the ownership of the application (A and B own all of the invention, regardless of the individual percentages they own).

The appropriate one of form paragraphs 14.27.04to 14.27.08 (reproduced below) may be used to provide 

applicant or patent owner with an example of acceptable terminal disclaimer language. Additionally, copies of forms PTO/SB/25 and PTO/SB/26 (provided at the end of this Chapter) may be attached to the Office action to provide sample terminal disclaimers.

Pursuant to the last sentence of 35 U.S.C. 253, “any patentee or applicant may disclaim or dedicate to the public... any terminal part of the term, of the patent granted or to be granted”. Accordingly, the disclaimer must be of a terminal portion of the term of the entire patent to be granted. A disclaimer of a terminal portion of the term of an individual claim, or individual claims will not be accepted. It is further noted that a disclaimer of the term of individual claims would not be appropriate since the claims of a pending application or proceeding are subject to cancelation, amendment, or renumbering. The statute does not provide for conditional disclaimers and accordingly, a proposed disclaimer which is made contingent on the allowance of certain claims cannot be accepted. The disclaimer should identify the disclaimant and his or her interest in the application and should specify the date when the disclaimer is to become effective.

B.Effect of Disclaimers in Continuing Applications and in Reissues

A terminal disclaimer filed to obviate a double patenting rejection is effective only with respect to the application identified in the disclaimer unless by its terms it extends to continuing applications. For example, a terminal disclaimer filed in a parent application normally has no effect on a continuing application claiming filing date benefits of the parent application under 35 U.S.C. 120. A terminal disclaimer filed in a parent application to obviate a double patenting rejection does, however, carry over to a continued prosecution application (CPA) filed under 37 CFR 1.53(d) (effective July 14, 2003, CPAs are only available in design applications). The terminal disclaimer filed in the parent application carries over because the CPA retains the same application number as the parent application, i.e., the application number to which the previously filed terminal disclaimer is directed. If applicant does not want the terminal disclaimer to carry over to the CPA, applicant must file a petition under 37 CFR 1.182, along with the required petition fee, requesting the terminal disclaimer filed in the parent application not be carried over to the CPA; see below “Withdrawing a Terminal Disclaimer” (paragraph “A. Before Issuance of Patent”). If applicant files a Request for Continued Examination (RCE) of an application under 37 CFR 1.114 (which can be filed on or after May 29, 2000 for an application filed on or after June 8, 1995), any terminal disclaimer present will continue to operate, since a new application has not been filed, but rather prosecution has been continued in the existing application. A petition under 37 CFR 1.182, along with the required petition fee, may be filed, if withdrawal of the terminal disclaimer is to be requested.

Reissue applications: Where a terminal disclaimer was filed in an original application, a copy of that terminal disclaimer is not required be filed by applicant in the reissue.

For reissue application files that are maintained in paper:

The face of the file wrapper of the reissue application should, however, be marked by the examiner in order to indicate that a terminal disclaimer has been filed for the patent (and will be effective for the patent as it will be reissued). Further, a copy of the terminal disclaimer should be placed in the reissue application file by the Technology Center.

For IFW reissue applications:

The “Final SPRE Review” form will be filled in to indicate that a terminal disclaimer has been filed for the patent (and will be effective for the patent as it will be reissued). Further, a copy of the terminal disclaimer should be scanned into the reissue application file history by the Technology Center.

C.Disclaimer Identifies the Wrong Target Application or Patent

In some instances a terminal disclaimer filed to obviate an obviousness type double patenting rejection will identify the wrong target application or patent (i.e., an application or patent which is not the basis for the double patenting rejection). In these instances, a replacement terminal disclaimer identifying the correct target application or patent would be required by the examiner. Once a correct replacement terminal disclaimer is received, the next Office action should make it clear that “the second terminal disclaimer replaces the first terminal disclaimer, and the first terminal disclaimer is thus void.” A second terminal disclaimer fee should not be assessed/charged, since the first fee is applied to the second terminal disclaimer.

D.Two or More Copending Applications

If two (or more) pending applications are filed, in each of which a rejection of one claimed invention over the other on the ground of provisional obviousness- type double patenting (ODP) is proper, the ODP rejection will be made in each application. If the ODP rejection is the only rejection remaining in the earlier filed of the two pending applications, (but the later- filed application is rejectable on other grounds), the examiner should then withdraw that rejection and permit the earlier-filed application to issue as a patent without a terminal disclaimer. If the ODP rejection is the only rejection remaining in the later-filed application, (while the earlier-filed application is rejectable on other grounds), a terminal disclaimer must be required in the later-filed application, before the ODP rejection can be withdrawn.

If the ODP rejections in both applications are the only rejections remaining in those applications, the examiner should then withdraw the ODP rejection in the earlier filed application thereby permitting that application to issue without need of a terminal disclaimer. A terminal disclaimer must be required in the later-filed application before the ODP rejection can be withdrawn and the application be permitted to issue.

If both applications are filed on the same day, the examiner should determine which application claims the base invention and which application claims the improvement (added limitations). The ODP rejection in the base application can be withdrawn without a terminal disclaimer, while the ODP rejection in the improvement application cannot be withdrawn without a terminal disclaimer.

Where there are three applications containing claims that conflict such that an ODP rejection is made in each application based upon the other two, it is not sufficient to file a terminal disclaimer in only one of the applications addressing the other two applications. Rather, an appropriate terminal disclaimer must be filed in at least two of the applications to link all three together. This is because a terminal disclaimer filed to obviate a double patenting rejection is effective only with respect to the application in which the terminal disclaimer is filed; it is not effective to link the other two applications to each other.

VI. WITHDRAWING A RECORDED TERMINAL DISCLAIMER

If timely requested, a recorded terminal disclaimer may be withdrawn before the application in which it is filed issues as a patent, or in a reexamination proceeding, before the reexamination certificate issues. After a patent or reexamination certificate issues, it is unlikely that a recorded terminal disclaimer will be nullified.

A. Before Issuance Of Patent

While the filing and recordation of an unnecessary terminal disclaimer has been characterized as an “unhappy circumstance” in In re Jentoft, 392 F.2d 633, 157 USPQ 363 (CCPA 1968), there is no statutory prohibition against nullifying or otherwise canceling the effect of a recorded terminal disclaimer which was erroneously filed before the patent issues. Since the terminal disclaimer would not take effect until the patent is granted, and the public has not had the opportunity to rely on the terminal disclaimer, relief from this unhappy circumstance may be available by way of petition or by refiling the application (other than by refiling it as a CPA).

Under appropriate circumstances, consistent with the orderly administration of the examination process, the nullification of a recorded terminal disclaimer may be addressed by filing a petition under 37 CFR 1.182 requesting withdrawal of the recorded terminal disclaimer. Petitions seeking to reopen the question of the propriety of the double patenting rejection that prompted the filing of the terminal disclaimer have not been favorably considered. The filing of a continuing application other than a CPA, while abandoning the application in which the terminal disclaimer has been filed, will typically nullify the effect of a terminal disclaimer. The filing of a Request for Continued Examination (RCE) of an application under 37 CFR 1.114 will not nullify the effect of a terminal disclaimer, since a new application has not been filed, but rather prosecution has been continued in the existing application.

B.After Issuance Of Patent

The mechanisms to correct a patent — Certificate of Correction (35 U.S.C. 255), reissue (35 U.S.C. 251), and reexamination (35 U.S.C. 305) — are not available to withdraw or otherwise nullify the effect of a recorded terminal disclaimer. As a general principle, public policy does not favor the restoration to the patent owner of something that has been freely dedicated to the public, particularly where the public interest is not protected in some manner — e.g., intervening rights in the case of a reissue patent. See, e.g., Altoona Publix Theatres v. American Tri-Ergon Corp., 294 U.S. 477, 24 USPQ 308 (1935).

Certificates of Correction (35 U.S.C. 255) are available for the correction of an applicant’s mistake. The scope of this remedial provision is limited in two ways — by the nature of the mistake for which correction is sought and the nature of the proposed correction. In re Arnott, 19 USPQ2d 1049 (Comm’r Pat. 1991). The nature of the mistake for which correction is sought is limited to those mistakes that are:

(A)of a clerical nature,

(B)of a typographical nature, or

(C)of a minor character.

The nature of the proposed correction is limited to those situations where the correction does not involve changes which would:

(A)constitute new matter, or

(B)require reexamination.

A mistake in filing a terminal disclaimer does not fall within any of the categories of mistake for which a certificate of correction of applicant’s mistake is permissible, and any attempt to remove or nullify the effect of the terminal disclaimer would typically require reexamination of the circumstances under which it was filed.

Although the remedial nature of reissue (35 U.S.C. 251) is well recognized, reissue is not available to correct all errors. It has been the Office position that reissue is not available to withdraw or otherwise nullify the effect of a terminal disclaimer recorded in an issued patent. First, the reissue statute only authorizes the Director of the USPTO to reissue a patent “for the unexpired part of the term of the original patent.” Since the granting of a reissue patent without the effect of a recorded terminal disclaimer would result in extending the term of the original patent, reissue under these circumstances would be contrary to the statute. Second, the principle against recapturing something that has been intentionally dedicated to the public dates back to Leggett v. Avery, 101 U.S. 256 (1879). The attempt to restore that portion of the patent term that was dedicated to the public to secure the grant of the original patent would be contrary to this recapture principle. Finally, applicants have the opportunity to challenge the need for a terminal disclaimer during the prosecution of the application that issues as a patent. “Reissue is not a substitute for Patent Office appeal procedures.” Ball Corp. v. United States, 729 F.2d 1429, 1435, 221 USPQ 289, 293 (Fed. Cir. 1984). Where applicants did not challenge the propriety of the examiner’s obvious-type double patenting rejection, but filed a terminal disclaimer to avoid the rejection, the filing of the terminal disclaimer did not constitute error within the meaning of 35 U.S.C. 251. Ex parte Anthony, 230 USPQ 467 (Bd. App. 1982), aff’d, No. 84-1357 (Fed. Cir. June 14, 1985).

Finally, the nullification of a recorded terminal disclaimer would not be appropriate in a reexamination proceeding. There is a prohibition (35 U.S.C. 305) against enlarging the scope of a claim during a reexamination proceeding. As noted by the Board in Anthony, supra, if a terminal disclaimer was nullified, “claims would be able to be sued upon for a longer period than would the claims of the original patent. Therefore, the vertical scope, as opposed to the horizontal scope (where the subject matter is enlarged), would be enlarged.”

← MPEP 1300 ↑ MPEP Table of Contents MPEP 1500 →